{"meta": {"doc_id": 2389, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 393, "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": " The world population is estimated to reach 10 billion people by 2050 sending the food industry on a desperate hunt to find alternative protein sources that are as tasty as they are sustainable. One provider looking to meet this growing demand is a Polish start-up known as NapiFeryn Biotech, which is using rapeseed \u2014 also known as canola \u2014 as a protein source for the plant-based food market."}
{"meta": {"doc_id": 2389, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 701, "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": "The world population is estimated to reach 10 billion people by 2050 sending the food industry on a desperate hunt to find alternative protein sources that are as tasty as they are sustainable. One provider looking to meet this growing demand is a Polish start-up known as NapiFeryn Biotech, which is using rapeseed \u2014 also known as canola \u2014 as a protein source for the plant-based food market. \u201cSo far, there has been no technology capable of extracting protein [from oilseeds] with sufficient quality and yield to make the process economically viable unitl now,\u201d NapiFeryn co-founder and chief technology officer Piotr Wnukowski stated at the Innoveit awards in Budapest, according to Food Navigator."}
{"meta": {"doc_id": 2389, "sent_id": 2, "sent_start_pos": 194, "sent_end_pos": 909, "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": "One provider looking to meet this growing demand is a Polish start-up known as NapiFeryn Biotech, which is using rapeseed \u2014 also known as canola \u2014 as a protein source for the plant-based food market. \u201cSo far, there has been no technology capable of extracting protein [from oilseeds] with sufficient quality and yield to make the process economically viable unitl now,\u201d NapiFeryn co-founder and chief technology officer Piotr Wnukowski stated at the Innoveit awards in Budapest, according to Food Navigator. Through its patented technology, the company has turned the seed of the bright yellow flower into a protein powder known as Raptein by extracting, purifying and isolating pure forms of protein from the seed."}
{"meta": {"doc_id": 2389, "sent_id": 3, "sent_start_pos": 394, "sent_end_pos": 1114, "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": "\u201cSo far, there has been no technology capable of extracting protein [from oilseeds] with sufficient quality and yield to make the process economically viable unitl now,\u201d NapiFeryn co-founder and chief technology officer Piotr Wnukowski stated at the Innoveit awards in Budapest, according to Food Navigator. Through its patented technology, the company has turned the seed of the bright yellow flower into a protein powder known as Raptein by extracting, purifying and isolating pure forms of protein from the seed. Rapeseed contains up to 20 percent protein but its bitter flavor has prohibited it from being commoditized as a nutritious food source for humans, instead limiting its scope to livestock and poultry feed."}
{"meta": {"doc_id": 2389, "sent_id": 4, "sent_start_pos": 702, "sent_end_pos": 1348, "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": "Through its patented technology, the company has turned the seed of the bright yellow flower into a protein powder known as Raptein by extracting, purifying and isolating pure forms of protein from the seed. Rapeseed contains up to 20 percent protein but its bitter flavor has prohibited it from being commoditized as a nutritious food source for humans, instead limiting its scope to livestock and poultry feed. The start-up claims their purification process is the fundamental step in reducing the flower\u2019s bitter flavor, which now allows for the ingredient to be incorporated in everything from shakes, and baked goods to mayonnaise and pasta."}
{"meta": {"doc_id": 2389, "sent_id": 5, "sent_start_pos": 910, "sent_end_pos": 1468, "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": "Rapeseed contains up to 20 percent protein but its bitter flavor has prohibited it from being commoditized as a nutritious food source for humans, instead limiting its scope to livestock and poultry feed. The start-up claims their purification process is the fundamental step in reducing the flower\u2019s bitter flavor, which now allows for the ingredient to be incorporated in everything from shakes, and baked goods to mayonnaise and pasta. The Raptein protein can also absorb fat and water and be used for emulsifying, gelling, and foaming in food processing."}
{"meta": {"doc_id": 2389, "sent_id": 6, "sent_start_pos": 1115, "sent_end_pos": 1777, "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": "The start-up claims their purification process is the fundamental step in reducing the flower\u2019s bitter flavor, which now allows for the ingredient to be incorporated in everything from shakes, and baked goods to mayonnaise and pasta. The Raptein protein can also absorb fat and water and be used for emulsifying, gelling, and foaming in food processing. The phenolic components render this bitter taste, and we are able [with our purification technology] to remove them effectively from the product,\u201d Wnukowski said."}
{"meta": {"doc_id": 2389, "sent_id": 7, "sent_start_pos": 1349, "sent_end_pos": 2056, "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": "The Raptein protein can also absorb fat and water and be used for emulsifying, gelling, and foaming in food processing. The phenolic components render this bitter taste, and we are able [with our purification technology] to remove them effectively from the product,\u201d Wnukowski said. The new approach could foster more growth in the plant-based food industry, which according to Markets and Markets research, is estimated to be worth 18.5 billion this year and is expected to reach 40.6 billion by 2025, increasing at a compound annual growth rate of 14 percent."}
{"meta": {"doc_id": 2389, "sent_id": 8, "sent_start_pos": 1615, "sent_end_pos": 2201, "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": "The phenolic components render this bitter taste, and we are able [with our purification technology] to remove them effectively from the product,\u201d Wnukowski said. The new approach could foster more growth in the plant-based food industry, which according to Markets and Markets research, is estimated to be worth 18.5 billion this year and is expected to reach 40.6 billion by 2025, increasing at a compound annual growth rate of 14 percent. Market growth mostly stems from the younger generation who are known to gravitate towards clean eating and more sustainability-sourced products."}
{"meta": {"doc_id": 2389, "sent_id": 9, "sent_start_pos": 1778, "sent_end_pos": 2460, "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": "The new approach could foster more growth in the plant-based food industry, which according to Markets and Markets research, is estimated to be worth 18.5 billion this year and is expected to reach 40.6 billion by 2025, increasing at a compound annual growth rate of 14 percent. Market growth mostly stems from the younger generation who are known to gravitate towards clean eating and more sustainability-sourced products. For now, soy is currently the most dominant ingredient in the plant-based food segment and is also the staple ingredient found in the Impossible Burger, giving it its famous faux-meat texture, but Wnukowski claims rapeseed could give soy a run for its money."}
{"meta": {"doc_id": 2389, "sent_id": 10, "sent_start_pos": 2057, "sent_end_pos": 2608, "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": "Market growth mostly stems from the younger generation who are known to gravitate towards clean eating and more sustainability-sourced products. For now, soy is currently the most dominant ingredient in the plant-based food segment and is also the staple ingredient found in the Impossible Burger, giving it its famous faux-meat texture, but Wnukowski claims rapeseed could give soy a run for its money. \u201cSoy has dominated the plant-based protein market to the extent that 95 percent of all plant-based proteins \u2014 with the exception of wheat \u2014 is soy."}
{"meta": {"doc_id": 2389, "sent_id": 11, "sent_start_pos": 2202, "sent_end_pos": 2847, "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": "For now, soy is currently the most dominant ingredient in the plant-based food segment and is also the staple ingredient found in the Impossible Burger, giving it its famous faux-meat texture, but Wnukowski claims rapeseed could give soy a run for its money. \u201cSoy has dominated the plant-based protein market to the extent that 95 percent of all plant-based proteins \u2014 with the exception of wheat \u2014 is soy. According to the start-up, rapeseed has more amino acids than soy and doesn\u2019t carry isoflavones, a type of plant estrogen (phytoestrogen) found in soy that can alter the estrogen levels in females."}
{"meta": {"doc_id": 2389, "sent_id": 12, "sent_start_pos": 2461, "sent_end_pos": 2980, "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": "\u201cSoy has dominated the plant-based protein market to the extent that 95 percent of all plant-based proteins \u2014 with the exception of wheat \u2014 is soy. According to the start-up, rapeseed has more amino acids than soy and doesn\u2019t carry isoflavones, a type of plant estrogen (phytoestrogen) found in soy that can alter the estrogen levels in females. As of now, NapiFeryn has no plans to sell Raptein itself, instead hoping to provide its technology to oil producers in the industry."}
{"meta": {"doc_id": 2389, "sent_id": 13, "sent_start_pos": 2650, "sent_end_pos": 3165, "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": "According to the start-up, rapeseed has more amino acids than soy and doesn\u2019t carry isoflavones, a type of plant estrogen (phytoestrogen) found in soy that can alter the estrogen levels in females. As of now, NapiFeryn has no plans to sell Raptein itself, instead hoping to provide its technology to oil producers in the industry. After the rapeseed protein is manufactured, the start-up would then connect the licensed oil producer with a global distributor it has handpicked for them to to sell their product too."}
{"meta": {"doc_id": 2389, "sent_id": 14, "sent_start_pos": 2848, "sent_end_pos": 3295, "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": "As of now, NapiFeryn has no plans to sell Raptein itself, instead hoping to provide its technology to oil producers in the industry. After the rapeseed protein is manufactured, the start-up would then connect the licensed oil producer with a global distributor it has handpicked for them to to sell their product too. Currently, Raptein is still in the early phases of development but consumers can expect it to hit the global food market by 2022."}
{"meta": {"doc_id": 2389, "sent_id": 15, "sent_start_pos": 2981, "sent_end_pos": [], "title": "Biotech Start-Up Claims Rapeseed is the Next Best Plant-Based Protein"}, "text": "After the rapeseed protein is manufactured, the start-up would then connect the licensed oil producer with a global distributor it has handpicked for them to to sell their product too. Currently, Raptein is still in the early phases of development but consumers can expect it to hit the global food market by 2022. "}
{"meta": {"doc_id": 2390, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 302, "title": "Biotech + \"plant based protein\""}, "text": " Start-up develops tech for \u2018Raptein\u2019 extraction\nRapeseed, or canola as it is known in the US and Canada, contains approximately 20% high-quality protein. This is what makes rapeseed cake \u2013 a by-product of rapeseed oil production \u2013 a nutritious feed for livestock."}
{"meta": {"doc_id": 2390, "sent_id": 1, "sent_start_pos": 39, "sent_end_pos": 431, "title": "Biotech + \"plant based protein\""}, "text": "Start-up develops tech for \u2018Raptein\u2019 extraction\nRapeseed, or canola as it is known in the US and Canada, contains approximately 20% high-quality protein. This is what makes rapeseed cake \u2013 a by-product of rapeseed oil production \u2013 a nutritious feed for livestock. However, concerns surrounding food security and the environmental impact of livestock farming is driving a food systems rethink."}
{"meta": {"doc_id": 2390, "sent_id": 2, "sent_start_pos": 193, "sent_end_pos": 579, "title": "Biotech + \"plant based protein\""}, "text": "This is what makes rapeseed cake \u2013 a by-product of rapeseed oil production \u2013 a nutritious feed for livestock. However, concerns surrounding food security and the environmental impact of livestock farming is driving a food systems rethink. If the grain used today as fodder was used to feed humans, for example, an additional 3.5 billion people would receive nutritious plant-based food."}
{"meta": {"doc_id": 2390, "sent_id": 3, "sent_start_pos": 303, "sent_end_pos": 765, "title": "Biotech + \"plant based protein\""}, "text": "However, concerns surrounding food security and the environmental impact of livestock farming is driving a food systems rethink. If the grain used today as fodder was used to feed humans, for example, an additional 3.5 billion people would receive nutritious plant-based food. This is the rationale behind Polish start-up NapiFeryn BioTech, which has developed technology it hopes will reduce food insecurity and encourage increased uptake of plant-based eating."}
{"meta": {"doc_id": 2390, "sent_id": 4, "sent_start_pos": 432, "sent_end_pos": 1029, "title": "Biotech + \"plant based protein\""}, "text": "If the grain used today as fodder was used to feed humans, for example, an additional 3.5 billion people would receive nutritious plant-based food. This is the rationale behind Polish start-up NapiFeryn BioTech, which has developed technology it hopes will reduce food insecurity and encourage increased uptake of plant-based eating. \u201cSo far, there has been no technology capable of extracting protein [from oilseeds] with sufficient quality and yield to make the process economically viable,\u201d explained co-founder and CTO Piotr Wnukowski at the INNOVEIT awards in Budapest this week, \u201cuntil now\u201d."}
{"meta": {"doc_id": 2390, "sent_id": 5, "sent_start_pos": 580, "sent_end_pos": 1197, "title": "Biotech + \"plant based protein\""}, "text": "This is the rationale behind Polish start-up NapiFeryn BioTech, which has developed technology it hopes will reduce food insecurity and encourage increased uptake of plant-based eating. \u201cSo far, there has been no technology capable of extracting protein [from oilseeds] with sufficient quality and yield to make the process economically viable,\u201d explained co-founder and CTO Piotr Wnukowski at the INNOVEIT awards in Budapest this week, \u201cuntil now\u201d. Patented technology removes bitter taste\nNapiFeryn\u2019s technology extracts, purifies, and isolates functional proteins derived from oilseeds for use in food formulation."}
{"meta": {"doc_id": 2390, "sent_id": 6, "sent_start_pos": 766, "sent_end_pos": 1279, "title": "Biotech + \"plant based protein\""}, "text": "\u201cSo far, there has been no technology capable of extracting protein [from oilseeds] with sufficient quality and yield to make the process economically viable,\u201d explained co-founder and CTO Piotr Wnukowski at the INNOVEIT awards in Budapest this week, \u201cuntil now\u201d. Patented technology removes bitter taste\nNapiFeryn\u2019s technology extracts, purifies, and isolates functional proteins derived from oilseeds for use in food formulation. The technology is protected by a \u2018family of patents\u2019, the CTO told FoodNavigator."}
{"meta": {"doc_id": 2390, "sent_id": 7, "sent_start_pos": 1030, "sent_end_pos": 1392, "title": "Biotech + \"plant based protein\""}, "text": "Patented technology removes bitter taste\nNapiFeryn\u2019s technology extracts, purifies, and isolates functional proteins derived from oilseeds for use in food formulation. The technology is protected by a \u2018family of patents\u2019, the CTO told FoodNavigator. \u201cWe have a patent on the extraction process, but also patents on the purification process further on downstream."}
{"meta": {"doc_id": 2390, "sent_id": 8, "sent_start_pos": 1198, "sent_end_pos": 1595, "title": "Biotech + \"plant based protein\""}, "text": "The technology is protected by a \u2018family of patents\u2019, the CTO told FoodNavigator. \u201cWe have a patent on the extraction process, but also patents on the purification process further on downstream. In the end, we are able to obtain protein in pure form.\u201d\nThe start-up\u2019s technology can be applied once oil producers complete a cold, virgin press, which the Wnukowski ensured us was a \u2018gentle process\u2019."}
{"meta": {"doc_id": 2390, "sent_id": 9, "sent_start_pos": 1280, "sent_end_pos": 1704, "title": "Biotech + \"plant based protein\""}, "text": "\u201cWe have a patent on the extraction process, but also patents on the purification process further on downstream. In the end, we are able to obtain protein in pure form.\u201d\nThe start-up\u2019s technology can be applied once oil producers complete a cold, virgin press, which the Wnukowski ensured us was a \u2018gentle process\u2019. The purification process is also integral to NapiFeryn\u2019s technology, given rapeseed\u2019s intense, bitter taste."}
{"meta": {"doc_id": 2390, "sent_id": 10, "sent_start_pos": 1393, "sent_end_pos": 1861, "title": "Biotech + \"plant based protein\""}, "text": "In the end, we are able to obtain protein in pure form.\u201d\nThe start-up\u2019s technology can be applied once oil producers complete a cold, virgin press, which the Wnukowski ensured us was a \u2018gentle process\u2019. The purification process is also integral to NapiFeryn\u2019s technology, given rapeseed\u2019s intense, bitter taste. It is this unpalatable element of rapeseed that has previously deterred industry from employing the rapeseed cake by-product in foods for human consumption."}
{"meta": {"doc_id": 2390, "sent_id": 11, "sent_start_pos": 1596, "sent_end_pos": 1930, "title": "Biotech + \"plant based protein\""}, "text": "The purification process is also integral to NapiFeryn\u2019s technology, given rapeseed\u2019s intense, bitter taste. It is this unpalatable element of rapeseed that has previously deterred industry from employing the rapeseed cake by-product in foods for human consumption. \u201cThis is our second trick, and our second patent,\u201d the CTO revealed."}
{"meta": {"doc_id": 2390, "sent_id": 12, "sent_start_pos": 1705, "sent_end_pos": 2002, "title": "Biotech + \"plant based protein\""}, "text": "It is this unpalatable element of rapeseed that has previously deterred industry from employing the rapeseed cake by-product in foods for human consumption. \u201cThis is our second trick, and our second patent,\u201d the CTO revealed. \u201cWe are able to purify protein from so-called anti-nutritional factors."}
{"meta": {"doc_id": 2390, "sent_id": 13, "sent_start_pos": 1862, "sent_end_pos": 2076, "title": "Biotech + \"plant based protein\""}, "text": "\u201cThis is our second trick, and our second patent,\u201d the CTO revealed. \u201cWe are able to purify protein from so-called anti-nutritional factors. There are two families of them: phytic components and phenolic compounds."}
{"meta": {"doc_id": 2390, "sent_id": 14, "sent_start_pos": 1931, "sent_end_pos": 2240, "title": "Biotech + \"plant based protein\""}, "text": "\u201cWe are able to purify protein from so-called anti-nutritional factors. There are two families of them: phytic components and phenolic compounds. And we are able [with our purification technology] to remove them effectively from the product.\u201d\nBetter than soy?"}
{"meta": {"doc_id": 2390, "sent_id": 15, "sent_start_pos": 2003, "sent_end_pos": 2393, "title": "Biotech + \"plant based protein\""}, "text": "There are two families of them: phytic components and phenolic compounds. And we are able [with our purification technology] to remove them effectively from the product.\u201d\nBetter than soy? The start-up claims the rapeseed protein, which it has named \u2018Raptein\u2019, could unhinge soy\u2019s dominance in the plant-based space for a variety of reasons."}
{"meta": {"doc_id": 2390, "sent_id": 16, "sent_start_pos": 2127, "sent_end_pos": 2483, "title": "Biotech + \"plant based protein\""}, "text": "And we are able [with our purification technology] to remove them effectively from the product.\u201d\nBetter than soy? The start-up claims the rapeseed protein, which it has named \u2018Raptein\u2019, could unhinge soy\u2019s dominance in the plant-based space for a variety of reasons. Raptein production, for example, does not require the use of the chemical solvent hexane."}
{"meta": {"doc_id": 2390, "sent_id": 17, "sent_start_pos": 2241, "sent_end_pos": 2577, "title": "Biotech + \"plant based protein\""}, "text": "The start-up claims the rapeseed protein, which it has named \u2018Raptein\u2019, could unhinge soy\u2019s dominance in the plant-based space for a variety of reasons. Raptein production, for example, does not require the use of the chemical solvent hexane. \u201cToday, industry is using hexane and other harsh chemicals to extract edible oils from seeds."}
{"meta": {"doc_id": 2390, "sent_id": 18, "sent_start_pos": 2394, "sent_end_pos": 2697, "title": "Biotech + \"plant based protein\""}, "text": "Raptein production, for example, does not require the use of the chemical solvent hexane. \u201cToday, industry is using hexane and other harsh chemicals to extract edible oils from seeds. All [soy] protein isolates have seen hexane in the production process,\u201d said Wnukowski."}
{"meta": {"doc_id": 2390, "sent_id": 19, "sent_start_pos": 2484, "sent_end_pos": 2838, "title": "Biotech + \"plant based protein\""}, "text": "\u201cToday, industry is using hexane and other harsh chemicals to extract edible oils from seeds. All [soy] protein isolates have seen hexane in the production process,\u201d said Wnukowski. \u201cSoy has dominated the plant-based protein market to the extent that 95% of all plant-based proteins \u2013 with the exception of wheat \u2013 is soy."}
{"meta": {"doc_id": 2390, "sent_id": 20, "sent_start_pos": 2610, "sent_end_pos": 3073, "title": "Biotech + \"plant based protein\""}, "text": "All [soy] protein isolates have seen hexane in the production process,\u201d said Wnukowski. \u201cSoy has dominated the plant-based protein market to the extent that 95% of all plant-based proteins \u2013 with the exception of wheat \u2013 is soy. But rapeseed\u2026is even better.\u201d\nThe start-up claims that rapeseed contains higher levels of certain amino acids than soy and is devoid of phytoestrogens \u2013 or isoflavones as they are known in soy \u2013 which have a weak estrogen-like action."}
{"meta": {"doc_id": 2390, "sent_id": 21, "sent_start_pos": 2698, "sent_end_pos": 3151, "title": "Biotech + \"plant based protein\""}, "text": "\u201cSoy has dominated the plant-based protein market to the extent that 95% of all plant-based proteins \u2013 with the exception of wheat \u2013 is soy. But rapeseed\u2026is even better.\u201d\nThe start-up claims that rapeseed contains higher levels of certain amino acids than soy and is devoid of phytoestrogens \u2013 or isoflavones as they are known in soy \u2013 which have a weak estrogen-like action. These active substances are suspected of disrupting females\u2019 hormone systems."}
{"meta": {"doc_id": 2390, "sent_id": 22, "sent_start_pos": 2839, "sent_end_pos": 3295, "title": "Biotech + \"plant based protein\""}, "text": "But rapeseed\u2026is even better.\u201d\nThe start-up claims that rapeseed contains higher levels of certain amino acids than soy and is devoid of phytoestrogens \u2013 or isoflavones as they are known in soy \u2013 which have a weak estrogen-like action. These active substances are suspected of disrupting females\u2019 hormone systems. An EIT RisingFoodStar\nNapiFeryn BioTech is a member of the European Institute of Innovation and Technology (EIT)\u2019s RisingFoodStars Association."}
{"meta": {"doc_id": 2390, "sent_id": 23, "sent_start_pos": 3074, "sent_end_pos": 3418, "title": "Biotech + \"plant based protein\""}, "text": "These active substances are suspected of disrupting females\u2019 hormone systems. An EIT RisingFoodStar\nNapiFeryn BioTech is a member of the European Institute of Innovation and Technology (EIT)\u2019s RisingFoodStars Association. EIT Food is a pan-European consortium funded by the EU that focuses on entrepreneurship and innovation in the food sector."}
{"meta": {"doc_id": 2390, "sent_id": 24, "sent_start_pos": 3152, "sent_end_pos": 3565, "title": "Biotech + \"plant based protein\""}, "text": "An EIT RisingFoodStar\nNapiFeryn BioTech is a member of the European Institute of Innovation and Technology (EIT)\u2019s RisingFoodStars Association. EIT Food is a pan-European consortium funded by the EU that focuses on entrepreneurship and innovation in the food sector. \u201cWe are elected as a rising star of EIT Food and are very happy to be affiliated with EIT,\u201d co-founder and CTO Piotr Wnukowski told FoodNavigator."}
{"meta": {"doc_id": 2390, "sent_id": 25, "sent_start_pos": 3296, "sent_end_pos": 3750, "title": "Biotech + \"plant based protein\""}, "text": "EIT Food is a pan-European consortium funded by the EU that focuses on entrepreneurship and innovation in the food sector. \u201cWe are elected as a rising star of EIT Food and are very happy to be affiliated with EIT,\u201d co-founder and CTO Piotr Wnukowski told FoodNavigator. \u201cIt gives us a very good opportunity to connect with innovative food companies and investors.\u201d\nThe protein can be used in a wide variety of applications, the CTO told this publication."}
{"meta": {"doc_id": 2390, "sent_id": 26, "sent_start_pos": 3419, "sent_end_pos": 3846, "title": "Biotech + \"plant based protein\""}, "text": "\u201cWe are elected as a rising star of EIT Food and are very happy to be affiliated with EIT,\u201d co-founder and CTO Piotr Wnukowski told FoodNavigator. \u201cIt gives us a very good opportunity to connect with innovative food companies and investors.\u201d\nThe protein can be used in a wide variety of applications, the CTO told this publication. \u201cIt is soluble, it has good emulsifying properties, gelling properties, and foaming properties."}
{"meta": {"doc_id": 2390, "sent_id": 27, "sent_start_pos": 3566, "sent_end_pos": 4153, "title": "Biotech + \"plant based protein\""}, "text": "\u201cIt gives us a very good opportunity to connect with innovative food companies and investors.\u201d\nThe protein can be used in a wide variety of applications, the CTO told this publication. \u201cIt is soluble, it has good emulsifying properties, gelling properties, and foaming properties. It absorbs fat and water, and you can use it in shakes, beverages, ice cream, bakery, pancakes, pasta, salsas, mayonnaise, meat extenders, you name it.\u201d\nMonetisation strategy\nNapiFeryn is currently in the pre-commercialisation phase, delivering sample quantities to the food industry from a pilot facility."}
{"meta": {"doc_id": 2390, "sent_id": 28, "sent_start_pos": 3751, "sent_end_pos": 4261, "title": "Biotech + \"plant based protein\""}, "text": "\u201cIt is soluble, it has good emulsifying properties, gelling properties, and foaming properties. It absorbs fat and water, and you can use it in shakes, beverages, ice cream, bakery, pancakes, pasta, salsas, mayonnaise, meat extenders, you name it.\u201d\nMonetisation strategy\nNapiFeryn is currently in the pre-commercialisation phase, delivering sample quantities to the food industry from a pilot facility. The start-up will not, however, be selling Raptein itself."}
{"meta": {"doc_id": 2390, "sent_id": 29, "sent_start_pos": 3847, "sent_end_pos": 4380, "title": "Biotech + \"plant based protein\""}, "text": "It absorbs fat and water, and you can use it in shakes, beverages, ice cream, bakery, pancakes, pasta, salsas, mayonnaise, meat extenders, you name it.\u201d\nMonetisation strategy\nNapiFeryn is currently in the pre-commercialisation phase, delivering sample quantities to the food industry from a pilot facility. The start-up will not, however, be selling Raptein itself. Rather, NapiFeryn plans to license its technology to oil producers, who will manufacture the food additive themselves."}
{"meta": {"doc_id": 2390, "sent_id": 30, "sent_start_pos": 4203, "sent_end_pos": 4545, "title": "Biotech + \"plant based protein\""}, "text": "The start-up will not, however, be selling Raptein itself. Rather, NapiFeryn plans to license its technology to oil producers, who will manufacture the food additive themselves. From there, the oil producer will sell Raptein to a global distributor \u2013 which has been selected by NapiFeryn \u2013 who will sell on to food and beverage manufacturers."}
{"meta": {"doc_id": 2390, "sent_id": 31, "sent_start_pos": 4262, "sent_end_pos": 4684, "title": "Biotech + \"plant based protein\""}, "text": "Rather, NapiFeryn plans to license its technology to oil producers, who will manufacture the food additive themselves. From there, the oil producer will sell Raptein to a global distributor \u2013 which has been selected by NapiFeryn \u2013 who will sell on to food and beverage manufacturers. This means that only oil producers that agree to sell to NapiFeryn\u2019s chosen \u2018go-to-market\u2019 partner will be able to license the technology."}
{"meta": {"doc_id": 2390, "sent_id": 32, "sent_start_pos": 4381, "sent_end_pos": 4755, "title": "Biotech + \"plant based protein\""}, "text": "From there, the oil producer will sell Raptein to a global distributor \u2013 which has been selected by NapiFeryn \u2013 who will sell on to food and beverage manufacturers. This means that only oil producers that agree to sell to NapiFeryn\u2019s chosen \u2018go-to-market\u2019 partner will be able to license the technology. The CTO could not yet disclose which distributor NapiFeryn had chosen."}
{"meta": {"doc_id": 2390, "sent_id": 33, "sent_start_pos": 4546, "sent_end_pos": 4922, "title": "Biotech + \"plant based protein\""}, "text": "This means that only oil producers that agree to sell to NapiFeryn\u2019s chosen \u2018go-to-market\u2019 partner will be able to license the technology. The CTO could not yet disclose which distributor NapiFeryn had chosen. \u201cWe are still in the process of selecting the best partner to go to market,\u201d he told FoodNavigator, but confirmed that the start-up is seeking a single global player."}
{"meta": {"doc_id": 2390, "sent_id": 34, "sent_start_pos": 4685, "sent_end_pos": 5024, "title": "Biotech + \"plant based protein\""}, "text": "The CTO could not yet disclose which distributor NapiFeryn had chosen. \u201cWe are still in the process of selecting the best partner to go to market,\u201d he told FoodNavigator, but confirmed that the start-up is seeking a single global player. \u201cRapeseed is the major oilseed crop in Europe and Europe is the world\u2019s largest producer of rapeseed."}
{"meta": {"doc_id": 2390, "sent_id": 35, "sent_start_pos": 4756, "sent_end_pos": 5164, "title": "Biotech + \"plant based protein\""}, "text": "\u201cWe are still in the process of selecting the best partner to go to market,\u201d he told FoodNavigator, but confirmed that the start-up is seeking a single global player. \u201cRapeseed is the major oilseed crop in Europe and Europe is the world\u2019s largest producer of rapeseed. So we aim to land our technology via licensing agreements in all these parts of the world.\u201d"}
{"meta": {"doc_id": 2390, "sent_id": 36, "sent_start_pos": 4923, "sent_end_pos": [], "title": "Biotech + \"plant based protein\""}, "text": "\u201cRapeseed is the major oilseed crop in Europe and Europe is the world\u2019s largest producer of rapeseed. So we aim to land our technology via licensing agreements in all these parts of the world.\u201d "}
{"meta": {"doc_id": 2392, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 26, "title": "THE FUTURE OF FOOD IS NOW"}, "text": " THE FUTURE OF\nFOOD IS NOW. FOOD IS NOW."}
{"meta": {"doc_id": 2392, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 85, "title": "THE FUTURE OF FOOD IS NOW"}, "text": "THE FUTURE OF\nFOOD IS NOW. FOOD IS NOW. LATEST NEWS & ANNOUNCEMENTS\nFOOD for thought."}
{"meta": {"doc_id": 2392, "sent_id": 2, "sent_start_pos": 14, "sent_end_pos": 139, "title": "THE FUTURE OF FOOD IS NOW"}, "text": "FOOD IS NOW. LATEST NEWS & ANNOUNCEMENTS\nFOOD for thought. Did you know that protein can be derived from plants?"}
{"meta": {"doc_id": 2392, "sent_id": 3, "sent_start_pos": 40, "sent_end_pos": 238, "title": "THE FUTURE OF FOOD IS NOW"}, "text": "LATEST NEWS & ANNOUNCEMENTS\nFOOD for thought. Did you know that protein can be derived from plants? Be-leaf it or not, plant proteins can be used in many forms and in a wide variety of applications!"}
{"meta": {"doc_id": 2392, "sent_id": 4, "sent_start_pos": 86, "sent_end_pos": 260, "title": "THE FUTURE OF FOOD IS NOW"}, "text": "Did you know that protein can be derived from plants? Be-leaf it or not, plant proteins can be used in many forms and in a wide variety of applications! Want to find out how?"}
{"meta": {"doc_id": 2392, "sent_id": 5, "sent_start_pos": 140, "sent_end_pos": 279, "title": "THE FUTURE OF FOOD IS NOW"}, "text": "Be-leaf it or not, plant proteins can be used in many forms and in a wide variety of applications! Want to find out how? Cream of the CROP."}
{"meta": {"doc_id": 2392, "sent_id": 6, "sent_start_pos": 239, "sent_end_pos": 425, "title": "THE FUTURE OF FOOD IS NOW"}, "text": "Want to find out how? Cream of the CROP. At Life3, we work tirelessly to develop novel solutions for sustainable and functional plant-based foods that are not only nutritious, but tasty!"}
{"meta": {"doc_id": 2392, "sent_id": 7, "sent_start_pos": 261, "sent_end_pos": 496, "title": "THE FUTURE OF FOOD IS NOW"}, "text": "Cream of the CROP. At Life3, we work tirelessly to develop novel solutions for sustainable and functional plant-based foods that are not only nutritious, but tasty! It\u2019s not rocket science but sometimes our ideas are out of this world!"}
{"meta": {"doc_id": 2392, "sent_id": 8, "sent_start_pos": 280, "sent_end_pos": 517, "title": "THE FUTURE OF FOOD IS NOW"}, "text": "At Life3, we work tirelessly to develop novel solutions for sustainable and functional plant-based foods that are not only nutritious, but tasty! It\u2019s not rocket science but sometimes our ideas are out of this world! SAVOUR the solution."}
{"meta": {"doc_id": 2392, "sent_id": 9, "sent_start_pos": 426, "sent_end_pos": 628, "title": "THE FUTURE OF FOOD IS NOW"}, "text": "It\u2019s not rocket science but sometimes our ideas are out of this world! SAVOUR the solution. Now more than ever, it is crucial to have access to nutritious and sustainable sources of food."}
{"meta": {"doc_id": 2392, "sent_id": 10, "sent_start_pos": 497, "sent_end_pos": 741, "title": "THE FUTURE OF FOOD IS NOW"}, "text": "SAVOUR the solution. Now more than ever, it is crucial to have access to nutritious and sustainable sources of food. The world faces rapid population growth and deterioration from decades of unsustainable food production methods."}
{"meta": {"doc_id": 2392, "sent_id": 11, "sent_start_pos": 533, "sent_end_pos": 874, "title": "THE FUTURE OF FOOD IS NOW"}, "text": "Now more than ever, it is crucial to have access to nutritious and sustainable sources of food. The world faces rapid population growth and deterioration from decades of unsustainable food production methods. But Life3 solutions aim to enable present and future generations to lead healthy lives, while supporting the health of Mother Earth."}
{"meta": {"doc_id": 2392, "sent_id": 12, "sent_start_pos": 629, "sent_end_pos": [], "title": "THE FUTURE OF FOOD IS NOW"}, "text": "The world faces rapid population growth and deterioration from decades of unsustainable food production methods. But Life3 solutions aim to enable present and future generations to lead healthy lives, while supporting the health of Mother Earth. "}
{"meta": {"doc_id": 2393, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 759, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": " August 26, 2019\nAgFunder News reports:\nPowerPlant Ventures, a private equity firm dedicated to investing in emerging plant-based food and beverage companies, and backer of some of the leading brands in the category, including Beyond Meat, Ripple Nutrition, and Thrive Market, announced it has closed its second fund - PPV Fund II, at $165 million. Founded in Los Angeles in 2015, PowerPlant is led by an impressive team of founders: Mark Rampolla, the founder of ZICO Beverages, a coconut water pioneer that was acquired by The Coca Cola Company in 2013; Kevin Boylan and TK Pillan, co-founders of Veggie Grill, the largest plant-centric restaurant company in the US; and Dan Gluck, co-founder of Health Warrior, a superfood brand acquired by PepsiCo in 2018."}
{"meta": {"doc_id": 2393, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 1248, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "August 26, 2019\nAgFunder News reports:\nPowerPlant Ventures, a private equity firm dedicated to investing in emerging plant-based food and beverage companies, and backer of some of the leading brands in the category, including Beyond Meat, Ripple Nutrition, and Thrive Market, announced it has closed its second fund - PPV Fund II, at $165 million. Founded in Los Angeles in 2015, PowerPlant is led by an impressive team of founders: Mark Rampolla, the founder of ZICO Beverages, a coconut water pioneer that was acquired by The Coca Cola Company in 2013; Kevin Boylan and TK Pillan, co-founders of Veggie Grill, the largest plant-centric restaurant company in the US; and Dan Gluck, co-founder of Health Warrior, a superfood brand acquired by PepsiCo in 2018. In 2016 the firm announced the close of its first fund at $42 million, with a portfolio at the time that included Hail Merry - a vegan, gluten-free, dairy-free, non-GMO snack company; REBBL - a plant-based protein drink company; Thrive Market - an online gluten-free, non-gmo, non-toxic, vegan marketplace; Terravia - a biotech company; Hampton Creek - a plant-based food company; Treasure8 - a food innovation and technology company; and Juicero - an organic, cold-pressed juice company."}
{"meta": {"doc_id": 2393, "sent_id": 2, "sent_start_pos": 348, "sent_end_pos": 1628, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "Founded in Los Angeles in 2015, PowerPlant is led by an impressive team of founders: Mark Rampolla, the founder of ZICO Beverages, a coconut water pioneer that was acquired by The Coca Cola Company in 2013; Kevin Boylan and TK Pillan, co-founders of Veggie Grill, the largest plant-centric restaurant company in the US; and Dan Gluck, co-founder of Health Warrior, a superfood brand acquired by PepsiCo in 2018. In 2016 the firm announced the close of its first fund at $42 million, with a portfolio at the time that included Hail Merry - a vegan, gluten-free, dairy-free, non-GMO snack company; REBBL - a plant-based protein drink company; Thrive Market - an online gluten-free, non-gmo, non-toxic, vegan marketplace; Terravia - a biotech company; Hampton Creek - a plant-based food company; Treasure8 - a food innovation and technology company; and Juicero - an organic, cold-pressed juice company. Plant-based proteins have possibly been the most prominent narrative within the food sector in recent years, leading the plant-based food sector to be one of the fastest growing and dynamic spaces within the investment universe - evidenced by PPV Fund II closing at more than three times its predecessor, and exceeding its original target of $100 million by more than 50 percent."}
{"meta": {"doc_id": 2393, "sent_id": 3, "sent_start_pos": 760, "sent_end_pos": 1806, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "In 2016 the firm announced the close of its first fund at $42 million, with a portfolio at the time that included Hail Merry - a vegan, gluten-free, dairy-free, non-GMO snack company; REBBL - a plant-based protein drink company; Thrive Market - an online gluten-free, non-gmo, non-toxic, vegan marketplace; Terravia - a biotech company; Hampton Creek - a plant-based food company; Treasure8 - a food innovation and technology company; and Juicero - an organic, cold-pressed juice company. Plant-based proteins have possibly been the most prominent narrative within the food sector in recent years, leading the plant-based food sector to be one of the fastest growing and dynamic spaces within the investment universe - evidenced by PPV Fund II closing at more than three times its predecessor, and exceeding its original target of $100 million by more than 50 percent. The team plans to either lead or co-lead Series A or B rounds - investment stages for early-stage food startups that PowerPlant sees as lacking capital, according to Crunchbase."}
{"meta": {"doc_id": 2393, "sent_id": 4, "sent_start_pos": 1249, "sent_end_pos": 1924, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "Plant-based proteins have possibly been the most prominent narrative within the food sector in recent years, leading the plant-based food sector to be one of the fastest growing and dynamic spaces within the investment universe - evidenced by PPV Fund II closing at more than three times its predecessor, and exceeding its original target of $100 million by more than 50 percent. The team plans to either lead or co-lead Series A or B rounds - investment stages for early-stage food startups that PowerPlant sees as lacking capital, according to Crunchbase. Each investment will be between $4 million and $8 million per deal, with capital held back for follow-on investments."}
{"meta": {"doc_id": 2393, "sent_id": 5, "sent_start_pos": 1629, "sent_end_pos": 1981, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "The team plans to either lead or co-lead Series A or B rounds - investment stages for early-stage food startups that PowerPlant sees as lacking capital, according to Crunchbase. Each investment will be between $4 million and $8 million per deal, with capital held back for follow-on investments. \"We are in the early innings of a major food revolution."}
{"meta": {"doc_id": 2393, "sent_id": 6, "sent_start_pos": 1807, "sent_end_pos": 2115, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "Each investment will be between $4 million and $8 million per deal, with capital held back for follow-on investments. \"We are in the early innings of a major food revolution. Upstart insurgent brands are responding to changing consumer demands at a much faster pace than the major incumbents,\" said Rampolla."}
{"meta": {"doc_id": 2393, "sent_id": 7, "sent_start_pos": 1925, "sent_end_pos": 2217, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "\"We are in the early innings of a major food revolution. Upstart insurgent brands are responding to changing consumer demands at a much faster pace than the major incumbents,\" said Rampolla. \"As a result, they have been capturing a significant share of the growth in the sector,\" added Gluck."}
{"meta": {"doc_id": 2393, "sent_id": 8, "sent_start_pos": 1982, "sent_end_pos": 2620, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "Upstart insurgent brands are responding to changing consumer demands at a much faster pace than the major incumbents,\" said Rampolla. \"As a result, they have been capturing a significant share of the growth in the sector,\" added Gluck. With a mission to build a better food system through the provision of capital and expertise to innovative and visionary entrepreneurs at the nexus of plant-based food and technology, PPV Fund II has already completed two investments in Vive Organic, a leader in the wellness and functional shots category, and Your Super, a producer of functional superfood mixes, and DTC plant-based nutrition company."}
{"meta": {"doc_id": 2393, "sent_id": 9, "sent_start_pos": 2116, "sent_end_pos": 2670, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "\"As a result, they have been capturing a significant share of the growth in the sector,\" added Gluck. With a mission to build a better food system through the provision of capital and expertise to innovative and visionary entrepreneurs at the nexus of plant-based food and technology, PPV Fund II has already completed two investments in Vive Organic, a leader in the wellness and functional shots category, and Your Super, a producer of functional superfood mixes, and DTC plant-based nutrition company. Demand for plant-based protein continues to rise."}
{"meta": {"doc_id": 2393, "sent_id": 10, "sent_start_pos": 2218, "sent_end_pos": 3050, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "With a mission to build a better food system through the provision of capital and expertise to innovative and visionary entrepreneurs at the nexus of plant-based food and technology, PPV Fund II has already completed two investments in Vive Organic, a leader in the wellness and functional shots category, and Your Super, a producer of functional superfood mixes, and DTC plant-based nutrition company. Demand for plant-based protein continues to rise. Between 2013 and 2017 launches of vegan-focused food and beverage startups saw average annual growth exceeding 45 percent, according to Innova Market Insights, and shipments of plant-based products to food service distributors to retailers and operators increased by 20 percent in the twelve months ending November 2018, compared to the previous year, according to the NPD Group."}
{"meta": {"doc_id": 2393, "sent_id": 11, "sent_start_pos": 2621, "sent_end_pos": 3252, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "Demand for plant-based protein continues to rise. Between 2013 and 2017 launches of vegan-focused food and beverage startups saw average annual growth exceeding 45 percent, according to Innova Market Insights, and shipments of plant-based products to food service distributors to retailers and operators increased by 20 percent in the twelve months ending November 2018, compared to the previous year, according to the NPD Group. Today, a full 25 percent of US consumers say they eat and drink plant-based foods for a variety of reasons, ranging from dietary and health reasons, to concerns over animal welfare and the environment."}
{"meta": {"doc_id": 2393, "sent_id": 12, "sent_start_pos": 2671, "sent_end_pos": 3571, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "Between 2013 and 2017 launches of vegan-focused food and beverage startups saw average annual growth exceeding 45 percent, according to Innova Market Insights, and shipments of plant-based products to food service distributors to retailers and operators increased by 20 percent in the twelve months ending November 2018, compared to the previous year, according to the NPD Group. Today, a full 25 percent of US consumers say they eat and drink plant-based foods for a variety of reasons, ranging from dietary and health reasons, to concerns over animal welfare and the environment. This shift toward animal-free eating has even sparked the opening of the Center for Plant-based Living (CPBL) in St. Louis, Missouri, the first completely plant-based culinary and nutrition education center in the US\n\"This is a natural progression of the business, CPBL founder Caryn Dugan told Food Ingredients First."}
{"meta": {"doc_id": 2393, "sent_id": 13, "sent_start_pos": 3051, "sent_end_pos": 3654, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "Today, a full 25 percent of US consumers say they eat and drink plant-based foods for a variety of reasons, ranging from dietary and health reasons, to concerns over animal welfare and the environment. This shift toward animal-free eating has even sparked the opening of the Center for Plant-based Living (CPBL) in St. Louis, Missouri, the first completely plant-based culinary and nutrition education center in the US\n\"This is a natural progression of the business, CPBL founder Caryn Dugan told Food Ingredients First. \"Over the years, I have watched this plant-based movement gain strength and speed."}
{"meta": {"doc_id": 2393, "sent_id": 14, "sent_start_pos": 3253, "sent_end_pos": 3812, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "This shift toward animal-free eating has even sparked the opening of the Center for Plant-based Living (CPBL) in St. Louis, Missouri, the first completely plant-based culinary and nutrition education center in the US\n\"This is a natural progression of the business, CPBL founder Caryn Dugan told Food Ingredients First. \"Over the years, I have watched this plant-based movement gain strength and speed. People are hungry for a place to go where they can always get reputable information and gain the skills they need to start adding more plants to their plate."}
{"meta": {"doc_id": 2393, "sent_id": 15, "sent_start_pos": 3572, "sent_end_pos": 3893, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "\"Over the years, I have watched this plant-based movement gain strength and speed. People are hungry for a place to go where they can always get reputable information and gain the skills they need to start adding more plants to their plate. They also need support - oftentimes the missing key component that halts change."}
{"meta": {"doc_id": 2393, "sent_id": 16, "sent_start_pos": 3655, "sent_end_pos": 3923, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "People are hungry for a place to go where they can always get reputable information and gain the skills they need to start adding more plants to their plate. They also need support - oftentimes the missing key component that halts change. CPBL will offer all of this.\""}
{"meta": {"doc_id": 2393, "sent_id": 17, "sent_start_pos": 3813, "sent_end_pos": 4101, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "They also need support - oftentimes the missing key component that halts change. CPBL will offer all of this.\" All of this rapid change - not only toward plant-based diets, but consumers also being more engaged in their food and its supply chains, has created a space ripe for investment."}
{"meta": {"doc_id": 2393, "sent_id": 18, "sent_start_pos": 3894, "sent_end_pos": 4193, "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "CPBL will offer all of this.\" All of this rapid change - not only toward plant-based diets, but consumers also being more engaged in their food and its supply chains, has created a space ripe for investment. \"We are capitalizing on the $5 trillion global food sector amidst disruption,\" said Boylan."}
{"meta": {"doc_id": 2393, "sent_id": 19, "sent_start_pos": 3924, "sent_end_pos": [], "title": "Investors Show Strong Interest in Plant-Based Protein"}, "text": "All of this rapid change - not only toward plant-based diets, but consumers also being more engaged in their food and its supply chains, has created a space ripe for investment. \"We are capitalizing on the $5 trillion global food sector amidst disruption,\" said Boylan. "}
{"meta": {"doc_id": 2394, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 296, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": " Will a meatless food industry featuring lab-grown meat, seafood substitutes, and insect protein be the future of food? As Covid-19 upends the traditional meat supply chain, food giants and startups alike are working to navigate a future where protein isn't dominated by conventional meat sources."}
{"meta": {"doc_id": 2394, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 458, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Will a meatless food industry featuring lab-grown meat, seafood substitutes, and insect protein be the future of food? As Covid-19 upends the traditional meat supply chain, food giants and startups alike are working to navigate a future where protein isn't dominated by conventional meat sources. By some estimates, 30% of the calories consumed globally by humans come from meat products, including beef, chicken, and pork."}
{"meta": {"doc_id": 2394, "sent_id": 2, "sent_start_pos": 119, "sent_end_pos": 576, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "As Covid-19 upends the traditional meat supply chain, food giants and startups alike are working to navigate a future where protein isn't dominated by conventional meat sources. By some estimates, 30% of the calories consumed globally by humans come from meat products, including beef, chicken, and pork. The global meat market could be worth as much as $2.7T by 2040, according to CB Insights\u2019 Industry Analyst Consensus."}
{"meta": {"doc_id": 2394, "sent_id": 3, "sent_start_pos": 332, "sent_end_pos": 730, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "By some estimates, 30% of the calories consumed globally by humans come from meat products, including beef, chicken, and pork. The global meat market could be worth as much as $2.7T by 2040, according to CB Insights\u2019 Industry Analyst Consensus. Americans consumed a near-record 220 pounds of red meat and poultry per capita in 2018 \u2014 in 1960, that figure was just 167 pounds, according to the USDA."}
{"meta": {"doc_id": 2394, "sent_id": 4, "sent_start_pos": 459, "sent_end_pos": 977, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The global meat market could be worth as much as $2.7T by 2040, according to CB Insights\u2019 Industry Analyst Consensus. Americans consumed a near-record 220 pounds of red meat and poultry per capita in 2018 \u2014 in 1960, that figure was just 167 pounds, according to the USDA. To meet this growing demand, the meat industry has evolved into a complex global business that involves farms and feed lots, as well as meat middle-men, like processing and storage centers, transportation and logistics, slaughterhouses, and more."}
{"meta": {"doc_id": 2394, "sent_id": 5, "sent_start_pos": 577, "sent_end_pos": 1110, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Americans consumed a near-record 220 pounds of red meat and poultry per capita in 2018 \u2014 in 1960, that figure was just 167 pounds, according to the USDA. To meet this growing demand, the meat industry has evolved into a complex global business that involves farms and feed lots, as well as meat middle-men, like processing and storage centers, transportation and logistics, slaughterhouses, and more. In the US, just 4 producers \u2014 Tyson Foods, JBS, Cargill, and National Beef \u2014 control more than two-thirds of all US beef processing."}
{"meta": {"doc_id": 2394, "sent_id": 6, "sent_start_pos": 731, "sent_end_pos": 1317, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "To meet this growing demand, the meat industry has evolved into a complex global business that involves farms and feed lots, as well as meat middle-men, like processing and storage centers, transportation and logistics, slaughterhouses, and more. In the US, just 4 producers \u2014 Tyson Foods, JBS, Cargill, and National Beef \u2014 control more than two-thirds of all US beef processing. But as Covid-19 spreads across the globe, shifting consumer behavior and virus outbreaks in factories dealt major blows to the meat supply chain, which is estimated to face losses of more than $20B in 2020."}
{"meta": {"doc_id": 2394, "sent_id": 7, "sent_start_pos": 978, "sent_end_pos": 1526, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In the US, just 4 producers \u2014 Tyson Foods, JBS, Cargill, and National Beef \u2014 control more than two-thirds of all US beef processing. But as Covid-19 spreads across the globe, shifting consumer behavior and virus outbreaks in factories dealt major blows to the meat supply chain, which is estimated to face losses of more than $20B in 2020. Source: Bloomberg\nIn contrast, startups focusing on plant-based protein \u2014 including Plantible Foods, Rebellyous Foods, Livekindly, and InnovoPro\u2014 have continued securing millions in funding amid the pandemic."}
{"meta": {"doc_id": 2394, "sent_id": 8, "sent_start_pos": 1111, "sent_end_pos": 1625, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "But as Covid-19 spreads across the globe, shifting consumer behavior and virus outbreaks in factories dealt major blows to the meat supply chain, which is estimated to face losses of more than $20B in 2020. Source: Bloomberg\nIn contrast, startups focusing on plant-based protein \u2014 including Plantible Foods, Rebellyous Foods, Livekindly, and InnovoPro\u2014 have continued securing millions in funding amid the pandemic. Demand for vegan meat soared, with sales up by a staggering 264% in the 9 weeks ended May 2, 2020."}
{"meta": {"doc_id": 2394, "sent_id": 9, "sent_start_pos": 1318, "sent_end_pos": 1779, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Source: Bloomberg\nIn contrast, startups focusing on plant-based protein \u2014 including Plantible Foods, Rebellyous Foods, Livekindly, and InnovoPro\u2014 have continued securing millions in funding amid the pandemic. Demand for vegan meat soared, with sales up by a staggering 264% in the 9 weeks ended May 2, 2020. Going forward, the meat value chain could be simplified dramatically, as \u201cclean meat\u201d labs could take the place of farms, feed lots, and slaughterhouses."}
{"meta": {"doc_id": 2394, "sent_id": 10, "sent_start_pos": 1527, "sent_end_pos": 1945, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Demand for vegan meat soared, with sales up by a staggering 264% in the 9 weeks ended May 2, 2020. Going forward, the meat value chain could be simplified dramatically, as \u201cclean meat\u201d labs could take the place of farms, feed lots, and slaughterhouses. Using CB Insights data, we dug into some of the major trends in the growing meatless industry, from startups to watch to key investors to future trends & challenges."}
{"meta": {"doc_id": 2394, "sent_id": 11, "sent_start_pos": 1626, "sent_end_pos": 2385, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Going forward, the meat value chain could be simplified dramatically, as \u201cclean meat\u201d labs could take the place of farms, feed lots, and slaughterhouses. Using CB Insights data, we dug into some of the major trends in the growing meatless industry, from startups to watch to key investors to future trends & challenges. TABLE OF CONTENTS\n- The current state of the meat and plant-based industriesWhy the shift towards meatless?Alternative protein startups are innovating across the meatless ecosystem\nThe current state of the meat and plant-based industries\nIn the past decade, the meat industry has seen massive consolidation, as companies like Hormel and Brazil-based JBS have grown bigger and bigger through the acquisition of new meat brands and products."}
{"meta": {"doc_id": 2394, "sent_id": 12, "sent_start_pos": 1780, "sent_end_pos": 2557, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Using CB Insights data, we dug into some of the major trends in the growing meatless industry, from startups to watch to key investors to future trends & challenges. TABLE OF CONTENTS\n- The current state of the meat and plant-based industriesWhy the shift towards meatless?Alternative protein startups are innovating across the meatless ecosystem\nThe current state of the meat and plant-based industries\nIn the past decade, the meat industry has seen massive consolidation, as companies like Hormel and Brazil-based JBS have grown bigger and bigger through the acquisition of new meat brands and products. One of the biggest deals in this space was pork producer WH Group\u2019s $4.7B acquisition of US-based Smithfield Foods, which owns brands such as Armour and Farmland, in 2013."}
{"meta": {"doc_id": 2394, "sent_id": 13, "sent_start_pos": 1946, "sent_end_pos": 2710, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "TABLE OF CONTENTS\n- The current state of the meat and plant-based industriesWhy the shift towards meatless?Alternative protein startups are innovating across the meatless ecosystem\nThe current state of the meat and plant-based industries\nIn the past decade, the meat industry has seen massive consolidation, as companies like Hormel and Brazil-based JBS have grown bigger and bigger through the acquisition of new meat brands and products. One of the biggest deals in this space was pork producer WH Group\u2019s $4.7B acquisition of US-based Smithfield Foods, which owns brands such as Armour and Farmland, in 2013. Since 2014, Hormel has spent around $3B on acquisitions, including Applegate, Fontanini Italian Meats and Sausages, Ceratti, and Columbus Manufacturing."}
{"meta": {"doc_id": 2394, "sent_id": 14, "sent_start_pos": 2386, "sent_end_pos": 2873, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "One of the biggest deals in this space was pork producer WH Group\u2019s $4.7B acquisition of US-based Smithfield Foods, which owns brands such as Armour and Farmland, in 2013. Since 2014, Hormel has spent around $3B on acquisitions, including Applegate, Fontanini Italian Meats and Sausages, Ceratti, and Columbus Manufacturing. Despite high-profile deals in the sector, the industrial meat industry faces a rising tide of challenges related to business, ethical, and environmental concerns."}
{"meta": {"doc_id": 2394, "sent_id": 15, "sent_start_pos": 2558, "sent_end_pos": 3005, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Since 2014, Hormel has spent around $3B on acquisitions, including Applegate, Fontanini Italian Meats and Sausages, Ceratti, and Columbus Manufacturing. Despite high-profile deals in the sector, the industrial meat industry faces a rising tide of challenges related to business, ethical, and environmental concerns. These corporations have also begun the shift into plant-based protein amid pressure from upstarts and changes in consumer behavior."}
{"meta": {"doc_id": 2394, "sent_id": 16, "sent_start_pos": 2711, "sent_end_pos": 3091, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Despite high-profile deals in the sector, the industrial meat industry faces a rising tide of challenges related to business, ethical, and environmental concerns. These corporations have also begun the shift into plant-based protein amid pressure from upstarts and changes in consumer behavior. The world\u2019s largest meat company, JBS launched its own meatless protein in June 2020."}
{"meta": {"doc_id": 2394, "sent_id": 17, "sent_start_pos": 2874, "sent_end_pos": 3210, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "These corporations have also begun the shift into plant-based protein amid pressure from upstarts and changes in consumer behavior. The world\u2019s largest meat company, JBS launched its own meatless protein in June 2020. Other meatpackers offering their own lines of plant-based alternatives include Tyson, Smithfield, Hormel, and Cargill."}
{"meta": {"doc_id": 2394, "sent_id": 18, "sent_start_pos": 3006, "sent_end_pos": 3342, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The world\u2019s largest meat company, JBS launched its own meatless protein in June 2020. Other meatpackers offering their own lines of plant-based alternatives include Tyson, Smithfield, Hormel, and Cargill. Meanwhile, startups using technology to engineer meat in labs or manufacture it from plant-based products are rising in popularity."}
{"meta": {"doc_id": 2394, "sent_id": 19, "sent_start_pos": 3092, "sent_end_pos": 3513, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Other meatpackers offering their own lines of plant-based alternatives include Tyson, Smithfield, Hormel, and Cargill. Meanwhile, startups using technology to engineer meat in labs or manufacture it from plant-based products are rising in popularity. In 2019, one of the world\u2019s biggest alternative protein brands, Beyond Meat, which manufactures the plant-based Beyond Burger, went public at a valuation of almost $1.5B."}
{"meta": {"doc_id": 2394, "sent_id": 20, "sent_start_pos": 3211, "sent_end_pos": 3646, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Meanwhile, startups using technology to engineer meat in labs or manufacture it from plant-based products are rising in popularity. In 2019, one of the world\u2019s biggest alternative protein brands, Beyond Meat, which manufactures the plant-based Beyond Burger, went public at a valuation of almost $1.5B. The company is making inroads into Asian markets, inking a deal with Starbucks in April 2020 to offer its meatless sausage in China."}
{"meta": {"doc_id": 2394, "sent_id": 21, "sent_start_pos": 3343, "sent_end_pos": 3771, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In 2019, one of the world\u2019s biggest alternative protein brands, Beyond Meat, which manufactures the plant-based Beyond Burger, went public at a valuation of almost $1.5B. The company is making inroads into Asian markets, inking a deal with Starbucks in April 2020 to offer its meatless sausage in China. In June, Beyond Meat also announced that it would debut its products in select KFC, Pizza Hut and Taco Bell stores in China."}
{"meta": {"doc_id": 2394, "sent_id": 22, "sent_start_pos": 3514, "sent_end_pos": 3853, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The company is making inroads into Asian markets, inking a deal with Starbucks in April 2020 to offer its meatless sausage in China. In June, Beyond Meat also announced that it would debut its products in select KFC, Pizza Hut and Taco Bell stores in China. Beyond Meat\u2019s chief competitor, Impossible Foods has also seen aggressive growth."}
{"meta": {"doc_id": 2394, "sent_id": 23, "sent_start_pos": 3647, "sent_end_pos": 3943, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In June, Beyond Meat also announced that it would debut its products in select KFC, Pizza Hut and Taco Bell stores in China. Beyond Meat\u2019s chief competitor, Impossible Foods has also seen aggressive growth. The Redwood City-based company has aggregated more than $1.3B in total disclosed funding."}
{"meta": {"doc_id": 2394, "sent_id": 24, "sent_start_pos": 3772, "sent_end_pos": 4033, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Beyond Meat\u2019s chief competitor, Impossible Foods has also seen aggressive growth. The Redwood City-based company has aggregated more than $1.3B in total disclosed funding. Its products can be found at chains like Burger King, Qdoba, White Castle, and Red Robin."}
{"meta": {"doc_id": 2394, "sent_id": 25, "sent_start_pos": 3854, "sent_end_pos": 4310, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The Redwood City-based company has aggregated more than $1.3B in total disclosed funding. Its products can be found at chains like Burger King, Qdoba, White Castle, and Red Robin. Valued at $4B as of March 2020, Impossible Foods has seen rapid expansion this year as well, forging a partnership with Kroger to sell its burgers across 1,700 Kroger-owned grocery stores nationwide, up from just 150 grocery stores selling its burger at the beginning of 2020."}
{"meta": {"doc_id": 2394, "sent_id": 26, "sent_start_pos": 3944, "sent_end_pos": 4407, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Its products can be found at chains like Burger King, Qdoba, White Castle, and Red Robin. Valued at $4B as of March 2020, Impossible Foods has seen rapid expansion this year as well, forging a partnership with Kroger to sell its burgers across 1,700 Kroger-owned grocery stores nationwide, up from just 150 grocery stores selling its burger at the beginning of 2020. Starbucks also recently announced that it would add an Impossible Foods sandwich to its US menu."}
{"meta": {"doc_id": 2394, "sent_id": 27, "sent_start_pos": 4034, "sent_end_pos": 4544, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Valued at $4B as of March 2020, Impossible Foods has seen rapid expansion this year as well, forging a partnership with Kroger to sell its burgers across 1,700 Kroger-owned grocery stores nationwide, up from just 150 grocery stores selling its burger at the beginning of 2020. Starbucks also recently announced that it would add an Impossible Foods sandwich to its US menu. Impossible Foods president Dennis Woodside has said he expects the company\u2019s retail footprint to expand more than 50-fold in 2020 alone."}
{"meta": {"doc_id": 2394, "sent_id": 28, "sent_start_pos": 4311, "sent_end_pos": 4788, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Starbucks also recently announced that it would add an Impossible Foods sandwich to its US menu. Impossible Foods president Dennis Woodside has said he expects the company\u2019s retail footprint to expand more than 50-fold in 2020 alone. \u201cThis is why I think people are increasingly aware plant-based products are going to completely replace the animal-based products in the food world within the next 15 years,\u201d Impossible Foods founder and CEO Pat Brown said in a June interview."}
{"meta": {"doc_id": 2394, "sent_id": 29, "sent_start_pos": 4408, "sent_end_pos": 5219, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Impossible Foods president Dennis Woodside has said he expects the company\u2019s retail footprint to expand more than 50-fold in 2020 alone. \u201cThis is why I think people are increasingly aware plant-based products are going to completely replace the animal-based products in the food world within the next 15 years,\u201d Impossible Foods founder and CEO Pat Brown said in a June interview. Covid-19 may accelerate the shift to meatless alternatives\nDuring the onset of the coronavirus pandemic, the meat industry was slammed by warnings of meat shortages due to shuttered plants, resulting price increases, and growing numbers of sick workers \u2014 conditions that would potentially present new opportunities for plant-based companies."}
{"meta": {"doc_id": 2394, "sent_id": 30, "sent_start_pos": 4545, "sent_end_pos": 5337, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "\u201cThis is why I think people are increasingly aware plant-based products are going to completely replace the animal-based products in the food world within the next 15 years,\u201d Impossible Foods founder and CEO Pat Brown said in a June interview. Covid-19 may accelerate the shift to meatless alternatives\nDuring the onset of the coronavirus pandemic, the meat industry was slammed by warnings of meat shortages due to shuttered plants, resulting price increases, and growing numbers of sick workers \u2014 conditions that would potentially present new opportunities for plant-based companies. Traditional meat distribution channels were and remain upended, as restaurants, schools, and other facilities closed."}
{"meta": {"doc_id": 2394, "sent_id": 31, "sent_start_pos": 4878, "sent_end_pos": 5462, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Covid-19 may accelerate the shift to meatless alternatives\nDuring the onset of the coronavirus pandemic, the meat industry was slammed by warnings of meat shortages due to shuttered plants, resulting price increases, and growing numbers of sick workers \u2014 conditions that would potentially present new opportunities for plant-based companies. Traditional meat distribution channels were and remain upended, as restaurants, schools, and other facilities closed. Declining output and rising prices left consumers with fewer options, and plant-based meat alternatives began to see a lift."}
{"meta": {"doc_id": 2394, "sent_id": 32, "sent_start_pos": 5220, "sent_end_pos": 5559, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Traditional meat distribution channels were and remain upended, as restaurants, schools, and other facilities closed. Declining output and rising prices left consumers with fewer options, and plant-based meat alternatives began to see a lift. Source: Bloomberg\nThe plant-based meat industry saw sales surge 264% in the 9 weeks ended May 2."}
{"meta": {"doc_id": 2394, "sent_id": 33, "sent_start_pos": 5338, "sent_end_pos": 5715, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Declining output and rising prices left consumers with fewer options, and plant-based meat alternatives began to see a lift. Source: Bloomberg\nThe plant-based meat industry saw sales surge 264% in the 9 weeks ended May 2. While these numbers are still a small portion of meat sales, their growth still highlights the opportunity that meat alternatives gained amid the pandemic."}
{"meta": {"doc_id": 2394, "sent_id": 34, "sent_start_pos": 5463, "sent_end_pos": 5869, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Source: Bloomberg\nThe plant-based meat industry saw sales surge 264% in the 9 weeks ended May 2. While these numbers are still a small portion of meat sales, their growth still highlights the opportunity that meat alternatives gained amid the pandemic. Even dairy alternatives saw a surge: in the first week of March, oat milk sales were up 347% year-over-year against a backdrop of declining dairy demand."}
{"meta": {"doc_id": 2394, "sent_id": 35, "sent_start_pos": 5560, "sent_end_pos": 6067, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "While these numbers are still a small portion of meat sales, their growth still highlights the opportunity that meat alternatives gained amid the pandemic. Even dairy alternatives saw a surge: in the first week of March, oat milk sales were up 347% year-over-year against a backdrop of declining dairy demand. Beyond the shortage, the pandemic has also forced many consumers to face issues in the meat supply chain for the first time, including the health of the workers or the ethical treatment of animals."}
{"meta": {"doc_id": 2394, "sent_id": 36, "sent_start_pos": 5716, "sent_end_pos": 6185, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Even dairy alternatives saw a surge: in the first week of March, oat milk sales were up 347% year-over-year against a backdrop of declining dairy demand. Beyond the shortage, the pandemic has also forced many consumers to face issues in the meat supply chain for the first time, including the health of the workers or the ethical treatment of animals. Reports of the millions of animals being euthanized as slaughterhouses were forced to close fueled consumer distaste."}
{"meta": {"doc_id": 2394, "sent_id": 37, "sent_start_pos": 5870, "sent_end_pos": 6346, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Beyond the shortage, the pandemic has also forced many consumers to face issues in the meat supply chain for the first time, including the health of the workers or the ethical treatment of animals. Reports of the millions of animals being euthanized as slaughterhouses were forced to close fueled consumer distaste. The outbreak has resulted in reportedly the largest pig culling the US has ever seen, with about a billion pounds of meat destroyed in the second quarter alone."}
{"meta": {"doc_id": 2394, "sent_id": 38, "sent_start_pos": 6068, "sent_end_pos": 6491, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Reports of the millions of animals being euthanized as slaughterhouses were forced to close fueled consumer distaste. The outbreak has resulted in reportedly the largest pig culling the US has ever seen, with about a billion pounds of meat destroyed in the second quarter alone. As America\u2019s largest meat suppliers reopened, their employees reported unsafe working conditions, with scarce precautions for social distancing."}
{"meta": {"doc_id": 2394, "sent_id": 39, "sent_start_pos": 6186, "sent_end_pos": 6718, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The outbreak has resulted in reportedly the largest pig culling the US has ever seen, with about a billion pounds of meat destroyed in the second quarter alone. As America\u2019s largest meat suppliers reopened, their employees reported unsafe working conditions, with scarce precautions for social distancing. Meatpacking plants were found to be coronavirus hotspots \u2014 at least 35,000+ meatpacking workers have tested positive for Covid-19 and over 150 food processing have died, according to the Food and Environment Reporting Network."}
{"meta": {"doc_id": 2394, "sent_id": 40, "sent_start_pos": 6347, "sent_end_pos": 6901, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "As America\u2019s largest meat suppliers reopened, their employees reported unsafe working conditions, with scarce precautions for social distancing. Meatpacking plants were found to be coronavirus hotspots \u2014 at least 35,000+ meatpacking workers have tested positive for Covid-19 and over 150 food processing have died, according to the Food and Environment Reporting Network. News of meat factories\u2019 concentrated Covid-19 outbreaks may cast traditional meat products in an unappealing light, influencing consumers to opt for plant-based alternatives instead."}
{"meta": {"doc_id": 2394, "sent_id": 41, "sent_start_pos": 6492, "sent_end_pos": 7152, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Meatpacking plants were found to be coronavirus hotspots \u2014 at least 35,000+ meatpacking workers have tested positive for Covid-19 and over 150 food processing have died, according to the Food and Environment Reporting Network. News of meat factories\u2019 concentrated Covid-19 outbreaks may cast traditional meat products in an unappealing light, influencing consumers to opt for plant-based alternatives instead. \u201cCovid is shining a light for consumers to start evaluating their own choices and whether or not they want to continue to buy meat,\u201d Josh Balk, vice president of farm animal protection for the Humane Society, said in an interview with Bloomberg News."}
{"meta": {"doc_id": 2394, "sent_id": 42, "sent_start_pos": 6719, "sent_end_pos": 7314, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "News of meat factories\u2019 concentrated Covid-19 outbreaks may cast traditional meat products in an unappealing light, influencing consumers to opt for plant-based alternatives instead. \u201cCovid is shining a light for consumers to start evaluating their own choices and whether or not they want to continue to buy meat,\u201d Josh Balk, vice president of farm animal protection for the Humane Society, said in an interview with Bloomberg News. Source: Bloomberg\nMacro reasons propelling the meatless trend\nBeyond Covid-19, there are several macro-level reasons for the shift toward a more meatless future."}
{"meta": {"doc_id": 2394, "sent_id": 43, "sent_start_pos": 6902, "sent_end_pos": 7426, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "\u201cCovid is shining a light for consumers to start evaluating their own choices and whether or not they want to continue to buy meat,\u201d Josh Balk, vice president of farm animal protection for the Humane Society, said in an interview with Bloomberg News. Source: Bloomberg\nMacro reasons propelling the meatless trend\nBeyond Covid-19, there are several macro-level reasons for the shift toward a more meatless future. Forces like urbanization, population growth, and a rising global middle class lead to greater meat consumption."}
{"meta": {"doc_id": 2394, "sent_id": 44, "sent_start_pos": 7153, "sent_end_pos": 7579, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Source: Bloomberg\nMacro reasons propelling the meatless trend\nBeyond Covid-19, there are several macro-level reasons for the shift toward a more meatless future. Forces like urbanization, population growth, and a rising global middle class lead to greater meat consumption. Approximately 55% of the world\u2019s population lives in urban settlements, and this percentage is expected to increase to 68% by 2050, according to the UN."}
{"meta": {"doc_id": 2394, "sent_id": 45, "sent_start_pos": 7315, "sent_end_pos": 7701, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Forces like urbanization, population growth, and a rising global middle class lead to greater meat consumption. Approximately 55% of the world\u2019s population lives in urban settlements, and this percentage is expected to increase to 68% by 2050, according to the UN. Meanwhile, the world\u2019s population is expected to surge to 9.7B by 2050, leading to a massive increase in food production."}
{"meta": {"doc_id": 2394, "sent_id": 46, "sent_start_pos": 7427, "sent_end_pos": 7900, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Approximately 55% of the world\u2019s population lives in urban settlements, and this percentage is expected to increase to 68% by 2050, according to the UN. Meanwhile, the world\u2019s population is expected to surge to 9.7B by 2050, leading to a massive increase in food production. Emerging markets are driving this growth: China, in particular, is the world\u2019s largest consumer of meat, with protein consumption expected to grow by around 4% a year due to its rising middle class."}
{"meta": {"doc_id": 2394, "sent_id": 47, "sent_start_pos": 7580, "sent_end_pos": 8036, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Meanwhile, the world\u2019s population is expected to surge to 9.7B by 2050, leading to a massive increase in food production. Emerging markets are driving this growth: China, in particular, is the world\u2019s largest consumer of meat, with protein consumption expected to grow by around 4% a year due to its rising middle class. This increasing demand could create challenges for feeding future generations, and meatless companies are looking to help fill the gap."}
{"meta": {"doc_id": 2394, "sent_id": 48, "sent_start_pos": 7702, "sent_end_pos": 8142, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Emerging markets are driving this growth: China, in particular, is the world\u2019s largest consumer of meat, with protein consumption expected to grow by around 4% a year due to its rising middle class. This increasing demand could create challenges for feeding future generations, and meatless companies are looking to help fill the gap. Alternative protein sources can reduce the negative environmental impact associated with meat production."}
{"meta": {"doc_id": 2394, "sent_id": 49, "sent_start_pos": 7901, "sent_end_pos": 8224, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "This increasing demand could create challenges for feeding future generations, and meatless companies are looking to help fill the gap. Alternative protein sources can reduce the negative environmental impact associated with meat production. As mentioned above, livestock is a major contributor to greenhouse gas emissions."}
{"meta": {"doc_id": 2394, "sent_id": 50, "sent_start_pos": 8037, "sent_end_pos": 8361, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Alternative protein sources can reduce the negative environmental impact associated with meat production. As mentioned above, livestock is a major contributor to greenhouse gas emissions. Additionally, reducing livestock could free up global cropland, decrease soil erosion, and relieve pressure on the world\u2019s water supply."}
{"meta": {"doc_id": 2394, "sent_id": 51, "sent_start_pos": 8143, "sent_end_pos": 8566, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "As mentioned above, livestock is a major contributor to greenhouse gas emissions. Additionally, reducing livestock could free up global cropland, decrease soil erosion, and relieve pressure on the world\u2019s water supply. Rising obesity rates across the globe, coupled with consumer interest in healthier food alternatives, are also driving demand for meatless proteins."}
{"meta": {"doc_id": 2394, "sent_id": 52, "sent_start_pos": 8225, "sent_end_pos": 8721, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Additionally, reducing livestock could free up global cropland, decrease soil erosion, and relieve pressure on the world\u2019s water supply. Rising obesity rates across the globe, coupled with consumer interest in healthier food alternatives, are also driving demand for meatless proteins. In 2019, the annual retail food market grew by 2.2%, but plant-based foods swelled by 11.4% in comparison, according to the Plant Based Foods Association."}
{"meta": {"doc_id": 2394, "sent_id": 53, "sent_start_pos": 8418, "sent_end_pos": 8819, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Rising obesity rates across the globe, coupled with consumer interest in healthier food alternatives, are also driving demand for meatless proteins. In 2019, the annual retail food market grew by 2.2%, but plant-based foods swelled by 11.4% in comparison, according to the Plant Based Foods Association. Additionally, advances in ag tech and synthetic biology are enabling high-tech meatless products."}
{"meta": {"doc_id": 2394, "sent_id": 54, "sent_start_pos": 8567, "sent_end_pos": 8979, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In 2019, the annual retail food market grew by 2.2%, but plant-based foods swelled by 11.4% in comparison, according to the Plant Based Foods Association. Additionally, advances in ag tech and synthetic biology are enabling high-tech meatless products. Cellular agriculture and molecular engineering are fueling tech-enabled meat substitutes that better emulate the flavor and texture of traditional animal meat."}
{"meta": {"doc_id": 2394, "sent_id": 55, "sent_start_pos": 8722, "sent_end_pos": 9061, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Additionally, advances in ag tech and synthetic biology are enabling high-tech meatless products. Cellular agriculture and molecular engineering are fueling tech-enabled meat substitutes that better emulate the flavor and texture of traditional animal meat. (We cover 100+ startups driving ingredient innovation in this client-only brief.)"}
{"meta": {"doc_id": 2394, "sent_id": 56, "sent_start_pos": 8820, "sent_end_pos": 9243, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Cellular agriculture and molecular engineering are fueling tech-enabled meat substitutes that better emulate the flavor and texture of traditional animal meat. (We cover 100+ startups driving ingredient innovation in this client-only brief.) Meatless consumption could also alleviate ethical questions around meat consumption, as the meat industry has long been subject to ethical concerns behind meat production practices."}
{"meta": {"doc_id": 2394, "sent_id": 57, "sent_start_pos": 8980, "sent_end_pos": 9413, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "(We cover 100+ startups driving ingredient innovation in this client-only brief.) Meatless consumption could also alleviate ethical questions around meat consumption, as the meat industry has long been subject to ethical concerns behind meat production practices. A spike in the discussion of blockchain in conjunction with meat and food, for example, indicates a rising consumer desire for transparency around the food supply chain."}
{"meta": {"doc_id": 2394, "sent_id": 58, "sent_start_pos": 9062, "sent_end_pos": 9560, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Meatless consumption could also alleviate ethical questions around meat consumption, as the meat industry has long been subject to ethical concerns behind meat production practices. A spike in the discussion of blockchain in conjunction with meat and food, for example, indicates a rising consumer desire for transparency around the food supply chain. Agriculture giant Cargill announced in 2017 that it was testing blockchain technology to show turkey buyers where their individual bird came from."}
{"meta": {"doc_id": 2394, "sent_id": 59, "sent_start_pos": 9244, "sent_end_pos": 9703, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "A spike in the discussion of blockchain in conjunction with meat and food, for example, indicates a rising consumer desire for transparency around the food supply chain. Agriculture giant Cargill announced in 2017 that it was testing blockchain technology to show turkey buyers where their individual bird came from. The Norwegian Seafood Association partnered with IBM in June 2020 to leverage its blockchain to ensure food traceability in its supply chains."}
{"meta": {"doc_id": 2394, "sent_id": 60, "sent_start_pos": 9414, "sent_end_pos": 9892, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Agriculture giant Cargill announced in 2017 that it was testing blockchain technology to show turkey buyers where their individual bird came from. The Norwegian Seafood Association partnered with IBM in June 2020 to leverage its blockchain to ensure food traceability in its supply chains. Alternative meats could also reduce contamination: Growing lab-grown meat in a sterile environment can cut back on contamination and eliminate antibiotics from the meat production process."}
{"meta": {"doc_id": 2394, "sent_id": 61, "sent_start_pos": 9561, "sent_end_pos": 10001, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The Norwegian Seafood Association partnered with IBM in June 2020 to leverage its blockchain to ensure food traceability in its supply chains. Alternative meats could also reduce contamination: Growing lab-grown meat in a sterile environment can cut back on contamination and eliminate antibiotics from the meat production process. This could play a role in reducing global health problems linked to the current food production value chain."}
{"meta": {"doc_id": 2394, "sent_id": 62, "sent_start_pos": 9704, "sent_end_pos": 10200, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Alternative meats could also reduce contamination: Growing lab-grown meat in a sterile environment can cut back on contamination and eliminate antibiotics from the meat production process. This could play a role in reducing global health problems linked to the current food production value chain. Alternative protein startups are innovating across the meatless ecosystem\nGiven rising consumer interest and pandemic-caused meat plant shutdowns, more startups are innovating in the meatless space."}
{"meta": {"doc_id": 2394, "sent_id": 63, "sent_start_pos": 9893, "sent_end_pos": 10417, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "This could play a role in reducing global health problems linked to the current food production value chain. Alternative protein startups are innovating across the meatless ecosystem\nGiven rising consumer interest and pandemic-caused meat plant shutdowns, more startups are innovating in the meatless space. They are not only competing with prepared and frozen meats, but also exploring other methods of incorporating non-meat proteins into diets, with snacks (such as Beyond the Shoreline\u2018s kelp jerky) or meal substitutes."}
{"meta": {"doc_id": 2394, "sent_id": 64, "sent_start_pos": 10002, "sent_end_pos": 10573, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Alternative protein startups are innovating across the meatless ecosystem\nGiven rising consumer interest and pandemic-caused meat plant shutdowns, more startups are innovating in the meatless space. They are not only competing with prepared and frozen meats, but also exploring other methods of incorporating non-meat proteins into diets, with snacks (such as Beyond the Shoreline\u2018s kelp jerky) or meal substitutes. MEAT & DAIRY ALTERNATIVES\nMeat & seafooD\nPlant-based burgers that \u2018bleed\u2019 and taste like the real thing\nPlant-based burgers have seen a jump in popularity."}
{"meta": {"doc_id": 2394, "sent_id": 65, "sent_start_pos": 10201, "sent_end_pos": 10813, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "They are not only competing with prepared and frozen meats, but also exploring other methods of incorporating non-meat proteins into diets, with snacks (such as Beyond the Shoreline\u2018s kelp jerky) or meal substitutes. MEAT & DAIRY ALTERNATIVES\nMeat & seafooD\nPlant-based burgers that \u2018bleed\u2019 and taste like the real thing\nPlant-based burgers have seen a jump in popularity. Startups producing these burgers are targeting both meat-based and plant-based diets by 1) increasing options for vegetarians and vegans and 2) using a meat-like taste to help entice meat eaters to consume environmentally-friendly protein."}
{"meta": {"doc_id": 2394, "sent_id": 66, "sent_start_pos": 10418, "sent_end_pos": 11333, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "MEAT & DAIRY ALTERNATIVES\nMeat & seafooD\nPlant-based burgers that \u2018bleed\u2019 and taste like the real thing\nPlant-based burgers have seen a jump in popularity. Startups producing these burgers are targeting both meat-based and plant-based diets by 1) increasing options for vegetarians and vegans and 2) using a meat-like taste to help entice meat eaters to consume environmentally-friendly protein. \u201cWe think of it as meat made a better way \u2026 Meat today basically is made using pre-historic technology, using animals to turn plants into this very special category of food \u2026 But to your typical consumer \u2026 the value proposition of meat has nothing to do with its coming from an animal.\u201d\n\u2013 Pat Brown, CEO of Impossible Foods\nImpossible Foods, one of the biggest players in this space, leverages molecular engineering to create \u201cbleeding\u201d plant-based burgers that the company claims is nearly indistinguishable from meat."}
{"meta": {"doc_id": 2394, "sent_id": 67, "sent_start_pos": 10574, "sent_end_pos": 11478, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Startups producing these burgers are targeting both meat-based and plant-based diets by 1) increasing options for vegetarians and vegans and 2) using a meat-like taste to help entice meat eaters to consume environmentally-friendly protein. \u201cWe think of it as meat made a better way \u2026 Meat today basically is made using pre-historic technology, using animals to turn plants into this very special category of food \u2026 But to your typical consumer \u2026 the value proposition of meat has nothing to do with its coming from an animal.\u201d\n\u2013 Pat Brown, CEO of Impossible Foods\nImpossible Foods, one of the biggest players in this space, leverages molecular engineering to create \u201cbleeding\u201d plant-based burgers that the company claims is nearly indistinguishable from meat. The company\u2019s use of heme, an iron-rich molecule in animal proteins, has enabled it to replicate the \u201cmeaty\u201d flavor in its plant-based products."}
{"meta": {"doc_id": 2394, "sent_id": 68, "sent_start_pos": 10814, "sent_end_pos": 11570, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "\u201cWe think of it as meat made a better way \u2026 Meat today basically is made using pre-historic technology, using animals to turn plants into this very special category of food \u2026 But to your typical consumer \u2026 the value proposition of meat has nothing to do with its coming from an animal.\u201d\n\u2013 Pat Brown, CEO of Impossible Foods\nImpossible Foods, one of the biggest players in this space, leverages molecular engineering to create \u201cbleeding\u201d plant-based burgers that the company claims is nearly indistinguishable from meat. The company\u2019s use of heme, an iron-rich molecule in animal proteins, has enabled it to replicate the \u201cmeaty\u201d flavor in its plant-based products. Impossible Foods last raised a $500M Series F in March 2020, bringing its valuation to $4B."}
{"meta": {"doc_id": 2394, "sent_id": 69, "sent_start_pos": 11334, "sent_end_pos": 11637, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The company\u2019s use of heme, an iron-rich molecule in animal proteins, has enabled it to replicate the \u201cmeaty\u201d flavor in its plant-based products. Impossible Foods last raised a $500M Series F in March 2020, bringing its valuation to $4B. To date, it\u2019s raked in more than $1.3B in total disclosed funding."}
{"meta": {"doc_id": 2394, "sent_id": 70, "sent_start_pos": 11479, "sent_end_pos": 11787, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Impossible Foods last raised a $500M Series F in March 2020, bringing its valuation to $4B. To date, it\u2019s raked in more than $1.3B in total disclosed funding. Instead of directly targeting consumers, Impossible Foods started by targeting the commercial and restaurant market with its meatless burger product."}
{"meta": {"doc_id": 2394, "sent_id": 71, "sent_start_pos": 11571, "sent_end_pos": 11864, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "To date, it\u2019s raked in more than $1.3B in total disclosed funding. Instead of directly targeting consumers, Impossible Foods started by targeting the commercial and restaurant market with its meatless burger product. In 2017, Impossible patties could only be found in around 40 US restaurants."}
{"meta": {"doc_id": 2394, "sent_id": 72, "sent_start_pos": 11638, "sent_end_pos": 11926, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Instead of directly targeting consumers, Impossible Foods started by targeting the commercial and restaurant market with its meatless burger product. In 2017, Impossible patties could only be found in around 40 US restaurants. By 2018, that figure had reportedly grown to more than 3,000."}
{"meta": {"doc_id": 2394, "sent_id": 73, "sent_start_pos": 11788, "sent_end_pos": 12044, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In 2017, Impossible patties could only be found in around 40 US restaurants. By 2018, that figure had reportedly grown to more than 3,000. In early 2019, Impossible Foods launched its largest restaurant partnership yet \u2014 the Burger King Impossible Whopper."}
{"meta": {"doc_id": 2394, "sent_id": 74, "sent_start_pos": 11865, "sent_end_pos": 12140, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "By 2018, that figure had reportedly grown to more than 3,000. In early 2019, Impossible Foods launched its largest restaurant partnership yet \u2014 the Burger King Impossible Whopper. Burger King also recently announced that it would add the Impossible Foods sausage to its menu."}
{"meta": {"doc_id": 2394, "sent_id": 75, "sent_start_pos": 11927, "sent_end_pos": 12358, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In early 2019, Impossible Foods launched its largest restaurant partnership yet \u2014 the Burger King Impossible Whopper. Burger King also recently announced that it would add the Impossible Foods sausage to its menu. In May 2020, Impossible Foods announced that its patties would be sold across 1,700 Kroger-owned grocery stores nationwide, a dramatic increase from just 150 grocery stores selling its burger at the beginning of 2020."}
{"meta": {"doc_id": 2394, "sent_id": 76, "sent_start_pos": 12045, "sent_end_pos": 12510, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Burger King also recently announced that it would add the Impossible Foods sausage to its menu. In May 2020, Impossible Foods announced that its patties would be sold across 1,700 Kroger-owned grocery stores nationwide, a dramatic increase from just 150 grocery stores selling its burger at the beginning of 2020. Impossible Foods also inked another major deal in June 2020, when Starbucks announced that it would add the Impossible Sausage sandwich to its US menu."}
{"meta": {"doc_id": 2394, "sent_id": 77, "sent_start_pos": 12141, "sent_end_pos": 12713, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In May 2020, Impossible Foods announced that its patties would be sold across 1,700 Kroger-owned grocery stores nationwide, a dramatic increase from just 150 grocery stores selling its burger at the beginning of 2020. Impossible Foods also inked another major deal in June 2020, when Starbucks announced that it would add the Impossible Sausage sandwich to its US menu. It is also working on a few other types of meat products to accompany its main ground beef product, including meat-free sausage and a plant-based pork product the company is planning to launch in China."}
{"meta": {"doc_id": 2394, "sent_id": 78, "sent_start_pos": 12359, "sent_end_pos": 12869, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Impossible Foods also inked another major deal in June 2020, when Starbucks announced that it would add the Impossible Sausage sandwich to its US menu. It is also working on a few other types of meat products to accompany its main ground beef product, including meat-free sausage and a plant-based pork product the company is planning to launch in China. Beyond Meat is another major competitor in the space, making plant-based burgers and other imitation meat products such as plant-based chicken and sausage."}
{"meta": {"doc_id": 2394, "sent_id": 79, "sent_start_pos": 12511, "sent_end_pos": 12968, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "It is also working on a few other types of meat products to accompany its main ground beef product, including meat-free sausage and a plant-based pork product the company is planning to launch in China. Beyond Meat is another major competitor in the space, making plant-based burgers and other imitation meat products such as plant-based chicken and sausage. After receiving a total of $164M in disclosed equity funding, Beyond Meat went public in May 2019."}
{"meta": {"doc_id": 2394, "sent_id": 80, "sent_start_pos": 12714, "sent_end_pos": 13131, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Beyond Meat is another major competitor in the space, making plant-based burgers and other imitation meat products such as plant-based chicken and sausage. After receiving a total of $164M in disclosed equity funding, Beyond Meat went public in May 2019. Beyond Meat\u2019s stock price surged after its IPO, with its market cap increasing more than 8x within a few months \u2014 its current market cap hovers around $8B to $9B."}
{"meta": {"doc_id": 2394, "sent_id": 81, "sent_start_pos": 12870, "sent_end_pos": 13346, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "After receiving a total of $164M in disclosed equity funding, Beyond Meat went public in May 2019. Beyond Meat\u2019s stock price surged after its IPO, with its market cap increasing more than 8x within a few months \u2014 its current market cap hovers around $8B to $9B. Beyond Meat, which primarily sells directly to consumers in grocery stores, has launched its own major retailer partnership, working with Dunkin\u2019 Donuts to roll out a plant-based sausage breakfast sandwich in 2019."}
{"meta": {"doc_id": 2394, "sent_id": 82, "sent_start_pos": 12969, "sent_end_pos": 13501, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Beyond Meat\u2019s stock price surged after its IPO, with its market cap increasing more than 8x within a few months \u2014 its current market cap hovers around $8B to $9B. Beyond Meat, which primarily sells directly to consumers in grocery stores, has launched its own major retailer partnership, working with Dunkin\u2019 Donuts to roll out a plant-based sausage breakfast sandwich in 2019. Looking beyond the American market, the company also announced a partnership with Starbucks to roll out its products in its China locations in March 2020."}
{"meta": {"doc_id": 2394, "sent_id": 83, "sent_start_pos": 13132, "sent_end_pos": 13683, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Beyond Meat, which primarily sells directly to consumers in grocery stores, has launched its own major retailer partnership, working with Dunkin\u2019 Donuts to roll out a plant-based sausage breakfast sandwich in 2019. Looking beyond the American market, the company also announced a partnership with Starbucks to roll out its products in its China locations in March 2020. Beyond Meat also already sells its products in Starbucks\u2019 Canadian locations, but was dealt a blow when Starbucks chose to debut Impossible Foods\u2019 products in its US stores instead."}
{"meta": {"doc_id": 2394, "sent_id": 84, "sent_start_pos": 13347, "sent_end_pos": 13857, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Looking beyond the American market, the company also announced a partnership with Starbucks to roll out its products in its China locations in March 2020. Beyond Meat also already sells its products in Starbucks\u2019 Canadian locations, but was dealt a blow when Starbucks chose to debut Impossible Foods\u2019 products in its US stores instead. The faux meat maker has maintained its goal to open a production facility in Asia before the end of 2020, and already sells its products in Taiwan, Singapore, and Hong Kong."}
{"meta": {"doc_id": 2394, "sent_id": 85, "sent_start_pos": 13502, "sent_end_pos": 14005, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Beyond Meat also already sells its products in Starbucks\u2019 Canadian locations, but was dealt a blow when Starbucks chose to debut Impossible Foods\u2019 products in its US stores instead. The faux meat maker has maintained its goal to open a production facility in Asia before the end of 2020, and already sells its products in Taiwan, Singapore, and Hong Kong. Fish-free seafood alternatives\nIn addition to land-based meat, companies are applying similar processes to create sustainable seafood alternatives."}
{"meta": {"doc_id": 2394, "sent_id": 86, "sent_start_pos": 13684, "sent_end_pos": 14073, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The faux meat maker has maintained its goal to open a production facility in Asia before the end of 2020, and already sells its products in Taiwan, Singapore, and Hong Kong. Fish-free seafood alternatives\nIn addition to land-based meat, companies are applying similar processes to create sustainable seafood alternatives. This is due to the ever-increasing demand on the ocean\u2019s resources."}
{"meta": {"doc_id": 2394, "sent_id": 87, "sent_start_pos": 13858, "sent_end_pos": 14260, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Fish-free seafood alternatives\nIn addition to land-based meat, companies are applying similar processes to create sustainable seafood alternatives. This is due to the ever-increasing demand on the ocean\u2019s resources. With 90% of global fish stocks overwhelmed and overfished due to rising global demand, startups are looking for ways to satiate consumers without fully depleting the earth\u2019s fish supply."}
{"meta": {"doc_id": 2394, "sent_id": 88, "sent_start_pos": 14006, "sent_end_pos": 14410, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "This is due to the ever-increasing demand on the ocean\u2019s resources. With 90% of global fish stocks overwhelmed and overfished due to rising global demand, startups are looking for ways to satiate consumers without fully depleting the earth\u2019s fish supply. Because of the increased pressure on the fishing industry, companies in the seafood-alternative space are seeing greater media attention and funding."}
{"meta": {"doc_id": 2394, "sent_id": 89, "sent_start_pos": 14074, "sent_end_pos": 14771, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "With 90% of global fish stocks overwhelmed and overfished due to rising global demand, startups are looking for ways to satiate consumers without fully depleting the earth\u2019s fish supply. Because of the increased pressure on the fishing industry, companies in the seafood-alternative space are seeing greater media attention and funding. \u201cShrimp has one of the worst supply chains in the seafood industry,\u201d \u2013 Dominique Barnes, New Wave Foods Co-Founder & CEO\nPennsylvania-based startup Good Catch Foods raised a $32M Series B in January 2020, as well as undisclosed investments from celebrities like Woody Harrelson, Paris Hilton, and Lance Bass in May, bringing its funding total to at least $51M."}
{"meta": {"doc_id": 2394, "sent_id": 90, "sent_start_pos": 14261, "sent_end_pos": 14916, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Because of the increased pressure on the fishing industry, companies in the seafood-alternative space are seeing greater media attention and funding. \u201cShrimp has one of the worst supply chains in the seafood industry,\u201d \u2013 Dominique Barnes, New Wave Foods Co-Founder & CEO\nPennsylvania-based startup Good Catch Foods raised a $32M Series B in January 2020, as well as undisclosed investments from celebrities like Woody Harrelson, Paris Hilton, and Lance Bass in May, bringing its funding total to at least $51M. The company develops vegetarian tuna, crab cakes, and fish patties and sells its products in Whole Foods, FreshDirect, and Thrive Market stores."}
{"meta": {"doc_id": 2394, "sent_id": 91, "sent_start_pos": 14411, "sent_end_pos": 15005, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "\u201cShrimp has one of the worst supply chains in the seafood industry,\u201d \u2013 Dominique Barnes, New Wave Foods Co-Founder & CEO\nPennsylvania-based startup Good Catch Foods raised a $32M Series B in January 2020, as well as undisclosed investments from celebrities like Woody Harrelson, Paris Hilton, and Lance Bass in May, bringing its funding total to at least $51M. The company develops vegetarian tuna, crab cakes, and fish patties and sells its products in Whole Foods, FreshDirect, and Thrive Market stores. Its seafood look-alikes are made from lentils, chickpeas, fava beans, and other legumes."}
{"meta": {"doc_id": 2394, "sent_id": 92, "sent_start_pos": 14772, "sent_end_pos": 15056, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The company develops vegetarian tuna, crab cakes, and fish patties and sells its products in Whole Foods, FreshDirect, and Thrive Market stores. Its seafood look-alikes are made from lentils, chickpeas, fava beans, and other legumes. There are a number of other startups in the space."}
{"meta": {"doc_id": 2394, "sent_id": 93, "sent_start_pos": 14917, "sent_end_pos": 15270, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Its seafood look-alikes are made from lentils, chickpeas, fava beans, and other legumes. There are a number of other startups in the space. Finless Foods, which has raised almost $7M, uses cellular agriculture to grow fish meat, while New Wave Foods, which has received backing from Tyson Ventures, produces pea protein and algae-based imitation shrimp."}
{"meta": {"doc_id": 2394, "sent_id": 94, "sent_start_pos": 15006, "sent_end_pos": 15402, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "There are a number of other startups in the space. Finless Foods, which has raised almost $7M, uses cellular agriculture to grow fish meat, while New Wave Foods, which has received backing from Tyson Ventures, produces pea protein and algae-based imitation shrimp. It raised a $12.5M Series A in October 2019 to bring its total funding to $16M."}
{"meta": {"doc_id": 2394, "sent_id": 95, "sent_start_pos": 15057, "sent_end_pos": 15514, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Finless Foods, which has raised almost $7M, uses cellular agriculture to grow fish meat, while New Wave Foods, which has received backing from Tyson Ventures, produces pea protein and algae-based imitation shrimp. It raised a $12.5M Series A in October 2019 to bring its total funding to $16M. Additionally, French startup Odontella, which produces algae-based salmon, raised a seed round in October 2017."}
{"meta": {"doc_id": 2394, "sent_id": 96, "sent_start_pos": 15323, "sent_end_pos": 15621, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "It raised a $12.5M Series A in October 2019 to bring its total funding to $16M. Additionally, French startup Odontella, which produces algae-based salmon, raised a seed round in October 2017. Its first product, a vegan smoked salmon from the Odontella aurita microalgae, was launched in April 2018."}
{"meta": {"doc_id": 2394, "sent_id": 97, "sent_start_pos": 15403, "sent_end_pos": 15735, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Additionally, French startup Odontella, which produces algae-based salmon, raised a seed round in October 2017. Its first product, a vegan smoked salmon from the Odontella aurita microalgae, was launched in April 2018. In mid-2019, the company announced that its next product would be a microalgae-based steak substitute named Tona."}
{"meta": {"doc_id": 2394, "sent_id": 98, "sent_start_pos": 15515, "sent_end_pos": 15868, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Its first product, a vegan smoked salmon from the Odontella aurita microalgae, was launched in April 2018. In mid-2019, the company announced that its next product would be a microalgae-based steak substitute named Tona. While still in the early stages of R&D, fish-free seafood products are further expanding the possibilities of an animal-free future."}
{"meta": {"doc_id": 2394, "sent_id": 99, "sent_start_pos": 15622, "sent_end_pos": 15989, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In mid-2019, the company announced that its next product would be a microalgae-based steak substitute named Tona. While still in the early stages of R&D, fish-free seafood products are further expanding the possibilities of an animal-free future. As with animal-free meat, fishless seafood could radically simplify and clean up the associated production value chains."}
{"meta": {"doc_id": 2394, "sent_id": 100, "sent_start_pos": 15736, "sent_end_pos": 16181, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "While still in the early stages of R&D, fish-free seafood products are further expanding the possibilities of an animal-free future. As with animal-free meat, fishless seafood could radically simplify and clean up the associated production value chains. Lab-grown products\nLab-grown or \u201ccultured meat\u201d is another alternative meat product, but unlike some other offerings in the space, this approach is not plant-based imitation meat \u2014 it\u2019s real."}
{"meta": {"doc_id": 2394, "sent_id": 101, "sent_start_pos": 15869, "sent_end_pos": 16391, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "As with animal-free meat, fishless seafood could radically simplify and clean up the associated production value chains. Lab-grown products\nLab-grown or \u201ccultured meat\u201d is another alternative meat product, but unlike some other offerings in the space, this approach is not plant-based imitation meat \u2014 it\u2019s real. San Francisco-based Memphis Meats produces meat from self-reproducing cells, thereby growing meat that is an \u201canimal-based\u201d product but avoiding the need to breed, raise, and slaughter huge numbers of animals."}
{"meta": {"doc_id": 2394, "sent_id": 102, "sent_start_pos": 15990, "sent_end_pos": 16527, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Lab-grown products\nLab-grown or \u201ccultured meat\u201d is another alternative meat product, but unlike some other offerings in the space, this approach is not plant-based imitation meat \u2014 it\u2019s real. San Francisco-based Memphis Meats produces meat from self-reproducing cells, thereby growing meat that is an \u201canimal-based\u201d product but avoiding the need to breed, raise, and slaughter huge numbers of animals. The company debuted its first synthetic meatball in 2016 and followed up with the world\u2019s first cell-cultured chicken and duck in 2017."}
{"meta": {"doc_id": 2394, "sent_id": 103, "sent_start_pos": 16182, "sent_end_pos": 16649, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "San Francisco-based Memphis Meats produces meat from self-reproducing cells, thereby growing meat that is an \u201canimal-based\u201d product but avoiding the need to breed, raise, and slaughter huge numbers of animals. The company debuted its first synthetic meatball in 2016 and followed up with the world\u2019s first cell-cultured chicken and duck in 2017. Source: Memphis Meats\nMemphis Meats aims to decrease the cost of lab-grown meat in order to compete with commercial meat."}
{"meta": {"doc_id": 2394, "sent_id": 104, "sent_start_pos": 16392, "sent_end_pos": 16767, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The company debuted its first synthetic meatball in 2016 and followed up with the world\u2019s first cell-cultured chicken and duck in 2017. Source: Memphis Meats\nMemphis Meats aims to decrease the cost of lab-grown meat in order to compete with commercial meat. While its original meat cost $18,000 a pound, by January 2018, the company had gotten costs down to $2,400 per pound."}
{"meta": {"doc_id": 2394, "sent_id": 105, "sent_start_pos": 16528, "sent_end_pos": 16916, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Source: Memphis Meats\nMemphis Meats aims to decrease the cost of lab-grown meat in order to compete with commercial meat. While its original meat cost $18,000 a pound, by January 2018, the company had gotten costs down to $2,400 per pound. The company also claims that it can produce animal-free products using just 1% of the land and 1% of the water compared to meat-producer incumbents."}
{"meta": {"doc_id": 2394, "sent_id": 106, "sent_start_pos": 16650, "sent_end_pos": 17018, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "While its original meat cost $18,000 a pound, by January 2018, the company had gotten costs down to $2,400 per pound. The company also claims that it can produce animal-free products using just 1% of the land and 1% of the water compared to meat-producer incumbents. In March 2018, the company announced its intention to bring clean chicken and duck to stores by 2021."}
{"meta": {"doc_id": 2394, "sent_id": 107, "sent_start_pos": 16768, "sent_end_pos": 17145, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The company also claims that it can produce animal-free products using just 1% of the land and 1% of the water compared to meat-producer incumbents. In March 2018, the company announced its intention to bring clean chicken and duck to stores by 2021. Memphis Meats has raised 2 tranches of its Series B totaling $186M in 2020 to date, bringing its total funding to about $211M."}
{"meta": {"doc_id": 2394, "sent_id": 108, "sent_start_pos": 16917, "sent_end_pos": 17234, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In March 2018, the company announced its intention to bring clean chicken and duck to stores by 2021. Memphis Meats has raised 2 tranches of its Series B totaling $186M in 2020 to date, bringing its total funding to about $211M. Additionally, Tyson Ventures backed the company for an undisclosed amount in early 2018."}
{"meta": {"doc_id": 2394, "sent_id": 109, "sent_start_pos": 17019, "sent_end_pos": 17492, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Memphis Meats has raised 2 tranches of its Series B totaling $186M in 2020 to date, bringing its total funding to about $211M. Additionally, Tyson Ventures backed the company for an undisclosed amount in early 2018. More recently, in a series of patents, the company announced its intention to use the gene-editing technique CRISPR in order to help it develop its lab-grown meat products with even less impact on the environment and even less consumption of land and water."}
{"meta": {"doc_id": 2394, "sent_id": 110, "sent_start_pos": 17146, "sent_end_pos": 17639, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Additionally, Tyson Ventures backed the company for an undisclosed amount in early 2018. More recently, in a series of patents, the company announced its intention to use the gene-editing technique CRISPR in order to help it develop its lab-grown meat products with even less impact on the environment and even less consumption of land and water. In the future, lab grown meat companies like Memphis Meats could cut production, slaughter, and processing out of the meat production value chain."}
{"meta": {"doc_id": 2394, "sent_id": 111, "sent_start_pos": 17235, "sent_end_pos": 17882, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "More recently, in a series of patents, the company announced its intention to use the gene-editing technique CRISPR in order to help it develop its lab-grown meat products with even less impact on the environment and even less consumption of land and water. In the future, lab grown meat companies like Memphis Meats could cut production, slaughter, and processing out of the meat production value chain. Memphis Meats wasn\u2019t the first company to explore lab-grown meat products: Dr. Mark Post, a Netherlands-based researcher, produced the world\u2019s first lab-grown burger in 2013, in research originally financed by Google\u2019s co-founder Sergey Brin."}
{"meta": {"doc_id": 2394, "sent_id": 112, "sent_start_pos": 17493, "sent_end_pos": 17981, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In the future, lab grown meat companies like Memphis Meats could cut production, slaughter, and processing out of the meat production value chain. Memphis Meats wasn\u2019t the first company to explore lab-grown meat products: Dr. Mark Post, a Netherlands-based researcher, produced the world\u2019s first lab-grown burger in 2013, in research originally financed by Google\u2019s co-founder Sergey Brin. This initiative spun off into MosaMeat, which aims to bring in vitro meat to market in the future."}
{"meta": {"doc_id": 2394, "sent_id": 113, "sent_start_pos": 17640, "sent_end_pos": 18084, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Memphis Meats wasn\u2019t the first company to explore lab-grown meat products: Dr. Mark Post, a Netherlands-based researcher, produced the world\u2019s first lab-grown burger in 2013, in research originally financed by Google\u2019s co-founder Sergey Brin. This initiative spun off into MosaMeat, which aims to bring in vitro meat to market in the future. Another company in this space, New Age Meats, has raised nearly $3M for its lab-grown sausage product."}
{"meta": {"doc_id": 2394, "sent_id": 114, "sent_start_pos": 17883, "sent_end_pos": 18144, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "This initiative spun off into MosaMeat, which aims to bring in vitro meat to market in the future. Another company in this space, New Age Meats, has raised nearly $3M for its lab-grown sausage product. The company plans to put its sausage on the market by 2021."}
{"meta": {"doc_id": 2394, "sent_id": 115, "sent_start_pos": 17982, "sent_end_pos": 18376, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Another company in this space, New Age Meats, has raised nearly $3M for its lab-grown sausage product. The company plans to put its sausage on the market by 2021. Source: MosaMeat\nBoth plant-based meat products and lab-grown \u201cclean\u201d meat have seen notable investors, including some top VCs (Khosla Ventures, Kleiner Perkins Caufield & Byers), meat corporates (Tyson Foods, Cargill), and others."}
{"meta": {"doc_id": 2394, "sent_id": 116, "sent_start_pos": 18085, "sent_end_pos": 18459, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The company plans to put its sausage on the market by 2021. Source: MosaMeat\nBoth plant-based meat products and lab-grown \u201cclean\u201d meat have seen notable investors, including some top VCs (Khosla Ventures, Kleiner Perkins Caufield & Byers), meat corporates (Tyson Foods, Cargill), and others. The regulatory future of lab-grown meat, however, is still a bit of an experiment."}
{"meta": {"doc_id": 2394, "sent_id": 117, "sent_start_pos": 18145, "sent_end_pos": 18670, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Source: MosaMeat\nBoth plant-based meat products and lab-grown \u201cclean\u201d meat have seen notable investors, including some top VCs (Khosla Ventures, Kleiner Perkins Caufield & Byers), meat corporates (Tyson Foods, Cargill), and others. The regulatory future of lab-grown meat, however, is still a bit of an experiment. The USDA regulates meat production and advocates for agriculture, but the potential conflict of interest surrounding lab-grown meat left both the FDA and USDA in charge of oversight of alternatively grown meat."}
{"meta": {"doc_id": 2394, "sent_id": 118, "sent_start_pos": 18377, "sent_end_pos": 18864, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The regulatory future of lab-grown meat, however, is still a bit of an experiment. The USDA regulates meat production and advocates for agriculture, but the potential conflict of interest surrounding lab-grown meat left both the FDA and USDA in charge of oversight of alternatively grown meat. Furthermore, while the environmental benefits of lab-grown meat are potentially dramatic, meatless products are still significantly more expensive on a per-pound basis than animal alternatives."}
{"meta": {"doc_id": 2394, "sent_id": 119, "sent_start_pos": 18460, "sent_end_pos": 18999, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The USDA regulates meat production and advocates for agriculture, but the potential conflict of interest surrounding lab-grown meat left both the FDA and USDA in charge of oversight of alternatively grown meat. Furthermore, while the environmental benefits of lab-grown meat are potentially dramatic, meatless products are still significantly more expensive on a per-pound basis than animal alternatives. Methane-based protein sees early funding\nBiotech companies are even exploring methods for engineering meat-like products from methane."}
{"meta": {"doc_id": 2394, "sent_id": 120, "sent_start_pos": 18671, "sent_end_pos": 19188, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Furthermore, while the environmental benefits of lab-grown meat are potentially dramatic, meatless products are still significantly more expensive on a per-pound basis than animal alternatives. Methane-based protein sees early funding\nBiotech companies are even exploring methods for engineering meat-like products from methane. While companies producing biotech foods are already creating methane-based animal feed, startups are now expressing interest in engineering methane-based protein fit for human consumption."}
{"meta": {"doc_id": 2394, "sent_id": 121, "sent_start_pos": 18865, "sent_end_pos": 19286, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Methane-based protein sees early funding\nBiotech companies are even exploring methods for engineering meat-like products from methane. While companies producing biotech foods are already creating methane-based animal feed, startups are now expressing interest in engineering methane-based protein fit for human consumption. California-based Calysta last raised $45M in 2019, bringing its total disclosed funding to $138M."}
{"meta": {"doc_id": 2394, "sent_id": 122, "sent_start_pos": 19000, "sent_end_pos": 19414, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "While companies producing biotech foods are already creating methane-based animal feed, startups are now expressing interest in engineering methane-based protein fit for human consumption. California-based Calysta last raised $45M in 2019, bringing its total disclosed funding to $138M. The startup manufactures its alternative protein product, which can replace traditional animal feed, by fermenting natural gas."}
{"meta": {"doc_id": 2394, "sent_id": 123, "sent_start_pos": 19189, "sent_end_pos": 19523, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "California-based Calysta last raised $45M in 2019, bringing its total disclosed funding to $138M. The startup manufactures its alternative protein product, which can replace traditional animal feed, by fermenting natural gas. It formed a joint venture with the China-based feed additive manufacturer Bluestar Adisseo in February 2020."}
{"meta": {"doc_id": 2394, "sent_id": 124, "sent_start_pos": 19287, "sent_end_pos": 19751, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The startup manufactures its alternative protein product, which can replace traditional animal feed, by fermenting natural gas. It formed a joint venture with the China-based feed additive manufacturer Bluestar Adisseo in February 2020. India-based String Bio, another startup in the space, has raised funding from Future Food Asia, Ankur Capital, and others to commercialize its technology, which leverages methane to develop alternative proteins for animal feed."}
{"meta": {"doc_id": 2394, "sent_id": 125, "sent_start_pos": 19415, "sent_end_pos": 20232, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "It formed a joint venture with the China-based feed additive manufacturer Bluestar Adisseo in February 2020. India-based String Bio, another startup in the space, has raised funding from Future Food Asia, Ankur Capital, and others to commercialize its technology, which leverages methane to develop alternative proteins for animal feed. \u201cWe\u2019d sell it [protein] to someone else who makes it into a steak-like product, or a fish-like product, or something like a tofu perhaps, that we could grill and eat\u2026\u201d\n\u2013 Ezhil Subbian, Founder & CEO at String Bio\nWhile protein products developed by these companies are not currently fit for human consumption, methane-based proteins could help reduce the environmental impact of meat production, and eventually further fuel the meatless revolution by creating another food source."}
{"meta": {"doc_id": 2394, "sent_id": 126, "sent_start_pos": 19524, "sent_end_pos": 20413, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "India-based String Bio, another startup in the space, has raised funding from Future Food Asia, Ankur Capital, and others to commercialize its technology, which leverages methane to develop alternative proteins for animal feed. \u201cWe\u2019d sell it [protein] to someone else who makes it into a steak-like product, or a fish-like product, or something like a tofu perhaps, that we could grill and eat\u2026\u201d\n\u2013 Ezhil Subbian, Founder & CEO at String Bio\nWhile protein products developed by these companies are not currently fit for human consumption, methane-based proteins could help reduce the environmental impact of meat production, and eventually further fuel the meatless revolution by creating another food source. In line with String Bio CEO Ezhil Subbian\u2019s comment, the first step is creating a methane-based protein that can be marketed to humans and subsequently integrated into their diets."}
{"meta": {"doc_id": 2394, "sent_id": 127, "sent_start_pos": 19752, "sent_end_pos": 20571, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "\u201cWe\u2019d sell it [protein] to someone else who makes it into a steak-like product, or a fish-like product, or something like a tofu perhaps, that we could grill and eat\u2026\u201d\n\u2013 Ezhil Subbian, Founder & CEO at String Bio\nWhile protein products developed by these companies are not currently fit for human consumption, methane-based proteins could help reduce the environmental impact of meat production, and eventually further fuel the meatless revolution by creating another food source. In line with String Bio CEO Ezhil Subbian\u2019s comment, the first step is creating a methane-based protein that can be marketed to humans and subsequently integrated into their diets. Open-source clean meat startups take an alternative route\nSome companies in the meatless space are competing to be first-to-market with animal-free products."}
{"meta": {"doc_id": 2394, "sent_id": 128, "sent_start_pos": 20233, "sent_end_pos": 20774, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In line with String Bio CEO Ezhil Subbian\u2019s comment, the first step is creating a methane-based protein that can be marketed to humans and subsequently integrated into their diets. Open-source clean meat startups take an alternative route\nSome companies in the meatless space are competing to be first-to-market with animal-free products. Taking a different approach, Yuki Hanyu, founder of Tokyo-based Integriculture and nonprofit Shojinmeat Project, is working to acclimate future generations to a meatless future through open-source tech."}
{"meta": {"doc_id": 2394, "sent_id": 129, "sent_start_pos": 20414, "sent_end_pos": 20952, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Open-source clean meat startups take an alternative route\nSome companies in the meatless space are competing to be first-to-market with animal-free products. Taking a different approach, Yuki Hanyu, founder of Tokyo-based Integriculture and nonprofit Shojinmeat Project, is working to acclimate future generations to a meatless future through open-source tech. Hanyu is providing Japanese high school students access to specially designed heated boxes that allow them to culture animal cells at home and grow them into meat-like products."}
{"meta": {"doc_id": 2394, "sent_id": 130, "sent_start_pos": 20572, "sent_end_pos": 21184, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Taking a different approach, Yuki Hanyu, founder of Tokyo-based Integriculture and nonprofit Shojinmeat Project, is working to acclimate future generations to a meatless future through open-source tech. Hanyu is providing Japanese high school students access to specially designed heated boxes that allow them to culture animal cells at home and grow them into meat-like products. The concept may seem far-flung, but the Shojinmeat Project is looking to establish a crowd-sourced, bottom-up approach to meat development that allows people to play with lab-grown meat and ultimately integrate it into their diets."}
{"meta": {"doc_id": 2394, "sent_id": 131, "sent_start_pos": 20775, "sent_end_pos": 21276, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Hanyu is providing Japanese high school students access to specially designed heated boxes that allow them to culture animal cells at home and grow them into meat-like products. The concept may seem far-flung, but the Shojinmeat Project is looking to establish a crowd-sourced, bottom-up approach to meat development that allows people to play with lab-grown meat and ultimately integrate it into their diets. In May 2020, Integriculture raised a $7.5M Series A to further develop its cell-based meat."}
{"meta": {"doc_id": 2394, "sent_id": 132, "sent_start_pos": 20953, "sent_end_pos": 21375, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The concept may seem far-flung, but the Shojinmeat Project is looking to establish a crowd-sourced, bottom-up approach to meat development that allows people to play with lab-grown meat and ultimately integrate it into their diets. In May 2020, Integriculture raised a $7.5M Series A to further develop its cell-based meat. Its first product will be a cell-based foie gras, which it plans to launch in restaurants by 2021."}
{"meta": {"doc_id": 2394, "sent_id": 133, "sent_start_pos": 21185, "sent_end_pos": 21561, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In May 2020, Integriculture raised a $7.5M Series A to further develop its cell-based meat. Its first product will be a cell-based foie gras, which it plans to launch in restaurants by 2021. In February 2020, bioresearch platform Kerafast teamed up with nonprofit Good Food Institute to launch an open-source catalog with \u201crecipes\u201d for sustainable, lab-grown meat and seafood."}
{"meta": {"doc_id": 2394, "sent_id": 134, "sent_start_pos": 21277, "sent_end_pos": 21639, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Its first product will be a cell-based foie gras, which it plans to launch in restaurants by 2021. In February 2020, bioresearch platform Kerafast teamed up with nonprofit Good Food Institute to launch an open-source catalog with \u201crecipes\u201d for sustainable, lab-grown meat and seafood. Dairy & eggs\nOat milk flew off the shelves in the early days of the pandemic."}
{"meta": {"doc_id": 2394, "sent_id": 135, "sent_start_pos": 21376, "sent_end_pos": 21771, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In February 2020, bioresearch platform Kerafast teamed up with nonprofit Good Food Institute to launch an open-source catalog with \u201crecipes\u201d for sustainable, lab-grown meat and seafood. Dairy & eggs\nOat milk flew off the shelves in the early days of the pandemic. But the plant milk craze began long before 2020, as consumers increasingly lean towards plant-based diets and protein alternatives."}
{"meta": {"doc_id": 2394, "sent_id": 136, "sent_start_pos": 21562, "sent_end_pos": 21873, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Dairy & eggs\nOat milk flew off the shelves in the early days of the pandemic. But the plant milk craze began long before 2020, as consumers increasingly lean towards plant-based diets and protein alternatives. Source: Bloomberg\nAmericans are consuming 40% less milk than they did in 1975, according to the USDA."}
{"meta": {"doc_id": 2394, "sent_id": 137, "sent_start_pos": 21640, "sent_end_pos": 22099, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "But the plant milk craze began long before 2020, as consumers increasingly lean towards plant-based diets and protein alternatives. Source: Bloomberg\nAmericans are consuming 40% less milk than they did in 1975, according to the USDA. Dairy alternatives have siphoned greater and greater market share from traditional dairy companies in recent years, squeezing traditional milk companies and even forcing some to begin production of alternative dairy products."}
{"meta": {"doc_id": 2394, "sent_id": 138, "sent_start_pos": 21772, "sent_end_pos": 22164, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Source: Bloomberg\nAmericans are consuming 40% less milk than they did in 1975, according to the USDA. Dairy alternatives have siphoned greater and greater market share from traditional dairy companies in recent years, squeezing traditional milk companies and even forcing some to begin production of alternative dairy products. The pressure has forced 2 major industry players to restructure."}
{"meta": {"doc_id": 2394, "sent_id": 139, "sent_start_pos": 21874, "sent_end_pos": 22304, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Dairy alternatives have siphoned greater and greater market share from traditional dairy companies in recent years, squeezing traditional milk companies and even forcing some to begin production of alternative dairy products. The pressure has forced 2 major industry players to restructure. Dairy icon Dean Foods declared bankruptcy in late 2019 and saw most of its assets snapped up by the Dairy Farmers of America in April 2020."}
{"meta": {"doc_id": 2394, "sent_id": 140, "sent_start_pos": 22100, "sent_end_pos": 22444, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The pressure has forced 2 major industry players to restructure. Dairy icon Dean Foods declared bankruptcy in late 2019 and saw most of its assets snapped up by the Dairy Farmers of America in April 2020. Borden Dairy followed soon after, filing for bankruptcy in January 2020, and was quickly acquired by KKR and a private equity firm in July."}
{"meta": {"doc_id": 2394, "sent_id": 141, "sent_start_pos": 22165, "sent_end_pos": 22556, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Dairy icon Dean Foods declared bankruptcy in late 2019 and saw most of its assets snapped up by the Dairy Farmers of America in April 2020. Borden Dairy followed soon after, filing for bankruptcy in January 2020, and was quickly acquired by KKR and a private equity firm in July. Several startups have capitalized on this trend, raising massive tranches of funding to address surging demand."}
{"meta": {"doc_id": 2394, "sent_id": 142, "sent_start_pos": 22305, "sent_end_pos": 22770, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Borden Dairy followed soon after, filing for bankruptcy in January 2020, and was quickly acquired by KKR and a private equity firm in July. Several startups have capitalized on this trend, raising massive tranches of funding to address surging demand. Pea-protein milk producer Ripple Foods, for example, recently saw a $30M Series D from Google Ventures, Inventages Venture Capital, and Prelude Ventures in June 2020, bringing its total disclosed funding to $151M."}
{"meta": {"doc_id": 2394, "sent_id": 143, "sent_start_pos": 22445, "sent_end_pos": 22880, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Several startups have capitalized on this trend, raising massive tranches of funding to address surging demand. Pea-protein milk producer Ripple Foods, for example, recently saw a $30M Series D from Google Ventures, Inventages Venture Capital, and Prelude Ventures in June 2020, bringing its total disclosed funding to $151M. In April 2020, AI-powered eggless mayo producer NotCo raked in a $33M Series B from Kaszek Ventures and SOSV."}
{"meta": {"doc_id": 2394, "sent_id": 144, "sent_start_pos": 22557, "sent_end_pos": 23016, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Pea-protein milk producer Ripple Foods, for example, recently saw a $30M Series D from Google Ventures, Inventages Venture Capital, and Prelude Ventures in June 2020, bringing its total disclosed funding to $151M. In April 2020, AI-powered eggless mayo producer NotCo raked in a $33M Series B from Kaszek Ventures and SOSV. Another company, Perfect Day, uses fermentation to make cow-free milk."}
{"meta": {"doc_id": 2394, "sent_id": 145, "sent_start_pos": 22771, "sent_end_pos": 23129, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In April 2020, AI-powered eggless mayo producer NotCo raked in a $33M Series B from Kaszek Ventures and SOSV. Another company, Perfect Day, uses fermentation to make cow-free milk. The company most recently raised a second tranche of funding, boosting its Series C to $300M total in July 2020."}
{"meta": {"doc_id": 2394, "sent_id": 146, "sent_start_pos": 22946, "sent_end_pos": 23330, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Another company, Perfect Day, uses fermentation to make cow-free milk. The company most recently raised a second tranche of funding, boosting its Series C to $300M total in July 2020. In 2018, plant-based startup Just (formerly Hampton Creek) started off producing vegan mayo, but has since expanded to vegan eggs, which are sold in select Whole Foods, Fairway, and Walmart locations."}
{"meta": {"doc_id": 2394, "sent_id": 147, "sent_start_pos": 23017, "sent_end_pos": 23465, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The company most recently raised a second tranche of funding, boosting its Series C to $300M total in July 2020. In 2018, plant-based startup Just (formerly Hampton Creek) started off producing vegan mayo, but has since expanded to vegan eggs, which are sold in select Whole Foods, Fairway, and Walmart locations. In February, it also announced a partnership with food provider Sodexo to serve its vegan egg product on campuses and corporate sites."}
{"meta": {"doc_id": 2394, "sent_id": 148, "sent_start_pos": 23130, "sent_end_pos": 23547, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In 2018, plant-based startup Just (formerly Hampton Creek) started off producing vegan mayo, but has since expanded to vegan eggs, which are sold in select Whole Foods, Fairway, and Walmart locations. In February, it also announced a partnership with food provider Sodexo to serve its vegan egg product on campuses and corporate sites. As of June 2020, the company says it has sold the equivalent of 40M chicken eggs."}
{"meta": {"doc_id": 2394, "sent_id": 149, "sent_start_pos": 23331, "sent_end_pos": 23726, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In February, it also announced a partnership with food provider Sodexo to serve its vegan egg product on campuses and corporate sites. As of June 2020, the company says it has sold the equivalent of 40M chicken eggs. Protein innovations\nBeyond meat and dairy substitutes, some startups are developing sustainable food solutions by leveraging alternative protein sources such as algae or insects."}
{"meta": {"doc_id": 2394, "sent_id": 150, "sent_start_pos": 23466, "sent_end_pos": 23916, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "As of June 2020, the company says it has sold the equivalent of 40M chicken eggs. Protein innovations\nBeyond meat and dairy substitutes, some startups are developing sustainable food solutions by leveraging alternative protein sources such as algae or insects. Algae farms gain traction for their sustainability\nAlgae serves as a source of sustainable, nutritious protein that grows rapidly, which has helped it garner some attention in recent years."}
{"meta": {"doc_id": 2394, "sent_id": 151, "sent_start_pos": 23548, "sent_end_pos": 24057, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Protein innovations\nBeyond meat and dairy substitutes, some startups are developing sustainable food solutions by leveraging alternative protein sources such as algae or insects. Algae farms gain traction for their sustainability\nAlgae serves as a source of sustainable, nutritious protein that grows rapidly, which has helped it garner some attention in recent years. Algae farms also avoid the problem of immense land and water usage that most farms face when growing traditional crops or raising livestock."}
{"meta": {"doc_id": 2394, "sent_id": 152, "sent_start_pos": 23727, "sent_end_pos": 24240, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Algae farms gain traction for their sustainability\nAlgae serves as a source of sustainable, nutritious protein that grows rapidly, which has helped it garner some attention in recent years. Algae farms also avoid the problem of immense land and water usage that most farms face when growing traditional crops or raising livestock. While a relatively niche market, companies like Algama Foods or Odontella are capitalizing on algae to make various food and beverage products, such as egg-free mayonnaise or salmon."}
{"meta": {"doc_id": 2394, "sent_id": 153, "sent_start_pos": 23917, "sent_end_pos": 24479, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Algae farms also avoid the problem of immense land and water usage that most farms face when growing traditional crops or raising livestock. While a relatively niche market, companies like Algama Foods or Odontella are capitalizing on algae to make various food and beverage products, such as egg-free mayonnaise or salmon. Source: Algama Foods\nChickpea protein grows popular among health-conscious consumers\nAs consumers clamor for healthier and allergen-free alternatives, chickpeas are a popular source of protein for companies developing vegan food products."}
{"meta": {"doc_id": 2394, "sent_id": 154, "sent_start_pos": 24058, "sent_end_pos": 24559, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "While a relatively niche market, companies like Algama Foods or Odontella are capitalizing on algae to make various food and beverage products, such as egg-free mayonnaise or salmon. Source: Algama Foods\nChickpea protein grows popular among health-conscious consumers\nAs consumers clamor for healthier and allergen-free alternatives, chickpeas are a popular source of protein for companies developing vegan food products. Many plant-based meat brands already use peas to add protein to their products."}
{"meta": {"doc_id": 2394, "sent_id": 155, "sent_start_pos": 24241, "sent_end_pos": 24711, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Source: Algama Foods\nChickpea protein grows popular among health-conscious consumers\nAs consumers clamor for healthier and allergen-free alternatives, chickpeas are a popular source of protein for companies developing vegan food products. Many plant-based meat brands already use peas to add protein to their products. Banza, which raised a $20M Series B round in November 2019, makes chickpea-based pasta, while Hippeas sells chickpea-based snacks like puffs and chips."}
{"meta": {"doc_id": 2394, "sent_id": 156, "sent_start_pos": 24480, "sent_end_pos": 24851, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Many plant-based meat brands already use peas to add protein to their products. Banza, which raised a $20M Series B round in November 2019, makes chickpea-based pasta, while Hippeas sells chickpea-based snacks like puffs and chips. In April 2020, Israel-based chickpea protein company InnovoPro also raised $15M from Jersualem Venture Partners, CPT Capital, among others."}
{"meta": {"doc_id": 2394, "sent_id": 157, "sent_start_pos": 24560, "sent_end_pos": 25042, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Banza, which raised a $20M Series B round in November 2019, makes chickpea-based pasta, while Hippeas sells chickpea-based snacks like puffs and chips. In April 2020, Israel-based chickpea protein company InnovoPro also raised $15M from Jersualem Venture Partners, CPT Capital, among others. Insect protein goes mainstream\nWhile the idea of eating insects is taboo in some countries, bugs and insects are nonetheless growing as a nutritious, environmentally-friendly protein source."}
{"meta": {"doc_id": 2394, "sent_id": 158, "sent_start_pos": 24712, "sent_end_pos": 25233, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In April 2020, Israel-based chickpea protein company InnovoPro also raised $15M from Jersualem Venture Partners, CPT Capital, among others. Insect protein goes mainstream\nWhile the idea of eating insects is taboo in some countries, bugs and insects are nonetheless growing as a nutritious, environmentally-friendly protein source. 2B people around the world eat insects, according to the UN\u2019s Food and Agriculture Organization, and more than 1,000 species of insects and bugs are eaten in 80% of nations around the world."}
{"meta": {"doc_id": 2394, "sent_id": 159, "sent_start_pos": 24852, "sent_end_pos": 25501, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Insect protein goes mainstream\nWhile the idea of eating insects is taboo in some countries, bugs and insects are nonetheless growing as a nutritious, environmentally-friendly protein source. 2B people around the world eat insects, according to the UN\u2019s Food and Agriculture Organization, and more than 1,000 species of insects and bugs are eaten in 80% of nations around the world. To make insect consumption more palatable, startups are using insects as alternative ingredients, eg making flour from crickets, mealworms, and other insects, which can be raised at scale, or using them to produce snacks, protein bars, and even insect-enriched pasta."}
{"meta": {"doc_id": 2394, "sent_id": 160, "sent_start_pos": 25043, "sent_end_pos": 25655, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "2B people around the world eat insects, according to the UN\u2019s Food and Agriculture Organization, and more than 1,000 species of insects and bugs are eaten in 80% of nations around the world. To make insect consumption more palatable, startups are using insects as alternative ingredients, eg making flour from crickets, mealworms, and other insects, which can be raised at scale, or using them to produce snacks, protein bars, and even insect-enriched pasta. Some notable startups in the space include Hargol, which makes protein bars out of locusts, and Entomo Farms, which raises insects for human consumption."}
{"meta": {"doc_id": 2394, "sent_id": 161, "sent_start_pos": 25234, "sent_end_pos": 25778, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "To make insect consumption more palatable, startups are using insects as alternative ingredients, eg making flour from crickets, mealworms, and other insects, which can be raised at scale, or using them to produce snacks, protein bars, and even insect-enriched pasta. Some notable startups in the space include Hargol, which makes protein bars out of locusts, and Entomo Farms, which raises insects for human consumption. Israel-based Flying Spark uses fruit fly larvae to produce protein powders, while Exo produces cricket-based protein bars."}
{"meta": {"doc_id": 2394, "sent_id": 162, "sent_start_pos": 25502, "sent_end_pos": 25923, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Some notable startups in the space include Hargol, which makes protein bars out of locusts, and Entomo Farms, which raises insects for human consumption. Israel-based Flying Spark uses fruit fly larvae to produce protein powders, while Exo produces cricket-based protein bars. It raised $5M before being acquired by Aspire Food Group, an edible insect company operating in both Ghana and the United States, in March 2018."}
{"meta": {"doc_id": 2394, "sent_id": 163, "sent_start_pos": 25656, "sent_end_pos": 26088, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Israel-based Flying Spark uses fruit fly larvae to produce protein powders, while Exo produces cricket-based protein bars. It raised $5M before being acquired by Aspire Food Group, an edible insect company operating in both Ghana and the United States, in March 2018. Chapul, an early player in the protein bar space, exited in the summer of 2019, citing difficulties convincing Western consumers to purchase cricket-based products."}
{"meta": {"doc_id": 2394, "sent_id": 164, "sent_start_pos": 25779, "sent_end_pos": 26312, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "It raised $5M before being acquired by Aspire Food Group, an edible insect company operating in both Ghana and the United States, in March 2018. Chapul, an early player in the protein bar space, exited in the summer of 2019, citing difficulties convincing Western consumers to purchase cricket-based products. Cricket-raising results in 100x lower greenhouse gas emissions than beef cow production, and crickets also have higher proportions of protein than beef or chicken."}
{"meta": {"doc_id": 2394, "sent_id": 165, "sent_start_pos": 25924, "sent_end_pos": 26420, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Chapul, an early player in the protein bar space, exited in the summer of 2019, citing difficulties convincing Western consumers to purchase cricket-based products. Cricket-raising results in 100x lower greenhouse gas emissions than beef cow production, and crickets also have higher proportions of protein than beef or chicken. And because crickets require proportionally less feed than livestock animals, production is more efficient."}
{"meta": {"doc_id": 2394, "sent_id": 166, "sent_start_pos": 26149, "sent_end_pos": 26586, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Cricket-raising results in 100x lower greenhouse gas emissions than beef cow production, and crickets also have higher proportions of protein than beef or chicken. And because crickets require proportionally less feed than livestock animals, production is more efficient. The Oklahoma startup All Things Bugs, founded in 2011, is seeking to develop a finely-milled cricket powder that can be supplemented as a base ingredient in recipes."}
{"meta": {"doc_id": 2394, "sent_id": 167, "sent_start_pos": 26313, "sent_end_pos": 26740, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "And because crickets require proportionally less feed than livestock animals, production is more efficient. The Oklahoma startup All Things Bugs, founded in 2011, is seeking to develop a finely-milled cricket powder that can be supplemented as a base ingredient in recipes. All Thing Bugs has supplied other insect-based food companies that are working in the cricket product space, including the aforementioned Exo and Chapul."}
{"meta": {"doc_id": 2394, "sent_id": 168, "sent_start_pos": 26421, "sent_end_pos": 26882, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The Oklahoma startup All Things Bugs, founded in 2011, is seeking to develop a finely-milled cricket powder that can be supplemented as a base ingredient in recipes. All Thing Bugs has supplied other insect-based food companies that are working in the cricket product space, including the aforementioned Exo and Chapul. San Francisco-based Bitty Foods, which has raised $1.2M in disclosed funding, has a line of snack products that are made with insect powders."}
{"meta": {"doc_id": 2394, "sent_id": 169, "sent_start_pos": 26587, "sent_end_pos": 26990, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "All Thing Bugs has supplied other insect-based food companies that are working in the cricket product space, including the aforementioned Exo and Chapul. San Francisco-based Bitty Foods, which has raised $1.2M in disclosed funding, has a line of snack products that are made with insect powders. The company\u2019s cricket chips use crickets exclusively from US farms specializing in insects for consumption."}
{"meta": {"doc_id": 2394, "sent_id": 170, "sent_start_pos": 26741, "sent_end_pos": 27114, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "San Francisco-based Bitty Foods, which has raised $1.2M in disclosed funding, has a line of snack products that are made with insect powders. The company\u2019s cricket chips use crickets exclusively from US farms specializing in insects for consumption. Insect-based protein brands could eventually displace meat-based snacks by offering healthier and more sustainable options."}
{"meta": {"doc_id": 2394, "sent_id": 171, "sent_start_pos": 26883, "sent_end_pos": 27337, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The company\u2019s cricket chips use crickets exclusively from US farms specializing in insects for consumption. Insect-based protein brands could eventually displace meat-based snacks by offering healthier and more sustainable options. Meal substitutes\nIt\u2019s not just meat substitutes disrupting the traditional food chain: meal replacement alternatives have gained some momentum in the food space, though the hype and momentum have diminished since its peak."}
{"meta": {"doc_id": 2394, "sent_id": 172, "sent_start_pos": 26991, "sent_end_pos": 27512, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Insect-based protein brands could eventually displace meat-based snacks by offering healthier and more sustainable options. Meal substitutes\nIt\u2019s not just meat substitutes disrupting the traditional food chain: meal replacement alternatives have gained some momentum in the food space, though the hype and momentum have diminished since its peak. Among these startups, Soylent leads the pack with over $71M in disclosed funding from investors like Andreessen Horowitz, Lerer Hippeau Ventures, Google Ventures, and others."}
{"meta": {"doc_id": 2394, "sent_id": 173, "sent_start_pos": 27115, "sent_end_pos": 27693, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Meal substitutes\nIt\u2019s not just meat substitutes disrupting the traditional food chain: meal replacement alternatives have gained some momentum in the food space, though the hype and momentum have diminished since its peak. Among these startups, Soylent leads the pack with over $71M in disclosed funding from investors like Andreessen Horowitz, Lerer Hippeau Ventures, Google Ventures, and others. The drink has run into some problems, including a now-lifted ban in Canada, where regulators said it does not meet all of their specific requirements for meal-replacement products."}
{"meta": {"doc_id": 2394, "sent_id": 174, "sent_start_pos": 27338, "sent_end_pos": 27895, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Among these startups, Soylent leads the pack with over $71M in disclosed funding from investors like Andreessen Horowitz, Lerer Hippeau Ventures, Google Ventures, and others. The drink has run into some problems, including a now-lifted ban in Canada, where regulators said it does not meet all of their specific requirements for meal-replacement products. The company has also experienced a management shake up and downsizing \u2014 the CFO replaced the CEO in February, and it also quietly shut down its Food Innovation Lab while downsizing to a smaller office."}
{"meta": {"doc_id": 2394, "sent_id": 175, "sent_start_pos": 27513, "sent_end_pos": 28112, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The drink has run into some problems, including a now-lifted ban in Canada, where regulators said it does not meet all of their specific requirements for meal-replacement products. The company has also experienced a management shake up and downsizing \u2014 the CFO replaced the CEO in February, and it also quietly shut down its Food Innovation Lab while downsizing to a smaller office. It focuses mostly on a D2C model, but is also available in retailers like 7-Eleven, Walmart, Target, and Kroger across the US, and launched in the UK in late 2018."}
{"meta": {"doc_id": 2394, "sent_id": 176, "sent_start_pos": 27694, "sent_end_pos": 28329, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The company has also experienced a management shake up and downsizing \u2014 the CFO replaced the CEO in February, and it also quietly shut down its Food Innovation Lab while downsizing to a smaller office. It focuses mostly on a D2C model, but is also available in retailers like 7-Eleven, Walmart, Target, and Kroger across the US, and launched in the UK in late 2018. Source: Soylent\nThe UK-based Huel, which raised $26M from Highland Europe, launched its product in 2015 and offers a flavored meal replacement shake similar to Soylent\u2019s It also launched a snack bar in December 2019."}
{"meta": {"doc_id": 2394, "sent_id": 177, "sent_start_pos": 27949, "sent_end_pos": 28471, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "It focuses mostly on a D2C model, but is also available in retailers like 7-Eleven, Walmart, Target, and Kroger across the US, and launched in the UK in late 2018. Source: Soylent\nThe UK-based Huel, which raised $26M from Highland Europe, launched its product in 2015 and offers a flavored meal replacement shake similar to Soylent\u2019s It also launched a snack bar in December 2019. The company says it was profitable for the first 3 years of its life, and though it made a loss in 2019, it expects to be profitable in 2020."}
{"meta": {"doc_id": 2394, "sent_id": 178, "sent_start_pos": 28113, "sent_end_pos": 28643, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Source: Soylent\nThe UK-based Huel, which raised $26M from Highland Europe, launched its product in 2015 and offers a flavored meal replacement shake similar to Soylent\u2019s It also launched a snack bar in December 2019. The company says it was profitable for the first 3 years of its life, and though it made a loss in 2019, it expects to be profitable in 2020. San Francisco-based startup Ample Foods raised $2M in seed funding in 2018 and 2 angel rounds over 2019 and 2020, bringing its total disclosed funding total to over $3.4M."}
{"meta": {"doc_id": 2394, "sent_id": 179, "sent_start_pos": 28330, "sent_end_pos": 28798, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The company says it was profitable for the first 3 years of its life, and though it made a loss in 2019, it expects to be profitable in 2020. San Francisco-based startup Ample Foods raised $2M in seed funding in 2018 and 2 angel rounds over 2019 and 2020, bringing its total disclosed funding total to over $3.4M. Ample has taken aim at the plant-based food industry by offering meal replacement products, including a vegan option and one intended for ketogenic diets."}
{"meta": {"doc_id": 2394, "sent_id": 180, "sent_start_pos": 28472, "sent_end_pos": 29037, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "San Francisco-based startup Ample Foods raised $2M in seed funding in 2018 and 2 angel rounds over 2019 and 2020, bringing its total disclosed funding total to over $3.4M. Ample has taken aim at the plant-based food industry by offering meal replacement products, including a vegan option and one intended for ketogenic diets. French powder-based meal replacement startup Feed raised $17M in 2018, bringing its total funding to over $21M, with the goal of propelling its meal-replacement products forward in Europe, with plans for future expansion to other regions."}
{"meta": {"doc_id": 2394, "sent_id": 181, "sent_start_pos": 28644, "sent_end_pos": 29216, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Ample has taken aim at the plant-based food industry by offering meal replacement products, including a vegan option and one intended for ketogenic diets. French powder-based meal replacement startup Feed raised $17M in 2018, bringing its total funding to over $21M, with the goal of propelling its meal-replacement products forward in Europe, with plans for future expansion to other regions. The company offers French-made, vegan, gluten-free, lactose-free, and GMO-free meal-replacement options, with the company saying that it has sold over 2M pounds of powder so far."}
{"meta": {"doc_id": 2394, "sent_id": 182, "sent_start_pos": 28799, "sent_end_pos": 29471, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "French powder-based meal replacement startup Feed raised $17M in 2018, bringing its total funding to over $21M, with the goal of propelling its meal-replacement products forward in Europe, with plans for future expansion to other regions. The company offers French-made, vegan, gluten-free, lactose-free, and GMO-free meal-replacement options, with the company saying that it has sold over 2M pounds of powder so far. Corporates and accelerators back the meatless future\nCorporates bet on new protein sources\nMajor corporations involved in the meat industry are investing in meat innovation, with some of the largest companies even rolling out their own meatless products."}
{"meta": {"doc_id": 2394, "sent_id": 183, "sent_start_pos": 29038, "sent_end_pos": 29616, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The company offers French-made, vegan, gluten-free, lactose-free, and GMO-free meal-replacement options, with the company saying that it has sold over 2M pounds of powder so far. Corporates and accelerators back the meatless future\nCorporates bet on new protein sources\nMajor corporations involved in the meat industry are investing in meat innovation, with some of the largest companies even rolling out their own meatless products. In early 2020, JBS USA\u2019s subsidiary, Planterra Foods, launched Ozo, a plant-based protein brand that offers burgers, meatballs, and ground meat."}
{"meta": {"doc_id": 2394, "sent_id": 184, "sent_start_pos": 29217, "sent_end_pos": 29814, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Corporates and accelerators back the meatless future\nCorporates bet on new protein sources\nMajor corporations involved in the meat industry are investing in meat innovation, with some of the largest companies even rolling out their own meatless products. In early 2020, JBS USA\u2019s subsidiary, Planterra Foods, launched Ozo, a plant-based protein brand that offers burgers, meatballs, and ground meat. Tyson, the world\u2019s second-largest meat processor, sells both plant-based alternatives, such as meatless chicken nuggets and plant-based shellfish, as well as blended, part-meat, part-plant options."}
{"meta": {"doc_id": 2394, "sent_id": 185, "sent_start_pos": 29472, "sent_end_pos": 29916, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In early 2020, JBS USA\u2019s subsidiary, Planterra Foods, launched Ozo, a plant-based protein brand that offers burgers, meatballs, and ground meat. Tyson, the world\u2019s second-largest meat processor, sells both plant-based alternatives, such as meatless chicken nuggets and plant-based shellfish, as well as blended, part-meat, part-plant options. Smithfield also manufactures a line of soy-based protein, and Hormel is selling meatless ground meat."}
{"meta": {"doc_id": 2394, "sent_id": 186, "sent_start_pos": 29617, "sent_end_pos": 30082, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Tyson, the world\u2019s second-largest meat processor, sells both plant-based alternatives, such as meatless chicken nuggets and plant-based shellfish, as well as blended, part-meat, part-plant options. Smithfield also manufactures a line of soy-based protein, and Hormel is selling meatless ground meat. Food-trading giant Cargill, which previously invested in Memphis Meats, announced in early 2020 that it would roll out faux meat patties made of pea and soy protein."}
{"meta": {"doc_id": 2394, "sent_id": 187, "sent_start_pos": 29815, "sent_end_pos": 30309, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Smithfield also manufactures a line of soy-based protein, and Hormel is selling meatless ground meat. Food-trading giant Cargill, which previously invested in Memphis Meats, announced in early 2020 that it would roll out faux meat patties made of pea and soy protein. Major food conglomerates are also jumping on the opportunity to invest in the plant-based trend, either by rolling out new product lines or investing in plant-based companies."}
{"meta": {"doc_id": 2394, "sent_id": 188, "sent_start_pos": 29917, "sent_end_pos": 30454, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Food-trading giant Cargill, which previously invested in Memphis Meats, announced in early 2020 that it would roll out faux meat patties made of pea and soy protein. Major food conglomerates are also jumping on the opportunity to invest in the plant-based trend, either by rolling out new product lines or investing in plant-based companies. Nestle, which has introduced a veggie burger, said in May 2020 that it plans to infuse $100M into building a plant-based food facility in China."}
{"meta": {"doc_id": 2394, "sent_id": 189, "sent_start_pos": 30134, "sent_end_pos": 30614, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Major food conglomerates are also jumping on the opportunity to invest in the plant-based trend, either by rolling out new product lines or investing in plant-based companies. Nestle, which has introduced a veggie burger, said in May 2020 that it plans to infuse $100M into building a plant-based food facility in China. General Mills\u2019 venture capital arm, 301 Inc, has infused cash into several plant-based food brands, such as Gathered Foods, Kite Hill, No Cow, and Beyond Meat."}
{"meta": {"doc_id": 2394, "sent_id": 190, "sent_start_pos": 30310, "sent_end_pos": 30718, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Nestle, which has introduced a veggie burger, said in May 2020 that it plans to infuse $100M into building a plant-based food facility in China. General Mills\u2019 venture capital arm, 301 Inc, has infused cash into several plant-based food brands, such as Gathered Foods, Kite Hill, No Cow, and Beyond Meat. In late 2019, Kellogg\u2019s launched a soy-based meat brand, Incogmeato, which offers burgers and sausages."}
{"meta": {"doc_id": 2394, "sent_id": 191, "sent_start_pos": 30455, "sent_end_pos": 30895, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "General Mills\u2019 venture capital arm, 301 Inc, has infused cash into several plant-based food brands, such as Gathered Foods, Kite Hill, No Cow, and Beyond Meat. In late 2019, Kellogg\u2019s launched a soy-based meat brand, Incogmeato, which offers burgers and sausages. Large grocery chains also began selling plant-based meat products, and more retailers, including Kroger, Wegmans, and Loblaw, have launched private label plant-based offerings."}
{"meta": {"doc_id": 2394, "sent_id": 192, "sent_start_pos": 30615, "sent_end_pos": 31049, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In late 2019, Kellogg\u2019s launched a soy-based meat brand, Incogmeato, which offers burgers and sausages. Large grocery chains also began selling plant-based meat products, and more retailers, including Kroger, Wegmans, and Loblaw, have launched private label plant-based offerings. Some have set their sights beyond the US, with PepsiCo snapping up Chinese snack company Be & Cheery, which offers plant-based sausage, in February 2020."}
{"meta": {"doc_id": 2394, "sent_id": 193, "sent_start_pos": 30719, "sent_end_pos": 31445, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Large grocery chains also began selling plant-based meat products, and more retailers, including Kroger, Wegmans, and Loblaw, have launched private label plant-based offerings. Some have set their sights beyond the US, with PepsiCo snapping up Chinese snack company Be & Cheery, which offers plant-based sausage, in February 2020. \u201cPlant-based protein is growing almost, at this point, a little faster than animal-based, so I think the migration may continue in that direction.\u201d\n\u2013 Tom Hayes CEO, Tyson Foods\nAdditionally, the rise of corporate-backed funds with a strong emphasis on alternative meat production and innovation, such as Tyson Ventures, indicates that meat producers foresee the possibility of a meatless future."}
{"meta": {"doc_id": 2394, "sent_id": 194, "sent_start_pos": 30896, "sent_end_pos": 31569, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Some have set their sights beyond the US, with PepsiCo snapping up Chinese snack company Be & Cheery, which offers plant-based sausage, in February 2020. \u201cPlant-based protein is growing almost, at this point, a little faster than animal-based, so I think the migration may continue in that direction.\u201d\n\u2013 Tom Hayes CEO, Tyson Foods\nAdditionally, the rise of corporate-backed funds with a strong emphasis on alternative meat production and innovation, such as Tyson Ventures, indicates that meat producers foresee the possibility of a meatless future. Tyson Ventures has made multiple investments in Beyond Meat, but exited before the plant-based protein company went public."}
{"meta": {"doc_id": 2394, "sent_id": 195, "sent_start_pos": 31050, "sent_end_pos": 31721, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "\u201cPlant-based protein is growing almost, at this point, a little faster than animal-based, so I think the migration may continue in that direction.\u201d\n\u2013 Tom Hayes CEO, Tyson Foods\nAdditionally, the rise of corporate-backed funds with a strong emphasis on alternative meat production and innovation, such as Tyson Ventures, indicates that meat producers foresee the possibility of a meatless future. Tyson Ventures has made multiple investments in Beyond Meat, but exited before the plant-based protein company went public. Tyson has since invested in other similar companies, like Memphis Meats, the Israel-based Future Meat Technologies, MycoTechnology, and New Wave Foods."}
{"meta": {"doc_id": 2394, "sent_id": 196, "sent_start_pos": 31446, "sent_end_pos": 31856, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Tyson Ventures has made multiple investments in Beyond Meat, but exited before the plant-based protein company went public. Tyson has since invested in other similar companies, like Memphis Meats, the Israel-based Future Meat Technologies, MycoTechnology, and New Wave Foods. With the launch of this \u201cInternet of Food\u201d fund, Tyson appears to be looking to pivot from a meat producer to a broader protein brand."}
{"meta": {"doc_id": 2394, "sent_id": 197, "sent_start_pos": 31570, "sent_end_pos": 32026, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Tyson has since invested in other similar companies, like Memphis Meats, the Israel-based Future Meat Technologies, MycoTechnology, and New Wave Foods. With the launch of this \u201cInternet of Food\u201d fund, Tyson appears to be looking to pivot from a meat producer to a broader protein brand. VC bets point to a meatless-minded future\nBeyond corporates, venture capital firms and accelerators are also funding research and development into these high-tech foods."}
{"meta": {"doc_id": 2394, "sent_id": 198, "sent_start_pos": 31722, "sent_end_pos": 32239, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "With the launch of this \u201cInternet of Food\u201d fund, Tyson appears to be looking to pivot from a meat producer to a broader protein brand. VC bets point to a meatless-minded future\nBeyond corporates, venture capital firms and accelerators are also funding research and development into these high-tech foods. Biotech accelerator IndieBio has placed many bets in animal-free foods, with notable investments in Memphis Meats, New Wave Foods, and Finless Foods, as well as startups focusing on dairy and gelatin substitutes."}
{"meta": {"doc_id": 2394, "sent_id": 199, "sent_start_pos": 31857, "sent_end_pos": 32460, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "VC bets point to a meatless-minded future\nBeyond corporates, venture capital firms and accelerators are also funding research and development into these high-tech foods. Biotech accelerator IndieBio has placed many bets in animal-free foods, with notable investments in Memphis Meats, New Wave Foods, and Finless Foods, as well as startups focusing on dairy and gelatin substitutes. Early-stage venture capital fund New Crop Capital funds startups that develop cultured and plant-based meat, dairy, and egg products, along with service companies that facilitate the promotion and sale of these products."}
{"meta": {"doc_id": 2394, "sent_id": 200, "sent_start_pos": 32027, "sent_end_pos": 32924, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Biotech accelerator IndieBio has placed many bets in animal-free foods, with notable investments in Memphis Meats, New Wave Foods, and Finless Foods, as well as startups focusing on dairy and gelatin substitutes. Early-stage venture capital fund New Crop Capital funds startups that develop cultured and plant-based meat, dairy, and egg products, along with service companies that facilitate the promotion and sale of these products. New Crop Capital\u2019s investments include participating in a $10M investment for plant-based seafood company Good Catch (which is run by the founder of New Crop Capital), multiple seed rounds for packaged plant-based foods company Alpha Foods, and participation in lab-cultured meat startup Memphis Meats\u2019 $17M Series A\nBig Idea Ventures is a hybrid venture firm that also offers an accelerator program, with a focus on plant-based food/alternative protein startups."}
{"meta": {"doc_id": 2394, "sent_id": 201, "sent_start_pos": 32240, "sent_end_pos": 33042, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Early-stage venture capital fund New Crop Capital funds startups that develop cultured and plant-based meat, dairy, and egg products, along with service companies that facilitate the promotion and sale of these products. New Crop Capital\u2019s investments include participating in a $10M investment for plant-based seafood company Good Catch (which is run by the founder of New Crop Capital), multiple seed rounds for packaged plant-based foods company Alpha Foods, and participation in lab-cultured meat startup Memphis Meats\u2019 $17M Series A\nBig Idea Ventures is a hybrid venture firm that also offers an accelerator program, with a focus on plant-based food/alternative protein startups. It closed a $50M fund in May 2019 to invest in plant-based foods, and most recently closed a $6.5M fund in June 2020."}
{"meta": {"doc_id": 2394, "sent_id": 202, "sent_start_pos": 32461, "sent_end_pos": 33168, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "New Crop Capital\u2019s investments include participating in a $10M investment for plant-based seafood company Good Catch (which is run by the founder of New Crop Capital), multiple seed rounds for packaged plant-based foods company Alpha Foods, and participation in lab-cultured meat startup Memphis Meats\u2019 $17M Series A\nBig Idea Ventures is a hybrid venture firm that also offers an accelerator program, with a focus on plant-based food/alternative protein startups. It closed a $50M fund in May 2019 to invest in plant-based foods, and most recently closed a $6.5M fund in June 2020. It\u2019s backed by Tyson Foods, Temasek, the Singaporean government\u2019s venture arm, and plant equipment manufacturer B\u00fchler Group."}
{"meta": {"doc_id": 2394, "sent_id": 203, "sent_start_pos": 32925, "sent_end_pos": 33339, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "It closed a $50M fund in May 2019 to invest in plant-based foods, and most recently closed a $6.5M fund in June 2020. It\u2019s backed by Tyson Foods, Temasek, the Singaporean government\u2019s venture arm, and plant equipment manufacturer B\u00fchler Group. The meatless revolution is global\nThe greatest concentration of alternative meat deals has occurred in the US, which is home to a well-developed food and beverage sector."}
{"meta": {"doc_id": 2394, "sent_id": 204, "sent_start_pos": 33043, "sent_end_pos": 33436, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "It\u2019s backed by Tyson Foods, Temasek, the Singaporean government\u2019s venture arm, and plant equipment manufacturer B\u00fchler Group. The meatless revolution is global\nThe greatest concentration of alternative meat deals has occurred in the US, which is home to a well-developed food and beverage sector. At the same time, there are also developed and fast-growing meatless markets in Europe and Asia."}
{"meta": {"doc_id": 2394, "sent_id": 205, "sent_start_pos": 33169, "sent_end_pos": 33632, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The meatless revolution is global\nThe greatest concentration of alternative meat deals has occurred in the US, which is home to a well-developed food and beverage sector. At the same time, there are also developed and fast-growing meatless markets in Europe and Asia. As Covid-19 has an increasingly negative impact on the meat industry, Chinese consumers are also opting for animal-free alternatives \u2014 and US-based companies are looking to break into the market."}
{"meta": {"doc_id": 2394, "sent_id": 206, "sent_start_pos": 33340, "sent_end_pos": 33838, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "At the same time, there are also developed and fast-growing meatless markets in Europe and Asia. As Covid-19 has an increasingly negative impact on the meat industry, Chinese consumers are also opting for animal-free alternatives \u2014 and US-based companies are looking to break into the market. Sales of Just\u2019s egg product on JD.com and Tmall have reportedly jumped 30% since the outbreak, while companies like Impossible Foods and Beyond Meat are working to launch their products in mainland stores."}
{"meta": {"doc_id": 2394, "sent_id": 207, "sent_start_pos": 33437, "sent_end_pos": 33980, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "As Covid-19 has an increasingly negative impact on the meat industry, Chinese consumers are also opting for animal-free alternatives \u2014 and US-based companies are looking to break into the market. Sales of Just\u2019s egg product on JD.com and Tmall have reportedly jumped 30% since the outbreak, while companies like Impossible Foods and Beyond Meat are working to launch their products in mainland stores. But competition is fierce, with local companies like Whole Perfect Food, Jinzi Ham Company, and Zhenmeat also looking to dominate the market."}
{"meta": {"doc_id": 2394, "sent_id": 208, "sent_start_pos": 33633, "sent_end_pos": 34221, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Sales of Just\u2019s egg product on JD.com and Tmall have reportedly jumped 30% since the outbreak, while companies like Impossible Foods and Beyond Meat are working to launch their products in mainland stores. But competition is fierce, with local companies like Whole Perfect Food, Jinzi Ham Company, and Zhenmeat also looking to dominate the market. In September 2017, China announced a $300M deal to import lab-grown meat from 3 Israel-based companies \u2014 SuperMeat, Future Meat Technologies, and Meat the Future \u2014 as part of a broader plan to decrease the country\u2019s meat consumption by 50%."}
{"meta": {"doc_id": 2394, "sent_id": 209, "sent_start_pos": 33839, "sent_end_pos": 34482, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "But competition is fierce, with local companies like Whole Perfect Food, Jinzi Ham Company, and Zhenmeat also looking to dominate the market. In September 2017, China announced a $300M deal to import lab-grown meat from 3 Israel-based companies \u2014 SuperMeat, Future Meat Technologies, and Meat the Future \u2014 as part of a broader plan to decrease the country\u2019s meat consumption by 50%. Regulation is also starting to play a bigger role, as regulators explore cellular agriculture as a viable food source in the future and individual US states, particularly in meat-producing regions, respond to the economic forces represented by meatless trends."}
{"meta": {"doc_id": 2394, "sent_id": 210, "sent_start_pos": 33981, "sent_end_pos": 34751, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In September 2017, China announced a $300M deal to import lab-grown meat from 3 Israel-based companies \u2014 SuperMeat, Future Meat Technologies, and Meat the Future \u2014 as part of a broader plan to decrease the country\u2019s meat consumption by 50%. Regulation is also starting to play a bigger role, as regulators explore cellular agriculture as a viable food source in the future and individual US states, particularly in meat-producing regions, respond to the economic forces represented by meatless trends. In March 2017, the National Academies of Sciences, Engineering, and Medicine in Washington, DC released a report on the future of biotechnology developments and regulation, while the White House launched a review of how US agencies regulate agricultural biotechnology."}
{"meta": {"doc_id": 2394, "sent_id": 211, "sent_start_pos": 34222, "sent_end_pos": 34980, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Regulation is also starting to play a bigger role, as regulators explore cellular agriculture as a viable food source in the future and individual US states, particularly in meat-producing regions, respond to the economic forces represented by meatless trends. In March 2017, the National Academies of Sciences, Engineering, and Medicine in Washington, DC released a report on the future of biotechnology developments and regulation, while the White House launched a review of how US agencies regulate agricultural biotechnology. Legislation seeking to prevent plant-based meat products from being labeled as \u201cmeat\u201d or \u201cbeef\u201d is now being developed in around half the states in the US, with successful bills passing in several prolific meat-producing states."}
{"meta": {"doc_id": 2394, "sent_id": 212, "sent_start_pos": 34483, "sent_end_pos": 35133, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In March 2017, the National Academies of Sciences, Engineering, and Medicine in Washington, DC released a report on the future of biotechnology developments and regulation, while the White House launched a review of how US agencies regulate agricultural biotechnology. Legislation seeking to prevent plant-based meat products from being labeled as \u201cmeat\u201d or \u201cbeef\u201d is now being developed in around half the states in the US, with successful bills passing in several prolific meat-producing states. In March 2019, the FDA and USDA announced a framework to regulate cell-based meat, outlining a transparent path to market for cell-based meat companies."}
{"meta": {"doc_id": 2394, "sent_id": 213, "sent_start_pos": 34752, "sent_end_pos": 35201, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Legislation seeking to prevent plant-based meat products from being labeled as \u201cmeat\u201d or \u201cbeef\u201d is now being developed in around half the states in the US, with successful bills passing in several prolific meat-producing states. In March 2019, the FDA and USDA announced a framework to regulate cell-based meat, outlining a transparent path to market for cell-based meat companies. As of now, artificial meat regulation is still in the early stages."}
{"meta": {"doc_id": 2394, "sent_id": 214, "sent_start_pos": 34981, "sent_end_pos": 35357, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In March 2019, the FDA and USDA announced a framework to regulate cell-based meat, outlining a transparent path to market for cell-based meat companies. As of now, artificial meat regulation is still in the early stages. Regulatory responsibility in an animal-free ecosystem could extend across multiple bodies, as biotechnology for food overlaps with many regulatory systems."}
{"meta": {"doc_id": 2394, "sent_id": 215, "sent_start_pos": 35134, "sent_end_pos": 35496, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "As of now, artificial meat regulation is still in the early stages. Regulatory responsibility in an animal-free ecosystem could extend across multiple bodies, as biotechnology for food overlaps with many regulatory systems. Alternatively, a single regulatory agency could be created in the future to deal with the unique challenges of artificial meat regulation."}
{"meta": {"doc_id": 2394, "sent_id": 216, "sent_start_pos": 35202, "sent_end_pos": 35630, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Regulatory responsibility in an animal-free ecosystem could extend across multiple bodies, as biotechnology for food overlaps with many regulatory systems. Alternatively, a single regulatory agency could be created in the future to deal with the unique challenges of artificial meat regulation. Challenges\nWhile plant-based products and other protein sources are taking off, lab-grown meat, in particular, faces a few obstacles."}
{"meta": {"doc_id": 2394, "sent_id": 217, "sent_start_pos": 35358, "sent_end_pos": 35805, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Alternatively, a single regulatory agency could be created in the future to deal with the unique challenges of artificial meat regulation. Challenges\nWhile plant-based products and other protein sources are taking off, lab-grown meat, in particular, faces a few obstacles. Many consumers face a psychological barrier towards eating lab-grown foods and may prefer the familiar taste of traditional meat products."}
{"meta": {"doc_id": 2394, "sent_id": 218, "sent_start_pos": 35497, "sent_end_pos": 35979, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Challenges\nWhile plant-based products and other protein sources are taking off, lab-grown meat, in particular, faces a few obstacles. Many consumers face a psychological barrier towards eating lab-grown foods and may prefer the familiar taste of traditional meat products. While groups like the aforementioned Shojinmeat Project are looking to acclimate future consumers to cultured meat, this socialization will need to happen on a global scale."}
{"meta": {"doc_id": 2394, "sent_id": 219, "sent_start_pos": 35667, "sent_end_pos": 36135, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Many consumers face a psychological barrier towards eating lab-grown foods and may prefer the familiar taste of traditional meat products. While groups like the aforementioned Shojinmeat Project are looking to acclimate future consumers to cultured meat, this socialization will need to happen on a global scale. Cost remains a largely prohibitive factor, with high-tech meat alternatives priced as luxury goods."}
{"meta": {"doc_id": 2394, "sent_id": 220, "sent_start_pos": 35806, "sent_end_pos": 36268, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "While groups like the aforementioned Shojinmeat Project are looking to acclimate future consumers to cultured meat, this socialization will need to happen on a global scale. Cost remains a largely prohibitive factor, with high-tech meat alternatives priced as luxury goods. One of the main reasons that lab-grown meat is so expensive is due to fetal bovine serum, or FBS, being prevalent in these products."}
{"meta": {"doc_id": 2394, "sent_id": 221, "sent_start_pos": 36036, "sent_end_pos": 36361, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Cost remains a largely prohibitive factor, with high-tech meat alternatives priced as luxury goods. One of the main reasons that lab-grown meat is so expensive is due to fetal bovine serum, or FBS, being prevalent in these products. FBS, which is extracted from cow fetuses, is a core and costly ingredient in lab-grown meat."}
{"meta": {"doc_id": 2394, "sent_id": 222, "sent_start_pos": 36136, "sent_end_pos": 36458, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "One of the main reasons that lab-grown meat is so expensive is due to fetal bovine serum, or FBS, being prevalent in these products. FBS, which is extracted from cow fetuses, is a core and costly ingredient in lab-grown meat. However, startups are looking to eliminate FBS from the meatless equation in order to cut costs."}
{"meta": {"doc_id": 2394, "sent_id": 223, "sent_start_pos": 36269, "sent_end_pos": 36637, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "FBS, which is extracted from cow fetuses, is a core and costly ingredient in lab-grown meat. However, startups are looking to eliminate FBS from the meatless equation in order to cut costs. Just has reported that it has developed a method to grow cell-cultured chicken without FBS, while Memphis Meats is validating methods to produce its meats without the ingredient."}
{"meta": {"doc_id": 2394, "sent_id": 224, "sent_start_pos": 36362, "sent_end_pos": 36936, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "However, startups are looking to eliminate FBS from the meatless equation in order to cut costs. Just has reported that it has developed a method to grow cell-cultured chicken without FBS, while Memphis Meats is validating methods to produce its meats without the ingredient. Though many startups in the space claim that their products will revolutionize meat consumption, the question remains whether clean meat will provide a scalable method to feed the future \u2014 or whether it\u2019s simply a new wave of molecular gastronomy."}
{"meta": {"doc_id": 2394, "sent_id": 225, "sent_start_pos": 36459, "sent_end_pos": 37041, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Just has reported that it has developed a method to grow cell-cultured chicken without FBS, while Memphis Meats is validating methods to produce its meats without the ingredient. Though many startups in the space claim that their products will revolutionize meat consumption, the question remains whether clean meat will provide a scalable method to feed the future \u2014 or whether it\u2019s simply a new wave of molecular gastronomy. The aforementioned cost considerations are crucial in scaling these products for mainstream consumption."}
{"meta": {"doc_id": 2394, "sent_id": 226, "sent_start_pos": 36689, "sent_end_pos": 37115, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Though many startups in the space claim that their products will revolutionize meat consumption, the question remains whether clean meat will provide a scalable method to feed the future \u2014 or whether it\u2019s simply a new wave of molecular gastronomy. The aforementioned cost considerations are crucial in scaling these products for mainstream consumption. Furthermore, will meatless products really be better for the environment?"}
{"meta": {"doc_id": 2394, "sent_id": 227, "sent_start_pos": 36937, "sent_end_pos": 37292, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The aforementioned cost considerations are crucial in scaling these products for mainstream consumption. Furthermore, will meatless products really be better for the environment? Despite claims that less meat consumption will reduce environmental impact, lab-based technologies come with their own high costs for electricity, heating, and other resources."}
{"meta": {"doc_id": 2394, "sent_id": 228, "sent_start_pos": 37042, "sent_end_pos": 37397, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Furthermore, will meatless products really be better for the environment? Despite claims that less meat consumption will reduce environmental impact, lab-based technologies come with their own high costs for electricity, heating, and other resources. The automation of meat production could have far-reaching job implications for the agriculture industry."}
{"meta": {"doc_id": 2394, "sent_id": 229, "sent_start_pos": 37116, "sent_end_pos": 37589, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Despite claims that less meat consumption will reduce environmental impact, lab-based technologies come with their own high costs for electricity, heating, and other resources. The automation of meat production could have far-reaching job implications for the agriculture industry. The meat sector is the largest employer within US agriculture, and mainstream meatless consumption could create economic challenges that eliminate jobs across the meat production value chain."}
{"meta": {"doc_id": 2394, "sent_id": 230, "sent_start_pos": 37293, "sent_end_pos": 37728, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The automation of meat production could have far-reaching job implications for the agriculture industry. The meat sector is the largest employer within US agriculture, and mainstream meatless consumption could create economic challenges that eliminate jobs across the meat production value chain. Meat producers, lobbyists, and other bodies have a great deal at risk when considering the effects of automation across the meat industry."}
{"meta": {"doc_id": 2394, "sent_id": 231, "sent_start_pos": 37398, "sent_end_pos": 37789, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "The meat sector is the largest employer within US agriculture, and mainstream meatless consumption could create economic challenges that eliminate jobs across the meat production value chain. Meat producers, lobbyists, and other bodies have a great deal at risk when considering the effects of automation across the meat industry. Where the meatless revolution is headed next\nThe race is on."}
{"meta": {"doc_id": 2394, "sent_id": 232, "sent_start_pos": 37590, "sent_end_pos": 37901, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Meat producers, lobbyists, and other bodies have a great deal at risk when considering the effects of automation across the meat industry. Where the meatless revolution is headed next\nThe race is on. Cost and scale are immediate considerations in moving these products from novelty purchases to kitchen staples."}
{"meta": {"doc_id": 2394, "sent_id": 233, "sent_start_pos": 37729, "sent_end_pos": 38089, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Where the meatless revolution is headed next\nThe race is on. Cost and scale are immediate considerations in moving these products from novelty purchases to kitchen staples. This issue is particularly urgent when attached to the $1.6T annual bill in economic costs that meat consumption could rack up globally by 2050, according to a University of Oxford study."}
{"meta": {"doc_id": 2394, "sent_id": 234, "sent_start_pos": 37790, "sent_end_pos": 38190, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Cost and scale are immediate considerations in moving these products from novelty purchases to kitchen staples. This issue is particularly urgent when attached to the $1.6T annual bill in economic costs that meat consumption could rack up globally by 2050, according to a University of Oxford study. In the next few years, we can likely expect to see the cost of lab-grown meat decrease considerably."}
{"meta": {"doc_id": 2394, "sent_id": 235, "sent_start_pos": 37902, "sent_end_pos": 38333, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "This issue is particularly urgent when attached to the $1.6T annual bill in economic costs that meat consumption could rack up globally by 2050, according to a University of Oxford study. In the next few years, we can likely expect to see the cost of lab-grown meat decrease considerably. From there, it\u2019s just a matter of which companies will get their products to market first and best position their products as worth the price."}
{"meta": {"doc_id": 2394, "sent_id": 236, "sent_start_pos": 38090, "sent_end_pos": 38499, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "In the next few years, we can likely expect to see the cost of lab-grown meat decrease considerably. From there, it\u2019s just a matter of which companies will get their products to market first and best position their products as worth the price. Continued advances in genetic engineering and plant-based innovation will enhance the taste, flavor, and healthiness of meatless products to incentivize consumption."}
{"meta": {"doc_id": 2394, "sent_id": 237, "sent_start_pos": 38191, "sent_end_pos": 38626, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "From there, it\u2019s just a matter of which companies will get their products to market first and best position their products as worth the price. Continued advances in genetic engineering and plant-based innovation will enhance the taste, flavor, and healthiness of meatless products to incentivize consumption. These technologies will also continue to expand across largely untouched meat and seafood categories (eg pork, duck, and eel)."}
{"meta": {"doc_id": 2394, "sent_id": 238, "sent_start_pos": 38334, "sent_end_pos": 38741, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Continued advances in genetic engineering and plant-based innovation will enhance the taste, flavor, and healthiness of meatless products to incentivize consumption. These technologies will also continue to expand across largely untouched meat and seafood categories (eg pork, duck, and eel). We could see direct competitors to meat incumbent brands across virtually all frozen and prepared food categories."}
{"meta": {"doc_id": 2394, "sent_id": 239, "sent_start_pos": 38500, "sent_end_pos": 38933, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "These technologies will also continue to expand across largely untouched meat and seafood categories (eg pork, duck, and eel). We could see direct competitors to meat incumbent brands across virtually all frozen and prepared food categories. Amid Covid-19-induced shortages and the heightened consumer focus on ethical consumption, alternative meat products are seeing soaring interest, capturing investor and public attention alike."}
{"meta": {"doc_id": 2394, "sent_id": 240, "sent_start_pos": 38627, "sent_end_pos": 39569, "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "We could see direct competitors to meat incumbent brands across virtually all frozen and prepared food categories. Amid Covid-19-induced shortages and the heightened consumer focus on ethical consumption, alternative meat products are seeing soaring interest, capturing investor and public attention alike. This report was created with data from CB Insights\u2019 emerging technology insights platform, which offers clarity into emerging tech and new business strategies through tools like:\n- Earnings Transcripts Search Engine & Analytics to get an information edge on competitors\u2019 and incumbents\u2019 strategies\n- Patent Analytics to see where innovation is happening next\n- Company Mosaic Scores to evaluate startup health, based on our National Science Foundation-backed algorithm\n- Business Relationships to quickly see a company\u2019s competitors, partners, and more\n- Market Sizing Tools to visualize market growth and spot the next big opportunity"}
{"meta": {"doc_id": 2394, "sent_id": 241, "sent_start_pos": 38742, "sent_end_pos": [], "title": "Our Meatless Future: How The $1.8T Global Meat Market Gets Disrupted"}, "text": "Amid Covid-19-induced shortages and the heightened consumer focus on ethical consumption, alternative meat products are seeing soaring interest, capturing investor and public attention alike. This report was created with data from CB Insights\u2019 emerging technology insights platform, which offers clarity into emerging tech and new business strategies through tools like:\n- Earnings Transcripts Search Engine & Analytics to get an information edge on competitors\u2019 and incumbents\u2019 strategies\n- Patent Analytics to see where innovation is happening next\n- Company Mosaic Scores to evaluate startup health, based on our National Science Foundation-backed algorithm\n- Business Relationships to quickly see a company\u2019s competitors, partners, and more\n- Market Sizing Tools to visualize market growth and spot the next big opportunity "}
{"meta": {"doc_id": 2395, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 497, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": " Kerry Acquires Plant Protein Biotechnology Company Pevesa\nNAAS, Ireland\u2014 Kerry, the Taste & Nutrition company, is pleased to officially announce that it has expanded its non-allergenic and organic plant protein capability by acquiring the Spanish company Pevesa Biotech. The acquisition enhances Kerry\u2019s leadership position in the hydrolysed plant protein space for specialized nutrition, and expands the company\u2019s capacity to serve the rapidly growing, high-quality, organic plant protein market."}
{"meta": {"doc_id": 2395, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 662, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "Kerry Acquires Plant Protein Biotechnology Company Pevesa\nNAAS, Ireland\u2014 Kerry, the Taste & Nutrition company, is pleased to officially announce that it has expanded its non-allergenic and organic plant protein capability by acquiring the Spanish company Pevesa Biotech. The acquisition enhances Kerry\u2019s leadership position in the hydrolysed plant protein space for specialized nutrition, and expands the company\u2019s capacity to serve the rapidly growing, high-quality, organic plant protein market. Based in Spain, Pevesa Biotech is a well-established global leader in non-allergenic, non-GMO plant proteins for the infant, general and clinical nutrition markets."}
{"meta": {"doc_id": 2395, "sent_id": 2, "sent_start_pos": 271, "sent_end_pos": 859, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "The acquisition enhances Kerry\u2019s leadership position in the hydrolysed plant protein space for specialized nutrition, and expands the company\u2019s capacity to serve the rapidly growing, high-quality, organic plant protein market. Based in Spain, Pevesa Biotech is a well-established global leader in non-allergenic, non-GMO plant proteins for the infant, general and clinical nutrition markets. Pevesa offer a range of high-quality plant proteins, including organic pea and rice protein and protein hydrolysates and is a European leader in non-allergenic plant proteins for infant nutrition."}
{"meta": {"doc_id": 2395, "sent_id": 3, "sent_start_pos": 498, "sent_end_pos": 1138, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "Based in Spain, Pevesa Biotech is a well-established global leader in non-allergenic, non-GMO plant proteins for the infant, general and clinical nutrition markets. Pevesa offer a range of high-quality plant proteins, including organic pea and rice protein and protein hydrolysates and is a European leader in non-allergenic plant proteins for infant nutrition. Pevesa has also developed a range of organic and standard biofertilizers for fruit, olive and specialist garden growers, and has had a strong corporate focus for many years on developing sustainable solutions to important nutrition, health, biowaste and agricultural challenges."}
{"meta": {"doc_id": 2395, "sent_id": 4, "sent_start_pos": 663, "sent_end_pos": 1308, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "Pevesa offer a range of high-quality plant proteins, including organic pea and rice protein and protein hydrolysates and is a European leader in non-allergenic plant proteins for infant nutrition. Pevesa has also developed a range of organic and standard biofertilizers for fruit, olive and specialist garden growers, and has had a strong corporate focus for many years on developing sustainable solutions to important nutrition, health, biowaste and agricultural challenges. \u201cKerry is extremely pleased to bring the global expertise of Pevesa into our leading plant protein portfolio,\u201d said John Reilly, VP Business Development Proteins, Kerry."}
{"meta": {"doc_id": 2395, "sent_id": 5, "sent_start_pos": 860, "sent_end_pos": 1484, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "Pevesa has also developed a range of organic and standard biofertilizers for fruit, olive and specialist garden growers, and has had a strong corporate focus for many years on developing sustainable solutions to important nutrition, health, biowaste and agricultural challenges. \u201cKerry is extremely pleased to bring the global expertise of Pevesa into our leading plant protein portfolio,\u201d said John Reilly, VP Business Development Proteins, Kerry. \u201cKerry was attracted to Pevesa because of its expertise, innovation, high-quality manufacturing leadership, and patented technology in the non-allergenic plant protein market."}
{"meta": {"doc_id": 2395, "sent_id": 6, "sent_start_pos": 1139, "sent_end_pos": 1858, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "\u201cKerry is extremely pleased to bring the global expertise of Pevesa into our leading plant protein portfolio,\u201d said John Reilly, VP Business Development Proteins, Kerry. \u201cKerry was attracted to Pevesa because of its expertise, innovation, high-quality manufacturing leadership, and patented technology in the non-allergenic plant protein market. This will be a good fit with Kerry\u2019s growing plant protein product portfolio, and Pevesa\u2019s customers will benefit from the synergy between its market-leading technology and Kerry\u2019s protein processing expertise.\u201d\nThe growing inclination of consumers toward natural and plant-based products has been fueling the explosive demand for plant-based foods over the last few years."}
{"meta": {"doc_id": 2395, "sent_id": 7, "sent_start_pos": 1309, "sent_end_pos": 2147, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "\u201cKerry was attracted to Pevesa because of its expertise, innovation, high-quality manufacturing leadership, and patented technology in the non-allergenic plant protein market. This will be a good fit with Kerry\u2019s growing plant protein product portfolio, and Pevesa\u2019s customers will benefit from the synergy between its market-leading technology and Kerry\u2019s protein processing expertise.\u201d\nThe growing inclination of consumers toward natural and plant-based products has been fueling the explosive demand for plant-based foods over the last few years. As consumers reduce their consumption of dairy and soya proteins (for allergy, health, sustainability or animal welfare reasons), rice and pea protein have become two of the fastest-growing plant protein segments globally."}
{"meta": {"doc_id": 2395, "sent_id": 8, "sent_start_pos": 1485, "sent_end_pos": 2391, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "This will be a good fit with Kerry\u2019s growing plant protein product portfolio, and Pevesa\u2019s customers will benefit from the synergy between its market-leading technology and Kerry\u2019s protein processing expertise.\u201d\nThe growing inclination of consumers toward natural and plant-based products has been fueling the explosive demand for plant-based foods over the last few years. As consumers reduce their consumption of dairy and soya proteins (for allergy, health, sustainability or animal welfare reasons), rice and pea protein have become two of the fastest-growing plant protein segments globally. The global plant proteins ingredient market is projected to grow at 6.6% per annum from 2018 to 2023; the organic rice protein market was estimated at $42 million in 2018; while the organic pea protein market was valued at $11 million in 2018."}
{"meta": {"doc_id": 2395, "sent_id": 9, "sent_start_pos": 1925, "sent_end_pos": 2569, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "As consumers reduce their consumption of dairy and soya proteins (for allergy, health, sustainability or animal welfare reasons), rice and pea protein have become two of the fastest-growing plant protein segments globally. The global plant proteins ingredient market is projected to grow at 6.6% per annum from 2018 to 2023; the organic rice protein market was estimated at $42 million in 2018; while the organic pea protein market was valued at $11 million in 2018. *\n* Sources: DataM Intelligence, Global Plant Protein Market 2018-2025, MarketsandMarkets: Organic Rice Protein Market 2018, Markets and Markets: Organic Pea Protein Market 2018."}
{"meta": {"doc_id": 2395, "sent_id": 10, "sent_start_pos": 2148, "sent_end_pos": 2749, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "The global plant proteins ingredient market is projected to grow at 6.6% per annum from 2018 to 2023; the organic rice protein market was estimated at $42 million in 2018; while the organic pea protein market was valued at $11 million in 2018. *\n* Sources: DataM Intelligence, Global Plant Protein Market 2018-2025, MarketsandMarkets: Organic Rice Protein Market 2018, Markets and Markets: Organic Pea Protein Market 2018. About Pevesa\nPevesa is a biotechnology company specializing in highly sustainable non-GMO plant-based rice and pea proteins for the infant, general and clinical nutrition markets."}
{"meta": {"doc_id": 2395, "sent_id": 11, "sent_start_pos": 2391, "sent_end_pos": 2928, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "*\n* Sources: DataM Intelligence, Global Plant Protein Market 2018-2025, MarketsandMarkets: Organic Rice Protein Market 2018, Markets and Markets: Organic Pea Protein Market 2018. About Pevesa\nPevesa is a biotechnology company specializing in highly sustainable non-GMO plant-based rice and pea proteins for the infant, general and clinical nutrition markets. Through its proprietary expertise in plant-based protein contaminant reduction, Pevesa is a leader in the application of plant-based hydrolysates for the infant nutrition market."}
{"meta": {"doc_id": 2395, "sent_id": 12, "sent_start_pos": 2570, "sent_end_pos": 3166, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "About Pevesa\nPevesa is a biotechnology company specializing in highly sustainable non-GMO plant-based rice and pea proteins for the infant, general and clinical nutrition markets. Through its proprietary expertise in plant-based protein contaminant reduction, Pevesa is a leader in the application of plant-based hydrolysates for the infant nutrition market. The company\u2019s products include rice protein hydrolysates (including organic), pea protein isolate, rice protein (including organic), pea protein (including organic), partially hydrolysed pea and rice proteins, and organic biofertilizers."}
{"meta": {"doc_id": 2395, "sent_id": 13, "sent_start_pos": 2750, "sent_end_pos": 3298, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "Through its proprietary expertise in plant-based protein contaminant reduction, Pevesa is a leader in the application of plant-based hydrolysates for the infant nutrition market. The company\u2019s products include rice protein hydrolysates (including organic), pea protein isolate, rice protein (including organic), pea protein (including organic), partially hydrolysed pea and rice proteins, and organic biofertilizers. Pevesa also produces biofertilizers organic and standard) using high-quality plant protein hydrolysates for use in organic farming."}
{"meta": {"doc_id": 2395, "sent_id": 14, "sent_start_pos": 2929, "sent_end_pos": 3435, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "The company\u2019s products include rice protein hydrolysates (including organic), pea protein isolate, rice protein (including organic), pea protein (including organic), partially hydrolysed pea and rice proteins, and organic biofertilizers. Pevesa also produces biofertilizers organic and standard) using high-quality plant protein hydrolysates for use in organic farming. These natural biofertilizers give fruit, olive and specialist garden growers increased yield, crop quality and protection against pests."}
{"meta": {"doc_id": 2395, "sent_id": 15, "sent_start_pos": 3167, "sent_end_pos": 3618, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "Pevesa also produces biofertilizers organic and standard) using high-quality plant protein hydrolysates for use in organic farming. These natural biofertilizers give fruit, olive and specialist garden growers increased yield, crop quality and protection against pests. About Kerry Taste & Nutrition\nKerry, the Taste & Nutrition company, offers solutions that nourish lives all over the world."}
{"meta": {"doc_id": 2395, "sent_id": 16, "sent_start_pos": 3299, "sent_end_pos": 3883, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "These natural biofertilizers give fruit, olive and specialist garden growers increased yield, crop quality and protection against pests. About Kerry Taste & Nutrition\nKerry, the Taste & Nutrition company, offers solutions that nourish lives all over the world. From humble beginnings as an Irish dairy co-operative, Kerry has grown into a large international food industry leader, with offices in 32 countries, 151 manufacturing facilities and an employer to over 26,000 people globally, including over 1,000 food scientists."}
{"meta": {"doc_id": 2395, "sent_id": 17, "sent_start_pos": 3495, "sent_end_pos": 4127, "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "About Kerry Taste & Nutrition\nKerry, the Taste & Nutrition company, offers solutions that nourish lives all over the world. From humble beginnings as an Irish dairy co-operative, Kerry has grown into a large international food industry leader, with offices in 32 countries, 151 manufacturing facilities and an employer to over 26,000 people globally, including over 1,000 food scientists. We bring to the table our strong food heritage, coupled with over 40 years of experience, global insights and market knowledge, culinary and applications expertise as well as our unique solutions to anticipate and address our customers\u2019 needs."}
{"meta": {"doc_id": 2395, "sent_id": 18, "sent_start_pos": 3619, "sent_end_pos": [], "title": "Kerry Acquires Plant Protein Biotechnology Company Pevesa"}, "text": "From humble beginnings as an Irish dairy co-operative, Kerry has grown into a large international food industry leader, with offices in 32 countries, 151 manufacturing facilities and an employer to over 26,000 people globally, including over 1,000 food scientists. We bring to the table our strong food heritage, coupled with over 40 years of experience, global insights and market knowledge, culinary and applications expertise as well as our unique solutions to anticipate and address our customers\u2019 needs. "}
{"meta": {"doc_id": 2397, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 368, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": " Dive Brief:\nIrish ingredients firm Kerry acquired Pevesa Biotech, a Spanish company specializing in non-allergenic and organic plant protein ingredients for infant, general and clinical nutrition. Kerry said the transaction will expand its position in the hydrolyzed plant protein space and enhance its ability to service the fast-growing organic plant protein market."}
{"meta": {"doc_id": 2397, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 587, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "Dive Brief:\nIrish ingredients firm Kerry acquired Pevesa Biotech, a Spanish company specializing in non-allergenic and organic plant protein ingredients for infant, general and clinical nutrition. Kerry said the transaction will expand its position in the hydrolyzed plant protein space and enhance its ability to service the fast-growing organic plant protein market. The firm's products include organic and conventional rice protein hydrolysates and pea protein isolate, plus partially hydrolyzed pea and rice proteins."}
{"meta": {"doc_id": 2397, "sent_id": 2, "sent_start_pos": 197, "sent_end_pos": 718, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "Kerry said the transaction will expand its position in the hydrolyzed plant protein space and enhance its ability to service the fast-growing organic plant protein market. The firm's products include organic and conventional rice protein hydrolysates and pea protein isolate, plus partially hydrolyzed pea and rice proteins. The company also makes residue- and chemical-free biofertilizers containing plant protein hydrolysates for use in organic farming."}
{"meta": {"doc_id": 2397, "sent_id": 3, "sent_start_pos": 435, "sent_end_pos": 976, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "The firm's products include organic and conventional rice protein hydrolysates and pea protein isolate, plus partially hydrolyzed pea and rice proteins. The company also makes residue- and chemical-free biofertilizers containing plant protein hydrolysates for use in organic farming. John Reilly, Kerry's vice president of business development proteins, said in a statement that his company was attracted to Pevesa due to its expertise, innovation, manufacturing leadership and patented technology in the non-allergenic plant protein market."}
{"meta": {"doc_id": 2397, "sent_id": 4, "sent_start_pos": 588, "sent_end_pos": 1140, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "The company also makes residue- and chemical-free biofertilizers containing plant protein hydrolysates for use in organic farming. John Reilly, Kerry's vice president of business development proteins, said in a statement that his company was attracted to Pevesa due to its expertise, innovation, manufacturing leadership and patented technology in the non-allergenic plant protein market. Dive Insight:\nKerry has been expanding its presence in the plant-based protein ingredients market, so the acquisition of Pevesa is a continuation of that strategy."}
{"meta": {"doc_id": 2397, "sent_id": 5, "sent_start_pos": 719, "sent_end_pos": 1363, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "John Reilly, Kerry's vice president of business development proteins, said in a statement that his company was attracted to Pevesa due to its expertise, innovation, manufacturing leadership and patented technology in the non-allergenic plant protein market. Dive Insight:\nKerry has been expanding its presence in the plant-based protein ingredients market, so the acquisition of Pevesa is a continuation of that strategy. Not only does the Spanish company bring patented technology in the non-allergenic plant protein market, but it has expertise in organic and conventional biofertilizers for producers of fruit, olives and specialist gardens."}
{"meta": {"doc_id": 2397, "sent_id": 6, "sent_start_pos": 977, "sent_end_pos": 1537, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "Dive Insight:\nKerry has been expanding its presence in the plant-based protein ingredients market, so the acquisition of Pevesa is a continuation of that strategy. Not only does the Spanish company bring patented technology in the non-allergenic plant protein market, but it has expertise in organic and conventional biofertilizers for producers of fruit, olives and specialist gardens. Last year, Kerry launched its Radicle brand of plant-based ingredients for proteins and dairy alternatives."}
{"meta": {"doc_id": 2397, "sent_id": 7, "sent_start_pos": 1141, "sent_end_pos": 1672, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "Not only does the Spanish company bring patented technology in the non-allergenic plant protein market, but it has expertise in organic and conventional biofertilizers for producers of fruit, olives and specialist gardens. Last year, Kerry launched its Radicle brand of plant-based ingredients for proteins and dairy alternatives. The company said the move was designed to boost nutrition in plant-based foods and result in more authentic tastes and cleaner labels."}
{"meta": {"doc_id": 2397, "sent_id": 8, "sent_start_pos": 1430, "sent_end_pos": 1965, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "Last year, Kerry launched its Radicle brand of plant-based ingredients for proteins and dairy alternatives. The company said the move was designed to boost nutrition in plant-based foods and result in more authentic tastes and cleaner labels. These aspects, along with the nutritional profile, higher protein content and fewer ingredients could improve adoption of plant-based meat products, according to a 2019 Kerry white paper, so manufacturers are likely to be on the lookout for these ingredients to include in their formulations."}
{"meta": {"doc_id": 2397, "sent_id": 9, "sent_start_pos": 1538, "sent_end_pos": 2092, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "The company said the move was designed to boost nutrition in plant-based foods and result in more authentic tastes and cleaner labels. These aspects, along with the nutritional profile, higher protein content and fewer ingredients could improve adoption of plant-based meat products, according to a 2019 Kerry white paper, so manufacturers are likely to be on the lookout for these ingredients to include in their formulations. Kerry said the plant-based protein market is projected to hit $24.5 billion by 2026, at a compound annual growth rate of 9.1%."}
{"meta": {"doc_id": 2397, "sent_id": 10, "sent_start_pos": 1673, "sent_end_pos": 2260, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "These aspects, along with the nutritional profile, higher protein content and fewer ingredients could improve adoption of plant-based meat products, according to a 2019 Kerry white paper, so manufacturers are likely to be on the lookout for these ingredients to include in their formulations. Kerry said the plant-based protein market is projected to hit $24.5 billion by 2026, at a compound annual growth rate of 9.1%. The category includes plant-based burgers and meat-free sausages, along with an ever-increasing array of food and beverage products free of animal-sourced ingredients."}
{"meta": {"doc_id": 2397, "sent_id": 11, "sent_start_pos": 1966, "sent_end_pos": 2390, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "Kerry said the plant-based protein market is projected to hit $24.5 billion by 2026, at a compound annual growth rate of 9.1%. The category includes plant-based burgers and meat-free sausages, along with an ever-increasing array of food and beverage products free of animal-sourced ingredients. This trend is likely to continue as more consumers try out flexitarian diets and add more plant-based items to their daily menus."}
{"meta": {"doc_id": 2397, "sent_id": 12, "sent_start_pos": 2093, "sent_end_pos": 2511, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "The category includes plant-based burgers and meat-free sausages, along with an ever-increasing array of food and beverage products free of animal-sourced ingredients. This trend is likely to continue as more consumers try out flexitarian diets and add more plant-based items to their daily menus. Competitors also are looking for growth, so there are other opportunities for ingredients firms to take advantage of it."}
{"meta": {"doc_id": 2397, "sent_id": 13, "sent_start_pos": 2261, "sent_end_pos": 2834, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "This trend is likely to continue as more consumers try out flexitarian diets and add more plant-based items to their daily menus. Competitors also are looking for growth, so there are other opportunities for ingredients firms to take advantage of it. Cargill has invested in pea protein producer Puris, Israel Chemicals is expanding its Rovitaris protein technology for the meat alternatives market, and Ingredion just launched a pea protein isolate line said to contain at least 80% protein."}
{"meta": {"doc_id": 2397, "sent_id": 14, "sent_start_pos": 2391, "sent_end_pos": 3095, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "Competitors also are looking for growth, so there are other opportunities for ingredients firms to take advantage of it. Cargill has invested in pea protein producer Puris, Israel Chemicals is expanding its Rovitaris protein technology for the meat alternatives market, and Ingredion just launched a pea protein isolate line said to contain at least 80% protein. As more plant-based ingredient options become available, manufacturers are likely to have even more suppliers ready to provide them with whatever combination of qualities they're looking for in order to appeal to this ever-growing segment of the food industry."}
{"meta": {"doc_id": 2397, "sent_id": 15, "sent_start_pos": 2593, "sent_end_pos": 3352, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "Cargill has invested in pea protein producer Puris, Israel Chemicals is expanding its Rovitaris protein technology for the meat alternatives market, and Ingredion just launched a pea protein isolate line said to contain at least 80% protein. As more plant-based ingredient options become available, manufacturers are likely to have even more suppliers ready to provide them with whatever combination of qualities they're looking for in order to appeal to this ever-growing segment of the food industry. The ingredients market has been a hotbed on M&A activity during the last few years as companies seek to create a powerhouse that can address more of a food manufacturers' needs, including meeting multiple trends such as functional and better-for-you foods."}
{"meta": {"doc_id": 2397, "sent_id": 16, "sent_start_pos": 2835, "sent_end_pos": 3538, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "As more plant-based ingredient options become available, manufacturers are likely to have even more suppliers ready to provide them with whatever combination of qualities they're looking for in order to appeal to this ever-growing segment of the food industry. The ingredients market has been a hotbed on M&A activity during the last few years as companies seek to create a powerhouse that can address more of a food manufacturers' needs, including meeting multiple trends such as functional and better-for-you foods. By combining the portfolio and research prowess, the merged company could develop new products faster or provide additional convenience for their customers by acting as a one-stop shop."}
{"meta": {"doc_id": 2397, "sent_id": 17, "sent_start_pos": 3096, "sent_end_pos": 3697, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "The ingredients market has been a hotbed on M&A activity during the last few years as companies seek to create a powerhouse that can address more of a food manufacturers' needs, including meeting multiple trends such as functional and better-for-you foods. By combining the portfolio and research prowess, the merged company could develop new products faster or provide additional convenience for their customers by acting as a one-stop shop. DuPont announced last December that will merge its nutrition business with International Flavors & Fragrances in a deal the companies valued at $26.2 billion."}
{"meta": {"doc_id": 2397, "sent_id": 18, "sent_start_pos": 3353, "sent_end_pos": 4033, "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "By combining the portfolio and research prowess, the merged company could develop new products faster or provide additional convenience for their customers by acting as a one-stop shop. DuPont announced last December that will merge its nutrition business with International Flavors & Fragrances in a deal the companies valued at $26.2 billion. Consolidation, both among large players and mid-size and smaller up-and-comers in flavors and ingredients, is unlikely to abate anytime soon in the race to keep up with shifting consumer demands in such areas as plant-based foods."}
{"meta": {"doc_id": 2397, "sent_id": 19, "sent_start_pos": 3539, "sent_end_pos": [], "title": "Kerry acquires Spanish plant protein ingredients company"}, "text": "DuPont announced last December that will merge its nutrition business with International Flavors & Fragrances in a deal the companies valued at $26.2 billion. Consolidation, both among large players and mid-size and smaller up-and-comers in flavors and ingredients, is unlikely to abate anytime soon in the race to keep up with shifting consumer demands in such areas as plant-based foods. "}
{"meta": {"doc_id": 2398, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 323, "title": "GIANT EUROPEAN PROTEIN FACTORY OPENING TO MAKE VEGAN MEAT MORE AFFORDABLE"}, "text": " A first-of-its-kind plant-based protein factory is set to open in Europe, which will help make vegan meat more affordable and scalable. Ten partners, including plant-based meat brand Vivera, clean meat startup Mosa Meat, sustainable biotech protein company 3F Bio, and European meat giant ABP Foods, are behind the project."}
{"meta": {"doc_id": 2398, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 512, "title": "GIANT EUROPEAN PROTEIN FACTORY OPENING TO MAKE VEGAN MEAT MORE AFFORDABLE"}, "text": "A first-of-its-kind plant-based protein factory is set to open in Europe, which will help make vegan meat more affordable and scalable. Ten partners, including plant-based meat brand Vivera, clean meat startup Mosa Meat, sustainable biotech protein company 3F Bio, and European meat giant ABP Foods, are behind the project. Named Plenitude, the project is joint-funded by 3F Bio and a \u20ac17m grant from Bio Based Industries Joint Undertaking under the European Union\u2019s Horizon 2020 program, Food Navigator reports."}
{"meta": {"doc_id": 2398, "sent_id": 2, "sent_start_pos": 136, "sent_end_pos": 746, "title": "GIANT EUROPEAN PROTEIN FACTORY OPENING TO MAKE VEGAN MEAT MORE AFFORDABLE"}, "text": "Ten partners, including plant-based meat brand Vivera, clean meat startup Mosa Meat, sustainable biotech protein company 3F Bio, and European meat giant ABP Foods, are behind the project. Named Plenitude, the project is joint-funded by 3F Bio and a \u20ac17m grant from Bio Based Industries Joint Undertaking under the European Union\u2019s Horizon 2020 program, Food Navigator reports. The large-scale biorefinery will use two \u201cestablished processes\u201d to produce plant-based protein for food and bioethanol from low-cost crops."}
{"meta": {"doc_id": 2398, "sent_id": 3, "sent_start_pos": 324, "sent_end_pos": 913, "title": "GIANT EUROPEAN PROTEIN FACTORY OPENING TO MAKE VEGAN MEAT MORE AFFORDABLE"}, "text": "Named Plenitude, the project is joint-funded by 3F Bio and a \u20ac17m grant from Bio Based Industries Joint Undertaking under the European Union\u2019s Horizon 2020 program, Food Navigator reports. The large-scale biorefinery will use two \u201cestablished processes\u201d to produce plant-based protein for food and bioethanol from low-cost crops. 3F Bio CEO Jim Laird explained that the biorefinery will use part of a cereal crop to create feedstock for the fermentation process that makes its Abunda mycoprotein."}
{"meta": {"doc_id": 2398, "sent_id": 4, "sent_start_pos": 606, "sent_end_pos": 1036, "title": "GIANT EUROPEAN PROTEIN FACTORY OPENING TO MAKE VEGAN MEAT MORE AFFORDABLE"}, "text": "The large-scale biorefinery will use two \u201cestablished processes\u201d to produce plant-based protein for food and bioethanol from low-cost crops. 3F Bio CEO Jim Laird explained that the biorefinery will use part of a cereal crop to create feedstock for the fermentation process that makes its Abunda mycoprotein. \u201cThe process uses large scale fermentation to grow protein using sugars found in grains such as wheat and maize,\u201d he said."}
{"meta": {"doc_id": 2398, "sent_id": 5, "sent_start_pos": 747, "sent_end_pos": 1160, "title": "GIANT EUROPEAN PROTEIN FACTORY OPENING TO MAKE VEGAN MEAT MORE AFFORDABLE"}, "text": "3F Bio CEO Jim Laird explained that the biorefinery will use part of a cereal crop to create feedstock for the fermentation process that makes its Abunda mycoprotein. \u201cThe process uses large scale fermentation to grow protein using sugars found in grains such as wheat and maize,\u201d he said. The company\u2019s food sector customers use the mycoprotein to make vegan meat products such as burgers, sausages, and chicken."}
{"meta": {"doc_id": 2398, "sent_id": 6, "sent_start_pos": 914, "sent_end_pos": 1378, "title": "GIANT EUROPEAN PROTEIN FACTORY OPENING TO MAKE VEGAN MEAT MORE AFFORDABLE"}, "text": "\u201cThe process uses large scale fermentation to grow protein using sugars found in grains such as wheat and maize,\u201d he said. The company\u2019s food sector customers use the mycoprotein to make vegan meat products such as burgers, sausages, and chicken. Making Vegan Meat More Affordable\nThe Ghent-based factory will be capable of producing 16,000 tonnes of plant-based protein annually, which may ultimately bring down the cost of vegan meat and feed the growing demand."}
{"meta": {"doc_id": 2398, "sent_id": 7, "sent_start_pos": 1037, "sent_end_pos": 1590, "title": "GIANT EUROPEAN PROTEIN FACTORY OPENING TO MAKE VEGAN MEAT MORE AFFORDABLE"}, "text": "The company\u2019s food sector customers use the mycoprotein to make vegan meat products such as burgers, sausages, and chicken. Making Vegan Meat More Affordable\nThe Ghent-based factory will be capable of producing 16,000 tonnes of plant-based protein annually, which may ultimately bring down the cost of vegan meat and feed the growing demand. To Laird, the increased availability of vegan meat products is just one part of the solution toward creating a more environmentally-friendly food system \u2014 to be truly sustainable, it also needs to be affordable."}
{"meta": {"doc_id": 2398, "sent_id": 8, "sent_start_pos": 1161, "sent_end_pos": 1805, "title": "GIANT EUROPEAN PROTEIN FACTORY OPENING TO MAKE VEGAN MEAT MORE AFFORDABLE"}, "text": "Making Vegan Meat More Affordable\nThe Ghent-based factory will be capable of producing 16,000 tonnes of plant-based protein annually, which may ultimately bring down the cost of vegan meat and feed the growing demand. To Laird, the increased availability of vegan meat products is just one part of the solution toward creating a more environmentally-friendly food system \u2014 to be truly sustainable, it also needs to be affordable. \u201cOur focus is sustainability and for us that means sustainable both environmentally and economically,\u201d Laird said, noting that he hopes the biorefinery is a model that can be scaled and repeated in other locations."}
{"meta": {"doc_id": 2398, "sent_id": 9, "sent_start_pos": 1379, "sent_end_pos": 2004, "title": "GIANT EUROPEAN PROTEIN FACTORY OPENING TO MAKE VEGAN MEAT MORE AFFORDABLE"}, "text": "To Laird, the increased availability of vegan meat products is just one part of the solution toward creating a more environmentally-friendly food system \u2014 to be truly sustainable, it also needs to be affordable. \u201cOur focus is sustainability and for us that means sustainable both environmentally and economically,\u201d Laird said, noting that he hopes the biorefinery is a model that can be scaled and repeated in other locations. Laird added that it is \u201cvitally important\u201d to find sustainable, scalable solutions to meet the demand for plant-based meat, driven by consumer concern for health, climate change, and animal welfare."}
{"meta": {"doc_id": 2398, "sent_id": 10, "sent_start_pos": 1591, "sent_end_pos": 2169, "title": "GIANT EUROPEAN PROTEIN FACTORY OPENING TO MAKE VEGAN MEAT MORE AFFORDABLE"}, "text": "\u201cOur focus is sustainability and for us that means sustainable both environmentally and economically,\u201d Laird said, noting that he hopes the biorefinery is a model that can be scaled and repeated in other locations. Laird added that it is \u201cvitally important\u201d to find sustainable, scalable solutions to meet the demand for plant-based meat, driven by consumer concern for health, climate change, and animal welfare. \u201cGlobal experts in governments and bodies such as the UN and the FAO all consistently highlight the need to reduce the reliance on protein from livestock,\u201d he said."}
{"meta": {"doc_id": 2398, "sent_id": 11, "sent_start_pos": 1806, "sent_end_pos": 2355, "title": "GIANT EUROPEAN PROTEIN FACTORY OPENING TO MAKE VEGAN MEAT MORE AFFORDABLE"}, "text": "Laird added that it is \u201cvitally important\u201d to find sustainable, scalable solutions to meet the demand for plant-based meat, driven by consumer concern for health, climate change, and animal welfare. \u201cGlobal experts in governments and bodies such as the UN and the FAO all consistently highlight the need to reduce the reliance on protein from livestock,\u201d he said. \u201cFrom an environmental perspective this is one of the crises of our time.\u201d\nIf Plentitude proves successful, the first facility may have the potential to produce 50,000 tonnes each year."}
{"meta": {"doc_id": 2398, "sent_id": 12, "sent_start_pos": 2005, "sent_end_pos": [], "title": "GIANT EUROPEAN PROTEIN FACTORY OPENING TO MAKE VEGAN MEAT MORE AFFORDABLE"}, "text": "\u201cGlobal experts in governments and bodies such as the UN and the FAO all consistently highlight the need to reduce the reliance on protein from livestock,\u201d he said. \u201cFrom an environmental perspective this is one of the crises of our time.\u201d\nIf Plentitude proves successful, the first facility may have the potential to produce 50,000 tonnes each year. "}
{"meta": {"doc_id": 2399, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 187, "title": "About LIFE3 Biotech"}, "text": " Proud to be HOMEGROWN. Based in Singapore, we are an innovative, award-winning company that focuses on revolutionising how people view health, nutrition and the future of functional food."}
{"meta": {"doc_id": 2399, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 346, "title": "About LIFE3 Biotech"}, "text": "Proud to be HOMEGROWN. Based in Singapore, we are an innovative, award-winning company that focuses on revolutionising how people view health, nutrition and the future of functional food. Our flagship product is a proprietary plant-based protein that aims to meet a rising demand for both sustainable and nutritionally-optimised food ingredients."}
{"meta": {"doc_id": 2399, "sent_id": 2, "sent_start_pos": 23, "sent_end_pos": 372, "title": "About LIFE3 Biotech"}, "text": "Based in Singapore, we are an innovative, award-winning company that focuses on revolutionising how people view health, nutrition and the future of functional food. Our flagship product is a proprietary plant-based protein that aims to meet a rising demand for both sustainable and nutritionally-optimised food ingredients. Seeing beyond the CANOPY."}
{"meta": {"doc_id": 2399, "sent_id": 3, "sent_start_pos": 188, "sent_end_pos": 393, "title": "About LIFE3 Biotech"}, "text": "Our flagship product is a proprietary plant-based protein that aims to meet a rising demand for both sustainable and nutritionally-optimised food ingredients. Seeing beyond the CANOPY. Our vision is clear."}
{"meta": {"doc_id": 2399, "sent_id": 4, "sent_start_pos": 347, "sent_end_pos": 489, "title": "About LIFE3 Biotech"}, "text": "Seeing beyond the CANOPY. Our vision is clear. We aspire to be the leading innovator of future foods that cater to a healthy modern lifestyle."}
{"meta": {"doc_id": 2399, "sent_id": 5, "sent_start_pos": 373, "sent_end_pos": 764, "title": "About LIFE3 Biotech"}, "text": "Our vision is clear. We aspire to be the leading innovator of future foods that cater to a healthy modern lifestyle. As a leader in the management of Human Health & Wellness, Life3 strives to be at the forefront of Functional Food & Nutrition derived from plant-based ingredients, which can help boost health and reduce the risk of developing chronic diseases such as cardiovascular disease."}
{"meta": {"doc_id": 2399, "sent_id": 6, "sent_start_pos": 394, "sent_end_pos": 780, "title": "About LIFE3 Biotech"}, "text": "We aspire to be the leading innovator of future foods that cater to a healthy modern lifestyle. As a leader in the management of Human Health & Wellness, Life3 strives to be at the forefront of Functional Food & Nutrition derived from plant-based ingredients, which can help boost health and reduce the risk of developing chronic diseases such as cardiovascular disease. T(h)REE in one."}
{"meta": {"doc_id": 2399, "sent_id": 7, "sent_start_pos": 490, "sent_end_pos": 843, "title": "About LIFE3 Biotech"}, "text": "As a leader in the management of Human Health & Wellness, Life3 strives to be at the forefront of Functional Food & Nutrition derived from plant-based ingredients, which can help boost health and reduce the risk of developing chronic diseases such as cardiovascular disease. T(h)REE in one. There\u2019s an old saying stating that good things come in threes."}
{"meta": {"doc_id": 2399, "sent_id": 8, "sent_start_pos": 765, "sent_end_pos": 910, "title": "About LIFE3 Biotech"}, "text": "T(h)REE in one. There\u2019s an old saying stating that good things come in threes. We agree wholeheartedly because our expertise lies in three areas."}
{"meta": {"doc_id": 2399, "sent_id": 9, "sent_start_pos": 781, "sent_end_pos": 1491, "title": "About LIFE3 Biotech"}, "text": "There\u2019s an old saying stating that good things come in threes. We agree wholeheartedly because our expertise lies in three areas. AGRITECH\nWe synergise technologies from different disciplines to:\nDevelop plant recipes and varieties to enhance nutritional profile and quality in produce\nRedesign end-to-end cultivation systems to \"grow more with less\"\nImprove energy efficiency and circularity of urban farms\nBIOTECH\nWe combine different fields in Biotech \u2014 such as microbiology, biochemistry and bioprocessing \u2014 to shape the future of food through:\nResearch and Development\nFood and Beverage formulations\nProvision of proof points for functional claims\nFOODTECH\nFoodtech is at the heart of what we do at Life3."}
{"meta": {"doc_id": 2399, "sent_id": 10, "sent_start_pos": 844, "sent_end_pos": 1722, "title": "About LIFE3 Biotech"}, "text": "We agree wholeheartedly because our expertise lies in three areas. AGRITECH\nWe synergise technologies from different disciplines to:\nDevelop plant recipes and varieties to enhance nutritional profile and quality in produce\nRedesign end-to-end cultivation systems to \"grow more with less\"\nImprove energy efficiency and circularity of urban farms\nBIOTECH\nWe combine different fields in Biotech \u2014 such as microbiology, biochemistry and bioprocessing \u2014 to shape the future of food through:\nResearch and Development\nFood and Beverage formulations\nProvision of proof points for functional claims\nFOODTECH\nFoodtech is at the heart of what we do at Life3. In our quest to churn out functional foods, we focus on:\nApplication to create flavours of Ocean and Meat alternatives\nDeveloping Asian-based flavours\nCreating functional fats for taste and flavouring\nWe TECH it to the next level."}
{"meta": {"doc_id": 2399, "sent_id": 11, "sent_start_pos": 911, "sent_end_pos": 1843, "title": "About LIFE3 Biotech"}, "text": "AGRITECH\nWe synergise technologies from different disciplines to:\nDevelop plant recipes and varieties to enhance nutritional profile and quality in produce\nRedesign end-to-end cultivation systems to \"grow more with less\"\nImprove energy efficiency and circularity of urban farms\nBIOTECH\nWe combine different fields in Biotech \u2014 such as microbiology, biochemistry and bioprocessing \u2014 to shape the future of food through:\nResearch and Development\nFood and Beverage formulations\nProvision of proof points for functional claims\nFOODTECH\nFoodtech is at the heart of what we do at Life3. In our quest to churn out functional foods, we focus on:\nApplication to create flavours of Ocean and Meat alternatives\nDeveloping Asian-based flavours\nCreating functional fats for taste and flavouring\nWe TECH it to the next level. We will spare you the tech jargon but rest assured that Life3 only uses state-of-the-art and ground breaking technology."}
{"meta": {"doc_id": 2399, "sent_id": 12, "sent_start_pos": 1492, "sent_end_pos": 1886, "title": "About LIFE3 Biotech"}, "text": "In our quest to churn out functional foods, we focus on:\nApplication to create flavours of Ocean and Meat alternatives\nDeveloping Asian-based flavours\nCreating functional fats for taste and flavouring\nWe TECH it to the next level. We will spare you the tech jargon but rest assured that Life3 only uses state-of-the-art and ground breaking technology. Let\u2019s break it down into digestible bites."}
{"meta": {"doc_id": 2399, "sent_id": 13, "sent_start_pos": 1723, "sent_end_pos": 2083, "title": "About LIFE3 Biotech"}, "text": "We will spare you the tech jargon but rest assured that Life3 only uses state-of-the-art and ground breaking technology. Let\u2019s break it down into digestible bites. Machine Learning\nWe rely on sophisticated machines help us with tedious work like characterising an internal database of 200+ plant samples and their bioactive ingredients for precise formulation."}
{"meta": {"doc_id": 2399, "sent_id": 14, "sent_start_pos": 1844, "sent_end_pos": 2201, "title": "About LIFE3 Biotech"}, "text": "Let\u2019s break it down into digestible bites. Machine Learning\nWe rely on sophisticated machines help us with tedious work like characterising an internal database of 200+ plant samples and their bioactive ingredients for precise formulation. Proprietary Technology\nOur bioprocessing capabilities are a result of our own research and development in this field."}
{"meta": {"doc_id": 2399, "sent_id": 15, "sent_start_pos": 1887, "sent_end_pos": 2228, "title": "About LIFE3 Biotech"}, "text": "Machine Learning\nWe rely on sophisticated machines help us with tedious work like characterising an internal database of 200+ plant samples and their bioactive ingredients for precise formulation. Proprietary Technology\nOur bioprocessing capabilities are a result of our own research and development in this field. What kind of capabilities?"}
{"meta": {"doc_id": 2399, "sent_id": 16, "sent_start_pos": 2084, "sent_end_pos": 2305, "title": "About LIFE3 Biotech"}, "text": "Proprietary Technology\nOur bioprocessing capabilities are a result of our own research and development in this field. What kind of capabilities? Namely, microencapsulation, shear-cell and thermal pre-treatment technology."}
{"meta": {"doc_id": 2399, "sent_id": 17, "sent_start_pos": 2202, "sent_end_pos": 2328, "title": "About LIFE3 Biotech"}, "text": "What kind of capabilities? Namely, microencapsulation, shear-cell and thermal pre-treatment technology. It\u2019s quite a mouthful!"}
{"meta": {"doc_id": 2399, "sent_id": 18, "sent_start_pos": 2229, "sent_end_pos": 2425, "title": "About LIFE3 Biotech"}, "text": "Namely, microencapsulation, shear-cell and thermal pre-treatment technology. It\u2019s quite a mouthful! But we know what we want and the best way to guarantee results is to develop our own technology."}
{"meta": {"doc_id": 2399, "sent_id": 19, "sent_start_pos": 2306, "sent_end_pos": 2546, "title": "About LIFE3 Biotech"}, "text": "It\u2019s quite a mouthful! But we know what we want and the best way to guarantee results is to develop our own technology. In-House R&D Protocols\nWe observe strict in-house R&D protocols for achieving precise evidence on any functional claims."}
{"meta": {"doc_id": 2399, "sent_id": 20, "sent_start_pos": 2329, "sent_end_pos": 2609, "title": "About LIFE3 Biotech"}, "text": "But we know what we want and the best way to guarantee results is to develop our own technology. In-House R&D Protocols\nWe observe strict in-house R&D protocols for achieving precise evidence on any functional claims. When it comes to quality, we put the money where our mouth is."}
{"meta": {"doc_id": 2399, "sent_id": 21, "sent_start_pos": 2426, "sent_end_pos": 2670, "title": "About LIFE3 Biotech"}, "text": "In-House R&D Protocols\nWe observe strict in-house R&D protocols for achieving precise evidence on any functional claims. When it comes to quality, we put the money where our mouth is. You won\u2019t find us making unjustified claims on our products!"}
{"meta": {"doc_id": 2399, "sent_id": 22, "sent_start_pos": 2547, "sent_end_pos": 2805, "title": "About LIFE3 Biotech"}, "text": "When it comes to quality, we put the money where our mouth is. You won\u2019t find us making unjustified claims on our products! Proprietary Agritech Protocol\nDid you know that there are ways to optimise the bioactive nutrients and production yield of some crops?"}
{"meta": {"doc_id": 2399, "sent_id": 23, "sent_start_pos": 2610, "sent_end_pos": 2867, "title": "About LIFE3 Biotech"}, "text": "You won\u2019t find us making unjustified claims on our products! Proprietary Agritech Protocol\nDid you know that there are ways to optimise the bioactive nutrients and production yield of some crops? We have discovered how through a great deal of heavy lifting."}
{"meta": {"doc_id": 2399, "sent_id": 24, "sent_start_pos": 2671, "sent_end_pos": 2943, "title": "About LIFE3 Biotech"}, "text": "Proprietary Agritech Protocol\nDid you know that there are ways to optimise the bioactive nutrients and production yield of some crops? We have discovered how through a great deal of heavy lifting. Let us deal with the extensive scientific research and advanced technology."}
{"meta": {"doc_id": 2399, "sent_id": 25, "sent_start_pos": 2806, "sent_end_pos": 3005, "title": "About LIFE3 Biotech"}, "text": "We have discovered how through a great deal of heavy lifting. Let us deal with the extensive scientific research and advanced technology. You just need to sit back and enjoy the fruits of our labour."}
{"meta": {"doc_id": 2399, "sent_id": 26, "sent_start_pos": 2868, "sent_end_pos": 3288, "title": "About LIFE3 Biotech"}, "text": "Let us deal with the extensive scientific research and advanced technology. You just need to sit back and enjoy the fruits of our labour. MILESTONES\nParticipated in Food Innovation Awards 2016, 2018 and 2019:\nWon Most Functional Food (2016 and 2019)\n1st Runner Up (2018)\nDesign Innovation Award from Design Singapore Council\nA growing portfolio of new product developments\nIn-house IP for formulation with patent-pending"}
{"meta": {"doc_id": 2399, "sent_id": 27, "sent_start_pos": 2944, "sent_end_pos": [], "title": "About LIFE3 Biotech"}, "text": "You just need to sit back and enjoy the fruits of our labour. MILESTONES\nParticipated in Food Innovation Awards 2016, 2018 and 2019:\nWon Most Functional Food (2016 and 2019)\n1st Runner Up (2018)\nDesign Innovation Award from Design Singapore Council\nA growing portfolio of new product developments\nIn-house IP for formulation with patent-pending "}
{"meta": {"doc_id": 2401, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 428, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": " Contributed Content: Part II \u2013 Plant-based protein is here to stay\nDecember 6, 2019\nBy Adam Bergman \u2013 AgTech & FoodTech Investment Banker\nThis is the second of a two-part article series written by Adam Bergman. When I wrote my initial article on plant-based protein less than six months ago, I considered myself to be one of the more bullish people covering this sector."}
{"meta": {"doc_id": 2401, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 575, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Contributed Content: Part II \u2013 Plant-based protein is here to stay\nDecember 6, 2019\nBy Adam Bergman \u2013 AgTech & FoodTech Investment Banker\nThis is the second of a two-part article series written by Adam Bergman. When I wrote my initial article on plant-based protein less than six months ago, I considered myself to be one of the more bullish people covering this sector. However, when I look at where things stand today, it seems that even I underestimated how rapidly this sector could grow and gain market adoption."}
{"meta": {"doc_id": 2401, "sent_id": 2, "sent_start_pos": 269, "sent_end_pos": 865, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "When I wrote my initial article on plant-based protein less than six months ago, I considered myself to be one of the more bullish people covering this sector. However, when I look at where things stand today, it seems that even I underestimated how rapidly this sector could grow and gain market adoption. The Impossible Whopper Now on the Menu\nThe best evidence of this is the recent news that Burger King\u2019s US comparable sales jumped 5 percent in the 3rd quarter following the launch of the Impossible Whopper, which is a strong indication that alternative protein is going mainstream quickly."}
{"meta": {"doc_id": 2401, "sent_id": 3, "sent_start_pos": 429, "sent_end_pos": 1149, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "However, when I look at where things stand today, it seems that even I underestimated how rapidly this sector could grow and gain market adoption. The Impossible Whopper Now on the Menu\nThe best evidence of this is the recent news that Burger King\u2019s US comparable sales jumped 5 percent in the 3rd quarter following the launch of the Impossible Whopper, which is a strong indication that alternative protein is going mainstream quickly. According to an October 28, 2019 earnings call, given by Jos\u00e9 Cil, CEO of Restaurant Brands International, Burger King\u2019s parent company, \u201cThe Impossible Whopper is a huge hit with our guests and has quickly become one of the most successful product launches in Burger King\u2019s history."}
{"meta": {"doc_id": 2401, "sent_id": 4, "sent_start_pos": 576, "sent_end_pos": 1702, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "The Impossible Whopper Now on the Menu\nThe best evidence of this is the recent news that Burger King\u2019s US comparable sales jumped 5 percent in the 3rd quarter following the launch of the Impossible Whopper, which is a strong indication that alternative protein is going mainstream quickly. According to an October 28, 2019 earnings call, given by Jos\u00e9 Cil, CEO of Restaurant Brands International, Burger King\u2019s parent company, \u201cThe Impossible Whopper is a huge hit with our guests and has quickly become one of the most successful product launches in Burger King\u2019s history. What\u2019s especially exciting is that the sales of the Impossible Whopper have been highly incremental and have attracted new types of guests into our restaurants.\u201d Although it is easy to be bullish on the sector based on the tremendous performance of the Impossible Whopper, I wonder, when the novelty wears off, whether these new customers will make return visits to Burger King, or whether current Burger King customers who tried the Impossible Whopper, will order Impossible Whoppers on future visits or go back to eating the traditional beef Whopper."}
{"meta": {"doc_id": 2401, "sent_id": 5, "sent_start_pos": 866, "sent_end_pos": 1967, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "According to an October 28, 2019 earnings call, given by Jos\u00e9 Cil, CEO of Restaurant Brands International, Burger King\u2019s parent company, \u201cThe Impossible Whopper is a huge hit with our guests and has quickly become one of the most successful product launches in Burger King\u2019s history. What\u2019s especially exciting is that the sales of the Impossible Whopper have been highly incremental and have attracted new types of guests into our restaurants.\u201d Although it is easy to be bullish on the sector based on the tremendous performance of the Impossible Whopper, I wonder, when the novelty wears off, whether these new customers will make return visits to Burger King, or whether current Burger King customers who tried the Impossible Whopper, will order Impossible Whoppers on future visits or go back to eating the traditional beef Whopper. Nevertheless, success in the fast food industry is not limited to Burger King: Dunkin\u2019 Donuts recently moved forward the nationwide rollout of its Beyond Meat breakfast sandwich by two months, following the success of the item in its New York City initial release."}
{"meta": {"doc_id": 2401, "sent_id": 6, "sent_start_pos": 1150, "sent_end_pos": 2069, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "What\u2019s especially exciting is that the sales of the Impossible Whopper have been highly incremental and have attracted new types of guests into our restaurants.\u201d Although it is easy to be bullish on the sector based on the tremendous performance of the Impossible Whopper, I wonder, when the novelty wears off, whether these new customers will make return visits to Burger King, or whether current Burger King customers who tried the Impossible Whopper, will order Impossible Whoppers on future visits or go back to eating the traditional beef Whopper. Nevertheless, success in the fast food industry is not limited to Burger King: Dunkin\u2019 Donuts recently moved forward the nationwide rollout of its Beyond Meat breakfast sandwich by two months, following the success of the item in its New York City initial release. We also have seen plant-based protein offerings showing up at Carl\u2019s Jr., KFC, McDonalds, and Subway."}
{"meta": {"doc_id": 2401, "sent_id": 7, "sent_start_pos": 1703, "sent_end_pos": 2374, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Nevertheless, success in the fast food industry is not limited to Burger King: Dunkin\u2019 Donuts recently moved forward the nationwide rollout of its Beyond Meat breakfast sandwich by two months, following the success of the item in its New York City initial release. We also have seen plant-based protein offerings showing up at Carl\u2019s Jr., KFC, McDonalds, and Subway. As articulated by Mr. Cil, the fast food sector has struggled to attract new types of customers, so the success that plant-based proteins have had in bringing in new customers will likely drive more fast food restaurants to offer at least one plant-based protein product for breakfast, lunch, and dinner."}
{"meta": {"doc_id": 2401, "sent_id": 8, "sent_start_pos": 1968, "sent_end_pos": 2586, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "We also have seen plant-based protein offerings showing up at Carl\u2019s Jr., KFC, McDonalds, and Subway. As articulated by Mr. Cil, the fast food sector has struggled to attract new types of customers, so the success that plant-based proteins have had in bringing in new customers will likely drive more fast food restaurants to offer at least one plant-based protein product for breakfast, lunch, and dinner. With the recent roll-outs of these new food options, which have led to long lines and sold-out products, the fast food industry recognizes that plant-based protein is a product offering that must be on the menu."}
{"meta": {"doc_id": 2401, "sent_id": 9, "sent_start_pos": 2070, "sent_end_pos": 2740, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "As articulated by Mr. Cil, the fast food sector has struggled to attract new types of customers, so the success that plant-based proteins have had in bringing in new customers will likely drive more fast food restaurants to offer at least one plant-based protein product for breakfast, lunch, and dinner. With the recent roll-outs of these new food options, which have led to long lines and sold-out products, the fast food industry recognizes that plant-based protein is a product offering that must be on the menu. As long as the fast food industry continues to attract consumers looking for new plant-based protein products, we should expect this trend to accelerate."}
{"meta": {"doc_id": 2401, "sent_id": 10, "sent_start_pos": 2375, "sent_end_pos": 2964, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "With the recent roll-outs of these new food options, which have led to long lines and sold-out products, the fast food industry recognizes that plant-based protein is a product offering that must be on the menu. As long as the fast food industry continues to attract consumers looking for new plant-based protein products, we should expect this trend to accelerate. With the strong market traction achieved by Beyond Meat and Impossible Foods during the past two years, incumbent animal protein companies have no choice but to develop products that appeal to this growing customer segment."}
{"meta": {"doc_id": 2401, "sent_id": 11, "sent_start_pos": 2587, "sent_end_pos": 3164, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "As long as the fast food industry continues to attract consumers looking for new plant-based protein products, we should expect this trend to accelerate. With the strong market traction achieved by Beyond Meat and Impossible Foods during the past two years, incumbent animal protein companies have no choice but to develop products that appeal to this growing customer segment. It is particularly impressive how effective Beyond Meat and Impossible Foods have been in branding their burgers, as beef is generally not a branded product in supermarkets and fast food restaurants."}
{"meta": {"doc_id": 2401, "sent_id": 12, "sent_start_pos": 2741, "sent_end_pos": 3511, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "With the strong market traction achieved by Beyond Meat and Impossible Foods during the past two years, incumbent animal protein companies have no choice but to develop products that appeal to this growing customer segment. It is particularly impressive how effective Beyond Meat and Impossible Foods have been in branding their burgers, as beef is generally not a branded product in supermarkets and fast food restaurants. The fact that Beyond Meat and Impossible Foods have been so successful in gaining market share and brand recognition in the beef-burger segment\u2014the largest and most established fast food product offering\u2014provides a strong incentive for companies working towards bringing to market other animal protein substitutes like poultry, pork, and seafood."}
{"meta": {"doc_id": 2401, "sent_id": 13, "sent_start_pos": 2965, "sent_end_pos": 4010, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "It is particularly impressive how effective Beyond Meat and Impossible Foods have been in branding their burgers, as beef is generally not a branded product in supermarkets and fast food restaurants. The fact that Beyond Meat and Impossible Foods have been so successful in gaining market share and brand recognition in the beef-burger segment\u2014the largest and most established fast food product offering\u2014provides a strong incentive for companies working towards bringing to market other animal protein substitutes like poultry, pork, and seafood. Looking Beyond Beef\nI want to share with you additional growth drivers that I either overlooked or underestimated in my prior article, based on conversations I have had over the past six months with FoodTech industry thought leaders like Bruce Friedrich, CEO, The Good Food Institute; Dan Altschuler Malek, Partner, New Crop Capital; and Paul Shapiro, CEO, The Better Meat Co.\nFirstly, there has been significant growth in the range of plant-based protein product offerings for poultry and seafood."}
{"meta": {"doc_id": 2401, "sent_id": 14, "sent_start_pos": 3165, "sent_end_pos": 4262, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "The fact that Beyond Meat and Impossible Foods have been so successful in gaining market share and brand recognition in the beef-burger segment\u2014the largest and most established fast food product offering\u2014provides a strong incentive for companies working towards bringing to market other animal protein substitutes like poultry, pork, and seafood. Looking Beyond Beef\nI want to share with you additional growth drivers that I either overlooked or underestimated in my prior article, based on conversations I have had over the past six months with FoodTech industry thought leaders like Bruce Friedrich, CEO, The Good Food Institute; Dan Altschuler Malek, Partner, New Crop Capital; and Paul Shapiro, CEO, The Better Meat Co.\nFirstly, there has been significant growth in the range of plant-based protein product offerings for poultry and seafood. While beef has been the initial focus for most of the plant-based protein sector, more attention is shifting to poultry and seafood, which together are almost as large a market opportunity in the US as beef, and a significantly larger market globally."}
{"meta": {"doc_id": 2401, "sent_id": 15, "sent_start_pos": 3512, "sent_end_pos": 4517, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Looking Beyond Beef\nI want to share with you additional growth drivers that I either overlooked or underestimated in my prior article, based on conversations I have had over the past six months with FoodTech industry thought leaders like Bruce Friedrich, CEO, The Good Food Institute; Dan Altschuler Malek, Partner, New Crop Capital; and Paul Shapiro, CEO, The Better Meat Co.\nFirstly, there has been significant growth in the range of plant-based protein product offerings for poultry and seafood. While beef has been the initial focus for most of the plant-based protein sector, more attention is shifting to poultry and seafood, which together are almost as large a market opportunity in the US as beef, and a significantly larger market globally. It should come as no surprise, then, that established meat producers and leading consumer packaged goods (CPG) companies also are getting serious about plant-based proteins, with recent product launches by Conagra, Kraft Heinz, Nestle, Purdue, and Tyson."}
{"meta": {"doc_id": 2401, "sent_id": 16, "sent_start_pos": 4011, "sent_end_pos": 4764, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "While beef has been the initial focus for most of the plant-based protein sector, more attention is shifting to poultry and seafood, which together are almost as large a market opportunity in the US as beef, and a significantly larger market globally. It should come as no surprise, then, that established meat producers and leading consumer packaged goods (CPG) companies also are getting serious about plant-based proteins, with recent product launches by Conagra, Kraft Heinz, Nestle, Purdue, and Tyson. The advantage of blending is that it allows consumers to enjoy the benefits of reducing their meat intake without having to give up meat entirely."}
{"meta": {"doc_id": 2401, "sent_id": 17, "sent_start_pos": 4263, "sent_end_pos": 4885, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "It should come as no surprise, then, that established meat producers and leading consumer packaged goods (CPG) companies also are getting serious about plant-based proteins, with recent product launches by Conagra, Kraft Heinz, Nestle, Purdue, and Tyson. The advantage of blending is that it allows consumers to enjoy the benefits of reducing their meat intake without having to give up meat entirely. Moreover, blending provides health benefits by offering lower cholesterol and calories than 100 percent animal proteins."}
{"meta": {"doc_id": 2401, "sent_id": 18, "sent_start_pos": 4618, "sent_end_pos": 5163, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "The advantage of blending is that it allows consumers to enjoy the benefits of reducing their meat intake without having to give up meat entirely. Moreover, blending provides health benefits by offering lower cholesterol and calories than 100 percent animal proteins. Blending provides a particularly interesting avenue to increase consumption of plant-based proteins as many consumers, who are not ready to move to 100 percent plant-based protein, are more likely to consume blended products, where they still feel that they get the meat taste."}
{"meta": {"doc_id": 2401, "sent_id": 19, "sent_start_pos": 4765, "sent_end_pos": 5363, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Moreover, blending provides health benefits by offering lower cholesterol and calories than 100 percent animal proteins. Blending provides a particularly interesting avenue to increase consumption of plant-based proteins as many consumers, who are not ready to move to 100 percent plant-based protein, are more likely to consume blended products, where they still feel that they get the meat taste. Another benefit of blending is that by decreasing the amount of animal protein consumed, it could lessen the environmental impact of the consumption of animal protein, including reducing overfishing."}
{"meta": {"doc_id": 2401, "sent_id": 20, "sent_start_pos": 4886, "sent_end_pos": 5527, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Blending provides a particularly interesting avenue to increase consumption of plant-based proteins as many consumers, who are not ready to move to 100 percent plant-based protein, are more likely to consume blended products, where they still feel that they get the meat taste. Another benefit of blending is that by decreasing the amount of animal protein consumed, it could lessen the environmental impact of the consumption of animal protein, including reducing overfishing. Blending is becoming more mainstream with Purdue working with the Better Meat Co. on a blended chicken nugget and Tyson developing its own blended chicken nuggets."}
{"meta": {"doc_id": 2401, "sent_id": 21, "sent_start_pos": 5164, "sent_end_pos": 5722, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Another benefit of blending is that by decreasing the amount of animal protein consumed, it could lessen the environmental impact of the consumption of animal protein, including reducing overfishing. Blending is becoming more mainstream with Purdue working with the Better Meat Co. on a blended chicken nugget and Tyson developing its own blended chicken nuggets. Poultry isn\u2019t the only area where blending is gaining traction; Ocean Hugger Foods has been providing Ahimi, a plant-based alternative to raw tuna, for blending with tuna in Google\u2019s cafeterias."}
{"meta": {"doc_id": 2401, "sent_id": 22, "sent_start_pos": 5364, "sent_end_pos": 5902, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Blending is becoming more mainstream with Purdue working with the Better Meat Co. on a blended chicken nugget and Tyson developing its own blended chicken nuggets. Poultry isn\u2019t the only area where blending is gaining traction; Ocean Hugger Foods has been providing Ahimi, a plant-based alternative to raw tuna, for blending with tuna in Google\u2019s cafeterias. One more factor likely to help increase future consumption of plant-based proteins is that most consumers eat meat that either is ground and/or comes with lots of sauce or spices."}
{"meta": {"doc_id": 2401, "sent_id": 23, "sent_start_pos": 5528, "sent_end_pos": 5986, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Poultry isn\u2019t the only area where blending is gaining traction; Ocean Hugger Foods has been providing Ahimi, a plant-based alternative to raw tuna, for blending with tuna in Google\u2019s cafeterias. One more factor likely to help increase future consumption of plant-based proteins is that most consumers eat meat that either is ground and/or comes with lots of sauce or spices. The more consumers add flavorings, the less they are able to taste the actual meat."}
{"meta": {"doc_id": 2401, "sent_id": 24, "sent_start_pos": 5723, "sent_end_pos": 6136, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "One more factor likely to help increase future consumption of plant-based proteins is that most consumers eat meat that either is ground and/or comes with lots of sauce or spices. The more consumers add flavorings, the less they are able to taste the actual meat. Consequently, the threshold for plant-based protein adoption for ground meat is much lower than it would for the replacement of a steak or pork chop."}
{"meta": {"doc_id": 2401, "sent_id": 25, "sent_start_pos": 5903, "sent_end_pos": 6432, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "The more consumers add flavorings, the less they are able to taste the actual meat. Consequently, the threshold for plant-based protein adoption for ground meat is much lower than it would for the replacement of a steak or pork chop. Consumer Tastes are Evolving\nThere is no doubt that the consumption of plant-based proteins is a trend that is only going to grow, and will thus have a significant long-term impact on both the animal protein industry as well as the plant-based protein ingredients sector (ie lentils, peas, soy)."}
{"meta": {"doc_id": 2401, "sent_id": 26, "sent_start_pos": 5987, "sent_end_pos": 6635, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Consequently, the threshold for plant-based protein adoption for ground meat is much lower than it would for the replacement of a steak or pork chop. Consumer Tastes are Evolving\nThere is no doubt that the consumption of plant-based proteins is a trend that is only going to grow, and will thus have a significant long-term impact on both the animal protein industry as well as the plant-based protein ingredients sector (ie lentils, peas, soy). I also am hopeful that, as future generations of plant-based protein offerings are developed using fresher and healthier ingredients, this will also have a positive impact on human health and nutrition."}
{"meta": {"doc_id": 2401, "sent_id": 27, "sent_start_pos": 6137, "sent_end_pos": 6846, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Consumer Tastes are Evolving\nThere is no doubt that the consumption of plant-based proteins is a trend that is only going to grow, and will thus have a significant long-term impact on both the animal protein industry as well as the plant-based protein ingredients sector (ie lentils, peas, soy). I also am hopeful that, as future generations of plant-based protein offerings are developed using fresher and healthier ingredients, this will also have a positive impact on human health and nutrition. Although the science-based evidence is still pending, incumbents will do well to take a leadership role in providing a healthier and more nutritious product offering or fear getting leapfrogged by new entrants."}
{"meta": {"doc_id": 2401, "sent_id": 28, "sent_start_pos": 6433, "sent_end_pos": 7030, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "I also am hopeful that, as future generations of plant-based protein offerings are developed using fresher and healthier ingredients, this will also have a positive impact on human health and nutrition. Although the science-based evidence is still pending, incumbents will do well to take a leadership role in providing a healthier and more nutritious product offering or fear getting leapfrogged by new entrants. Customers believe they have a good understanding of the food they eat and have traditionally made their purchases based on a variety of factors, including brand name, cost, and taste."}
{"meta": {"doc_id": 2401, "sent_id": 29, "sent_start_pos": 6636, "sent_end_pos": 7252, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Although the science-based evidence is still pending, incumbents will do well to take a leadership role in providing a healthier and more nutritious product offering or fear getting leapfrogged by new entrants. Customers believe they have a good understanding of the food they eat and have traditionally made their purchases based on a variety of factors, including brand name, cost, and taste. Today, new factors are playing a part in consumer decisions, including environmental impact and ingredient lists, making developing products with a clean label and that are more environmentally sustainable more important."}
{"meta": {"doc_id": 2401, "sent_id": 30, "sent_start_pos": 6847, "sent_end_pos": 7483, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Customers believe they have a good understanding of the food they eat and have traditionally made their purchases based on a variety of factors, including brand name, cost, and taste. Today, new factors are playing a part in consumer decisions, including environmental impact and ingredient lists, making developing products with a clean label and that are more environmentally sustainable more important. Despite my bullish long-term views, it would not be surprising to see a slowdown in sales growth, following tremendous growth in 2019, once the hype around plant-based protein fades and some consumers return to a meat-filled diet."}
{"meta": {"doc_id": 2401, "sent_id": 31, "sent_start_pos": 7031, "sent_end_pos": 7807, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Today, new factors are playing a part in consumer decisions, including environmental impact and ingredient lists, making developing products with a clean label and that are more environmentally sustainable more important. Despite my bullish long-term views, it would not be surprising to see a slowdown in sales growth, following tremendous growth in 2019, once the hype around plant-based protein fades and some consumers return to a meat-filled diet. It would be naive to believe that the current plant-based protein movement is being driven by an increasing trend of vegetarianism/veganism and that consumers are starting to abandon animal protein for good; rather this should be seen as more of a pivot towards a flexitarian diet, where consumers forego meat occasionally."}
{"meta": {"doc_id": 2401, "sent_id": 32, "sent_start_pos": 7253, "sent_end_pos": 8011, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Despite my bullish long-term views, it would not be surprising to see a slowdown in sales growth, following tremendous growth in 2019, once the hype around plant-based protein fades and some consumers return to a meat-filled diet. It would be naive to believe that the current plant-based protein movement is being driven by an increasing trend of vegetarianism/veganism and that consumers are starting to abandon animal protein for good; rather this should be seen as more of a pivot towards a flexitarian diet, where consumers forego meat occasionally. In the longer-term, there are signs that younger consumers (Millennials and Gen Z) are showing a higher likelihood to identify as vegetarian/vegan due to concerns about climate change and animal cruelty."}
{"meta": {"doc_id": 2401, "sent_id": 33, "sent_start_pos": 7484, "sent_end_pos": 8238, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "It would be naive to believe that the current plant-based protein movement is being driven by an increasing trend of vegetarianism/veganism and that consumers are starting to abandon animal protein for good; rather this should be seen as more of a pivot towards a flexitarian diet, where consumers forego meat occasionally. In the longer-term, there are signs that younger consumers (Millennials and Gen Z) are showing a higher likelihood to identify as vegetarian/vegan due to concerns about climate change and animal cruelty. With much more information available today about how consumers feel about the alternative protein sector and an increasing number of food options available to consumers, I expect consumption levels to continue to grow rapidly."}
{"meta": {"doc_id": 2401, "sent_id": 34, "sent_start_pos": 7808, "sent_end_pos": 8625, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "In the longer-term, there are signs that younger consumers (Millennials and Gen Z) are showing a higher likelihood to identify as vegetarian/vegan due to concerns about climate change and animal cruelty. With much more information available today about how consumers feel about the alternative protein sector and an increasing number of food options available to consumers, I expect consumption levels to continue to grow rapidly. Also, as consumption of foods with plant-based proteins accelerate and fast food and other food retailers devote an increasing portion of their menus and marketing dollars to respond to a younger generation of consumers focused on more environmentally sustainable food options, there is no doubt that the animal protein sector is poised for significant disruption in the coming decades."}
{"meta": {"doc_id": 2401, "sent_id": 35, "sent_start_pos": 8012, "sent_end_pos": 8823, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "With much more information available today about how consumers feel about the alternative protein sector and an increasing number of food options available to consumers, I expect consumption levels to continue to grow rapidly. Also, as consumption of foods with plant-based proteins accelerate and fast food and other food retailers devote an increasing portion of their menus and marketing dollars to respond to a younger generation of consumers focused on more environmentally sustainable food options, there is no doubt that the animal protein sector is poised for significant disruption in the coming decades. About the Author:\nAdam Bergman has over 22 years\u2019 experience in investment banking, including over 20 years working with growth companies and more than 15 years covering the broad CleanTech sector."}
{"meta": {"doc_id": 2401, "sent_id": 36, "sent_start_pos": 8239, "sent_end_pos": 9085, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Also, as consumption of foods with plant-based proteins accelerate and fast food and other food retailers devote an increasing portion of their menus and marketing dollars to respond to a younger generation of consumers focused on more environmentally sustainable food options, there is no doubt that the animal protein sector is poised for significant disruption in the coming decades. About the Author:\nAdam Bergman has over 22 years\u2019 experience in investment banking, including over 20 years working with growth companies and more than 15 years covering the broad CleanTech sector. Bergman has built an industry leading practice by connecting food and ag executives with foodtech and agtech executives and investors as means to create an ecosystem to help drive adoption of technology and innovation throughout the broad food & Ag value chain."}
{"meta": {"doc_id": 2401, "sent_id": 37, "sent_start_pos": 8626, "sent_end_pos": 9383, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "About the Author:\nAdam Bergman has over 22 years\u2019 experience in investment banking, including over 20 years working with growth companies and more than 15 years covering the broad CleanTech sector. Bergman has built an industry leading practice by connecting food and ag executives with foodtech and agtech executives and investors as means to create an ecosystem to help drive adoption of technology and innovation throughout the broad food & Ag value chain. He also has developed an extensive industry network throughout the whole supply chain from farm to fork, with early stage and growth companies covering Ag Biotech, Alternative Protein, Automation & Robotics, Digital Ag, Fintech, Food Waste Mitigation, Indoor Farming and Supply Chain Technologies."}
{"meta": {"doc_id": 2401, "sent_id": 38, "sent_start_pos": 8824, "sent_end_pos": 9584, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Bergman has built an industry leading practice by connecting food and ag executives with foodtech and agtech executives and investors as means to create an ecosystem to help drive adoption of technology and innovation throughout the broad food & Ag value chain. He also has developed an extensive industry network throughout the whole supply chain from farm to fork, with early stage and growth companies covering Ag Biotech, Alternative Protein, Automation & Robotics, Digital Ag, Fintech, Food Waste Mitigation, Indoor Farming and Supply Chain Technologies. Additionally, Adam was tasked with creating the AgTech cohort for Wells Fargo\u2019s innovation incubator (IN2), which was established at the Donald Danforth Plant Science Center in St. Louis, MO, in 2018."}
{"meta": {"doc_id": 2401, "sent_id": 39, "sent_start_pos": 9086, "sent_end_pos": 9799, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "He also has developed an extensive industry network throughout the whole supply chain from farm to fork, with early stage and growth companies covering Ag Biotech, Alternative Protein, Automation & Robotics, Digital Ag, Fintech, Food Waste Mitigation, Indoor Farming and Supply Chain Technologies. Additionally, Adam was tasked with creating the AgTech cohort for Wells Fargo\u2019s innovation incubator (IN2), which was established at the Donald Danforth Plant Science Center in St. Louis, MO, in 2018. Bergman has completed over 40 domestic and international financings valued at over $12 billion and over 25 domestic and cross border M&A, restructuring and strategic advisory assignments valued at over $25 billion."}
{"meta": {"doc_id": 2401, "sent_id": 40, "sent_start_pos": 9384, "sent_end_pos": 9932, "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Additionally, Adam was tasked with creating the AgTech cohort for Wells Fargo\u2019s innovation incubator (IN2), which was established at the Donald Danforth Plant Science Center in St. Louis, MO, in 2018. Bergman has completed over 40 domestic and international financings valued at over $12 billion and over 25 domestic and cross border M&A, restructuring and strategic advisory assignments valued at over $25 billion. Join the Global AgInvesting Community\nShare your email to be notified about upcoming events, receive leading industry news and more."}
{"meta": {"doc_id": 2401, "sent_id": 41, "sent_start_pos": 9585, "sent_end_pos": [], "title": "CONTRIBUTED CONTENT: PART II \u2013 PLANT-BASED PROTEIN IS HERE TO STAY"}, "text": "Bergman has completed over 40 domestic and international financings valued at over $12 billion and over 25 domestic and cross border M&A, restructuring and strategic advisory assignments valued at over $25 billion. Join the Global AgInvesting Community\nShare your email to be notified about upcoming events, receive leading industry news and more. "}
{"meta": {"doc_id": 2402, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 817, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": " Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain Nataly Cure December 17 | 2019 Naturally Splendid Enterprises Ltd. (\u201cNaturally Splendid\u201d, \u201cNSE\u201d or \u201cthe Company\u201d) (TSXV:NSP, FRANKFURT:50N, OTC:NSPDF) a healthy food, hemp product developer and large scale producer for in-house brands as well as global contract manufacturer of nutritional plant-based products, is pleased to announce that a contract manufacturing client of Prosnack, a 100% owned division of the Company, will be distributing two (2) flavours of gluten free, plant-based protein bites to a major convenience store chain across Canada. Prosnack developed two (2) formulations for this contract manufacturing client that will be sold under their brand in over 6oo locations across Canada."}
{"meta": {"doc_id": 2402, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 904, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain Nataly Cure December 17 | 2019 Naturally Splendid Enterprises Ltd. (\u201cNaturally Splendid\u201d, \u201cNSE\u201d or \u201cthe Company\u201d) (TSXV:NSP, FRANKFURT:50N, OTC:NSPDF) a healthy food, hemp product developer and large scale producer for in-house brands as well as global contract manufacturer of nutritional plant-based products, is pleased to announce that a contract manufacturing client of Prosnack, a 100% owned division of the Company, will be distributing two (2) flavours of gluten free, plant-based protein bites to a major convenience store chain across Canada. Prosnack developed two (2) formulations for this contract manufacturing client that will be sold under their brand in over 6oo locations across Canada. These products are formulated with plant-based ingredients, are vegan and gluten-free."}
{"meta": {"doc_id": 2402, "sent_id": 2, "sent_start_pos": 666, "sent_end_pos": 1079, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "Prosnack developed two (2) formulations for this contract manufacturing client that will be sold under their brand in over 6oo locations across Canada. These products are formulated with plant-based ingredients, are vegan and gluten-free. Naturally Splendid Vice President Bryan Carson states, \u201cThis relationship is indicative of the contract manufacturing business we are developing within the Prosnack Division."}
{"meta": {"doc_id": 2402, "sent_id": 3, "sent_start_pos": 818, "sent_end_pos": 1147, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "These products are formulated with plant-based ingredients, are vegan and gluten-free. Naturally Splendid Vice President Bryan Carson states, \u201cThis relationship is indicative of the contract manufacturing business we are developing within the Prosnack Division. We continue to attract new business for the healthy snack category."}
{"meta": {"doc_id": 2402, "sent_id": 4, "sent_start_pos": 905, "sent_end_pos": 1403, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "Naturally Splendid Vice President Bryan Carson states, \u201cThis relationship is indicative of the contract manufacturing business we are developing within the Prosnack Division. We continue to attract new business for the healthy snack category. Additionally, the certifications within our facility are often required by retail chains which continues to drive multiple business opportunities in this category and in fact, helps our contract manufacturing clients secure distribution in many instances."}
{"meta": {"doc_id": 2402, "sent_id": 5, "sent_start_pos": 1080, "sent_end_pos": 1526, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "We continue to attract new business for the healthy snack category. Additionally, the certifications within our facility are often required by retail chains which continues to drive multiple business opportunities in this category and in fact, helps our contract manufacturing clients secure distribution in many instances. We are pleased to report that sales as of the third quarter for this division, have surpassed gross sales for all of 2018."}
{"meta": {"doc_id": 2402, "sent_id": 6, "sent_start_pos": 1148, "sent_end_pos": 1696, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "Additionally, the certifications within our facility are often required by retail chains which continues to drive multiple business opportunities in this category and in fact, helps our contract manufacturing clients secure distribution in many instances. We are pleased to report that sales as of the third quarter for this division, have surpassed gross sales for all of 2018. This was accomplished even through the Safe Quality Food Level 2 certification process as well as several facility upgrades in 2019 limited production to less than 50%\u201d."}
{"meta": {"doc_id": 2402, "sent_id": 7, "sent_start_pos": 1404, "sent_end_pos": 1904, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "We are pleased to report that sales as of the third quarter for this division, have surpassed gross sales for all of 2018. This was accomplished even through the Safe Quality Food Level 2 certification process as well as several facility upgrades in 2019 limited production to less than 50%\u201d. Naturally Splendid continues to grow the Prosnack Division for a market where consumers are demanding clean ingredient decks and retailers are demanding these products be manufactured in credible facilities."}
{"meta": {"doc_id": 2402, "sent_id": 8, "sent_start_pos": 1527, "sent_end_pos": 2248, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "This was accomplished even through the Safe Quality Food Level 2 certification process as well as several facility upgrades in 2019 limited production to less than 50%\u201d. Naturally Splendid continues to grow the Prosnack Division for a market where consumers are demanding clean ingredient decks and retailers are demanding these products be manufactured in credible facilities. According to a recent report Vegan Food Market, published by Grand View Research, the global vegan food market size was valued at USD 12.69 billion in 2018 and is projected to expand at a CAGR of 9.6% from 2019 to 2025 Increasing awareness about the benefits of following vegan diet is the key factor responsible for the growth of this market."}
{"meta": {"doc_id": 2402, "sent_id": 9, "sent_start_pos": 1697, "sent_end_pos": 2349, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "Naturally Splendid continues to grow the Prosnack Division for a market where consumers are demanding clean ingredient decks and retailers are demanding these products be manufactured in credible facilities. According to a recent report Vegan Food Market, published by Grand View Research, the global vegan food market size was valued at USD 12.69 billion in 2018 and is projected to expand at a CAGR of 9.6% from 2019 to 2025 Increasing awareness about the benefits of following vegan diet is the key factor responsible for the growth of this market. North America, Europe, and Asia Pacific, in particular, have a large percentage of vegan population."}
{"meta": {"doc_id": 2402, "sent_id": 10, "sent_start_pos": 1905, "sent_end_pos": 2512, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "According to a recent report Vegan Food Market, published by Grand View Research, the global vegan food market size was valued at USD 12.69 billion in 2018 and is projected to expand at a CAGR of 9.6% from 2019 to 2025 Increasing awareness about the benefits of following vegan diet is the key factor responsible for the growth of this market. North America, Europe, and Asia Pacific, in particular, have a large percentage of vegan population. Growing awareness about animal health and animal cruelty in the food industry has been encouraging people to shift from animal-based to plant-based food products."}
{"meta": {"doc_id": 2402, "sent_id": 11, "sent_start_pos": 2249, "sent_end_pos": 2603, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "North America, Europe, and Asia Pacific, in particular, have a large percentage of vegan population. Growing awareness about animal health and animal cruelty in the food industry has been encouraging people to shift from animal-based to plant-based food products. According to The Vegan Society, from 2012 to 2017, the meat-free food demand grew by 987%."}
{"meta": {"doc_id": 2402, "sent_id": 12, "sent_start_pos": 2350, "sent_end_pos": 2685, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "Growing awareness about animal health and animal cruelty in the food industry has been encouraging people to shift from animal-based to plant-based food products. According to The Vegan Society, from 2012 to 2017, the meat-free food demand grew by 987%. The product is Googled three times more than gluten-free and vegetarian products."}
{"meta": {"doc_id": 2402, "sent_id": 13, "sent_start_pos": 2513, "sent_end_pos": 2918, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "According to The Vegan Society, from 2012 to 2017, the meat-free food demand grew by 987%. The product is Googled three times more than gluten-free and vegetarian products. According to a new report Global Healthy Snacks Market, published by KBV research, the Global Healthy Snacks Market size is expected to reach $32.3 billion by 2025, rising at a market growth of 5.07% CAGR during the forecast period."}
{"meta": {"doc_id": 2402, "sent_id": 14, "sent_start_pos": 2604, "sent_end_pos": 3085, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "The product is Googled three times more than gluten-free and vegetarian products. According to a new report Global Healthy Snacks Market, published by KBV research, the Global Healthy Snacks Market size is expected to reach $32.3 billion by 2025, rising at a market growth of 5.07% CAGR during the forecast period. Global Healthy Snack Market Size Naturally Splendid CEO Mr. Craig Goodwin states, \u201cIt is trends such as this that continue to drive business to our Prosnack Division."}
{"meta": {"doc_id": 2402, "sent_id": 15, "sent_start_pos": 2686, "sent_end_pos": 3276, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "According to a new report Global Healthy Snacks Market, published by KBV research, the Global Healthy Snacks Market size is expected to reach $32.3 billion by 2025, rising at a market growth of 5.07% CAGR during the forecast period. Global Healthy Snack Market Size Naturally Splendid CEO Mr. Craig Goodwin states, \u201cIt is trends such as this that continue to drive business to our Prosnack Division. The decision to invest further in our facility and to focus on plant-based ingredient based formulations is creating a sustainable business model for the Company in the healthy snack market."}
{"meta": {"doc_id": 2402, "sent_id": 16, "sent_start_pos": 2919, "sent_end_pos": 3437, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "Global Healthy Snack Market Size Naturally Splendid CEO Mr. Craig Goodwin states, \u201cIt is trends such as this that continue to drive business to our Prosnack Division. The decision to invest further in our facility and to focus on plant-based ingredient based formulations is creating a sustainable business model for the Company in the healthy snack market. This in turn is creating a viable, growing revenue stream to drive shareholder value and continue our growth in the healthy snack and plant-based food sectors\u201d."}
{"meta": {"doc_id": 2402, "sent_id": 17, "sent_start_pos": 3086, "sent_end_pos": 3649, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "The decision to invest further in our facility and to focus on plant-based ingredient based formulations is creating a sustainable business model for the Company in the healthy snack market. This in turn is creating a viable, growing revenue stream to drive shareholder value and continue our growth in the healthy snack and plant-based food sectors\u201d. About Naturally Splendid Enterprises Ltd. NSE has established numerous healthy, functional foods under recognized brands such as Natera Sport(TM), Natera Hemp Foods, CHII (TM), Elevate Me(TM) and Woods Wild Bar."}
{"meta": {"doc_id": 2402, "sent_id": 18, "sent_start_pos": 3277, "sent_end_pos": 3757, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "This in turn is creating a viable, growing revenue stream to drive shareholder value and continue our growth in the healthy snack and plant-based food sectors\u201d. About Naturally Splendid Enterprises Ltd. NSE has established numerous healthy, functional foods under recognized brands such as Natera Sport(TM), Natera Hemp Foods, CHII (TM), Elevate Me(TM) and Woods Wild Bar. The Company has a myriad of new products and line extensions under development that are approaching launch."}
{"meta": {"doc_id": 2402, "sent_id": 19, "sent_start_pos": 3438, "sent_end_pos": 3878, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "About Naturally Splendid Enterprises Ltd. NSE has established numerous healthy, functional foods under recognized brands such as Natera Sport(TM), Natera Hemp Foods, CHII (TM), Elevate Me(TM) and Woods Wild Bar. The Company has a myriad of new products and line extensions under development that are approaching launch. NSE has also developed proprietary technologies for the extraction of high demand, healthy omega 3 and 6 oils from hemp."}
{"meta": {"doc_id": 2402, "sent_id": 20, "sent_start_pos": 3650, "sent_end_pos": 4073, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "The Company has a myriad of new products and line extensions under development that are approaching launch. NSE has also developed proprietary technologies for the extraction of high demand, healthy omega 3 and 6 oils from hemp. (NSE sales revenues for the first half of 2019 exceeded FY2018).NSE is the current \u201cgo-to\u201d manufacturer for healthy, functional food products and ingredients focusing on plant-based ingredients."}
{"meta": {"doc_id": 2402, "sent_id": 21, "sent_start_pos": 3758, "sent_end_pos": 4270, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "NSE has also developed proprietary technologies for the extraction of high demand, healthy omega 3 and 6 oils from hemp. (NSE sales revenues for the first half of 2019 exceeded FY2018).NSE is the current \u201cgo-to\u201d manufacturer for healthy, functional food products and ingredients focusing on plant-based ingredients. The Company provides contract manufacturing services for many global healthy food companies, private labelling a wide variety of nutritional food products destined for global healthy food markets."}
{"meta": {"doc_id": 2402, "sent_id": 22, "sent_start_pos": 3879, "sent_end_pos": 4395, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "(NSE sales revenues for the first half of 2019 exceeded FY2018).NSE is the current \u201cgo-to\u201d manufacturer for healthy, functional food products and ingredients focusing on plant-based ingredients. The Company provides contract manufacturing services for many global healthy food companies, private labelling a wide variety of nutritional food products destined for global healthy food markets. NSE plans to utilize current and new technologies to meet the expected exponential demand developing in the cannabis market."}
{"meta": {"doc_id": 2402, "sent_id": 23, "sent_start_pos": 4074, "sent_end_pos": 4666, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "The Company provides contract manufacturing services for many global healthy food companies, private labelling a wide variety of nutritional food products destined for global healthy food markets. NSE plans to utilize current and new technologies to meet the expected exponential demand developing in the cannabis market. Pending appropriate NSE licensing and regulations in permitting jurisdictions, NSE\u2019s current production facilities will be one of very few facilities that is capable of meeting the demand for infused edibles and oils for both in-house and contract manufacturers\u2019 brands."}
{"meta": {"doc_id": 2402, "sent_id": 24, "sent_start_pos": 4271, "sent_end_pos": 5286, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "NSE plans to utilize current and new technologies to meet the expected exponential demand developing in the cannabis market. Pending appropriate NSE licensing and regulations in permitting jurisdictions, NSE\u2019s current production facilities will be one of very few facilities that is capable of meeting the demand for infused edibles and oils for both in-house and contract manufacturers\u2019 brands. For more information e-mail info@naturallysplendid.com or call Investor Relations at 604-673-9573 On Behalf of the Board of Directors Mr. J Craig Goodwin CEO, President, Director Contact Information Naturally Splendid Enterprises Ltd. (NSP \u2013 TSX Venture; NSPDF \u2013 OTCQB; 50N Frankfurt) #108-19100 Airport Way Pitt Meadows, BC, V3Y 0E2 Office: (604) 465-0548 Fax: (604) 465-1128 E-mail: info@naturallysplendid.com Website: www.naturallysplendid.com Forward-Looking Statements Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release."}
{"meta": {"doc_id": 2402, "sent_id": 25, "sent_start_pos": 4396, "sent_end_pos": 5381, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "Pending appropriate NSE licensing and regulations in permitting jurisdictions, NSE\u2019s current production facilities will be one of very few facilities that is capable of meeting the demand for infused edibles and oils for both in-house and contract manufacturers\u2019 brands. For more information e-mail info@naturallysplendid.com or call Investor Relations at 604-673-9573 On Behalf of the Board of Directors Mr. J Craig Goodwin CEO, President, Director Contact Information Naturally Splendid Enterprises Ltd. (NSP \u2013 TSX Venture; NSPDF \u2013 OTCQB; 50N Frankfurt) #108-19100 Airport Way Pitt Meadows, BC, V3Y 0E2 Office: (604) 465-0548 Fax: (604) 465-1128 E-mail: info@naturallysplendid.com Website: www.naturallysplendid.com Forward-Looking Statements Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management\u2019s current estimates, beliefs, intentions and expectations."}
{"meta": {"doc_id": 2402, "sent_id": 26, "sent_start_pos": 4667, "sent_end_pos": 5428, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "For more information e-mail info@naturallysplendid.com or call Investor Relations at 604-673-9573 On Behalf of the Board of Directors Mr. J Craig Goodwin CEO, President, Director Contact Information Naturally Splendid Enterprises Ltd. (NSP \u2013 TSX Venture; NSPDF \u2013 OTCQB; 50N Frankfurt) #108-19100 Airport Way Pitt Meadows, BC, V3Y 0E2 Office: (604) 465-0548 Fax: (604) 465-1128 E-mail: info@naturallysplendid.com Website: www.naturallysplendid.com Forward-Looking Statements Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management\u2019s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance."}
{"meta": {"doc_id": 2402, "sent_id": 27, "sent_start_pos": 5287, "sent_end_pos": 6028, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "These statements reflect management\u2019s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid\u2019s control including, Naturally Splendid\u2019s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; customers will complete on sales contracts; and the risk that any of the potential applications may not receive all required regulatory or legal approval."}
{"meta": {"doc_id": 2402, "sent_id": 28, "sent_start_pos": 5382, "sent_end_pos": 6226, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid\u2019s control including, Naturally Splendid\u2019s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; customers will complete on sales contracts; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information."}
{"meta": {"doc_id": 2402, "sent_id": 29, "sent_start_pos": 5429, "sent_end_pos": 6388, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid\u2019s control including, Naturally Splendid\u2019s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; customers will complete on sales contracts; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information."}
{"meta": {"doc_id": 2402, "sent_id": 30, "sent_start_pos": 6029, "sent_end_pos": 6475, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information. Click here to connect with Naturally Splendid (TSXV:NSP) for an Investor Presentation."}
{"meta": {"doc_id": 2402, "sent_id": 31, "sent_start_pos": 6227, "sent_end_pos": 6530, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information. Click here to connect with Naturally Splendid (TSXV:NSP) for an Investor Presentation. Source Cannabis - Will The Fortune 500 Join The Party?"}
{"meta": {"doc_id": 2402, "sent_id": 32, "sent_start_pos": 6389, "sent_end_pos": 6626, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "Click here to connect with Naturally Splendid (TSXV:NSP) for an Investor Presentation. Source Cannabis - Will The Fortune 500 Join The Party? Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!"}
{"meta": {"doc_id": 2402, "sent_id": 33, "sent_start_pos": 6476, "sent_end_pos": 6650, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "Source Cannabis - Will The Fortune 500 Join The Party? Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing! Grab Your Report Today!"}
{"meta": {"doc_id": 2402, "sent_id": 34, "sent_start_pos": 6531, "sent_end_pos": 6960, "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing! Grab Your Report Today! {\"customDimensions\": {\"8\":\"company-news\",\"9\":\"Health Canada, NATERA\\u2122, naturally splendid, Naturally Splendid Extracts Ltd., OTC:NSPDF, TSXV:NSP\",\"10\":\"12/17/2019\",\"13\":2648435754,\"7\":\"Nataly Cure\"}, \"post\": {\"providerId\": 20, \"sections\": [0, 525706955, 527577852], \"buckets\": [], \"authors\": [20365703]} }"}
{"meta": {"doc_id": 2402, "sent_id": 35, "sent_start_pos": 6627, "sent_end_pos": [], "title": "Naturally Splendid Announces Contract Manufacturing Client to Launch Nationally in Major Convenience Store Chain"}, "text": "Grab Your Report Today! {\"customDimensions\": {\"8\":\"company-news\",\"9\":\"Health Canada, NATERA\\u2122, naturally splendid, Naturally Splendid Extracts Ltd., OTC:NSPDF, TSXV:NSP\",\"10\":\"12/17/2019\",\"13\":2648435754,\"7\":\"Nataly Cure\"}, \"post\": {\"providerId\": 20, \"sections\": [0, 525706955, 527577852], \"buckets\": [], \"authors\": [20365703]} } "}
{"meta": {"doc_id": 2403, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 546, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": " Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg\n- Biotech start-up Ginkgo Bioworks is launching Motif Ingredients to find the next big thing in plant-based food after the success of the Impossible Burger. - Ginkgo has tapped PepsiCo veteran Jonathan McIntyre as CEO of the new venture, which has been funded by investors including Breakthrough Energy Ventures, a who's who of billionaire venture capital, led by Bill Gates and representing many of the world's richest people."}
{"meta": {"doc_id": 2403, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 709, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg\n- Biotech start-up Ginkgo Bioworks is launching Motif Ingredients to find the next big thing in plant-based food after the success of the Impossible Burger. - Ginkgo has tapped PepsiCo veteran Jonathan McIntyre as CEO of the new venture, which has been funded by investors including Breakthrough Energy Ventures, a who's who of billionaire venture capital, led by Bill Gates and representing many of the world's richest people. As demand for plant-based food like fake burgers heats up, biotech start-up Ginkgo Bioworks is launching a venture to bring scale to the rapidly growing industry."}
{"meta": {"doc_id": 2403, "sent_id": 2, "sent_start_pos": 276, "sent_end_pos": 879, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "- Ginkgo has tapped PepsiCo veteran Jonathan McIntyre as CEO of the new venture, which has been funded by investors including Breakthrough Energy Ventures, a who's who of billionaire venture capital, led by Bill Gates and representing many of the world's richest people. As demand for plant-based food like fake burgers heats up, biotech start-up Ginkgo Bioworks is launching a venture to bring scale to the rapidly growing industry. US retail sales of plant-based foods that replace animal products grew by 17 percent to $3.7 billion in 2018, according to data from Nielsen and the Good Food Institute."}
{"meta": {"doc_id": 2403, "sent_id": 3, "sent_start_pos": 547, "sent_end_pos": 1030, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "As demand for plant-based food like fake burgers heats up, biotech start-up Ginkgo Bioworks is launching a venture to bring scale to the rapidly growing industry. US retail sales of plant-based foods that replace animal products grew by 17 percent to $3.7 billion in 2018, according to data from Nielsen and the Good Food Institute. Impossible Foods took the top prize at the Consumer Electronics Show in January for the latest version of its burger known for its realistic bleeding."}
{"meta": {"doc_id": 2403, "sent_id": 4, "sent_start_pos": 710, "sent_end_pos": 1203, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "US retail sales of plant-based foods that replace animal products grew by 17 percent to $3.7 billion in 2018, according to data from Nielsen and the Good Food Institute. Impossible Foods took the top prize at the Consumer Electronics Show in January for the latest version of its burger known for its realistic bleeding. Beyond Meat, which sells products like Beyond Sausage and Beyond Burger on the shelves of Kroger, Target and Amazon's Whole Foods, has filed for an initial public offering."}
{"meta": {"doc_id": 2403, "sent_id": 5, "sent_start_pos": 880, "sent_end_pos": 1359, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "Impossible Foods took the top prize at the Consumer Electronics Show in January for the latest version of its burger known for its realistic bleeding. Beyond Meat, which sells products like Beyond Sausage and Beyond Burger on the shelves of Kroger, Target and Amazon's Whole Foods, has filed for an initial public offering. It's the success of Impossible Foods that drove Ginkgo to begin planning Motif Ingredients in mid-2017, according to Ginkgo co-founder and CEO Jason Kelly."}
{"meta": {"doc_id": 2403, "sent_id": 6, "sent_start_pos": 1031, "sent_end_pos": 1494, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "Beyond Meat, which sells products like Beyond Sausage and Beyond Burger on the shelves of Kroger, Target and Amazon's Whole Foods, has filed for an initial public offering. It's the success of Impossible Foods that drove Ginkgo to begin planning Motif Ingredients in mid-2017, according to Ginkgo co-founder and CEO Jason Kelly. Silicon Valley-based Impossible Foods genetically engineers heme, a protein that makes the vegetarian-friendly burger taste like meat."}
{"meta": {"doc_id": 2403, "sent_id": 7, "sent_start_pos": 1204, "sent_end_pos": 1794, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "It's the success of Impossible Foods that drove Ginkgo to begin planning Motif Ingredients in mid-2017, according to Ginkgo co-founder and CEO Jason Kelly. Silicon Valley-based Impossible Foods genetically engineers heme, a protein that makes the vegetarian-friendly burger taste like meat. The company, started by a Stanford University scientist, received a key FDA approval last July for its protein, but its plan to sell uncooked Impossible Burgers in retail grocery stores requires a separate FDA color additive review, which is still pending ahead of a planned retail launch this year."}
{"meta": {"doc_id": 2403, "sent_id": 8, "sent_start_pos": 1360, "sent_end_pos": 1989, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "Silicon Valley-based Impossible Foods genetically engineers heme, a protein that makes the vegetarian-friendly burger taste like meat. The company, started by a Stanford University scientist, received a key FDA approval last July for its protein, but its plan to sell uncooked Impossible Burgers in retail grocery stores requires a separate FDA color additive review, which is still pending ahead of a planned retail launch this year. Kelly said it is difficult for other companies to follow in Impossible Foods' footsteps, because few people have both the experience to build a successful food brand and a Ph.D in biotechnology."}
{"meta": {"doc_id": 2403, "sent_id": 9, "sent_start_pos": 1495, "sent_end_pos": 2077, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "The company, started by a Stanford University scientist, received a key FDA approval last July for its protein, but its plan to sell uncooked Impossible Burgers in retail grocery stores requires a separate FDA color additive review, which is still pending ahead of a planned retail launch this year. Kelly said it is difficult for other companies to follow in Impossible Foods' footsteps, because few people have both the experience to build a successful food brand and a Ph.D in biotechnology. That's where Motif thinks it can play a role as the plant-based protein market matures."}
{"meta": {"doc_id": 2403, "sent_id": 10, "sent_start_pos": 1795, "sent_end_pos": 2309, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "Kelly said it is difficult for other companies to follow in Impossible Foods' footsteps, because few people have both the experience to build a successful food brand and a Ph.D in biotechnology. That's where Motif thinks it can play a role as the plant-based protein market matures. The Boston-based start-up will help food companies \u2014 both large and small \u2014 find the next big thing in laboratory-based food by developing the key ingredients and leaving the rest of the work to the food companies, Kelly told CNBC."}
{"meta": {"doc_id": 2403, "sent_id": 11, "sent_start_pos": 1990, "sent_end_pos": 2455, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "That's where Motif thinks it can play a role as the plant-based protein market matures. The Boston-based start-up will help food companies \u2014 both large and small \u2014 find the next big thing in laboratory-based food by developing the key ingredients and leaving the rest of the work to the food companies, Kelly told CNBC. The company plans to use biotechnology and fermentation \u2014 rather than animal agriculture \u2014 to engineer proteins derived from dairy, egg and meat."}
{"meta": {"doc_id": 2403, "sent_id": 12, "sent_start_pos": 2078, "sent_end_pos": 2604, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "The Boston-based start-up will help food companies \u2014 both large and small \u2014 find the next big thing in laboratory-based food by developing the key ingredients and leaving the rest of the work to the food companies, Kelly told CNBC. The company plans to use biotechnology and fermentation \u2014 rather than animal agriculture \u2014 to engineer proteins derived from dairy, egg and meat. Billionaire burgers of the future\nMotif Ingredients attracted some high-profile investors to a $90 million Series A funding round announced Tuesday."}
{"meta": {"doc_id": 2403, "sent_id": 13, "sent_start_pos": 2310, "sent_end_pos": 2920, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "The company plans to use biotechnology and fermentation \u2014 rather than animal agriculture \u2014 to engineer proteins derived from dairy, egg and meat. Billionaire burgers of the future\nMotif Ingredients attracted some high-profile investors to a $90 million Series A funding round announced Tuesday. The Bill Gates-led investing entity Breakthrough Energy Ventures \u2014 which includes among its roster of billionaire backers Jeff Bezos, Michael Bloomberg, Richard Branson, hedge fund titan Ray Dalio, LinkedIn co-founder Reid Hoffman, Alibaba's Jack Ma and Softbank founder Masayoshi Son \u2014 was in on the venture round."}
{"meta": {"doc_id": 2403, "sent_id": 14, "sent_start_pos": 2456, "sent_end_pos": 3054, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "Billionaire burgers of the future\nMotif Ingredients attracted some high-profile investors to a $90 million Series A funding round announced Tuesday. The Bill Gates-led investing entity Breakthrough Energy Ventures \u2014 which includes among its roster of billionaire backers Jeff Bezos, Michael Bloomberg, Richard Branson, hedge fund titan Ray Dalio, LinkedIn co-founder Reid Hoffman, Alibaba's Jack Ma and Softbank founder Masayoshi Son \u2014 was in on the venture round. Investors also included hedge fund Viking Global Investors, Louis Dreyfus Companies and New Zealand-based dairy cooperative Fonterra."}
{"meta": {"doc_id": 2403, "sent_id": 15, "sent_start_pos": 2605, "sent_end_pos": 3171, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "The Bill Gates-led investing entity Breakthrough Energy Ventures \u2014 which includes among its roster of billionaire backers Jeff Bezos, Michael Bloomberg, Richard Branson, hedge fund titan Ray Dalio, LinkedIn co-founder Reid Hoffman, Alibaba's Jack Ma and Softbank founder Masayoshi Son \u2014 was in on the venture round. Investors also included hedge fund Viking Global Investors, Louis Dreyfus Companies and New Zealand-based dairy cooperative Fonterra. Gates is an investor in several lab-based food companies, including Impossible Foods, Beyond Meat and Memphis Meats."}
{"meta": {"doc_id": 2403, "sent_id": 16, "sent_start_pos": 2921, "sent_end_pos": 3392, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "Investors also included hedge fund Viking Global Investors, Louis Dreyfus Companies and New Zealand-based dairy cooperative Fonterra. Gates is an investor in several lab-based food companies, including Impossible Foods, Beyond Meat and Memphis Meats. Earlier this month, Breakthrough Energy Ventures led a funding round for Chicago-based Sustainable Bioproducts, which is working with a fermentation process to grow edible protein as a replacement for animal-based meats."}
{"meta": {"doc_id": 2403, "sent_id": 17, "sent_start_pos": 3055, "sent_end_pos": 3592, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "Gates is an investor in several lab-based food companies, including Impossible Foods, Beyond Meat and Memphis Meats. Earlier this month, Breakthrough Energy Ventures led a funding round for Chicago-based Sustainable Bioproducts, which is working with a fermentation process to grow edible protein as a replacement for animal-based meats. Cascade Investment, Bill Gates' personal investment firm, already is an investor in Ginkgo, which builds made-to-order microbes for customers in sectors such as agriculture, pharmaceuticals and food."}
{"meta": {"doc_id": 2403, "sent_id": 18, "sent_start_pos": 3172, "sent_end_pos": 3809, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "Earlier this month, Breakthrough Energy Ventures led a funding round for Chicago-based Sustainable Bioproducts, which is working with a fermentation process to grow edible protein as a replacement for animal-based meats. Cascade Investment, Bill Gates' personal investment firm, already is an investor in Ginkgo, which builds made-to-order microbes for customers in sectors such as agriculture, pharmaceuticals and food. Scientists estimate the world population will reach 9.6 billion by the year 2050, and according to the Food and Agricultural Organization of the United Nations, world food production will need to increase 70 percent."}
{"meta": {"doc_id": 2403, "sent_id": 19, "sent_start_pos": 3393, "sent_end_pos": 3972, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "Cascade Investment, Bill Gates' personal investment firm, already is an investor in Ginkgo, which builds made-to-order microbes for customers in sectors such as agriculture, pharmaceuticals and food. Scientists estimate the world population will reach 9.6 billion by the year 2050, and according to the Food and Agricultural Organization of the United Nations, world food production will need to increase 70 percent. \"Raising meat takes a great deal of land and water and has a substantial environmental impact,\" Gates wrote on his personal blog, Gatesnotes.com, a few years ago."}
{"meta": {"doc_id": 2403, "sent_id": 20, "sent_start_pos": 3593, "sent_end_pos": 4045, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "Scientists estimate the world population will reach 9.6 billion by the year 2050, and according to the Food and Agricultural Organization of the United Nations, world food production will need to increase 70 percent. \"Raising meat takes a great deal of land and water and has a substantial environmental impact,\" Gates wrote on his personal blog, Gatesnotes.com, a few years ago. \"Put simply, there's no way to produce enough meat for 9 billion people."}
{"meta": {"doc_id": 2403, "sent_id": 21, "sent_start_pos": 3810, "sent_end_pos": 4179, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "\"Raising meat takes a great deal of land and water and has a substantial environmental impact,\" Gates wrote on his personal blog, Gatesnotes.com, a few years ago. \"Put simply, there's no way to produce enough meat for 9 billion people. That's why we need more options for producing meat without depleting our resources.\""}
{"meta": {"doc_id": 2403, "sent_id": 22, "sent_start_pos": 3973, "sent_end_pos": 4272, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "\"Put simply, there's no way to produce enough meat for 9 billion people. That's why we need more options for producing meat without depleting our resources.\" Between 2016 and late 2018, Beyond Meat had sold more than 25 million of its Beyond Burgers."}
{"meta": {"doc_id": 2403, "sent_id": 23, "sent_start_pos": 4095, "sent_end_pos": 4458, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "That's why we need more options for producing meat without depleting our resources.\" Between 2016 and late 2018, Beyond Meat had sold more than 25 million of its Beyond Burgers. The rise of lab-based foods has resulted in legal challenges and regulatory scrutiny."}
{"meta": {"doc_id": 2403, "sent_id": 24, "sent_start_pos": 4180, "sent_end_pos": 4695, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "Between 2016 and late 2018, Beyond Meat had sold more than 25 million of its Beyond Burgers. The rise of lab-based foods has resulted in legal challenges and regulatory scrutiny. In recent weeks, beef and farming trade groups successfully lobbied a dozen states to introduce laws that would make it illegal to use the word meat to describe burgers and sausages created from plant-based ingredients or grown in labs."}
{"meta": {"doc_id": 2403, "sent_id": 25, "sent_start_pos": 4373, "sent_end_pos": 4996, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "The rise of lab-based foods has resulted in legal challenges and regulatory scrutiny. In recent weeks, beef and farming trade groups successfully lobbied a dozen states to introduce laws that would make it illegal to use the word meat to describe burgers and sausages created from plant-based ingredients or grown in labs. Ginkgo, which has made the CNBC Disruptor 50 list three times, has tapped Jonathan McIntyre \u2014 whose experience includes a stint as the head of research and development for PepsiCo's snack division and head of R&D at another CNBC Disruptor 50 start-up, Indigo Agriculture \u2014 as CEO for the new company."}
{"meta": {"doc_id": 2403, "sent_id": 26, "sent_start_pos": 4459, "sent_end_pos": 5142, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "In recent weeks, beef and farming trade groups successfully lobbied a dozen states to introduce laws that would make it illegal to use the word meat to describe burgers and sausages created from plant-based ingredients or grown in labs. Ginkgo, which has made the CNBC Disruptor 50 list three times, has tapped Jonathan McIntyre \u2014 whose experience includes a stint as the head of research and development for PepsiCo's snack division and head of R&D at another CNBC Disruptor 50 start-up, Indigo Agriculture \u2014 as CEO for the new company. \"Sustainability and accessible nutrition are among the biggest challenges facing the food industry today,\" McIntyre said in a release on Tuesday."}
{"meta": {"doc_id": 2403, "sent_id": 27, "sent_start_pos": 4696, "sent_end_pos": 5227, "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "Ginkgo, which has made the CNBC Disruptor 50 list three times, has tapped Jonathan McIntyre \u2014 whose experience includes a stint as the head of research and development for PepsiCo's snack division and head of R&D at another CNBC Disruptor 50 start-up, Indigo Agriculture \u2014 as CEO for the new company. \"Sustainability and accessible nutrition are among the biggest challenges facing the food industry today,\" McIntyre said in a release on Tuesday. WATCH: Jeff Bezos is so much bigger than Amazon \u2014 a look at his extraordinary empire"}
{"meta": {"doc_id": 2403, "sent_id": 28, "sent_start_pos": 4997, "sent_end_pos": [], "title": "Ginkgo Bioworks joins hunt for next Impossible Burger with billionaire investors, including Gates, Bezos and Bloomberg"}, "text": "\"Sustainability and accessible nutrition are among the biggest challenges facing the food industry today,\" McIntyre said in a release on Tuesday. WATCH: Jeff Bezos is so much bigger than Amazon \u2014 a look at his extraordinary empire "}
{"meta": {"doc_id": 2404, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 261, "title": "Singaporean Startup Develops Vegan Alternative To Lab Meat"}, "text": " A food tech Singaporean startup has developed a meat substitute product that resembles lab meat and tastes like \u2018real\u2019 chicken. The startup, Life3 Biotech, is hoping to attract over $1 million in funding to set up a production facility for the plant-based meat."}
{"meta": {"doc_id": 2404, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 374, "title": "Singaporean Startup Develops Vegan Alternative To Lab Meat"}, "text": "A food tech Singaporean startup has developed a meat substitute product that resembles lab meat and tastes like \u2018real\u2019 chicken. The startup, Life3 Biotech, is hoping to attract over $1 million in funding to set up a production facility for the plant-based meat. Called \u2018Veego\u2019, the plant-based protein is considered to be the closest made-in-Singapore product to \u2018lab meat\u2019."}
{"meta": {"doc_id": 2404, "sent_id": 2, "sent_start_pos": 128, "sent_end_pos": 535, "title": "Singaporean Startup Develops Vegan Alternative To Lab Meat"}, "text": "The startup, Life3 Biotech, is hoping to attract over $1 million in funding to set up a production facility for the plant-based meat. Called \u2018Veego\u2019, the plant-based protein is considered to be the closest made-in-Singapore product to \u2018lab meat\u2019. Slaughter-free\nKnown as \u2018cultured\u2019 or \u2018clean\u2019 meat, lab meat is grown from animal cells, without the farming of animals \u2013 but it still can involve slaughtering."}
{"meta": {"doc_id": 2404, "sent_id": 3, "sent_start_pos": 262, "sent_end_pos": 688, "title": "Singaporean Startup Develops Vegan Alternative To Lab Meat"}, "text": "Called \u2018Veego\u2019, the plant-based protein is considered to be the closest made-in-Singapore product to \u2018lab meat\u2019. Slaughter-free\nKnown as \u2018cultured\u2019 or \u2018clean\u2019 meat, lab meat is grown from animal cells, without the farming of animals \u2013 but it still can involve slaughtering. The Singaporean plant-based alternative to meat could mean that vegans will be able to enjoy what would resemble lab meat \u2013 but entirely slaughter-free."}
{"meta": {"doc_id": 2404, "sent_id": 4, "sent_start_pos": 375, "sent_end_pos": 791, "title": "Singaporean Startup Develops Vegan Alternative To Lab Meat"}, "text": "Slaughter-free\nKnown as \u2018cultured\u2019 or \u2018clean\u2019 meat, lab meat is grown from animal cells, without the farming of animals \u2013 but it still can involve slaughtering. The Singaporean plant-based alternative to meat could mean that vegans will be able to enjoy what would resemble lab meat \u2013 but entirely slaughter-free. Veego\nVeego can be sliced like real meat \u2013 it can also be steamed, stir-fried, deep-fried, and cooked."}
{"meta": {"doc_id": 2404, "sent_id": 5, "sent_start_pos": 536, "sent_end_pos": 915, "title": "Singaporean Startup Develops Vegan Alternative To Lab Meat"}, "text": "The Singaporean plant-based alternative to meat could mean that vegans will be able to enjoy what would resemble lab meat \u2013 but entirely slaughter-free. Veego\nVeego can be sliced like real meat \u2013 it can also be steamed, stir-fried, deep-fried, and cooked. Although the exact ingredients have been kept secret, Life3 Biotech announced that it uses legumes, grains, and soya beans."}
{"meta": {"doc_id": 2404, "sent_id": 6, "sent_start_pos": 689, "sent_end_pos": 1079, "title": "Singaporean Startup Develops Vegan Alternative To Lab Meat"}, "text": "Veego\nVeego can be sliced like real meat \u2013 it can also be steamed, stir-fried, deep-fried, and cooked. Although the exact ingredients have been kept secret, Life3 Biotech announced that it uses legumes, grains, and soya beans. According to founder Ricky Lin, the plant meat \u2013 which is also gluten-free \u2013 contains at least 18 grams of protein, and is high in fiber and low in saturated fats."}
{"meta": {"doc_id": 2404, "sent_id": 7, "sent_start_pos": 792, "sent_end_pos": 1358, "title": "Singaporean Startup Develops Vegan Alternative To Lab Meat"}, "text": "Although the exact ingredients have been kept secret, Life3 Biotech announced that it uses legumes, grains, and soya beans. According to founder Ricky Lin, the plant meat \u2013 which is also gluten-free \u2013 contains at least 18 grams of protein, and is high in fiber and low in saturated fats. READ MORE:\nCONTROVERSIAL: Lab Meat Continues To Spark Debate Among Vegans\nVICTORY: California Court Reinstates Ban On Foie Gras\nBAN: China Prohibits European Cheese For Containing \u2018Too Much Bacteria\u2019"}
{"meta": {"doc_id": 2404, "sent_id": 8, "sent_start_pos": 916, "sent_end_pos": [], "title": "Singaporean Startup Develops Vegan Alternative To Lab Meat"}, "text": "According to founder Ricky Lin, the plant meat \u2013 which is also gluten-free \u2013 contains at least 18 grams of protein, and is high in fiber and low in saturated fats. READ MORE:\nCONTROVERSIAL: Lab Meat Continues To Spark Debate Among Vegans\nVICTORY: California Court Reinstates Ban On Foie Gras\nBAN: China Prohibits European Cheese For Containing \u2018Too Much Bacteria\u2019 "}
{"meta": {"doc_id": 2405, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 95, "title": "Industrial-scale plant-based protein production in a cell-free platform"}, "text": " CORDIS website requires JavaScript enabled in order to work properly. Please enable JavaScript."}
{"meta": {"doc_id": 2405, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 185, "title": "Industrial-scale plant-based protein production in a cell-free platform"}, "text": "CORDIS website requires JavaScript enabled in order to work properly. Please enable JavaScript. Le site web de CORDIS n\u00e9cessite l\u2019activation de JavaScript pour fonctionner correctement."}
{"meta": {"doc_id": 2405, "sent_id": 2, "sent_start_pos": 70, "sent_end_pos": 214, "title": "Industrial-scale plant-based protein production in a cell-free platform"}, "text": "Please enable JavaScript. Le site web de CORDIS n\u00e9cessite l\u2019activation de JavaScript pour fonctionner correctement. Veuillez activer JavaScript."}
{"meta": {"doc_id": 2405, "sent_id": 3, "sent_start_pos": 96, "sent_end_pos": 302, "title": "Industrial-scale plant-based protein production in a cell-free platform"}, "text": "Le site web de CORDIS n\u00e9cessite l\u2019activation de JavaScript pour fonctionner correctement. Veuillez activer JavaScript. El sitio web de CORDIS requiere tener activado JavaScript para funcionar correctamente."}
{"meta": {"doc_id": 2405, "sent_id": 4, "sent_start_pos": 186, "sent_end_pos": 332, "title": "Industrial-scale plant-based protein production in a cell-free platform"}, "text": "Veuillez activer JavaScript. El sitio web de CORDIS requiere tener activado JavaScript para funcionar correctamente. Por favor, active JavaScript."}
{"meta": {"doc_id": 2405, "sent_id": 5, "sent_start_pos": 215, "sent_end_pos": 414, "title": "Industrial-scale plant-based protein production in a cell-free platform"}, "text": "El sitio web de CORDIS requiere tener activado JavaScript para funcionar correctamente. Por favor, active JavaScript. F\u00fcr die fehlerfreie Verwendung der CORDIS-Website muss JavaScript aktiviert sein."}
{"meta": {"doc_id": 2405, "sent_id": 6, "sent_start_pos": 303, "sent_end_pos": 447, "title": "Industrial-scale plant-based protein production in a cell-free platform"}, "text": "Por favor, active JavaScript. F\u00fcr die fehlerfreie Verwendung der CORDIS-Website muss JavaScript aktiviert sein. Bitte aktivieren Sie JavaScript."}
{"meta": {"doc_id": 2405, "sent_id": 7, "sent_start_pos": 333, "sent_end_pos": 536, "title": "Industrial-scale plant-based protein production in a cell-free platform"}, "text": "F\u00fcr die fehlerfreie Verwendung der CORDIS-Website muss JavaScript aktiviert sein. Bitte aktivieren Sie JavaScript. Il sito web di CORDIS prevede che JavaScript sia abilitato per funzionare correttamente."}
{"meta": {"doc_id": 2405, "sent_id": 8, "sent_start_pos": 415, "sent_end_pos": 570, "title": "Industrial-scale plant-based protein production in a cell-free platform"}, "text": "Bitte aktivieren Sie JavaScript. Il sito web di CORDIS prevede che JavaScript sia abilitato per funzionare correttamente. Si prega di abilitare JavaScript."}
{"meta": {"doc_id": 2405, "sent_id": 9, "sent_start_pos": 448, "sent_end_pos": 647, "title": "Industrial-scale plant-based protein production in a cell-free platform"}, "text": "Il sito web di CORDIS prevede che JavaScript sia abilitato per funzionare correttamente. Si prega di abilitare JavaScript. Aby witryna CORDIS dzia\u0142a\u0142a poprawnie, obs\u0142uga JavaScript musi by\u0107 w\u0142\u0105czona."}
{"meta": {"doc_id": 2405, "sent_id": 10, "sent_start_pos": 537, "sent_end_pos": 673, "title": "Industrial-scale plant-based protein production in a cell-free platform"}, "text": "Si prega di abilitare JavaScript. Aby witryna CORDIS dzia\u0142a\u0142a poprawnie, obs\u0142uga JavaScript musi by\u0107 w\u0142\u0105czona. W\u0142\u0105cz obs\u0142ug\u0119 JavaScript."}
{"meta": {"doc_id": 2405, "sent_id": 11, "sent_start_pos": 571, "sent_end_pos": [], "title": "Industrial-scale plant-based protein production in a cell-free platform"}, "text": "Aby witryna CORDIS dzia\u0142a\u0142a poprawnie, obs\u0142uga JavaScript musi by\u0107 w\u0142\u0105czona. W\u0142\u0105cz obs\u0142ug\u0119 JavaScript. "}
{"meta": {"doc_id": 2407, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 253, "title": "Motif Ingredients Launches, Raises $90M to Democratize Plant-Based Ingredients"}, "text": " Making a burger (or chicken nugget, or egg) out of plants that tastes like the real thing is no easy feat. It takes years of R&D, teams of scientists, and large amounts of funding, and for many small startups, the development process is a slow struggle."}
{"meta": {"doc_id": 2407, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 358, "title": "Motif Ingredients Launches, Raises $90M to Democratize Plant-Based Ingredients"}, "text": "Making a burger (or chicken nugget, or egg) out of plants that tastes like the real thing is no easy feat. It takes years of R&D, teams of scientists, and large amounts of funding, and for many small startups, the development process is a slow struggle. A new company is working to make it easier for plant-based protein companies to develop better products."}
{"meta": {"doc_id": 2407, "sent_id": 2, "sent_start_pos": 107, "sent_end_pos": 523, "title": "Motif Ingredients Launches, Raises $90M to Democratize Plant-Based Ingredients"}, "text": "It takes years of R&D, teams of scientists, and large amounts of funding, and for many small startups, the development process is a slow struggle. A new company is working to make it easier for plant-based protein companies to develop better products. Today Ginkgo Bioworks, a Boston-based biotech company (and unicorn), unveiled Motif Ingredients, a spinoff company developing ingredients to replace animal protein."}
{"meta": {"doc_id": 2407, "sent_id": 3, "sent_start_pos": 254, "sent_end_pos": 738, "title": "Motif Ingredients Launches, Raises $90M to Democratize Plant-Based Ingredients"}, "text": "A new company is working to make it easier for plant-based protein companies to develop better products. Today Ginkgo Bioworks, a Boston-based biotech company (and unicorn), unveiled Motif Ingredients, a spinoff company developing ingredients to replace animal protein. The company\u2019s off to a running start: today it also announced it has raised a 90 million Series A funding round from Breakthrough Energy Ventures, Fonterra and food processing giant Louis Dreyfus Co., among others."}
{"meta": {"doc_id": 2407, "sent_id": 4, "sent_start_pos": 359, "sent_end_pos": 897, "title": "Motif Ingredients Launches, Raises $90M to Democratize Plant-Based Ingredients"}, "text": "Today Ginkgo Bioworks, a Boston-based biotech company (and unicorn), unveiled Motif Ingredients, a spinoff company developing ingredients to replace animal protein. The company\u2019s off to a running start: today it also announced it has raised a 90 million Series A funding round from Breakthrough Energy Ventures, Fonterra and food processing giant Louis Dreyfus Co., among others. Motif will use engineered microbes (like yeast) to \u201cbrew\u201d food proteins that can mimic the same ones that give animal products their unique taste and texture."}
{"meta": {"doc_id": 2407, "sent_id": 5, "sent_start_pos": 524, "sent_end_pos": 1058, "title": "Motif Ingredients Launches, Raises $90M to Democratize Plant-Based Ingredients"}, "text": "The company\u2019s off to a running start: today it also announced it has raised a 90 million Series A funding round from Breakthrough Energy Ventures, Fonterra and food processing giant Louis Dreyfus Co., among others. Motif will use engineered microbes (like yeast) to \u201cbrew\u201d food proteins that can mimic the same ones that give animal products their unique taste and texture. The resulting ingredients can be used to make everything from regular ol\u2019 cow milk and chicken meat to more unique offerings, like sturgeon eggs and camel milk."}
{"meta": {"doc_id": 2407, "sent_id": 6, "sent_start_pos": 739, "sent_end_pos": 1292, "title": "Motif Ingredients Launches, Raises $90M to Democratize Plant-Based Ingredients"}, "text": "Motif will use engineered microbes (like yeast) to \u201cbrew\u201d food proteins that can mimic the same ones that give animal products their unique taste and texture. The resulting ingredients can be used to make everything from regular ol\u2019 cow milk and chicken meat to more unique offerings, like sturgeon eggs and camel milk. Established players like Impossible Foods, Beyond Meat, and JUST have their own dedicated R&D labs, filled with robots sussing out plant properties and teams of scientists with extensive backgrounds in biotechnology and food science."}
{"meta": {"doc_id": 2407, "sent_id": 7, "sent_start_pos": 898, "sent_end_pos": 1388, "title": "Motif Ingredients Launches, Raises $90M to Democratize Plant-Based Ingredients"}, "text": "The resulting ingredients can be used to make everything from regular ol\u2019 cow milk and chicken meat to more unique offerings, like sturgeon eggs and camel milk. Established players like Impossible Foods, Beyond Meat, and JUST have their own dedicated R&D labs, filled with robots sussing out plant properties and teams of scientists with extensive backgrounds in biotechnology and food science. Big Food \u2014 along with its extensive resources \u2014 is also entering the plant-based protein space."}
{"meta": {"doc_id": 2407, "sent_id": 8, "sent_start_pos": 1059, "sent_end_pos": 1477, "title": "Motif Ingredients Launches, Raises $90M to Democratize Plant-Based Ingredients"}, "text": "Established players like Impossible Foods, Beyond Meat, and JUST have their own dedicated R&D labs, filled with robots sussing out plant properties and teams of scientists with extensive backgrounds in biotechnology and food science. Big Food \u2014 along with its extensive resources \u2014 is also entering the plant-based protein space. In fact, Tyson recently announced plans to develop its own meatless products internally."}
{"meta": {"doc_id": 2407, "sent_id": 9, "sent_start_pos": 1293, "sent_end_pos": 1609, "title": "Motif Ingredients Launches, Raises $90M to Democratize Plant-Based Ingredients"}, "text": "Big Food \u2014 along with its extensive resources \u2014 is also entering the plant-based protein space. In fact, Tyson recently announced plans to develop its own meatless products internally. But for smaller startups, developing their own plant-based ingredients can be a prohibitively expensive and time-consuming process."}
{"meta": {"doc_id": 2407, "sent_id": 10, "sent_start_pos": 1389, "sent_end_pos": 1741, "title": "Motif Ingredients Launches, Raises $90M to Democratize Plant-Based Ingredients"}, "text": "In fact, Tyson recently announced plans to develop its own meatless products internally. But for smaller startups, developing their own plant-based ingredients can be a prohibitively expensive and time-consuming process. By partnering with Motif, however, these companies could outsource the costly R&D process and accelerate their product development."}
{"meta": {"doc_id": 2407, "sent_id": 11, "sent_start_pos": 1478, "sent_end_pos": 1937, "title": "Motif Ingredients Launches, Raises $90M to Democratize Plant-Based Ingredients"}, "text": "But for smaller startups, developing their own plant-based ingredients can be a prohibitively expensive and time-consuming process. By partnering with Motif, however, these companies could outsource the costly R&D process and accelerate their product development. If successful \u2014 and with $90 million in funding and a unicorn parent company, I don\u2019t see why they wouldn\u2019t be \u2014 Motif\u2019s services could help usher in a flood of new plant-based protein companies."}
{"meta": {"doc_id": 2407, "sent_id": 12, "sent_start_pos": 1610, "sent_end_pos": [], "title": "Motif Ingredients Launches, Raises $90M to Democratize Plant-Based Ingredients"}, "text": "By partnering with Motif, however, these companies could outsource the costly R&D process and accelerate their product development. If successful \u2014 and with $90 million in funding and a unicorn parent company, I don\u2019t see why they wouldn\u2019t be \u2014 Motif\u2019s services could help usher in a flood of new plant-based protein companies. "}
{"meta": {"doc_id": 2408, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 203, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": " Impossible Foods, known for its meatless burgers, is launching plant-based pork. Impossible Pork debuts at tech conference CES in Las Vegas this week, and attendees will be able to taste the new product."}
{"meta": {"doc_id": 2408, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 333, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Impossible Foods, known for its meatless burgers, is launching plant-based pork. Impossible Pork debuts at tech conference CES in Las Vegas this week, and attendees will be able to taste the new product. Like the Impossible Burger, the plant-based pork is made with soy protein and is designed to look, taste and cook like real meat."}
{"meta": {"doc_id": 2408, "sent_id": 2, "sent_start_pos": 81, "sent_end_pos": 458, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Impossible Pork debuts at tech conference CES in Las Vegas this week, and attendees will be able to taste the new product. Like the Impossible Burger, the plant-based pork is made with soy protein and is designed to look, taste and cook like real meat. Others will be able to try a sausage version of the product when it arrives at 139 Burger King restaurants later this month."}
{"meta": {"doc_id": 2408, "sent_id": 3, "sent_start_pos": 204, "sent_end_pos": 623, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Like the Impossible Burger, the plant-based pork is made with soy protein and is designed to look, taste and cook like real meat. Others will be able to try a sausage version of the product when it arrives at 139 Burger King restaurants later this month. Some locations in Georgia, Michigan, Illinois, New Mexico and Alabama will serve a croissant breakfast sandwich featuring the Impossible Sausage for a limited time."}
{"meta": {"doc_id": 2408, "sent_id": 4, "sent_start_pos": 334, "sent_end_pos": 707, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Others will be able to try a sausage version of the product when it arrives at 139 Burger King restaurants later this month. Some locations in Georgia, Michigan, Illinois, New Mexico and Alabama will serve a croissant breakfast sandwich featuring the Impossible Sausage for a limited time. Much of the hype surrounding plant-based meat has been focused on beef substitutes."}
{"meta": {"doc_id": 2408, "sent_id": 5, "sent_start_pos": 459, "sent_end_pos": 847, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Some locations in Georgia, Michigan, Illinois, New Mexico and Alabama will serve a croissant breakfast sandwich featuring the Impossible Sausage for a limited time. Much of the hype surrounding plant-based meat has been focused on beef substitutes. But pork could be the next big thing because of the industry\u2019s ambitions in Asia, where African Swine Fever has devastated the pork supply."}
{"meta": {"doc_id": 2408, "sent_id": 6, "sent_start_pos": 624, "sent_end_pos": 925, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Much of the hype surrounding plant-based meat has been focused on beef substitutes. But pork could be the next big thing because of the industry\u2019s ambitions in Asia, where African Swine Fever has devastated the pork supply. There\u2019s also an increasing demand for meat alternatives in the United States."}
{"meta": {"doc_id": 2408, "sent_id": 7, "sent_start_pos": 708, "sent_end_pos": 1036, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "But pork could be the next big thing because of the industry\u2019s ambitions in Asia, where African Swine Fever has devastated the pork supply. There\u2019s also an increasing demand for meat alternatives in the United States. Focus on Asia\nImpossible and its main competitor, Beyond Meat, both see huge opportunities for growth in Asia."}
{"meta": {"doc_id": 2408, "sent_id": 8, "sent_start_pos": 848, "sent_end_pos": 1319, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "There\u2019s also an increasing demand for meat alternatives in the United States. Focus on Asia\nImpossible and its main competitor, Beyond Meat, both see huge opportunities for growth in Asia. Garner startup lands deal to make plant-based protein jerky for Perky Jerky\n\u201cIn the next year or two, we\u2019re putting a lot of effort into expanding into international markets, particularly in Asia, where pork is the dominant meat product,\u201d Impossible CEO Pat Brown told CNN Business."}
{"meta": {"doc_id": 2408, "sent_id": 9, "sent_start_pos": 926, "sent_end_pos": 1678, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Focus on Asia\nImpossible and its main competitor, Beyond Meat, both see huge opportunities for growth in Asia. Garner startup lands deal to make plant-based protein jerky for Perky Jerky\n\u201cIn the next year or two, we\u2019re putting a lot of effort into expanding into international markets, particularly in Asia, where pork is the dominant meat product,\u201d Impossible CEO Pat Brown told CNN Business. During a call discussing Beyond Meat\u2019s third-quarter earnings, the company\u2019s CEO Ethan Brown said that \u201clike many, we believe that Asia is a very attractive market for us,\u201d adding \u201cyou\u2019ll see us continue to be aggressive there.\u201d The opportunity \u201cto produce and sell pork dumplings, for example, in Asia is significant and not one that\u2019s lost on us,\u201d he said."}
{"meta": {"doc_id": 2408, "sent_id": 10, "sent_start_pos": 1037, "sent_end_pos": 1824, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Garner startup lands deal to make plant-based protein jerky for Perky Jerky\n\u201cIn the next year or two, we\u2019re putting a lot of effort into expanding into international markets, particularly in Asia, where pork is the dominant meat product,\u201d Impossible CEO Pat Brown told CNN Business. During a call discussing Beyond Meat\u2019s third-quarter earnings, the company\u2019s CEO Ethan Brown said that \u201clike many, we believe that Asia is a very attractive market for us,\u201d adding \u201cyou\u2019ll see us continue to be aggressive there.\u201d The opportunity \u201cto produce and sell pork dumplings, for example, in Asia is significant and not one that\u2019s lost on us,\u201d he said. Impossible is showcasing its new plant-based pork product in a variety of Asian dishes, including dumplings, noodles, dim sum and bao sandwiches."}
{"meta": {"doc_id": 2408, "sent_id": 11, "sent_start_pos": 1320, "sent_end_pos": 1991, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "During a call discussing Beyond Meat\u2019s third-quarter earnings, the company\u2019s CEO Ethan Brown said that \u201clike many, we believe that Asia is a very attractive market for us,\u201d adding \u201cyou\u2019ll see us continue to be aggressive there.\u201d The opportunity \u201cto produce and sell pork dumplings, for example, in Asia is significant and not one that\u2019s lost on us,\u201d he said. Impossible is showcasing its new plant-based pork product in a variety of Asian dishes, including dumplings, noodles, dim sum and bao sandwiches. Impossible\u2019s interest in Asia preceded the recent swine flu outbreak, which drove regional pork prices up dramatically and halved China\u2019s pig herd, by some estimates."}
{"meta": {"doc_id": 2408, "sent_id": 12, "sent_start_pos": 1679, "sent_end_pos": 2077, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Impossible is showcasing its new plant-based pork product in a variety of Asian dishes, including dumplings, noodles, dim sum and bao sandwiches. Impossible\u2019s interest in Asia preceded the recent swine flu outbreak, which drove regional pork prices up dramatically and halved China\u2019s pig herd, by some estimates. For now, plant-based meat is generally more expensive for consumers than animal meat."}
{"meta": {"doc_id": 2408, "sent_id": 13, "sent_start_pos": 1825, "sent_end_pos": 2245, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Impossible\u2019s interest in Asia preceded the recent swine flu outbreak, which drove regional pork prices up dramatically and halved China\u2019s pig herd, by some estimates. For now, plant-based meat is generally more expensive for consumers than animal meat. But that could change as companies like Beyond Meat and Impossible scale up, and major food companies like Kellogg and Nestl\u00e9 make more plant-based options mainstream."}
{"meta": {"doc_id": 2408, "sent_id": 14, "sent_start_pos": 1992, "sent_end_pos": 2404, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "For now, plant-based meat is generally more expensive for consumers than animal meat. But that could change as companies like Beyond Meat and Impossible scale up, and major food companies like Kellogg and Nestl\u00e9 make more plant-based options mainstream. Although the crisis didn\u2019t drive Impossible\u2019s decision to start selling plant-based pork, it has \u201cexacerbated the demand for a product like ours,\u201d Brown said."}
{"meta": {"doc_id": 2408, "sent_id": 15, "sent_start_pos": 2078, "sent_end_pos": 2616, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "But that could change as companies like Beyond Meat and Impossible scale up, and major food companies like Kellogg and Nestl\u00e9 make more plant-based options mainstream. Although the crisis didn\u2019t drive Impossible\u2019s decision to start selling plant-based pork, it has \u201cexacerbated the demand for a product like ours,\u201d Brown said. It also highlights the dangers of relying on animal meat for food, said Caroline Bushnell, associate director of corporate engagement at the Good Food Institute, a nonprofit that supports plant-based businesses."}
{"meta": {"doc_id": 2408, "sent_id": 16, "sent_start_pos": 2246, "sent_end_pos": 2728, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Although the crisis didn\u2019t drive Impossible\u2019s decision to start selling plant-based pork, it has \u201cexacerbated the demand for a product like ours,\u201d Brown said. It also highlights the dangers of relying on animal meat for food, said Caroline Bushnell, associate director of corporate engagement at the Good Food Institute, a nonprofit that supports plant-based businesses. \u201cWhat it\u2019s exposed is the inherent vulnerability of a supply chain that\u2019s dependent on animals,\u201d Bushnell said."}
{"meta": {"doc_id": 2408, "sent_id": 17, "sent_start_pos": 2405, "sent_end_pos": 3047, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "It also highlights the dangers of relying on animal meat for food, said Caroline Bushnell, associate director of corporate engagement at the Good Food Institute, a nonprofit that supports plant-based businesses. \u201cWhat it\u2019s exposed is the inherent vulnerability of a supply chain that\u2019s dependent on animals,\u201d Bushnell said. \u201cWe\u2019re absolutely seeing that this current pork shortage has created a gap that the next generation of plant-based pork is perfectly poised to fill.\u201d\nDomestic interest grows\nAs Americans think about ways to eat less meat, they\u2019re increasingly checking out pork alternatives in addition to chicken and beef substitutes."}
{"meta": {"doc_id": 2408, "sent_id": 18, "sent_start_pos": 2617, "sent_end_pos": 3280, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "\u201cWhat it\u2019s exposed is the inherent vulnerability of a supply chain that\u2019s dependent on animals,\u201d Bushnell said. \u201cWe\u2019re absolutely seeing that this current pork shortage has created a gap that the next generation of plant-based pork is perfectly poised to fill.\u201d\nDomestic interest grows\nAs Americans think about ways to eat less meat, they\u2019re increasingly checking out pork alternatives in addition to chicken and beef substitutes. Fake meat trend grows hotter: Nestle\u2019s beefs up plant protein menu with vegan bacon, cheese\nSales of pork alternatives grew nearly 15% in the United States in the 12 months ending in April 2019, according to the Good Food Institute."}
{"meta": {"doc_id": 2408, "sent_id": 19, "sent_start_pos": 2729, "sent_end_pos": 3392, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "\u201cWe\u2019re absolutely seeing that this current pork shortage has created a gap that the next generation of plant-based pork is perfectly poised to fill.\u201d\nDomestic interest grows\nAs Americans think about ways to eat less meat, they\u2019re increasingly checking out pork alternatives in addition to chicken and beef substitutes. Fake meat trend grows hotter: Nestle\u2019s beefs up plant protein menu with vegan bacon, cheese\nSales of pork alternatives grew nearly 15% in the United States in the 12 months ending in April 2019, according to the Good Food Institute. During that period, demand for jackfruit, which is often used to make vegan pork substitutes, jumped about 20%."}
{"meta": {"doc_id": 2408, "sent_id": 20, "sent_start_pos": 3048, "sent_end_pos": 3467, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Fake meat trend grows hotter: Nestle\u2019s beefs up plant protein menu with vegan bacon, cheese\nSales of pork alternatives grew nearly 15% in the United States in the 12 months ending in April 2019, according to the Good Food Institute. During that period, demand for jackfruit, which is often used to make vegan pork substitutes, jumped about 20%. \u201cA lot of the innovation to date has \u2026 been in beef,\u201d said GFI\u2019s Bushnell."}
{"meta": {"doc_id": 2408, "sent_id": 21, "sent_start_pos": 3281, "sent_end_pos": 3586, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "During that period, demand for jackfruit, which is often used to make vegan pork substitutes, jumped about 20%. \u201cA lot of the innovation to date has \u2026 been in beef,\u201d said GFI\u2019s Bushnell. \u201cBut we\u2019re already seeing a ton of exciting innovation across other product types within plant-based meat,\u201d she added."}
{"meta": {"doc_id": 2408, "sent_id": 22, "sent_start_pos": 3393, "sent_end_pos": 3719, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "\u201cA lot of the innovation to date has \u2026 been in beef,\u201d said GFI\u2019s Bushnell. \u201cBut we\u2019re already seeing a ton of exciting innovation across other product types within plant-based meat,\u201d she added. People who have turned to plant-based beef as a healthier alternative to meat may find meatless pork attractive for the same reason."}
{"meta": {"doc_id": 2408, "sent_id": 23, "sent_start_pos": 3468, "sent_end_pos": 3853, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "\u201cBut we\u2019re already seeing a ton of exciting innovation across other product types within plant-based meat,\u201d she added. People who have turned to plant-based beef as a healthier alternative to meat may find meatless pork attractive for the same reason. A raw, two-ounce serving of the Impossible Sausage has 130 calories, 7 grams of protein, 9 grams of fat and 4 grams of saturated fat."}
{"meta": {"doc_id": 2408, "sent_id": 24, "sent_start_pos": 3587, "sent_end_pos": 3985, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "People who have turned to plant-based beef as a healthier alternative to meat may find meatless pork attractive for the same reason. A raw, two-ounce serving of the Impossible Sausage has 130 calories, 7 grams of protein, 9 grams of fat and 4 grams of saturated fat. A comparable serving of real pork sausage is usually higher in fat and more caloric, and delivers about the same amount of protein."}
{"meta": {"doc_id": 2408, "sent_id": 25, "sent_start_pos": 3720, "sent_end_pos": 4095, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "A raw, two-ounce serving of the Impossible Sausage has 130 calories, 7 grams of protein, 9 grams of fat and 4 grams of saturated fat. A comparable serving of real pork sausage is usually higher in fat and more caloric, and delivers about the same amount of protein. Both products are processed and may not appeal to consumers who are seeking whole foods with few ingredients."}
{"meta": {"doc_id": 2408, "sent_id": 26, "sent_start_pos": 3854, "sent_end_pos": 4227, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "A comparable serving of real pork sausage is usually higher in fat and more caloric, and delivers about the same amount of protein. Both products are processed and may not appeal to consumers who are seeking whole foods with few ingredients. \u201cI expect we\u2019ll see an explosion in the number of plant-based pork options available over the next couple of years,\u201d Bushnell said."}
{"meta": {"doc_id": 2408, "sent_id": 27, "sent_start_pos": 3986, "sent_end_pos": 4325, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Both products are processed and may not appeal to consumers who are seeking whole foods with few ingredients. \u201cI expect we\u2019ll see an explosion in the number of plant-based pork options available over the next couple of years,\u201d Bushnell said. Plant-based meat is still a small sector compared to the massive meat industry, but it\u2019s growing."}
{"meta": {"doc_id": 2408, "sent_id": 28, "sent_start_pos": 4096, "sent_end_pos": 4496, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "\u201cI expect we\u2019ll see an explosion in the number of plant-based pork options available over the next couple of years,\u201d Bushnell said. Plant-based meat is still a small sector compared to the massive meat industry, but it\u2019s growing. In May, Barclays predicted that the alternative meat sector could reach about $140 billion in sales over the next decade, capturing about 10% of the global meat industry."}
{"meta": {"doc_id": 2408, "sent_id": 29, "sent_start_pos": 4228, "sent_end_pos": 4650, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Plant-based meat is still a small sector compared to the massive meat industry, but it\u2019s growing. In May, Barclays predicted that the alternative meat sector could reach about $140 billion in sales over the next decade, capturing about 10% of the global meat industry. Restaurant chains are also looking for more ways to participate in the plant-based meat craze \u2014 particularly in the highly-competitive breakfast segment."}
{"meta": {"doc_id": 2408, "sent_id": 30, "sent_start_pos": 4326, "sent_end_pos": 4760, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "In May, Barclays predicted that the alternative meat sector could reach about $140 billion in sales over the next decade, capturing about 10% of the global meat industry. Restaurant chains are also looking for more ways to participate in the plant-based meat craze \u2014 particularly in the highly-competitive breakfast segment. Plant-based sausages offer a new opportunity, and restaurants are starting to add the product to their menus."}
{"meta": {"doc_id": 2408, "sent_id": 31, "sent_start_pos": 4497, "sent_end_pos": 4911, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Restaurant chains are also looking for more ways to participate in the plant-based meat craze \u2014 particularly in the highly-competitive breakfast segment. Plant-based sausages offer a new opportunity, and restaurants are starting to add the product to their menus. Burger King\u2019s decision to test out a plant-based sausage sandwich follows Dunkin\u2019s nationwide launch of a breakfast sandwich featuring Beyond Sausage."}
{"meta": {"doc_id": 2408, "sent_id": 32, "sent_start_pos": 4651, "sent_end_pos": 5030, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Plant-based sausages offer a new opportunity, and restaurants are starting to add the product to their menus. Burger King\u2019s decision to test out a plant-based sausage sandwich follows Dunkin\u2019s nationwide launch of a breakfast sandwich featuring Beyond Sausage. In December, Hardee\u2019s and Carl\u2019s Jr. announced a new suite of breakfast items that were also made with Beyond Sausage."}
{"meta": {"doc_id": 2408, "sent_id": 33, "sent_start_pos": 4761, "sent_end_pos": 5171, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Burger King\u2019s decision to test out a plant-based sausage sandwich follows Dunkin\u2019s nationwide launch of a breakfast sandwich featuring Beyond Sausage. In December, Hardee\u2019s and Carl\u2019s Jr. announced a new suite of breakfast items that were also made with Beyond Sausage. The chain first tested out a Beyond Sausage sandwich at its Manhattan locations this summer."}
{"meta": {"doc_id": 2408, "sent_id": 34, "sent_start_pos": 4912, "sent_end_pos": 5281, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "In December, Hardee\u2019s and Carl\u2019s Jr. announced a new suite of breakfast items that were also made with Beyond Sausage. The chain first tested out a Beyond Sausage sandwich at its Manhattan locations this summer. The sandwich performed so well that the company decided to roll the product out nationally ahead of schedule."}
{"meta": {"doc_id": 2408, "sent_id": 35, "sent_start_pos": 5079, "sent_end_pos": 5601, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "The chain first tested out a Beyond Sausage sandwich at its Manhattan locations this summer. The sandwich performed so well that the company decided to roll the product out nationally ahead of schedule. \u201cWe were very pleased with how it performed in Manhattan,\u201d said Dunkin\u2019 CEO David Hoffman during an analyst call discussing third-quarter earnings, adding that the brand was especially happy to see customers buying the product more than once \u2014 a sign that they see the plant-based sandwich was more than just a novelty."}
{"meta": {"doc_id": 2408, "sent_id": 36, "sent_start_pos": 5172, "sent_end_pos": 5810, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "The sandwich performed so well that the company decided to roll the product out nationally ahead of schedule. \u201cWe were very pleased with how it performed in Manhattan,\u201d said Dunkin\u2019 CEO David Hoffman during an analyst call discussing third-quarter earnings, adding that the brand was especially happy to see customers buying the product more than once \u2014 a sign that they see the plant-based sandwich was more than just a novelty. Burger King\u2019s chief marketing officer Fernando Machado said that the new breakfast product could help the fast food chain compete during breakfast, adding that \u201cbreakfast sets the intention for the whole day."}
{"meta": {"doc_id": 2408, "sent_id": 37, "sent_start_pos": 5282, "sent_end_pos": 6041, "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "\u201cWe were very pleased with how it performed in Manhattan,\u201d said Dunkin\u2019 CEO David Hoffman during an analyst call discussing third-quarter earnings, adding that the brand was especially happy to see customers buying the product more than once \u2014 a sign that they see the plant-based sandwich was more than just a novelty. Burger King\u2019s chief marketing officer Fernando Machado said that the new breakfast product could help the fast food chain compete during breakfast, adding that \u201cbreakfast sets the intention for the whole day. If you can switch to a plant-based patty at breakfast, you can do it at other times too.\u201d\nThat could help out restaurants like Burger King, which found that the Impossible Whopper helps boost sales and bring customers into stores."}
{"meta": {"doc_id": 2408, "sent_id": 38, "sent_start_pos": 5602, "sent_end_pos": [], "title": "Plant-based pork? Yes, says Impossible Foods"}, "text": "Burger King\u2019s chief marketing officer Fernando Machado said that the new breakfast product could help the fast food chain compete during breakfast, adding that \u201cbreakfast sets the intention for the whole day. If you can switch to a plant-based patty at breakfast, you can do it at other times too.\u201d\nThat could help out restaurants like Burger King, which found that the Impossible Whopper helps boost sales and bring customers into stores. "}
{"meta": {"doc_id": 2409, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 317, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": " Capitalizing on an increasingly health and environmentally conscious era, plant-based meat substitute companies are positioning themselves as the future of protein. On May 2, 2019, Beyond Meat became the first plant-based product company to go public."}
{"meta": {"doc_id": 2409, "sent_id": 1, "sent_start_pos": 66, "sent_end_pos": 421, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "Capitalizing on an increasingly health and environmentally conscious era, plant-based meat substitute companies are positioning themselves as the future of protein. On May 2, 2019, Beyond Meat became the first plant-based product company to go public. Its stock skyrocketed to become the highest performing first-day public offering in nearly two decades."}
{"meta": {"doc_id": 2409, "sent_id": 2, "sent_start_pos": 231, "sent_end_pos": 571, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "On May 2, 2019, Beyond Meat became the first plant-based product company to go public. Its stock skyrocketed to become the highest performing first-day public offering in nearly two decades. While the company is in no rush to go public, they just secured $300 million in their latest funding round."}
{"meta": {"doc_id": 2409, "sent_id": 3, "sent_start_pos": 318, "sent_end_pos": 683, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "Its stock skyrocketed to become the highest performing first-day public offering in nearly two decades. While the company is in no rush to go public, they just secured $300 million in their latest funding round. In light of these recent successes, the meat industry is grappling with how to address the new food phenomenon."}
{"meta": {"doc_id": 2409, "sent_id": 4, "sent_start_pos": 464, "sent_end_pos": 839, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "While the company is in no rush to go public, they just secured $300 million in their latest funding round. In light of these recent successes, the meat industry is grappling with how to address the new food phenomenon. With the long-term viability of the alternative meat market yet to be seen, traditional meat companies are taking both an offensive and defensive approach."}
{"meta": {"doc_id": 2409, "sent_id": 5, "sent_start_pos": 572, "sent_end_pos": 927, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "In light of these recent successes, the meat industry is grappling with how to address the new food phenomenon. With the long-term viability of the alternative meat market yet to be seen, traditional meat companies are taking both an offensive and defensive approach. Many Big Food companies view cell-based meat as an opportunity rather than a liability."}
{"meta": {"doc_id": 2409, "sent_id": 6, "sent_start_pos": 684, "sent_end_pos": 1072, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "With the long-term viability of the alternative meat market yet to be seen, traditional meat companies are taking both an offensive and defensive approach. Many Big Food companies view cell-based meat as an opportunity rather than a liability. Taking the \u201cif you can\u2019t beat \u2019em, join \u2019em\u201d approach, these companies are integrating plant-based protein investments into their own portfolio."}
{"meta": {"doc_id": 2409, "sent_id": 7, "sent_start_pos": 840, "sent_end_pos": 1263, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "Many Big Food companies view cell-based meat as an opportunity rather than a liability. Taking the \u201cif you can\u2019t beat \u2019em, join \u2019em\u201d approach, these companies are integrating plant-based protein investments into their own portfolio. Tyson recently sold its 6.52% stake in the company, but Tyson is still fully committed to competing in the plant-based protein space."}
{"meta": {"doc_id": 2409, "sent_id": 8, "sent_start_pos": 928, "sent_end_pos": 1381, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "Taking the \u201cif you can\u2019t beat \u2019em, join \u2019em\u201d approach, these companies are integrating plant-based protein investments into their own portfolio. Tyson recently sold its 6.52% stake in the company, but Tyson is still fully committed to competing in the plant-based protein space. Tyson announced that it plans to launch an \u201calternative protein product\u201d with market testing as early as this summer."}
{"meta": {"doc_id": 2409, "sent_id": 9, "sent_start_pos": 1130, "sent_end_pos": 1521, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "Tyson recently sold its 6.52% stake in the company, but Tyson is still fully committed to competing in the plant-based protein space. Tyson announced that it plans to launch an \u201calternative protein product\u201d with market testing as early as this summer. The fact that Tyson is a household name synonymous with meat could impede its ability to build brand loyalty in the alternative meat space."}
{"meta": {"doc_id": 2409, "sent_id": 10, "sent_start_pos": 1264, "sent_end_pos": 1736, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "Tyson announced that it plans to launch an \u201calternative protein product\u201d with market testing as early as this summer. The fact that Tyson is a household name synonymous with meat could impede its ability to build brand loyalty in the alternative meat space. That said, the producer\u2019s well-established distribution networks and manufacturing facilities will enable them to hit the ground running\u2014an advantage that start-up companies in the emerging market necessarily lack."}
{"meta": {"doc_id": 2409, "sent_id": 11, "sent_start_pos": 1382, "sent_end_pos": 1894, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "The fact that Tyson is a household name synonymous with meat could impede its ability to build brand loyalty in the alternative meat space. That said, the producer\u2019s well-established distribution networks and manufacturing facilities will enable them to hit the ground running\u2014an advantage that start-up companies in the emerging market necessarily lack. Simultaneously, however, the meat industry is taking active measures to hedge against what, on its face, appears to be an impending threat of market erosion."}
{"meta": {"doc_id": 2409, "sent_id": 12, "sent_start_pos": 1522, "sent_end_pos": 2079, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "That said, the producer\u2019s well-established distribution networks and manufacturing facilities will enable them to hit the ground running\u2014an advantage that start-up companies in the emerging market necessarily lack. Simultaneously, however, the meat industry is taking active measures to hedge against what, on its face, appears to be an impending threat of market erosion. The meat industry is also lobbying for laws banning any non-slaughterhouse-derived protein product from being labeled \u201cmeat.\u201d Last year, Missouri was the first state to formally do so."}
{"meta": {"doc_id": 2409, "sent_id": 13, "sent_start_pos": 1737, "sent_end_pos": 2205, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "Simultaneously, however, the meat industry is taking active measures to hedge against what, on its face, appears to be an impending threat of market erosion. The meat industry is also lobbying for laws banning any non-slaughterhouse-derived protein product from being labeled \u201cmeat.\u201d Last year, Missouri was the first state to formally do so. Lawmakers in 17 states\u2014including Arkansas, Kentucky, Mississippi, North Dakota, South Dakota, and Wyoming\u2014have followed suit."}
{"meta": {"doc_id": 2409, "sent_id": 14, "sent_start_pos": 1895, "sent_end_pos": 2279, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "The meat industry is also lobbying for laws banning any non-slaughterhouse-derived protein product from being labeled \u201cmeat.\u201d Last year, Missouri was the first state to formally do so. Lawmakers in 17 states\u2014including Arkansas, Kentucky, Mississippi, North Dakota, South Dakota, and Wyoming\u2014have followed suit. Laws in Montana, Georgia, Nebraska, and Oklahoma are also on the horizon."}
{"meta": {"doc_id": 2409, "sent_id": 15, "sent_start_pos": 2080, "sent_end_pos": 2385, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "Lawmakers in 17 states\u2014including Arkansas, Kentucky, Mississippi, North Dakota, South Dakota, and Wyoming\u2014have followed suit. Laws in Montana, Georgia, Nebraska, and Oklahoma are also on the horizon. Legislators and meat industry lobbyists are touting these laws as necessary consumer protection measures."}
{"meta": {"doc_id": 2409, "sent_id": 16, "sent_start_pos": 2206, "sent_end_pos": 2559, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "Laws in Montana, Georgia, Nebraska, and Oklahoma are also on the horizon. Legislators and meat industry lobbyists are touting these laws as necessary consumer protection measures. Not surprisingly, proponents of plant-based meat disagree and are fighting back against legislation they say is aimed to protect cattle and livestock producers\u2019 bottom line."}
{"meta": {"doc_id": 2409, "sent_id": 17, "sent_start_pos": 2280, "sent_end_pos": 2736, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "Legislators and meat industry lobbyists are touting these laws as necessary consumer protection measures. Not surprisingly, proponents of plant-based meat disagree and are fighting back against legislation they say is aimed to protect cattle and livestock producers\u2019 bottom line. Tofurkey, the Good Food Institute, the American Civil Liberties Union of Missouri, and the Animal Legal Defense Fund are challenging the Missouri law on constitutional grounds."}
{"meta": {"doc_id": 2409, "sent_id": 18, "sent_start_pos": 2386, "sent_end_pos": 3070, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "Not surprisingly, proponents of plant-based meat disagree and are fighting back against legislation they say is aimed to protect cattle and livestock producers\u2019 bottom line. Tofurkey, the Good Food Institute, the American Civil Liberties Union of Missouri, and the Animal Legal Defense Fund are challenging the Missouri law on constitutional grounds. Jessica Almy, director of policy for the Good Food Institute believes that the appeal should put other states on notice \u201cthat there are significant constitutional problems with these laws\u201d because labeling is a form of \u201ccommercial speech, which is protected as long as it\u2019s truthful.\u201d The constitutional issue has yet to be resolved."}
{"meta": {"doc_id": 2409, "sent_id": 19, "sent_start_pos": 2560, "sent_end_pos": 3216, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "Tofurkey, the Good Food Institute, the American Civil Liberties Union of Missouri, and the Animal Legal Defense Fund are challenging the Missouri law on constitutional grounds. Jessica Almy, director of policy for the Good Food Institute believes that the appeal should put other states on notice \u201cthat there are significant constitutional problems with these laws\u201d because labeling is a form of \u201ccommercial speech, which is protected as long as it\u2019s truthful.\u201d The constitutional issue has yet to be resolved. If Big Food is on board as a champion of plant-based protein rather than an opponent, the future for the protein industry certainly looks bright."}
{"meta": {"doc_id": 2409, "sent_id": 20, "sent_start_pos": 2737, "sent_end_pos": 3464, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "Jessica Almy, director of policy for the Good Food Institute believes that the appeal should put other states on notice \u201cthat there are significant constitutional problems with these laws\u201d because labeling is a form of \u201ccommercial speech, which is protected as long as it\u2019s truthful.\u201d The constitutional issue has yet to be resolved. If Big Food is on board as a champion of plant-based protein rather than an opponent, the future for the protein industry certainly looks bright. But, it appears\u2014at least for the time being\u2014that meat alternative companies will have their work cut out for them as they navigate a newly developing (and often times conflicting) patchwork of state laws designed to stifle their marketing efforts."}
{"meta": {"doc_id": 2409, "sent_id": 21, "sent_start_pos": 3071, "sent_end_pos": 3700, "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "If Big Food is on board as a champion of plant-based protein rather than an opponent, the future for the protein industry certainly looks bright. But, it appears\u2014at least for the time being\u2014that meat alternative companies will have their work cut out for them as they navigate a newly developing (and often times conflicting) patchwork of state laws designed to stifle their marketing efforts. These uncertainties will continue to trigger disputes about what producers (that often operate in multiple states) can say about their products without misleading consumers, and just how far states can go to regulate commercial speech."}
{"meta": {"doc_id": 2409, "sent_id": 22, "sent_start_pos": 3217, "sent_end_pos": [], "title": "Big Food and Plant-Based Protein: Potential MEATing of the Minds?"}, "text": "But, it appears\u2014at least for the time being\u2014that meat alternative companies will have their work cut out for them as they navigate a newly developing (and often times conflicting) patchwork of state laws designed to stifle their marketing efforts. These uncertainties will continue to trigger disputes about what producers (that often operate in multiple states) can say about their products without misleading consumers, and just how far states can go to regulate commercial speech. "}
{"meta": {"doc_id": 2410, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 283, "title": "Reifon Biotech Co. Ltd. - Company description"}, "text": " Reifon Biotech Co. Ltd.\nAbout\nCompany description\nReifon is a leading manufacturer of extruded crisps including protein crisps and cereal crisps. Reifon Crisps deliver high plant based protein and fiber, create crispy texture, which made from Pea, Rice, Quinoa, Soy and other grains."}
{"meta": {"doc_id": 2410, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 401, "title": "Reifon Biotech Co. Ltd. - Company description"}, "text": "Reifon Biotech Co. Ltd.\nAbout\nCompany description\nReifon is a leading manufacturer of extruded crisps including protein crisps and cereal crisps. Reifon Crisps deliver high plant based protein and fiber, create crispy texture, which made from Pea, Rice, Quinoa, Soy and other grains. Reifon crisps is the best choice for Nutrition bar, Snack Food, Cluster, Crunchy topping and inclusions applications."}
{"meta": {"doc_id": 2410, "sent_id": 2, "sent_start_pos": 146, "sent_end_pos": 621, "title": "Reifon Biotech Co. Ltd. - Company description"}, "text": "Reifon Crisps deliver high plant based protein and fiber, create crispy texture, which made from Pea, Rice, Quinoa, Soy and other grains. Reifon crisps is the best choice for Nutrition bar, Snack Food, Cluster, Crunchy topping and inclusions applications. We has the capability to provide extruded solution by different formulation, shapes, sizes, color, flavor and textures to meet customer\u2019s demand."}
{"meta": {"doc_id": 2410, "sent_id": 3, "sent_start_pos": 284, "sent_end_pos": 729, "title": "Reifon Biotech Co. Ltd. - Company description"}, "text": "Reifon crisps is the best choice for Nutrition bar, Snack Food, Cluster, Crunchy topping and inclusions applications. We has the capability to provide extruded solution by different formulation, shapes, sizes, color, flavor and textures to meet customer\u2019s demand. The Main Product is Pea Protein Crisps, Soy Protein Crisps, Extruded Quinoa Crisps and other grains crisps."}
{"meta": {"doc_id": 2410, "sent_id": 4, "sent_start_pos": 476, "sent_end_pos": 883, "title": "Reifon Biotech Co. Ltd. - Company description"}, "text": "We has the capability to provide extruded solution by different formulation, shapes, sizes, color, flavor and textures to meet customer\u2019s demand. The Main Product is Pea Protein Crisps, Soy Protein Crisps, Extruded Quinoa Crisps and other grains crisps. Reifon has Global Food Safety Certification through BRC and other certification like Non-GMO IP supply chain, Kosher, Halal, HACCP, ISO9001 and ISO22000."}
{"meta": {"doc_id": 2410, "sent_id": 5, "sent_start_pos": 622, "sent_end_pos": 1186, "title": "Reifon Biotech Co. Ltd. - Company description"}, "text": "The Main Product is Pea Protein Crisps, Soy Protein Crisps, Extruded Quinoa Crisps and other grains crisps. Reifon has Global Food Safety Certification through BRC and other certification like Non-GMO IP supply chain, Kosher, Halal, HACCP, ISO9001 and ISO22000. Quick facts\nUpcoming events\nFi Europe co-located with Hi Europe 2021\nOur Top products\nReifon\u00ae Pea Protein Crisps\nReifon\u00ae Pea Protein Crisps is a ideal ingredients for Nutrition bar, Snack Food, Cluster, Crunchy topping and inclusions applications."}
{"meta": {"doc_id": 2410, "sent_id": 6, "sent_start_pos": 730, "sent_end_pos": 1267, "title": "Reifon Biotech Co. Ltd. - Company description"}, "text": "Reifon has Global Food Safety Certification through BRC and other certification like Non-GMO IP supply chain, Kosher, Halal, HACCP, ISO9001 and ISO22000. Quick facts\nUpcoming events\nFi Europe co-located with Hi Europe 2021\nOur Top products\nReifon\u00ae Pea Protein Crisps\nReifon\u00ae Pea Protein Crisps is a ideal ingredients for Nutrition bar, Snack Food, Cluster, Crunchy topping and inclusions applications. This high protein crisp product is made from Non-GMO pea protein and rice flour."}
{"meta": {"doc_id": 2410, "sent_id": 7, "sent_start_pos": 939, "sent_end_pos": 1409, "title": "Reifon Biotech Co. Ltd. - Company description"}, "text": "Quick facts\nUpcoming events\nFi Europe co-located with Hi Europe 2021\nOur Top products\nReifon\u00ae Pea Protein Crisps\nReifon\u00ae Pea Protein Crisps is a ideal ingredients for Nutrition bar, Snack Food, Cluster, Crunchy topping and inclusions applications. This high protein crisp product is made from Non-GMO pea protein and rice flour. These plant based, soy-free crisps offers an excellent ami... More info\nReifon\u00ae Quinoa Crisps\nQuinoa is high in protein, fiber and nutrients."}
{"meta": {"doc_id": 2410, "sent_id": 8, "sent_start_pos": 1187, "sent_end_pos": 1537, "title": "Reifon Biotech Co. Ltd. - Company description"}, "text": "This high protein crisp product is made from Non-GMO pea protein and rice flour. These plant based, soy-free crisps offers an excellent ami... More info\nReifon\u00ae Quinoa Crisps\nQuinoa is high in protein, fiber and nutrients. It also contains all the essential amino acids that you need, making it an excellent protein source for vegetarians and vegans."}
{"meta": {"doc_id": 2410, "sent_id": 9, "sent_start_pos": 1268, "sent_end_pos": 1741, "title": "Reifon Biotech Co. Ltd. - Company description"}, "text": "These plant based, soy-free crisps offers an excellent ami... More info\nReifon\u00ae Quinoa Crisps\nQuinoa is high in protein, fiber and nutrients. It also contains all the essential amino acids that you need, making it an excellent protein source for vegetarians and vegans. Reifon\u00ae Quinoa Puff is a ideal ingredients for Nutrition bar, Snack Food, Cluster, Crunchy topping and ... More info\nReifon\u00ae Soy Protein Crisps\nSoy Protein Crisps is high in protein, fiber and nutrients."}
{"meta": {"doc_id": 2410, "sent_id": 10, "sent_start_pos": 1410, "sent_end_pos": 1869, "title": "Reifon Biotech Co. Ltd. - Company description"}, "text": "It also contains all the essential amino acids that you need, making it an excellent protein source for vegetarians and vegans. Reifon\u00ae Quinoa Puff is a ideal ingredients for Nutrition bar, Snack Food, Cluster, Crunchy topping and ... More info\nReifon\u00ae Soy Protein Crisps\nSoy Protein Crisps is high in protein, fiber and nutrients. It also contains all the essential amino acids that you need, making it an excellent protein source for vegetarians and vegans."}
{"meta": {"doc_id": 2410, "sent_id": 11, "sent_start_pos": 1538, "sent_end_pos": 2030, "title": "Reifon Biotech Co. Ltd. - Company description"}, "text": "Reifon\u00ae Quinoa Puff is a ideal ingredients for Nutrition bar, Snack Food, Cluster, Crunchy topping and ... More info\nReifon\u00ae Soy Protein Crisps\nSoy Protein Crisps is high in protein, fiber and nutrients. It also contains all the essential amino acids that you need, making it an excellent protein source for vegetarians and vegans. Reifon\u00ae Soy Protein Crisps is a ideal ingredients for Nutrition bar, Snack Food, Cluster, Crunch... More info\nCategories affiliated with Reifon Biotech Co. Ltd."}
{"meta": {"doc_id": 2410, "sent_id": 12, "sent_start_pos": 1742, "sent_end_pos": 2347, "title": "Reifon Biotech Co. Ltd. - Company description"}, "text": "It also contains all the essential amino acids that you need, making it an excellent protein source for vegetarians and vegans. Reifon\u00ae Soy Protein Crisps is a ideal ingredients for Nutrition bar, Snack Food, Cluster, Crunch... More info\nCategories affiliated with Reifon Biotech Co. Ltd. Here's what we can do for you\n- Generate quality leads for your business\n- Stay visible for 365 days of the year\n- Receive product inquiries and respond to meeting requests directly\n- Improve company online presence through Search Engine Optimisation"}
{"meta": {"doc_id": 2410, "sent_id": 13, "sent_start_pos": 1870, "sent_end_pos": [], "title": "Reifon Biotech Co. Ltd. - Company description"}, "text": "Reifon\u00ae Soy Protein Crisps is a ideal ingredients for Nutrition bar, Snack Food, Cluster, Crunch... More info\nCategories affiliated with Reifon Biotech Co. Ltd. Here's what we can do for you\n- Generate quality leads for your business\n- Stay visible for 365 days of the year\n- Receive product inquiries and respond to meeting requests directly\n- Improve company online presence through Search Engine Optimisation "}
{"meta": {"doc_id": 2411, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 318, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": " Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype\nBeyond Meat's plant-based burger is all the rage in Canada these days. Designed to mimic the taste of actual meat, it draws not only vegetarians but also meat lovers with its promise of being a healthier alternative to red meat."}
{"meta": {"doc_id": 2411, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 525, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype\nBeyond Meat's plant-based burger is all the rage in Canada these days. Designed to mimic the taste of actual meat, it draws not only vegetarians but also meat lovers with its promise of being a healthier alternative to red meat. Despite its popularity, health experts are still uncertain about it since there is no hard evidence at the moment to prove that the plant-based meat is a better option over beef, as promoted by the company."}
{"meta": {"doc_id": 2411, "sent_id": 2, "sent_start_pos": 161, "sent_end_pos": 694, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "Designed to mimic the taste of actual meat, it draws not only vegetarians but also meat lovers with its promise of being a healthier alternative to red meat. Despite its popularity, health experts are still uncertain about it since there is no hard evidence at the moment to prove that the plant-based meat is a better option over beef, as promoted by the company. The fact that Beyond Burger has more than 20 ingredients easily qualifies it as a highly-processed food, according to Toronto-based registered dietitian Rosie Schwartz."}
{"meta": {"doc_id": 2411, "sent_id": 3, "sent_start_pos": 319, "sent_end_pos": 825, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "Despite its popularity, health experts are still uncertain about it since there is no hard evidence at the moment to prove that the plant-based meat is a better option over beef, as promoted by the company. The fact that Beyond Burger has more than 20 ingredients easily qualifies it as a highly-processed food, according to Toronto-based registered dietitian Rosie Schwartz. \"When Health Canada says we should be choosing more plant-based protein alternatives, I believe they're talking about whole foods."}
{"meta": {"doc_id": 2411, "sent_id": 4, "sent_start_pos": 526, "sent_end_pos": 886, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "The fact that Beyond Burger has more than 20 ingredients easily qualifies it as a highly-processed food, according to Toronto-based registered dietitian Rosie Schwartz. \"When Health Canada says we should be choosing more plant-based protein alternatives, I believe they're talking about whole foods. They're not talking about ultra-processed foods,\" she added."}
{"meta": {"doc_id": 2411, "sent_id": 5, "sent_start_pos": 695, "sent_end_pos": 1105, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "\"When Health Canada says we should be choosing more plant-based protein alternatives, I believe they're talking about whole foods. They're not talking about ultra-processed foods,\" she added. Beyond Meat CEO Ethan Brown responded that health risks (eg, cancer and health disease), which are usually linked with eating beef, should be taken into account before comparing their product to red and processed meat."}
{"meta": {"doc_id": 2411, "sent_id": 6, "sent_start_pos": 826, "sent_end_pos": 1180, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "They're not talking about ultra-processed foods,\" she added. Beyond Meat CEO Ethan Brown responded that health risks (eg, cancer and health disease), which are usually linked with eating beef, should be taken into account before comparing their product to red and processed meat. He also encouraged people to be more discerning and do their own research."}
{"meta": {"doc_id": 2411, "sent_id": 7, "sent_start_pos": 887, "sent_end_pos": 1450, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "Beyond Meat CEO Ethan Brown responded that health risks (eg, cancer and health disease), which are usually linked with eating beef, should be taken into account before comparing their product to red and processed meat. He also encouraged people to be more discerning and do their own research. A study conducted by the Harvard TH Chan School of Public Health shows that \"the health implications of red and processed meat really stretch far beyond saturated fat levels\" and that replacing meat with plant-based protein food can reduce the risk for premature death."}
{"meta": {"doc_id": 2411, "sent_id": 8, "sent_start_pos": 1106, "sent_end_pos": 1639, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "He also encouraged people to be more discerning and do their own research. A study conducted by the Harvard TH Chan School of Public Health shows that \"the health implications of red and processed meat really stretch far beyond saturated fat levels\" and that replacing meat with plant-based protein food can reduce the risk for premature death. Although these results are promising, Dr. Frank Hu, senior author of the study, pointed out that it hasn't been used to show that a processed plant-based burger is a healthier food choice."}
{"meta": {"doc_id": 2411, "sent_id": 9, "sent_start_pos": 1181, "sent_end_pos": 1725, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "A study conducted by the Harvard TH Chan School of Public Health shows that \"the health implications of red and processed meat really stretch far beyond saturated fat levels\" and that replacing meat with plant-based protein food can reduce the risk for premature death. Although these results are promising, Dr. Frank Hu, senior author of the study, pointed out that it hasn't been used to show that a processed plant-based burger is a healthier food choice. For more information, read the news article in Genetic Literacy Project and CBC News."}
{"meta": {"doc_id": 2411, "sent_id": 10, "sent_start_pos": 1451, "sent_end_pos": 1761, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "Although these results are promising, Dr. Frank Hu, senior author of the study, pointed out that it hasn't been used to show that a processed plant-based burger is a healthier food choice. For more information, read the news article in Genetic Literacy Project and CBC News. You might also like:\n- Pocket K No."}
{"meta": {"doc_id": 2411, "sent_id": 11, "sent_start_pos": 1640, "sent_end_pos": 1801, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "For more information, read the news article in Genetic Literacy Project and CBC News. You might also like:\n- Pocket K No. 3: Are Food Derived from GM Crops Safe?"}
{"meta": {"doc_id": 2411, "sent_id": 12, "sent_start_pos": 1726, "sent_end_pos": 1816, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "You might also like:\n- Pocket K No. 3: Are Food Derived from GM Crops Safe? - Pocket K No."}
{"meta": {"doc_id": 2411, "sent_id": 13, "sent_start_pos": 1762, "sent_end_pos": 1916, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "3: Are Food Derived from GM Crops Safe? - Pocket K No. 30: Contributions of Agricultural Biotechnology in Alleviation of Poverty and Hunger\n- Pocket K No."}
{"meta": {"doc_id": 2411, "sent_id": 14, "sent_start_pos": 1802, "sent_end_pos": 2025, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "- Pocket K No. 30: Contributions of Agricultural Biotechnology in Alleviation of Poverty and Hunger\n- Pocket K No. 7: Labeling GM Foods\nThe Crop Biotech Update is a weekly newsletter of ISAAA, a non-for-profit organization."}
{"meta": {"doc_id": 2411, "sent_id": 15, "sent_start_pos": 1817, "sent_end_pos": 2194, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "30: Contributions of Agricultural Biotechnology in Alleviation of Poverty and Hunger\n- Pocket K No. 7: Labeling GM Foods\nThe Crop Biotech Update is a weekly newsletter of ISAAA, a non-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology."}
{"meta": {"doc_id": 2411, "sent_id": 16, "sent_start_pos": 1917, "sent_end_pos": 2269, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "7: Labeling GM Foods\nThe Crop Biotech Update is a weekly newsletter of ISAAA, a non-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge."}
{"meta": {"doc_id": 2411, "sent_id": 17, "sent_start_pos": 2026, "sent_end_pos": 2312, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10."}
{"meta": {"doc_id": 2411, "sent_id": 18, "sent_start_pos": 2195, "sent_end_pos": 3280, "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10. See more articles:\nNews from Around the World\n- Reference Genomes Show Strengths, Similarities of Grain and Sweet Sorghum\n- USDA Approves Field Trials of Gene-edited, Virus Resistant Tomatoes\n- Scientists and Regulators Tackle Issues on Agri-biotech and Biosafety in Jember, Indonesia\n- New Software Enables Sensitive and Customized Off-target Detection for CRISPR-Cas9\n- European Commission Grants Import Permit for Corn Rootworm Resistant Corn\n- Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype\n- European Commission Authorizes 10 GM Crops for Food and Feed\nResearch Highlights\n- OsNCED5 Gene Controls Salt and Water Stress Tolerance in Rice\n- Scientists Pinpoint a Rice Gene that Confers Broad-spectrum Herbicide Resistance\nPlant Breeding Innovations\n- DNA-free Genome Editing Using Preassembled CRISPR-Cas9 with Ribonucleoproteins\n- European Scientists Join Forces to Enable Potential of Genome Editing\nSubscribe to CBU:\n-"}
{"meta": {"doc_id": 2411, "sent_id": 19, "sent_start_pos": 2270, "sent_end_pos": [], "title": "Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype"}, "text": "You can help by donating as little as $10. See more articles:\nNews from Around the World\n- Reference Genomes Show Strengths, Similarities of Grain and Sweet Sorghum\n- USDA Approves Field Trials of Gene-edited, Virus Resistant Tomatoes\n- Scientists and Regulators Tackle Issues on Agri-biotech and Biosafety in Jember, Indonesia\n- New Software Enables Sensitive and Customized Off-target Detection for CRISPR-Cas9\n- European Commission Grants Import Permit for Corn Rootworm Resistant Corn\n- Plant-based Beyond Meat Offers a Healthier Option, Nutrition Experts Weigh In on the Hype\n- European Commission Authorizes 10 GM Crops for Food and Feed\nResearch Highlights\n- OsNCED5 Gene Controls Salt and Water Stress Tolerance in Rice\n- Scientists Pinpoint a Rice Gene that Confers Broad-spectrum Herbicide Resistance\nPlant Breeding Innovations\n- DNA-free Genome Editing Using Preassembled CRISPR-Cas9 with Ribonucleoproteins\n- European Scientists Join Forces to Enable Potential of Genome Editing\nSubscribe to CBU:\n- "}
{"meta": {"doc_id": 2412, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 406, "title": "Spira creates ingredients from Spirulina for the food industry"}, "text": " Spira\u2019s solution is to use colorful carbon-negative microalgae and a gl...\nSpira\u2019s solution is to use colorful carbon-negative microalgae and a global network of aquaculture farms in the developing world to create sustainable food-safe pigments that are engineered to be stable at low pH(<3) and high temperatures (>65\u25e6C). These dyes are non-toxic and prevent harmful runoff from polluting local waterways."}
{"meta": {"doc_id": 2412, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 550, "title": "Spira creates ingredients from Spirulina for the food industry"}, "text": "Spira\u2019s solution is to use colorful carbon-negative microalgae and a gl...\nSpira\u2019s solution is to use colorful carbon-negative microalgae and a global network of aquaculture farms in the developing world to create sustainable food-safe pigments that are engineered to be stable at low pH(<3) and high temperatures (>65\u25e6C). These dyes are non-toxic and prevent harmful runoff from polluting local waterways. Spira has generated over $65,000 in sales and 55 letters of intent, which corresponds to a projected $33 million in potential billable revenue."}
{"meta": {"doc_id": 2412, "sent_id": 2, "sent_start_pos": 323, "sent_end_pos": 723, "title": "Spira creates ingredients from Spirulina for the food industry"}, "text": "These dyes are non-toxic and prevent harmful runoff from polluting local waterways. Spira has generated over $65,000 in sales and 55 letters of intent, which corresponds to a projected $33 million in potential billable revenue. We've successfully piloted our ingredients with beverage, alcohol, cosmetic, textile, candy and confectionery brands and have interest from clients like Clorox and Kellogg."}
{"meta": {"doc_id": 2412, "sent_id": 3, "sent_start_pos": 407, "sent_end_pos": 852, "title": "Spira creates ingredients from Spirulina for the food industry"}, "text": "Spira has generated over $65,000 in sales and 55 letters of intent, which corresponds to a projected $33 million in potential billable revenue. We've successfully piloted our ingredients with beverage, alcohol, cosmetic, textile, candy and confectionery brands and have interest from clients like Clorox and Kellogg. Investors\nAdvisors\nEmployees\nRecommendations\nWe love working with the team at Spira and their big vision for the future of food!"}
{"meta": {"doc_id": 2412, "sent_id": 4, "sent_start_pos": 551, "sent_end_pos": 946, "title": "Spira creates ingredients from Spirulina for the food industry"}, "text": "We've successfully piloted our ingredients with beverage, alcohol, cosmetic, textile, candy and confectionery brands and have interest from clients like Clorox and Kellogg. Investors\nAdvisors\nEmployees\nRecommendations\nWe love working with the team at Spira and their big vision for the future of food! Spira is led by a tenacious founder with the ability to attract and motivate a talented team."}
{"meta": {"doc_id": 2412, "sent_id": 5, "sent_start_pos": 724, "sent_end_pos": 1010, "title": "Spira creates ingredients from Spirulina for the food industry"}, "text": "Investors\nAdvisors\nEmployees\nRecommendations\nWe love working with the team at Spira and their big vision for the future of food! Spira is led by a tenacious founder with the ability to attract and motivate a talented team. These are the keys of innovation and early startup development."}
{"meta": {"doc_id": 2412, "sent_id": 6, "sent_start_pos": 853, "sent_end_pos": 1125, "title": "Spira creates ingredients from Spirulina for the food industry"}, "text": "Spira is led by a tenacious founder with the ability to attract and motivate a talented team. These are the keys of innovation and early startup development. Spira has been recognized internationally and is relentless in attacking hard science issues to compelling issues."}
{"meta": {"doc_id": 2412, "sent_id": 7, "sent_start_pos": 947, "sent_end_pos": 1260, "title": "Spira creates ingredients from Spirulina for the food industry"}, "text": "These are the keys of innovation and early startup development. Spira has been recognized internationally and is relentless in attacking hard science issues to compelling issues. We are proud to be working with team Spira and Lighthouse Labs and hope to help them continue to advance in dramatic and winning ways!"}
{"meta": {"doc_id": 2412, "sent_id": 8, "sent_start_pos": 1011, "sent_end_pos": 1318, "title": "Spira creates ingredients from Spirulina for the food industry"}, "text": "Spira has been recognized internationally and is relentless in attacking hard science issues to compelling issues. We are proud to be working with team Spira and Lighthouse Labs and hope to help them continue to advance in dramatic and winning ways! Elliot is a smart, young chap on a mission with his team."}
{"meta": {"doc_id": 2412, "sent_id": 9, "sent_start_pos": 1126, "sent_end_pos": 1388, "title": "Spira creates ingredients from Spirulina for the food industry"}, "text": "We are proud to be working with team Spira and Lighthouse Labs and hope to help them continue to advance in dramatic and winning ways! Elliot is a smart, young chap on a mission with his team. Their mission is by no means an easy one, but it is a worthwhile one."}
{"meta": {"doc_id": 2412, "sent_id": 10, "sent_start_pos": 1261, "sent_end_pos": 1524, "title": "Spira creates ingredients from Spirulina for the food industry"}, "text": "Elliot is a smart, young chap on a mission with his team. Their mission is by no means an easy one, but it is a worthwhile one. There is a possibility their product can be on the shelves and distributed within products in every retailer you know and will hear of."}
{"meta": {"doc_id": 2412, "sent_id": 11, "sent_start_pos": 1319, "sent_end_pos": 1650, "title": "Spira creates ingredients from Spirulina for the food industry"}, "text": "Their mission is by no means an easy one, but it is a worthwhile one. There is a possibility their product can be on the shelves and distributed within products in every retailer you know and will hear of. Endless protein at an affordable price for the consumer and the planet is the goal of the talented and passionate Spira team."}
{"meta": {"doc_id": 2412, "sent_id": 12, "sent_start_pos": 1389, "sent_end_pos": [], "title": "Spira creates ingredients from Spirulina for the food industry"}, "text": "There is a possibility their product can be on the shelves and distributed within products in every retailer you know and will hear of. Endless protein at an affordable price for the consumer and the planet is the goal of the talented and passionate Spira team. "}
{"meta": {"doc_id": 2413, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 187, "title": "AgBio+AgTech\u2014Plant Based and Clean Meat with Good Food Institute"}, "text": " Are you looking for opportunities in the alternative protein space? Wondering why big companies like Tyson and Perdue are pouring money into something other than broiler house operations?"}
{"meta": {"doc_id": 2413, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 348, "title": "AgBio+AgTech\u2014Plant Based and Clean Meat with Good Food Institute"}, "text": "Are you looking for opportunities in the alternative protein space? Wondering why big companies like Tyson and Perdue are pouring money into something other than broiler house operations? Maybe the BeyondMeat IPO inspired you or got you thinking about how you can leverage your expertise to help build a more diverse and sustainable protein future."}
{"meta": {"doc_id": 2413, "sent_id": 2, "sent_start_pos": 68, "sent_end_pos": 549, "title": "AgBio+AgTech\u2014Plant Based and Clean Meat with Good Food Institute"}, "text": "Wondering why big companies like Tyson and Perdue are pouring money into something other than broiler house operations? Maybe the BeyondMeat IPO inspired you or got you thinking about how you can leverage your expertise to help build a more diverse and sustainable protein future. Alternative protein innovators and investors, the convinced and the curious will want to join Michael Fotinatos of the Good Food Institute for a glimpse into Plant-Based Protein and Clean Meat future."}
{"meta": {"doc_id": 2413, "sent_id": 3, "sent_start_pos": 188, "sent_end_pos": 631, "title": "AgBio+AgTech\u2014Plant Based and Clean Meat with Good Food Institute"}, "text": "Maybe the BeyondMeat IPO inspired you or got you thinking about how you can leverage your expertise to help build a more diverse and sustainable protein future. Alternative protein innovators and investors, the convinced and the curious will want to join Michael Fotinatos of the Good Food Institute for a glimpse into Plant-Based Protein and Clean Meat future. Event is hosted by AgBio+AgTech Meet-up group and sponsored by Unbound Coworking."}
{"meta": {"doc_id": 2413, "sent_id": 4, "sent_start_pos": 349, "sent_end_pos": 988, "title": "AgBio+AgTech\u2014Plant Based and Clean Meat with Good Food Institute"}, "text": "Alternative protein innovators and investors, the convinced and the curious will want to join Michael Fotinatos of the Good Food Institute for a glimpse into Plant-Based Protein and Clean Meat future. Event is hosted by AgBio+AgTech Meet-up group and sponsored by Unbound Coworking. Agenda\n5:00-5:10pm Arrival at Durty Bull Brewery in Durham (courtesy of Unbound\nCoworking https://agbioagtech.com/discounts-from-sponsors/ )\n5:10pm Introduction of Speaker and Talk\n5:15-5:55pm Speaker: Michael Fotinatos\nStrategic Implementation Specialist\nThe Good Food Institute\n5:55pm Networking\nDurty Bull Brewing Company\n206 Broadway St #104\nDurham, NC"}
{"meta": {"doc_id": 2413, "sent_id": 5, "sent_start_pos": 550, "sent_end_pos": [], "title": "AgBio+AgTech\u2014Plant Based and Clean Meat with Good Food Institute"}, "text": "Event is hosted by AgBio+AgTech Meet-up group and sponsored by Unbound Coworking. Agenda\n5:00-5:10pm Arrival at Durty Bull Brewery in Durham (courtesy of Unbound\nCoworking https://agbioagtech.com/discounts-from-sponsors/ )\n5:10pm Introduction of Speaker and Talk\n5:15-5:55pm Speaker: Michael Fotinatos\nStrategic Implementation Specialist\nThe Good Food Institute\n5:55pm Networking\nDurty Bull Brewing Company\n206 Broadway St #104\nDurham, NC "}
{"meta": {"doc_id": 2414, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 558, "title": "\u2018Big meat\u2019 vs. scrappy startups: Nestl\u00e9, Tyson, Hormel roll out plant-based products to compete with Impossible, Beyond"}, "text": " Beyond Meat and Impossible Foods, scrappy start-ups that share a penchant for superlatives and a commitment to protecting the environment, have dominated the relatively new market for vegetarian food that looks and tastes like meat. But with plant-based burgers, sausages and chicken increasingly popular and available in fast-food restaurants and grocery stores across the United States, a new group of companies has started making meatless meat: the food conglomerates and meat producers that Beyond Meat and Impossible Foods originally set out to disrupt."}
{"meta": {"doc_id": 2414, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 777, "title": "\u2018Big meat\u2019 vs. scrappy startups: Nestl\u00e9, Tyson, Hormel roll out plant-based products to compete with Impossible, Beyond"}, "text": "Beyond Meat and Impossible Foods, scrappy start-ups that share a penchant for superlatives and a commitment to protecting the environment, have dominated the relatively new market for vegetarian food that looks and tastes like meat. But with plant-based burgers, sausages and chicken increasingly popular and available in fast-food restaurants and grocery stores across the United States, a new group of companies has started making meatless meat: the food conglomerates and meat producers that Beyond Meat and Impossible Foods originally set out to disrupt. In recent months, major food companies like Tyson, Smithfield, Perdue, Hormel and Nestl\u00e9 have rolled out their own meat alternatives, filling supermarket shelves with plant-based burgers, meatballs and chicken nuggets."}
{"meta": {"doc_id": 2414, "sent_id": 2, "sent_start_pos": 233, "sent_end_pos": 1016, "title": "\u2018Big meat\u2019 vs. scrappy startups: Nestl\u00e9, Tyson, Hormel roll out plant-based products to compete with Impossible, Beyond"}, "text": "But with plant-based burgers, sausages and chicken increasingly popular and available in fast-food restaurants and grocery stores across the United States, a new group of companies has started making meatless meat: the food conglomerates and meat producers that Beyond Meat and Impossible Foods originally set out to disrupt. In recent months, major food companies like Tyson, Smithfield, Perdue, Hormel and Nestl\u00e9 have rolled out their own meat alternatives, filling supermarket shelves with plant-based burgers, meatballs and chicken nuggets. Once largely the domain of vegans and vegetarians, plant-based meat is fast becoming a staple of more people\u2019s diets, as consumers look to reduce their meat intake amid concerns about its health effects and contribution to climate change."}
{"meta": {"doc_id": 2414, "sent_id": 3, "sent_start_pos": 559, "sent_end_pos": 1157, "title": "\u2018Big meat\u2019 vs. scrappy startups: Nestl\u00e9, Tyson, Hormel roll out plant-based products to compete with Impossible, Beyond"}, "text": "In recent months, major food companies like Tyson, Smithfield, Perdue, Hormel and Nestl\u00e9 have rolled out their own meat alternatives, filling supermarket shelves with plant-based burgers, meatballs and chicken nuggets. Once largely the domain of vegans and vegetarians, plant-based meat is fast becoming a staple of more people\u2019s diets, as consumers look to reduce their meat intake amid concerns about its health effects and contribution to climate change. Analysts project that the market for plant-based protein and lab-created meat alternatives could be worth as much as $85 billion by 2030."}
{"meta": {"doc_id": 2414, "sent_id": 4, "sent_start_pos": 778, "sent_end_pos": 1222, "title": "\u2018Big meat\u2019 vs. scrappy startups: Nestl\u00e9, Tyson, Hormel roll out plant-based products to compete with Impossible, Beyond"}, "text": "Once largely the domain of vegans and vegetarians, plant-based meat is fast becoming a staple of more people\u2019s diets, as consumers look to reduce their meat intake amid concerns about its health effects and contribution to climate change. Analysts project that the market for plant-based protein and lab-created meat alternatives could be worth as much as $85 billion by 2030. Read full, original article: The New Makers of Plant-Based Meat?"}
{"meta": {"doc_id": 2414, "sent_id": 5, "sent_start_pos": 1020, "sent_end_pos": [], "title": "\u2018Big meat\u2019 vs. scrappy startups: Nestl\u00e9, Tyson, Hormel roll out plant-based products to compete with Impossible, Beyond"}, "text": "Analysts project that the market for plant-based protein and lab-created meat alternatives could be worth as much as $85 billion by 2030. Read full, original article: The New Makers of Plant-Based Meat? "}
{"meta": {"doc_id": 2416, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 327, "title": "Giordano's, Protein Bar introduce fake meat"}, "text": " Chicago-style pizza chain Giordano's and healthy fast-food chain Protein Bar & Kitchen are the latest to join a group of restaurants offering plant-based protein menus. These two will add Impossible Pizza and Beyond Meat options to their menus Nov. 5."}
{"meta": {"doc_id": 2416, "sent_id": 1, "sent_start_pos": 76, "sent_end_pos": 560, "title": "Giordano's, Protein Bar introduce fake meat"}, "text": "Chicago-style pizza chain Giordano's and healthy fast-food chain Protein Bar & Kitchen are the latest to join a group of restaurants offering plant-based protein menus. These two will add Impossible Pizza and Beyond Meat options to their menus Nov. 5. Meat-free sausages will be available all across 70 Giordano's locations from its first day of introduction, while Beyond Beef Meatballs and chili are available only at Chicago-area Protein Bar & Kitchen restaurants until early 2020."}
{"meta": {"doc_id": 2416, "sent_id": 2, "sent_start_pos": 245, "sent_end_pos": 808, "title": "Giordano's, Protein Bar introduce fake meat"}, "text": "These two will add Impossible Pizza and Beyond Meat options to their menus Nov. 5. Meat-free sausages will be available all across 70 Giordano's locations from its first day of introduction, while Beyond Beef Meatballs and chili are available only at Chicago-area Protein Bar & Kitchen restaurants until early 2020. As more customers became aware of meat-based diet\u2019s impact on climate change and health consequences, many traditional restaurant chains have started to offer plant-based meat options from biotech startups such as Beyond Meat and Impossible Foods."}
{"meta": {"doc_id": 2416, "sent_id": 3, "sent_start_pos": 328, "sent_end_pos": 936, "title": "Giordano's, Protein Bar introduce fake meat"}, "text": "Meat-free sausages will be available all across 70 Giordano's locations from its first day of introduction, while Beyond Beef Meatballs and chili are available only at Chicago-area Protein Bar & Kitchen restaurants until early 2020. As more customers became aware of meat-based diet\u2019s impact on climate change and health consequences, many traditional restaurant chains have started to offer plant-based meat options from biotech startups such as Beyond Meat and Impossible Foods. The Hard Rock Cafe has served Impossible Burgers since December 2018, and Burger King rolled out Impossible Whoppers in August."}
{"meta": {"doc_id": 2416, "sent_id": 4, "sent_start_pos": 561, "sent_end_pos": 1116, "title": "Giordano's, Protein Bar introduce fake meat"}, "text": "As more customers became aware of meat-based diet\u2019s impact on climate change and health consequences, many traditional restaurant chains have started to offer plant-based meat options from biotech startups such as Beyond Meat and Impossible Foods. The Hard Rock Cafe has served Impossible Burgers since December 2018, and Burger King rolled out Impossible Whoppers in August. International food companies recently started to jump into these markets, including Nestle\u2019s Awesome Burger, Smithfield\u2019s soy-based meatballs and Hormel\u2019s plant-based ground meat."}
{"meta": {"doc_id": 2416, "sent_id": 5, "sent_start_pos": 809, "sent_end_pos": 1302, "title": "Giordano's, Protein Bar introduce fake meat"}, "text": "The Hard Rock Cafe has served Impossible Burgers since December 2018, and Burger King rolled out Impossible Whoppers in August. International food companies recently started to jump into these markets, including Nestle\u2019s Awesome Burger, Smithfield\u2019s soy-based meatballs and Hormel\u2019s plant-based ground meat. The market for plant-based protein and lab-created meat alternatives is projected to be $85 billion by 2030, according to a recent report by the Swiss financial services firm UBS Group."}
{"meta": {"doc_id": 2416, "sent_id": 6, "sent_start_pos": 937, "sent_end_pos": [], "title": "Giordano's, Protein Bar introduce fake meat"}, "text": "International food companies recently started to jump into these markets, including Nestle\u2019s Awesome Burger, Smithfield\u2019s soy-based meatballs and Hormel\u2019s plant-based ground meat. The market for plant-based protein and lab-created meat alternatives is projected to be $85 billion by 2030, according to a recent report by the Swiss financial services firm UBS Group. "}
{"meta": {"doc_id": 2417, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 199, "title": "OUR PRODUCTS"}, "text": " Imagine your favorite meaty dishes like burgers and tacos delivering the juicy, delicious taste you know and love, while being better for you and the planet. That\u2019s the future we\u2019re working to build."}
{"meta": {"doc_id": 2417, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 295, "title": "OUR PRODUCTS"}, "text": "Imagine your favorite meaty dishes like burgers and tacos delivering the juicy, delicious taste you know and love, while being better for you and the planet. That\u2019s the future we\u2019re working to build. Click below to learn more about each of our products and discover The Future of Protein\u00ae today!"}
{"meta": {"doc_id": 2417, "sent_id": 2, "sent_start_pos": 158, "sent_end_pos": 334, "title": "OUR PRODUCTS"}, "text": "That\u2019s the future we\u2019re working to build. Click below to learn more about each of our products and discover The Future of Protein\u00ae today! The latest and greatest Beyond Burger."}
{"meta": {"doc_id": 2417, "sent_id": 3, "sent_start_pos": 200, "sent_end_pos": 363, "title": "OUR PRODUCTS"}, "text": "Click below to learn more about each of our products and discover The Future of Protein\u00ae today! The latest and greatest Beyond Burger. It's everything a burger is."}
{"meta": {"doc_id": 2417, "sent_id": 4, "sent_start_pos": 296, "sent_end_pos": 405, "title": "OUR PRODUCTS"}, "text": "The latest and greatest Beyond Burger. It's everything a burger is. It's everything a burger has always been."}
{"meta": {"doc_id": 2417, "sent_id": 5, "sent_start_pos": 335, "sent_end_pos": 453, "title": "OUR PRODUCTS"}, "text": "It's everything a burger is. It's everything a burger has always been. For your health, for your planet, for your bbq."}
{"meta": {"doc_id": 2417, "sent_id": 6, "sent_start_pos": 364, "sent_end_pos": 577, "title": "OUR PRODUCTS"}, "text": "It's everything a burger has always been. For your health, for your planet, for your bbq. Pre-formed and ready to cook, these plant-based meatballs are a convenient, nutritious and satisfying addition to any meal."}
{"meta": {"doc_id": 2417, "sent_id": 7, "sent_start_pos": 406, "sent_end_pos": 604, "title": "OUR PRODUCTS"}, "text": "For your health, for your planet, for your bbq. Pre-formed and ready to cook, these plant-based meatballs are a convenient, nutritious and satisfying addition to any meal. Find it in the meat aisle."}
{"meta": {"doc_id": 2417, "sent_id": 8, "sent_start_pos": 454, "sent_end_pos": 729, "title": "OUR PRODUCTS"}, "text": "Pre-formed and ready to cook, these plant-based meatballs are a convenient, nutritious and satisfying addition to any meal. Find it in the meat aisle. Easy-to-cook plant-based patties and links that are seasoned to perfection and ready to power your day."}
{"meta": {"doc_id": 2417, "sent_id": 9, "sent_start_pos": 578, "sent_end_pos": 794, "title": "OUR PRODUCTS"}, "text": "Find it in the meat aisle. Easy-to-cook plant-based patties and links that are seasoned to perfection and ready to power your day. Find patties in the frozen aisle, links in the fresh meat aisle."}
{"meta": {"doc_id": 2417, "sent_id": 10, "sent_start_pos": 626, "sent_end_pos": 897, "title": "OUR PRODUCTS"}, "text": "Easy-to-cook plant-based patties and links that are seasoned to perfection and ready to power your day. Find patties in the frozen aisle, links in the fresh meat aisle. Cookout Classic is juicy, meaty and delicious, and available as a value-pack to feed the whole family."}
{"meta": {"doc_id": 2417, "sent_id": 11, "sent_start_pos": 730, "sent_end_pos": 928, "title": "OUR PRODUCTS"}, "text": "Find patties in the frozen aisle, links in the fresh meat aisle. Cookout Classic is juicy, meaty and delicious, and available as a value-pack to feed the whole family. Find it in the frozen section."}
{"meta": {"doc_id": 2417, "sent_id": 12, "sent_start_pos": 795, "sent_end_pos": 1013, "title": "OUR PRODUCTS"}, "text": "Cookout Classic is juicy, meaty and delicious, and available as a value-pack to feed the whole family. Find it in the frozen section. The freedom and versatility to turn any recipe into a meaty plant-based masterpiece."}
{"meta": {"doc_id": 2417, "sent_id": 13, "sent_start_pos": 898, "sent_end_pos": 1040, "title": "OUR PRODUCTS"}, "text": "Find it in the frozen section. The freedom and versatility to turn any recipe into a meaty plant-based masterpiece. Find it in the meat aisle."}
{"meta": {"doc_id": 2417, "sent_id": 14, "sent_start_pos": 929, "sent_end_pos": 1150, "title": "OUR PRODUCTS"}, "text": "The freedom and versatility to turn any recipe into a meaty plant-based masterpiece. Find it in the meat aisle. From grill to griddle to frying pan, plant-based sausage stuffed with delicious flavor and satisfying sizzle."}
{"meta": {"doc_id": 2417, "sent_id": 15, "sent_start_pos": 1014, "sent_end_pos": 1177, "title": "OUR PRODUCTS"}, "text": "Find it in the meat aisle. From grill to griddle to frying pan, plant-based sausage stuffed with delicious flavor and satisfying sizzle. Find it in the meat aisle."}
{"meta": {"doc_id": 2417, "sent_id": 16, "sent_start_pos": 1041, "sent_end_pos": 1246, "title": "OUR PRODUCTS"}, "text": "From grill to griddle to frying pan, plant-based sausage stuffed with delicious flavor and satisfying sizzle. Find it in the meat aisle. Delicious and versatile crumbles perfect for any ground beef recipe."}
{"meta": {"doc_id": 2417, "sent_id": 17, "sent_start_pos": 1151, "sent_end_pos": 1275, "title": "OUR PRODUCTS"}, "text": "Find it in the meat aisle. Delicious and versatile crumbles perfect for any ground beef recipe. Find it in the frozen aisle."}
{"meta": {"doc_id": 2417, "sent_id": 18, "sent_start_pos": 1178, "sent_end_pos": 1419, "title": "OUR PRODUCTS"}, "text": "Delicious and versatile crumbles perfect for any ground beef recipe. Find it in the frozen aisle. To receive exclusive coupons, availability updates of our sizzling Beyond Burger and Beyond Sausage, and other news you can use, sign up below!"}
{"meta": {"doc_id": 2417, "sent_id": 19, "sent_start_pos": 1247, "sent_end_pos": 1557, "title": "OUR PRODUCTS"}, "text": "Find it in the frozen aisle. To receive exclusive coupons, availability updates of our sizzling Beyond Burger and Beyond Sausage, and other news you can use, sign up below! By clicking 'GO', you consent to Beyond Meat using your email address and postal code to receive emails about products, recipes and more."}
{"meta": {"doc_id": 2417, "sent_id": 20, "sent_start_pos": 1276, "sent_end_pos": 1586, "title": "OUR PRODUCTS"}, "text": "To receive exclusive coupons, availability updates of our sizzling Beyond Burger and Beyond Sausage, and other news you can use, sign up below! By clicking 'GO', you consent to Beyond Meat using your email address and postal code to receive emails about products, recipes and more. You can opt out at any time."}
{"meta": {"doc_id": 2417, "sent_id": 21, "sent_start_pos": 1420, "sent_end_pos": [], "title": "OUR PRODUCTS"}, "text": "By clicking 'GO', you consent to Beyond Meat using your email address and postal code to receive emails about products, recipes and more. You can opt out at any time. "}
{"meta": {"doc_id": 2418, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 869, "title": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development"}, "text": " iBio Taps Pharmaceutical and Biotech Research Leader Terence E Ryan, PhD To Drive New Business Development\nMove Comes As Disruptive Plant-based Protein Technology Platform Readies for 4Q10 Clinical Trials Ryan to drive licensing agreements for iBioLaunchTM in familiar turf of Medium and Big Pharma\nJuly 27, 2010 - Newark, DE - iBio, Inc. (OTCBB: IBPM) - eyeing rapidly approaching, significant therapeutic protein opportunities for its disruptive plant-based technology platform in orphan biologics, bio-similars and bio-betters - announces today the appointment of Terence (Terry) E Ryan, PhD as Senior Vice President, Business Development. Highly accomplished in recombinant protein expression and with a PhD in Microbiology, Ryan's distinguished 20-year career includes serving as lead biological technology evaluator for pharmaceutical business development groups."}
{"meta": {"doc_id": 2418, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 1004, "title": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development"}, "text": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E Ryan, PhD To Drive New Business Development\nMove Comes As Disruptive Plant-based Protein Technology Platform Readies for 4Q10 Clinical Trials Ryan to drive licensing agreements for iBioLaunchTM in familiar turf of Medium and Big Pharma\nJuly 27, 2010 - Newark, DE - iBio, Inc. (OTCBB: IBPM) - eyeing rapidly approaching, significant therapeutic protein opportunities for its disruptive plant-based technology platform in orphan biologics, bio-similars and bio-betters - announces today the appointment of Terence (Terry) E Ryan, PhD as Senior Vice President, Business Development. Highly accomplished in recombinant protein expression and with a PhD in Microbiology, Ryan's distinguished 20-year career includes serving as lead biological technology evaluator for pharmaceutical business development groups. Ryan has worked for such industry leaders as Wyeth (Pfizer) Research, GlaxoSmithKline, Celera Genomics, and Regeneron Pharmaceuticals."}
{"meta": {"doc_id": 2418, "sent_id": 2, "sent_start_pos": 643, "sent_end_pos": 1405, "title": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development"}, "text": "Highly accomplished in recombinant protein expression and with a PhD in Microbiology, Ryan's distinguished 20-year career includes serving as lead biological technology evaluator for pharmaceutical business development groups. Ryan has worked for such industry leaders as Wyeth (Pfizer) Research, GlaxoSmithKline, Celera Genomics, and Regeneron Pharmaceuticals. \"Terry's substantial experience with commercial implementation of technology combined with his scientific pedigree and understanding of the needs of medium and big pharma make him the ideal addition to the iBio executive team,\" said Robert B Kay, CEO and Executive Chairman of iBio, Inc. \"He will have a key role in the current commercialization of our revolutionary plant-based technology platform.\""}
{"meta": {"doc_id": 2418, "sent_id": 3, "sent_start_pos": 870, "sent_end_pos": 1613, "title": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development"}, "text": "Ryan has worked for such industry leaders as Wyeth (Pfizer) Research, GlaxoSmithKline, Celera Genomics, and Regeneron Pharmaceuticals. \"Terry's substantial experience with commercial implementation of technology combined with his scientific pedigree and understanding of the needs of medium and big pharma make him the ideal addition to the iBio executive team,\" said Robert B Kay, CEO and Executive Chairman of iBio, Inc. \"He will have a key role in the current commercialization of our revolutionary plant-based technology platform.\" Ryan will be directly responsible for all aspects of new business development including cultivating relationships with major pharmaceutical companies and procuring grants and awards from government agencies."}
{"meta": {"doc_id": 2418, "sent_id": 4, "sent_start_pos": 1005, "sent_end_pos": 1904, "title": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development"}, "text": "\"Terry's substantial experience with commercial implementation of technology combined with his scientific pedigree and understanding of the needs of medium and big pharma make him the ideal addition to the iBio executive team,\" said Robert B Kay, CEO and Executive Chairman of iBio, Inc. \"He will have a key role in the current commercialization of our revolutionary plant-based technology platform.\" Ryan will be directly responsible for all aspects of new business development including cultivating relationships with major pharmaceutical companies and procuring grants and awards from government agencies. Additionally, Ryan will be interfacing with iBio's development collaborator, Fraunhofer USA CMB, on ongoing development and refinement of the iBio-proprietary iBioLaunchTM platform for broad applications in the growth markets of orphan biologics; bio-similars and bio-betters, and vaccines."}
{"meta": {"doc_id": 2418, "sent_id": 5, "sent_start_pos": 1406, "sent_end_pos": 2153, "title": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development"}, "text": "Ryan will be directly responsible for all aspects of new business development including cultivating relationships with major pharmaceutical companies and procuring grants and awards from government agencies. Additionally, Ryan will be interfacing with iBio's development collaborator, Fraunhofer USA CMB, on ongoing development and refinement of the iBio-proprietary iBioLaunchTM platform for broad applications in the growth markets of orphan biologics; bio-similars and bio-betters, and vaccines. \"The low-cost, high-quality iBioLaunch platform has moved past the research bench to clinical trials, and is soon expected to make possible cost-effective medicines for a wide variety of diseases in the first world as well as the third,\" said Ryan."}
{"meta": {"doc_id": 2418, "sent_id": 6, "sent_start_pos": 1614, "sent_end_pos": 2350, "title": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development"}, "text": "Additionally, Ryan will be interfacing with iBio's development collaborator, Fraunhofer USA CMB, on ongoing development and refinement of the iBio-proprietary iBioLaunchTM platform for broad applications in the growth markets of orphan biologics; bio-similars and bio-betters, and vaccines. \"The low-cost, high-quality iBioLaunch platform has moved past the research bench to clinical trials, and is soon expected to make possible cost-effective medicines for a wide variety of diseases in the first world as well as the third,\" said Ryan. \"I am thrilled to be onboard to help bring this game-changing biologics technology to the benefit of patients via pharmaceutical companies, governments and health organizations on a global scale.\""}
{"meta": {"doc_id": 2418, "sent_id": 7, "sent_start_pos": 1905, "sent_end_pos": 2527, "title": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development"}, "text": "\"The low-cost, high-quality iBioLaunch platform has moved past the research bench to clinical trials, and is soon expected to make possible cost-effective medicines for a wide variety of diseases in the first world as well as the third,\" said Ryan. \"I am thrilled to be onboard to help bring this game-changing biologics technology to the benefit of patients via pharmaceutical companies, governments and health organizations on a global scale.\" Ryan's career includes most recently serving as Assistant Vice President and formerly Senior Director, Biological Technologies, Discovery Research with Wyeth (Pfizer) Research."}
{"meta": {"doc_id": 2418, "sent_id": 8, "sent_start_pos": 2154, "sent_end_pos": 2751, "title": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development"}, "text": "\"I am thrilled to be onboard to help bring this game-changing biologics technology to the benefit of patients via pharmaceutical companies, governments and health organizations on a global scale.\" Ryan's career includes most recently serving as Assistant Vice President and formerly Senior Director, Biological Technologies, Discovery Research with Wyeth (Pfizer) Research. He was previously GlaxoSmithKline's Director, Integrative Biology (Department of High Throughput Biology, Discovery Research), and founded Celera Genomics' Cell Biology Group while serving as Director of Cell Biology there."}
{"meta": {"doc_id": 2418, "sent_id": 9, "sent_start_pos": 2351, "sent_end_pos": 2926, "title": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development"}, "text": "Ryan's career includes most recently serving as Assistant Vice President and formerly Senior Director, Biological Technologies, Discovery Research with Wyeth (Pfizer) Research. He was previously GlaxoSmithKline's Director, Integrative Biology (Department of High Throughput Biology, Discovery Research), and founded Celera Genomics' Cell Biology Group while serving as Director of Cell Biology there. Other posts included Associate Director, Cell Technology with Regeneron Pharmaceuticals, and Senior Scientist, Molecular Virology in the Pandex Division of Baxter Healthcare."}
{"meta": {"doc_id": 2418, "sent_id": 10, "sent_start_pos": 2528, "sent_end_pos": 3062, "title": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development"}, "text": "He was previously GlaxoSmithKline's Director, Integrative Biology (Department of High Throughput Biology, Discovery Research), and founded Celera Genomics' Cell Biology Group while serving as Director of Cell Biology there. Other posts included Associate Director, Cell Technology with Regeneron Pharmaceuticals, and Senior Scientist, Molecular Virology in the Pandex Division of Baxter Healthcare. Ryan boasts a strong record of recent peer-reviewed publications and is a frequently invited presenter at major scientific conferences."}
{"meta": {"doc_id": 2418, "sent_id": 11, "sent_start_pos": 2752, "sent_end_pos": 3210, "title": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development"}, "text": "Other posts included Associate Director, Cell Technology with Regeneron Pharmaceuticals, and Senior Scientist, Molecular Virology in the Pandex Division of Baxter Healthcare. Ryan boasts a strong record of recent peer-reviewed publications and is a frequently invited presenter at major scientific conferences. Ryan holds a PhD in Microbiology from Rutgers University, an MS in Microbiology, also from Rutgers, and an AB in Biology from Princeton University."}
{"meta": {"doc_id": 2418, "sent_id": 12, "sent_start_pos": 2927, "sent_end_pos": 3311, "title": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development"}, "text": "Ryan boasts a strong record of recent peer-reviewed publications and is a frequently invited presenter at major scientific conferences. Ryan holds a PhD in Microbiology from Rutgers University, an MS in Microbiology, also from Rutgers, and an AB in Biology from Princeton University. He served his Post-Doctoral Fellow at the University of Wisconsin, Laboratory of Molecular Virology."}
{"meta": {"doc_id": 2418, "sent_id": 13, "sent_start_pos": 3063, "sent_end_pos": 3374, "title": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development"}, "text": "Ryan holds a PhD in Microbiology from Rutgers University, an MS in Microbiology, also from Rutgers, and an AB in Biology from Princeton University. He served his Post-Doctoral Fellow at the University of Wisconsin, Laboratory of Molecular Virology. Ryan will be based in iBio's headquarters in Newark, Delaware."}
{"meta": {"doc_id": 2418, "sent_id": 14, "sent_start_pos": 3211, "sent_end_pos": [], "title": "iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development"}, "text": "He served his Post-Doctoral Fellow at the University of Wisconsin, Laboratory of Molecular Virology. Ryan will be based in iBio's headquarters in Newark, Delaware. "}
{"meta": {"doc_id": 2419, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 143, "title": "Interest growing in cultivation of plant-based protein alternatives"}, "text": " Close\nNote: Search is limited to the most recent 250 articles. To access earlier articles, click Advanced Search and set an earlier date range."}
{"meta": {"doc_id": 2419, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 224, "title": "Interest growing in cultivation of plant-based protein alternatives"}, "text": "Close\nNote: Search is limited to the most recent 250 articles. To access earlier articles, click Advanced Search and set an earlier date range. Search Engineering News\nNote: Search is limited to the most recent 250 articles."}
{"meta": {"doc_id": 2419, "sent_id": 2, "sent_start_pos": 63, "sent_end_pos": 305, "title": "Interest growing in cultivation of plant-based protein alternatives"}, "text": "To access earlier articles, click Advanced Search and set an earlier date range. Search Engineering News\nNote: Search is limited to the most recent 250 articles. To access earlier articles, click Advanced Search and set an earlier date range."}
{"meta": {"doc_id": 2419, "sent_id": 3, "sent_start_pos": 144, "sent_end_pos": 442, "title": "Interest growing in cultivation of plant-based protein alternatives"}, "text": "Search Engineering News\nNote: Search is limited to the most recent 250 articles. To access earlier articles, click Advanced Search and set an earlier date range. To search for a term containing the '&' symbol, click Advanced Search and use the 'search headings' and/or 'in first paragraph' options."}
{"meta": {"doc_id": 2419, "sent_id": 4, "sent_start_pos": 225, "sent_end_pos": 504, "title": "Interest growing in cultivation of plant-based protein alternatives"}, "text": "To access earlier articles, click Advanced Search and set an earlier date range. To search for a term containing the '&' symbol, click Advanced Search and use the 'search headings' and/or 'in first paragraph' options. Sponsored by\nLegal Notice Comment Guidelines \u00a9 Copyright 2021"}
{"meta": {"doc_id": 2419, "sent_id": 5, "sent_start_pos": 306, "sent_end_pos": [], "title": "Interest growing in cultivation of plant-based protein alternatives"}, "text": "To search for a term containing the '&' symbol, click Advanced Search and use the 'search headings' and/or 'in first paragraph' options. Sponsored by\nLegal Notice Comment Guidelines \u00a9 Copyright 2021 "}
{"meta": {"doc_id": 2421, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 349, "title": "Biochemistry of a burger"}, "text": " Biochemistry of a burger\nIn what has become a journalistic clich\u00e9, I took my boyfriend, a vegetarian for the past 10 years, to our local greasy spoon to try out an Impossible Burger. He had lost his taste for ground beef and found the experience of a plant-based, completely vegan yet beefy-tasting burger less than appealing."}
{"meta": {"doc_id": 2421, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 475, "title": "Biochemistry of a burger"}, "text": "Biochemistry of a burger\nIn what has become a journalistic clich\u00e9, I took my boyfriend, a vegetarian for the past 10 years, to our local greasy spoon to try out an Impossible Burger. He had lost his taste for ground beef and found the experience of a plant-based, completely vegan yet beefy-tasting burger less than appealing. I, on the other hand, was a fan; his burger tasted better to me than my own, which was made the old-fashioned way, with beef."}
{"meta": {"doc_id": 2421, "sent_id": 2, "sent_start_pos": 206, "sent_end_pos": 636, "title": "Biochemistry of a burger"}, "text": "He had lost his taste for ground beef and found the experience of a plant-based, completely vegan yet beefy-tasting burger less than appealing. I, on the other hand, was a fan; his burger tasted better to me than my own, which was made the old-fashioned way, with beef. People like me are exactly the people Impossible Burger is targeting: millennials who eat meat sometimes but fret about its impacts on a crowded, warming world."}
{"meta": {"doc_id": 2421, "sent_id": 3, "sent_start_pos": 350, "sent_end_pos": 783, "title": "Biochemistry of a burger"}, "text": "I, on the other hand, was a fan; his burger tasted better to me than my own, which was made the old-fashioned way, with beef. People like me are exactly the people Impossible Burger is targeting: millennials who eat meat sometimes but fret about its impacts on a crowded, warming world. David Welch is the director of science and technology at the Good Food Institute, a think tank promoting the burgeoning plant-based meat industry."}
{"meta": {"doc_id": 2421, "sent_id": 4, "sent_start_pos": 476, "sent_end_pos": 943, "title": "Biochemistry of a burger"}, "text": "People like me are exactly the people Impossible Burger is targeting: millennials who eat meat sometimes but fret about its impacts on a crowded, warming world. David Welch is the director of science and technology at the Good Food Institute, a think tank promoting the burgeoning plant-based meat industry. He said one of the reasons Impossible Foods and its strongest competitor, Beyond Meat, have garnered so much interest from investors is their average customer."}
{"meta": {"doc_id": 2421, "sent_id": 5, "sent_start_pos": 637, "sent_end_pos": 1253, "title": "Biochemistry of a burger"}, "text": "David Welch is the director of science and technology at the Good Food Institute, a think tank promoting the burgeoning plant-based meat industry. He said one of the reasons Impossible Foods and its strongest competitor, Beyond Meat, have garnered so much interest from investors is their average customer. \u201cThey\u2019re targeting the meat eater who is being more conscious about their decision.\u201d\n\u201cWe were approaching (meat) the same way you might approach figuring out the entire system for replicating genes,\u201d Brown said during an interview in June."}
{"meta": {"doc_id": 2421, "sent_id": 6, "sent_start_pos": 784, "sent_end_pos": 1535, "title": "Biochemistry of a burger"}, "text": "He said one of the reasons Impossible Foods and its strongest competitor, Beyond Meat, have garnered so much interest from investors is their average customer. \u201cThey\u2019re targeting the meat eater who is being more conscious about their decision.\u201d\n\u201cWe were approaching (meat) the same way you might approach figuring out the entire system for replicating genes,\u201d Brown said during an interview in June. \u201cBasically, start looking at what are all the possible components that could be players \u2026 and then deconstruct and reconstitute the biochemical system.\u201d\nMarket and mission\nThe world eats a lot of beef: 57 pounds per person per year in the US, with consumption increasing worldwide."}
{"meta": {"doc_id": 2421, "sent_id": 7, "sent_start_pos": 1014, "sent_end_pos": 1733, "title": "Biochemistry of a burger"}, "text": "\u201cThey\u2019re targeting the meat eater who is being more conscious about their decision.\u201d\n\u201cWe were approaching (meat) the same way you might approach figuring out the entire system for replicating genes,\u201d Brown said during an interview in June. \u201cBasically, start looking at what are all the possible components that could be players \u2026 and then deconstruct and reconstitute the biochemical system.\u201d\nMarket and mission\nThe world eats a lot of beef: 57 pounds per person per year in the US, with consumption increasing worldwide. Because cattle are the least efficient livestock animal at converting feed into edible meat, environmentalists have argued for years that reducing beef consumption is an important conservation act."}
{"meta": {"doc_id": 2421, "sent_id": 8, "sent_start_pos": 1254, "sent_end_pos": 1896, "title": "Biochemistry of a burger"}, "text": "\u201cBasically, start looking at what are all the possible components that could be players \u2026 and then deconstruct and reconstitute the biochemical system.\u201d\nMarket and mission\nThe world eats a lot of beef: 57 pounds per person per year in the US, with consumption increasing worldwide. Because cattle are the least efficient livestock animal at converting feed into edible meat, environmentalists have argued for years that reducing beef consumption is an important conservation act. Brown, who has been vegetarian for decades, says that those arguments have not been effective, even when made by parties as influential as the Chinese government."}
{"meta": {"doc_id": 2421, "sent_id": 9, "sent_start_pos": 1536, "sent_end_pos": 2088, "title": "Biochemistry of a burger"}, "text": "Because cattle are the least efficient livestock animal at converting feed into edible meat, environmentalists have argued for years that reducing beef consumption is an important conservation act. Brown, who has been vegetarian for decades, says that those arguments have not been effective, even when made by parties as influential as the Chinese government. \u201cThat experiment has been done,\u201d he told an audience of microbiologists during the American Society for Microbiology\u2019s keynote lecture in June, which he delivered wearing a \u201cno cows\u201d T-shirt."}
{"meta": {"doc_id": 2421, "sent_id": 10, "sent_start_pos": 1734, "sent_end_pos": 2268, "title": "Biochemistry of a burger"}, "text": "Brown, who has been vegetarian for decades, says that those arguments have not been effective, even when made by parties as influential as the Chinese government. \u201cThat experiment has been done,\u201d he told an audience of microbiologists during the American Society for Microbiology\u2019s keynote lecture in June, which he delivered wearing a \u201cno cows\u201d T-shirt. \u201cYou don\u2019t solve the problem by asking people to change their diets.\u201d\nBrown frames the problem instead as relying on an outdated technology \u2014 namely the cow \u2014 for beef production."}
{"meta": {"doc_id": 2421, "sent_id": 11, "sent_start_pos": 1897, "sent_end_pos": 2396, "title": "Biochemistry of a burger"}, "text": "\u201cThat experiment has been done,\u201d he told an audience of microbiologists during the American Society for Microbiology\u2019s keynote lecture in June, which he delivered wearing a \u201cno cows\u201d T-shirt. \u201cYou don\u2019t solve the problem by asking people to change their diets.\u201d\nBrown frames the problem instead as relying on an outdated technology \u2014 namely the cow \u2014 for beef production. He wants to solve the problem by making meat imitations so appealing that they\u2019ll outcompete what he calls the legacy industry."}
{"meta": {"doc_id": 2421, "sent_id": 12, "sent_start_pos": 2089, "sent_end_pos": 2517, "title": "Biochemistry of a burger"}, "text": "\u201cYou don\u2019t solve the problem by asking people to change their diets.\u201d\nBrown frames the problem instead as relying on an outdated technology \u2014 namely the cow \u2014 for beef production. He wants to solve the problem by making meat imitations so appealing that they\u2019ll outcompete what he calls the legacy industry. Impossible Foods explicitly states that its mission is to eliminate all animals from the food production system by 2035."}
{"meta": {"doc_id": 2421, "sent_id": 13, "sent_start_pos": 2269, "sent_end_pos": 2590, "title": "Biochemistry of a burger"}, "text": "He wants to solve the problem by making meat imitations so appealing that they\u2019ll outcompete what he calls the legacy industry. Impossible Foods explicitly states that its mission is to eliminate all animals from the food production system by 2035. Staffing with scientists\nBecoming a CEO wasn\u2019t in Brown\u2019s original plan."}
{"meta": {"doc_id": 2421, "sent_id": 14, "sent_start_pos": 2397, "sent_end_pos": 2667, "title": "Biochemistry of a burger"}, "text": "Impossible Foods explicitly states that its mission is to eliminate all animals from the food production system by 2035. Staffing with scientists\nBecoming a CEO wasn\u2019t in Brown\u2019s original plan. Compared with being a professor, he thought a job in business would be dull."}
{"meta": {"doc_id": 2421, "sent_id": 15, "sent_start_pos": 2518, "sent_end_pos": 2848, "title": "Biochemistry of a burger"}, "text": "Staffing with scientists\nBecoming a CEO wasn\u2019t in Brown\u2019s original plan. Compared with being a professor, he thought a job in business would be dull. He first set out to eradicate animal agriculture while on sabbatical from Stanford in 2009 and thought he could do it by persuading someone else to take on disrupting the industry."}
{"meta": {"doc_id": 2421, "sent_id": 16, "sent_start_pos": 2591, "sent_end_pos": 2966, "title": "Biochemistry of a burger"}, "text": "Compared with being a professor, he thought a job in business would be dull. He first set out to eradicate animal agriculture while on sabbatical from Stanford in 2009 and thought he could do it by persuading someone else to take on disrupting the industry. He anticipated that an established food producer would adopt the meat-alternative idea as enthusiastically as he had."}
{"meta": {"doc_id": 2421, "sent_id": 17, "sent_start_pos": 2668, "sent_end_pos": 3176, "title": "Biochemistry of a burger"}, "text": "He first set out to eradicate animal agriculture while on sabbatical from Stanford in 2009 and thought he could do it by persuading someone else to take on disrupting the industry. He anticipated that an established food producer would adopt the meat-alternative idea as enthusiastically as he had. \u201cI went around to food industry conferences and gave a spiel to the effect that someone\u2019s going to make a killing if they are the first mover to replace animals in food production technology,\u201d he said in 2017."}
{"meta": {"doc_id": 2421, "sent_id": 18, "sent_start_pos": 2849, "sent_end_pos": 3358, "title": "Biochemistry of a burger"}, "text": "He anticipated that an established food producer would adopt the meat-alternative idea as enthusiastically as he had. \u201cI went around to food industry conferences and gave a spiel to the effect that someone\u2019s going to make a killing if they are the first mover to replace animals in food production technology,\u201d he said in 2017. \u201cThat was stupid.\u201d\nWhen the food industry didn\u2019t bite and a workshop he organized at the National Academies resulted in no discernible policy change, Brown decided to do it himself."}
{"meta": {"doc_id": 2421, "sent_id": 19, "sent_start_pos": 2967, "sent_end_pos": 3483, "title": "Biochemistry of a burger"}, "text": "\u201cI went around to food industry conferences and gave a spiel to the effect that someone\u2019s going to make a killing if they are the first mover to replace animals in food production technology,\u201d he said in 2017. \u201cThat was stupid.\u201d\nWhen the food industry didn\u2019t bite and a workshop he organized at the National Academies resulted in no discernible policy change, Brown decided to do it himself. \u201cI was not a savvy business person, but I had the very good fortune of living in the epicenter of venture capital,\u201d he said."}
{"meta": {"doc_id": 2421, "sent_id": 20, "sent_start_pos": 3177, "sent_end_pos": 3652, "title": "Biochemistry of a burger"}, "text": "\u201cThat was stupid.\u201d\nWhen the food industry didn\u2019t bite and a workshop he organized at the National Academies resulted in no discernible policy change, Brown decided to do it himself. \u201cI was not a savvy business person, but I had the very good fortune of living in the epicenter of venture capital,\u201d he said. The funding may have had less to do with Brown\u2019s physical proximity to the venture capital firms of San Francisco than his track record of disrupting scientific fields."}
{"meta": {"doc_id": 2421, "sent_id": 21, "sent_start_pos": 3359, "sent_end_pos": 3785, "title": "Biochemistry of a burger"}, "text": "\u201cI was not a savvy business person, but I had the very good fortune of living in the epicenter of venture capital,\u201d he said. The funding may have had less to do with Brown\u2019s physical proximity to the venture capital firms of San Francisco than his track record of disrupting scientific fields. Early on, Brown hired mostly biochemists, many from his professional circles at Stanford \u2014 along with some of his closest relatives."}
{"meta": {"doc_id": 2421, "sent_id": 22, "sent_start_pos": 3484, "sent_end_pos": 3915, "title": "Biochemistry of a burger"}, "text": "The funding may have had less to do with Brown\u2019s physical proximity to the venture capital firms of San Francisco than his track record of disrupting scientific fields. Early on, Brown hired mostly biochemists, many from his professional circles at Stanford \u2014 along with some of his closest relatives. \u201cI knew a lot of talented students and postdocs, and a lot of my friends were scientists and they knew a lot of people,\u201d he said."}
{"meta": {"doc_id": 2421, "sent_id": 23, "sent_start_pos": 3653, "sent_end_pos": 4029, "title": "Biochemistry of a burger"}, "text": "Early on, Brown hired mostly biochemists, many from his professional circles at Stanford \u2014 along with some of his closest relatives. \u201cI knew a lot of talented students and postdocs, and a lot of my friends were scientists and they knew a lot of people,\u201d he said. \u201cOf course, there was no field of creating meat directly from plants, so they came from all kinds of backgrounds."}
{"meta": {"doc_id": 2421, "sent_id": 24, "sent_start_pos": 3786, "sent_end_pos": 4221, "title": "Biochemistry of a burger"}, "text": "\u201cI knew a lot of talented students and postdocs, and a lot of my friends were scientists and they knew a lot of people,\u201d he said. \u201cOf course, there was no field of creating meat directly from plants, so they came from all kinds of backgrounds. All I really wanted was raw scientific talent.\u201d\nAccording to the Good Food Institute\u2019s David Welch, staffing at Impossible Foods is unlike that at more established meat-alternative companies."}
{"meta": {"doc_id": 2421, "sent_id": 25, "sent_start_pos": 3916, "sent_end_pos": 4336, "title": "Biochemistry of a burger"}, "text": "\u201cOf course, there was no field of creating meat directly from plants, so they came from all kinds of backgrounds. All I really wanted was raw scientific talent.\u201d\nAccording to the Good Food Institute\u2019s David Welch, staffing at Impossible Foods is unlike that at more established meat-alternative companies. \u201cAt tech-focused companies like Impossible Foods and Beyond Meat, the R&D teams are full of biochemists,\u201d he said."}
{"meta": {"doc_id": 2421, "sent_id": 26, "sent_start_pos": 4030, "sent_end_pos": 4625, "title": "Biochemistry of a burger"}, "text": "All I really wanted was raw scientific talent.\u201d\nAccording to the Good Food Institute\u2019s David Welch, staffing at Impossible Foods is unlike that at more established meat-alternative companies. \u201cAt tech-focused companies like Impossible Foods and Beyond Meat, the R&D teams are full of biochemists,\u201d he said. \u201cA more traditional plant-based meat company may have had a different balance in terms of the scientific talent within that company, with much more focus on food science and culinary aspects of assembling ingredients.\u201d\nBrown said that he looked for scientists who were up for a challenge."}
{"meta": {"doc_id": 2421, "sent_id": 27, "sent_start_pos": 4222, "sent_end_pos": 4837, "title": "Biochemistry of a burger"}, "text": "\u201cAt tech-focused companies like Impossible Foods and Beyond Meat, the R&D teams are full of biochemists,\u201d he said. \u201cA more traditional plant-based meat company may have had a different balance in terms of the scientific talent within that company, with much more focus on food science and culinary aspects of assembling ingredients.\u201d\nBrown said that he looked for scientists who were up for a challenge. \u201cI had the most awesome recruiting tool, which is that I could tell them with a straight face that we are working on unequivocally the most important scientific problem in the world, and it\u2019s really challenging."}
{"meta": {"doc_id": 2421, "sent_id": 28, "sent_start_pos": 4337, "sent_end_pos": 5059, "title": "Biochemistry of a burger"}, "text": "\u201cA more traditional plant-based meat company may have had a different balance in terms of the scientific talent within that company, with much more focus on food science and culinary aspects of assembling ingredients.\u201d\nBrown said that he looked for scientists who were up for a challenge. \u201cI had the most awesome recruiting tool, which is that I could tell them with a straight face that we are working on unequivocally the most important scientific problem in the world, and it\u2019s really challenging. If you want to get great scientists to work for you, that\u2019s pretty much what you need.\u201d\nFor people like Laura Kliman, a senior flavor scientist at Impossible Foods, the company\u2019s environmental mission was a selling point."}
{"meta": {"doc_id": 2421, "sent_id": 29, "sent_start_pos": 4626, "sent_end_pos": 5138, "title": "Biochemistry of a burger"}, "text": "\u201cI had the most awesome recruiting tool, which is that I could tell them with a straight face that we are working on unequivocally the most important scientific problem in the world, and it\u2019s really challenging. If you want to get great scientists to work for you, that\u2019s pretty much what you need.\u201d\nFor people like Laura Kliman, a senior flavor scientist at Impossible Foods, the company\u2019s environmental mission was a selling point. In 2016, Kliman, an organic chemist by training, was working as a pastry chef."}
{"meta": {"doc_id": 2421, "sent_id": 30, "sent_start_pos": 4838, "sent_end_pos": 5255, "title": "Biochemistry of a burger"}, "text": "If you want to get great scientists to work for you, that\u2019s pretty much what you need.\u201d\nFor people like Laura Kliman, a senior flavor scientist at Impossible Foods, the company\u2019s environmental mission was a selling point. In 2016, Kliman, an organic chemist by training, was working as a pastry chef. She had just left a job as a chemist at a company that once developed biofuels but was transitioning to natural gas."}
{"meta": {"doc_id": 2421, "sent_id": 31, "sent_start_pos": 5060, "sent_end_pos": 5320, "title": "Biochemistry of a burger"}, "text": "In 2016, Kliman, an organic chemist by training, was working as a pastry chef. She had just left a job as a chemist at a company that once developed biofuels but was transitioning to natural gas. She heard about Impossible Foods from a news story on the radio."}
{"meta": {"doc_id": 2421, "sent_id": 32, "sent_start_pos": 5139, "sent_end_pos": 5384, "title": "Biochemistry of a burger"}, "text": "She had just left a job as a chemist at a company that once developed biofuels but was transitioning to natural gas. She heard about Impossible Foods from a news story on the radio. \u201cI couldn\u2019t believe how exciting and perfect it was,\u201d she said."}
{"meta": {"doc_id": 2421, "sent_id": 33, "sent_start_pos": 5256, "sent_end_pos": 5686, "title": "Biochemistry of a burger"}, "text": "She heard about Impossible Foods from a news story on the radio. \u201cI couldn\u2019t believe how exciting and perfect it was,\u201d she said. \u201cObviously extremely focused on sustainability, while incorporating culinary (aspects) as well as chemistry.\u201d\nEric Decker, head of the department of food science at the University of Massachusetts at Amherst, said that Impossible Foods is not unique in hiring scientists with no food science training."}
{"meta": {"doc_id": 2421, "sent_id": 34, "sent_start_pos": 5321, "sent_end_pos": 5811, "title": "Biochemistry of a burger"}, "text": "\u201cI couldn\u2019t believe how exciting and perfect it was,\u201d she said. \u201cObviously extremely focused on sustainability, while incorporating culinary (aspects) as well as chemistry.\u201d\nEric Decker, head of the department of food science at the University of Massachusetts at Amherst, said that Impossible Foods is not unique in hiring scientists with no food science training. \u201cThere have been biochemists \u2014 and organic chemists, and analytical chemists \u2014 in the food sector for decades,\u201d Decker said."}
{"meta": {"doc_id": 2421, "sent_id": 35, "sent_start_pos": 5385, "sent_end_pos": 6108, "title": "Biochemistry of a burger"}, "text": "\u201cObviously extremely focused on sustainability, while incorporating culinary (aspects) as well as chemistry.\u201d\nEric Decker, head of the department of food science at the University of Massachusetts at Amherst, said that Impossible Foods is not unique in hiring scientists with no food science training. \u201cThere have been biochemists \u2014 and organic chemists, and analytical chemists \u2014 in the food sector for decades,\u201d Decker said. \u201cAnd flavor houses have been trying to replicate meat for a long time.\u201d\nRather, he said, what sets Impossible Foods apart are its startup-style business model, which has allowed the company to invest tremendous resources in a single product, and its patented plant-based heme protein ingredients."}
{"meta": {"doc_id": 2421, "sent_id": 36, "sent_start_pos": 5687, "sent_end_pos": 6376, "title": "Biochemistry of a burger"}, "text": "\u201cThere have been biochemists \u2014 and organic chemists, and analytical chemists \u2014 in the food sector for decades,\u201d Decker said. \u201cAnd flavor houses have been trying to replicate meat for a long time.\u201d\nRather, he said, what sets Impossible Foods apart are its startup-style business model, which has allowed the company to invest tremendous resources in a single product, and its patented plant-based heme protein ingredients. Flavor chemistry\nThe team at Impossible Foods set out to define a burger biochemically by heating grocery store ground beef and, with a gas chromatography system and a mass spectrometer, characterizing the products of the complex reactions that resulted as it cooked."}
{"meta": {"doc_id": 2421, "sent_id": 37, "sent_start_pos": 5812, "sent_end_pos": 6584, "title": "Biochemistry of a burger"}, "text": "\u201cAnd flavor houses have been trying to replicate meat for a long time.\u201d\nRather, he said, what sets Impossible Foods apart are its startup-style business model, which has allowed the company to invest tremendous resources in a single product, and its patented plant-based heme protein ingredients. Flavor chemistry\nThe team at Impossible Foods set out to define a burger biochemically by heating grocery store ground beef and, with a gas chromatography system and a mass spectrometer, characterizing the products of the complex reactions that resulted as it cooked. Then, instead of trying to incorporate all the aromatic chemicals they identified into a veggie patty, Brown\u2019s team used precursors to the final flavor compounds, letting the chemistry happen during cooking."}
{"meta": {"doc_id": 2421, "sent_id": 38, "sent_start_pos": 6109, "sent_end_pos": 6978, "title": "Biochemistry of a burger"}, "text": "Flavor chemistry\nThe team at Impossible Foods set out to define a burger biochemically by heating grocery store ground beef and, with a gas chromatography system and a mass spectrometer, characterizing the products of the complex reactions that resulted as it cooked. Then, instead of trying to incorporate all the aromatic chemicals they identified into a veggie patty, Brown\u2019s team used precursors to the final flavor compounds, letting the chemistry happen during cooking. \u201cOne of the things that I think sets us apart,\u201d Kliman said, \u201cis that we really took the time to research meat on the molecular level and understand all the actual reactions that are happening and what the products are that are being created.\u201d\nAccording to most coverage of Impossible Foods, its scientists were the very first to take a reductionist approach to replicating the flavor of meat."}
{"meta": {"doc_id": 2421, "sent_id": 39, "sent_start_pos": 6377, "sent_end_pos": 7379, "title": "Biochemistry of a burger"}, "text": "Then, instead of trying to incorporate all the aromatic chemicals they identified into a veggie patty, Brown\u2019s team used precursors to the final flavor compounds, letting the chemistry happen during cooking. \u201cOne of the things that I think sets us apart,\u201d Kliman said, \u201cis that we really took the time to research meat on the molecular level and understand all the actual reactions that are happening and what the products are that are being created.\u201d\nAccording to most coverage of Impossible Foods, its scientists were the very first to take a reductionist approach to replicating the flavor of meat. An industry report for the National Cattlemen\u2019s Beef Association in 2006 summarizes a literature spanning decades of analytical chemistry work in numerous food science journals, most of which aimed to identify the most important flavor compounds in beef and determine what affected them; Brown and colleagues had a lot of background to work with."}
{"meta": {"doc_id": 2421, "sent_id": 40, "sent_start_pos": 6585, "sent_end_pos": 7492, "title": "Biochemistry of a burger"}, "text": "\u201cOne of the things that I think sets us apart,\u201d Kliman said, \u201cis that we really took the time to research meat on the molecular level and understand all the actual reactions that are happening and what the products are that are being created.\u201d\nAccording to most coverage of Impossible Foods, its scientists were the very first to take a reductionist approach to replicating the flavor of meat. An industry report for the National Cattlemen\u2019s Beef Association in 2006 summarizes a literature spanning decades of analytical chemistry work in numerous food science journals, most of which aimed to identify the most important flavor compounds in beef and determine what affected them; Brown and colleagues had a lot of background to work with. That report focused on optimizing husbandry, meat handling and processing practices to improve the final flavor."}
{"meta": {"doc_id": 2421, "sent_id": 41, "sent_start_pos": 7033, "sent_end_pos": 7622, "title": "Biochemistry of a burger"}, "text": "An industry report for the National Cattlemen\u2019s Beef Association in 2006 summarizes a literature spanning decades of analytical chemistry work in numerous food science journals, most of which aimed to identify the most important flavor compounds in beef and determine what affected them; Brown and colleagues had a lot of background to work with. That report focused on optimizing husbandry, meat handling and processing practices to improve the final flavor. But in other contexts, scientists have worked for years to develop additives based on a thorough understanding of meat chemistry."}
{"meta": {"doc_id": 2421, "sent_id": 42, "sent_start_pos": 7380, "sent_end_pos": 7772, "title": "Biochemistry of a burger"}, "text": "That report focused on optimizing husbandry, meat handling and processing practices to improve the final flavor. But in other contexts, scientists have worked for years to develop additives based on a thorough understanding of meat chemistry. As early as the 1960s, food companies like Procter and Gamble patented precursors that could give bland protein isolates a beefy flavor upon heating."}
{"meta": {"doc_id": 2421, "sent_id": 43, "sent_start_pos": 7493, "sent_end_pos": 7954, "title": "Biochemistry of a burger"}, "text": "But in other contexts, scientists have worked for years to develop additives based on a thorough understanding of meat chemistry. As early as the 1960s, food companies like Procter and Gamble patented precursors that could give bland protein isolates a beefy flavor upon heating. Chemists working to recreate beef flavors have long focused on two major types of reactions that occur when a piece of meat hits a hot grill: lipid oxidation and Maillard reactions."}
{"meta": {"doc_id": 2421, "sent_id": 44, "sent_start_pos": 7623, "sent_end_pos": 8085, "title": "Biochemistry of a burger"}, "text": "As early as the 1960s, food companies like Procter and Gamble patented precursors that could give bland protein isolates a beefy flavor upon heating. Chemists working to recreate beef flavors have long focused on two major types of reactions that occur when a piece of meat hits a hot grill: lipid oxidation and Maillard reactions. Lipid oxidation occurs when reactive oxygen species oxidize lipids, especially polyunsaturated fatty acids, at their double bonds."}
{"meta": {"doc_id": 2421, "sent_id": 45, "sent_start_pos": 7773, "sent_end_pos": 8244, "title": "Biochemistry of a burger"}, "text": "Chemists working to recreate beef flavors have long focused on two major types of reactions that occur when a piece of meat hits a hot grill: lipid oxidation and Maillard reactions. Lipid oxidation occurs when reactive oxygen species oxidize lipids, especially polyunsaturated fatty acids, at their double bonds. The reaction can generate low\u2013molecular-weight fission products and, sometimes, short-lived epoxide compounds; some of these taste appealing, but most do not."}
{"meta": {"doc_id": 2421, "sent_id": 46, "sent_start_pos": 7955, "sent_end_pos": 8325, "title": "Biochemistry of a burger"}, "text": "Lipid oxidation occurs when reactive oxygen species oxidize lipids, especially polyunsaturated fatty acids, at their double bonds. The reaction can generate low\u2013molecular-weight fission products and, sometimes, short-lived epoxide compounds; some of these taste appealing, but most do not. \u201cIron is the major problem in any (food) that undergoes oxidation,\u201d Decker said."}
{"meta": {"doc_id": 2421, "sent_id": 47, "sent_start_pos": 8086, "sent_end_pos": 8496, "title": "Biochemistry of a burger"}, "text": "The reaction can generate low\u2013molecular-weight fission products and, sometimes, short-lived epoxide compounds; some of these taste appealing, but most do not. \u201cIron is the major problem in any (food) that undergoes oxidation,\u201d Decker said. Either free or balanced in the aromatic, heterocyclic ring complex of heme, iron can catalyze oxidation of polyunsaturated fatty acids, resulting in a warmed-over flavor."}
{"meta": {"doc_id": 2421, "sent_id": 48, "sent_start_pos": 8245, "sent_end_pos": 8630, "title": "Biochemistry of a burger"}, "text": "\u201cIron is the major problem in any (food) that undergoes oxidation,\u201d Decker said. Either free or balanced in the aromatic, heterocyclic ring complex of heme, iron can catalyze oxidation of polyunsaturated fatty acids, resulting in a warmed-over flavor. Maillard reactions, the second major reaction family driving beef flavor, happen when an amino acid and a sugar are mixed and heated."}
{"meta": {"doc_id": 2421, "sent_id": 49, "sent_start_pos": 8326, "sent_end_pos": 8816, "title": "Biochemistry of a burger"}, "text": "Either free or balanced in the aromatic, heterocyclic ring complex of heme, iron can catalyze oxidation of polyunsaturated fatty acids, resulting in a warmed-over flavor. Maillard reactions, the second major reaction family driving beef flavor, happen when an amino acid and a sugar are mixed and heated. The reaction, an umbrella term for condensation between a nucleophilic amine and an electrophilic carbonyl, is important in cooking chemistry from browning pretzels to flavoring roasts."}
{"meta": {"doc_id": 2421, "sent_id": 50, "sent_start_pos": 8497, "sent_end_pos": 9034, "title": "Biochemistry of a burger"}, "text": "Maillard reactions, the second major reaction family driving beef flavor, happen when an amino acid and a sugar are mixed and heated. The reaction, an umbrella term for condensation between a nucleophilic amine and an electrophilic carbonyl, is important in cooking chemistry from browning pretzels to flavoring roasts. One of the best-studied Maillard reactions involved in flavoring meat takes place when ribose and cysteine are heated, creating a range of cyclic volatile compounds that contribute characteristic flavor notes to meat."}
{"meta": {"doc_id": 2421, "sent_id": 51, "sent_start_pos": 8631, "sent_end_pos": 9195, "title": "Biochemistry of a burger"}, "text": "The reaction, an umbrella term for condensation between a nucleophilic amine and an electrophilic carbonyl, is important in cooking chemistry from browning pretzels to flavoring roasts. One of the best-studied Maillard reactions involved in flavoring meat takes place when ribose and cysteine are heated, creating a range of cyclic volatile compounds that contribute characteristic flavor notes to meat. Hydrogen sulfide derived from cysteine plays an important role in making some of those compounds, catalyzing addition of sulfhydryl groups to reaction products."}
{"meta": {"doc_id": 2421, "sent_id": 52, "sent_start_pos": 8817, "sent_end_pos": 9412, "title": "Biochemistry of a burger"}, "text": "One of the best-studied Maillard reactions involved in flavoring meat takes place when ribose and cysteine are heated, creating a range of cyclic volatile compounds that contribute characteristic flavor notes to meat. Hydrogen sulfide derived from cysteine plays an important role in making some of those compounds, catalyzing addition of sulfhydryl groups to reaction products. But a key part of Impossible Foods\u2019 story is its discovery of a new effect of heme iron, which the company calls its \u201cmagic ingredient,\u201d on the flavor of meat."}
{"meta": {"doc_id": 2421, "sent_id": 53, "sent_start_pos": 9035, "sent_end_pos": 9578, "title": "Biochemistry of a burger"}, "text": "Hydrogen sulfide derived from cysteine plays an important role in making some of those compounds, catalyzing addition of sulfhydryl groups to reaction products. But a key part of Impossible Foods\u2019 story is its discovery of a new effect of heme iron, which the company calls its \u201cmagic ingredient,\u201d on the flavor of meat. \u201cBasically, that\u2019s just an assay \u2014 like radioactive thymidine incorporation in the early days of DNA replication."}
{"meta": {"doc_id": 2421, "sent_id": 54, "sent_start_pos": 9253, "sent_end_pos": 9679, "title": "Biochemistry of a burger"}, "text": "But a key part of Impossible Foods\u2019 story is its discovery of a new effect of heme iron, which the company calls its \u201cmagic ingredient,\u201d on the flavor of meat. \u201cBasically, that\u2019s just an assay \u2014 like radioactive thymidine incorporation in the early days of DNA replication. It\u2019s just an assay that tells you whether what you\u2019re trying to get to happen is actually happening."}
{"meta": {"doc_id": 2421, "sent_id": 55, "sent_start_pos": 9465, "sent_end_pos": 9896, "title": "Biochemistry of a burger"}, "text": "\u201cBasically, that\u2019s just an assay \u2014 like radioactive thymidine incorporation in the early days of DNA replication. It\u2019s just an assay that tells you whether what you\u2019re trying to get to happen is actually happening. And then, you deconstruct and reconstitute the biochemical system.\u201d\nIf a researcher heats a simple solution of cysteine and glucose, an Impossible Foods patent asserts, the product will have a faint rotten-egg smell."}
{"meta": {"doc_id": 2421, "sent_id": 56, "sent_start_pos": 9579, "sent_end_pos": 10036, "title": "Biochemistry of a burger"}, "text": "It\u2019s just an assay that tells you whether what you\u2019re trying to get to happen is actually happening. And then, you deconstruct and reconstitute the biochemical system.\u201d\nIf a researcher heats a simple solution of cysteine and glucose, an Impossible Foods patent asserts, the product will have a faint rotten-egg smell. Should that researcher add ferrous gluconate, which contains an iron cation similar to the one in heme, again the product smells sulfurous."}
{"meta": {"doc_id": 2421, "sent_id": 57, "sent_start_pos": 9680, "sent_end_pos": 10187, "title": "Biochemistry of a burger"}, "text": "And then, you deconstruct and reconstitute the biochemical system.\u201d\nIf a researcher heats a simple solution of cysteine and glucose, an Impossible Foods patent asserts, the product will have a faint rotten-egg smell. Should that researcher add ferrous gluconate, which contains an iron cation similar to the one in heme, again the product smells sulfurous. But replace the gluconate with a heme protein, and that unappetizing odor is replaced with smells that evoke chicken broth, burnt mushrooms and bread."}
{"meta": {"doc_id": 2421, "sent_id": 58, "sent_start_pos": 9897, "sent_end_pos": 10488, "title": "Biochemistry of a burger"}, "text": "Should that researcher add ferrous gluconate, which contains an iron cation similar to the one in heme, again the product smells sulfurous. But replace the gluconate with a heme protein, and that unappetizing odor is replaced with smells that evoke chicken broth, burnt mushrooms and bread. Given the odors mentioned in the patent, it\u2019s tempting to speculate that the answer may have something to do with interaction between heme and hydrogen sulfide derived from cysteine."}
{"meta": {"doc_id": 2421, "sent_id": 59, "sent_start_pos": 10037, "sent_end_pos": 10645, "title": "Biochemistry of a burger"}, "text": "But replace the gluconate with a heme protein, and that unappetizing odor is replaced with smells that evoke chicken broth, burnt mushrooms and bread. Given the odors mentioned in the patent, it\u2019s tempting to speculate that the answer may have something to do with interaction between heme and hydrogen sulfide derived from cysteine. According to Ruma Banerjee, whose lab at the University of Michigan Medical School studies hydrogen sulfide signaling, such speculation is not unreasonable."}
{"meta": {"doc_id": 2421, "sent_id": 60, "sent_start_pos": 10306, "sent_end_pos": 10844, "title": "Biochemistry of a burger"}, "text": "Given the odors mentioned in the patent, it\u2019s tempting to speculate that the answer may have something to do with interaction between heme and hydrogen sulfide derived from cysteine. According to Ruma Banerjee, whose lab at the University of Michigan Medical School studies hydrogen sulfide signaling, such speculation is not unreasonable. Banerjee\u2019s lab discovered that hemoglobin in red blood cells, which lack normal hydrogen sulfide turnover pathways, can oxidize hydrogen sulfide to generate more complex sulfur-containing molecules."}
{"meta": {"doc_id": 2421, "sent_id": 61, "sent_start_pos": 10489, "sent_end_pos": 10921, "title": "Biochemistry of a burger"}, "text": "According to Ruma Banerjee, whose lab at the University of Michigan Medical School studies hydrogen sulfide signaling, such speculation is not unreasonable. Banerjee\u2019s lab discovered that hemoglobin in red blood cells, which lack normal hydrogen sulfide turnover pathways, can oxidize hydrogen sulfide to generate more complex sulfur-containing molecules. \u201cThe biochemical evidence for this chemistry is very strong,\u201d Banerjee said."}
{"meta": {"doc_id": 2421, "sent_id": 62, "sent_start_pos": 10646, "sent_end_pos": 11184, "title": "Biochemistry of a burger"}, "text": "Banerjee\u2019s lab discovered that hemoglobin in red blood cells, which lack normal hydrogen sulfide turnover pathways, can oxidize hydrogen sulfide to generate more complex sulfur-containing molecules. \u201cThe biochemical evidence for this chemistry is very strong,\u201d Banerjee said. \u201cIt\u2019s not just reversible binding; the sulfide is actually transformed by the heme in air to oxidized products.\u201d\nPerhaps such catalysis is part of how heme diminishes the off-putting odors and promotes more palatable flavors in the simple two-ingredient mixture."}
{"meta": {"doc_id": 2421, "sent_id": 63, "sent_start_pos": 10845, "sent_end_pos": 11352, "title": "Biochemistry of a burger"}, "text": "\u201cThe biochemical evidence for this chemistry is very strong,\u201d Banerjee said. \u201cIt\u2019s not just reversible binding; the sulfide is actually transformed by the heme in air to oxidized products.\u201d\nPerhaps such catalysis is part of how heme diminishes the off-putting odors and promotes more palatable flavors in the simple two-ingredient mixture. By adding additional molecules \u2014 ribose, thiamine, various amino acids and lipids \u2014 the researcher can make the product both more complex and more reminiscent of meat."}
{"meta": {"doc_id": 2421, "sent_id": 64, "sent_start_pos": 10922, "sent_end_pos": 11418, "title": "Biochemistry of a burger"}, "text": "\u201cIt\u2019s not just reversible binding; the sulfide is actually transformed by the heme in air to oxidized products.\u201d\nPerhaps such catalysis is part of how heme diminishes the off-putting odors and promotes more palatable flavors in the simple two-ingredient mixture. By adding additional molecules \u2014 ribose, thiamine, various amino acids and lipids \u2014 the researcher can make the product both more complex and more reminiscent of meat. This, in essence, is the approach the Impossible Foods team took."}
{"meta": {"doc_id": 2421, "sent_id": 65, "sent_start_pos": 11185, "sent_end_pos": 11612, "title": "Biochemistry of a burger"}, "text": "By adding additional molecules \u2014 ribose, thiamine, various amino acids and lipids \u2014 the researcher can make the product both more complex and more reminiscent of meat. This, in essence, is the approach the Impossible Foods team took. A patent describes a mixture of amino acids, sugars and metabolites titrated to match meat tissue; when heated with leghemoglobin, it enables the key reactions that build a meat flavor profile."}
{"meta": {"doc_id": 2421, "sent_id": 66, "sent_start_pos": 11353, "sent_end_pos": 11791, "title": "Biochemistry of a burger"}, "text": "This, in essence, is the approach the Impossible Foods team took. A patent describes a mixture of amino acids, sugars and metabolites titrated to match meat tissue; when heated with leghemoglobin, it enables the key reactions that build a meat flavor profile. Meanwhile, according to Decker, levels of polyunsaturated fats are lower in the Impossible Burger than in meat, which may prevent the added heme from boosting unpleasant flavors."}
{"meta": {"doc_id": 2421, "sent_id": 67, "sent_start_pos": 11419, "sent_end_pos": 11950, "title": "Biochemistry of a burger"}, "text": "A patent describes a mixture of amino acids, sugars and metabolites titrated to match meat tissue; when heated with leghemoglobin, it enables the key reactions that build a meat flavor profile. Meanwhile, according to Decker, levels of polyunsaturated fats are lower in the Impossible Burger than in meat, which may prevent the added heme from boosting unpleasant flavors. But applying insights from a simple mixture of two or three ingredients to the complex chemical and material mixture in a vegetable patty is a difficult task."}
{"meta": {"doc_id": 2421, "sent_id": 68, "sent_start_pos": 11613, "sent_end_pos": 12029, "title": "Biochemistry of a burger"}, "text": "Meanwhile, according to Decker, levels of polyunsaturated fats are lower in the Impossible Burger than in meat, which may prevent the added heme from boosting unpleasant flavors. But applying insights from a simple mixture of two or three ingredients to the complex chemical and material mixture in a vegetable patty is a difficult task. \u201cAs an organic chemist, you have so much control over what\u2019s in your reaction."}
{"meta": {"doc_id": 2421, "sent_id": 69, "sent_start_pos": 11792, "sent_end_pos": 12379, "title": "Biochemistry of a burger"}, "text": "But applying insights from a simple mixture of two or three ingredients to the complex chemical and material mixture in a vegetable patty is a difficult task. \u201cAs an organic chemist, you have so much control over what\u2019s in your reaction. \u201cThere are so many reactions that it\u2019s hard to track them all and to know what products are being produced from what sort of precursors.\u201d\nGlobins without animals\nWhen characterizing meat, Brown said, \u201cThe thesis was that there\u2019s absolutely nothing that was required that was specific to animals."}
{"meta": {"doc_id": 2421, "sent_id": 70, "sent_start_pos": 11951, "sent_end_pos": 12558, "title": "Biochemistry of a burger"}, "text": "\u201cAs an organic chemist, you have so much control over what\u2019s in your reaction. \u201cThere are so many reactions that it\u2019s hard to track them all and to know what products are being produced from what sort of precursors.\u201d\nGlobins without animals\nWhen characterizing meat, Brown said, \u201cThe thesis was that there\u2019s absolutely nothing that was required that was specific to animals. It turned out to be right, which was good.\u201d\nBrown thought he knew a good place to harvest heme without killing an animal: the root nodules of legumes."}
{"meta": {"doc_id": 2421, "sent_id": 71, "sent_start_pos": 12084, "sent_end_pos": 12733, "title": "Biochemistry of a burger"}, "text": "\u201cThere are so many reactions that it\u2019s hard to track them all and to know what products are being produced from what sort of precursors.\u201d\nGlobins without animals\nWhen characterizing meat, Brown said, \u201cThe thesis was that there\u2019s absolutely nothing that was required that was specific to animals. It turned out to be right, which was good.\u201d\nBrown thought he knew a good place to harvest heme without killing an animal: the root nodules of legumes. Sharon Long, a colleague on the biochemistry faculty at Stanford, studied these tiny hotbeds of nitrogen fixation, and Brown was familiar with their iron-rich microecosystem."}
{"meta": {"doc_id": 2421, "sent_id": 72, "sent_start_pos": 12408, "sent_end_pos": 13033, "title": "Biochemistry of a burger"}, "text": "It turned out to be right, which was good.\u201d\nBrown thought he knew a good place to harvest heme without killing an animal: the root nodules of legumes. Sharon Long, a colleague on the biochemistry faculty at Stanford, studied these tiny hotbeds of nitrogen fixation, and Brown was familiar with their iron-rich microecosystem. \u201cWe spent quite a lot of money and quite a large fraction of our time in the first year and a half on this quest to figure out a way to harvest root nodules \u2026 and creating all these kind of Rube Goldberg contraptions,\u201d Brown said in a podcast with the American Society for Microbiology\u2019s Julie Wolf."}
{"meta": {"doc_id": 2421, "sent_id": 73, "sent_start_pos": 12559, "sent_end_pos": 13181, "title": "Biochemistry of a burger"}, "text": "Sharon Long, a colleague on the biochemistry faculty at Stanford, studied these tiny hotbeds of nitrogen fixation, and Brown was familiar with their iron-rich microecosystem. \u201cWe spent quite a lot of money and quite a large fraction of our time in the first year and a half on this quest to figure out a way to harvest root nodules \u2026 and creating all these kind of Rube Goldberg contraptions,\u201d Brown said in a podcast with the American Society for Microbiology\u2019s Julie Wolf. It turned out that harvesting and cleaning root nodules and extracting their leghemoglobin, while possible, was impractical at an industrial scale."}
{"meta": {"doc_id": 2421, "sent_id": 74, "sent_start_pos": 12734, "sent_end_pos": 13421, "title": "Biochemistry of a burger"}, "text": "\u201cWe spent quite a lot of money and quite a large fraction of our time in the first year and a half on this quest to figure out a way to harvest root nodules \u2026 and creating all these kind of Rube Goldberg contraptions,\u201d Brown said in a podcast with the American Society for Microbiology\u2019s Julie Wolf. It turned out that harvesting and cleaning root nodules and extracting their leghemoglobin, while possible, was impractical at an industrial scale. Constant optimization\nThough heme as a magic molecule is key to the company\u2019s brand narrative, Brown often stresses that there\u2019s more to an Impossible Burger than that."}
{"meta": {"doc_id": 2421, "sent_id": 75, "sent_start_pos": 13034, "sent_end_pos": 13515, "title": "Biochemistry of a burger"}, "text": "It turned out that harvesting and cleaning root nodules and extracting their leghemoglobin, while possible, was impractical at an industrial scale. Constant optimization\nThough heme as a magic molecule is key to the company\u2019s brand narrative, Brown often stresses that there\u2019s more to an Impossible Burger than that. \u201cIf you\u2019ve nailed the flavor chemistry and nothing else, well, you have beef broth,\u201d he said."}
{"meta": {"doc_id": 2421, "sent_id": 76, "sent_start_pos": 13253, "sent_end_pos": 13602, "title": "Biochemistry of a burger"}, "text": "Constant optimization\nThough heme as a magic molecule is key to the company\u2019s brand narrative, Brown often stresses that there\u2019s more to an Impossible Burger than that. \u201cIf you\u2019ve nailed the flavor chemistry and nothing else, well, you have beef broth,\u201d he said. \u201cAnd if you\u2019ve nailed the texture, and you don\u2019t have the flavor, you have crab cakes."}
{"meta": {"doc_id": 2421, "sent_id": 77, "sent_start_pos": 13422, "sent_end_pos": 13798, "title": "Biochemistry of a burger"}, "text": "\u201cIf you\u2019ve nailed the flavor chemistry and nothing else, well, you have beef broth,\u201d he said. \u201cAnd if you\u2019ve nailed the texture, and you don\u2019t have the flavor, you have crab cakes. \u2026 Basically, the more progress we make on one dimension, the more we think, \u2018Oh, we\u2019ve gotta make more progress on the next.\u2019\u201d\nThe first prototype ranked somewhere below crab cakes or beef broth."}
{"meta": {"doc_id": 2421, "sent_id": 78, "sent_start_pos": 13516, "sent_end_pos": 13912, "title": "Biochemistry of a burger"}, "text": "\u201cAnd if you\u2019ve nailed the texture, and you don\u2019t have the flavor, you have crab cakes. \u2026 Basically, the more progress we make on one dimension, the more we think, \u2018Oh, we\u2019ve gotta make more progress on the next.\u2019\u201d\nThe first prototype ranked somewhere below crab cakes or beef broth. Supertasters on staff compared it to \u201crancid polenta.\u201d But, according to Brown, improvement was swift after that."}
{"meta": {"doc_id": 2421, "sent_id": 79, "sent_start_pos": 13603, "sent_end_pos": 14010, "title": "Biochemistry of a burger"}, "text": "\u2026 Basically, the more progress we make on one dimension, the more we think, \u2018Oh, we\u2019ve gotta make more progress on the next.\u2019\u201d\nThe first prototype ranked somewhere below crab cakes or beef broth. Supertasters on staff compared it to \u201crancid polenta.\u201d But, according to Brown, improvement was swift after that. This is part of the company\u2019s mindset; a perfect reproduction of ground beef is not its end goal."}
{"meta": {"doc_id": 2421, "sent_id": 80, "sent_start_pos": 13799, "sent_end_pos": 14148, "title": "Biochemistry of a burger"}, "text": "Supertasters on staff compared it to \u201crancid polenta.\u201d But, according to Brown, improvement was swift after that. This is part of the company\u2019s mindset; a perfect reproduction of ground beef is not its end goal. If chemists can improve on the eating experience, producing something with fewer off flavors or a more palatable texture, then they will."}
{"meta": {"doc_id": 2421, "sent_id": 81, "sent_start_pos": 13913, "sent_end_pos": 14259, "title": "Biochemistry of a burger"}, "text": "This is part of the company\u2019s mindset; a perfect reproduction of ground beef is not its end goal. If chemists can improve on the eating experience, producing something with fewer off flavors or a more palatable texture, then they will. \u201cIn a certain sense, we\u2019ll declare victory when the incumbent industry is in the rearview mirror,\u201d Brown said."}
{"meta": {"doc_id": 2421, "sent_id": 82, "sent_start_pos": 14011, "sent_end_pos": 14439, "title": "Biochemistry of a burger"}, "text": "If chemists can improve on the eating experience, producing something with fewer off flavors or a more palatable texture, then they will. \u201cIn a certain sense, we\u2019ll declare victory when the incumbent industry is in the rearview mirror,\u201d Brown said. \u201cBut, on the other hand, to the extent that we can make people happier and our product more affordable and versatile and food secure, we\u2019re going to just keep working and working."}
{"meta": {"doc_id": 2421, "sent_id": 83, "sent_start_pos": 14149, "sent_end_pos": 14661, "title": "Biochemistry of a burger"}, "text": "\u201cIn a certain sense, we\u2019ll declare victory when the incumbent industry is in the rearview mirror,\u201d Brown said. \u201cBut, on the other hand, to the extent that we can make people happier and our product more affordable and versatile and food secure, we\u2019re going to just keep working and working. I\u2019m not sure whether it will ever end.\u201d\nProduction problems\nThis year, Impossible Foods introduced a new formulation that chefs say is a better match for beef, but the company was also hindered by its own runaway success."}
{"meta": {"doc_id": 2421, "sent_id": 84, "sent_start_pos": 14260, "sent_end_pos": 14785, "title": "Biochemistry of a burger"}, "text": "\u201cBut, on the other hand, to the extent that we can make people happier and our product more affordable and versatile and food secure, we\u2019re going to just keep working and working. I\u2019m not sure whether it will ever end.\u201d\nProduction problems\nThis year, Impossible Foods introduced a new formulation that chefs say is a better match for beef, but the company was also hindered by its own runaway success. After launching the new recipe, this spring the company became unable to keep up with accelerating demand for its products."}
{"meta": {"doc_id": 2421, "sent_id": 85, "sent_start_pos": 14440, "sent_end_pos": 14892, "title": "Biochemistry of a burger"}, "text": "I\u2019m not sure whether it will ever end.\u201d\nProduction problems\nThis year, Impossible Foods introduced a new formulation that chefs say is a better match for beef, but the company was also hindered by its own runaway success. After launching the new recipe, this spring the company became unable to keep up with accelerating demand for its products. The timing was unfortunate; the company was in the midst of a regional pilot partnership with Burger King."}
{"meta": {"doc_id": 2421, "sent_id": 86, "sent_start_pos": 14662, "sent_end_pos": 15112, "title": "Biochemistry of a burger"}, "text": "After launching the new recipe, this spring the company became unable to keep up with accelerating demand for its products. The timing was unfortunate; the company was in the midst of a regional pilot partnership with Burger King. Brown told The New York Times that the company\u2019s efforts to scale up production had been \u201clike changing the tires while driving down the freeway.\u201d\nTalking to ASBMB Today, he elaborated on their reaction to the shortage."}
{"meta": {"doc_id": 2421, "sent_id": 87, "sent_start_pos": 14786, "sent_end_pos": 15384, "title": "Biochemistry of a burger"}, "text": "The timing was unfortunate; the company was in the midst of a regional pilot partnership with Burger King. Brown told The New York Times that the company\u2019s efforts to scale up production had been \u201clike changing the tires while driving down the freeway.\u201d\nTalking to ASBMB Today, he elaborated on their reaction to the shortage. \u201cWhen we realized that manufacturing was limiting, I sent out a call to everybody in our R&D facility operation, basically saying, \u2018OK, I need volunteers to work 12-hour shifts that either start or end at 3 am, just doing whatever it takes in a room that\u2019s 37 Fahrenheit."}
{"meta": {"doc_id": 2421, "sent_id": 88, "sent_start_pos": 14893, "sent_end_pos": 15561, "title": "Biochemistry of a burger"}, "text": "Brown told The New York Times that the company\u2019s efforts to scale up production had been \u201clike changing the tires while driving down the freeway.\u201d\nTalking to ASBMB Today, he elaborated on their reaction to the shortage. \u201cWhen we realized that manufacturing was limiting, I sent out a call to everybody in our R&D facility operation, basically saying, \u2018OK, I need volunteers to work 12-hour shifts that either start or end at 3 am, just doing whatever it takes in a room that\u2019s 37 Fahrenheit. And it\u2019s across the (San Francisco) Bay.\u2019 And within 24 hours, a hundred people had volunteered.\u201d\nHe tells the story with evident pride in his team\u2019s dedication to the mission."}
{"meta": {"doc_id": 2421, "sent_id": 89, "sent_start_pos": 15113, "sent_end_pos": 15777, "title": "Biochemistry of a burger"}, "text": "\u201cWhen we realized that manufacturing was limiting, I sent out a call to everybody in our R&D facility operation, basically saying, \u2018OK, I need volunteers to work 12-hour shifts that either start or end at 3 am, just doing whatever it takes in a room that\u2019s 37 Fahrenheit. And it\u2019s across the (San Francisco) Bay.\u2019 And within 24 hours, a hundred people had volunteered.\u201d\nHe tells the story with evident pride in his team\u2019s dedication to the mission. On the website Glassdoor, where workers can post reviews of their employers, anonymous posts reveal mixed feelings about the company\u2019s monthslong production sprint, and several note a lack of food industry know-how."}
{"meta": {"doc_id": 2421, "sent_id": 90, "sent_start_pos": 15385, "sent_end_pos": 15970, "title": "Biochemistry of a burger"}, "text": "And it\u2019s across the (San Francisco) Bay.\u2019 And within 24 hours, a hundred people had volunteered.\u201d\nHe tells the story with evident pride in his team\u2019s dedication to the mission. On the website Glassdoor, where workers can post reviews of their employers, anonymous posts reveal mixed feelings about the company\u2019s monthslong production sprint, and several note a lack of food industry know-how. Kliman, the flavor scientist, said, \u201cIn an academic lab \u2014 this is sort of a sweeping generalization \u2014 you have a lot of time, and you have almost no money."}
{"meta": {"doc_id": 2421, "sent_id": 91, "sent_start_pos": 15562, "sent_end_pos": 16117, "title": "Biochemistry of a burger"}, "text": "On the website Glassdoor, where workers can post reviews of their employers, anonymous posts reveal mixed feelings about the company\u2019s monthslong production sprint, and several note a lack of food industry know-how. Kliman, the flavor scientist, said, \u201cIn an academic lab \u2014 this is sort of a sweeping generalization \u2014 you have a lot of time, and you have almost no money. In an industry (lab), let\u2019s say pharma, it\u2019s very much about the bottom line, and time is money."}
{"meta": {"doc_id": 2421, "sent_id": 92, "sent_start_pos": 15815, "sent_end_pos": 16265, "title": "Biochemistry of a burger"}, "text": "Kliman, the flavor scientist, said, \u201cIn an academic lab \u2014 this is sort of a sweeping generalization \u2014 you have a lot of time, and you have almost no money. In an industry (lab), let\u2019s say pharma, it\u2019s very much about the bottom line, and time is money. Here at Impossible, it\u2019s like the best of both worlds,\u201d with a dual focus on optimizing the company\u2019s products and contributing ideas for new ones."}
{"meta": {"doc_id": 2421, "sent_id": 93, "sent_start_pos": 16021, "sent_end_pos": 16393, "title": "Biochemistry of a burger"}, "text": "In an industry (lab), let\u2019s say pharma, it\u2019s very much about the bottom line, and time is money. Here at Impossible, it\u2019s like the best of both worlds,\u201d with a dual focus on optimizing the company\u2019s products and contributing ideas for new ones. She cited periodic innovation weeks when the research and development team spends all its time trying new ideas or experiments."}
{"meta": {"doc_id": 2421, "sent_id": 94, "sent_start_pos": 16118, "sent_end_pos": 16561, "title": "Biochemistry of a burger"}, "text": "Here at Impossible, it\u2019s like the best of both worlds,\u201d with a dual focus on optimizing the company\u2019s products and contributing ideas for new ones. She cited periodic innovation weeks when the research and development team spends all its time trying new ideas or experiments. In April, Impossible Foods hired Dennis Woodside, a lawyer by training with some 16 years of corporate leadership experience, into the newly created role of president."}
{"meta": {"doc_id": 2421, "sent_id": 95, "sent_start_pos": 16266, "sent_end_pos": 16717, "title": "Biochemistry of a burger"}, "text": "She cited periodic innovation weeks when the research and development team spends all its time trying new ideas or experiments. In April, Impossible Foods hired Dennis Woodside, a lawyer by training with some 16 years of corporate leadership experience, into the newly created role of president. Having a president, Brown said in June, would free him up to focus on future innovations \u2014 as soon as the company caught up to its manufacturing shortfall."}
{"meta": {"doc_id": 2421, "sent_id": 96, "sent_start_pos": 16394, "sent_end_pos": 16856, "title": "Biochemistry of a burger"}, "text": "In April, Impossible Foods hired Dennis Woodside, a lawyer by training with some 16 years of corporate leadership experience, into the newly created role of president. Having a president, Brown said in June, would free him up to focus on future innovations \u2014 as soon as the company caught up to its manufacturing shortfall. \u201cI want to spend a lot more time on R&D, but even our R&D team are all hands on deck trying to get this manufacturing caught up,\u201d he said."}
{"meta": {"doc_id": 2421, "sent_id": 97, "sent_start_pos": 16562, "sent_end_pos": 16979, "title": "Biochemistry of a burger"}, "text": "Having a president, Brown said in June, would free him up to focus on future innovations \u2014 as soon as the company caught up to its manufacturing shortfall. \u201cI want to spend a lot more time on R&D, but even our R&D team are all hands on deck trying to get this manufacturing caught up,\u201d he said. In July, the company declared an end to the shortage and announced its plans to open a second production plant in Chicago."}
{"meta": {"doc_id": 2421, "sent_id": 98, "sent_start_pos": 16718, "sent_end_pos": 17113, "title": "Biochemistry of a burger"}, "text": "\u201cI want to spend a lot more time on R&D, but even our R&D team are all hands on deck trying to get this manufacturing caught up,\u201d he said. In July, the company declared an end to the shortage and announced its plans to open a second production plant in Chicago. Changing the meat industry\nFor the Impossible Foods plan to succeed, ranching needs to go from marginally profitable to losing money."}
{"meta": {"doc_id": 2421, "sent_id": 99, "sent_start_pos": 16857, "sent_end_pos": 17237, "title": "Biochemistry of a burger"}, "text": "In July, the company declared an end to the shortage and announced its plans to open a second production plant in Chicago. Changing the meat industry\nFor the Impossible Foods plan to succeed, ranching needs to go from marginally profitable to losing money. This is not at all popular in the beef industry, which has lobbied for restrictions on marketing plant-based foods as meat."}
{"meta": {"doc_id": 2421, "sent_id": 100, "sent_start_pos": 16980, "sent_end_pos": 17327, "title": "Biochemistry of a burger"}, "text": "Changing the meat industry\nFor the Impossible Foods plan to succeed, ranching needs to go from marginally profitable to losing money. This is not at all popular in the beef industry, which has lobbied for restrictions on marketing plant-based foods as meat. The product, on the other hand, is growing in popularity \u2014 and improving as a substitute."}
{"meta": {"doc_id": 2421, "sent_id": 101, "sent_start_pos": 17114, "sent_end_pos": 17436, "title": "Biochemistry of a burger"}, "text": "This is not at all popular in the beef industry, which has lobbied for restrictions on marketing plant-based foods as meat. The product, on the other hand, is growing in popularity \u2014 and improving as a substitute. According to market analyses, in 2019 plant-based meat is a $12 billion industry, and it\u2019s expected to grow."}
{"meta": {"doc_id": 2421, "sent_id": 102, "sent_start_pos": 17238, "sent_end_pos": 17515, "title": "Biochemistry of a burger"}, "text": "The product, on the other hand, is growing in popularity \u2014 and improving as a substitute. According to market analyses, in 2019 plant-based meat is a $12 billion industry, and it\u2019s expected to grow. Impossible Foods, which is privately owned, does not report its sales figures."}
{"meta": {"doc_id": 2421, "sent_id": 103, "sent_start_pos": 17328, "sent_end_pos": 17620, "title": "Biochemistry of a burger"}, "text": "According to market analyses, in 2019 plant-based meat is a $12 billion industry, and it\u2019s expected to grow. Impossible Foods, which is privately owned, does not report its sales figures. But its closest competitor, Beyond Meat, reported that its revenues more than doubled from 2017 to 2018."}
{"meta": {"doc_id": 2421, "sent_id": 104, "sent_start_pos": 17437, "sent_end_pos": 17726, "title": "Biochemistry of a burger"}, "text": "Impossible Foods, which is privately owned, does not report its sales figures. But its closest competitor, Beyond Meat, reported that its revenues more than doubled from 2017 to 2018. In light of that reality, more of the food industry is beginning to adopt plant-based protein production."}
{"meta": {"doc_id": 2421, "sent_id": 105, "sent_start_pos": 17516, "sent_end_pos": 17926, "title": "Biochemistry of a burger"}, "text": "But its closest competitor, Beyond Meat, reported that its revenues more than doubled from 2017 to 2018. In light of that reality, more of the food industry is beginning to adopt plant-based protein production. This year, Tyson Foods, the largest meat company in the United States, appointed a vice president for alternative proteins and sustainability and announced a new brand that\u2019s set to launch this fall."}
{"meta": {"doc_id": 2421, "sent_id": 106, "sent_start_pos": 17621, "sent_end_pos": 18146, "title": "Biochemistry of a burger"}, "text": "In light of that reality, more of the food industry is beginning to adopt plant-based protein production. This year, Tyson Foods, the largest meat company in the United States, appointed a vice president for alternative proteins and sustainability and announced a new brand that\u2019s set to launch this fall. Even legacy companies like Morningstar Farms, which has been making plant-based protein foods for 40 years, have introduced new faux meats that seek to compete more successfully against Impossible Foods and Beyond Meat."}
{"meta": {"doc_id": 2421, "sent_id": 107, "sent_start_pos": 17727, "sent_end_pos": 18304, "title": "Biochemistry of a burger"}, "text": "This year, Tyson Foods, the largest meat company in the United States, appointed a vice president for alternative proteins and sustainability and announced a new brand that\u2019s set to launch this fall. Even legacy companies like Morningstar Farms, which has been making plant-based protein foods for 40 years, have introduced new faux meats that seek to compete more successfully against Impossible Foods and Beyond Meat. Somewhat upstream from burger production, ingredient companies are aiming to catch the plant-based meat wave by providing pure protein and other ingredients."}
{"meta": {"doc_id": 2421, "sent_id": 108, "sent_start_pos": 17927, "sent_end_pos": 18439, "title": "Biochemistry of a burger"}, "text": "Even legacy companies like Morningstar Farms, which has been making plant-based protein foods for 40 years, have introduced new faux meats that seek to compete more successfully against Impossible Foods and Beyond Meat. Somewhat upstream from burger production, ingredient companies are aiming to catch the plant-based meat wave by providing pure protein and other ingredients. For example, Motif is a Boston startup that focuses on using biotechnology methods to produce components other food companies can use."}
{"meta": {"doc_id": 2421, "sent_id": 109, "sent_start_pos": 18147, "sent_end_pos": 18582, "title": "Biochemistry of a burger"}, "text": "Somewhat upstream from burger production, ingredient companies are aiming to catch the plant-based meat wave by providing pure protein and other ingredients. For example, Motif is a Boston startup that focuses on using biotechnology methods to produce components other food companies can use. \u201cMotif is somewhat unique in that they\u2019re taking a synthetic biology or recombinant biology approach to creating new ingredients,\u201d Welch said."}
{"meta": {"doc_id": 2421, "sent_id": 110, "sent_start_pos": 18305, "sent_end_pos": 18698, "title": "Biochemistry of a burger"}, "text": "For example, Motif is a Boston startup that focuses on using biotechnology methods to produce components other food companies can use. \u201cMotif is somewhat unique in that they\u2019re taking a synthetic biology or recombinant biology approach to creating new ingredients,\u201d Welch said. The approach is similar to the way Impossible Foods generated a yeast strain to produce soy leghemoglobin at scale."}
{"meta": {"doc_id": 2421, "sent_id": 111, "sent_start_pos": 18440, "sent_end_pos": 18807, "title": "Biochemistry of a burger"}, "text": "\u201cMotif is somewhat unique in that they\u2019re taking a synthetic biology or recombinant biology approach to creating new ingredients,\u201d Welch said. The approach is similar to the way Impossible Foods generated a yeast strain to produce soy leghemoglobin at scale. Welch said that Motif is trying to do similar things with other possible ingredients, such as milk proteins."}
{"meta": {"doc_id": 2421, "sent_id": 112, "sent_start_pos": 18583, "sent_end_pos": 18917, "title": "Biochemistry of a burger"}, "text": "The approach is similar to the way Impossible Foods generated a yeast strain to produce soy leghemoglobin at scale. Welch said that Motif is trying to do similar things with other possible ingredients, such as milk proteins. There\u2019s also some evidence that the surge in popularity of plant-based meat is changing American crop fields."}
{"meta": {"doc_id": 2421, "sent_id": 113, "sent_start_pos": 18699, "sent_end_pos": 18978, "title": "Biochemistry of a burger"}, "text": "Welch said that Motif is trying to do similar things with other possible ingredients, such as milk proteins. There\u2019s also some evidence that the surge in popularity of plant-based meat is changing American crop fields. \u201cWe\u2019re starting to see some examples of it now,\u201d Welch said."}
{"meta": {"doc_id": 2421, "sent_id": 114, "sent_start_pos": 18808, "sent_end_pos": 19260, "title": "Biochemistry of a burger"}, "text": "There\u2019s also some evidence that the surge in popularity of plant-based meat is changing American crop fields. \u201cWe\u2019re starting to see some examples of it now,\u201d Welch said. \u201cI think, in the future, we\u2019ll see more examples of crops being grown that are specifically bred for plant-based meat applications.\u201d\nProtein foods for the future\nWith characteristic confidence, Brown has moved on to making plans to further redefine the food industry of the future."}
{"meta": {"doc_id": 2421, "sent_id": 115, "sent_start_pos": 18918, "sent_end_pos": 19431, "title": "Biochemistry of a burger"}, "text": "\u201cWe\u2019re starting to see some examples of it now,\u201d Welch said. \u201cI think, in the future, we\u2019ll see more examples of crops being grown that are specifically bred for plant-based meat applications.\u201d\nProtein foods for the future\nWith characteristic confidence, Brown has moved on to making plans to further redefine the food industry of the future. \u201cIf the technology we develop is used to produce a significant fraction of the world\u2019s food supply and protein and so forth, it\u2019s a huge responsibility,\u201d he said in June."}
{"meta": {"doc_id": 2421, "sent_id": 116, "sent_start_pos": 18979, "sent_end_pos": 19684, "title": "Biochemistry of a burger"}, "text": "\u201cI think, in the future, we\u2019ll see more examples of crops being grown that are specifically bred for plant-based meat applications.\u201d\nProtein foods for the future\nWith characteristic confidence, Brown has moved on to making plans to further redefine the food industry of the future. \u201cIf the technology we develop is used to produce a significant fraction of the world\u2019s food supply and protein and so forth, it\u2019s a huge responsibility,\u201d he said in June. \u201cImpossible Foods the company is not going to be responsible for all of that \u2014 but we\u2019re developing the technology to enable (it).\u201d\nThe company has announced that prototypes of chicken, fish and even eggs, all made without animal products, are in hand."}
{"meta": {"doc_id": 2421, "sent_id": 117, "sent_start_pos": 19261, "sent_end_pos": 19792, "title": "Biochemistry of a burger"}, "text": "\u201cIf the technology we develop is used to produce a significant fraction of the world\u2019s food supply and protein and so forth, it\u2019s a huge responsibility,\u201d he said in June. \u201cImpossible Foods the company is not going to be responsible for all of that \u2014 but we\u2019re developing the technology to enable (it).\u201d\nThe company has announced that prototypes of chicken, fish and even eggs, all made without animal products, are in hand. Meanwhile, a crop of smaller competitors also are developing and introducing their replicas of those foods."}
{"meta": {"doc_id": 2421, "sent_id": 118, "sent_start_pos": 19432, "sent_end_pos": 19871, "title": "Biochemistry of a burger"}, "text": "\u201cImpossible Foods the company is not going to be responsible for all of that \u2014 but we\u2019re developing the technology to enable (it).\u201d\nThe company has announced that prototypes of chicken, fish and even eggs, all made without animal products, are in hand. Meanwhile, a crop of smaller competitors also are developing and introducing their replicas of those foods. Now, Brown is thinking about what plant ingredients to use as source material."}
{"meta": {"doc_id": 2421, "sent_id": 119, "sent_start_pos": 19685, "sent_end_pos": 20068, "title": "Biochemistry of a burger"}, "text": "Meanwhile, a crop of smaller competitors also are developing and introducing their replicas of those foods. Now, Brown is thinking about what plant ingredients to use as source material. One possibility that seems to have caught his imagination \u2014 lately he has volunteered it a lot in interviews \u2014 is to replace plant-derived protein from grains and legumes with protein from leaves."}
{"meta": {"doc_id": 2421, "sent_id": 120, "sent_start_pos": 19793, "sent_end_pos": 20234, "title": "Biochemistry of a burger"}, "text": "Now, Brown is thinking about what plant ingredients to use as source material. One possibility that seems to have caught his imagination \u2014 lately he has volunteered it a lot in interviews \u2014 is to replace plant-derived protein from grains and legumes with protein from leaves. Impossible Foods has patented an approach to purify the protein rubisco in bulk from the leavealfs of alfa, a crop presently used for animal fodder, or other plants."}
{"meta": {"doc_id": 2421, "sent_id": 121, "sent_start_pos": 19872, "sent_end_pos": 20388, "title": "Biochemistry of a burger"}, "text": "One possibility that seems to have caught his imagination \u2014 lately he has volunteered it a lot in interviews \u2014 is to replace plant-derived protein from grains and legumes with protein from leaves. Impossible Foods has patented an approach to purify the protein rubisco in bulk from the leavealfs of alfa, a crop presently used for animal fodder, or other plants. But according to David Welch, the protein feedstocks of the future are as likely to be generated from bacteria, algae or fungi as from traditional crops."}
{"meta": {"doc_id": 2421, "sent_id": 122, "sent_start_pos": 20069, "sent_end_pos": 20707, "title": "Biochemistry of a burger"}, "text": "Impossible Foods has patented an approach to purify the protein rubisco in bulk from the leavealfs of alfa, a crop presently used for animal fodder, or other plants. But according to David Welch, the protein feedstocks of the future are as likely to be generated from bacteria, algae or fungi as from traditional crops. \u201cAnything you can think of to generate a plant-based protein, or other sorts of nutrients and ingredients, we\u2019re interested in looking at that and seeing if we can turn it into something amazing.\u201d\n\u201cPeople are always telling me, \u2018You\u2019ve got to focus more,\u2019\u201d Brown said."}
{"meta": {"doc_id": 2421, "sent_id": 123, "sent_start_pos": 20235, "sent_end_pos": 20871, "title": "Biochemistry of a burger"}, "text": "But according to David Welch, the protein feedstocks of the future are as likely to be generated from bacteria, algae or fungi as from traditional crops. \u201cAnything you can think of to generate a plant-based protein, or other sorts of nutrients and ingredients, we\u2019re interested in looking at that and seeing if we can turn it into something amazing.\u201d\n\u201cPeople are always telling me, \u2018You\u2019ve got to focus more,\u2019\u201d Brown said. \u201cAnd I feel like being unfocused is incredibly valuable \u2026 when you know where you want to go, but there\u2019s no road map, and you have to figure out how to get there."}
{"meta": {"doc_id": 2421, "sent_id": 124, "sent_start_pos": 20439, "sent_end_pos": 21004, "title": "Biochemistry of a burger"}, "text": "\u201cAnything you can think of to generate a plant-based protein, or other sorts of nutrients and ingredients, we\u2019re interested in looking at that and seeing if we can turn it into something amazing.\u201d\n\u201cPeople are always telling me, \u2018You\u2019ve got to focus more,\u2019\u201d Brown said. \u201cAnd I feel like being unfocused is incredibly valuable \u2026 when you know where you want to go, but there\u2019s no road map, and you have to figure out how to get there. \u201cThe last thing you want to do is say, \u2018I\u2019m just going to go down this trail and I\u2019m gonna keep going until I fall off a cliff.\u2019 No."}
{"meta": {"doc_id": 2421, "sent_id": 125, "sent_start_pos": 20708, "sent_end_pos": 21129, "title": "Biochemistry of a burger"}, "text": "\u201cAnd I feel like being unfocused is incredibly valuable \u2026 when you know where you want to go, but there\u2019s no road map, and you have to figure out how to get there. \u201cThe last thing you want to do is say, \u2018I\u2019m just going to go down this trail and I\u2019m gonna keep going until I fall off a cliff.\u2019 No. I\u2019m going to explore and wander.\u201d\nAnd as a postscript: This fall, my vegetarian boyfriend gave the Impossible Whopper a try."}
{"meta": {"doc_id": 2421, "sent_id": 126, "sent_start_pos": 20872, "sent_end_pos": 21214, "title": "Biochemistry of a burger"}, "text": "\u201cThe last thing you want to do is say, \u2018I\u2019m just going to go down this trail and I\u2019m gonna keep going until I fall off a cliff.\u2019 No. I\u2019m going to explore and wander.\u201d\nAnd as a postscript: This fall, my vegetarian boyfriend gave the Impossible Whopper a try. He enjoyed it enough to order a second \u2014 Impossible Foods converts another customer."}
{"meta": {"doc_id": 2421, "sent_id": 127, "sent_start_pos": 21005, "sent_end_pos": 21358, "title": "Biochemistry of a burger"}, "text": "I\u2019m going to explore and wander.\u201d\nAnd as a postscript: This fall, my vegetarian boyfriend gave the Impossible Whopper a try. He enjoyed it enough to order a second \u2014 Impossible Foods converts another customer. A research career\nBefore launching Impossible Foods, Pat Brown was already well known for a 30-year career in research and scientific activism."}
{"meta": {"doc_id": 2421, "sent_id": 128, "sent_start_pos": 21130, "sent_end_pos": 21634, "title": "Biochemistry of a burger"}, "text": "He enjoyed it enough to order a second \u2014 Impossible Foods converts another customer. A research career\nBefore launching Impossible Foods, Pat Brown was already well known for a 30-year career in research and scientific activism. Now, he\u2019s so famous as an entrepreneur that news articles sometimes mention that first life \u2014 during which he established the field of functional genomics and started rolling a rock that\u2019s now an avalanche of open-access publication in the life sciences \u2014 as an afterthought."}
{"meta": {"doc_id": 2421, "sent_id": 129, "sent_start_pos": 21215, "sent_end_pos": 21749, "title": "Biochemistry of a burger"}, "text": "A research career\nBefore launching Impossible Foods, Pat Brown was already well known for a 30-year career in research and scientific activism. Now, he\u2019s so famous as an entrepreneur that news articles sometimes mention that first life \u2014 during which he established the field of functional genomics and started rolling a rock that\u2019s now an avalanche of open-access publication in the life sciences \u2014 as an afterthought. According to his colleagues, Brown always has excelled at coming up with creative solutions to difficult problems."}
{"meta": {"doc_id": 2421, "sent_id": 130, "sent_start_pos": 21359, "sent_end_pos": 21852, "title": "Biochemistry of a burger"}, "text": "Now, he\u2019s so famous as an entrepreneur that news articles sometimes mention that first life \u2014 during which he established the field of functional genomics and started rolling a rock that\u2019s now an avalanche of open-access publication in the life sciences \u2014 as an afterthought. According to his colleagues, Brown always has excelled at coming up with creative solutions to difficult problems. Throughout his career, these problems have grown in scale and expanded in impact beyond the lab bench."}
{"meta": {"doc_id": 2421, "sent_id": 131, "sent_start_pos": 21635, "sent_end_pos": 22036, "title": "Biochemistry of a burger"}, "text": "According to his colleagues, Brown always has excelled at coming up with creative solutions to difficult problems. Throughout his career, these problems have grown in scale and expanded in impact beyond the lab bench. Brown learned the process of detailed biochemical investigation, which his team would later apply to the humble hamburger, from some of the most noted biochemists of the 20th century."}
{"meta": {"doc_id": 2421, "sent_id": 132, "sent_start_pos": 21750, "sent_end_pos": 22134, "title": "Biochemistry of a burger"}, "text": "Throughout his career, these problems have grown in scale and expanded in impact beyond the lab bench. Brown learned the process of detailed biochemical investigation, which his team would later apply to the humble hamburger, from some of the most noted biochemists of the 20th century. As a graduate student at the University of Chicago, he trained with the late Nicholas Cozzarelli."}
{"meta": {"doc_id": 2421, "sent_id": 133, "sent_start_pos": 21853, "sent_end_pos": 22393, "title": "Biochemistry of a burger"}, "text": "Brown learned the process of detailed biochemical investigation, which his team would later apply to the humble hamburger, from some of the most noted biochemists of the 20th century. As a graduate student at the University of Chicago, he trained with the late Nicholas Cozzarelli. After finishing a Ph.D and a medical residency, Brown joined the lab of biochemist J Michael Bishop at the University of California, San Francisco, as a postdoc, where he collaborated closely with members of Harold Varmus\u2019 lab to study HIV molecular biology."}
{"meta": {"doc_id": 2421, "sent_id": 134, "sent_start_pos": 22037, "sent_end_pos": 22709, "title": "Biochemistry of a burger"}, "text": "As a graduate student at the University of Chicago, he trained with the late Nicholas Cozzarelli. After finishing a Ph.D and a medical residency, Brown joined the lab of biochemist J Michael Bishop at the University of California, San Francisco, as a postdoc, where he collaborated closely with members of Harold Varmus\u2019 lab to study HIV molecular biology. Bruce Bowerman, who worked closely with Brown at UCSF, recollected a sign over Brown\u2019s lab bench \u201cthat said, in bold black letters, \u2018If I have seen farther, it is by standing on the shoulders of \u2014\u2019 and instead of \u2018giants,\u2019 which is the Newton quote, he had written, \u2018idiots.\u2019\n\u201cPat was not a modest person,\u201d he said."}
{"meta": {"doc_id": 2421, "sent_id": 135, "sent_start_pos": 22135, "sent_end_pos": 22859, "title": "Biochemistry of a burger"}, "text": "After finishing a Ph.D and a medical residency, Brown joined the lab of biochemist J Michael Bishop at the University of California, San Francisco, as a postdoc, where he collaborated closely with members of Harold Varmus\u2019 lab to study HIV molecular biology. Bruce Bowerman, who worked closely with Brown at UCSF, recollected a sign over Brown\u2019s lab bench \u201cthat said, in bold black letters, \u2018If I have seen farther, it is by standing on the shoulders of \u2014\u2019 and instead of \u2018giants,\u2019 which is the Newton quote, he had written, \u2018idiots.\u2019\n\u201cPat was not a modest person,\u201d he said. \u201cBut he wasn\u2019t unpleasant at all.\u201d\nIn 1988, Brown was hired as an assistant professor at Stanford, where he would remain on the faculty for 25 years."}
{"meta": {"doc_id": 2421, "sent_id": 136, "sent_start_pos": 22394, "sent_end_pos": 23094, "title": "Biochemistry of a burger"}, "text": "Bruce Bowerman, who worked closely with Brown at UCSF, recollected a sign over Brown\u2019s lab bench \u201cthat said, in bold black letters, \u2018If I have seen farther, it is by standing on the shoulders of \u2014\u2019 and instead of \u2018giants,\u2019 which is the Newton quote, he had written, \u2018idiots.\u2019\n\u201cPat was not a modest person,\u201d he said. \u201cBut he wasn\u2019t unpleasant at all.\u201d\nIn 1988, Brown was hired as an assistant professor at Stanford, where he would remain on the faculty for 25 years. The scientific work he\u2019s most famous for in that time is developing the DNA microarray, a technique that originally was envisioned for genetic mapping but became popular as the first method to measure changes to a whole transcriptome."}
{"meta": {"doc_id": 2421, "sent_id": 137, "sent_start_pos": 22710, "sent_end_pos": 23282, "title": "Biochemistry of a burger"}, "text": "\u201cBut he wasn\u2019t unpleasant at all.\u201d\nIn 1988, Brown was hired as an assistant professor at Stanford, where he would remain on the faculty for 25 years. The scientific work he\u2019s most famous for in that time is developing the DNA microarray, a technique that originally was envisioned for genetic mapping but became popular as the first method to measure changes to a whole transcriptome. To interpret the data on regulation of thousands of genes produced by a microarray, Brown and his team hoped to mine the scientific literature, which was beginning to be available online."}
{"meta": {"doc_id": 2421, "sent_id": 138, "sent_start_pos": 22860, "sent_end_pos": 23371, "title": "Biochemistry of a burger"}, "text": "The scientific work he\u2019s most famous for in that time is developing the DNA microarray, a technique that originally was envisioned for genetic mapping but became popular as the first method to measure changes to a whole transcriptome. To interpret the data on regulation of thousands of genes produced by a microarray, Brown and his team hoped to mine the scientific literature, which was beginning to be available online. But they found that journals, which depended on subscriptions, weren\u2019t open to the idea."}
{"meta": {"doc_id": 2421, "sent_id": 139, "sent_start_pos": 23095, "sent_end_pos": 23628, "title": "Biochemistry of a burger"}, "text": "To interpret the data on regulation of thousands of genes produced by a microarray, Brown and his team hoped to mine the scientific literature, which was beginning to be available online. But they found that journals, which depended on subscriptions, weren\u2019t open to the idea. With Varmus and Michael Eisen, a postdoc in his lab, Brown embarked on an advocacy project for open access to the scientific literature that started with a proposal to expand PubMed and culminated in founding a new publisher, the Public Library of Science."}
{"meta": {"doc_id": 2421, "sent_id": 140, "sent_start_pos": 23283, "sent_end_pos": 23772, "title": "Biochemistry of a burger"}, "text": "But they found that journals, which depended on subscriptions, weren\u2019t open to the idea. With Varmus and Michael Eisen, a postdoc in his lab, Brown embarked on an advocacy project for open access to the scientific literature that started with a proposal to expand PubMed and culminated in founding a new publisher, the Public Library of Science. When Brown decided to run Impossible Foods full time, he left Stanford, giving up his status as a Howard Hughes Medical Institute investigator."}
{"meta": {"doc_id": 2421, "sent_id": 141, "sent_start_pos": 23372, "sent_end_pos": 23906, "title": "Biochemistry of a burger"}, "text": "With Varmus and Michael Eisen, a postdoc in his lab, Brown embarked on an advocacy project for open access to the scientific literature that started with a proposal to expand PubMed and culminated in founding a new publisher, the Public Library of Science. When Brown decided to run Impossible Foods full time, he left Stanford, giving up his status as a Howard Hughes Medical Institute investigator. J Michael Bishop, a Nobel laureate who advised Brown as a postdoc, attended the HHMI meeting where Brown gave notice of his decision."}
{"meta": {"doc_id": 2421, "sent_id": 142, "sent_start_pos": 23629, "sent_end_pos": 24049, "title": "Biochemistry of a burger"}, "text": "When Brown decided to run Impossible Foods full time, he left Stanford, giving up his status as a Howard Hughes Medical Institute investigator. J Michael Bishop, a Nobel laureate who advised Brown as a postdoc, attended the HHMI meeting where Brown gave notice of his decision. \u201cInstead of giving a valedictory with his science, he gave a 20-minute talk on the ecological problem that he wanted to address,\u201d Bishop said."}
{"meta": {"doc_id": 2421, "sent_id": 143, "sent_start_pos": 23773, "sent_end_pos": 24119, "title": "Biochemistry of a burger"}, "text": "J Michael Bishop, a Nobel laureate who advised Brown as a postdoc, attended the HHMI meeting where Brown gave notice of his decision. \u201cInstead of giving a valedictory with his science, he gave a 20-minute talk on the ecological problem that he wanted to address,\u201d Bishop said. It wasn\u2019t a swan song; it was a presentation on his next big project."}
{"meta": {"doc_id": 2421, "sent_id": 144, "sent_start_pos": 23907, "sent_end_pos": 24287, "title": "Biochemistry of a burger"}, "text": "\u201cInstead of giving a valedictory with his science, he gave a 20-minute talk on the ecological problem that he wanted to address,\u201d Bishop said. It wasn\u2019t a swan song; it was a presentation on his next big project. \u201cI think we were all surprised that someone as well situated as he was academically \u2026 and who still had a passion for the science would make that change,\u201d Varmus said."}
{"meta": {"doc_id": 2421, "sent_id": 145, "sent_start_pos": 24050, "sent_end_pos": 24589, "title": "Biochemistry of a burger"}, "text": "It wasn\u2019t a swan song; it was a presentation on his next big project. \u201cI think we were all surprised that someone as well situated as he was academically \u2026 and who still had a passion for the science would make that change,\u201d Varmus said. \u201cBut I\u2019d say it worked out pretty damn well for him.\u201d\nAll in the family\nThere\u2019s plenty of science in Impossible Foods founder Pat Brown\u2019s family; his wife, Sue Klapholz, whom he met at the University of Chicago, holds an MD and a Ph.D and works as the company\u2019s vice president of nutrition and health."}
{"meta": {"doc_id": 2421, "sent_id": 146, "sent_start_pos": 24120, "sent_end_pos": 24712, "title": "Biochemistry of a burger"}, "text": "\u201cI think we were all surprised that someone as well situated as he was academically \u2026 and who still had a passion for the science would make that change,\u201d Varmus said. \u201cBut I\u2019d say it worked out pretty damn well for him.\u201d\nAll in the family\nThere\u2019s plenty of science in Impossible Foods founder Pat Brown\u2019s family; his wife, Sue Klapholz, whom he met at the University of Chicago, holds an MD and a Ph.D and works as the company\u2019s vice president of nutrition and health. One of Brown\u2019s brothers, a neuroscientist, has worked at the company for about three years as a sensory perception expert."}
{"meta": {"doc_id": 2421, "sent_id": 147, "sent_start_pos": 24288, "sent_end_pos": 24918, "title": "Biochemistry of a burger"}, "text": "\u201cBut I\u2019d say it worked out pretty damn well for him.\u201d\nAll in the family\nThere\u2019s plenty of science in Impossible Foods founder Pat Brown\u2019s family; his wife, Sue Klapholz, whom he met at the University of Chicago, holds an MD and a Ph.D and works as the company\u2019s vice president of nutrition and health. One of Brown\u2019s brothers, a neuroscientist, has worked at the company for about three years as a sensory perception expert. But the most startling team member is Brown\u2019s daughter, Ariel Klapholz\u2013Brown, who studied film in college before starting as an early employee in the labs of the company that would become Impossible Foods."}
{"meta": {"doc_id": 2421, "sent_id": 148, "sent_start_pos": 24590, "sent_end_pos": 25007, "title": "Biochemistry of a burger"}, "text": "One of Brown\u2019s brothers, a neuroscientist, has worked at the company for about three years as a sensory perception expert. But the most startling team member is Brown\u2019s daughter, Ariel Klapholz\u2013Brown, who studied film in college before starting as an early employee in the labs of the company that would become Impossible Foods. Today she\u2019s a senior research associate on Impossible Foods\u2019 materials and texture team."}
{"meta": {"doc_id": 2421, "sent_id": 149, "sent_start_pos": 24713, "sent_end_pos": 25121, "title": "Biochemistry of a burger"}, "text": "But the most startling team member is Brown\u2019s daughter, Ariel Klapholz\u2013Brown, who studied film in college before starting as an early employee in the labs of the company that would become Impossible Foods. Today she\u2019s a senior research associate on Impossible Foods\u2019 materials and texture team. \u201cI love working with my daughter,\u201d Brown said, adding that she\u2019d always been a talented math and science student."}
{"meta": {"doc_id": 2421, "sent_id": 150, "sent_start_pos": 24919, "sent_end_pos": 25204, "title": "Biochemistry of a burger"}, "text": "Today she\u2019s a senior research associate on Impossible Foods\u2019 materials and texture team. \u201cI love working with my daughter,\u201d Brown said, adding that she\u2019d always been a talented math and science student. \u201cShe notices everything, which is just a great quality for the role that she\u2019s in."}
{"meta": {"doc_id": 2421, "sent_id": 151, "sent_start_pos": 25008, "sent_end_pos": 25311, "title": "Biochemistry of a burger"}, "text": "\u201cI love working with my daughter,\u201d Brown said, adding that she\u2019d always been a talented math and science student. \u201cShe notices everything, which is just a great quality for the role that she\u2019s in. There\u2019s an art to creating new prototypes, and also there\u2019s an incredibly important demand on observation."}
{"meta": {"doc_id": 2421, "sent_id": 152, "sent_start_pos": 25122, "sent_end_pos": 25782, "title": "Biochemistry of a burger"}, "text": "\u201cShe notices everything, which is just a great quality for the role that she\u2019s in. There\u2019s an art to creating new prototypes, and also there\u2019s an incredibly important demand on observation. You have to pick up subtle things that you\u2019re not looking for.\u201d\nOn working with family and friends, he added, \u201cIf you have people that you know are all-in on what you\u2019re doing and talented, and you know for sure that you can tolerate them, that they\u2019re going to be good colleagues, then that\u2019s great.\u201d\nBuffering oxygen\nLegumes \u2014 plants like soy, pea and clover \u2014 are well known for converting atmospheric nitrogen into ammonia, which is a source of nutritional nitrogen."}
{"meta": {"doc_id": 2421, "sent_id": 153, "sent_start_pos": 25205, "sent_end_pos": 25968, "title": "Biochemistry of a burger"}, "text": "There\u2019s an art to creating new prototypes, and also there\u2019s an incredibly important demand on observation. You have to pick up subtle things that you\u2019re not looking for.\u201d\nOn working with family and friends, he added, \u201cIf you have people that you know are all-in on what you\u2019re doing and talented, and you know for sure that you can tolerate them, that they\u2019re going to be good colleagues, then that\u2019s great.\u201d\nBuffering oxygen\nLegumes \u2014 plants like soy, pea and clover \u2014 are well known for converting atmospheric nitrogen into ammonia, which is a source of nutritional nitrogen. The reducing reaction called nitrogen fixation, for which the plants often get credit, is in fact carried out by symbiotic bacteria that live in specialized organs in the plants\u2019 roots."}
{"meta": {"doc_id": 2421, "sent_id": 154, "sent_start_pos": 25312, "sent_end_pos": 26131, "title": "Biochemistry of a burger"}, "text": "You have to pick up subtle things that you\u2019re not looking for.\u201d\nOn working with family and friends, he added, \u201cIf you have people that you know are all-in on what you\u2019re doing and talented, and you know for sure that you can tolerate them, that they\u2019re going to be good colleagues, then that\u2019s great.\u201d\nBuffering oxygen\nLegumes \u2014 plants like soy, pea and clover \u2014 are well known for converting atmospheric nitrogen into ammonia, which is a source of nutritional nitrogen. The reducing reaction called nitrogen fixation, for which the plants often get credit, is in fact carried out by symbiotic bacteria that live in specialized organs in the plants\u2019 roots. Mark O\u2019Brian, chair of the biochemistry department at the University at Buffalo, studies nitrogen fixation by Bradyrhizobium japonicum, which colonizes soy roots."}
{"meta": {"doc_id": 2421, "sent_id": 155, "sent_start_pos": 25783, "sent_end_pos": 26235, "title": "Biochemistry of a burger"}, "text": "The reducing reaction called nitrogen fixation, for which the plants often get credit, is in fact carried out by symbiotic bacteria that live in specialized organs in the plants\u2019 roots. Mark O\u2019Brian, chair of the biochemistry department at the University at Buffalo, studies nitrogen fixation by Bradyrhizobium japonicum, which colonizes soy roots. A Bradyrhizobium enzyme called nitrogenase breaks the bonds in atmospheric nitrogen, O\u2019Brian explained."}
{"meta": {"doc_id": 2421, "sent_id": 156, "sent_start_pos": 25969, "sent_end_pos": 26345, "title": "Biochemistry of a burger"}, "text": "Mark O\u2019Brian, chair of the biochemistry department at the University at Buffalo, studies nitrogen fixation by Bradyrhizobium japonicum, which colonizes soy roots. A Bradyrhizobium enzyme called nitrogenase breaks the bonds in atmospheric nitrogen, O\u2019Brian explained. The process demands a tremendous amount of energy, which Bradyrhizobium supplies through aerobic respiration."}
{"meta": {"doc_id": 2421, "sent_id": 157, "sent_start_pos": 26132, "sent_end_pos": 26429, "title": "Biochemistry of a burger"}, "text": "A Bradyrhizobium enzyme called nitrogenase breaks the bonds in atmospheric nitrogen, O\u2019Brian explained. The process demands a tremendous amount of energy, which Bradyrhizobium supplies through aerobic respiration. But an appetite for oxygen, the ultimate oxidizer, is perilous for the nitrogenase."}
{"meta": {"doc_id": 2421, "sent_id": 158, "sent_start_pos": 26236, "sent_end_pos": 26573, "title": "Biochemistry of a burger"}, "text": "The process demands a tremendous amount of energy, which Bradyrhizobium supplies through aerobic respiration. But an appetite for oxygen, the ultimate oxidizer, is perilous for the nitrogenase. Plant tissue in root nodules express a high level of leghemoglobin, a protein that, like other heme proteins, coordinates oxygen cooperatively."}
{"meta": {"doc_id": 2421, "sent_id": 159, "sent_start_pos": 26346, "sent_end_pos": 26703, "title": "Biochemistry of a burger"}, "text": "But an appetite for oxygen, the ultimate oxidizer, is perilous for the nitrogenase. Plant tissue in root nodules express a high level of leghemoglobin, a protein that, like other heme proteins, coordinates oxygen cooperatively. \u201cYou need oxygen for the bacteria to respire, but you can\u2019t have a lot of free oxygen because it\u2019s going to kill the nitrogenase."}
{"meta": {"doc_id": 2421, "sent_id": 160, "sent_start_pos": 26430, "sent_end_pos": 26870, "title": "Biochemistry of a burger"}, "text": "Plant tissue in root nodules express a high level of leghemoglobin, a protein that, like other heme proteins, coordinates oxygen cooperatively. \u201cYou need oxygen for the bacteria to respire, but you can\u2019t have a lot of free oxygen because it\u2019s going to kill the nitrogenase. Leghemoglobin really resolves that paradox,\u201d O\u2019Brian said, by binding with high affinity to free oxygen and releasing it only when the concentration of oxygen is low."}
{"meta": {"doc_id": 2421, "sent_id": 161, "sent_start_pos": 26574, "sent_end_pos": 27112, "title": "Biochemistry of a burger"}, "text": "\u201cYou need oxygen for the bacteria to respire, but you can\u2019t have a lot of free oxygen because it\u2019s going to kill the nitrogenase. Leghemoglobin really resolves that paradox,\u201d O\u2019Brian said, by binding with high affinity to free oxygen and releasing it only when the concentration of oxygen is low. \u201cEssentially, it\u2019s facilitating oxygen diffusion, which is similar to what myoglobin does in the muscle of animals.\u201d\nSince Impossible Foods has become prominent, O\u2019Brian said, he has found it easier to describe his research to nonscientists."}
{"meta": {"doc_id": 2421, "sent_id": 162, "sent_start_pos": 26704, "sent_end_pos": 27171, "title": "Biochemistry of a burger"}, "text": "Leghemoglobin really resolves that paradox,\u201d O\u2019Brian said, by binding with high affinity to free oxygen and releasing it only when the concentration of oxygen is low. \u201cEssentially, it\u2019s facilitating oxygen diffusion, which is similar to what myoglobin does in the muscle of animals.\u201d\nSince Impossible Foods has become prominent, O\u2019Brian said, he has found it easier to describe his research to nonscientists. \u201cIf you say, \u2018We work on ABCD,\u2019 it\u2019ll put people to sleep."}
{"meta": {"doc_id": 2421, "sent_id": 163, "sent_start_pos": 26871, "sent_end_pos": 27352, "title": "Biochemistry of a burger"}, "text": "\u201cEssentially, it\u2019s facilitating oxygen diffusion, which is similar to what myoglobin does in the muscle of animals.\u201d\nSince Impossible Foods has become prominent, O\u2019Brian said, he has found it easier to describe his research to nonscientists. \u201cIf you say, \u2018We work on ABCD,\u2019 it\u2019ll put people to sleep. But if you say, \u2018This is being used for the Impossible Burger,\u2019 people are interested.\u201d\nJoin the ASBMB Today mailing list\nSign up to get updates on articles, interviews and events."}
{"meta": {"doc_id": 2421, "sent_id": 164, "sent_start_pos": 27113, "sent_end_pos": 27477, "title": "Biochemistry of a burger"}, "text": "\u201cIf you say, \u2018We work on ABCD,\u2019 it\u2019ll put people to sleep. But if you say, \u2018This is being used for the Impossible Burger,\u2019 people are interested.\u201d\nJoin the ASBMB Today mailing list\nSign up to get updates on articles, interviews and events. Latest in Industry\nIndustry highlights or most popular articles\nWhy is the FDA funded in part by the companies it regulates?"}
{"meta": {"doc_id": 2421, "sent_id": 165, "sent_start_pos": 27172, "sent_end_pos": 27615, "title": "Biochemistry of a burger"}, "text": "But if you say, \u2018This is being used for the Impossible Burger,\u2019 people are interested.\u201d\nJoin the ASBMB Today mailing list\nSign up to get updates on articles, interviews and events. Latest in Industry\nIndustry highlights or most popular articles\nWhy is the FDA funded in part by the companies it regulates? The US Food and Drug Administration receives almost half its funding from companies it regulates, such as drug and medical device makers."}
{"meta": {"doc_id": 2421, "sent_id": 166, "sent_start_pos": 27353, "sent_end_pos": 27836, "title": "Biochemistry of a burger"}, "text": "Latest in Industry\nIndustry highlights or most popular articles\nWhy is the FDA funded in part by the companies it regulates? The US Food and Drug Administration receives almost half its funding from companies it regulates, such as drug and medical device makers. Out for blood in the search to stall aging\nA gaggle of biotech startups are trying vastly different approaches to spin animal studies into the next big anti-aging therapy."}
{"meta": {"doc_id": 2421, "sent_id": 167, "sent_start_pos": 27478, "sent_end_pos": 28057, "title": "Biochemistry of a burger"}, "text": "The US Food and Drug Administration receives almost half its funding from companies it regulates, such as drug and medical device makers. Out for blood in the search to stall aging\nA gaggle of biotech startups are trying vastly different approaches to spin animal studies into the next big anti-aging therapy. Climbing the research ladder in industry\nOur industry careers columnist offers brief descriptions of entry-level, mid-level and senior-level positions in the R&D world."}
{"meta": {"doc_id": 2421, "sent_id": 168, "sent_start_pos": 27665, "sent_end_pos": 28260, "title": "Biochemistry of a burger"}, "text": "Out for blood in the search to stall aging\nA gaggle of biotech startups are trying vastly different approaches to spin animal studies into the next big anti-aging therapy. Climbing the research ladder in industry\nOur industry careers columnist offers brief descriptions of entry-level, mid-level and senior-level positions in the R&D world. Targeting 20,000 proteins by 2035\nThe organizers of Target 2035, the Structural Genome Consortium, have an ambitious aim: to invent an inhibitor or probe for every protein in the human proteome by 2035."}
{"meta": {"doc_id": 2421, "sent_id": 169, "sent_start_pos": 27889, "sent_end_pos": 28434, "title": "Biochemistry of a burger"}, "text": "Climbing the research ladder in industry\nOur industry careers columnist offers brief descriptions of entry-level, mid-level and senior-level positions in the R&D world. Targeting 20,000 proteins by 2035\nThe organizers of Target 2035, the Structural Genome Consortium, have an ambitious aim: to invent an inhibitor or probe for every protein in the human proteome by 2035. \u2018I could be happy doing other things\u2019\nForensic investigations, IVF embryology, custom virus production for research: Alanna Mitsopoulos has done it all."}
{"meta": {"doc_id": 2421, "sent_id": 170, "sent_start_pos": 28058, "sent_end_pos": 28499, "title": "Biochemistry of a burger"}, "text": "Targeting 20,000 proteins by 2035\nThe organizers of Target 2035, the Structural Genome Consortium, have an ambitious aim: to invent an inhibitor or probe for every protein in the human proteome by 2035. \u2018I could be happy doing other things\u2019\nForensic investigations, IVF embryology, custom virus production for research: Alanna Mitsopoulos has done it all. In a Q&A with ASBMB Today, she describes her career path so far."}
{"meta": {"doc_id": 2421, "sent_id": 171, "sent_start_pos": 28282, "sent_end_pos": 28711, "title": "Biochemistry of a burger"}, "text": "\u2018I could be happy doing other things\u2019\nForensic investigations, IVF embryology, custom virus production for research: Alanna Mitsopoulos has done it all. In a Q&A with ASBMB Today, she describes her career path so far. Working on sustainable science in industry\nOur industry careers columnist talked to Jake Courtney of Conagen, a biotechnology company that focuses on synthetic biology, about his role as a scientist in industry."}
{"meta": {"doc_id": 2421, "sent_id": 172, "sent_start_pos": 28435, "sent_end_pos": [], "title": "Biochemistry of a burger"}, "text": "In a Q&A with ASBMB Today, she describes her career path so far. Working on sustainable science in industry\nOur industry careers columnist talked to Jake Courtney of Conagen, a biotechnology company that focuses on synthetic biology, about his role as a scientist in industry. "}
{"meta": {"doc_id": 2422, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 330, "title": "Fake meat, served six ways"}, "text": " By Joi Ito\nAround the time I turned 40, I decided to address the trifecta of concerns I had about climate change, animal rights, and my health: I went hard vegan. My doctor had been warning me to cut down on red meat, and I had also moved to a rural Japanese farming village populated by farmers growing a wide variety of veggies."}
{"meta": {"doc_id": 2422, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 479, "title": "Fake meat, served six ways"}, "text": "By Joi Ito\nAround the time I turned 40, I decided to address the trifecta of concerns I had about climate change, animal rights, and my health: I went hard vegan. My doctor had been warning me to cut down on red meat, and I had also moved to a rural Japanese farming village populated by farmers growing a wide variety of veggies. After a while, the euphoria wore off and the culinary limitations of vegan food, especially when traveling, became challenging."}
{"meta": {"doc_id": 2422, "sent_id": 2, "sent_start_pos": 163, "sent_end_pos": 635, "title": "Fake meat, served six ways"}, "text": "My doctor had been warning me to cut down on red meat, and I had also moved to a rural Japanese farming village populated by farmers growing a wide variety of veggies. After a while, the euphoria wore off and the culinary limitations of vegan food, especially when traveling, became challenging. (I wonder if this article will get me bumped off of the Wikipedia Notable Vegans list.)"}
{"meta": {"doc_id": 2422, "sent_id": 3, "sent_start_pos": 352, "sent_end_pos": 828, "title": "Fake meat, served six ways"}, "text": "After a while, the euphoria wore off and the culinary limitations of vegan food, especially when traveling, became challenging. (I wonder if this article will get me bumped off of the Wikipedia Notable Vegans list.) Five years later, the great Tohoku earthquake of 2011 hit Japan, dumping a pile of radioactive cesium-137 on top of our organic garden and shattering the wonderful organic loop we had created."}
{"meta": {"doc_id": 2422, "sent_id": 4, "sent_start_pos": 548, "sent_end_pos": 972, "title": "Fake meat, served six ways"}, "text": "(I wonder if this article will get me bumped off of the Wikipedia Notable Vegans list.) Five years later, the great Tohoku earthquake of 2011 hit Japan, dumping a pile of radioactive cesium-137 on top of our organic garden and shattering the wonderful organic loop we had created. I took my job at the Media Lab and moved to the US the same year, thus starting my slow but steady reentry into the community of animal eaters."}
{"meta": {"doc_id": 2422, "sent_id": 5, "sent_start_pos": 636, "sent_end_pos": 1308, "title": "Fake meat, served six ways"}, "text": "Five years later, the great Tohoku earthquake of 2011 hit Japan, dumping a pile of radioactive cesium-137 on top of our organic garden and shattering the wonderful organic loop we had created. I took my job at the Media Lab and moved to the US the same year, thus starting my slow but steady reentry into the community of animal eaters. Ten years after I proclaimed myself vegan, I met Isha Datar(1), the executive director of New Harvest, an organization devoted to advancing the science of what she calls \u201ccellular agriculture.\u201d Isha is trying to figure out how to grow any agricultural product\u2014milk, eggs, flavors, fragrances, fish, fruit\u2014from cells instead of animals."}
{"meta": {"doc_id": 2422, "sent_id": 6, "sent_start_pos": 829, "sent_end_pos": 1484, "title": "Fake meat, served six ways"}, "text": "I took my job at the Media Lab and moved to the US the same year, thus starting my slow but steady reentry into the community of animal eaters. Ten years after I proclaimed myself vegan, I met Isha Datar(1), the executive director of New Harvest, an organization devoted to advancing the science of what she calls \u201ccellular agriculture.\u201d Isha is trying to figure out how to grow any agricultural product\u2014milk, eggs, flavors, fragrances, fish, fruit\u2014from cells instead of animals. Art fans will remember Oron Catts and Ionat Zurr, who in 2003 served \u201csemi-living steak\u201d grown from the skeletal muscles of frogs as an art project called Disembodied Cuisine."}
{"meta": {"doc_id": 2422, "sent_id": 7, "sent_start_pos": 973, "sent_end_pos": 1663, "title": "Fake meat, served six ways"}, "text": "Ten years after I proclaimed myself vegan, I met Isha Datar(1), the executive director of New Harvest, an organization devoted to advancing the science of what she calls \u201ccellular agriculture.\u201d Isha is trying to figure out how to grow any agricultural product\u2014milk, eggs, flavors, fragrances, fish, fruit\u2014from cells instead of animals. Art fans will remember Oron Catts and Ionat Zurr, who in 2003 served \u201csemi-living steak\u201d grown from the skeletal muscles of frogs as an art project called Disembodied Cuisine. Five years later, they presented \u201cVictimless Leather\u201d at MoMA in New York, an installation that involved tissue growing inside a glass container in the shape of a leather jacket."}
{"meta": {"doc_id": 2422, "sent_id": 8, "sent_start_pos": 1309, "sent_end_pos": 1773, "title": "Fake meat, served six ways"}, "text": "Art fans will remember Oron Catts and Ionat Zurr, who in 2003 served \u201csemi-living steak\u201d grown from the skeletal muscles of frogs as an art project called Disembodied Cuisine. Five years later, they presented \u201cVictimless Leather\u201d at MoMA in New York, an installation that involved tissue growing inside a glass container in the shape of a leather jacket. Protests broke out when the museum had to disconnect the life support system because the jacket grew too big."}
{"meta": {"doc_id": 2422, "sent_id": 9, "sent_start_pos": 1485, "sent_end_pos": 2054, "title": "Fake meat, served six ways"}, "text": "Five years later, they presented \u201cVictimless Leather\u201d at MoMA in New York, an installation that involved tissue growing inside a glass container in the shape of a leather jacket. Protests broke out when the museum had to disconnect the life support system because the jacket grew too big. We now have more challenging choices to make than simply whether to be vegan, pescatarian or carnivore, thanks to technology that has given us an explosion of meat-like products that run the ethical gambit in their production processes."}
{"meta": {"doc_id": 2422, "sent_id": 10, "sent_start_pos": 1664, "sent_end_pos": 2205, "title": "Fake meat, served six ways"}, "text": "Protests broke out when the museum had to disconnect the life support system because the jacket grew too big. We now have more challenging choices to make than simply whether to be vegan, pescatarian or carnivore, thanks to technology that has given us an explosion of meat-like products that run the ethical gambit in their production processes. She was and is trying to solve our food problem, and New Harvest is supporting and coordinating research efforts at numerous labs and research groups."}
{"meta": {"doc_id": 2422, "sent_id": 11, "sent_start_pos": 1818, "sent_end_pos": 2399, "title": "Fake meat, served six ways"}, "text": "We now have more challenging choices to make than simply whether to be vegan, pescatarian or carnivore, thanks to technology that has given us an explosion of meat-like products that run the ethical gambit in their production processes. She was and is trying to solve our food problem, and New Harvest is supporting and coordinating research efforts at numerous labs and research groups. Civilians often clump the alternative meat companies and labs together in some kind of big meatless meatball, but, just like different kinds of self-driving car systems, they\u2019re quite distinct."}
{"meta": {"doc_id": 2422, "sent_id": 12, "sent_start_pos": 2055, "sent_end_pos": 2524, "title": "Fake meat, served six ways"}, "text": "She was and is trying to solve our food problem, and New Harvest is supporting and coordinating research efforts at numerous labs and research groups. Civilians often clump the alternative meat companies and labs together in some kind of big meatless meatball, but, just like different kinds of self-driving car systems, they\u2019re quite distinct. The Society of Automotive Engineers identifies five levels of autonomy; similarly, I see six levels of cellular agriculture."}
{"meta": {"doc_id": 2422, "sent_id": 13, "sent_start_pos": 2206, "sent_end_pos": 2723, "title": "Fake meat, served six ways"}, "text": "Civilians often clump the alternative meat companies and labs together in some kind of big meatless meatball, but, just like different kinds of self-driving car systems, they\u2019re quite distinct. The Society of Automotive Engineers identifies five levels of autonomy; similarly, I see six levels of cellular agriculture. Just as \u201cdriver assist\u201d is nice, having a car pick me up and drive me home is a completely different deal, and the latter might not evolve from the former\u2014they might have separate development paths."}
{"meta": {"doc_id": 2422, "sent_id": 14, "sent_start_pos": 2400, "sent_end_pos": 2807, "title": "Fake meat, served six ways"}, "text": "The Society of Automotive Engineers identifies five levels of autonomy; similarly, I see six levels of cellular agriculture. Just as \u201cdriver assist\u201d is nice, having a car pick me up and drive me home is a completely different deal, and the latter might not evolve from the former\u2014they might have separate development paths. I think the different branches of cellular agriculture are developing the same way."}
{"meta": {"doc_id": 2422, "sent_id": 15, "sent_start_pos": 2525, "sent_end_pos": 2924, "title": "Fake meat, served six ways"}, "text": "Just as \u201cdriver assist\u201d is nice, having a car pick me up and drive me home is a completely different deal, and the latter might not evolve from the former\u2014they might have separate development paths. I think the different branches of cellular agriculture are developing the same way. Level 0: Just Be Vegan\nSome plants are very high in protein, like beans, and they taste great just the way they are."}
{"meta": {"doc_id": 2422, "sent_id": 16, "sent_start_pos": 2724, "sent_end_pos": 3051, "title": "Fake meat, served six ways"}, "text": "I think the different branches of cellular agriculture are developing the same way. Level 0: Just Be Vegan\nSome plants are very high in protein, like beans, and they taste great just the way they are. Level 1: Go Alternative\nAs a vegan, I ate a lot of processed plant-based proteins like tofu that feel fleshy and taste savory."}
{"meta": {"doc_id": 2422, "sent_id": 17, "sent_start_pos": 2808, "sent_end_pos": 3244, "title": "Fake meat, served six ways"}, "text": "Level 0: Just Be Vegan\nSome plants are very high in protein, like beans, and they taste great just the way they are. Level 1: Go Alternative\nAs a vegan, I ate a lot of processed plant-based proteins like tofu that feel fleshy and taste savory. Many vegan Chinese restaurants serve \u201cfake meat,\u201d which is usually some sort of seitan, a wheat gluten, or textured vegetable protein like textured soy."}
{"meta": {"doc_id": 2422, "sent_id": 18, "sent_start_pos": 2925, "sent_end_pos": 3329, "title": "Fake meat, served six ways"}, "text": "Level 1: Go Alternative\nAs a vegan, I ate a lot of processed plant-based proteins like tofu that feel fleshy and taste savory. Many vegan Chinese restaurants serve \u201cfake meat,\u201d which is usually some sort of seitan, a wheat gluten, or textured vegetable protein like textured soy. It\u2019s flavored and has a texture similar to some sort of animal protein, say, shrimp."}
{"meta": {"doc_id": 2422, "sent_id": 19, "sent_start_pos": 3092, "sent_end_pos": 3457, "title": "Fake meat, served six ways"}, "text": "Many vegan Chinese restaurants serve \u201cfake meat,\u201d which is usually some sort of seitan, a wheat gluten, or textured vegetable protein like textured soy. It\u2019s flavored and has a texture similar to some sort of animal protein, say, shrimp. This kind of protein substitute is a meat alternative\u2014a plant-based protein that starts to mimic the experience of eating meat."}
{"meta": {"doc_id": 2422, "sent_id": 20, "sent_start_pos": 3245, "sent_end_pos": 3657, "title": "Fake meat, served six ways"}, "text": "It\u2019s flavored and has a texture similar to some sort of animal protein, say, shrimp. This kind of protein substitute is a meat alternative\u2014a plant-based protein that starts to mimic the experience of eating meat. Level 2: Get Cultured\nThese meat alternatives are also plant-based, but they contain some \u201ccultured\u201d proteins that are produced using a new scientific process."}
{"meta": {"doc_id": 2422, "sent_id": 21, "sent_start_pos": 3330, "sent_end_pos": 3859, "title": "Fake meat, served six ways"}, "text": "This kind of protein substitute is a meat alternative\u2014a plant-based protein that starts to mimic the experience of eating meat. Level 2: Get Cultured\nThese meat alternatives are also plant-based, but they contain some \u201ccultured\u201d proteins that are produced using a new scientific process. Yeast or bacteria are engineered to ferment some plant substances and output products that mimic or even replicate the proteins that make a plant-based recipe taste, smell, look or feel more like meat."}
{"meta": {"doc_id": 2422, "sent_id": 22, "sent_start_pos": 3498, "sent_end_pos": 4022, "title": "Fake meat, served six ways"}, "text": "Level 2: Get Cultured\nThese meat alternatives are also plant-based, but they contain some \u201ccultured\u201d proteins that are produced using a new scientific process. Yeast or bacteria are engineered to ferment some plant substances and output products that mimic or even replicate the proteins that make a plant-based recipe taste, smell, look or feel more like meat. Impossible Foods\u2019 Impossible Burger falls into this category because its key ingredient is a protein called heme that is produced by genetically engineered yeast."}
{"meta": {"doc_id": 2422, "sent_id": 23, "sent_start_pos": 3658, "sent_end_pos": 4234, "title": "Fake meat, served six ways"}, "text": "Yeast or bacteria are engineered to ferment some plant substances and output products that mimic or even replicate the proteins that make a plant-based recipe taste, smell, look or feel more like meat. Impossible Foods\u2019 Impossible Burger falls into this category because its key ingredient is a protein called heme that is produced by genetically engineered yeast. This process relies on the industrial biotechnology and large-scale fermentation systems that are already used in the food industry."}
{"meta": {"doc_id": 2422, "sent_id": 24, "sent_start_pos": 3860, "sent_end_pos": 4432, "title": "Fake meat, served six ways"}, "text": "Impossible Foods\u2019 Impossible Burger falls into this category because its key ingredient is a protein called heme that is produced by genetically engineered yeast. This process relies on the industrial biotechnology and large-scale fermentation systems that are already used in the food industry. JUST\u2019s Just Scramble \u201cscrambled eggs\u201d uses a proprietary process to create a plant-based protein as well, combining processes used in the pharmaceutical business, food R&D labs, and chemistry labs."}
{"meta": {"doc_id": 2422, "sent_id": 25, "sent_start_pos": 4102, "sent_end_pos": 4600, "title": "Fake meat, served six ways"}, "text": "This process relies on the industrial biotechnology and large-scale fermentation systems that are already used in the food industry. JUST\u2019s Just Scramble \u201cscrambled eggs\u201d uses a proprietary process to create a plant-based protein as well, combining processes used in the pharmaceutical business, food R&D labs, and chemistry labs. Level 3: Post-Vegan\nFoods at this level are made of plant-based ingredients combined with cultured animal cells (as opposed to the products of bacterial fermentation)."}
{"meta": {"doc_id": 2422, "sent_id": 26, "sent_start_pos": 4235, "sent_end_pos": 4738, "title": "Fake meat, served six ways"}, "text": "JUST\u2019s Just Scramble \u201cscrambled eggs\u201d uses a proprietary process to create a plant-based protein as well, combining processes used in the pharmaceutical business, food R&D labs, and chemistry labs. Level 3: Post-Vegan\nFoods at this level are made of plant-based ingredients combined with cultured animal cells (as opposed to the products of bacterial fermentation). The animal cells provide the color, smell, or taste of meat, but not the substance."}
{"meta": {"doc_id": 2422, "sent_id": 27, "sent_start_pos": 4433, "sent_end_pos": 4857, "title": "Fake meat, served six ways"}, "text": "Level 3: Post-Vegan\nFoods at this level are made of plant-based ingredients combined with cultured animal cells (as opposed to the products of bacterial fermentation). The animal cells provide the color, smell, or taste of meat, but not the substance. This relies on industrial biotech and large-scale cell-culture production methods already used in the pharma industry."}
{"meta": {"doc_id": 2422, "sent_id": 28, "sent_start_pos": 4655, "sent_end_pos": 4977, "title": "Fake meat, served six ways"}, "text": "The animal cells provide the color, smell, or taste of meat, but not the substance. This relies on industrial biotech and large-scale cell-culture production methods already used in the pharma industry. Level 3 is the first level that requires going beyond the tools and the science already available in the food business."}
{"meta": {"doc_id": 2422, "sent_id": 29, "sent_start_pos": 4739, "sent_end_pos": 5121, "title": "Fake meat, served six ways"}, "text": "This relies on industrial biotech and large-scale cell-culture production methods already used in the pharma industry. Level 3 is the first level that requires going beyond the tools and the science already available in the food business. Level 4: That's a Spicy Meatball\nLevel 4 alternatives are pure cultured animal cells like the products Memphis Meats and others are working on."}
{"meta": {"doc_id": 2422, "sent_id": 30, "sent_start_pos": 4858, "sent_end_pos": 5266, "title": "Fake meat, served six ways"}, "text": "Level 3 is the first level that requires going beyond the tools and the science already available in the food business. Level 4: That's a Spicy Meatball\nLevel 4 alternatives are pure cultured animal cells like the products Memphis Meats and others are working on. The texture and shape of a real steak comes from the muscle cells that grow around the bones and otherwise self-organize into bundles of tissue."}
{"meta": {"doc_id": 2422, "sent_id": 31, "sent_start_pos": 4978, "sent_end_pos": 5402, "title": "Fake meat, served six ways"}, "text": "Level 4: That's a Spicy Meatball\nLevel 4 alternatives are pure cultured animal cells like the products Memphis Meats and others are working on. The texture and shape of a real steak comes from the muscle cells that grow around the bones and otherwise self-organize into bundles of tissue. At Level 4, we aren\u2019t really dealing with sophisticated texture yet, so we\u2019re pretty much turning the cells we\u2019ve grown into meatballs."}
{"meta": {"doc_id": 2422, "sent_id": 32, "sent_start_pos": 5122, "sent_end_pos": 5570, "title": "Fake meat, served six ways"}, "text": "The texture and shape of a real steak comes from the muscle cells that grow around the bones and otherwise self-organize into bundles of tissue. At Level 4, we aren\u2019t really dealing with sophisticated texture yet, so we\u2019re pretty much turning the cells we\u2019ve grown into meatballs. (The difference between this and Level 3 is that most of the mass of the food here is animal cells, whereas Level 3 is mostly plant-based with cells sprinkled on top.)"}
{"meta": {"doc_id": 2422, "sent_id": 33, "sent_start_pos": 5267, "sent_end_pos": 5794, "title": "Fake meat, served six ways"}, "text": "At Level 4, we aren\u2019t really dealing with sophisticated texture yet, so we\u2019re pretty much turning the cells we\u2019ve grown into meatballs. (The difference between this and Level 3 is that most of the mass of the food here is animal cells, whereas Level 3 is mostly plant-based with cells sprinkled on top.) Right now, the primary \u201cmedia\u201d for cell cultures is fetal serum (the most common type is harvested from cow fetuses), and it currently takes roughly 50 liters of serum and costs about $6,000 to produce a single beef burger."}
{"meta": {"doc_id": 2422, "sent_id": 34, "sent_start_pos": 5403, "sent_end_pos": 5937, "title": "Fake meat, served six ways"}, "text": "(The difference between this and Level 3 is that most of the mass of the food here is animal cells, whereas Level 3 is mostly plant-based with cells sprinkled on top.) Right now, the primary \u201cmedia\u201d for cell cultures is fetal serum (the most common type is harvested from cow fetuses), and it currently takes roughly 50 liters of serum and costs about $6,000 to produce a single beef burger. A key breakthrough needed to push us into Level 4 reasonably is figuring out a viable way of feeding cells using non-animal sources of energy."}
{"meta": {"doc_id": 2422, "sent_id": 35, "sent_start_pos": 5571, "sent_end_pos": 6007, "title": "Fake meat, served six ways"}, "text": "Right now, the primary \u201cmedia\u201d for cell cultures is fetal serum (the most common type is harvested from cow fetuses), and it currently takes roughly 50 liters of serum and costs about $6,000 to produce a single beef burger. A key breakthrough needed to push us into Level 4 reasonably is figuring out a viable way of feeding cells using non-animal sources of energy. This will involve new science on the cell side and on the media side."}
{"meta": {"doc_id": 2422, "sent_id": 36, "sent_start_pos": 5795, "sent_end_pos": 6125, "title": "Fake meat, served six ways"}, "text": "A key breakthrough needed to push us into Level 4 reasonably is figuring out a viable way of feeding cells using non-animal sources of energy. This will involve new science on the cell side and on the media side. And we need to better understand and reproduce nutrients and flavor molecules in addition to producing pure calories."}
{"meta": {"doc_id": 2422, "sent_id": 37, "sent_start_pos": 5938, "sent_end_pos": 6222, "title": "Fake meat, served six ways"}, "text": "This will involve new science on the cell side and on the media side. And we need to better understand and reproduce nutrients and flavor molecules in addition to producing pure calories. Level 5: Tastes Like Chicken\nNow we get something actually like a chicken thigh or T-bone steak."}
{"meta": {"doc_id": 2422, "sent_id": 38, "sent_start_pos": 6008, "sent_end_pos": 6404, "title": "Fake meat, served six ways"}, "text": "And we need to better understand and reproduce nutrients and flavor molecules in addition to producing pure calories. Level 5: Tastes Like Chicken\nNow we get something actually like a chicken thigh or T-bone steak. This is the Jetsons\u2019 version that people imagine when they hear the phrase \u201clab-grown meat.\u201d It is very much the goal of the alternative meat effort, and no one has achieved it yet."}
{"meta": {"doc_id": 2422, "sent_id": 39, "sent_start_pos": 6126, "sent_end_pos": 6599, "title": "Fake meat, served six ways"}, "text": "Level 5: Tastes Like Chicken\nNow we get something actually like a chicken thigh or T-bone steak. This is the Jetsons\u2019 version that people imagine when they hear the phrase \u201clab-grown meat.\u201d It is very much the goal of the alternative meat effort, and no one has achieved it yet. Scientifically, this requires the kind of advanced tissue science that is currently being developed to allow us to swap failed organs in our bodies with replacements grown outside of our bodies."}
{"meta": {"doc_id": 2422, "sent_id": 40, "sent_start_pos": 6223, "sent_end_pos": 6810, "title": "Fake meat, served six ways"}, "text": "This is the Jetsons\u2019 version that people imagine when they hear the phrase \u201clab-grown meat.\u201d It is very much the goal of the alternative meat effort, and no one has achieved it yet. Scientifically, this requires the kind of advanced tissue science that is currently being developed to allow us to swap failed organs in our bodies with replacements grown outside of our bodies. A beaker full of animal cells doesn\u2019t give you the texture of a steak; with this technology, scientists can use 3-D scaffolding to encourage 3-D growth, and they can grow blood vessels in these tissues as well."}
{"meta": {"doc_id": 2422, "sent_id": 41, "sent_start_pos": 6405, "sent_end_pos": 6968, "title": "Fake meat, served six ways"}, "text": "Scientifically, this requires the kind of advanced tissue science that is currently being developed to allow us to swap failed organs in our bodies with replacements grown outside of our bodies. A beaker full of animal cells doesn\u2019t give you the texture of a steak; with this technology, scientists can use 3-D scaffolding to encourage 3-D growth, and they can grow blood vessels in these tissues as well. We can even use plant-based materials as the scaffolding, but what we really want is for that scaffolding to also grow, which is how organs in our body grow."}
{"meta": {"doc_id": 2422, "sent_id": 42, "sent_start_pos": 6600, "sent_end_pos": 7211, "title": "Fake meat, served six ways"}, "text": "A beaker full of animal cells doesn\u2019t give you the texture of a steak; with this technology, scientists can use 3-D scaffolding to encourage 3-D growth, and they can grow blood vessels in these tissues as well. We can even use plant-based materials as the scaffolding, but what we really want is for that scaffolding to also grow, which is how organs in our body grow. It turns out that research in regenerative medicine and tissue science is giving us a better understanding of how we might create the texture and scaffolding required to grow an actual kidney instead of just a petri dish full of kidney cells."}
{"meta": {"doc_id": 2422, "sent_id": 43, "sent_start_pos": 6811, "sent_end_pos": 7313, "title": "Fake meat, served six ways"}, "text": "We can even use plant-based materials as the scaffolding, but what we really want is for that scaffolding to also grow, which is how organs in our body grow. It turns out that research in regenerative medicine and tissue science is giving us a better understanding of how we might create the texture and scaffolding required to grow an actual kidney instead of just a petri dish full of kidney cells. Scientists have not really focused however, on the idea of deploying tissue science for food ... yet."}
{"meta": {"doc_id": 2422, "sent_id": 44, "sent_start_pos": 6969, "sent_end_pos": 7526, "title": "Fake meat, served six ways"}, "text": "It turns out that research in regenerative medicine and tissue science is giving us a better understanding of how we might create the texture and scaffolding required to grow an actual kidney instead of just a petri dish full of kidney cells. Scientists have not really focused however, on the idea of deploying tissue science for food ... yet. Tasty fake meat is exciting, but not nearly as exciting as the idea of a completely new food system with a diversity of inputs and completely new outputs\u2014a completely new food science."}
{"meta": {"doc_id": 2422, "sent_id": 45, "sent_start_pos": 7212, "sent_end_pos": 7843, "title": "Fake meat, served six ways"}, "text": "Scientists have not really focused however, on the idea of deploying tissue science for food ... yet. Tasty fake meat is exciting, but not nearly as exciting as the idea of a completely new food system with a diversity of inputs and completely new outputs\u2014a completely new food science. Imagine augmented meat tissue with novel nutritional profiles, texture, flavor and other characteristics\u2014in other words, instead of just trying to recreate meat, scientists develop completely new ingredients that are actually \u201cpost-meat.\u201d\nLet me explain what investors and I find so exciting about all this activity."}
{"meta": {"doc_id": 2422, "sent_id": 46, "sent_start_pos": 7342, "sent_end_pos": 8079, "title": "Fake meat, served six ways"}, "text": "Tasty fake meat is exciting, but not nearly as exciting as the idea of a completely new food system with a diversity of inputs and completely new outputs\u2014a completely new food science. Imagine augmented meat tissue with novel nutritional profiles, texture, flavor and other characteristics\u2014in other words, instead of just trying to recreate meat, scientists develop completely new ingredients that are actually \u201cpost-meat.\u201d\nLet me explain what investors and I find so exciting about all this activity. My dream, and Isha\u2019s dream, is that we figure out a way to make use of extremely efficient \u201cenergy harvesters\u201d like algae, kelp, fungi, or anything else that can take a renewable energy source like the sun and convert it into calories."}
{"meta": {"doc_id": 2422, "sent_id": 47, "sent_start_pos": 7527, "sent_end_pos": 8253, "title": "Fake meat, served six ways"}, "text": "Imagine augmented meat tissue with novel nutritional profiles, texture, flavor and other characteristics\u2014in other words, instead of just trying to recreate meat, scientists develop completely new ingredients that are actually \u201cpost-meat.\u201d\nLet me explain what investors and I find so exciting about all this activity. My dream, and Isha\u2019s dream, is that we figure out a way to make use of extremely efficient \u201cenergy harvesters\u201d like algae, kelp, fungi, or anything else that can take a renewable energy source like the sun and convert it into calories. The idea is to figure out a mechanism to convert these organic stores of energy into inputs for bioreactors, which would then transform these calories into anything we want."}
{"meta": {"doc_id": 2422, "sent_id": 48, "sent_start_pos": 7844, "sent_end_pos": 8717, "title": "Fake meat, served six ways"}, "text": "My dream, and Isha\u2019s dream, is that we figure out a way to make use of extremely efficient \u201cenergy harvesters\u201d like algae, kelp, fungi, or anything else that can take a renewable energy source like the sun and convert it into calories. The idea is to figure out a mechanism to convert these organic stores of energy into inputs for bioreactors, which would then transform these calories into anything we want. Scientists have made so many advances in terms of using microbes as factories (including fermentation) as well as in genomics, tissue engineering, and stem cells, that it\u2019s feasible to imagine a system that unleashes a culinary bonanza of nutritional, flavor and texture options for future chefs while also lowering the environmental impact of belching cows, concentrated animal-feeding operations, and expensive and energy-inefficient refrigerated supply chains."}
{"meta": {"doc_id": 2422, "sent_id": 49, "sent_start_pos": 8080, "sent_end_pos": 8874, "title": "Fake meat, served six ways"}, "text": "The idea is to figure out a mechanism to convert these organic stores of energy into inputs for bioreactors, which would then transform these calories into anything we want. Scientists have made so many advances in terms of using microbes as factories (including fermentation) as well as in genomics, tissue engineering, and stem cells, that it\u2019s feasible to imagine a system that unleashes a culinary bonanza of nutritional, flavor and texture options for future chefs while also lowering the environmental impact of belching cows, concentrated animal-feeding operations, and expensive and energy-inefficient refrigerated supply chains. (The livestock industry uses 70 percent of all land suitable for agriculture, and livestock accounts for as much as 51 percent of greenhouse gas emissions.)"}
{"meta": {"doc_id": 2422, "sent_id": 50, "sent_start_pos": 8254, "sent_end_pos": 8948, "title": "Fake meat, served six ways"}, "text": "Scientists have made so many advances in terms of using microbes as factories (including fermentation) as well as in genomics, tissue engineering, and stem cells, that it\u2019s feasible to imagine a system that unleashes a culinary bonanza of nutritional, flavor and texture options for future chefs while also lowering the environmental impact of belching cows, concentrated animal-feeding operations, and expensive and energy-inefficient refrigerated supply chains. (The livestock industry uses 70 percent of all land suitable for agriculture, and livestock accounts for as much as 51 percent of greenhouse gas emissions.) Eating meat is one of the most environmentally negative things humans do."}
{"meta": {"doc_id": 2422, "sent_id": 51, "sent_start_pos": 8718, "sent_end_pos": 9251, "title": "Fake meat, served six ways"}, "text": "(The livestock industry uses 70 percent of all land suitable for agriculture, and livestock accounts for as much as 51 percent of greenhouse gas emissions.) Eating meat is one of the most environmentally negative things humans do. I can imagine a food supply system that is even more efficient than eating fresh plants, which still requires refrigeration: Move the materials and calories around in shelf-stable forms, and simply \u201cjust add water\u201d at the end in the way that adding water magically spawned sea monkeys when I was a kid."}
{"meta": {"doc_id": 2422, "sent_id": 52, "sent_start_pos": 8875, "sent_end_pos": 9452, "title": "Fake meat, served six ways"}, "text": "Eating meat is one of the most environmentally negative things humans do. I can imagine a food supply system that is even more efficient than eating fresh plants, which still requires refrigeration: Move the materials and calories around in shelf-stable forms, and simply \u201cjust add water\u201d at the end in the way that adding water magically spawned sea monkeys when I was a kid. Such a food industry would also need to develop bioreactors\u2014think bread machines with cell cartridges or breweries that make meat, not beer\u2014that would intake the raw materials and spit out lamb chops."}
{"meta": {"doc_id": 2422, "sent_id": 53, "sent_start_pos": 8949, "sent_end_pos": 9548, "title": "Fake meat, served six ways"}, "text": "I can imagine a food supply system that is even more efficient than eating fresh plants, which still requires refrigeration: Move the materials and calories around in shelf-stable forms, and simply \u201cjust add water\u201d at the end in the way that adding water magically spawned sea monkeys when I was a kid. Such a food industry would also need to develop bioreactors\u2014think bread machines with cell cartridges or breweries that make meat, not beer\u2014that would intake the raw materials and spit out lamb chops. That feels like an engineering task to be undertaken once the cellular biology gets worked out."}
{"meta": {"doc_id": 2422, "sent_id": 54, "sent_start_pos": 9252, "sent_end_pos": 9678, "title": "Fake meat, served six ways"}, "text": "Such a food industry would also need to develop bioreactors\u2014think bread machines with cell cartridges or breweries that make meat, not beer\u2014that would intake the raw materials and spit out lamb chops. That feels like an engineering task to be undertaken once the cellular biology gets worked out. So far, most of the investment in the companies trying to rethink meat has come from venture capitalists, and they are impatient."}
{"meta": {"doc_id": 2422, "sent_id": 55, "sent_start_pos": 9453, "sent_end_pos": 9888, "title": "Fake meat, served six ways"}, "text": "That feels like an engineering task to be undertaken once the cellular biology gets worked out. So far, most of the investment in the companies trying to rethink meat has come from venture capitalists, and they are impatient. This puts the startups they underwrite under pressure to get products to market quickly and generate financial returns, and makes it highly unlikely that we\u2019ll get to Level 4 or 5 with VC-backed science alone."}
{"meta": {"doc_id": 2422, "sent_id": 56, "sent_start_pos": 9549, "sent_end_pos": 10079, "title": "Fake meat, served six ways"}, "text": "So far, most of the investment in the companies trying to rethink meat has come from venture capitalists, and they are impatient. This puts the startups they underwrite under pressure to get products to market quickly and generate financial returns, and makes it highly unlikely that we\u2019ll get to Level 4 or 5 with VC-backed science alone. Basic research funding from philanthropy and government needs to be increased, and biomedical researchers need to be convinced to apply their expertise and knowledge to cellular agriculture."}
{"meta": {"doc_id": 2422, "sent_id": 57, "sent_start_pos": 9679, "sent_end_pos": 10163, "title": "Fake meat, served six ways"}, "text": "This puts the startups they underwrite under pressure to get products to market quickly and generate financial returns, and makes it highly unlikely that we\u2019ll get to Level 4 or 5 with VC-backed science alone. Basic research funding from philanthropy and government needs to be increased, and biomedical researchers need to be convinced to apply their expertise and knowledge to cellular agriculture. And, indeed, many labs that Isha is working with are working on the basic research."}
{"meta": {"doc_id": 2422, "sent_id": 58, "sent_start_pos": 9889, "sent_end_pos": 10409, "title": "Fake meat, served six ways"}, "text": "Basic research funding from philanthropy and government needs to be increased, and biomedical researchers need to be convinced to apply their expertise and knowledge to cellular agriculture. And, indeed, many labs that Isha is working with are working on the basic research. Some are focused on establishing cell cultures from agricultural animals; others are working to grow animals cells on plants by removing cells from the plants, replacing them with living muscle cells effectively using the plant as a scaffolding."}
{"meta": {"doc_id": 2422, "sent_id": 59, "sent_start_pos": 10080, "sent_end_pos": 10563, "title": "Fake meat, served six ways"}, "text": "And, indeed, many labs that Isha is working with are working on the basic research. Some are focused on establishing cell cultures from agricultural animals; others are working to grow animals cells on plants by removing cells from the plants, replacing them with living muscle cells effectively using the plant as a scaffolding. The work of Isha's small network of scientists reminds me of the early days of neuroscience, when there was almost no federal funding for brain research."}
{"meta": {"doc_id": 2422, "sent_id": 60, "sent_start_pos": 10164, "sent_end_pos": 10838, "title": "Fake meat, served six ways"}, "text": "Some are focused on establishing cell cultures from agricultural animals; others are working to grow animals cells on plants by removing cells from the plants, replacing them with living muscle cells effectively using the plant as a scaffolding. The work of Isha's small network of scientists reminds me of the early days of neuroscience, when there was almost no federal funding for brain research. Then, suddenly, it became \u201ca thing.\u201d I think we\u2019re reaching that same moment for meat, as climate change becomes an ever more pressing concern; the health impact of eating meat becomes more clear; and our population approaches 10 billion people, threatening our food supply."}
{"meta": {"doc_id": 2422, "sent_id": 61, "sent_start_pos": 10410, "sent_end_pos": 10941, "title": "Fake meat, served six ways"}, "text": "The work of Isha's small network of scientists reminds me of the early days of neuroscience, when there was almost no federal funding for brain research. Then, suddenly, it became \u201ca thing.\u201d I think we\u2019re reaching that same moment for meat, as climate change becomes an ever more pressing concern; the health impact of eating meat becomes more clear; and our population approaches 10 billion people, threatening our food supply. Most of the people currently supporting the cellular agriculture movement are animal rights advocates."}
{"meta": {"doc_id": 2422, "sent_id": 62, "sent_start_pos": 10564, "sent_end_pos": 11095, "title": "Fake meat, served six ways"}, "text": "Then, suddenly, it became \u201ca thing.\u201d I think we\u2019re reaching that same moment for meat, as climate change becomes an ever more pressing concern; the health impact of eating meat becomes more clear; and our population approaches 10 billion people, threatening our food supply. Most of the people currently supporting the cellular agriculture movement are animal rights advocates. That\u2019s a fine motivation, but figuring out a completely new design for the creation of food is going to take some real science, and we need to start now."}
{"meta": {"doc_id": 2422, "sent_id": 63, "sent_start_pos": 10839, "sent_end_pos": 11347, "title": "Fake meat, served six ways"}, "text": "Most of the people currently supporting the cellular agriculture movement are animal rights advocates. That\u2019s a fine motivation, but figuring out a completely new design for the creation of food is going to take some real science, and we need to start now. Not only might it save us from future starvation, make a major contribution to reversing climate change, correct the antibiotic resistance armageddon, and help restore fish populations in the oceans, it might also unlock a culinary creative explosion."}
{"meta": {"doc_id": 2422, "sent_id": 64, "sent_start_pos": 10942, "sent_end_pos": 11498, "title": "Fake meat, served six ways"}, "text": "That\u2019s a fine motivation, but figuring out a completely new design for the creation of food is going to take some real science, and we need to start now. Not only might it save us from future starvation, make a major contribution to reversing climate change, correct the antibiotic resistance armageddon, and help restore fish populations in the oceans, it might also unlock a culinary creative explosion. (1) Disclosure: After meeting Isha, I recruited her to be a Director\u2019s Fellow at the Media Lab where she is inspiring us with her work and her vision."}
{"meta": {"doc_id": 2422, "sent_id": 65, "sent_start_pos": 11096, "sent_end_pos": [], "title": "Fake meat, served six ways"}, "text": "Not only might it save us from future starvation, make a major contribution to reversing climate change, correct the antibiotic resistance armageddon, and help restore fish populations in the oceans, it might also unlock a culinary creative explosion. (1) Disclosure: After meeting Isha, I recruited her to be a Director\u2019s Fellow at the Media Lab where she is inspiring us with her work and her vision. "}
{"meta": {"doc_id": 2423, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 261, "title": "A Fresh Take on Fake Meat"}, "text": " Export articles to Mendeley\nGet article recommendations from ACS based on references in your Mendeley library. Export articles to Mendeley\nGet article recommendations from ACS based on references in your Mendeley library."}
{"meta": {"doc_id": 2423, "sent_id": 1, "sent_start_pos": 20, "sent_end_pos": 326, "title": "A Fresh Take on Fake Meat"}, "text": "Export articles to Mendeley\nGet article recommendations from ACS based on references in your Mendeley library. Export articles to Mendeley\nGet article recommendations from ACS based on references in your Mendeley library. You\u2019ve supercharged your research process with ACS and Mendeley!"}
{"meta": {"doc_id": 2423, "sent_id": 2, "sent_start_pos": 151, "sent_end_pos": 431, "title": "A Fresh Take on Fake Meat"}, "text": "Export articles to Mendeley\nGet article recommendations from ACS based on references in your Mendeley library. You\u2019ve supercharged your research process with ACS and Mendeley! Please note: If you switch to a different device, you may be asked to login again with only your ACS ID."}
{"meta": {"doc_id": 2423, "sent_id": 3, "sent_start_pos": 262, "sent_end_pos": 431, "title": "A Fresh Take on Fake Meat"}, "text": "You\u2019ve supercharged your research process with ACS and Mendeley! Please note: If you switch to a different device, you may be asked to login again with only your ACS ID. Please note: If you switch to a different device, you may be asked to login again with only your ACS ID."}
{"meta": {"doc_id": 2423, "sent_id": 4, "sent_start_pos": 327, "sent_end_pos": 431, "title": "A Fresh Take on Fake Meat"}, "text": "Please note: If you switch to a different device, you may be asked to login again with only your ACS ID. Please note: If you switch to a different device, you may be asked to login again with only your ACS ID. Please note: If you switch to a different device, you may be asked to login again with only your ACS ID."}
{"meta": {"doc_id": 2423, "sent_id": 5, "sent_start_pos": 327, "sent_end_pos": 715, "title": "A Fresh Take on Fake Meat"}, "text": "Please note: If you switch to a different device, you may be asked to login again with only your ACS ID. Please note: If you switch to a different device, you may be asked to login again with only your ACS ID. Please login with your ACS ID before connecting to your Mendeley account."}
{"meta": {"doc_id": 2423, "sent_id": 6, "sent_start_pos": 327, "sent_end_pos": [], "title": "A Fresh Take on Fake Meat"}, "text": "Please note: If you switch to a different device, you may be asked to login again with only your ACS ID. Please login with your ACS ID before connecting to your Mendeley account. "}
{"meta": {"doc_id": 2424, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 508, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": " London, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Globally, increasing demand for animal protein is driving the livestock production, which leads to key issues such as increased greenhouse gas emissions and increased pressure on land and water usage. This has opened a great opportunity for alternative proteins, such as plant-based protein, edible insects, cultured meats, algal protein, and microbial protein, which have the capability to satisfy food need with the high nutrition and environmental sustainability."}
{"meta": {"doc_id": 2424, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 729, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "London, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Globally, increasing demand for animal protein is driving the livestock production, which leads to key issues such as increased greenhouse gas emissions and increased pressure on land and water usage. This has opened a great opportunity for alternative proteins, such as plant-based protein, edible insects, cultured meats, algal protein, and microbial protein, which have the capability to satisfy food need with the high nutrition and environmental sustainability. Since 4-5 years, there has been a growing consumer and investor interest in the alternative protein, which have a great potential to play a vital role in reducing the impact on the current food and agriculture ecosystem."}
{"meta": {"doc_id": 2424, "sent_id": 2, "sent_start_pos": 243, "sent_end_pos": 1260, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "This has opened a great opportunity for alternative proteins, such as plant-based protein, edible insects, cultured meats, algal protein, and microbial protein, which have the capability to satisfy food need with the high nutrition and environmental sustainability. Since 4-5 years, there has been a growing consumer and investor interest in the alternative protein, which have a great potential to play a vital role in reducing the impact on the current food and agriculture ecosystem. According to a new market research report \u201cAlternative Protein Market by Stage/Type (Insect, Algae, Duckweed, Lab Meat, Pea, Rice, Potato, Corn, Soy, Wheat, Corn, Mycoprotein, Mushrooms), Application, and Geography - Global Forecast to 2025\u201d, published by Meticulous Research\u00ae, the global alternative protein market, in terms of value, is expected to grow at a CAGR of 9.5% from 2019 to reach $17.9 billion by 2025; while in terms of volume, the market is expected to grow at a CAGR of 5.2% from 2019 to reach 9,787.4 KMT by 2025."}
{"meta": {"doc_id": 2424, "sent_id": 3, "sent_start_pos": 509, "sent_end_pos": 1615, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "Since 4-5 years, there has been a growing consumer and investor interest in the alternative protein, which have a great potential to play a vital role in reducing the impact on the current food and agriculture ecosystem. According to a new market research report \u201cAlternative Protein Market by Stage/Type (Insect, Algae, Duckweed, Lab Meat, Pea, Rice, Potato, Corn, Soy, Wheat, Corn, Mycoprotein, Mushrooms), Application, and Geography - Global Forecast to 2025\u201d, published by Meticulous Research\u00ae, the global alternative protein market, in terms of value, is expected to grow at a CAGR of 9.5% from 2019 to reach $17.9 billion by 2025; while in terms of volume, the market is expected to grow at a CAGR of 5.2% from 2019 to reach 9,787.4 KMT by 2025. The high growth of the global alternative protein market is mainly attributed to growing urbanization with new consumer aspiration, rising venture investments in alternative protein companies, innovation in food technology, high nutritional value of edible insects, and environmental sustainability with production and consumption of alternative protein."}
{"meta": {"doc_id": 2424, "sent_id": 4, "sent_start_pos": 730, "sent_end_pos": 1766, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "According to a new market research report \u201cAlternative Protein Market by Stage/Type (Insect, Algae, Duckweed, Lab Meat, Pea, Rice, Potato, Corn, Soy, Wheat, Corn, Mycoprotein, Mushrooms), Application, and Geography - Global Forecast to 2025\u201d, published by Meticulous Research\u00ae, the global alternative protein market, in terms of value, is expected to grow at a CAGR of 9.5% from 2019 to reach $17.9 billion by 2025; while in terms of volume, the market is expected to grow at a CAGR of 5.2% from 2019 to reach 9,787.4 KMT by 2025. The high growth of the global alternative protein market is mainly attributed to growing urbanization with new consumer aspiration, rising venture investments in alternative protein companies, innovation in food technology, high nutritional value of edible insects, and environmental sustainability with production and consumption of alternative protein. Moreover, growing research & development and emerging economies provides significant growth opportunities for the various stakeholders in this market."}
{"meta": {"doc_id": 2424, "sent_id": 5, "sent_start_pos": 1261, "sent_end_pos": 1926, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "The high growth of the global alternative protein market is mainly attributed to growing urbanization with new consumer aspiration, rising venture investments in alternative protein companies, innovation in food technology, high nutritional value of edible insects, and environmental sustainability with production and consumption of alternative protein. Moreover, growing research & development and emerging economies provides significant growth opportunities for the various stakeholders in this market. However, high cost of alternative protein and significant preference for animal-based products are expected to hamper the growth of this market to some extent."}
{"meta": {"doc_id": 2424, "sent_id": 6, "sent_start_pos": 1616, "sent_end_pos": 2218, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "Moreover, growing research & development and emerging economies provides significant growth opportunities for the various stakeholders in this market. However, high cost of alternative protein and significant preference for animal-based products are expected to hamper the growth of this market to some extent. The factors such as desire for clean labels, ease of digestion, the need or desire to avoid allergens, compatibility with vegetarian and vegan lifestyles, and concerns about sustainability among the general population are putting the spotlight on plant proteins in alternative protein space."}
{"meta": {"doc_id": 2424, "sent_id": 7, "sent_start_pos": 1767, "sent_end_pos": 2332, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "However, high cost of alternative protein and significant preference for animal-based products are expected to hamper the growth of this market to some extent. The factors such as desire for clean labels, ease of digestion, the need or desire to avoid allergens, compatibility with vegetarian and vegan lifestyles, and concerns about sustainability among the general population are putting the spotlight on plant proteins in alternative protein space. Based on type, soy protein segment commanded the largest share of the overall plant-based protein market in 2019."}
{"meta": {"doc_id": 2424, "sent_id": 8, "sent_start_pos": 1927, "sent_end_pos": 2679, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "The factors such as desire for clean labels, ease of digestion, the need or desire to avoid allergens, compatibility with vegetarian and vegan lifestyles, and concerns about sustainability among the general population are putting the spotlight on plant proteins in alternative protein space. Based on type, soy protein segment commanded the largest share of the overall plant-based protein market in 2019. The large share of soy protein is mainly attributed to higher consumer acceptance level, presence of large number of manufacturers and their high scale of production, low cost than other types of plant proteins, increased demand for plant-based products, easy availability of raw materials, and large number of applications in various industries."}
{"meta": {"doc_id": 2424, "sent_id": 9, "sent_start_pos": 2219, "sent_end_pos": 2900, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "Based on type, soy protein segment commanded the largest share of the overall plant-based protein market in 2019. The large share of soy protein is mainly attributed to higher consumer acceptance level, presence of large number of manufacturers and their high scale of production, low cost than other types of plant proteins, increased demand for plant-based products, easy availability of raw materials, and large number of applications in various industries. Enquire before buying: https://www.meticulousresearch.com/enquire-before-buying/cp_id=4985\nBased on application, plant-based protein products commanded the largest share of the overall alternative protein market in 2019."}
{"meta": {"doc_id": 2424, "sent_id": 10, "sent_start_pos": 2333, "sent_end_pos": 3209, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "The large share of soy protein is mainly attributed to higher consumer acceptance level, presence of large number of manufacturers and their high scale of production, low cost than other types of plant proteins, increased demand for plant-based products, easy availability of raw materials, and large number of applications in various industries. Enquire before buying: https://www.meticulousresearch.com/enquire-before-buying/cp_id=4985\nBased on application, plant-based protein products commanded the largest share of the overall alternative protein market in 2019. The large share of this segment is mainly attributed to the high consumer demand for sustainable products, growing knowledge about the health benefits of plant protein, increasing health concerns over animal products and ingredients, increasing vegan population, and rising meat prices and clean label trend."}
{"meta": {"doc_id": 2424, "sent_id": 11, "sent_start_pos": 2680, "sent_end_pos": 3576, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "Enquire before buying: https://www.meticulousresearch.com/enquire-before-buying/cp_id=4985\nBased on application, plant-based protein products commanded the largest share of the overall alternative protein market in 2019. The large share of this segment is mainly attributed to the high consumer demand for sustainable products, growing knowledge about the health benefits of plant protein, increasing health concerns over animal products and ingredients, increasing vegan population, and rising meat prices and clean label trend. However, the edible insect-based products are expected to witness a significant growth, owing to high nutritional value of insects, increasing demand for novel food products, growing familiarity with insects-as-food, growing acceptance of insects and insect-based food among people, and environmental sustainability with production and consumption of edible insects."}
{"meta": {"doc_id": 2424, "sent_id": 12, "sent_start_pos": 2901, "sent_end_pos": 3722, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "The large share of this segment is mainly attributed to the high consumer demand for sustainable products, growing knowledge about the health benefits of plant protein, increasing health concerns over animal products and ingredients, increasing vegan population, and rising meat prices and clean label trend. However, the edible insect-based products are expected to witness a significant growth, owing to high nutritional value of insects, increasing demand for novel food products, growing familiarity with insects-as-food, growing acceptance of insects and insect-based food among people, and environmental sustainability with production and consumption of edible insects. Geographically, North America commanded the largest share of the overall alternative protein market in 2019, followed by Europe and Asia-Pacific."}
{"meta": {"doc_id": 2424, "sent_id": 13, "sent_start_pos": 3210, "sent_end_pos": 3990, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "However, the edible insect-based products are expected to witness a significant growth, owing to high nutritional value of insects, increasing demand for novel food products, growing familiarity with insects-as-food, growing acceptance of insects and insect-based food among people, and environmental sustainability with production and consumption of edible insects. Geographically, North America commanded the largest share of the overall alternative protein market in 2019, followed by Europe and Asia-Pacific. The large share of this region is mainly attributed to the well-established food and feed industry, rising concerns over animal products and protein, increasing vegan population, growing preference to meat alternatives, and technological advancement in food industry."}
{"meta": {"doc_id": 2424, "sent_id": 14, "sent_start_pos": 3577, "sent_end_pos": 4298, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "Geographically, North America commanded the largest share of the overall alternative protein market in 2019, followed by Europe and Asia-Pacific. The large share of this region is mainly attributed to the well-established food and feed industry, rising concerns over animal products and protein, increasing vegan population, growing preference to meat alternatives, and technological advancement in food industry. However, Asia-Pacific region is expected to grow at the fastest CAGR during the forecast period, mainly due to increasing protein rich diet awareness, increasing health consciousness, growing technological advancements in food & beverages industry, growing economy, and increasing raw material availability."}
{"meta": {"doc_id": 2424, "sent_id": 15, "sent_start_pos": 3723, "sent_end_pos": 4534, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "The large share of this region is mainly attributed to the well-established food and feed industry, rising concerns over animal products and protein, increasing vegan population, growing preference to meat alternatives, and technological advancement in food industry. However, Asia-Pacific region is expected to grow at the fastest CAGR during the forecast period, mainly due to increasing protein rich diet awareness, increasing health consciousness, growing technological advancements in food & beverages industry, growing economy, and increasing raw material availability. Also, factors such as rising adoption of emerging technologies for product innovation, collaboration between international and domestic food companies, and presence of large number of players supports the growth of Asia Pacific market."}
{"meta": {"doc_id": 2424, "sent_id": 16, "sent_start_pos": 3991, "sent_end_pos": 4902, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "However, Asia-Pacific region is expected to grow at the fastest CAGR during the forecast period, mainly due to increasing protein rich diet awareness, increasing health consciousness, growing technological advancements in food & beverages industry, growing economy, and increasing raw material availability. Also, factors such as rising adoption of emerging technologies for product innovation, collaboration between international and domestic food companies, and presence of large number of players supports the growth of Asia Pacific market. Some of the key players operating in the global alternative protein market are AgriProtein (South Africa), Ynsect (France), Enterra Feed Corporation (Canada), Protix (The Netherlands), Proti-Farm Holding NV (The Netherlands), Entomo Farms (Canada), Global Bugs Asia Co., Ltd. (Thailand), Aspire Food Group (US), Tiny Farms (US), EntoCube (Finland), EnviroFlight, LCC."}
{"meta": {"doc_id": 2424, "sent_id": 17, "sent_start_pos": 4299, "sent_end_pos": 4926, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "Also, factors such as rising adoption of emerging technologies for product innovation, collaboration between international and domestic food companies, and presence of large number of players supports the growth of Asia Pacific market. Some of the key players operating in the global alternative protein market are AgriProtein (South Africa), Ynsect (France), Enterra Feed Corporation (Canada), Protix (The Netherlands), Proti-Farm Holding NV (The Netherlands), Entomo Farms (Canada), Global Bugs Asia Co., Ltd. (Thailand), Aspire Food Group (US), Tiny Farms (US), EntoCube (Finland), EnviroFlight, LCC. (US), Entofood Sdn Bhd."}
{"meta": {"doc_id": 2424, "sent_id": 18, "sent_start_pos": 4535, "sent_end_pos": 5190, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "Some of the key players operating in the global alternative protein market are AgriProtein (South Africa), Ynsect (France), Enterra Feed Corporation (Canada), Protix (The Netherlands), Proti-Farm Holding NV (The Netherlands), Entomo Farms (Canada), Global Bugs Asia Co., Ltd. (Thailand), Aspire Food Group (US), Tiny Farms (US), EntoCube (Finland), EnviroFlight, LCC. (US), Entofood Sdn Bhd. (Malaysia), Coalo Vally Farms (US), Armstrong Cricket Farm Georgia (US), Rocky Mountain Micro Ranch (US), DIC Corporation (Japan), Cellana Inc. (US), Taiwan Chlorella Manufacturing Company (China), Microalgaetech International Sdn Bhd (Malaysia), BlueBioTech Int."}
{"meta": {"doc_id": 2424, "sent_id": 19, "sent_start_pos": 4903, "sent_end_pos": 5993, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "(US), Entofood Sdn Bhd. (Malaysia), Coalo Vally Farms (US), Armstrong Cricket Farm Georgia (US), Rocky Mountain Micro Ranch (US), DIC Corporation (Japan), Cellana Inc. (US), Taiwan Chlorella Manufacturing Company (China), Microalgaetech International Sdn Bhd (Malaysia), BlueBioTech Int. GmbH (Germany), Algatechologies Ltd. (Israel), Pond Technologies Inc. (Canada), EID - Parry (India) Limited (India), Tianjin Norland Biotech Co., Ltd (China), AlgaeCan Biotech Ltd. (Canada), Corbion NV (The Netherlands), Sun Chlorella Corporation (Japan), Parabel, Inc. (US), Plantible Foods, Inc. (US), Archer Daniels Midland Company (US), Cargill, Incorporated (US), Roquette Fr\u00e8res Le Romain (France), Ingredion Inc (US), Kerry Group (Ireland), EI Dupont de Nemours and Company (US), Now foods (US), Tate & Lyle Plc (UK), AXIOM Foods Inc. (US), Burcon NutraScience Corporation (Canada), BENEO GmbH (Germany), Glanbia Plc (Ireland), Sotexpro (France), Farbest Brands (US), and CHS Inc. (US), Just, Inc. (US), Mosa Meat (The Netherlands), Memphis Meats (US), and MycoTechnology Inc. (US) among others."}
{"meta": {"doc_id": 2424, "sent_id": 20, "sent_start_pos": 4927, "sent_end_pos": 9357, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "(Malaysia), Coalo Vally Farms (US), Armstrong Cricket Farm Georgia (US), Rocky Mountain Micro Ranch (US), DIC Corporation (Japan), Cellana Inc. (US), Taiwan Chlorella Manufacturing Company (China), Microalgaetech International Sdn Bhd (Malaysia), BlueBioTech Int. GmbH (Germany), Algatechologies Ltd. (Israel), Pond Technologies Inc. (Canada), EID - Parry (India) Limited (India), Tianjin Norland Biotech Co., Ltd (China), AlgaeCan Biotech Ltd. (Canada), Corbion NV (The Netherlands), Sun Chlorella Corporation (Japan), Parabel, Inc. (US), Plantible Foods, Inc. (US), Archer Daniels Midland Company (US), Cargill, Incorporated (US), Roquette Fr\u00e8res Le Romain (France), Ingredion Inc (US), Kerry Group (Ireland), EI Dupont de Nemours and Company (US), Now foods (US), Tate & Lyle Plc (UK), AXIOM Foods Inc. (US), Burcon NutraScience Corporation (Canada), BENEO GmbH (Germany), Glanbia Plc (Ireland), Sotexpro (France), Farbest Brands (US), and CHS Inc. (US), Just, Inc. (US), Mosa Meat (The Netherlands), Memphis Meats (US), and MycoTechnology Inc. (US) among others. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/alternative-protein-market-4985/\nScope of the Report:\nAlternative Protein Market by Stage/Type\n- Emerging Alternative ProteinInsectAlgaeDuckweedLab Meat\n- Adolescent Alternative ProteinPeaRiceCornPotatoOthers\n- Matured Alternative ProteinSoyWheatCanolaMushroomMycoproteinOthers\nAlternative Protein Market by Application\n- Plant Protein Market, by ApplicationFood and BeveragesMeat, Poultry, and SeafoodBakeryMeat AnalogueDairy and Dairy AlternativesCereals and SnacksBeveragesOthersAnimal FeedNutrition and Health SupplementPharmaceuticalsOthersAutomatic\n- Insect Protein Market, By ApplicationValue Added Whole InsectsAnimal and Pet Feed ProductsValue Added Insect PowderInsect Protein Bars and Protein ShakesInsect Baked Products and SnacksInsect ConfectionariesInsect BeveragesOthers\n- Aquatic Plant Protein Market, by ApplicationFood and FeedNutraceuticalCosmeticsChemicalsOthers\n- Microbial Protein Market, By ApplicationDairy AlternativesBeveragesFermented ProductsOthers\n- Cultured Meat Market, by ApplicationMeatballsBurgersSausagesHot DogsNuggets\nAlternative Protein Market by Geography\n- North AmericaU.SCanada\n- EuropeGermanyU.KFranceItalySpainThe NetherlandBelgiumDenmarkFinlandRest of Europe (RoE)\n- Asia-Pacific (APAC)ChinaIndiaJapanThailandSouth KoreaVietnamRest of APAC (RoAPAC)\n- Rest of WorldLatin AmericaBrazilMexicoArgentinaRest of Latin America (RoLATAM)Middle East and Africa\nDownload Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4985\nBrowse more related reports:\nBlack Soldier Fly Market by Product Type (Protein Meal, Whole Dried Larvae, Oil, Biofertilizer, Live Insect, Chitin/Chitosan), Application (Animal Feed, Agriculture, Pet Food, Pharmaceutical, and Cosmetics), and Geography- Global Forecast to 2030\nPlant Based Protein Market by Type (Soy Protein, Wheat Protein, Pea Protein, Potato Protein, Rice Protein, Corn Protein) and Application (Foods and Beverage, Animal Feed, Nutrition and Health Supplements, Pharmaceuticals) - Global Forecast to 2025\nFrozen Bakery Market by Type (Breads, Pizza Crusts, Cakes and Pastries, Cookies, Donuts and Pies, Waffles), Product (Ready-to-Prove, Ready-to-Bake, Fully Baked), by Distribution Channel (Food Service, Retail, Industrial, and Online), Speciality Type (Low-Calories, Gluten Free, Organic, Fortified, Sugar Free, Other Specialty Types), End-User ( Artisans bakers, Hotel, Restaurants, and Catering, Supermarkets and Hypermarkets, Bakery Chains, Food Processing Industry) - Global Forecast to 2025\nSoluble Dietary Fibers Market by Source, Type, and Application \u2013 Global Opportunity Analysis and Industry Forecast to 2023\nAlgal Pigments Market by Type (Beta Carotene, Astaxanthin, Fucoxanthin, Phycocyanin, Phycoerythrin), Application (Food and Beverages, Nutraceuticals, Aquaculture, Cosmetics, Pharmaceuticals), and Geography - Global Forecast to 2025\nHuman Nutrition Market by Type (Vitamin, Probiotics, Proteins, Carbohydrates, Fatty Acid, Minerals), Age (Adult, Childhood), Population (Pediatric, Geriatric, Maternal), and Application (Dietary Supplement, Functional Nutrients) - Global Forecast to 2025\nAbout Meticulous Research\u00ae\nThe name of our company defines our services, strengths, and values."}
{"meta": {"doc_id": 2424, "sent_id": 21, "sent_start_pos": 5191, "sent_end_pos": 9490, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "GmbH (Germany), Algatechologies Ltd. (Israel), Pond Technologies Inc. (Canada), EID - Parry (India) Limited (India), Tianjin Norland Biotech Co., Ltd (China), AlgaeCan Biotech Ltd. (Canada), Corbion NV (The Netherlands), Sun Chlorella Corporation (Japan), Parabel, Inc. (US), Plantible Foods, Inc. (US), Archer Daniels Midland Company (US), Cargill, Incorporated (US), Roquette Fr\u00e8res Le Romain (France), Ingredion Inc (US), Kerry Group (Ireland), EI Dupont de Nemours and Company (US), Now foods (US), Tate & Lyle Plc (UK), AXIOM Foods Inc. (US), Burcon NutraScience Corporation (Canada), BENEO GmbH (Germany), Glanbia Plc (Ireland), Sotexpro (France), Farbest Brands (US), and CHS Inc. (US), Just, Inc. (US), Mosa Meat (The Netherlands), Memphis Meats (US), and MycoTechnology Inc. (US) among others. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/alternative-protein-market-4985/\nScope of the Report:\nAlternative Protein Market by Stage/Type\n- Emerging Alternative ProteinInsectAlgaeDuckweedLab Meat\n- Adolescent Alternative ProteinPeaRiceCornPotatoOthers\n- Matured Alternative ProteinSoyWheatCanolaMushroomMycoproteinOthers\nAlternative Protein Market by Application\n- Plant Protein Market, by ApplicationFood and BeveragesMeat, Poultry, and SeafoodBakeryMeat AnalogueDairy and Dairy AlternativesCereals and SnacksBeveragesOthersAnimal FeedNutrition and Health SupplementPharmaceuticalsOthersAutomatic\n- Insect Protein Market, By ApplicationValue Added Whole InsectsAnimal and Pet Feed ProductsValue Added Insect PowderInsect Protein Bars and Protein ShakesInsect Baked Products and SnacksInsect ConfectionariesInsect BeveragesOthers\n- Aquatic Plant Protein Market, by ApplicationFood and FeedNutraceuticalCosmeticsChemicalsOthers\n- Microbial Protein Market, By ApplicationDairy AlternativesBeveragesFermented ProductsOthers\n- Cultured Meat Market, by ApplicationMeatballsBurgersSausagesHot DogsNuggets\nAlternative Protein Market by Geography\n- North AmericaU.SCanada\n- EuropeGermanyU.KFranceItalySpainThe NetherlandBelgiumDenmarkFinlandRest of Europe (RoE)\n- Asia-Pacific (APAC)ChinaIndiaJapanThailandSouth KoreaVietnamRest of APAC (RoAPAC)\n- Rest of WorldLatin AmericaBrazilMexicoArgentinaRest of Latin America (RoLATAM)Middle East and Africa\nDownload Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4985\nBrowse more related reports:\nBlack Soldier Fly Market by Product Type (Protein Meal, Whole Dried Larvae, Oil, Biofertilizer, Live Insect, Chitin/Chitosan), Application (Animal Feed, Agriculture, Pet Food, Pharmaceutical, and Cosmetics), and Geography- Global Forecast to 2030\nPlant Based Protein Market by Type (Soy Protein, Wheat Protein, Pea Protein, Potato Protein, Rice Protein, Corn Protein) and Application (Foods and Beverage, Animal Feed, Nutrition and Health Supplements, Pharmaceuticals) - Global Forecast to 2025\nFrozen Bakery Market by Type (Breads, Pizza Crusts, Cakes and Pastries, Cookies, Donuts and Pies, Waffles), Product (Ready-to-Prove, Ready-to-Bake, Fully Baked), by Distribution Channel (Food Service, Retail, Industrial, and Online), Speciality Type (Low-Calories, Gluten Free, Organic, Fortified, Sugar Free, Other Specialty Types), End-User ( Artisans bakers, Hotel, Restaurants, and Catering, Supermarkets and Hypermarkets, Bakery Chains, Food Processing Industry) - Global Forecast to 2025\nSoluble Dietary Fibers Market by Source, Type, and Application \u2013 Global Opportunity Analysis and Industry Forecast to 2023\nAlgal Pigments Market by Type (Beta Carotene, Astaxanthin, Fucoxanthin, Phycocyanin, Phycoerythrin), Application (Food and Beverages, Nutraceuticals, Aquaculture, Cosmetics, Pharmaceuticals), and Geography - Global Forecast to 2025\nHuman Nutrition Market by Type (Vitamin, Probiotics, Proteins, Carbohydrates, Fatty Acid, Minerals), Age (Adult, Childhood), Population (Pediatric, Geriatric, Maternal), and Application (Dietary Supplement, Functional Nutrients) - Global Forecast to 2025\nAbout Meticulous Research\u00ae\nThe name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details."}
{"meta": {"doc_id": 2424, "sent_id": 22, "sent_start_pos": 5994, "sent_end_pos": 9583, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/alternative-protein-market-4985/\nScope of the Report:\nAlternative Protein Market by Stage/Type\n- Emerging Alternative ProteinInsectAlgaeDuckweedLab Meat\n- Adolescent Alternative ProteinPeaRiceCornPotatoOthers\n- Matured Alternative ProteinSoyWheatCanolaMushroomMycoproteinOthers\nAlternative Protein Market by Application\n- Plant Protein Market, by ApplicationFood and BeveragesMeat, Poultry, and SeafoodBakeryMeat AnalogueDairy and Dairy AlternativesCereals and SnacksBeveragesOthersAnimal FeedNutrition and Health SupplementPharmaceuticalsOthersAutomatic\n- Insect Protein Market, By ApplicationValue Added Whole InsectsAnimal and Pet Feed ProductsValue Added Insect PowderInsect Protein Bars and Protein ShakesInsect Baked Products and SnacksInsect ConfectionariesInsect BeveragesOthers\n- Aquatic Plant Protein Market, by ApplicationFood and FeedNutraceuticalCosmeticsChemicalsOthers\n- Microbial Protein Market, By ApplicationDairy AlternativesBeveragesFermented ProductsOthers\n- Cultured Meat Market, by ApplicationMeatballsBurgersSausagesHot DogsNuggets\nAlternative Protein Market by Geography\n- North AmericaU.SCanada\n- EuropeGermanyU.KFranceItalySpainThe NetherlandBelgiumDenmarkFinlandRest of Europe (RoE)\n- Asia-Pacific (APAC)ChinaIndiaJapanThailandSouth KoreaVietnamRest of APAC (RoAPAC)\n- Rest of WorldLatin AmericaBrazilMexicoArgentinaRest of Latin America (RoLATAM)Middle East and Africa\nDownload Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4985\nBrowse more related reports:\nBlack Soldier Fly Market by Product Type (Protein Meal, Whole Dried Larvae, Oil, Biofertilizer, Live Insect, Chitin/Chitosan), Application (Animal Feed, Agriculture, Pet Food, Pharmaceutical, and Cosmetics), and Geography- Global Forecast to 2030\nPlant Based Protein Market by Type (Soy Protein, Wheat Protein, Pea Protein, Potato Protein, Rice Protein, Corn Protein) and Application (Foods and Beverage, Animal Feed, Nutrition and Health Supplements, Pharmaceuticals) - Global Forecast to 2025\nFrozen Bakery Market by Type (Breads, Pizza Crusts, Cakes and Pastries, Cookies, Donuts and Pies, Waffles), Product (Ready-to-Prove, Ready-to-Bake, Fully Baked), by Distribution Channel (Food Service, Retail, Industrial, and Online), Speciality Type (Low-Calories, Gluten Free, Organic, Fortified, Sugar Free, Other Specialty Types), End-User ( Artisans bakers, Hotel, Restaurants, and Catering, Supermarkets and Hypermarkets, Bakery Chains, Food Processing Industry) - Global Forecast to 2025\nSoluble Dietary Fibers Market by Source, Type, and Application \u2013 Global Opportunity Analysis and Industry Forecast to 2023\nAlgal Pigments Market by Type (Beta Carotene, Astaxanthin, Fucoxanthin, Phycocyanin, Phycoerythrin), Application (Food and Beverages, Nutraceuticals, Aquaculture, Cosmetics, Pharmaceuticals), and Geography - Global Forecast to 2025\nHuman Nutrition Market by Type (Vitamin, Probiotics, Proteins, Carbohydrates, Fatty Acid, Minerals), Age (Adult, Childhood), Population (Pediatric, Geriatric, Maternal), and Application (Dietary Supplement, Functional Nutrients) - Global Forecast to 2025\nAbout Meticulous Research\u00ae\nThe name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details. Meticulous Research\u00ae was founded in 2010 and incorporated as Meticulous Market Research Pvt."}
{"meta": {"doc_id": 2424, "sent_id": 23, "sent_start_pos": 9358, "sent_end_pos": 9656, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details. Meticulous Research\u00ae was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956."}
{"meta": {"doc_id": 2424, "sent_id": 24, "sent_start_pos": 9491, "sent_end_pos": 9897, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "Meticulous Research\u00ae was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions."}
{"meta": {"doc_id": 2424, "sent_id": 25, "sent_start_pos": 9584, "sent_end_pos": 10133, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts."}
{"meta": {"doc_id": 2424, "sent_id": 26, "sent_start_pos": 9657, "sent_end_pos": 10355, "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth."}
{"meta": {"doc_id": 2424, "sent_id": 27, "sent_start_pos": 9898, "sent_end_pos": [], "title": "Alternative Protein Market is Expected to Grow at a CAGR of 9.5% to Reach $17.9 Billion by 2025- Meticulous Research"}, "text": "With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. "}
{"meta": {"doc_id": 2425, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 430, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": " May 30, 2019 PAO-M05-19-CL-002\niBio\u2019s contract development and manufacturing services are built around the advantages provided by our plant-based recombinant protein production technology. We have been developing our plant expression system for many years, investing in continued research and development to improve the properties and performance of the host plant, the expression vectors and the expression system that we employ."}
{"meta": {"doc_id": 2425, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 542, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "May 30, 2019 PAO-M05-19-CL-002\niBio\u2019s contract development and manufacturing services are built around the advantages provided by our plant-based recombinant protein production technology. We have been developing our plant expression system for many years, investing in continued research and development to improve the properties and performance of the host plant, the expression vectors and the expression system that we employ. Though highly innovative, the concept of plant-based expression of therapeutic proteins is not necessarily new."}
{"meta": {"doc_id": 2425, "sent_id": 2, "sent_start_pos": 189, "sent_end_pos": 796, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "We have been developing our plant expression system for many years, investing in continued research and development to improve the properties and performance of the host plant, the expression vectors and the expression system that we employ. Though highly innovative, the concept of plant-based expression of therapeutic proteins is not necessarily new. The ability of these systems to produce various antibodies, vaccines, enzyme therapies and other therapeutic proteins has been explored for more than two decades, with several products evaluated in clinical trials and some achieving regulatory approval."}
{"meta": {"doc_id": 2425, "sent_id": 3, "sent_start_pos": 431, "sent_end_pos": 1012, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Though highly innovative, the concept of plant-based expression of therapeutic proteins is not necessarily new. The ability of these systems to produce various antibodies, vaccines, enzyme therapies and other therapeutic proteins has been explored for more than two decades, with several products evaluated in clinical trials and some achieving regulatory approval. With a plant-based transient expression system, there is no need to develop optimized cell lines or invest in expensive bioreactor technologies for large-scale production, as is the case with mammalian cell culture."}
{"meta": {"doc_id": 2425, "sent_id": 4, "sent_start_pos": 543, "sent_end_pos": 1149, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "The ability of these systems to produce various antibodies, vaccines, enzyme therapies and other therapeutic proteins has been explored for more than two decades, with several products evaluated in clinical trials and some achieving regulatory approval. With a plant-based transient expression system, there is no need to develop optimized cell lines or invest in expensive bioreactor technologies for large-scale production, as is the case with mammalian cell culture. Transient transfection is applied at manufacturing scale; the plant is the bioreactor, and scale-up simply involves growing more plants."}
{"meta": {"doc_id": 2425, "sent_id": 5, "sent_start_pos": 797, "sent_end_pos": 1242, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "With a plant-based transient expression system, there is no need to develop optimized cell lines or invest in expensive bioreactor technologies for large-scale production, as is the case with mammalian cell culture. Transient transfection is applied at manufacturing scale; the plant is the bioreactor, and scale-up simply involves growing more plants. The result is consistent expression levels and protein quality, whether producing 1g or 1kg."}
{"meta": {"doc_id": 2425, "sent_id": 6, "sent_start_pos": 1013, "sent_end_pos": 1444, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Transient transfection is applied at manufacturing scale; the plant is the bioreactor, and scale-up simply involves growing more plants. The result is consistent expression levels and protein quality, whether producing 1g or 1kg. The use of plants rather than mammalian cells also eliminates potential contamination from adventitious agents, because human viruses do not replicate in plants, which simplifies downstream processing."}
{"meta": {"doc_id": 2425, "sent_id": 7, "sent_start_pos": 1150, "sent_end_pos": 1669, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "The result is consistent expression levels and protein quality, whether producing 1g or 1kg. The use of plants rather than mammalian cells also eliminates potential contamination from adventitious agents, because human viruses do not replicate in plants, which simplifies downstream processing. iBio\u2019s protein-expression platform technology employs Nicotiana Benthamiana as a host, a model plant that has been used to express numerous recombinant proteins in the past and is very well adapted to hydroponic cultivation."}
{"meta": {"doc_id": 2425, "sent_id": 8, "sent_start_pos": 1243, "sent_end_pos": 1821, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "The use of plants rather than mammalian cells also eliminates potential contamination from adventitious agents, because human viruses do not replicate in plants, which simplifies downstream processing. iBio\u2019s protein-expression platform technology employs Nicotiana Benthamiana as a host, a model plant that has been used to express numerous recombinant proteins in the past and is very well adapted to hydroponic cultivation. After about five weeks of plant biomass amplification, genes of interest are delivered to plant cells using Agrobacterium tumefaciens as a DNA vehicle."}
{"meta": {"doc_id": 2425, "sent_id": 9, "sent_start_pos": 1445, "sent_end_pos": 1997, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "iBio\u2019s protein-expression platform technology employs Nicotiana Benthamiana as a host, a model plant that has been used to express numerous recombinant proteins in the past and is very well adapted to hydroponic cultivation. After about five weeks of plant biomass amplification, genes of interest are delivered to plant cells using Agrobacterium tumefaciens as a DNA vehicle. Then, protein expression starts rapidly, resulting in the accumulation of up to gram quantities of target protein in leaves per kilogram of fresh plant tissue within one week."}
{"meta": {"doc_id": 2425, "sent_id": 10, "sent_start_pos": 1670, "sent_end_pos": 2102, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "After about five weeks of plant biomass amplification, genes of interest are delivered to plant cells using Agrobacterium tumefaciens as a DNA vehicle. Then, protein expression starts rapidly, resulting in the accumulation of up to gram quantities of target protein in leaves per kilogram of fresh plant tissue within one week. All plants are grown in chemically defined media in climatically controlled vertical farming grow rooms."}
{"meta": {"doc_id": 2425, "sent_id": 11, "sent_start_pos": 1822, "sent_end_pos": 2310, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Then, protein expression starts rapidly, resulting in the accumulation of up to gram quantities of target protein in leaves per kilogram of fresh plant tissue within one week. All plants are grown in chemically defined media in climatically controlled vertical farming grow rooms. Plant health is confirmed at various checkpoints, and scale-up is achieved by simply growing more plants, with no concerns about changes in yield, protein structure or posttranslational modifications (PTMs)."}
{"meta": {"doc_id": 2425, "sent_id": 12, "sent_start_pos": 1998, "sent_end_pos": 2461, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "All plants are grown in chemically defined media in climatically controlled vertical farming grow rooms. Plant health is confirmed at various checkpoints, and scale-up is achieved by simply growing more plants, with no concerns about changes in yield, protein structure or posttranslational modifications (PTMs). As a result, iBio\u2019s plant-based system offers rapid evaluation ofprotein expression in an environment that greatly resembles manufacturing conditions."}
{"meta": {"doc_id": 2425, "sent_id": 13, "sent_start_pos": 2103, "sent_end_pos": 2596, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Plant health is confirmed at various checkpoints, and scale-up is achieved by simply growing more plants, with no concerns about changes in yield, protein structure or posttranslational modifications (PTMs). As a result, iBio\u2019s plant-based system offers rapid evaluation ofprotein expression in an environment that greatly resembles manufacturing conditions. With iBio\u2019s technology, the time to IND filing can be reduced by six months or more compared with that required for CHO-based systems."}
{"meta": {"doc_id": 2425, "sent_id": 14, "sent_start_pos": 2311, "sent_end_pos": 2940, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "As a result, iBio\u2019s plant-based system offers rapid evaluation ofprotein expression in an environment that greatly resembles manufacturing conditions. With iBio\u2019s technology, the time to IND filing can be reduced by six months or more compared with that required for CHO-based systems. A techno-economic analysis revealed that a plant-based protein manufacturing facility similar to iBio\u2019s Bryan, Texas site would only cost a fraction of the amount required to build an equivalent modern CHO facility, and the cost of goods (COGS) for a mAb produced by iBio is less than published COGS values for mAbs produced using CHO systems."}
{"meta": {"doc_id": 2425, "sent_id": 15, "sent_start_pos": 2462, "sent_end_pos": 3272, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "With iBio\u2019s technology, the time to IND filing can be reduced by six months or more compared with that required for CHO-based systems. A techno-economic analysis revealed that a plant-based protein manufacturing facility similar to iBio\u2019s Bryan, Texas site would only cost a fraction of the amount required to build an equivalent modern CHO facility, and the cost of goods (COGS) for a mAb produced by iBio is less than published COGS values for mAbs produced using CHO systems. Notably, vaccine antigens, including virus-like particles, antibodies, fusion proteins, interferons and cytokines, growth factors, protease inhibitors, clotting factors, enzymes for replacement therapy and other products that cannot be produced using more traditional expression systems have been expressed using the iBio platform."}
{"meta": {"doc_id": 2425, "sent_id": 16, "sent_start_pos": 2597, "sent_end_pos": 3404, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "A techno-economic analysis revealed that a plant-based protein manufacturing facility similar to iBio\u2019s Bryan, Texas site would only cost a fraction of the amount required to build an equivalent modern CHO facility, and the cost of goods (COGS) for a mAb produced by iBio is less than published COGS values for mAbs produced using CHO systems. Notably, vaccine antigens, including virus-like particles, antibodies, fusion proteins, interferons and cytokines, growth factors, protease inhibitors, clotting factors, enzymes for replacement therapy and other products that cannot be produced using more traditional expression systems have been expressed using the iBio platform. The US Food and Drug Administration encourages pharmaceutical manufacturers to design quality into their processes from the outset."}
{"meta": {"doc_id": 2425, "sent_id": 17, "sent_start_pos": 2941, "sent_end_pos": 3541, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Notably, vaccine antigens, including virus-like particles, antibodies, fusion proteins, interferons and cytokines, growth factors, protease inhibitors, clotting factors, enzymes for replacement therapy and other products that cannot be produced using more traditional expression systems have been expressed using the iBio platform. The US Food and Drug Administration encourages pharmaceutical manufacturers to design quality into their processes from the outset. At iBio, the use of a quality-by-design approach ensures the development of robust processes with high and reproducible product quality."}
{"meta": {"doc_id": 2425, "sent_id": 18, "sent_start_pos": 3273, "sent_end_pos": 3665, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "The US Food and Drug Administration encourages pharmaceutical manufacturers to design quality into their processes from the outset. At iBio, the use of a quality-by-design approach ensures the development of robust processes with high and reproducible product quality. Our process development laboratory and pilot production facility were constructed using a quality-by-design (QbD) approach."}
{"meta": {"doc_id": 2425, "sent_id": 19, "sent_start_pos": 3405, "sent_end_pos": 3792, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "At iBio, the use of a quality-by-design approach ensures the development of robust processes with high and reproducible product quality. Our process development laboratory and pilot production facility were constructed using a quality-by-design (QbD) approach. Typically, labs and pilot-scale facilities are built by pharmaceutical companies before any manufacturing site is constructed."}
{"meta": {"doc_id": 2425, "sent_id": 20, "sent_start_pos": 3542, "sent_end_pos": 3901, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Our process development laboratory and pilot production facility were constructed using a quality-by-design (QbD) approach. Typically, labs and pilot-scale facilities are built by pharmaceutical companies before any manufacturing site is constructed. However, at iBio, we take the opposite approach to facilitate and speed up technology transfer and scale-up."}
{"meta": {"doc_id": 2425, "sent_id": 21, "sent_start_pos": 3666, "sent_end_pos": 4051, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Typically, labs and pilot-scale facilities are built by pharmaceutical companies before any manufacturing site is constructed. However, at iBio, we take the opposite approach to facilitate and speed up technology transfer and scale-up. Our manufacturing facility was constructed and operated first at full scale, allowing us the time to gain a robust understanding of its key features."}
{"meta": {"doc_id": 2425, "sent_id": 22, "sent_start_pos": 3793, "sent_end_pos": 4280, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "However, at iBio, we take the opposite approach to facilitate and speed up technology transfer and scale-up. Our manufacturing facility was constructed and operated first at full scale, allowing us the time to gain a robust understanding of its key features. We built the process development lab and pilot plant after we had time to study data from the manufacturing facility \u2014 notably using the same design as the manufacturing plant and with scaled-down versions of the same equipment."}
{"meta": {"doc_id": 2425, "sent_id": 23, "sent_start_pos": 3902, "sent_end_pos": 4470, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Our manufacturing facility was constructed and operated first at full scale, allowing us the time to gain a robust understanding of its key features. We built the process development lab and pilot plant after we had time to study data from the manufacturing facility \u2014 notably using the same design as the manufacturing plant and with scaled-down versions of the same equipment. When we develop processes and scale them to the pilot plant, we do so knowing how they will translate to manufacturing scale."}
{"meta": {"doc_id": 2425, "sent_id": 24, "sent_start_pos": 4052, "sent_end_pos": 4820, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "We built the process development lab and pilot plant after we had time to study data from the manufacturing facility \u2014 notably using the same design as the manufacturing plant and with scaled-down versions of the same equipment. When we develop processes and scale them to the pilot plant, we do so knowing how they will translate to manufacturing scale. iBio has invested in a state-of-the-art facility in Bryan, Texas with the capability to provide clients and collaborators with an integrated suite of services ranging from early product lead optimization, process development, production of preclinical and clinical batches of pharmaceutical active ingredient, analytical support and sterile filling."}
{"meta": {"doc_id": 2425, "sent_id": 25, "sent_start_pos": 4345, "sent_end_pos": 4948, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "When we develop processes and scale them to the pilot plant, we do so knowing how they will translate to manufacturing scale. iBio has invested in a state-of-the-art facility in Bryan, Texas with the capability to provide clients and collaborators with an integrated suite of services ranging from early product lead optimization, process development, production of preclinical and clinical batches of pharmaceutical active ingredient, analytical support and sterile filling. The technology and facility are capable of supporting the development and manufacture of both vaccine and therapeutic products."}
{"meta": {"doc_id": 2425, "sent_id": 26, "sent_start_pos": 4471, "sent_end_pos": 5049, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "iBio has invested in a state-of-the-art facility in Bryan, Texas with the capability to provide clients and collaborators with an integrated suite of services ranging from early product lead optimization, process development, production of preclinical and clinical batches of pharmaceutical active ingredient, analytical support and sterile filling. The technology and facility are capable of supporting the development and manufacture of both vaccine and therapeutic products. as well as recombinant proteins for use in medical devices and diagnostics and as clinical reagents."}
{"meta": {"doc_id": 2425, "sent_id": 27, "sent_start_pos": 4821, "sent_end_pos": 5227, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "The technology and facility are capable of supporting the development and manufacture of both vaccine and therapeutic products. as well as recombinant proteins for use in medical devices and diagnostics and as clinical reagents. We work with our clients to design and perform feasibility studies to enable them to determine whether the product generated using our plant-based technology is fit-for-purpose."}
{"meta": {"doc_id": 2425, "sent_id": 28, "sent_start_pos": 4949, "sent_end_pos": 5327, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "as well as recombinant proteins for use in medical devices and diagnostics and as clinical reagents. We work with our clients to design and perform feasibility studies to enable them to determine whether the product generated using our plant-based technology is fit-for-purpose. Customers can have milligrams of protein for evaluation within six weeks after contract initiation."}
{"meta": {"doc_id": 2425, "sent_id": 29, "sent_start_pos": 5050, "sent_end_pos": 5528, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "We work with our clients to design and perform feasibility studies to enable them to determine whether the product generated using our plant-based technology is fit-for-purpose. Customers can have milligrams of protein for evaluation within six weeks after contract initiation. We can then take processes from the lab scale through process optimization for scale-up to cGMP protocols and move projects to clinical toxicology studies, human clinical trials and commercialization."}
{"meta": {"doc_id": 2425, "sent_id": 30, "sent_start_pos": 5228, "sent_end_pos": 5837, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Customers can have milligrams of protein for evaluation within six weeks after contract initiation. We can then take processes from the lab scale through process optimization for scale-up to cGMP protocols and move projects to clinical toxicology studies, human clinical trials and commercialization. Importantly, all of this work \u2014from feasibility studies to process development, scale-up to non-cGMP and cGMP manufacturing \u2014is performed in the same facility, eliminating the additional cost and delays typically associated with transferring technology from one site to another, even within the same company."}
{"meta": {"doc_id": 2425, "sent_id": 31, "sent_start_pos": 5328, "sent_end_pos": 5964, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "We can then take processes from the lab scale through process optimization for scale-up to cGMP protocols and move projects to clinical toxicology studies, human clinical trials and commercialization. Importantly, all of this work \u2014from feasibility studies to process development, scale-up to non-cGMP and cGMP manufacturing \u2014is performed in the same facility, eliminating the additional cost and delays typically associated with transferring technology from one site to another, even within the same company. We also propose proprietary approaches to improved gene expression through codon optimization and expression vector selection."}
{"meta": {"doc_id": 2425, "sent_id": 32, "sent_start_pos": 5529, "sent_end_pos": 6111, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Importantly, all of this work \u2014from feasibility studies to process development, scale-up to non-cGMP and cGMP manufacturing \u2014is performed in the same facility, eliminating the additional cost and delays typically associated with transferring technology from one site to another, even within the same company. We also propose proprietary approaches to improved gene expression through codon optimization and expression vector selection. iBio is positioned to help clients screen and select optimal lead candidates and refine processes to ensure the best product yields and stability."}
{"meta": {"doc_id": 2425, "sent_id": 33, "sent_start_pos": 5838, "sent_end_pos": 6398, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "We also propose proprietary approaches to improved gene expression through codon optimization and expression vector selection. iBio is positioned to help clients screen and select optimal lead candidates and refine processes to ensure the best product yields and stability. In addition to cloning the necessary vectors, biomass production, protein extraction and purification, iBio supports clients with automated and manual sterile fill and finish activities (ranging from hundreds to thousands of vials for early stage clinical trials and stability testing)."}
{"meta": {"doc_id": 2425, "sent_id": 34, "sent_start_pos": 5965, "sent_end_pos": 6609, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "iBio is positioned to help clients screen and select optimal lead candidates and refine processes to ensure the best product yields and stability. In addition to cloning the necessary vectors, biomass production, protein extraction and purification, iBio supports clients with automated and manual sterile fill and finish activities (ranging from hundreds to thousands of vials for early stage clinical trials and stability testing). Finally, experienced analytical staff provide method development and validation support as part of projects and on an ad hoc basis, with special capabilities in protein characterization using mass spectrometry."}
{"meta": {"doc_id": 2425, "sent_id": 35, "sent_start_pos": 6112, "sent_end_pos": 6786, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "In addition to cloning the necessary vectors, biomass production, protein extraction and purification, iBio supports clients with automated and manual sterile fill and finish activities (ranging from hundreds to thousands of vials for early stage clinical trials and stability testing). Finally, experienced analytical staff provide method development and validation support as part of projects and on an ad hoc basis, with special capabilities in protein characterization using mass spectrometry. A partnership with regulatory consultant CBR International, which has 20 years of experience in plant-based protein manufacturing, further ensures successful regulatory filing."}
{"meta": {"doc_id": 2425, "sent_id": 36, "sent_start_pos": 6399, "sent_end_pos": 6931, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Finally, experienced analytical staff provide method development and validation support as part of projects and on an ad hoc basis, with special capabilities in protein characterization using mass spectrometry. A partnership with regulatory consultant CBR International, which has 20 years of experience in plant-based protein manufacturing, further ensures successful regulatory filing. iBio is interested in supporting both early stage biotech and large pharma companies, as well as universities, spinouts and government agencies."}
{"meta": {"doc_id": 2425, "sent_id": 37, "sent_start_pos": 6610, "sent_end_pos": 7151, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "A partnership with regulatory consultant CBR International, which has 20 years of experience in plant-based protein manufacturing, further ensures successful regulatory filing. iBio is interested in supporting both early stage biotech and large pharma companies, as well as universities, spinouts and government agencies. In particular, we seek collaboration with companies in the early stages of development that have not yet committed to a specific manufacturing route or that have already decided to use plant-based expression technology."}
{"meta": {"doc_id": 2425, "sent_id": 38, "sent_start_pos": 6787, "sent_end_pos": 7358, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "iBio is interested in supporting both early stage biotech and large pharma companies, as well as universities, spinouts and government agencies. In particular, we seek collaboration with companies in the early stages of development that have not yet committed to a specific manufacturing route or that have already decided to use plant-based expression technology. The simplicity of our plant-based bioprocessing technology makes it well suited for implementation in areas of the world where there is limited access to capital or highly skilled biopharmaceutical workers."}
{"meta": {"doc_id": 2425, "sent_id": 39, "sent_start_pos": 6932, "sent_end_pos": 7484, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "In particular, we seek collaboration with companies in the early stages of development that have not yet committed to a specific manufacturing route or that have already decided to use plant-based expression technology. The simplicity of our plant-based bioprocessing technology makes it well suited for implementation in areas of the world where there is limited access to capital or highly skilled biopharmaceutical workers. The short project timelines also make it attractive for the rapid development of drugs and vaccines in response to pandemics."}
{"meta": {"doc_id": 2425, "sent_id": 40, "sent_start_pos": 7152, "sent_end_pos": 7618, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "The simplicity of our plant-based bioprocessing technology makes it well suited for implementation in areas of the world where there is limited access to capital or highly skilled biopharmaceutical workers. The short project timelines also make it attractive for the rapid development of drugs and vaccines in response to pandemics. Despite the well-established underlying technology, plant-based therapeutic protein bioprocessing remains a relatively nascent field."}
{"meta": {"doc_id": 2425, "sent_id": 41, "sent_start_pos": 7359, "sent_end_pos": 7764, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "The short project timelines also make it attractive for the rapid development of drugs and vaccines in response to pandemics. Despite the well-established underlying technology, plant-based therapeutic protein bioprocessing remains a relatively nascent field. When companies or government agencies wish to establish autonomous manufacturing capability using this technology, they often require assistance."}
{"meta": {"doc_id": 2425, "sent_id": 42, "sent_start_pos": 7485, "sent_end_pos": 7879, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Despite the well-established underlying technology, plant-based therapeutic protein bioprocessing remains a relatively nascent field. When companies or government agencies wish to establish autonomous manufacturing capability using this technology, they often require assistance. iBio has established the capacity to support such projects, enabling customers to license our platform technology."}
{"meta": {"doc_id": 2425, "sent_id": 43, "sent_start_pos": 7619, "sent_end_pos": 8066, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "When companies or government agencies wish to establish autonomous manufacturing capability using this technology, they often require assistance. iBio has established the capacity to support such projects, enabling customers to license our platform technology. We also provide assistance with facility design and process implementation, certifying that their facility is operated in compliance with cGMP standards for pharmaceutical manufacturing."}
{"meta": {"doc_id": 2425, "sent_id": 44, "sent_start_pos": 7765, "sent_end_pos": 8228, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "iBio has established the capacity to support such projects, enabling customers to license our platform technology. We also provide assistance with facility design and process implementation, certifying that their facility is operated in compliance with cGMP standards for pharmaceutical manufacturing. While we do not serve as architects or contractors, we participate in the early design stages, working in cooperation with our client\u2019s engineers and architects."}
{"meta": {"doc_id": 2425, "sent_id": 45, "sent_start_pos": 7880, "sent_end_pos": 8391, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "We also provide assistance with facility design and process implementation, certifying that their facility is operated in compliance with cGMP standards for pharmaceutical manufacturing. While we do not serve as architects or contractors, we participate in the early design stages, working in cooperation with our client\u2019s engineers and architects. This approach is particularly relevant in developing economies where large capital investments in biologics manufacturing infrastructure have not yet taken place."}
{"meta": {"doc_id": 2425, "sent_id": 46, "sent_start_pos": 8067, "sent_end_pos": 8571, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "While we do not serve as architects or contractors, we participate in the early design stages, working in cooperation with our client\u2019s engineers and architects. This approach is particularly relevant in developing economies where large capital investments in biologics manufacturing infrastructure have not yet taken place. By supporting these types of projects, iBio is helping governments, NGOs, corporations and academic institutions install advanced manufacturing capabilities in developing markets."}
{"meta": {"doc_id": 2425, "sent_id": 47, "sent_start_pos": 8229, "sent_end_pos": 8673, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "This approach is particularly relevant in developing economies where large capital investments in biologics manufacturing infrastructure have not yet taken place. By supporting these types of projects, iBio is helping governments, NGOs, corporations and academic institutions install advanced manufacturing capabilities in developing markets. It is unusual for a biopharmaceutical manufacturer to seek out opportunities for technology transfer."}
{"meta": {"doc_id": 2425, "sent_id": 48, "sent_start_pos": 8392, "sent_end_pos": 8817, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "By supporting these types of projects, iBio is helping governments, NGOs, corporations and academic institutions install advanced manufacturing capabilities in developing markets. It is unusual for a biopharmaceutical manufacturer to seek out opportunities for technology transfer. Most information-based sciences are advancing so rapidly, however, that the notion of holding on to advanced technologies is becoming outdated."}
{"meta": {"doc_id": 2425, "sent_id": 49, "sent_start_pos": 8572, "sent_end_pos": 9086, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "It is unusual for a biopharmaceutical manufacturer to seek out opportunities for technology transfer. Most information-based sciences are advancing so rapidly, however, that the notion of holding on to advanced technologies is becoming outdated. iBio believes that, by sharing our technology platform through licensing partnerships, we are empowering others to meet the crucial needs of patients through the production of life-changing biologic drugs at reasonable costs \u2014 while establishing a successful business."}
{"meta": {"doc_id": 2425, "sent_id": 50, "sent_start_pos": 8674, "sent_end_pos": 9326, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Most information-based sciences are advancing so rapidly, however, that the notion of holding on to advanced technologies is becoming outdated. iBio believes that, by sharing our technology platform through licensing partnerships, we are empowering others to meet the crucial needs of patients through the production of life-changing biologic drugs at reasonable costs \u2014 while establishing a successful business. Examples of this approach are represented by partnerships with Bio-Manguinhos/Fiocruz, the technical scientific unit of the Oswaldo Cruz Foundation (Fiocruz) in Brazil, AzarGen Biotechnologies in South Africa and CC-Pharming Ltd. in China."}
{"meta": {"doc_id": 2425, "sent_id": 51, "sent_start_pos": 8818, "sent_end_pos": 9504, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "iBio believes that, by sharing our technology platform through licensing partnerships, we are empowering others to meet the crucial needs of patients through the production of life-changing biologic drugs at reasonable costs \u2014 while establishing a successful business. Examples of this approach are represented by partnerships with Bio-Manguinhos/Fiocruz, the technical scientific unit of the Oswaldo Cruz Foundation (Fiocruz) in Brazil, AzarGen Biotechnologies in South Africa and CC-Pharming Ltd. in China. Bio-Manguinhos/Fiocruz will use iBio\u2019s technology in a new plant-based multipurpose manufacturing facility in Brazil for the low-cost production of a novel yellow fever vaccine."}
{"meta": {"doc_id": 2425, "sent_id": 52, "sent_start_pos": 9087, "sent_end_pos": 9615, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Examples of this approach are represented by partnerships with Bio-Manguinhos/Fiocruz, the technical scientific unit of the Oswaldo Cruz Foundation (Fiocruz) in Brazil, AzarGen Biotechnologies in South Africa and CC-Pharming Ltd. in China. Bio-Manguinhos/Fiocruz will use iBio\u2019s technology in a new plant-based multipurpose manufacturing facility in Brazil for the low-cost production of a novel yellow fever vaccine. The project has reached the technical design stage but is temporarily on hold at the behest of the government."}
{"meta": {"doc_id": 2425, "sent_id": 53, "sent_start_pos": 9327, "sent_end_pos": 9815, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Bio-Manguinhos/Fiocruz will use iBio\u2019s technology in a new plant-based multipurpose manufacturing facility in Brazil for the low-cost production of a novel yellow fever vaccine. The project has reached the technical design stage but is temporarily on hold at the behest of the government. AzarGen Biotechnologies is an early stage pharma company developing a biosimilar rituximab product for the treatment of non-Hodgkin\u2019s lymphoma using a plant-based process initially developed by iBio."}
{"meta": {"doc_id": 2425, "sent_id": 54, "sent_start_pos": 9505, "sent_end_pos": 9928, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "The project has reached the technical design stage but is temporarily on hold at the behest of the government. AzarGen Biotechnologies is an early stage pharma company developing a biosimilar rituximab product for the treatment of non-Hodgkin\u2019s lymphoma using a plant-based process initially developed by iBio. The company is ready to produce material for preclinical studies and is preparing a pre-IND package for the FDA."}
{"meta": {"doc_id": 2425, "sent_id": 55, "sent_start_pos": 9616, "sent_end_pos": 10068, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "AzarGen Biotechnologies is an early stage pharma company developing a biosimilar rituximab product for the treatment of non-Hodgkin\u2019s lymphoma using a plant-based process initially developed by iBio. The company is ready to produce material for preclinical studies and is preparing a pre-IND package for the FDA. The plant-based expression technology provides the only economically viable platform for the production of this biosimilar in South Africa."}
{"meta": {"doc_id": 2425, "sent_id": 56, "sent_start_pos": 9816, "sent_end_pos": 10273, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "The company is ready to produce material for preclinical studies and is preparing a pre-IND package for the FDA. The plant-based expression technology provides the only economically viable platform for the production of this biosimilar in South Africa. CC-Pharming Ltd. and iBio recently formed a strategic partnership to develop products and manufacturing facilities for the Chinese biopharmaceutical market that leverage plant-based expression technology."}
{"meta": {"doc_id": 2425, "sent_id": 57, "sent_start_pos": 9929, "sent_end_pos": 10484, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "The plant-based expression technology provides the only economically viable platform for the production of this biosimilar in South Africa. CC-Pharming Ltd. and iBio recently formed a strategic partnership to develop products and manufacturing facilities for the Chinese biopharmaceutical market that leverage plant-based expression technology. iBio will provide development and manufacturing services, and the two firms will work together to design and construct a manufacturing facility in China."}
{"meta": {"doc_id": 2425, "sent_id": 58, "sent_start_pos": 10069, "sent_end_pos": 10594, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "CC-Pharming Ltd. and iBio recently formed a strategic partnership to develop products and manufacturing facilities for the Chinese biopharmaceutical market that leverage plant-based expression technology. iBio will provide development and manufacturing services, and the two firms will work together to design and construct a manufacturing facility in China. Additional products will eventually be selected for development and sale in both China and the United States."}
{"meta": {"doc_id": 2425, "sent_id": 59, "sent_start_pos": 10331, "sent_end_pos": 10776, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "iBio will provide development and manufacturing services, and the two firms will work together to design and construct a manufacturing facility in China. Additional products will eventually be selected for development and sale in both China and the United States. As a result, iBio is both empowering CC-Pharming to perform autonomous manufacturing and collaborating with the company on additional products and sharing in its commercial success."}
{"meta": {"doc_id": 2425, "sent_id": 60, "sent_start_pos": 10485, "sent_end_pos": 10946, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Additional products will eventually be selected for development and sale in both China and the United States. As a result, iBio is both empowering CC-Pharming to perform autonomous manufacturing and collaborating with the company on additional products and sharing in its commercial success. We are confident in the direct advantages that plant-based manufacturing and development offer and look forward to bringing drugs to market using this opportune process."}
{"meta": {"doc_id": 2425, "sent_id": 61, "sent_start_pos": 10595, "sent_end_pos": 11087, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "As a result, iBio is both empowering CC-Pharming to perform autonomous manufacturing and collaborating with the company on additional products and sharing in its commercial success. We are confident in the direct advantages that plant-based manufacturing and development offer and look forward to bringing drugs to market using this opportune process. Sylvain Marcel, Ph.D\nDr. Marcel is a Senior Scientist in Molecular Biology and the Director of Early Stage Project Development at iBio CDMO."}
{"meta": {"doc_id": 2425, "sent_id": 62, "sent_start_pos": 10777, "sent_end_pos": 11216, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "We are confident in the direct advantages that plant-based manufacturing and development offer and look forward to bringing drugs to market using this opportune process. Sylvain Marcel, Ph.D\nDr. Marcel is a Senior Scientist in Molecular Biology and the Director of Early Stage Project Development at iBio CDMO. He received his Ph.D in plant cell and molecular biology at the RWTH University \u2013 Fraunhofer Institute, Aachen, Germany in 2006."}
{"meta": {"doc_id": 2425, "sent_id": 63, "sent_start_pos": 10947, "sent_end_pos": 11434, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Sylvain Marcel, Ph.D\nDr. Marcel is a Senior Scientist in Molecular Biology and the Director of Early Stage Project Development at iBio CDMO. He received his Ph.D in plant cell and molecular biology at the RWTH University \u2013 Fraunhofer Institute, Aachen, Germany in 2006. Dr. Marcel joined the team of Dr. Barry Holtz in 2010 to develop and implement the midstream manufacturing protocols during the construction and operation of the biotherapeutics manufacturing facility in Bryan, Texas."}
{"meta": {"doc_id": 2425, "sent_id": 64, "sent_start_pos": 11088, "sent_end_pos": 11580, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "He received his Ph.D in plant cell and molecular biology at the RWTH University \u2013 Fraunhofer Institute, Aachen, Germany in 2006. Dr. Marcel joined the team of Dr. Barry Holtz in 2010 to develop and implement the midstream manufacturing protocols during the construction and operation of the biotherapeutics manufacturing facility in Bryan, Texas. As a senior scientist, Dr. Marcel optimized upstream and midstream manufacturing protocols and co-designed and operated the pilot-scale facility."}
{"meta": {"doc_id": 2425, "sent_id": 65, "sent_start_pos": 11217, "sent_end_pos": 11821, "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "Dr. Marcel joined the team of Dr. Barry Holtz in 2010 to develop and implement the midstream manufacturing protocols during the construction and operation of the biotherapeutics manufacturing facility in Bryan, Texas. As a senior scientist, Dr. Marcel optimized upstream and midstream manufacturing protocols and co-designed and operated the pilot-scale facility. Robert Erwin\n89 Fifth Avenue\nFifth Floor\nNew York\nNY 10003-3020\nNew York \u2013 San Diego \u2013 ChicagoLondon \u2013 Frankfurt \u2013 Shanghai\nNice Insight is the market research division of That\u2019s Nice LLC, the leading marketing agency serving life sciences."}
{"meta": {"doc_id": 2425, "sent_id": 66, "sent_start_pos": 11435, "sent_end_pos": [], "title": "The Advantage of Plant-Based Expression Solutions Around the Globe"}, "text": "As a senior scientist, Dr. Marcel optimized upstream and midstream manufacturing protocols and co-designed and operated the pilot-scale facility. Robert Erwin\n89 Fifth Avenue\nFifth Floor\nNew York\nNY 10003-3020\nNew York \u2013 San Diego \u2013 ChicagoLondon \u2013 Frankfurt \u2013 Shanghai\nNice Insight is the market research division of That\u2019s Nice LLC, the leading marketing agency serving life sciences. "}
{"meta": {"doc_id": 2426, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 554, "title": "Surge in Alternative and Plant-based Proteins - Top focus at 2nd Food Proteins Asia 2019"}, "text": " Surge in Alternative and Plant-based Proteins - Top focus at 2nd Food Proteins Asia 2019\nCMT's 2nd Food Proteins Asia held on 22-23 January, 2019 in Bangkok highlights the shift towards alternative protein sources - especially plant-based proteins such as soy, chickpeas, peas, hemp, cassava as well as new innovations and regulatory framework. BANGKOK, Nov. 28, 2018 /PRNewswire/ -- Demand for protein fortified food is on the rise while there is also a growing shift towards alternative and plant based food protein - from chickpeas to peas to insects."}
{"meta": {"doc_id": 2426, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 785, "title": "Surge in Alternative and Plant-based Proteins - Top focus at 2nd Food Proteins Asia 2019"}, "text": "Surge in Alternative and Plant-based Proteins - Top focus at 2nd Food Proteins Asia 2019\nCMT's 2nd Food Proteins Asia held on 22-23 January, 2019 in Bangkok highlights the shift towards alternative protein sources - especially plant-based proteins such as soy, chickpeas, peas, hemp, cassava as well as new innovations and regulatory framework. BANGKOK, Nov. 28, 2018 /PRNewswire/ -- Demand for protein fortified food is on the rise while there is also a growing shift towards alternative and plant based food protein - from chickpeas to peas to insects. On 22 & 23rdJanuary 2019, food ingredients companies, brand owners, insect protein producers, food manufacturers and several others are convening in Bangkok for a 2 day summit discussing the future of food proteins market in Asia."}
{"meta": {"doc_id": 2426, "sent_id": 2, "sent_start_pos": 345, "sent_end_pos": 1111, "title": "Surge in Alternative and Plant-based Proteins - Top focus at 2nd Food Proteins Asia 2019"}, "text": "BANGKOK, Nov. 28, 2018 /PRNewswire/ -- Demand for protein fortified food is on the rise while there is also a growing shift towards alternative and plant based food protein - from chickpeas to peas to insects. On 22 & 23rdJanuary 2019, food ingredients companies, brand owners, insect protein producers, food manufacturers and several others are convening in Bangkok for a 2 day summit discussing the future of food proteins market in Asia. Photo - https://mma.prnewswire.com/media/789920/CMT_food_proteins_asia_2019.jpg\nOrganizer, Centre for Management Technology (CMT), confirms that agribusiness group - Wilmar International will present a paper on the 'Future of Plant Protein in Asia' addressing technologies, driving factors for plant proteins habits and more."}
{"meta": {"doc_id": 2426, "sent_id": 3, "sent_start_pos": 555, "sent_end_pos": 1362, "title": "Surge in Alternative and Plant-based Proteins - Top focus at 2nd Food Proteins Asia 2019"}, "text": "On 22 & 23rdJanuary 2019, food ingredients companies, brand owners, insect protein producers, food manufacturers and several others are convening in Bangkok for a 2 day summit discussing the future of food proteins market in Asia. Photo - https://mma.prnewswire.com/media/789920/CMT_food_proteins_asia_2019.jpg\nOrganizer, Centre for Management Technology (CMT), confirms that agribusiness group - Wilmar International will present a paper on the 'Future of Plant Protein in Asia' addressing technologies, driving factors for plant proteins habits and more. Thailand'sTipco Foods, which recently launched its first plant-based protein beverage in the country, will speak about Thailand's market for high protein drinks while Vietnam'sTH Food reveals how it is 'Expanding its Portfolio into Plant Based Milk'."}
{"meta": {"doc_id": 2426, "sent_id": 4, "sent_start_pos": 786, "sent_end_pos": 2532, "title": "Surge in Alternative and Plant-based Proteins - Top focus at 2nd Food Proteins Asia 2019"}, "text": "Photo - https://mma.prnewswire.com/media/789920/CMT_food_proteins_asia_2019.jpg\nOrganizer, Centre for Management Technology (CMT), confirms that agribusiness group - Wilmar International will present a paper on the 'Future of Plant Protein in Asia' addressing technologies, driving factors for plant proteins habits and more. Thailand'sTipco Foods, which recently launched its first plant-based protein beverage in the country, will speak about Thailand's market for high protein drinks while Vietnam'sTH Food reveals how it is 'Expanding its Portfolio into Plant Based Milk'. Also participating as speakers are:\nStart-ups in Asia venturing into alternative proteins:\n- Novel and sustainable plant-based protein - Life3 Biotech\n- Seafood, Reinvented - A Singapore-Based Cell-Based Meat Company - Shiok Meats\n- Farming Sustainable Protein on Cassava Waste - Cricket One\nPlus, industry leaders sharing their insights on:\n- Plant based, healthy, protein-rich food centred around Lupin - The Lupin Co\n- Promise of Chickpea Protein - ChickP\n- Hemp, Plant Protein & Beyond in a New World of Adoption - Blue Sky Biologicals\n- New process for vegan protein and test on cassava - SiccaDania\n- Pea Protein - Breaking into the Market Dominated by Soy - Cosucra\n- Microalgae, a major solution to build a more healthy and sustainable food industry - Algama Foods\n- Spirulina as the New Protein Substitute - Chitose Bio Evolution, Tavelmout Corporation\nThe summit will sum up with sessions on 'Disruption of the Protein Industry' from a Venture Capitalist Perspective by New Protein Capital, 'Labelling Regulations on Protein & Novel Protein Ingredients with Focus on China' by Keller & Heckman and 'Challenges for Protein Processing Diversity' by Improve SAS."}
{"meta": {"doc_id": 2426, "sent_id": 5, "sent_start_pos": 1112, "sent_end_pos": 2631, "title": "Surge in Alternative and Plant-based Proteins - Top focus at 2nd Food Proteins Asia 2019"}, "text": "Thailand'sTipco Foods, which recently launched its first plant-based protein beverage in the country, will speak about Thailand's market for high protein drinks while Vietnam'sTH Food reveals how it is 'Expanding its Portfolio into Plant Based Milk'. Also participating as speakers are:\nStart-ups in Asia venturing into alternative proteins:\n- Novel and sustainable plant-based protein - Life3 Biotech\n- Seafood, Reinvented - A Singapore-Based Cell-Based Meat Company - Shiok Meats\n- Farming Sustainable Protein on Cassava Waste - Cricket One\nPlus, industry leaders sharing their insights on:\n- Plant based, healthy, protein-rich food centred around Lupin - The Lupin Co\n- Promise of Chickpea Protein - ChickP\n- Hemp, Plant Protein & Beyond in a New World of Adoption - Blue Sky Biologicals\n- New process for vegan protein and test on cassava - SiccaDania\n- Pea Protein - Breaking into the Market Dominated by Soy - Cosucra\n- Microalgae, a major solution to build a more healthy and sustainable food industry - Algama Foods\n- Spirulina as the New Protein Substitute - Chitose Bio Evolution, Tavelmout Corporation\nThe summit will sum up with sessions on 'Disruption of the Protein Industry' from a Venture Capitalist Perspective by New Protein Capital, 'Labelling Regulations on Protein & Novel Protein Ingredients with Focus on China' by Keller & Heckman and 'Challenges for Protein Processing Diversity' by Improve SAS. View event website or contact Ms. Huiyan at huiyan@cmtsp.com.sg or call +65-6346-9113 for details."}
{"meta": {"doc_id": 2426, "sent_id": 6, "sent_start_pos": 1363, "sent_end_pos": [], "title": "Surge in Alternative and Plant-based Proteins - Top focus at 2nd Food Proteins Asia 2019"}, "text": "Also participating as speakers are:\nStart-ups in Asia venturing into alternative proteins:\n- Novel and sustainable plant-based protein - Life3 Biotech\n- Seafood, Reinvented - A Singapore-Based Cell-Based Meat Company - Shiok Meats\n- Farming Sustainable Protein on Cassava Waste - Cricket One\nPlus, industry leaders sharing their insights on:\n- Plant based, healthy, protein-rich food centred around Lupin - The Lupin Co\n- Promise of Chickpea Protein - ChickP\n- Hemp, Plant Protein & Beyond in a New World of Adoption - Blue Sky Biologicals\n- New process for vegan protein and test on cassava - SiccaDania\n- Pea Protein - Breaking into the Market Dominated by Soy - Cosucra\n- Microalgae, a major solution to build a more healthy and sustainable food industry - Algama Foods\n- Spirulina as the New Protein Substitute - Chitose Bio Evolution, Tavelmout Corporation\nThe summit will sum up with sessions on 'Disruption of the Protein Industry' from a Venture Capitalist Perspective by New Protein Capital, 'Labelling Regulations on Protein & Novel Protein Ingredients with Focus on China' by Keller & Heckman and 'Challenges for Protein Processing Diversity' by Improve SAS. View event website or contact Ms. Huiyan at huiyan@cmtsp.com.sg or call +65-6346-9113 for details. "}
{"meta": {"doc_id": 2430, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 160, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": " High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein."}
{"meta": {"doc_id": 2430, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 589, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein. October 03, 2018, Costa Mesa, Calif. -- High Performance Nutrition, Inc., a health and wellness company specializing in breakthrough and cutting edge dietary supplementation as well as working closely with Professional Sports teams and maintaining stringent efficacy guidelines with approvals from the NSF and the Banned Substance Control Group (BSCG), has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC."}
{"meta": {"doc_id": 2430, "sent_id": 2, "sent_start_pos": 109, "sent_end_pos": 644, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "to bring the next evolution in plant-based protein. October 03, 2018, Costa Mesa, Calif. -- High Performance Nutrition, Inc., a health and wellness company specializing in breakthrough and cutting edge dietary supplementation as well as working closely with Professional Sports teams and maintaining stringent efficacy guidelines with approvals from the NSF and the Banned Substance Control Group (BSCG), has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. in bringing the next evolution in plant-based protein."}
{"meta": {"doc_id": 2430, "sent_id": 3, "sent_start_pos": 161, "sent_end_pos": 790, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "October 03, 2018, Costa Mesa, Calif. -- High Performance Nutrition, Inc., a health and wellness company specializing in breakthrough and cutting edge dietary supplementation as well as working closely with Professional Sports teams and maintaining stringent efficacy guidelines with approvals from the NSF and the Banned Substance Control Group (BSCG), has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. in bringing the next evolution in plant-based protein. High Performance Nutrition, Inc. has gained recognition in developing and bringing to market the most innovative dietary supplementation to date."}
{"meta": {"doc_id": 2430, "sent_id": 4, "sent_start_pos": 590, "sent_end_pos": 932, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "in bringing the next evolution in plant-based protein. High Performance Nutrition, Inc. has gained recognition in developing and bringing to market the most innovative dietary supplementation to date. First, in 2013 with the introduction of N(R) Nicotinamide Riboside, then in 2015 with M(6) AnthOrigin, and later in 2016 with PA(7) Mediator."}
{"meta": {"doc_id": 2430, "sent_id": 5, "sent_start_pos": 645, "sent_end_pos": 1235, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "High Performance Nutrition, Inc. has gained recognition in developing and bringing to market the most innovative dietary supplementation to date. First, in 2013 with the introduction of N(R) Nicotinamide Riboside, then in 2015 with M(6) AnthOrigin, and later in 2016 with PA(7) Mediator. Today, High Performance Nutrition, Inc. CEO Sean Torbati announced that a new and innovative plant-based protein formulation will become available under the brand name, Ambrosia Nutraceuticals, LLC., a venture he co-found with Pro Bodybuilder Marc \u201cThe Machine\u201d Lobliner and Pro Boxer Mike Rashid King."}
{"meta": {"doc_id": 2430, "sent_id": 6, "sent_start_pos": 791, "sent_end_pos": 1341, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "First, in 2013 with the introduction of N(R) Nicotinamide Riboside, then in 2015 with M(6) AnthOrigin, and later in 2016 with PA(7) Mediator. Today, High Performance Nutrition, Inc. CEO Sean Torbati announced that a new and innovative plant-based protein formulation will become available under the brand name, Ambrosia Nutraceuticals, LLC., a venture he co-found with Pro Bodybuilder Marc \u201cThe Machine\u201d Lobliner and Pro Boxer Mike Rashid King. \u201cI am very excited about this new formulation \u2013 it took almost 8 years to perfect it,\u201d said Sean Torbati."}
{"meta": {"doc_id": 2430, "sent_id": 7, "sent_start_pos": 933, "sent_end_pos": 1530, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "Today, High Performance Nutrition, Inc. CEO Sean Torbati announced that a new and innovative plant-based protein formulation will become available under the brand name, Ambrosia Nutraceuticals, LLC., a venture he co-found with Pro Bodybuilder Marc \u201cThe Machine\u201d Lobliner and Pro Boxer Mike Rashid King. \u201cI am very excited about this new formulation \u2013 it took almost 8 years to perfect it,\u201d said Sean Torbati. \u201cThe market has not seen anything like this \u2013 I am confident in saying we have the best plant-based protein, period.\u201d\nPlant-based protein is a growing market with a lot of room to improve."}
{"meta": {"doc_id": 2430, "sent_id": 8, "sent_start_pos": 1236, "sent_end_pos": 1623, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "\u201cI am very excited about this new formulation \u2013 it took almost 8 years to perfect it,\u201d said Sean Torbati. \u201cThe market has not seen anything like this \u2013 I am confident in saying we have the best plant-based protein, period.\u201d\nPlant-based protein is a growing market with a lot of room to improve. The collaboration between High Performance Nutrition, Inc. and Ambrosia Nutraceuticals, LLC."}
{"meta": {"doc_id": 2430, "sent_id": 9, "sent_start_pos": 1342, "sent_end_pos": 1781, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "\u201cThe market has not seen anything like this \u2013 I am confident in saying we have the best plant-based protein, period.\u201d\nPlant-based protein is a growing market with a lot of room to improve. The collaboration between High Performance Nutrition, Inc. and Ambrosia Nutraceuticals, LLC. \u201cFor years I tried making a plant-based protein that made any sense \u2013 to no surprise, they all failed,\u201d said co-founder Marc Lobliner."}
{"meta": {"doc_id": 2430, "sent_id": 10, "sent_start_pos": 1531, "sent_end_pos": 1889, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "The collaboration between High Performance Nutrition, Inc. and Ambrosia Nutraceuticals, LLC. \u201cFor years I tried making a plant-based protein that made any sense \u2013 to no surprise, they all failed,\u201d said co-founder Marc Lobliner. \u201cMy whey protein brand, MTS, has seen massive success but plant-based protein is a whole another ball game."}
{"meta": {"doc_id": 2430, "sent_id": 11, "sent_start_pos": 1647, "sent_end_pos": 2075, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "\u201cFor years I tried making a plant-based protein that made any sense \u2013 to no surprise, they all failed,\u201d said co-founder Marc Lobliner. \u201cMy whey protein brand, MTS, has seen massive success but plant-based protein is a whole another ball game. Doing one doesn\u2019t guarantee the other.\u201d\nBut with this new formulation, the team at Ambrosia Nutraceuticals, LLC feel extremely confident they have a whole new product like never before."}
{"meta": {"doc_id": 2430, "sent_id": 12, "sent_start_pos": 1782, "sent_end_pos": 2218, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "\u201cMy whey protein brand, MTS, has seen massive success but plant-based protein is a whole another ball game. Doing one doesn\u2019t guarantee the other.\u201d\nBut with this new formulation, the team at Ambrosia Nutraceuticals, LLC feel extremely confident they have a whole new product like never before. \u201cPlant protein is very tricky \u2013 everything matters; how it blends, how it tastes, the texture \u2013 everything,\u201d said co-founder Mike Rashid King."}
{"meta": {"doc_id": 2430, "sent_id": 13, "sent_start_pos": 1890, "sent_end_pos": 2358, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "Doing one doesn\u2019t guarantee the other.\u201d\nBut with this new formulation, the team at Ambrosia Nutraceuticals, LLC feel extremely confident they have a whole new product like never before. \u201cPlant protein is very tricky \u2013 everything matters; how it blends, how it tastes, the texture \u2013 everything,\u201d said co-founder Mike Rashid King. \u201cThis one is extra special because it gives you what you\u2019ll never expect from a plant protein \u2013 a full amino profile from a natural source."}
{"meta": {"doc_id": 2430, "sent_id": 14, "sent_start_pos": 2076, "sent_end_pos": 2546, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "\u201cPlant protein is very tricky \u2013 everything matters; how it blends, how it tastes, the texture \u2013 everything,\u201d said co-founder Mike Rashid King. \u201cThis one is extra special because it gives you what you\u2019ll never expect from a plant protein \u2013 a full amino profile from a natural source. This is a vegan\u2019s dream come true and a secret weapon for any bodybuilder out there.\u201d\nThe new line of Plant-based Protein, branded under the name Planta\u2122, launched today October 1st 2018."}
{"meta": {"doc_id": 2430, "sent_id": 15, "sent_start_pos": 2219, "sent_end_pos": 2676, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "\u201cThis one is extra special because it gives you what you\u2019ll never expect from a plant protein \u2013 a full amino profile from a natural source. This is a vegan\u2019s dream come true and a secret weapon for any bodybuilder out there.\u201d\nThe new line of Plant-based Protein, branded under the name Planta\u2122, launched today October 1st 2018. Ambrosia Nutraceuticals, LLC will launch with three flavors Cacao (Chocolate), Madagascar Vanilla, and Banana Maple French Toast."}
{"meta": {"doc_id": 2430, "sent_id": 16, "sent_start_pos": 2359, "sent_end_pos": 2765, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "This is a vegan\u2019s dream come true and a secret weapon for any bodybuilder out there.\u201d\nThe new line of Plant-based Protein, branded under the name Planta\u2122, launched today October 1st 2018. Ambrosia Nutraceuticals, LLC will launch with three flavors Cacao (Chocolate), Madagascar Vanilla, and Banana Maple French Toast. Ambrosia Nutraceuticals plans on releasing six more flavors, bringing the total to nine."}
{"meta": {"doc_id": 2430, "sent_id": 17, "sent_start_pos": 2547, "sent_end_pos": 2957, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "Ambrosia Nutraceuticals, LLC will launch with three flavors Cacao (Chocolate), Madagascar Vanilla, and Banana Maple French Toast. Ambrosia Nutraceuticals plans on releasing six more flavors, bringing the total to nine. About High Performance Nutrition, Inc.\nHigh Performance Nutrition, Inc., is a privately held health and wellness company specializing in breakthrough and cutting edge dietary supplementation."}
{"meta": {"doc_id": 2430, "sent_id": 18, "sent_start_pos": 2677, "sent_end_pos": 3097, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "Ambrosia Nutraceuticals plans on releasing six more flavors, bringing the total to nine. About High Performance Nutrition, Inc.\nHigh Performance Nutrition, Inc., is a privately held health and wellness company specializing in breakthrough and cutting edge dietary supplementation. High Performance Nutrition has gained recognition in developing and bringing to market the most innovative dietary supplementation to date."}
{"meta": {"doc_id": 2430, "sent_id": 19, "sent_start_pos": 2766, "sent_end_pos": 3239, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "About High Performance Nutrition, Inc.\nHigh Performance Nutrition, Inc., is a privately held health and wellness company specializing in breakthrough and cutting edge dietary supplementation. High Performance Nutrition has gained recognition in developing and bringing to market the most innovative dietary supplementation to date. First, in 2013 with the introduction of N(R) Nicotinamide Riboside, then in 2015 with M(6) AnthOrigin, and later in 2016 with PA(7) Mediator."}
{"meta": {"doc_id": 2430, "sent_id": 20, "sent_start_pos": 2958, "sent_end_pos": 3310, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "High Performance Nutrition has gained recognition in developing and bringing to market the most innovative dietary supplementation to date. First, in 2013 with the introduction of N(R) Nicotinamide Riboside, then in 2015 with M(6) AnthOrigin, and later in 2016 with PA(7) Mediator. It currently operates in the Wholesale and Direct-to-Consumer sectors."}
{"meta": {"doc_id": 2430, "sent_id": 21, "sent_start_pos": 3098, "sent_end_pos": 3448, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "First, in 2013 with the introduction of N(R) Nicotinamide Riboside, then in 2015 with M(6) AnthOrigin, and later in 2016 with PA(7) Mediator. It currently operates in the Wholesale and Direct-to-Consumer sectors. It also works exclusively with Professional Sports teams and retains approval from the NSF and the Banned Substance Control Group (BSCG)."}
{"meta": {"doc_id": 2430, "sent_id": 22, "sent_start_pos": 3240, "sent_end_pos": 3539, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "It currently operates in the Wholesale and Direct-to-Consumer sectors. It also works exclusively with Professional Sports teams and retains approval from the NSF and the Banned Substance Control Group (BSCG). To learn more about High Performance Nutrition, Inc., please visit www.HPNSupplements.com."}
{"meta": {"doc_id": 2430, "sent_id": 23, "sent_start_pos": 3311, "sent_end_pos": 3755, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "It also works exclusively with Professional Sports teams and retains approval from the NSF and the Banned Substance Control Group (BSCG). To learn more about High Performance Nutrition, Inc., please visit www.HPNSupplements.com. Ambrosia Nutraceuticals is a collective effort formed in 2015 by three respected industry leaders of the health and fitness industry; Marc Lobliner, Mike Rashid, and Sean Torbati."}
{"meta": {"doc_id": 2430, "sent_id": 24, "sent_start_pos": 3449, "sent_end_pos": 3906, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "To learn more about High Performance Nutrition, Inc., please visit www.HPNSupplements.com. Ambrosia Nutraceuticals is a collective effort formed in 2015 by three respected industry leaders of the health and fitness industry; Marc Lobliner, Mike Rashid, and Sean Torbati. The three founders of Ambrosia represent professional athletes, professional body builders, and an expertise in everything health and fitness related."}
{"meta": {"doc_id": 2430, "sent_id": 25, "sent_start_pos": 3576, "sent_end_pos": 3973, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "Ambrosia Nutraceuticals is a collective effort formed in 2015 by three respected industry leaders of the health and fitness industry; Marc Lobliner, Mike Rashid, and Sean Torbati. The three founders of Ambrosia represent professional athletes, professional body builders, and an expertise in everything health and fitness related. Ambrosia is propelled by the spirit of innovation and progression."}
{"meta": {"doc_id": 2430, "sent_id": 26, "sent_start_pos": 3756, "sent_end_pos": 4053, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "The three founders of Ambrosia represent professional athletes, professional body builders, and an expertise in everything health and fitness related. Ambrosia is propelled by the spirit of innovation and progression. Marc Lobliner popularized the category of BCAA with his breakout product Xtend."}
{"meta": {"doc_id": 2430, "sent_id": 27, "sent_start_pos": 3907, "sent_end_pos": 4204, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "Ambrosia is propelled by the spirit of innovation and progression. Marc Lobliner popularized the category of BCAA with his breakout product Xtend. Sean Torbati similarly created the category of NAD+ supplementation by being the first to commercialize a brand new ingredient, Nicotinamide Riboside."}
{"meta": {"doc_id": 2430, "sent_id": 28, "sent_start_pos": 3974, "sent_end_pos": 4426, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "Marc Lobliner popularized the category of BCAA with his breakout product Xtend. Sean Torbati similarly created the category of NAD+ supplementation by being the first to commercialize a brand new ingredient, Nicotinamide Riboside. Mike Rashid King pioneered the concept of \"Overtraining\" and \"Mental Jewels\" making him perhaps the only wellness/fitness expert to focus nearly entirely on the mental aspect of physical training and personal development."}
{"meta": {"doc_id": 2430, "sent_id": 29, "sent_start_pos": 4054, "sent_end_pos": 4503, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "Sean Torbati similarly created the category of NAD+ supplementation by being the first to commercialize a brand new ingredient, Nicotinamide Riboside. Mike Rashid King pioneered the concept of \"Overtraining\" and \"Mental Jewels\" making him perhaps the only wellness/fitness expert to focus nearly entirely on the mental aspect of physical training and personal development. Collectively, all of this experience has come together to form a new entity."}
{"meta": {"doc_id": 2430, "sent_id": 30, "sent_start_pos": 4205, "sent_end_pos": 4634, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "Mike Rashid King pioneered the concept of \"Overtraining\" and \"Mental Jewels\" making him perhaps the only wellness/fitness expert to focus nearly entirely on the mental aspect of physical training and personal development. Collectively, all of this experience has come together to form a new entity. Ambrosia is greater than any individual member and is poised to change our entire approach to health, wellness, and mental growth."}
{"meta": {"doc_id": 2430, "sent_id": 31, "sent_start_pos": 4427, "sent_end_pos": 4958, "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "Collectively, all of this experience has come together to form a new entity. Ambrosia is greater than any individual member and is poised to change our entire approach to health, wellness, and mental growth. For more information on this press release visit:\nhttp://www.abnewswire.com/\nMedia Contact:\nCompany Name: High Performance Nutrition\nContact Person: Zaid Mendez, President & COO\nEmail: CustomerCare@\nPhone: 18009714318\nAddress: 1630 Superior Avenue, Suite D\nCity: Costa Mesa\nState: CA\nCountry: United States\nWebsite: http://"}
{"meta": {"doc_id": 2430, "sent_id": 32, "sent_start_pos": 4504, "sent_end_pos": [], "title": "High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. to bring the next evolution in plant-based protein"}, "text": "Ambrosia is greater than any individual member and is poised to change our entire approach to health, wellness, and mental growth. For more information on this press release visit:\nhttp://www.abnewswire.com/\nMedia Contact:\nCompany Name: High Performance Nutrition\nContact Person: Zaid Mendez, President & COO\nEmail: CustomerCare@\nPhone: 18009714318\nAddress: 1630 Superior Avenue, Suite D\nCity: Costa Mesa\nState: CA\nCountry: United States\nWebsite: http:// "}
{"meta": {"doc_id": 2436, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 281, "title": "MEMBERS"}, "text": " Please visit this page again soon or contact us for special/package availability. A-OX Welding\nFeaturing a state-of-the art ISO/IEC 17025:2005 Accredited gas lab and full-service retail locations across the region."}
{"meta": {"doc_id": 2436, "sent_id": 1, "sent_start_pos": 56, "sent_end_pos": 438, "title": "MEMBERS"}, "text": "Please visit this page again soon or contact us for special/package availability. A-OX Welding\nFeaturing a state-of-the art ISO/IEC 17025:2005 Accredited gas lab and full-service retail locations across the region. Visit www.aoxwelding.com to find out ways that A-OX Welding Supply can facilitate all of your specialty gas, industrial supply, and industrial safety needs."}
{"meta": {"doc_id": 2436, "sent_id": 2, "sent_start_pos": 149, "sent_end_pos": 564, "title": "MEMBERS"}, "text": "A-OX Welding\nFeaturing a state-of-the art ISO/IEC 17025:2005 Accredited gas lab and full-service retail locations across the region. Visit www.aoxwelding.com to find out ways that A-OX Welding Supply can facilitate all of your specialty gas, industrial supply, and industrial safety needs. Amgen\nA biotechnology pioneer since 1980, Amgen discovers, develops, manufactures and delivers innovative human therapeutics."}
{"meta": {"doc_id": 2436, "sent_id": 3, "sent_start_pos": 282, "sent_end_pos": 720, "title": "MEMBERS"}, "text": "Visit www.aoxwelding.com to find out ways that A-OX Welding Supply can facilitate all of your specialty gas, industrial supply, and industrial safety needs. Amgen\nA biotechnology pioneer since 1980, Amgen discovers, develops, manufactures and delivers innovative human therapeutics. Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient."}
{"meta": {"doc_id": 2436, "sent_id": 4, "sent_start_pos": 439, "sent_end_pos": 930, "title": "MEMBERS"}, "text": "Amgen\nA biotechnology pioneer since 1980, Amgen discovers, develops, manufactures and delivers innovative human therapeutics. Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. AT Analytical Inc.\nBased in Baltic, South Dakota, AT Analytical is an ISO 9001 Certified Calibration Company specializing in Rx Clean-room Compliance."}
{"meta": {"doc_id": 2436, "sent_id": 5, "sent_start_pos": 565, "sent_end_pos": 1227, "title": "MEMBERS"}, "text": "Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. AT Analytical Inc.\nBased in Baltic, South Dakota, AT Analytical is an ISO 9001 Certified Calibration Company specializing in Rx Clean-room Compliance. The company is an authorized service agent for several manufacturers including Baker, Consolidated Still and Sterilizers, Fisher Scientific and Thermo Fishers, NuAire, Sanyo, Scientek and Tuttnauer, and VWR/Sheldon."}
{"meta": {"doc_id": 2436, "sent_id": 6, "sent_start_pos": 780, "sent_end_pos": 1411, "title": "MEMBERS"}, "text": "AT Analytical Inc.\nBased in Baltic, South Dakota, AT Analytical is an ISO 9001 Certified Calibration Company specializing in Rx Clean-room Compliance. The company is an authorized service agent for several manufacturers including Baker, Consolidated Still and Sterilizers, Fisher Scientific and Thermo Fishers, NuAire, Sanyo, Scientek and Tuttnauer, and VWR/Sheldon. Augustana University\nFounded in 1860, Augustana University in Sioux Falls, SD, is a selective, residential, comprehensive college of the Evangelical Lutheran Church of America (ELCA)."}
{"meta": {"doc_id": 2436, "sent_id": 7, "sent_start_pos": 1012, "sent_end_pos": 1642, "title": "MEMBERS"}, "text": "The company is an authorized service agent for several manufacturers including Baker, Consolidated Still and Sterilizers, Fisher Scientific and Thermo Fishers, NuAire, Sanyo, Scientek and Tuttnauer, and VWR/Sheldon. Augustana University\nFounded in 1860, Augustana University in Sioux Falls, SD, is a selective, residential, comprehensive college of the Evangelical Lutheran Church of America (ELCA). With more than 2,080 (1,749 undergraduate) from 29 states and 36 countries, and student-to-faculty ratio of 12 to 1, with most Augustana science students take part in research programs and experiences as a part of their education."}
{"meta": {"doc_id": 2436, "sent_id": 8, "sent_start_pos": 1228, "sent_end_pos": 1931, "title": "MEMBERS"}, "text": "Augustana University\nFounded in 1860, Augustana University in Sioux Falls, SD, is a selective, residential, comprehensive college of the Evangelical Lutheran Church of America (ELCA). With more than 2,080 (1,749 undergraduate) from 29 states and 36 countries, and student-to-faculty ratio of 12 to 1, with most Augustana science students take part in research programs and experiences as a part of their education. Augustana is featured among \"America's Top Colleges\" by Forbes; was ranked among the top 10 baccalaureate colleges in the nation for its efforts to advance social mobility, research and service by Washington Monthly; and has been named a \"Best Midwestern College\" by The Princeton Review."}
{"meta": {"doc_id": 2436, "sent_id": 9, "sent_start_pos": 1412, "sent_end_pos": 2086, "title": "MEMBERS"}, "text": "With more than 2,080 (1,749 undergraduate) from 29 states and 36 countries, and student-to-faculty ratio of 12 to 1, with most Augustana science students take part in research programs and experiences as a part of their education. Augustana is featured among \"America's Top Colleges\" by Forbes; was ranked among the top 10 baccalaureate colleges in the nation for its efforts to advance social mobility, research and service by Washington Monthly; and has been named a \"Best Midwestern College\" by The Princeton Review. Avera Health\nThe Avera Health system has over 18,000 employees and physicians, serving more than 300 locations and 100 communities in a five-state region."}
{"meta": {"doc_id": 2436, "sent_id": 10, "sent_start_pos": 1643, "sent_end_pos": 2332, "title": "MEMBERS"}, "text": "Augustana is featured among \"America's Top Colleges\" by Forbes; was ranked among the top 10 baccalaureate colleges in the nation for its efforts to advance social mobility, research and service by Washington Monthly; and has been named a \"Best Midwestern College\" by The Princeton Review. Avera Health\nThe Avera Health system has over 18,000 employees and physicians, serving more than 300 locations and 100 communities in a five-state region. We carry on the health care legacy of the Benedictine and Presentation Sisters, delivering care in an environment guided by our values of compassion, hospitality and stewardship."}
{"meta": {"doc_id": 2436, "sent_id": 11, "sent_start_pos": 1932, "sent_end_pos": 2592, "title": "MEMBERS"}, "text": "Avera Health\nThe Avera Health system has over 18,000 employees and physicians, serving more than 300 locations and 100 communities in a five-state region. We carry on the health care legacy of the Benedictine and Presentation Sisters, delivering care in an environment guided by our values of compassion, hospitality and stewardship. Bion\nBion specializes in the production of analytical standards and reference materials, analytical testing services, proficiency testing programs, laboratory consultation, and quality accreditation services."}
{"meta": {"doc_id": 2436, "sent_id": 12, "sent_start_pos": 2154, "sent_end_pos": 2846, "title": "MEMBERS"}, "text": "We carry on the health care legacy of the Benedictine and Presentation Sisters, delivering care in an environment guided by our values of compassion, hospitality and stewardship. Bion\nBion specializes in the production of analytical standards and reference materials, analytical testing services, proficiency testing programs, laboratory consultation, and quality accreditation services. Brookings Economic Development Corporation\nBrookings Economic Development Corporation is a private nonprofit 501(c)(6) corporation organized in 1995 as the primary engine for promoting economic growth in Brookings, South Dakota and the surrounding area."}
{"meta": {"doc_id": 2436, "sent_id": 13, "sent_start_pos": 2384, "sent_end_pos": 3147, "title": "MEMBERS"}, "text": "Bion\nBion specializes in the production of analytical standards and reference materials, analytical testing services, proficiency testing programs, laboratory consultation, and quality accreditation services. Brookings Economic Development Corporation\nBrookings Economic Development Corporation is a private nonprofit 501(c)(6) corporation organized in 1995 as the primary engine for promoting economic growth in Brookings, South Dakota and the surrounding area. The BEDC serves as an advocate for the business community by building relationships with companies that allow them to take advantage of the area's science and technology infrastructure, optimal business environment, University research resources, high-performance workforce and progressive community."}
{"meta": {"doc_id": 2436, "sent_id": 14, "sent_start_pos": 2593, "sent_end_pos": 3347, "title": "MEMBERS"}, "text": "Brookings Economic Development Corporation\nBrookings Economic Development Corporation is a private nonprofit 501(c)(6) corporation organized in 1995 as the primary engine for promoting economic growth in Brookings, South Dakota and the surrounding area. The BEDC serves as an advocate for the business community by building relationships with companies that allow them to take advantage of the area's science and technology infrastructure, optimal business environment, University research resources, high-performance workforce and progressive community. CEGA Innovations\nCEGA Innovations engages in the ideation, development, manufacturing, and distribution of medical products that are targeted for use through innovative design and business practices."}
{"meta": {"doc_id": 2436, "sent_id": 15, "sent_start_pos": 2847, "sent_end_pos": 3481, "title": "MEMBERS"}, "text": "The BEDC serves as an advocate for the business community by building relationships with companies that allow them to take advantage of the area's science and technology infrastructure, optimal business environment, University research resources, high-performance workforce and progressive community. CEGA Innovations\nCEGA Innovations engages in the ideation, development, manufacturing, and distribution of medical products that are targeted for use through innovative design and business practices. Celgene\nCelgene is a global biopharmaceutical company committed to improving the lives of patients worldwide."}
{"meta": {"doc_id": 2436, "sent_id": 16, "sent_start_pos": 3148, "sent_end_pos": 3571, "title": "MEMBERS"}, "text": "CEGA Innovations\nCEGA Innovations engages in the ideation, development, manufacturing, and distribution of medical products that are targeted for use through innovative design and business practices. Celgene\nCelgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients."}
{"meta": {"doc_id": 2436, "sent_id": 17, "sent_start_pos": 3372, "sent_end_pos": 3819, "title": "MEMBERS"}, "text": "Celgene\nCelgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions."}
{"meta": {"doc_id": 2436, "sent_id": 18, "sent_start_pos": 3482, "sent_end_pos": 4159, "title": "MEMBERS"}, "text": "At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. Christiansen Land and Cattle, Ltd.\nA founding member of South Dakota Biotech, the Kimball-based business also is a diversified one, with more than 10,000 acres of corn, soybeans and winter wheat along with a large ranching operation with 12 to 18 employees throughout the year."}
{"meta": {"doc_id": 2436, "sent_id": 19, "sent_start_pos": 3572, "sent_end_pos": 4286, "title": "MEMBERS"}, "text": "Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. Christiansen Land and Cattle, Ltd.\nA founding member of South Dakota Biotech, the Kimball-based business also is a diversified one, with more than 10,000 acres of corn, soybeans and winter wheat along with a large ranching operation with 12 to 18 employees throughout the year. Christiansen Land and Cattle, Ltd. has served the biotech industry by providing livestock management and biosecurity services."}
{"meta": {"doc_id": 2436, "sent_id": 20, "sent_start_pos": 3882, "sent_end_pos": 4577, "title": "MEMBERS"}, "text": "Christiansen Land and Cattle, Ltd.\nA founding member of South Dakota Biotech, the Kimball-based business also is a diversified one, with more than 10,000 acres of corn, soybeans and winter wheat along with a large ranching operation with 12 to 18 employees throughout the year. Christiansen Land and Cattle, Ltd. has served the biotech industry by providing livestock management and biosecurity services. Dakota Provisions\nFor more information visit dakotaprovisions.com\nFisher Scientific\nFisher Scientific offers customers convenient access to a complete portfolio of laboratory equipment, chemicals, supplies and services used in scientific research, health care, safety and education markets."}
{"meta": {"doc_id": 2436, "sent_id": 21, "sent_start_pos": 4160, "sent_end_pos": 4833, "title": "MEMBERS"}, "text": "Christiansen Land and Cattle, Ltd. has served the biotech industry by providing livestock management and biosecurity services. Dakota Provisions\nFor more information visit dakotaprovisions.com\nFisher Scientific\nFisher Scientific offers customers convenient access to a complete portfolio of laboratory equipment, chemicals, supplies and services used in scientific research, health care, safety and education markets. A global network of direct sales professionals, industry-specific catalogs, e-commerce capabilities and supply-chain management services enables Fisher Scientific to offer a broad mix of products manufactured by Thermo Fisher Scientific and third parties."}
{"meta": {"doc_id": 2436, "sent_id": 22, "sent_start_pos": 4287, "sent_end_pos": 4907, "title": "MEMBERS"}, "text": "Dakota Provisions\nFor more information visit dakotaprovisions.com\nFisher Scientific\nFisher Scientific offers customers convenient access to a complete portfolio of laboratory equipment, chemicals, supplies and services used in scientific research, health care, safety and education markets. A global network of direct sales professionals, industry-specific catalogs, e-commerce capabilities and supply-chain management services enables Fisher Scientific to offer a broad mix of products manufactured by Thermo Fisher Scientific and third parties. Fredrikson & Byron\nFredrikson & Byron was founded in Minneapolis in 1948."}
{"meta": {"doc_id": 2436, "sent_id": 23, "sent_start_pos": 4578, "sent_end_pos": 5066, "title": "MEMBERS"}, "text": "A global network of direct sales professionals, industry-specific catalogs, e-commerce capabilities and supply-chain management services enables Fisher Scientific to offer a broad mix of products manufactured by Thermo Fisher Scientific and third parties. Fredrikson & Byron\nFredrikson & Byron was founded in Minneapolis in 1948. Since then, we've grown into an international firm of over 280 attorneys in over 35 practice and industry areas, serving clients from seven offices worldwide."}
{"meta": {"doc_id": 2436, "sent_id": 24, "sent_start_pos": 4834, "sent_end_pos": 5293, "title": "MEMBERS"}, "text": "Fredrikson & Byron\nFredrikson & Byron was founded in Minneapolis in 1948. Since then, we've grown into an international firm of over 280 attorneys in over 35 practice and industry areas, serving clients from seven offices worldwide. We serve a broad variety of publicly and privately held businesses, financial institutions, municipalities, professional corporations, limited liability companies, nonprofits, trade associations, partnerships, and individuals."}
{"meta": {"doc_id": 2436, "sent_id": 25, "sent_start_pos": 4908, "sent_end_pos": 5450, "title": "MEMBERS"}, "text": "Since then, we've grown into an international firm of over 280 attorneys in over 35 practice and industry areas, serving clients from seven offices worldwide. We serve a broad variety of publicly and privately held businesses, financial institutions, municipalities, professional corporations, limited liability companies, nonprofits, trade associations, partnerships, and individuals. Clients include new ventures, small and medium-sized companies, family businesses, and national and international companies traded on world stock exchanges."}
{"meta": {"doc_id": 2436, "sent_id": 26, "sent_start_pos": 5067, "sent_end_pos": 5643, "title": "MEMBERS"}, "text": "We serve a broad variety of publicly and privately held businesses, financial institutions, municipalities, professional corporations, limited liability companies, nonprofits, trade associations, partnerships, and individuals. Clients include new ventures, small and medium-sized companies, family businesses, and national and international companies traded on world stock exchanges. Genetech\nGenentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions."}
{"meta": {"doc_id": 2436, "sent_id": 27, "sent_start_pos": 5294, "sent_end_pos": 5770, "title": "MEMBERS"}, "text": "Clients include new ventures, small and medium-sized companies, family businesses, and national and international companies traded on world stock exchanges. Genetech\nGenentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline."}
{"meta": {"doc_id": 2436, "sent_id": 28, "sent_start_pos": 5451, "sent_end_pos": 5966, "title": "MEMBERS"}, "text": "Genetech\nGenentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline. GlycoScience Research Inc LOGO GlycoScience Research IncOver the last 20+ years, WH Land & Livecstock LLC has have built a flock of genetically selected carriers for the GM1 gangliosidosis trait."}
{"meta": {"doc_id": 2436, "sent_id": 29, "sent_start_pos": 5644, "sent_end_pos": 6103, "title": "MEMBERS"}, "text": "We are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline. GlycoScience Research Inc LOGO GlycoScience Research IncOver the last 20+ years, WH Land & Livecstock LLC has have built a flock of genetically selected carriers for the GM1 gangliosidosis trait. GlycoScience Research Inc (GSR), was incorporated to develop a safe, natural source of GM1 for ganglioside research and therapeutic use."}
{"meta": {"doc_id": 2436, "sent_id": 30, "sent_start_pos": 5771, "sent_end_pos": 6236, "title": "MEMBERS"}, "text": "GlycoScience Research Inc LOGO GlycoScience Research IncOver the last 20+ years, WH Land & Livecstock LLC has have built a flock of genetically selected carriers for the GM1 gangliosidosis trait. GlycoScience Research Inc (GSR), was incorporated to develop a safe, natural source of GM1 for ganglioside research and therapeutic use. Our mission is to produce and promote ovine GM1 ganglioside as a treatment for Huntington's Disease and other neurological diseases."}
{"meta": {"doc_id": 2436, "sent_id": 31, "sent_start_pos": 5967, "sent_end_pos": 6409, "title": "MEMBERS"}, "text": "GlycoScience Research Inc (GSR), was incorporated to develop a safe, natural source of GM1 for ganglioside research and therapeutic use. Our mission is to produce and promote ovine GM1 ganglioside as a treatment for Huntington's Disease and other neurological diseases. Inanovate\nInanovate is developing new blood tests to diagnose and monitor breast cancer and breast cancer recurrence."}
{"meta": {"doc_id": 2436, "sent_id": 32, "sent_start_pos": 6104, "sent_end_pos": 6553, "title": "MEMBERS"}, "text": "Our mission is to produce and promote ovine GM1 ganglioside as a treatment for Huntington's Disease and other neurological diseases. Inanovate\nInanovate is developing new blood tests to diagnose and monitor breast cancer and breast cancer recurrence. Inanovate's blood tests are based on the accurate detection and measurement of multiple cancer related biomarkers from a patients blood sample."}
{"meta": {"doc_id": 2436, "sent_id": 33, "sent_start_pos": 6292, "sent_end_pos": 6714, "title": "MEMBERS"}, "text": "Inanovate\nInanovate is developing new blood tests to diagnose and monitor breast cancer and breast cancer recurrence. Inanovate's blood tests are based on the accurate detection and measurement of multiple cancer related biomarkers from a patients blood sample. The first test, a test to supplement a positive mammogram result and help decrease false positive diagnoses, is targeted for initial clinical launch in Q3 2020."}
{"meta": {"doc_id": 2436, "sent_id": 34, "sent_start_pos": 6410, "sent_end_pos": 6840, "title": "MEMBERS"}, "text": "Inanovate's blood tests are based on the accurate detection and measurement of multiple cancer related biomarkers from a patients blood sample. The first test, a test to supplement a positive mammogram result and help decrease false positive diagnoses, is targeted for initial clinical launch in Q3 2020. Medgene Labs\nMedgene Labs is breaking the paradigms of herd health management via its powerful animal health service ISPRIME."}
{"meta": {"doc_id": 2436, "sent_id": 35, "sent_start_pos": 6554, "sent_end_pos": 7009, "title": "MEMBERS"}, "text": "The first test, a test to supplement a positive mammogram result and help decrease false positive diagnoses, is targeted for initial clinical launch in Q3 2020. Medgene Labs\nMedgene Labs is breaking the paradigms of herd health management via its powerful animal health service ISPRIME. \u201cIS\u201d stands for \u201cImmunological Services.\u201d Immunological refers to the scientific study of the immune system and the application of research and carefully acquired data."}
{"meta": {"doc_id": 2436, "sent_id": 36, "sent_start_pos": 6715, "sent_end_pos": 7131, "title": "MEMBERS"}, "text": "Medgene Labs\nMedgene Labs is breaking the paradigms of herd health management via its powerful animal health service ISPRIME. \u201cIS\u201d stands for \u201cImmunological Services.\u201d Immunological refers to the scientific study of the immune system and the application of research and carefully acquired data. Services refers to a relationship between the immunologist, the producer, and the veterinarian involved in animal health."}
{"meta": {"doc_id": 2436, "sent_id": 37, "sent_start_pos": 6841, "sent_end_pos": 7251, "title": "MEMBERS"}, "text": "\u201cIS\u201d stands for \u201cImmunological Services.\u201d Immunological refers to the scientific study of the immune system and the application of research and carefully acquired data. Services refers to a relationship between the immunologist, the producer, and the veterinarian involved in animal health. \u201cPrime\u201d refers to the fact that this valuable immunological service is reserved for a community of livestock producers."}
{"meta": {"doc_id": 2436, "sent_id": 38, "sent_start_pos": 7010, "sent_end_pos": 7380, "title": "MEMBERS"}, "text": "Services refers to a relationship between the immunologist, the producer, and the veterinarian involved in animal health. \u201cPrime\u201d refers to the fact that this valuable immunological service is reserved for a community of livestock producers. Using technologies and methods developed by Medgene Labs, effective vaccines are created with extraordinary precision and speed."}
{"meta": {"doc_id": 2436, "sent_id": 39, "sent_start_pos": 7132, "sent_end_pos": 7475, "title": "MEMBERS"}, "text": "\u201cPrime\u201d refers to the fact that this valuable immunological service is reserved for a community of livestock producers. Using technologies and methods developed by Medgene Labs, effective vaccines are created with extraordinary precision and speed. These vaccines are deployed where and when they're needed through the producer's veterinarian."}
{"meta": {"doc_id": 2436, "sent_id": 40, "sent_start_pos": 7252, "sent_end_pos": 7635, "title": "MEMBERS"}, "text": "Using technologies and methods developed by Medgene Labs, effective vaccines are created with extraordinary precision and speed. These vaccines are deployed where and when they're needed through the producer's veterinarian. Monsanto\nMonsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality."}
{"meta": {"doc_id": 2436, "sent_id": 41, "sent_start_pos": 7381, "sent_end_pos": 7827, "title": "MEMBERS"}, "text": "These vaccines are deployed where and when they're needed through the producer's veterinarian. Monsanto\nMonsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of the world's natural resources such as water and energy."}
{"meta": {"doc_id": 2436, "sent_id": 42, "sent_start_pos": 7476, "sent_end_pos": 8048, "title": "MEMBERS"}, "text": "Monsanto\nMonsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of the world's natural resources such as water and energy. Nanopareil, LLC\nNanopareil, LLC is positioned to become a leading global provider of products, solutions and services for bioprocessing purification using the Company's proprietary nanotechnology membranes and processes."}
{"meta": {"doc_id": 2436, "sent_id": 43, "sent_start_pos": 7636, "sent_end_pos": 8306, "title": "MEMBERS"}, "text": "Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of the world's natural resources such as water and energy. Nanopareil, LLC\nNanopareil, LLC is positioned to become a leading global provider of products, solutions and services for bioprocessing purification using the Company's proprietary nanotechnology membranes and processes. Nanopareil's technology will enable fundamental (ie orders of magnitude) transformations over conventional processes in the time-to-market, process economics, adaptability and scalability for biopharmaceutical firms in discovery, development and production."}
{"meta": {"doc_id": 2436, "sent_id": 44, "sent_start_pos": 7828, "sent_end_pos": 8521, "title": "MEMBERS"}, "text": "Nanopareil, LLC\nNanopareil, LLC is positioned to become a leading global provider of products, solutions and services for bioprocessing purification using the Company's proprietary nanotechnology membranes and processes. Nanopareil's technology will enable fundamental (ie orders of magnitude) transformations over conventional processes in the time-to-market, process economics, adaptability and scalability for biopharmaceutical firms in discovery, development and production. The core technology was spun out of the South Dakota School of Mines and Technology in 2011 and is protected by a patent portfolio and trade secrets covering its evolution, production processes and product designs."}
{"meta": {"doc_id": 2436, "sent_id": 45, "sent_start_pos": 8049, "sent_end_pos": 8714, "title": "MEMBERS"}, "text": "Nanopareil's technology will enable fundamental (ie orders of magnitude) transformations over conventional processes in the time-to-market, process economics, adaptability and scalability for biopharmaceutical firms in discovery, development and production. The core technology was spun out of the South Dakota School of Mines and Technology in 2011 and is protected by a patent portfolio and trade secrets covering its evolution, production processes and product designs. Development has been supported through National Science Foundation (NSF) grants, local investors, including investments from the Black Hills Angel Fund and South Dakota Equity Partners (SDEP)."}
{"meta": {"doc_id": 2436, "sent_id": 46, "sent_start_pos": 8307, "sent_end_pos": 8956, "title": "MEMBERS"}, "text": "The core technology was spun out of the South Dakota School of Mines and Technology in 2011 and is protected by a patent portfolio and trade secrets covering its evolution, production processes and product designs. Development has been supported through National Science Foundation (NSF) grants, local investors, including investments from the Black Hills Angel Fund and South Dakota Equity Partners (SDEP). Northern State University\nLocated in Aberdeen and founded in 1901, Northern State University is a public institution characterized by outstanding instruction, extraordinary community relations, and unparalleled extracurricular opportunities."}
{"meta": {"doc_id": 2436, "sent_id": 47, "sent_start_pos": 8522, "sent_end_pos": 9098, "title": "MEMBERS"}, "text": "Development has been supported through National Science Foundation (NSF) grants, local investors, including investments from the Black Hills Angel Fund and South Dakota Equity Partners (SDEP). Northern State University\nLocated in Aberdeen and founded in 1901, Northern State University is a public institution characterized by outstanding instruction, extraordinary community relations, and unparalleled extracurricular opportunities. It has a total undergraduate enrollment of 3,600 with representation from 42 states and 42 foreign countries and the campus size is 72 acres."}
{"meta": {"doc_id": 2436, "sent_id": 48, "sent_start_pos": 8715, "sent_end_pos": 9193, "title": "MEMBERS"}, "text": "Northern State University\nLocated in Aberdeen and founded in 1901, Northern State University is a public institution characterized by outstanding instruction, extraordinary community relations, and unparalleled extracurricular opportunities. It has a total undergraduate enrollment of 3,600 with representation from 42 states and 42 foreign countries and the campus size is 72 acres. Novartis\nNovartis is a Swiss multinational pharmaceutical company based in Basel, Switzerland."}
{"meta": {"doc_id": 2436, "sent_id": 49, "sent_start_pos": 8957, "sent_end_pos": 9284, "title": "MEMBERS"}, "text": "It has a total undergraduate enrollment of 3,600 with representation from 42 states and 42 foreign countries and the campus size is 72 acres. Novartis\nNovartis is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales."}
{"meta": {"doc_id": 2436, "sent_id": 50, "sent_start_pos": 9099, "sent_end_pos": 9450, "title": "MEMBERS"}, "text": "Novartis\nNovartis is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales. We use innovative science and technology to address some of society's most challenging healthcare issues."}
{"meta": {"doc_id": 2436, "sent_id": 51, "sent_start_pos": 9194, "sent_end_pos": 9784, "title": "MEMBERS"}, "text": "It is one of the largest pharmaceutical companies by both market capitalization and sales. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible\nNovita Nutrition\nNovita Nutrition is an animal nutrition company that produces two branded products, including NovaMeal\u00ae, a highly digestible protein for the dairy market and NovaOil\u00ae, a renewable oil used in animal feed."}
{"meta": {"doc_id": 2436, "sent_id": 52, "sent_start_pos": 9345, "sent_end_pos": 9893, "title": "MEMBERS"}, "text": "We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible\nNovita Nutrition\nNovita Nutrition is an animal nutrition company that produces two branded products, including NovaMeal\u00ae, a highly digestible protein for the dairy market and NovaOil\u00ae, a renewable oil used in animal feed. Novo Nordisk\nAt Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions."}
{"meta": {"doc_id": 2436, "sent_id": 53, "sent_start_pos": 9451, "sent_end_pos": 9998, "title": "MEMBERS"}, "text": "We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible\nNovita Nutrition\nNovita Nutrition is an animal nutrition company that produces two branded products, including NovaMeal\u00ae, a highly digestible protein for the dairy market and NovaOil\u00ae, a renewable oil used in animal feed. Novo Nordisk\nAt Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions. Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care."}
{"meta": {"doc_id": 2436, "sent_id": 54, "sent_start_pos": 9785, "sent_end_pos": 10200, "title": "MEMBERS"}, "text": "Novo Nordisk\nAt Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions. Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: rare bleeding disorders, growth hormone related disorders and obesity."}
{"meta": {"doc_id": 2436, "sent_id": 55, "sent_start_pos": 9894, "sent_end_pos": 10344, "title": "MEMBERS"}, "text": "Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: rare bleeding disorders, growth hormone related disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 42,700 people in 79 countries and markets its products in more than 170 countries."}
{"meta": {"doc_id": 2436, "sent_id": 56, "sent_start_pos": 9999, "sent_end_pos": 10487, "title": "MEMBERS"}, "text": "This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: rare bleeding disorders, growth hormone related disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 42,700 people in 79 countries and markets its products in more than 170 countries. Nutraferma\nWith manufacturing and R&D facilities in South Dakota, throughout the US and South Korea, Nutraferma\u00ae is a leading biotech company."}
{"meta": {"doc_id": 2436, "sent_id": 57, "sent_start_pos": 10201, "sent_end_pos": 10603, "title": "MEMBERS"}, "text": "Headquartered in Denmark, Novo Nordisk employs approximately 42,700 people in 79 countries and markets its products in more than 170 countries. Nutraferma\nWith manufacturing and R&D facilities in South Dakota, throughout the US and South Korea, Nutraferma\u00ae is a leading biotech company. Nutraferma pioneered a cutting edge solid state fermentation process to produce high value proteins and microbials."}
{"meta": {"doc_id": 2436, "sent_id": 58, "sent_start_pos": 10345, "sent_end_pos": 10736, "title": "MEMBERS"}, "text": "Nutraferma\nWith manufacturing and R&D facilities in South Dakota, throughout the US and South Korea, Nutraferma\u00ae is a leading biotech company. Nutraferma pioneered a cutting edge solid state fermentation process to produce high value proteins and microbials. Nutraferma's extensive research work has also produced state-of-the-art yeast products, bioactive peptides and phytogenic additives."}
{"meta": {"doc_id": 2436, "sent_id": 59, "sent_start_pos": 10488, "sent_end_pos": 10820, "title": "MEMBERS"}, "text": "Nutraferma pioneered a cutting edge solid state fermentation process to produce high value proteins and microbials. Nutraferma's extensive research work has also produced state-of-the-art yeast products, bioactive peptides and phytogenic additives. OmegaQuant, LLC\nOmegaQuant, LLC is the exclusive provider of the HS-Omega-3 Index\u00ae."}
{"meta": {"doc_id": 2436, "sent_id": 60, "sent_start_pos": 10604, "sent_end_pos": 10943, "title": "MEMBERS"}, "text": "Nutraferma's extensive research work has also produced state-of-the-art yeast products, bioactive peptides and phytogenic additives. OmegaQuant, LLC\nOmegaQuant, LLC is the exclusive provider of the HS-Omega-3 Index\u00ae. This novel blood test was developed to measure the level of omega-3 fatty acids (EPA and DHA) in red blood cell membranes."}
{"meta": {"doc_id": 2436, "sent_id": 61, "sent_start_pos": 10737, "sent_end_pos": 11228, "title": "MEMBERS"}, "text": "OmegaQuant, LLC\nOmegaQuant, LLC is the exclusive provider of the HS-Omega-3 Index\u00ae. This novel blood test was developed to measure the level of omega-3 fatty acids (EPA and DHA) in red blood cell membranes. The risk for sudden cardiac death is reduced by up to 90% in individuals with the highest HS-Omega-3 Index\u00ae, and there is growing evidence for an association between omega-3 biostatus and other conditions such as dry eye, macular degeneration, dementia, depression, joint health, etc."}
{"meta": {"doc_id": 2436, "sent_id": 62, "sent_start_pos": 10821, "sent_end_pos": 11376, "title": "MEMBERS"}, "text": "This novel blood test was developed to measure the level of omega-3 fatty acids (EPA and DHA) in red blood cell membranes. The risk for sudden cardiac death is reduced by up to 90% in individuals with the highest HS-Omega-3 Index\u00ae, and there is growing evidence for an association between omega-3 biostatus and other conditions such as dry eye, macular degeneration, dementia, depression, joint health, etc. PCS Biotech Services, LLC\nPenny (Carpenter) Sattgast, MS, founded PCS Biotech Services, LLC in March of 2017."}
{"meta": {"doc_id": 2436, "sent_id": 63, "sent_start_pos": 10944, "sent_end_pos": 11490, "title": "MEMBERS"}, "text": "The risk for sudden cardiac death is reduced by up to 90% in individuals with the highest HS-Omega-3 Index\u00ae, and there is growing evidence for an association between omega-3 biostatus and other conditions such as dry eye, macular degeneration, dementia, depression, joint health, etc. PCS Biotech Services, LLC\nPenny (Carpenter) Sattgast, MS, founded PCS Biotech Services, LLC in March of 2017. Prior to that, Penny worked for Elanco Animal Health and served as a Clinical Trial Study Director and Scientist."}
{"meta": {"doc_id": 2436, "sent_id": 64, "sent_start_pos": 11267, "sent_end_pos": 11659, "title": "MEMBERS"}, "text": "PCS Biotech Services, LLC\nPenny (Carpenter) Sattgast, MS, founded PCS Biotech Services, LLC in March of 2017. Prior to that, Penny worked for Elanco Animal Health and served as a Clinical Trial Study Director and Scientist. While working full time for Novartis Animal Health, Penny attended South Dakota State University in Brookings, SD where she earned a Master\u2019s degree in Biology in 2013."}
{"meta": {"doc_id": 2436, "sent_id": 65, "sent_start_pos": 11377, "sent_end_pos": 11807, "title": "MEMBERS"}, "text": "Prior to that, Penny worked for Elanco Animal Health and served as a Clinical Trial Study Director and Scientist. While working full time for Novartis Animal Health, Penny attended South Dakota State University in Brookings, SD where she earned a Master\u2019s degree in Biology in 2013. Penny brings 16 years of diverse clinical trial management, product licensure, and laboratory experience in the biologics industry to her business."}
{"meta": {"doc_id": 2436, "sent_id": 66, "sent_start_pos": 11491, "sent_end_pos": 12010, "title": "MEMBERS"}, "text": "While working full time for Novartis Animal Health, Penny attended South Dakota State University in Brookings, SD where she earned a Master\u2019s degree in Biology in 2013. Penny brings 16 years of diverse clinical trial management, product licensure, and laboratory experience in the biologics industry to her business. For more information visit pcsbiotechservices.com\nPoet\nPOET, one of the world's largest ethanol producers, is a leader in biorefining through its efficient, vertically integrated approach to production."}
{"meta": {"doc_id": 2436, "sent_id": 67, "sent_start_pos": 11660, "sent_end_pos": 12208, "title": "MEMBERS"}, "text": "Penny brings 16 years of diverse clinical trial management, product licensure, and laboratory experience in the biologics industry to her business. For more information visit pcsbiotechservices.com\nPoet\nPOET, one of the world's largest ethanol producers, is a leader in biorefining through its efficient, vertically integrated approach to production. The 25-year-old company has a production capacity in excess of 1.6 billion gallons of ethanol and 9 billion pounds of high-protein animal feed annually from its network of 27 production facilities."}
{"meta": {"doc_id": 2436, "sent_id": 68, "sent_start_pos": 11808, "sent_end_pos": 12438, "title": "MEMBERS"}, "text": "For more information visit pcsbiotechservices.com\nPoet\nPOET, one of the world's largest ethanol producers, is a leader in biorefining through its efficient, vertically integrated approach to production. The 25-year-old company has a production capacity in excess of 1.6 billion gallons of ethanol and 9 billion pounds of high-protein animal feed annually from its network of 27 production facilities. POET also operates a pilot-scale cellulosic bio-ethanol plant, which uses corn cobs, leaves, husk and some stalk as feedstock, and expects to commercialize the process in Emmetsburg, Iowa through its joint venture with Royal DSM."}
{"meta": {"doc_id": 2436, "sent_id": 69, "sent_start_pos": 12011, "sent_end_pos": 12741, "title": "MEMBERS"}, "text": "The 25-year-old company has a production capacity in excess of 1.6 billion gallons of ethanol and 9 billion pounds of high-protein animal feed annually from its network of 27 production facilities. POET also operates a pilot-scale cellulosic bio-ethanol plant, which uses corn cobs, leaves, husk and some stalk as feedstock, and expects to commercialize the process in Emmetsburg, Iowa through its joint venture with Royal DSM. Prairie AquaTech\nPrairie AquaTech is addressing aquaculture's challenges, which are unique: sustainability of feed resources, profitability of feed manufacturers, efficiency of aquaculture producers, traceability for the health of consumers\u2026and common to all these challenges is the health of the fish."}
{"meta": {"doc_id": 2436, "sent_id": 70, "sent_start_pos": 12209, "sent_end_pos": 12846, "title": "MEMBERS"}, "text": "POET also operates a pilot-scale cellulosic bio-ethanol plant, which uses corn cobs, leaves, husk and some stalk as feedstock, and expects to commercialize the process in Emmetsburg, Iowa through its joint venture with Royal DSM. Prairie AquaTech\nPrairie AquaTech is addressing aquaculture's challenges, which are unique: sustainability of feed resources, profitability of feed manufacturers, efficiency of aquaculture producers, traceability for the health of consumers\u2026and common to all these challenges is the health of the fish. The company researches, develops, and manufactures feed ingredients that start with plant-based protein."}
{"meta": {"doc_id": 2436, "sent_id": 71, "sent_start_pos": 12439, "sent_end_pos": 13044, "title": "MEMBERS"}, "text": "Prairie AquaTech\nPrairie AquaTech is addressing aquaculture's challenges, which are unique: sustainability of feed resources, profitability of feed manufacturers, efficiency of aquaculture producers, traceability for the health of consumers\u2026and common to all these challenges is the health of the fish. The company researches, develops, and manufactures feed ingredients that start with plant-based protein. Prairie AquaTech's flagship product, ME-PRO\u00ae, is a non-genetically modified, plant-based ingredient that is 70% protein (as fed), 100% digestible, with high phosphorus availability for clean water."}
{"meta": {"doc_id": 2436, "sent_id": 72, "sent_start_pos": 12742, "sent_end_pos": 13222, "title": "MEMBERS"}, "text": "The company researches, develops, and manufactures feed ingredients that start with plant-based protein. Prairie AquaTech's flagship product, ME-PRO\u00ae, is a non-genetically modified, plant-based ingredient that is 70% protein (as fed), 100% digestible, with high phosphorus availability for clean water. The company consists of extraordinary individuals, partnerships and associations, enabling the company to work locally but fulfill globally for feed manufacturers and producers."}
{"meta": {"doc_id": 2436, "sent_id": 73, "sent_start_pos": 12847, "sent_end_pos": 13406, "title": "MEMBERS"}, "text": "Prairie AquaTech's flagship product, ME-PRO\u00ae, is a non-genetically modified, plant-based ingredient that is 70% protein (as fed), 100% digestible, with high phosphorus availability for clean water. The company consists of extraordinary individuals, partnerships and associations, enabling the company to work locally but fulfill globally for feed manufacturers and producers. Public Affairs Co. (PhRMA)\nPhRMA, the Pharmaceutical Research and Manufacturers of America, represents the country's leading biopharmaceutical researchers and biotechnology companies."}
{"meta": {"doc_id": 2436, "sent_id": 74, "sent_start_pos": 13045, "sent_end_pos": 13637, "title": "MEMBERS"}, "text": "The company consists of extraordinary individuals, partnerships and associations, enabling the company to work locally but fulfill globally for feed manufacturers and producers. Public Affairs Co. (PhRMA)\nPhRMA, the Pharmaceutical Research and Manufacturers of America, represents the country's leading biopharmaceutical researchers and biotechnology companies. The members are committed to finding tomorrow's cures and treatments for some of the most serious diseases such as Cancer, Alzheimer's Disease, Cystic Fibrosis and Parkinson's\nRemuda Communications\nMore information is coming soon."}
{"meta": {"doc_id": 2436, "sent_id": 75, "sent_start_pos": 13223, "sent_end_pos": 13781, "title": "MEMBERS"}, "text": "Public Affairs Co. (PhRMA)\nPhRMA, the Pharmaceutical Research and Manufacturers of America, represents the country's leading biopharmaceutical researchers and biotechnology companies. The members are committed to finding tomorrow's cures and treatments for some of the most serious diseases such as Cancer, Alzheimer's Disease, Cystic Fibrosis and Parkinson's\nRemuda Communications\nMore information is coming soon. Research Park at SDSU\nThe Research Park at South Dakota State University and Innovation Center are managed by the SDSU Growth Partnership, Ltd."}
{"meta": {"doc_id": 2436, "sent_id": 76, "sent_start_pos": 13407, "sent_end_pos": 13885, "title": "MEMBERS"}, "text": "The members are committed to finding tomorrow's cures and treatments for some of the most serious diseases such as Cancer, Alzheimer's Disease, Cystic Fibrosis and Parkinson's\nRemuda Communications\nMore information is coming soon. Research Park at SDSU\nThe Research Park at South Dakota State University and Innovation Center are managed by the SDSU Growth Partnership, Ltd. The Board of Directors delivers both unique insight and experience to the management of these entities."}
{"meta": {"doc_id": 2436, "sent_id": 77, "sent_start_pos": 13638, "sent_end_pos": 13988, "title": "MEMBERS"}, "text": "Research Park at SDSU\nThe Research Park at South Dakota State University and Innovation Center are managed by the SDSU Growth Partnership, Ltd. The Board of Directors delivers both unique insight and experience to the management of these entities. Their leadership has placed South Dakota State University in a strong position moving into the future."}
{"meta": {"doc_id": 2436, "sent_id": 78, "sent_start_pos": 13782, "sent_end_pos": 14115, "title": "MEMBERS"}, "text": "The Board of Directors delivers both unique insight and experience to the management of these entities. Their leadership has placed South Dakota State University in a strong position moving into the future. They understand the importance of how university talent can assist the economic growth of business and industry in the region."}
{"meta": {"doc_id": 2436, "sent_id": 79, "sent_start_pos": 13886, "sent_end_pos": 14257, "title": "MEMBERS"}, "text": "Their leadership has placed South Dakota State University in a strong position moving into the future. They understand the importance of how university talent can assist the economic growth of business and industry in the region. RTI., LLC - RESEARCH\ufffdTECHNOLOGY\ufffdINNOVATION\nRTI, LLC (RTI) is a leading veterinary contract research organization and microbiology laboratory."}
{"meta": {"doc_id": 2436, "sent_id": 80, "sent_start_pos": 13989, "sent_end_pos": 14414, "title": "MEMBERS"}, "text": "They understand the importance of how university talent can assist the economic growth of business and industry in the region. RTI., LLC - RESEARCH\ufffdTECHNOLOGY\ufffdINNOVATION\nRTI, LLC (RTI) is a leading veterinary contract research organization and microbiology laboratory. Established in 1994, the company provides clientele with quality services and support, with expertise in vaccinology, microbiology, virology, and nutrition."}
{"meta": {"doc_id": 2436, "sent_id": 81, "sent_start_pos": 14116, "sent_end_pos": 14580, "title": "MEMBERS"}, "text": "RTI., LLC - RESEARCH\ufffdTECHNOLOGY\ufffdINNOVATION\nRTI, LLC (RTI) is a leading veterinary contract research organization and microbiology laboratory. Established in 1994, the company provides clientele with quality services and support, with expertise in vaccinology, microbiology, virology, and nutrition. Specializing in biologicals for food animals, RTI's clients include several Fortune 500 companies, as well as, multi-nationals, mid-size, and start-up biotech firms."}
{"meta": {"doc_id": 2436, "sent_id": 82, "sent_start_pos": 14258, "sent_end_pos": 14690, "title": "MEMBERS"}, "text": "Established in 1994, the company provides clientele with quality services and support, with expertise in vaccinology, microbiology, virology, and nutrition. Specializing in biologicals for food animals, RTI's clients include several Fortune 500 companies, as well as, multi-nationals, mid-size, and start-up biotech firms. With RTI's diagnostic reagent area, they offer extensive array of monoclonal antibodies for laboratory needs."}
{"meta": {"doc_id": 2436, "sent_id": 83, "sent_start_pos": 14415, "sent_end_pos": 14879, "title": "MEMBERS"}, "text": "Specializing in biologicals for food animals, RTI's clients include several Fortune 500 companies, as well as, multi-nationals, mid-size, and start-up biotech firms. With RTI's diagnostic reagent area, they offer extensive array of monoclonal antibodies for laboratory needs. The company's research team strives to stay at the forefront of animal heath advances and improvements while demonstrating leadership in the field of veterinary research and biotechnology."}
{"meta": {"doc_id": 2436, "sent_id": 84, "sent_start_pos": 14581, "sent_end_pos": 15163, "title": "MEMBERS"}, "text": "With RTI's diagnostic reagent area, they offer extensive array of monoclonal antibodies for laboratory needs. The company's research team strives to stay at the forefront of animal heath advances and improvements while demonstrating leadership in the field of veterinary research and biotechnology. SAB Biotherapeutics, Inc.\nSAB Biotherapeutics, Inc. (SAB), is a biopharmaceutical company on the leading edge of innovation, developing natural technologies that have the potential to transform the treatment and prevention of diseases from cancer to Ebola, and diabetes to influenza."}
{"meta": {"doc_id": 2436, "sent_id": 85, "sent_start_pos": 14691, "sent_end_pos": 15318, "title": "MEMBERS"}, "text": "The company's research team strives to stay at the forefront of animal heath advances and improvements while demonstrating leadership in the field of veterinary research and biotechnology. SAB Biotherapeutics, Inc.\nSAB Biotherapeutics, Inc. (SAB), is a biopharmaceutical company on the leading edge of innovation, developing natural technologies that have the potential to transform the treatment and prevention of diseases from cancer to Ebola, and diabetes to influenza. SAB's first-of-its-kind therapeutic production platform holds the promise of treatment of rare conditions, long-term diseases and global pandemic threats."}
{"meta": {"doc_id": 2436, "sent_id": 86, "sent_start_pos": 14880, "sent_end_pos": 15556, "title": "MEMBERS"}, "text": "SAB Biotherapeutics, Inc.\nSAB Biotherapeutics, Inc. (SAB), is a biopharmaceutical company on the leading edge of innovation, developing natural technologies that have the potential to transform the treatment and prevention of diseases from cancer to Ebola, and diabetes to influenza. SAB's first-of-its-kind therapeutic production platform holds the promise of treatment of rare conditions, long-term diseases and global pandemic threats. Sanford Health\nSanford Health, one of the largest health systems in the United States, is dedicated to the integrated delivery of health care, genomic medicine, senior care and services, global clinics, research and affordable insurance."}
{"meta": {"doc_id": 2436, "sent_id": 87, "sent_start_pos": 15164, "sent_end_pos": 15753, "title": "MEMBERS"}, "text": "SAB's first-of-its-kind therapeutic production platform holds the promise of treatment of rare conditions, long-term diseases and global pandemic threats. Sanford Health\nSanford Health, one of the largest health systems in the United States, is dedicated to the integrated delivery of health care, genomic medicine, senior care and services, global clinics, research and affordable insurance. Headquartered in Sioux Falls, South Dakota, the organization includes 44 hospitals, 1,400 physicians and more than 200 Good Samaritan Society senior care locations in 26 states and nine countries."}
{"meta": {"doc_id": 2436, "sent_id": 88, "sent_start_pos": 15319, "sent_end_pos": 15922, "title": "MEMBERS"}, "text": "Sanford Health\nSanford Health, one of the largest health systems in the United States, is dedicated to the integrated delivery of health care, genomic medicine, senior care and services, global clinics, research and affordable insurance. Headquartered in Sioux Falls, South Dakota, the organization includes 44 hospitals, 1,400 physicians and more than 200 Good Samaritan Society senior care locations in 26 states and nine countries. Sioux Falls Development Foundation\nThe Sioux Falls Development Foundation works to encourage local business expansion and attract new business and talent to the region."}
{"meta": {"doc_id": 2436, "sent_id": 89, "sent_start_pos": 15557, "sent_end_pos": 16153, "title": "MEMBERS"}, "text": "Headquartered in Sioux Falls, South Dakota, the organization includes 44 hospitals, 1,400 physicians and more than 200 Good Samaritan Society senior care locations in 26 states and nine countries. Sioux Falls Development Foundation\nThe Sioux Falls Development Foundation works to encourage local business expansion and attract new business and talent to the region. By promoting the unique business advantages of a Sioux Falls location and helping innovative firms to network for rapid business growth, the Development Foundation has been particularly helpful to the biotech industry in the area."}
{"meta": {"doc_id": 2436, "sent_id": 90, "sent_start_pos": 15754, "sent_end_pos": 16301, "title": "MEMBERS"}, "text": "Sioux Falls Development Foundation\nThe Sioux Falls Development Foundation works to encourage local business expansion and attract new business and talent to the region. By promoting the unique business advantages of a Sioux Falls location and helping innovative firms to network for rapid business growth, the Development Foundation has been particularly helpful to the biotech industry in the area. South Dakota EPSCoR\nIn 1980, the National Science Foundation (NSF) established the Experimental Program to Stimulate Competitive Research (EPSCoR)."}
{"meta": {"doc_id": 2436, "sent_id": 91, "sent_start_pos": 15923, "sent_end_pos": 16513, "title": "MEMBERS"}, "text": "By promoting the unique business advantages of a Sioux Falls location and helping innovative firms to network for rapid business growth, the Development Foundation has been particularly helpful to the biotech industry in the area. South Dakota EPSCoR\nIn 1980, the National Science Foundation (NSF) established the Experimental Program to Stimulate Competitive Research (EPSCoR). The EPSCoR program is designed to assist states to establish a self-sustaining academic research enterprise with the competitive capability that will contribute to the states' economic viability and development."}
{"meta": {"doc_id": 2436, "sent_id": 92, "sent_start_pos": 16154, "sent_end_pos": 16727, "title": "MEMBERS"}, "text": "South Dakota EPSCoR\nIn 1980, the National Science Foundation (NSF) established the Experimental Program to Stimulate Competitive Research (EPSCoR). The EPSCoR program is designed to assist states to establish a self-sustaining academic research enterprise with the competitive capability that will contribute to the states' economic viability and development. SD EPSCoR's mission is to strengthen research and education in science, technology, engineering and mathematics (STEM) across South Dakota to increase science literacy and drive science-based economic development."}
{"meta": {"doc_id": 2436, "sent_id": 93, "sent_start_pos": 16302, "sent_end_pos": 16860, "title": "MEMBERS"}, "text": "The EPSCoR program is designed to assist states to establish a self-sustaining academic research enterprise with the competitive capability that will contribute to the states' economic viability and development. SD EPSCoR's mission is to strengthen research and education in science, technology, engineering and mathematics (STEM) across South Dakota to increase science literacy and drive science-based economic development. SD EPSCoR helps build South Dakota's research infrastructure and increases its capacity to successfully compete for federal funding."}
{"meta": {"doc_id": 2436, "sent_id": 94, "sent_start_pos": 16514, "sent_end_pos": 17176, "title": "MEMBERS"}, "text": "SD EPSCoR's mission is to strengthen research and education in science, technology, engineering and mathematics (STEM) across South Dakota to increase science literacy and drive science-based economic development. SD EPSCoR helps build South Dakota's research infrastructure and increases its capacity to successfully compete for federal funding. South Dakota Governor's Office of Economic Development (GOED)\nSouth Dakota Innovation Partners\nSouth Dakota Mines\nHistory\nFounded in 1885 to provide instruction in the region\u2019s primary industry, mining, today South Dakota Mines has evolved into one of the leading science and engineering universities in the region."}
{"meta": {"doc_id": 2436, "sent_id": 95, "sent_start_pos": 16728, "sent_end_pos": 17485, "title": "MEMBERS"}, "text": "SD EPSCoR helps build South Dakota's research infrastructure and increases its capacity to successfully compete for federal funding. South Dakota Governor's Office of Economic Development (GOED)\nSouth Dakota Innovation Partners\nSouth Dakota Mines\nHistory\nFounded in 1885 to provide instruction in the region\u2019s primary industry, mining, today South Dakota Mines has evolved into one of the leading science and engineering universities in the region. University History | University Leadership\nWhy South Dakota Mines\nLocated in Rapid City, in the beautiful Black Hills of South Dakota, South Dakota Mines offers a rigorous academic experience, supported by small class sizes, committed faculty members, and many student development programs and organizations."}
{"meta": {"doc_id": 2436, "sent_id": 96, "sent_start_pos": 16861, "sent_end_pos": 17757, "title": "MEMBERS"}, "text": "South Dakota Governor's Office of Economic Development (GOED)\nSouth Dakota Innovation Partners\nSouth Dakota Mines\nHistory\nFounded in 1885 to provide instruction in the region\u2019s primary industry, mining, today South Dakota Mines has evolved into one of the leading science and engineering universities in the region. University History | University Leadership\nWhy South Dakota Mines\nLocated in Rapid City, in the beautiful Black Hills of South Dakota, South Dakota Mines offers a rigorous academic experience, supported by small class sizes, committed faculty members, and many student development programs and organizations. We\u2019re known for:\n- STEM Academics\n- Personal Attention\n- Outstanding Internship Opportunities\n- Great Value\n- Our wonderful location: the Rushmore Region\nSouth Dakota State University\nSouth Dakota State University is the state's largest and most comprehensive university."}
{"meta": {"doc_id": 2436, "sent_id": 97, "sent_start_pos": 17177, "sent_end_pos": 17873, "title": "MEMBERS"}, "text": "University History | University Leadership\nWhy South Dakota Mines\nLocated in Rapid City, in the beautiful Black Hills of South Dakota, South Dakota Mines offers a rigorous academic experience, supported by small class sizes, committed faculty members, and many student development programs and organizations. We\u2019re known for:\n- STEM Academics\n- Personal Attention\n- Outstanding Internship Opportunities\n- Great Value\n- Our wonderful location: the Rushmore Region\nSouth Dakota State University\nSouth Dakota State University is the state's largest and most comprehensive university. It is recognized by the Carnegie Foundation for the Advancement of Teaching as a research university/high activity."}
{"meta": {"doc_id": 2436, "sent_id": 98, "sent_start_pos": 17486, "sent_end_pos": 17980, "title": "MEMBERS"}, "text": "We\u2019re known for:\n- STEM Academics\n- Personal Attention\n- Outstanding Internship Opportunities\n- Great Value\n- Our wonderful location: the Rushmore Region\nSouth Dakota State University\nSouth Dakota State University is the state's largest and most comprehensive university. It is recognized by the Carnegie Foundation for the Advancement of Teaching as a research university/high activity. Enrollment at SDSU is nearly 13,000 students from throughout South Dakota, all 50 states and 52 countries."}
{"meta": {"doc_id": 2436, "sent_id": 99, "sent_start_pos": 17758, "sent_end_pos": 18059, "title": "MEMBERS"}, "text": "It is recognized by the Carnegie Foundation for the Advancement of Teaching as a research university/high activity. Enrollment at SDSU is nearly 13,000 students from throughout South Dakota, all 50 states and 52 countries. The university offers 12 Ph.D programs and two professional doctoral programs."}
{"meta": {"doc_id": 2436, "sent_id": 100, "sent_start_pos": 17874, "sent_end_pos": 18229, "title": "MEMBERS"}, "text": "Enrollment at SDSU is nearly 13,000 students from throughout South Dakota, all 50 states and 52 countries. The university offers 12 Ph.D programs and two professional doctoral programs. SDSU has a contiguous campus of 272 acres in Brookings and nearly 15,000 acres in seven locations from Buffalo to Beresford for agricultural research and demonstrations."}
{"meta": {"doc_id": 2436, "sent_id": 101, "sent_start_pos": 17981, "sent_end_pos": 18425, "title": "MEMBERS"}, "text": "The university offers 12 Ph.D programs and two professional doctoral programs. SDSU has a contiguous campus of 272 acres in Brookings and nearly 15,000 acres in seven locations from Buffalo to Beresford for agricultural research and demonstrations. Biotechnology research education programs include agricultural crops, veterinary and biomedical sciences, industrial biotechnology, pharmaceutical sciences, livestock, bioenergy and other fields."}
{"meta": {"doc_id": 2436, "sent_id": 102, "sent_start_pos": 18060, "sent_end_pos": 18591, "title": "MEMBERS"}, "text": "SDSU has a contiguous campus of 272 acres in Brookings and nearly 15,000 acres in seven locations from Buffalo to Beresford for agricultural research and demonstrations. Biotechnology research education programs include agricultural crops, veterinary and biomedical sciences, industrial biotechnology, pharmaceutical sciences, livestock, bioenergy and other fields. Syngenta\nSyngenta is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources."}
{"meta": {"doc_id": 2436, "sent_id": 103, "sent_start_pos": 18230, "sent_end_pos": 18781, "title": "MEMBERS"}, "text": "Biotechnology research education programs include agricultural crops, veterinary and biomedical sciences, industrial biotechnology, pharmaceutical sciences, livestock, bioenergy and other fields. Syngenta\nSyngenta is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources. University of South Dakota\nUSD Discovery District\nThe USD Discovery District is a resource to help grow companies in South Dakota and connect universities with innovation-driven businesses."}
{"meta": {"doc_id": 2436, "sent_id": 104, "sent_start_pos": 18426, "sent_end_pos": 18901, "title": "MEMBERS"}, "text": "Syngenta\nSyngenta is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources. University of South Dakota\nUSD Discovery District\nThe USD Discovery District is a resource to help grow companies in South Dakota and connect universities with innovation-driven businesses. The Master Plan envisions a dynamic environment for students, researchers and entrepreneurs developing new innovations."}
{"meta": {"doc_id": 2436, "sent_id": 105, "sent_start_pos": 18592, "sent_end_pos": 19133, "title": "MEMBERS"}, "text": "University of South Dakota\nUSD Discovery District\nThe USD Discovery District is a resource to help grow companies in South Dakota and connect universities with innovation-driven businesses. The Master Plan envisions a dynamic environment for students, researchers and entrepreneurs developing new innovations. The 80-acre site includes the Graduate Education and Applied Research (GEAR) Center that provides a physical location for both private sector and university research activities, including USD's Biomedical Engineering Program (BME)."}
{"meta": {"doc_id": 2436, "sent_id": 106, "sent_start_pos": 18782, "sent_end_pos": 19283, "title": "MEMBERS"}, "text": "The Master Plan envisions a dynamic environment for students, researchers and entrepreneurs developing new innovations. The 80-acre site includes the Graduate Education and Applied Research (GEAR) Center that provides a physical location for both private sector and university research activities, including USD's Biomedical Engineering Program (BME). At 22,000 square feet, the Center's specialized research suites, equipment and technical staff support public and private sector research activities."}
{"meta": {"doc_id": 2436, "sent_id": 107, "sent_start_pos": 18902, "sent_end_pos": 19525, "title": "MEMBERS"}, "text": "The 80-acre site includes the Graduate Education and Applied Research (GEAR) Center that provides a physical location for both private sector and university research activities, including USD's Biomedical Engineering Program (BME). At 22,000 square feet, the Center's specialized research suites, equipment and technical staff support public and private sector research activities. An Aseptic GMP Production and Training Center provides pilot-scale cGMP and BME faculty and students are actively engaged in industry collaborations to advance the frontiers of biomedical science and engineering bring new products to market."}
{"meta": {"doc_id": 2436, "sent_id": 108, "sent_start_pos": 19134, "sent_end_pos": 19846, "title": "MEMBERS"}, "text": "At 22,000 square feet, the Center's specialized research suites, equipment and technical staff support public and private sector research activities. An Aseptic GMP Production and Training Center provides pilot-scale cGMP and BME faculty and students are actively engaged in industry collaborations to advance the frontiers of biomedical science and engineering bring new products to market. Vertex\nVertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.We discove\nred and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease."}
{"meta": {"doc_id": 2436, "sent_id": 109, "sent_start_pos": 19284, "sent_end_pos": 20017, "title": "MEMBERS"}, "text": "An Aseptic GMP Production and Training Center provides pilot-scale cGMP and BME faculty and students are actively engaged in industry collaborations to advance the frontiers of biomedical science and engineering bring new products to market. Vertex\nVertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.We discove\nred and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases."}
{"meta": {"doc_id": 2436, "sent_id": 110, "sent_start_pos": 19526, "sent_end_pos": 20202, "title": "MEMBERS"}, "text": "Vertex\nVertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.We discove\nred and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston's Innovation District, and our international headquarters is in London, United Kingdom."}
{"meta": {"doc_id": 2436, "sent_id": 111, "sent_start_pos": 19847, "sent_end_pos": 20390, "title": "MEMBERS"}, "text": "In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston's Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 2,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development."}
{"meta": {"doc_id": 2436, "sent_id": 112, "sent_start_pos": 20018, "sent_end_pos": 20551, "title": "MEMBERS"}, "text": "Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston's Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 2,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development. Veterinary Medical Center\nThe Veterinary Medical Center, based in Worthington, MN, offers state-of-the-art veterinary services for both large and small animals."}
{"meta": {"doc_id": 2436, "sent_id": 113, "sent_start_pos": 20203, "sent_end_pos": 20740, "title": "MEMBERS"}, "text": "We currently employ approximately 2,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development. Veterinary Medical Center\nThe Veterinary Medical Center, based in Worthington, MN, offers state-of-the-art veterinary services for both large and small animals. The goal of the Veterinary Medical Center is to ensure their clients are equipped with the preventative, diagnostic, and educational tools necessary to ensure top health for their animals."}
{"meta": {"doc_id": 2436, "sent_id": 114, "sent_start_pos": 20391, "sent_end_pos": 20904, "title": "MEMBERS"}, "text": "Veterinary Medical Center\nThe Veterinary Medical Center, based in Worthington, MN, offers state-of-the-art veterinary services for both large and small animals. The goal of the Veterinary Medical Center is to ensure their clients are equipped with the preventative, diagnostic, and educational tools necessary to ensure top health for their animals. VMC has a reputation for being an early adapter of new technologies, and the practice is dedicated to finding practical solutions to complex animal disease issues."}
{"meta": {"doc_id": 2436, "sent_id": 115, "sent_start_pos": 20552, "sent_end_pos": 21020, "title": "MEMBERS"}, "text": "The goal of the Veterinary Medical Center is to ensure their clients are equipped with the preventative, diagnostic, and educational tools necessary to ensure top health for their animals. VMC has a reputation for being an early adapter of new technologies, and the practice is dedicated to finding practical solutions to complex animal disease issues. The staff at VMC prides itself on going the extra mile to provide clients with cost-effective and accurate answers."}
{"meta": {"doc_id": 2436, "sent_id": 116, "sent_start_pos": 20741, "sent_end_pos": 21220, "title": "MEMBERS"}, "text": "VMC has a reputation for being an early adapter of new technologies, and the practice is dedicated to finding practical solutions to complex animal disease issues. The staff at VMC prides itself on going the extra mile to provide clients with cost-effective and accurate answers. Zeal Center for Entrepreneurship\nThe Zeal Center for Entrepreneurship is the region's business incubation center, coworking space, and NBIA classified \u201cSuperHub\u201d entrepreneurial support organization."}
{"meta": {"doc_id": 2436, "sent_id": 117, "sent_start_pos": 20905, "sent_end_pos": 21553, "title": "MEMBERS"}, "text": "The staff at VMC prides itself on going the extra mile to provide clients with cost-effective and accurate answers. Zeal Center for Entrepreneurship\nThe Zeal Center for Entrepreneurship is the region's business incubation center, coworking space, and NBIA classified \u201cSuperHub\u201d entrepreneurial support organization. Established through a partnership initiative between the Sioux Falls Development Foundation and the Sioux Falls Area Chamber of Commerce through Forward Sioux Falls in 2004, Zeal client companies have collectively created more than 728 new jobs with an average salary of $69,000 and secured more than $172 million in equity funding."}
{"meta": {"doc_id": 2436, "sent_id": 118, "sent_start_pos": 21021, "sent_end_pos": 21648, "title": "MEMBERS"}, "text": "Zeal Center for Entrepreneurship\nThe Zeal Center for Entrepreneurship is the region's business incubation center, coworking space, and NBIA classified \u201cSuperHub\u201d entrepreneurial support organization. Established through a partnership initiative between the Sioux Falls Development Foundation and the Sioux Falls Area Chamber of Commerce through Forward Sioux Falls in 2004, Zeal client companies have collectively created more than 728 new jobs with an average salary of $69,000 and secured more than $172 million in equity funding. In addition, entrepreneurs associated with Zeal hold 65 patents with an additional 49 pending."}
{"meta": {"doc_id": 2436, "sent_id": 119, "sent_start_pos": 21221, "sent_end_pos": [], "title": "MEMBERS"}, "text": "Established through a partnership initiative between the Sioux Falls Development Foundation and the Sioux Falls Area Chamber of Commerce through Forward Sioux Falls in 2004, Zeal client companies have collectively created more than 728 new jobs with an average salary of $69,000 and secured more than $172 million in equity funding. In addition, entrepreneurs associated with Zeal hold 65 patents with an additional 49 pending. "}
{"meta": {"doc_id": 2438, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 207, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": " Harvesting The Long-Term Power Of The Plant-Based Movement\nThursday 20th June\nThe Food Industry is in crisis. It has been slow to adopt technology and rested on its laurels - and now it\u2019s trying to catch up."}
{"meta": {"doc_id": 2438, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 335, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "Harvesting The Long-Term Power Of The Plant-Based Movement\nThursday 20th June\nThe Food Industry is in crisis. It has been slow to adopt technology and rested on its laurels - and now it\u2019s trying to catch up. We have unprecedented diet-related health problems, climate crisis, unsustainable agriculture methods and a growing population."}
{"meta": {"doc_id": 2438, "sent_id": 2, "sent_start_pos": 110, "sent_end_pos": 524, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "It has been slow to adopt technology and rested on its laurels - and now it\u2019s trying to catch up. We have unprecedented diet-related health problems, climate crisis, unsustainable agriculture methods and a growing population. Throughout history, in times of crisis comes innovation and creativity and that\u2019s no different for the renaissance that the food industry can embark on if it makes the right decisions now."}
{"meta": {"doc_id": 2438, "sent_id": 3, "sent_start_pos": 208, "sent_end_pos": 743, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "We have unprecedented diet-related health problems, climate crisis, unsustainable agriculture methods and a growing population. Throughout history, in times of crisis comes innovation and creativity and that\u2019s no different for the renaissance that the food industry can embark on if it makes the right decisions now. A leading area of change is the plant-based world, with innovation coming at a rapid pace and the awareness of the movement being catalysed by the global food, climate and compassion problems that are in the limelight."}
{"meta": {"doc_id": 2438, "sent_id": 4, "sent_start_pos": 336, "sent_end_pos": 1037, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "Throughout history, in times of crisis comes innovation and creativity and that\u2019s no different for the renaissance that the food industry can embark on if it makes the right decisions now. A leading area of change is the plant-based world, with innovation coming at a rapid pace and the awareness of the movement being catalysed by the global food, climate and compassion problems that are in the limelight. We\u2019re seeing both the larger companies start to meaningfully get involved and incredible disruption from smaller companies, across media, new products, retail and hospitality \u2013 there\u2019s already a plant-based renaissance that\u2019s building and it\u2019s signs are showing it\u2019s only going to proliferate."}
{"meta": {"doc_id": 2438, "sent_id": 5, "sent_start_pos": 525, "sent_end_pos": 1386, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "A leading area of change is the plant-based world, with innovation coming at a rapid pace and the awareness of the movement being catalysed by the global food, climate and compassion problems that are in the limelight. We\u2019re seeing both the larger companies start to meaningfully get involved and incredible disruption from smaller companies, across media, new products, retail and hospitality \u2013 there\u2019s already a plant-based renaissance that\u2019s building and it\u2019s signs are showing it\u2019s only going to proliferate. In order to grow and scale this movement, three things are necessary: great products and innovative solutions to the challenges we\u2019re seeing in animal agriculture, investment and support of these disruptive businesses, and the larger industry players working with these small companies to bring their product to market in a commercially viable way."}
{"meta": {"doc_id": 2438, "sent_id": 6, "sent_start_pos": 744, "sent_end_pos": 1524, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "We\u2019re seeing both the larger companies start to meaningfully get involved and incredible disruption from smaller companies, across media, new products, retail and hospitality \u2013 there\u2019s already a plant-based renaissance that\u2019s building and it\u2019s signs are showing it\u2019s only going to proliferate. In order to grow and scale this movement, three things are necessary: great products and innovative solutions to the challenges we\u2019re seeing in animal agriculture, investment and support of these disruptive businesses, and the larger industry players working with these small companies to bring their product to market in a commercially viable way. DISRUPTING THE MARKET & LEADING INNOVATION\nThe product development and innovation in the plant based world is developing at a rapid pace."}
{"meta": {"doc_id": 2438, "sent_id": 7, "sent_start_pos": 1038, "sent_end_pos": 1719, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "In order to grow and scale this movement, three things are necessary: great products and innovative solutions to the challenges we\u2019re seeing in animal agriculture, investment and support of these disruptive businesses, and the larger industry players working with these small companies to bring their product to market in a commercially viable way. DISRUPTING THE MARKET & LEADING INNOVATION\nThe product development and innovation in the plant based world is developing at a rapid pace. We\u2019re seeing bio-tissue engineer, NovaMeat create 3d printed systems to make a meat replica that has the texture and taste of meat which when put into large scale rollout will be a game changer."}
{"meta": {"doc_id": 2438, "sent_id": 8, "sent_start_pos": 1387, "sent_end_pos": 1866, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "DISRUPTING THE MARKET & LEADING INNOVATION\nThe product development and innovation in the plant based world is developing at a rapid pace. We\u2019re seeing bio-tissue engineer, NovaMeat create 3d printed systems to make a meat replica that has the texture and taste of meat which when put into large scale rollout will be a game changer. Early stage developments to make it easier for people to eat plant-based at home come in the form of an all-in-one tempeh maker from Better Foods."}
{"meta": {"doc_id": 2438, "sent_id": 9, "sent_start_pos": 1525, "sent_end_pos": 1988, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "We\u2019re seeing bio-tissue engineer, NovaMeat create 3d printed systems to make a meat replica that has the texture and taste of meat which when put into large scale rollout will be a game changer. Early stage developments to make it easier for people to eat plant-based at home come in the form of an all-in-one tempeh maker from Better Foods. We\u2019re even seeing all of your daily vitamins & nutrients 3D printed into a plant-based gummy stack from company Nouris3d."}
{"meta": {"doc_id": 2438, "sent_id": 10, "sent_start_pos": 1720, "sent_end_pos": 2108, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "Early stage developments to make it easier for people to eat plant-based at home come in the form of an all-in-one tempeh maker from Better Foods. We\u2019re even seeing all of your daily vitamins & nutrients 3D printed into a plant-based gummy stack from company Nouris3d. FOLLOWING THE MONEY\nWhen you\u2019re looking to where the trends are going, it\u2019s wise to look at where investment is headed."}
{"meta": {"doc_id": 2438, "sent_id": 11, "sent_start_pos": 1867, "sent_end_pos": 2261, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "We\u2019re even seeing all of your daily vitamins & nutrients 3D printed into a plant-based gummy stack from company Nouris3d. FOLLOWING THE MONEY\nWhen you\u2019re looking to where the trends are going, it\u2019s wise to look at where investment is headed. The investment community think strategically about where the world is heading and invest in businesses that they feel are moving in the right direction."}
{"meta": {"doc_id": 2438, "sent_id": 12, "sent_start_pos": 1989, "sent_end_pos": 2388, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "FOLLOWING THE MONEY\nWhen you\u2019re looking to where the trends are going, it\u2019s wise to look at where investment is headed. The investment community think strategically about where the world is heading and invest in businesses that they feel are moving in the right direction. This is hugely evident in the recent IPO of Beyond Meat and the millions of high profile investment they received before that."}
{"meta": {"doc_id": 2438, "sent_id": 13, "sent_start_pos": 2109, "sent_end_pos": 2759, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "The investment community think strategically about where the world is heading and invest in businesses that they feel are moving in the right direction. This is hugely evident in the recent IPO of Beyond Meat and the millions of high profile investment they received before that. More excitingly we\u2019re seeing purpose-led funds like The Craftory who just lead a $30 Million round into NotCo, a company that uses artificial intelligence platform which analyses molecular structures to create unique food combinations derived only from plant-based ingredients helping them create substitutes for milk, mayonnaise and many other animal based ingredients."}
{"meta": {"doc_id": 2438, "sent_id": 14, "sent_start_pos": 2262, "sent_end_pos": 2994, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "This is hugely evident in the recent IPO of Beyond Meat and the millions of high profile investment they received before that. More excitingly we\u2019re seeing purpose-led funds like The Craftory who just lead a $30 Million round into NotCo, a company that uses artificial intelligence platform which analyses molecular structures to create unique food combinations derived only from plant-based ingredients helping them create substitutes for milk, mayonnaise and many other animal based ingredients. Or VBites, who created investment arm, VBites Ventures which not only invests in promising plant-based businesses but also gives them a manufacturing home, expertise in scaling up and relationships to help get the products on shelves."}
{"meta": {"doc_id": 2438, "sent_id": 15, "sent_start_pos": 2389, "sent_end_pos": 3179, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "More excitingly we\u2019re seeing purpose-led funds like The Craftory who just lead a $30 Million round into NotCo, a company that uses artificial intelligence platform which analyses molecular structures to create unique food combinations derived only from plant-based ingredients helping them create substitutes for milk, mayonnaise and many other animal based ingredients. Or VBites, who created investment arm, VBites Ventures which not only invests in promising plant-based businesses but also gives them a manufacturing home, expertise in scaling up and relationships to help get the products on shelves. More excitingly, and perhaps influential is the movement of the investment community to put pressure on their investments to reduce their reliance on animal products for their profits."}
{"meta": {"doc_id": 2438, "sent_id": 16, "sent_start_pos": 2760, "sent_end_pos": 3542, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "Or VBites, who created investment arm, VBites Ventures which not only invests in promising plant-based businesses but also gives them a manufacturing home, expertise in scaling up and relationships to help get the products on shelves. More excitingly, and perhaps influential is the movement of the investment community to put pressure on their investments to reduce their reliance on animal products for their profits. Jeremy Coller also set up a powerful investment arm called CPT Capital as part of his private family office, which invests in promising companies in plant-based protein such as Beyond Meat to recombinant proteins, with investments into exciting BioTech companies such as 3FBio who are creating proteins that taste great and remove reliance on animal agriculture."}
{"meta": {"doc_id": 2438, "sent_id": 17, "sent_start_pos": 2995, "sent_end_pos": 3702, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "More excitingly, and perhaps influential is the movement of the investment community to put pressure on their investments to reduce their reliance on animal products for their profits. Jeremy Coller also set up a powerful investment arm called CPT Capital as part of his private family office, which invests in promising companies in plant-based protein such as Beyond Meat to recombinant proteins, with investments into exciting BioTech companies such as 3FBio who are creating proteins that taste great and remove reliance on animal agriculture. WHEN INDUSTRY TAKES NOTICE IMPACT CAN BE SCALED\nThere\u2019s a lot more product innovation and investment to happen, but the signs of what\u2019s to come are incredible."}
{"meta": {"doc_id": 2438, "sent_id": 18, "sent_start_pos": 3180, "sent_end_pos": 3810, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "Jeremy Coller also set up a powerful investment arm called CPT Capital as part of his private family office, which invests in promising companies in plant-based protein such as Beyond Meat to recombinant proteins, with investments into exciting BioTech companies such as 3FBio who are creating proteins that taste great and remove reliance on animal agriculture. WHEN INDUSTRY TAKES NOTICE IMPACT CAN BE SCALED\nThere\u2019s a lot more product innovation and investment to happen, but the signs of what\u2019s to come are incredible. Large players are starting to get involved in the plant-based movement and seeing the benefits of doing so."}
{"meta": {"doc_id": 2438, "sent_id": 19, "sent_start_pos": 3543, "sent_end_pos": 3899, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "WHEN INDUSTRY TAKES NOTICE IMPACT CAN BE SCALED\nThere\u2019s a lot more product innovation and investment to happen, but the signs of what\u2019s to come are incredible. Large players are starting to get involved in the plant-based movement and seeing the benefits of doing so. We\u2019re seeing smaller companies collaborating with larger businesses to grow their reach."}
{"meta": {"doc_id": 2438, "sent_id": 20, "sent_start_pos": 3703, "sent_end_pos": 4060, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "Large players are starting to get involved in the plant-based movement and seeing the benefits of doing so. We\u2019re seeing smaller companies collaborating with larger businesses to grow their reach. From Finnish pulled oats company Gold & Green who\u2019ve just launched a trial with Taco Bell to Beyond Meat rolling out to Burger King locations throughout the US."}
{"meta": {"doc_id": 2438, "sent_id": 21, "sent_start_pos": 3811, "sent_end_pos": 4156, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "We\u2019re seeing smaller companies collaborating with larger businesses to grow their reach. From Finnish pulled oats company Gold & Green who\u2019ve just launched a trial with Taco Bell to Beyond Meat rolling out to Burger King locations throughout the US. And we\u2019re only seeing more industry players looking to partner with disruptive small companies."}
{"meta": {"doc_id": 2438, "sent_id": 22, "sent_start_pos": 3900, "sent_end_pos": 4260, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "From Finnish pulled oats company Gold & Green who\u2019ve just launched a trial with Taco Bell to Beyond Meat rolling out to Burger King locations throughout the US. And we\u2019re only seeing more industry players looking to partner with disruptive small companies. Large businesses that are paying attention are getting involved in bringing the movement to the masses."}
{"meta": {"doc_id": 2438, "sent_id": 23, "sent_start_pos": 4061, "sent_end_pos": 4440, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "And we\u2019re only seeing more industry players looking to partner with disruptive small companies. Large businesses that are paying attention are getting involved in bringing the movement to the masses. With the likes of Tesco launching a great line of plant-based ready meals to Sainsbury\u2019s aggressively bringing in new plant-based products we\u2019re seeing the retailers get on board."}
{"meta": {"doc_id": 2438, "sent_id": 24, "sent_start_pos": 4157, "sent_end_pos": 4657, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "Large businesses that are paying attention are getting involved in bringing the movement to the masses. With the likes of Tesco launching a great line of plant-based ready meals to Sainsbury\u2019s aggressively bringing in new plant-based products we\u2019re seeing the retailers get on board. Just this week Sainsbury\u2019s launched the UK\u2019s first vegan butcher \u2013 a pop-up to celebrate sales of their plant-based products having doubled in the past year, and give customers tips and advice on plant-based cooking."}
{"meta": {"doc_id": 2438, "sent_id": 25, "sent_start_pos": 4261, "sent_end_pos": 4960, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "With the likes of Tesco launching a great line of plant-based ready meals to Sainsbury\u2019s aggressively bringing in new plant-based products we\u2019re seeing the retailers get on board. Just this week Sainsbury\u2019s launched the UK\u2019s first vegan butcher \u2013 a pop-up to celebrate sales of their plant-based products having doubled in the past year, and give customers tips and advice on plant-based cooking. Hospitality is no different, with Pret a Manger turning a pop-up experiment with Veggie Pret into a profitable location that spurred them to open even more to Wagamama partnering with Vegan influencers to create and test its new menu items, it\u2019s never been a better time to order plant based in the UK."}
{"meta": {"doc_id": 2438, "sent_id": 26, "sent_start_pos": 4441, "sent_end_pos": 5106, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "Just this week Sainsbury\u2019s launched the UK\u2019s first vegan butcher \u2013 a pop-up to celebrate sales of their plant-based products having doubled in the past year, and give customers tips and advice on plant-based cooking. Hospitality is no different, with Pret a Manger turning a pop-up experiment with Veggie Pret into a profitable location that spurred them to open even more to Wagamama partnering with Vegan influencers to create and test its new menu items, it\u2019s never been a better time to order plant based in the UK. Better awareness by the public because of media outlets like Plant Based News, and the rise of influencers like BOSH!"}
{"meta": {"doc_id": 2438, "sent_id": 27, "sent_start_pos": 4658, "sent_end_pos": 5213, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "Hospitality is no different, with Pret a Manger turning a pop-up experiment with Veggie Pret into a profitable location that spurred them to open even more to Wagamama partnering with Vegan influencers to create and test its new menu items, it\u2019s never been a better time to order plant based in the UK. Better awareness by the public because of media outlets like Plant Based News, and the rise of influencers like BOSH! who educate the public on the plant-based movement and make cooking delicious plant-based food accessible."}
{"meta": {"doc_id": 2438, "sent_id": 28, "sent_start_pos": 4989, "sent_end_pos": 5360, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "Better awareness by the public because of media outlets like Plant Based News, and the rise of influencers like BOSH! who educate the public on the plant-based movement and make cooking delicious plant-based food accessible. With this growing movement and awareness, the public will continue to put pressure on the industry as they have the power to vote with their fork."}
{"meta": {"doc_id": 2438, "sent_id": 29, "sent_start_pos": 5107, "sent_end_pos": 5476, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "who educate the public on the plant-based movement and make cooking delicious plant-based food accessible. With this growing movement and awareness, the public will continue to put pressure on the industry as they have the power to vote with their fork. A vote which is incredibly potent and powerful, as with any business, you need to give your customer what you want."}
{"meta": {"doc_id": 2438, "sent_id": 30, "sent_start_pos": 5214, "sent_end_pos": 5679, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "With this growing movement and awareness, the public will continue to put pressure on the industry as they have the power to vote with their fork. A vote which is incredibly potent and powerful, as with any business, you need to give your customer what you want. At YFood, we\u2019re excited to be part of moving this industry forward by using our platform to bring investors, startups and brands together to learn about the trends, make partnerships and get investment."}
{"meta": {"doc_id": 2438, "sent_id": 31, "sent_start_pos": 5361, "sent_end_pos": 6078, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "A vote which is incredibly potent and powerful, as with any business, you need to give your customer what you want. At YFood, we\u2019re excited to be part of moving this industry forward by using our platform to bring investors, startups and brands together to learn about the trends, make partnerships and get investment. Nadia El Hadery, Founder & CEO and Athena Simpson, Partner & CMO at YFood are obsessed with driving positive innovation in the food industry and believe they can achieve this through spotting talented startups and innovations, helping bring smart money to the industry and creating positive and meaningful relationships between big and little to create positive impact in a commercially viable way."}
{"meta": {"doc_id": 2438, "sent_id": 32, "sent_start_pos": 5477, "sent_end_pos": 6158, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "At YFood, we\u2019re excited to be part of moving this industry forward by using our platform to bring investors, startups and brands together to learn about the trends, make partnerships and get investment. Nadia El Hadery, Founder & CEO and Athena Simpson, Partner & CMO at YFood are obsessed with driving positive innovation in the food industry and believe they can achieve this through spotting talented startups and innovations, helping bring smart money to the industry and creating positive and meaningful relationships between big and little to create positive impact in a commercially viable way. Subscribe to our mailing list for all the latest news from the Food Tech space."}
{"meta": {"doc_id": 2438, "sent_id": 33, "sent_start_pos": 5680, "sent_end_pos": 6257, "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "Nadia El Hadery, Founder & CEO and Athena Simpson, Partner & CMO at YFood are obsessed with driving positive innovation in the food industry and believe they can achieve this through spotting talented startups and innovations, helping bring smart money to the industry and creating positive and meaningful relationships between big and little to create positive impact in a commercially viable way. Subscribe to our mailing list for all the latest news from the Food Tech space. Never miss out on updates on our monthly Food Tech Wednesdays meetups and our next Food Tech Week."}
{"meta": {"doc_id": 2438, "sent_id": 34, "sent_start_pos": 6079, "sent_end_pos": [], "title": "Harvesting The Long-Term Power Of The Plant-Based Movement"}, "text": "Subscribe to our mailing list for all the latest news from the Food Tech space. Never miss out on updates on our monthly Food Tech Wednesdays meetups and our next Food Tech Week. "}
{"meta": {"doc_id": 2440, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 678, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": " Nutritionists and activists have long accused big food and beverage companies of courting poor consumers with unhealthy products, while doing too little to stem rising obesity and diet-related illnesses\nBy Annie Banerji and Thin Lei Win\nSATARA, India/SINGAPORE, April 30 (Thomson Reuters Foundation) - Indian health worker Chhaya Sunil Jadhav banned snack food at home after her daughter, 11, fell sick from eating cheap, salty chips after school every day. An ultrasound scan revealed \"a giant ball of glue\" in the girl's gut, which doctors blamed on too much junk food."}
{"meta": {"doc_id": 2440, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 922, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Nutritionists and activists have long accused big food and beverage companies of courting poor consumers with unhealthy products, while doing too little to stem rising obesity and diet-related illnesses\nBy Annie Banerji and Thin Lei Win\nSATARA, India/SINGAPORE, April 30 (Thomson Reuters Foundation) - Indian health worker Chhaya Sunil Jadhav banned snack food at home after her daughter, 11, fell sick from eating cheap, salty chips after school every day. An ultrasound scan revealed \"a giant ball of glue\" in the girl's gut, which doctors blamed on too much junk food. Now, US food giant Mars Inc and Mumbai-based charitable foundation Tata Trusts are marketing an alternative in western India: bite-sized squares made from yellow peas, which they say are packed with iron, protein, vitamins and micro-nutrients."}
{"meta": {"doc_id": 2440, "sent_id": 2, "sent_start_pos": 565, "sent_end_pos": 1107, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "An ultrasound scan revealed \"a giant ball of glue\" in the girl's gut, which doctors blamed on too much junk food. Now, US food giant Mars Inc and Mumbai-based charitable foundation Tata Trusts are marketing an alternative in western India: bite-sized squares made from yellow peas, which they say are packed with iron, protein, vitamins and micro-nutrients. \"If it is nutritious, I will buy this,\" said Jadhav, trying a pack of GoMo Dal Crunchies, which costs 10 rupees ($0.15), at a product demo in her village of Masur in Maharashtra state."}
{"meta": {"doc_id": 2440, "sent_id": 3, "sent_start_pos": 679, "sent_end_pos": 1280, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Now, US food giant Mars Inc and Mumbai-based charitable foundation Tata Trusts are marketing an alternative in western India: bite-sized squares made from yellow peas, which they say are packed with iron, protein, vitamins and micro-nutrients. \"If it is nutritious, I will buy this,\" said Jadhav, trying a pack of GoMo Dal Crunchies, which costs 10 rupees ($0.15), at a product demo in her village of Masur in Maharashtra state. Around the globe, worries about human health, animal welfare and the environment are driving food firms to find wacky ways to keep people's weight down and diseases at bay."}
{"meta": {"doc_id": 2440, "sent_id": 4, "sent_start_pos": 923, "sent_end_pos": 1450, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "\"If it is nutritious, I will buy this,\" said Jadhav, trying a pack of GoMo Dal Crunchies, which costs 10 rupees ($0.15), at a product demo in her village of Masur in Maharashtra state. Around the globe, worries about human health, animal welfare and the environment are driving food firms to find wacky ways to keep people's weight down and diseases at bay. For poor diet has overtaken smoking as the world's biggest killer, according to the latest Global Burden of Disease study, causing 20 percent of deaths globally in 2017."}
{"meta": {"doc_id": 2440, "sent_id": 5, "sent_start_pos": 1108, "sent_end_pos": 1716, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Around the globe, worries about human health, animal welfare and the environment are driving food firms to find wacky ways to keep people's weight down and diseases at bay. For poor diet has overtaken smoking as the world's biggest killer, according to the latest Global Burden of Disease study, causing 20 percent of deaths globally in 2017. Launched in November, the pea-based snack is the first joint product from Mars and Tata Trusts - which owns two-thirds of India's salt-to-software conglomerate Tata Sons - after they agreed in 2016 to boost nutrition and food safety in Asia's third-largest economy."}
{"meta": {"doc_id": 2440, "sent_id": 6, "sent_start_pos": 1281, "sent_end_pos": 1944, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "For poor diet has overtaken smoking as the world's biggest killer, according to the latest Global Burden of Disease study, causing 20 percent of deaths globally in 2017. Launched in November, the pea-based snack is the first joint product from Mars and Tata Trusts - which owns two-thirds of India's salt-to-software conglomerate Tata Sons - after they agreed in 2016 to boost nutrition and food safety in Asia's third-largest economy. The aim, said Tata Trusts advisor Mansharan Seth, is to offer an \"affordable, accessible, nutritious\" snack in rural India, where poverty and a lack of education mean many children suffer from health problems due to their diet."}
{"meta": {"doc_id": 2440, "sent_id": 7, "sent_start_pos": 1451, "sent_end_pos": 2128, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Launched in November, the pea-based snack is the first joint product from Mars and Tata Trusts - which owns two-thirds of India's salt-to-software conglomerate Tata Sons - after they agreed in 2016 to boost nutrition and food safety in Asia's third-largest economy. The aim, said Tata Trusts advisor Mansharan Seth, is to offer an \"affordable, accessible, nutritious\" snack in rural India, where poverty and a lack of education mean many children suffer from health problems due to their diet. \"We are (often) talking to someone who is probably hearing the words 'protein', 'minerals', 'vitamins' for the first time,\" she said at the new $75-million factory making the product."}
{"meta": {"doc_id": 2440, "sent_id": 8, "sent_start_pos": 1717, "sent_end_pos": 2344, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "The aim, said Tata Trusts advisor Mansharan Seth, is to offer an \"affordable, accessible, nutritious\" snack in rural India, where poverty and a lack of education mean many children suffer from health problems due to their diet. \"We are (often) talking to someone who is probably hearing the words 'protein', 'minerals', 'vitamins' for the first time,\" she said at the new $75-million factory making the product. CORPORATE BABY STEPS\nRecent data shows the problem is not only about getting enough food, but the right, healthy kind like whole grains, nuts, seeds, fresh fruits and vegetables."}
{"meta": {"doc_id": 2440, "sent_id": 9, "sent_start_pos": 1945, "sent_end_pos": 2554, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "\"We are (often) talking to someone who is probably hearing the words 'protein', 'minerals', 'vitamins' for the first time,\" she said at the new $75-million factory making the product. CORPORATE BABY STEPS\nRecent data shows the problem is not only about getting enough food, but the right, healthy kind like whole grains, nuts, seeds, fresh fruits and vegetables. The Global Burden of Disease study, led by the US-based Institute for Health Metrics and Evaluation, found people were eating food high in sugar and salt that contributed to heart disease, cancer and diabetes."}
{"meta": {"doc_id": 2440, "sent_id": 10, "sent_start_pos": 2166, "sent_end_pos": 2680, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "CORPORATE BABY STEPS\nRecent data shows the problem is not only about getting enough food, but the right, healthy kind like whole grains, nuts, seeds, fresh fruits and vegetables. The Global Burden of Disease study, led by the US-based Institute for Health Metrics and Evaluation, found people were eating food high in sugar and salt that contributed to heart disease, cancer and diabetes. Globally, diabetes affects 422 million people, killing about 1.6 million in 2016, according to the World Health Organization."}
{"meta": {"doc_id": 2440, "sent_id": 11, "sent_start_pos": 2345, "sent_end_pos": 2827, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "The Global Burden of Disease study, led by the US-based Institute for Health Metrics and Evaluation, found people were eating food high in sugar and salt that contributed to heart disease, cancer and diabetes. Globally, diabetes affects 422 million people, killing about 1.6 million in 2016, according to the World Health Organization. Rita Teaotia, head of the Food Safety and Standards Authority of India, said Indians accounted for the second-largest group of diabetics globally."}
{"meta": {"doc_id": 2440, "sent_id": 12, "sent_start_pos": 2555, "sent_end_pos": 3058, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Globally, diabetes affects 422 million people, killing about 1.6 million in 2016, according to the World Health Organization. Rita Teaotia, head of the Food Safety and Standards Authority of India, said Indians accounted for the second-largest group of diabetics globally. Nutritionists and activists have long accused big food and beverage companies of courting poor consumers with drinks and snacks high in salt, sugar and fat, while doing too little to stem rising obesity and diet-related illnesses."}
{"meta": {"doc_id": 2440, "sent_id": 13, "sent_start_pos": 2681, "sent_end_pos": 3290, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Rita Teaotia, head of the Food Safety and Standards Authority of India, said Indians accounted for the second-largest group of diabetics globally. Nutritionists and activists have long accused big food and beverage companies of courting poor consumers with drinks and snacks high in salt, sugar and fat, while doing too little to stem rising obesity and diet-related illnesses. Shweta Khandelwal, a nutritionist at the Public Health Foundation of India, said some firms tried to confuse consumers with misleading product descriptions and nutrition labels and too few were \"really trying to make a difference\"."}
{"meta": {"doc_id": 2440, "sent_id": 14, "sent_start_pos": 2828, "sent_end_pos": 3534, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Nutritionists and activists have long accused big food and beverage companies of courting poor consumers with drinks and snacks high in salt, sugar and fat, while doing too little to stem rising obesity and diet-related illnesses. Shweta Khandelwal, a nutritionist at the Public Health Foundation of India, said some firms tried to confuse consumers with misleading product descriptions and nutrition labels and too few were \"really trying to make a difference\". More than 20 corporations - including Mars, US cereal maker Kellogg Company and food and beverage firm Nestle - have pledged to reformulate recipes by 2022 as part of the \"Eat Right India\" campaign."}
{"meta": {"doc_id": 2440, "sent_id": 15, "sent_start_pos": 3059, "sent_end_pos": 3773, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Shweta Khandelwal, a nutritionist at the Public Health Foundation of India, said some firms tried to confuse consumers with misleading product descriptions and nutrition labels and too few were \"really trying to make a difference\". More than 20 corporations - including Mars, US cereal maker Kellogg Company and food and beverage firm Nestle - have pledged to reformulate recipes by 2022 as part of the \"Eat Right India\" campaign. Kellogg said it had cut more than 1,000 tonnes of sugar - the weight of 10 blue whales - and 200 tonnes of salt from its foods in Asia-Pacific, and had stopped using artificial colours, preservatives and flavours in its products globally."}
{"meta": {"doc_id": 2440, "sent_id": 16, "sent_start_pos": 3336, "sent_end_pos": 3889, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "More than 20 corporations - including Mars, US cereal maker Kellogg Company and food and beverage firm Nestle - have pledged to reformulate recipes by 2022 as part of the \"Eat Right India\" campaign. Kellogg said it had cut more than 1,000 tonnes of sugar - the weight of 10 blue whales - and 200 tonnes of salt from its foods in Asia-Pacific, and had stopped using artificial colours, preservatives and flavours in its products globally. Nestle said it had reduced sugar in its products by 34 percent since 2000 and hoped to chop 5 percent more by 2020."}
{"meta": {"doc_id": 2440, "sent_id": 17, "sent_start_pos": 3535, "sent_end_pos": 4096, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Kellogg said it had cut more than 1,000 tonnes of sugar - the weight of 10 blue whales - and 200 tonnes of salt from its foods in Asia-Pacific, and had stopped using artificial colours, preservatives and flavours in its products globally. Nestle said it had reduced sugar in its products by 34 percent since 2000 and hoped to chop 5 percent more by 2020. To help tackle the problem, Asia-based companies like Alchemy Foodtech and Nutrition Innovation are trying to lower the glycemic index (GI) of food, a measure of how quickly it can raise blood sugar levels."}
{"meta": {"doc_id": 2440, "sent_id": 18, "sent_start_pos": 3774, "sent_end_pos": 4283, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Nestle said it had reduced sugar in its products by 34 percent since 2000 and hoped to chop 5 percent more by 2020. To help tackle the problem, Asia-based companies like Alchemy Foodtech and Nutrition Innovation are trying to lower the glycemic index (GI) of food, a measure of how quickly it can raise blood sugar levels. In response to family problems, Singaporean couple Alan Phua and Verleen Goh have spent three years designing a plant-based product, 5ibrePlus, to add to common foods to reduce their GI."}
{"meta": {"doc_id": 2440, "sent_id": 19, "sent_start_pos": 3890, "sent_end_pos": 4469, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "To help tackle the problem, Asia-based companies like Alchemy Foodtech and Nutrition Innovation are trying to lower the glycemic index (GI) of food, a measure of how quickly it can raise blood sugar levels. In response to family problems, Singaporean couple Alan Phua and Verleen Goh have spent three years designing a plant-based product, 5ibrePlus, to add to common foods to reduce their GI. Both of Phua's grandmothers died of diabetes complications, while five of his mother's siblings are type-2 diabetic, he said at the Alchemy Food Tech office in a leafy Singapore suburb."}
{"meta": {"doc_id": 2440, "sent_id": 20, "sent_start_pos": 4097, "sent_end_pos": 4624, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "In response to family problems, Singaporean couple Alan Phua and Verleen Goh have spent three years designing a plant-based product, 5ibrePlus, to add to common foods to reduce their GI. Both of Phua's grandmothers died of diabetes complications, while five of his mother's siblings are type-2 diabetic, he said at the Alchemy Food Tech office in a leafy Singapore suburb. \"I wanted a kind of technology or solution that can be practical (and) fits everyday life, so that I can see my loved ones being protected,\" he explained."}
{"meta": {"doc_id": 2440, "sent_id": 21, "sent_start_pos": 4284, "sent_end_pos": 4746, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Both of Phua's grandmothers died of diabetes complications, while five of his mother's siblings are type-2 diabetic, he said at the Alchemy Food Tech office in a leafy Singapore suburb. \"I wanted a kind of technology or solution that can be practical (and) fits everyday life, so that I can see my loved ones being protected,\" he explained. Adding 5ibrePlus to jasmine rice can lower its GI to that of brown rice without changing the taste or texture, Phua said."}
{"meta": {"doc_id": 2440, "sent_id": 22, "sent_start_pos": 4470, "sent_end_pos": 4878, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "\"I wanted a kind of technology or solution that can be practical (and) fits everyday life, so that I can see my loved ones being protected,\" he explained. Adding 5ibrePlus to jasmine rice can lower its GI to that of brown rice without changing the taste or texture, Phua said. Alchemy's founders are working with bread and noodle producers and rice distributors to make the product available later this year."}
{"meta": {"doc_id": 2440, "sent_id": 23, "sent_start_pos": 4625, "sent_end_pos": 5065, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Adding 5ibrePlus to jasmine rice can lower its GI to that of brown rice without changing the taste or texture, Phua said. Alchemy's founders are working with bread and noodle producers and rice distributors to make the product available later this year. Nutrition Innovation, another Singapore-based firm, recently raised $5 million from investors for its technology that can be used by mills to produce low-GI sugar on an industrial scale."}
{"meta": {"doc_id": 2440, "sent_id": 24, "sent_start_pos": 4747, "sent_end_pos": 5187, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Alchemy's founders are working with bread and noodle producers and rice distributors to make the product available later this year. Nutrition Innovation, another Singapore-based firm, recently raised $5 million from investors for its technology that can be used by mills to produce low-GI sugar on an industrial scale. 'YUCKY TO YUMMY'\nMeanwhile, alternative meat companies are eyeing health and environmentally-conscious consumers in Asia."}
{"meta": {"doc_id": 2440, "sent_id": 25, "sent_start_pos": 4879, "sent_end_pos": 5304, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Nutrition Innovation, another Singapore-based firm, recently raised $5 million from investors for its technology that can be used by mills to produce low-GI sugar on an industrial scale. 'YUCKY TO YUMMY'\nMeanwhile, alternative meat companies are eyeing health and environmentally-conscious consumers in Asia. Life3 Biotech's plant-based protein, Veego, is slated to start production this year, said company founder Ricky Lin."}
{"meta": {"doc_id": 2440, "sent_id": 26, "sent_start_pos": 5066, "sent_end_pos": 5368, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "'YUCKY TO YUMMY'\nMeanwhile, alternative meat companies are eyeing health and environmentally-conscious consumers in Asia. Life3 Biotech's plant-based protein, Veego, is slated to start production this year, said company founder Ricky Lin. \"From yucky to yummy - it took about three years,\" laughed Lin."}
{"meta": {"doc_id": 2440, "sent_id": 27, "sent_start_pos": 5188, "sent_end_pos": 5479, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Life3 Biotech's plant-based protein, Veego, is slated to start production this year, said company founder Ricky Lin. \"From yucky to yummy - it took about three years,\" laughed Lin. Veego, he said, has a similar texture and protein level to chicken but without its usual fats and cholesterol."}
{"meta": {"doc_id": 2440, "sent_id": 28, "sent_start_pos": 5305, "sent_end_pos": 5708, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "\"From yucky to yummy - it took about three years,\" laughed Lin. Veego, he said, has a similar texture and protein level to chicken but without its usual fats and cholesterol. Singapore-based startup Shiok Meats hopes to supply products derived from seafood cells grown in a lab to high-end restaurants by the end of 2020, and sell them in supermarkets in three to five years, said co-founder Ka Yi Ling."}
{"meta": {"doc_id": 2440, "sent_id": 29, "sent_start_pos": 5369, "sent_end_pos": 5773, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Veego, he said, has a similar texture and protein level to chicken but without its usual fats and cholesterol. Singapore-based startup Shiok Meats hopes to supply products derived from seafood cells grown in a lab to high-end restaurants by the end of 2020, and sell them in supermarkets in three to five years, said co-founder Ka Yi Ling. \"In Asia, we eat a lot of seafood, especially shrimp,\" she said."}
{"meta": {"doc_id": 2440, "sent_id": 30, "sent_start_pos": 5480, "sent_end_pos": 5910, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Singapore-based startup Shiok Meats hopes to supply products derived from seafood cells grown in a lab to high-end restaurants by the end of 2020, and sell them in supermarkets in three to five years, said co-founder Ka Yi Ling. \"In Asia, we eat a lot of seafood, especially shrimp,\" she said. \"There is a lot of environmental impact ... and most importantly, with the population growth in Asia, it's hard to sustain that demand.\""}
{"meta": {"doc_id": 2440, "sent_id": 31, "sent_start_pos": 5709, "sent_end_pos": 6154, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "\"In Asia, we eat a lot of seafood, especially shrimp,\" she said. \"There is a lot of environmental impact ... and most importantly, with the population growth in Asia, it's hard to sustain that demand.\" Non-meat eaters, for their part, can take advantage of the one-year-old app \"abillionveg\", which reviews vegetarian and vegan dishes in photos snapped and uploaded by its users and notifies restaurants in a bid for motivate them to offer more."}
{"meta": {"doc_id": 2440, "sent_id": 32, "sent_start_pos": 5774, "sent_end_pos": 6313, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "\"There is a lot of environmental impact ... and most importantly, with the population growth in Asia, it's hard to sustain that demand.\" Non-meat eaters, for their part, can take advantage of the one-year-old app \"abillionveg\", which reviews vegetarian and vegan dishes in photos snapped and uploaded by its users and notifies restaurants in a bid for motivate them to offer more. Founder and lifelong vegetarian Vikas Garg remembered having to settle for a lacklustre salad at the numerous steak-houses he visited as an investment banker."}
{"meta": {"doc_id": 2440, "sent_id": 33, "sent_start_pos": 5911, "sent_end_pos": 6402, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Non-meat eaters, for their part, can take advantage of the one-year-old app \"abillionveg\", which reviews vegetarian and vegan dishes in photos snapped and uploaded by its users and notifies restaurants in a bid for motivate them to offer more. Founder and lifelong vegetarian Vikas Garg remembered having to settle for a lacklustre salad at the numerous steak-houses he visited as an investment banker. \"You don't want your vegetarian or vegan meal to be a compromise or sacrifice,\" he said."}
{"meta": {"doc_id": 2440, "sent_id": 34, "sent_start_pos": 6155, "sent_end_pos": 6511, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Founder and lifelong vegetarian Vikas Garg remembered having to settle for a lacklustre salad at the numerous steak-houses he visited as an investment banker. \"You don't want your vegetarian or vegan meal to be a compromise or sacrifice,\" he said. \"We're also trying to convince businesses that their plant-based dish should be the best thing on the menu.\""}
{"meta": {"doc_id": 2440, "sent_id": 35, "sent_start_pos": 6314, "sent_end_pos": 6627, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "\"You don't want your vegetarian or vegan meal to be a compromise or sacrifice,\" he said. \"We're also trying to convince businesses that their plant-based dish should be the best thing on the menu.\" (Reporting by Annie Banerji in India and Thin Lei Win in Singapore; editing by Megan Rowling and Belinda Goldsmith."}
{"meta": {"doc_id": 2440, "sent_id": 36, "sent_start_pos": 6403, "sent_end_pos": 6867, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "\"We're also trying to convince businesses that their plant-based dish should be the best thing on the menu.\" (Reporting by Annie Banerji in India and Thin Lei Win in Singapore; editing by Megan Rowling and Belinda Goldsmith. Please credit the Thomson Reuters Foundation, the charitable arm of Thomson Reuters that covers humanitarian issues, conflicts, land and property rights, modern slavery and human trafficking, gender equality, climate change and resilience."}
{"meta": {"doc_id": 2440, "sent_id": 37, "sent_start_pos": 6512, "sent_end_pos": 6969, "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "(Reporting by Annie Banerji in India and Thin Lei Win in Singapore; editing by Megan Rowling and Belinda Goldsmith. Please credit the Thomson Reuters Foundation, the charitable arm of Thomson Reuters that covers humanitarian issues, conflicts, land and property rights, modern slavery and human trafficking, gender equality, climate change and resilience. Visit http://news.trust.org to see more stories)\nOur Standards: The Thomson Reuters Trust Principles."}
{"meta": {"doc_id": 2440, "sent_id": 38, "sent_start_pos": 6628, "sent_end_pos": [], "title": "Food firms globally whip up wacky ways to battle bad diets"}, "text": "Please credit the Thomson Reuters Foundation, the charitable arm of Thomson Reuters that covers humanitarian issues, conflicts, land and property rights, modern slavery and human trafficking, gender equality, climate change and resilience. Visit http://news.trust.org to see more stories)\nOur Standards: The Thomson Reuters Trust Principles. "}
{"meta": {"doc_id": 2441, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 463, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": " REVIEW article\nPlant glyco-biotechnology on the way to synthetic biology\n- Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences, Vienna, Austria\nPlants are increasingly being used for the production of recombinant proteins. One reason is that plants are highly amenable to glycan engineering processes and allow the production of therapeutic proteins with increased efficacies due to optimized glycosylation profiles."}
{"meta": {"doc_id": 2441, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 665, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "REVIEW article\nPlant glyco-biotechnology on the way to synthetic biology\n- Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences, Vienna, Austria\nPlants are increasingly being used for the production of recombinant proteins. One reason is that plants are highly amenable to glycan engineering processes and allow the production of therapeutic proteins with increased efficacies due to optimized glycosylation profiles. Removal and insertion of glycosylation reactions by knock-out/knock-down approaches and introduction of glycosylation enzymes have paved the way for the humanization of the plant glycosylation pathway."}
{"meta": {"doc_id": 2441, "sent_id": 2, "sent_start_pos": 270, "sent_end_pos": 811, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "One reason is that plants are highly amenable to glycan engineering processes and allow the production of therapeutic proteins with increased efficacies due to optimized glycosylation profiles. Removal and insertion of glycosylation reactions by knock-out/knock-down approaches and introduction of glycosylation enzymes have paved the way for the humanization of the plant glycosylation pathway. The insertion of heterologous enzymes at exactly the right stage of the existing glycosylation pathway has turned out to be of utmost importance."}
{"meta": {"doc_id": 2441, "sent_id": 3, "sent_start_pos": 464, "sent_end_pos": 884, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Removal and insertion of glycosylation reactions by knock-out/knock-down approaches and introduction of glycosylation enzymes have paved the way for the humanization of the plant glycosylation pathway. The insertion of heterologous enzymes at exactly the right stage of the existing glycosylation pathway has turned out to be of utmost importance. To enable such precise targeting chimeric enzymes have been constructed."}
{"meta": {"doc_id": 2441, "sent_id": 4, "sent_start_pos": 666, "sent_end_pos": 1256, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The insertion of heterologous enzymes at exactly the right stage of the existing glycosylation pathway has turned out to be of utmost importance. To enable such precise targeting chimeric enzymes have been constructed. In this short review we will exemplify the importance of correct targeting of glycosyltransferases, we will give an overview of the targeting mechanism of glycosyltransferases, describe chimeric enzymes used in plant N-glycosylation engineering and illustrate how plant glycoengineering builds on the tools offered by synthetic biology to construct such chimeric enzymes."}
{"meta": {"doc_id": 2441, "sent_id": 5, "sent_start_pos": 812, "sent_end_pos": 1338, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "To enable such precise targeting chimeric enzymes have been constructed. In this short review we will exemplify the importance of correct targeting of glycosyltransferases, we will give an overview of the targeting mechanism of glycosyltransferases, describe chimeric enzymes used in plant N-glycosylation engineering and illustrate how plant glycoengineering builds on the tools offered by synthetic biology to construct such chimeric enzymes. Introduction\nThe medicinal use of proteins and blood products has a long history."}
{"meta": {"doc_id": 2441, "sent_id": 6, "sent_start_pos": 885, "sent_end_pos": 1561, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "In this short review we will exemplify the importance of correct targeting of glycosyltransferases, we will give an overview of the targeting mechanism of glycosyltransferases, describe chimeric enzymes used in plant N-glycosylation engineering and illustrate how plant glycoengineering builds on the tools offered by synthetic biology to construct such chimeric enzymes. Introduction\nThe medicinal use of proteins and blood products has a long history. Already in the 15th century ailing pope Innocent VIII was reportedly infused with blood from three healthy boys to give him back vigor and strength, however, with a fatal outcome for all four of them (Rivera et al., 2005)."}
{"meta": {"doc_id": 2441, "sent_id": 7, "sent_start_pos": 1257, "sent_end_pos": 1741, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Introduction\nThe medicinal use of proteins and blood products has a long history. Already in the 15th century ailing pope Innocent VIII was reportedly infused with blood from three healthy boys to give him back vigor and strength, however, with a fatal outcome for all four of them (Rivera et al., 2005). The first successful blood transfusion was made in 1665 between dogs (Felts, 2000) and it took over 150 years for the first successful transfusion between humans (Blundell, 1818)."}
{"meta": {"doc_id": 2441, "sent_id": 8, "sent_start_pos": 1339, "sent_end_pos": 2095, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Already in the 15th century ailing pope Innocent VIII was reportedly infused with blood from three healthy boys to give him back vigor and strength, however, with a fatal outcome for all four of them (Rivera et al., 2005). The first successful blood transfusion was made in 1665 between dogs (Felts, 2000) and it took over 150 years for the first successful transfusion between humans (Blundell, 1818). Proteins purified from animal or human tissues (growth hormones, insulin, clotting factors, or other blood components) have been used for medicinal purposes since the beginning of the 20th century (eg, Eibl, 2008; Blizzard, 2012) and with the advent of recombinant protein production possibilities, many of those proteins are now produced recombinantly."}
{"meta": {"doc_id": 2441, "sent_id": 9, "sent_start_pos": 1562, "sent_end_pos": 2305, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The first successful blood transfusion was made in 1665 between dogs (Felts, 2000) and it took over 150 years for the first successful transfusion between humans (Blundell, 1818). Proteins purified from animal or human tissues (growth hormones, insulin, clotting factors, or other blood components) have been used for medicinal purposes since the beginning of the 20th century (eg, Eibl, 2008; Blizzard, 2012) and with the advent of recombinant protein production possibilities, many of those proteins are now produced recombinantly. The market for pharmaceutical proteins is assumed to currently amount to roughly 150\u2013200 billion US$, and develops strongly with growth rates of \u223c10% and more (Walsh, 2010; Elvin et al., 2013; Aggarwal, 2014)."}
{"meta": {"doc_id": 2441, "sent_id": 10, "sent_start_pos": 1742, "sent_end_pos": 2478, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Proteins purified from animal or human tissues (growth hormones, insulin, clotting factors, or other blood components) have been used for medicinal purposes since the beginning of the 20th century (eg, Eibl, 2008; Blizzard, 2012) and with the advent of recombinant protein production possibilities, many of those proteins are now produced recombinantly. The market for pharmaceutical proteins is assumed to currently amount to roughly 150\u2013200 billion US$, and develops strongly with growth rates of \u223c10% and more (Walsh, 2010; Elvin et al., 2013; Aggarwal, 2014). Special drivers of this growth are antibodies and antibody related products, but also other types of proteins are selling well, like insulin, vaccines, erythropoietin, etc."}
{"meta": {"doc_id": 2441, "sent_id": 11, "sent_start_pos": 2096, "sent_end_pos": 2496, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The market for pharmaceutical proteins is assumed to currently amount to roughly 150\u2013200 billion US$, and develops strongly with growth rates of \u223c10% and more (Walsh, 2010; Elvin et al., 2013; Aggarwal, 2014). Special drivers of this growth are antibodies and antibody related products, but also other types of proteins are selling well, like insulin, vaccines, erythropoietin, etc. (Aggarwal, 2014)."}
{"meta": {"doc_id": 2441, "sent_id": 12, "sent_start_pos": 2306, "sent_end_pos": 2634, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Special drivers of this growth are antibodies and antibody related products, but also other types of proteins are selling well, like insulin, vaccines, erythropoietin, etc. (Aggarwal, 2014). A current major concern in producing biopharmaceuticals is a special type of post-translation modification (PTM), namely N-glycosylation."}
{"meta": {"doc_id": 2441, "sent_id": 13, "sent_start_pos": 2479, "sent_end_pos": 2855, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(Aggarwal, 2014). A current major concern in producing biopharmaceuticals is a special type of post-translation modification (PTM), namely N-glycosylation. This PTM is found on a large proportion of pharmaceutically relevant proteins (Walsh, 2010) and can influence protein characteristics like folding and assembly, solubility and charge, serum half-life, functionality, etc."}
{"meta": {"doc_id": 2441, "sent_id": 14, "sent_start_pos": 2497, "sent_end_pos": 2919, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "A current major concern in producing biopharmaceuticals is a special type of post-translation modification (PTM), namely N-glycosylation. This PTM is found on a large proportion of pharmaceutically relevant proteins (Walsh, 2010) and can influence protein characteristics like folding and assembly, solubility and charge, serum half-life, functionality, etc. (eg, Varki, 1993; Roth et al., 2010; Sol\u00e1 and Griebenow, 2010)."}
{"meta": {"doc_id": 2441, "sent_id": 15, "sent_start_pos": 2635, "sent_end_pos": 3149, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "This PTM is found on a large proportion of pharmaceutically relevant proteins (Walsh, 2010) and can influence protein characteristics like folding and assembly, solubility and charge, serum half-life, functionality, etc. (eg, Varki, 1993; Roth et al., 2010; Sol\u00e1 and Griebenow, 2010). As different cell types attach different glycans, the characteristics of the N-glycosylated protein can be strongly affected by the expression host \u2013 a fact that should be considered carefully when choosing the production system."}
{"meta": {"doc_id": 2441, "sent_id": 16, "sent_start_pos": 2856, "sent_end_pos": 3266, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(eg, Varki, 1993; Roth et al., 2010; Sol\u00e1 and Griebenow, 2010). As different cell types attach different glycans, the characteristics of the N-glycosylated protein can be strongly affected by the expression host \u2013 a fact that should be considered carefully when choosing the production system. For example, bacteria generally do not glycosylate proteins and yeasts attach larger glycan structures than mammals."}
{"meta": {"doc_id": 2441, "sent_id": 17, "sent_start_pos": 2920, "sent_end_pos": 3370, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "As different cell types attach different glycans, the characteristics of the N-glycosylated protein can be strongly affected by the expression host \u2013 a fact that should be considered carefully when choosing the production system. For example, bacteria generally do not glycosylate proteins and yeasts attach larger glycan structures than mammals. Insect cells decorate proteins with paucimannosidic N-glycans which are normally not present in humans."}
{"meta": {"doc_id": 2441, "sent_id": 18, "sent_start_pos": 3150, "sent_end_pos": 3709, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "For example, bacteria generally do not glycosylate proteins and yeasts attach larger glycan structures than mammals. Insect cells decorate proteins with paucimannosidic N-glycans which are normally not present in humans. Plants produce complex type N-glycans similar to humans, however, certain non-mammalian epitopes are attached and more complex human-type glycosylation cannot be produced (for reviews on typcial N-glycosylation patterns and glycoengineering of different expression hosts see, eg, Jacobs and Callewaert, 2009; Loos and Steinkellner, 2012)."}
{"meta": {"doc_id": 2441, "sent_id": 19, "sent_start_pos": 3267, "sent_end_pos": 3910, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Insect cells decorate proteins with paucimannosidic N-glycans which are normally not present in humans. Plants produce complex type N-glycans similar to humans, however, certain non-mammalian epitopes are attached and more complex human-type glycosylation cannot be produced (for reviews on typcial N-glycosylation patterns and glycoengineering of different expression hosts see, eg, Jacobs and Callewaert, 2009; Loos and Steinkellner, 2012). Another concern is glycan microheterogeneity, ie, attachment of different N-glycans to the same N-glycosylation site, as homogeneously glycosylated products are required by the regulatory authorities."}
{"meta": {"doc_id": 2441, "sent_id": 20, "sent_start_pos": 3371, "sent_end_pos": 4360, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plants produce complex type N-glycans similar to humans, however, certain non-mammalian epitopes are attached and more complex human-type glycosylation cannot be produced (for reviews on typcial N-glycosylation patterns and glycoengineering of different expression hosts see, eg, Jacobs and Callewaert, 2009; Loos and Steinkellner, 2012). Another concern is glycan microheterogeneity, ie, attachment of different N-glycans to the same N-glycosylation site, as homogeneously glycosylated products are required by the regulatory authorities. Thus, research has focused on modifying the glycosylation characteristics of a variety of expression systems to allow homogeneous, human-type N-glycosylation (Umana et al., 1999; Yamane-Ohnuki et al., 2004; Schuster et al., 2005; Cox et al., 2006; Li et al., 2006; Strasser et al., 2009; Pandhal and Wright, 2010; Meuris et al., 2014) and resulted in the production of proteins carrying modified glycans and often showing improved in vivo functions."}
{"meta": {"doc_id": 2441, "sent_id": 21, "sent_start_pos": 3710, "sent_end_pos": 4572, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Another concern is glycan microheterogeneity, ie, attachment of different N-glycans to the same N-glycosylation site, as homogeneously glycosylated products are required by the regulatory authorities. Thus, research has focused on modifying the glycosylation characteristics of a variety of expression systems to allow homogeneous, human-type N-glycosylation (Umana et al., 1999; Yamane-Ohnuki et al., 2004; Schuster et al., 2005; Cox et al., 2006; Li et al., 2006; Strasser et al., 2009; Pandhal and Wright, 2010; Meuris et al., 2014) and resulted in the production of proteins carrying modified glycans and often showing improved in vivo functions. Plants have proven their capability regarding production speed, ease of scale up and to meet quality standards demanded by regulatory agencies for clinical applications (Gleba et al., 2014; Stoger et al., 2014)."}
{"meta": {"doc_id": 2441, "sent_id": 22, "sent_start_pos": 3911, "sent_end_pos": 4802, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Thus, research has focused on modifying the glycosylation characteristics of a variety of expression systems to allow homogeneous, human-type N-glycosylation (Umana et al., 1999; Yamane-Ohnuki et al., 2004; Schuster et al., 2005; Cox et al., 2006; Li et al., 2006; Strasser et al., 2009; Pandhal and Wright, 2010; Meuris et al., 2014) and resulted in the production of proteins carrying modified glycans and often showing improved in vivo functions. Plants have proven their capability regarding production speed, ease of scale up and to meet quality standards demanded by regulatory agencies for clinical applications (Gleba et al., 2014; Stoger et al., 2014). Also governmental agencies like the Defense Advanced Research Projects Agency [DARPA] (2012) have recognized the advantages of this technology for the quick manufacturing of vaccines, difficult to produce biopharmaceuticals, etc."}
{"meta": {"doc_id": 2441, "sent_id": 23, "sent_start_pos": 4361, "sent_end_pos": 5060, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plants have proven their capability regarding production speed, ease of scale up and to meet quality standards demanded by regulatory agencies for clinical applications (Gleba et al., 2014; Stoger et al., 2014). Also governmental agencies like the Defense Advanced Research Projects Agency [DARPA] (2012) have recognized the advantages of this technology for the quick manufacturing of vaccines, difficult to produce biopharmaceuticals, etc. This has led to massive investments in research, production facilities complying with current quality standards (Defense Advanced Research Projects Agency [DARPA], 2012; www.federalgrants.com, 2012; Stoger et al., 2014) and the first products on the market."}
{"meta": {"doc_id": 2441, "sent_id": 24, "sent_start_pos": 4573, "sent_end_pos": 5271, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Also governmental agencies like the Defense Advanced Research Projects Agency [DARPA] (2012) have recognized the advantages of this technology for the quick manufacturing of vaccines, difficult to produce biopharmaceuticals, etc. This has led to massive investments in research, production facilities complying with current quality standards (Defense Advanced Research Projects Agency [DARPA], 2012; www.federalgrants.com, 2012; Stoger et al., 2014) and the first products on the market. Glucocerebrosidase, an enzyme to treat Gaucher\u2019s disease, has been approved by the FDA in 2013 as the first plant-produced, parenterally applied biopharmaceutical (Zimran et al., 2011; van Dussen et al., 2013)."}
{"meta": {"doc_id": 2441, "sent_id": 25, "sent_start_pos": 4803, "sent_end_pos": 5488, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "This has led to massive investments in research, production facilities complying with current quality standards (Defense Advanced Research Projects Agency [DARPA], 2012; www.federalgrants.com, 2012; Stoger et al., 2014) and the first products on the market. Glucocerebrosidase, an enzyme to treat Gaucher\u2019s disease, has been approved by the FDA in 2013 as the first plant-produced, parenterally applied biopharmaceutical (Zimran et al., 2011; van Dussen et al., 2013). Additionally, several plant-made pharmaceuticals have received approval for clinical trials and other plant-produced products are already marketed as research/diagnostic reagent, medical device, cosmetic product etc."}
{"meta": {"doc_id": 2441, "sent_id": 26, "sent_start_pos": 5061, "sent_end_pos": 5567, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Glucocerebrosidase, an enzyme to treat Gaucher\u2019s disease, has been approved by the FDA in 2013 as the first plant-produced, parenterally applied biopharmaceutical (Zimran et al., 2011; van Dussen et al., 2013). Additionally, several plant-made pharmaceuticals have received approval for clinical trials and other plant-produced products are already marketed as research/diagnostic reagent, medical device, cosmetic product etc. (recently reviewed by Gleba et al., 2014; Goodman, 2014; Stoger et al., 2014)."}
{"meta": {"doc_id": 2441, "sent_id": 27, "sent_start_pos": 5272, "sent_end_pos": 5608, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Additionally, several plant-made pharmaceuticals have received approval for clinical trials and other plant-produced products are already marketed as research/diagnostic reagent, medical device, cosmetic product etc. (recently reviewed by Gleba et al., 2014; Goodman, 2014; Stoger et al., 2014). Many of these proteins are glycosylated."}
{"meta": {"doc_id": 2441, "sent_id": 28, "sent_start_pos": 5489, "sent_end_pos": 5845, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(recently reviewed by Gleba et al., 2014; Goodman, 2014; Stoger et al., 2014). Many of these proteins are glycosylated. In this review we will discuss the approaches taken to engineer the N-glycosylation pathway in Nicotiana benthamiana and put a strong focus on recently developed and applied semi-synthetic strategies using chimeric glycosyltransferases."}
{"meta": {"doc_id": 2441, "sent_id": 29, "sent_start_pos": 5568, "sent_end_pos": 6098, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Many of these proteins are glycosylated. In this review we will discuss the approaches taken to engineer the N-glycosylation pathway in Nicotiana benthamiana and put a strong focus on recently developed and applied semi-synthetic strategies using chimeric glycosyltransferases. Plant Glycosylation\nIn plants as in other eukaryotes, the endoplasmic reticulum (ER) and the Golgi apparatus play the central role in protein glycosylation and contain the majority of glycan modifying enzymes (reviewed by, eg, Helenius and Aebi, 2001)."}
{"meta": {"doc_id": 2441, "sent_id": 30, "sent_start_pos": 5609, "sent_end_pos": 6302, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "In this review we will discuss the approaches taken to engineer the N-glycosylation pathway in Nicotiana benthamiana and put a strong focus on recently developed and applied semi-synthetic strategies using chimeric glycosyltransferases. Plant Glycosylation\nIn plants as in other eukaryotes, the endoplasmic reticulum (ER) and the Golgi apparatus play the central role in protein glycosylation and contain the majority of glycan modifying enzymes (reviewed by, eg, Helenius and Aebi, 2001). While the ER and its glycan processing repertoire are largely conserved between phyla (and kingdoms), morphology and function of the Golgi differ to some extent (Loos and Steinkellner, 2012; Aebi, 2013)."}
{"meta": {"doc_id": 2441, "sent_id": 31, "sent_start_pos": 5846, "sent_end_pos": 6484, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Glycosylation\nIn plants as in other eukaryotes, the endoplasmic reticulum (ER) and the Golgi apparatus play the central role in protein glycosylation and contain the majority of glycan modifying enzymes (reviewed by, eg, Helenius and Aebi, 2001). While the ER and its glycan processing repertoire are largely conserved between phyla (and kingdoms), morphology and function of the Golgi differ to some extent (Loos and Steinkellner, 2012; Aebi, 2013). For example, a main function of the plant but not the mammalian Golgi is to provide large amounts of polysaccharides, a fundamental component of the cell wall (Oikawa et al., 2013)."}
{"meta": {"doc_id": 2441, "sent_id": 32, "sent_start_pos": 6099, "sent_end_pos": 6703, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "While the ER and its glycan processing repertoire are largely conserved between phyla (and kingdoms), morphology and function of the Golgi differ to some extent (Loos and Steinkellner, 2012; Aebi, 2013). For example, a main function of the plant but not the mammalian Golgi is to provide large amounts of polysaccharides, a fundamental component of the cell wall (Oikawa et al., 2013). Early N-glycosylation steps that take place in ER and cis-Golgi are virtually identical in higher eukaryotes, while further processing differs (recently reviewd by, eg, Loos and Steinkellner, 2012; Bosch et al., 2013)."}
{"meta": {"doc_id": 2441, "sent_id": 33, "sent_start_pos": 6303, "sent_end_pos": 6951, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "For example, a main function of the plant but not the mammalian Golgi is to provide large amounts of polysaccharides, a fundamental component of the cell wall (Oikawa et al., 2013). Early N-glycosylation steps that take place in ER and cis-Golgi are virtually identical in higher eukaryotes, while further processing differs (recently reviewd by, eg, Loos and Steinkellner, 2012; Bosch et al., 2013). This is mainly due to a drastically reduced repertoire of glycosylation enzymes in plants, where a small number of Golgi-located N-glycan processing enzymes gives rise to typically two different glycan structures (Castilho and Steinkellner, 2012)."}
{"meta": {"doc_id": 2441, "sent_id": 34, "sent_start_pos": 6485, "sent_end_pos": 7167, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Early N-glycosylation steps that take place in ER and cis-Golgi are virtually identical in higher eukaryotes, while further processing differs (recently reviewd by, eg, Loos and Steinkellner, 2012; Bosch et al., 2013). This is mainly due to a drastically reduced repertoire of glycosylation enzymes in plants, where a small number of Golgi-located N-glycan processing enzymes gives rise to typically two different glycan structures (Castilho and Steinkellner, 2012). By comparison, over 2000 different N-glycans have been described on mammalian proteins which arise from several 100 enzymes in the secretory pathway (Campbell and Yarema, 2005; Ohtsubo and Marth, 2006; Varki, 2006)."}
{"meta": {"doc_id": 2441, "sent_id": 35, "sent_start_pos": 6704, "sent_end_pos": 7363, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "This is mainly due to a drastically reduced repertoire of glycosylation enzymes in plants, where a small number of Golgi-located N-glycan processing enzymes gives rise to typically two different glycan structures (Castilho and Steinkellner, 2012). By comparison, over 2000 different N-glycans have been described on mammalian proteins which arise from several 100 enzymes in the secretory pathway (Campbell and Yarema, 2005; Ohtsubo and Marth, 2006; Varki, 2006). Notwithstanding these differences, the Golgi of higher eukaryotes shares a remarkably high degree of homology, especially with respect to organization, proteome, and N-glycosylation capabilities."}
{"meta": {"doc_id": 2441, "sent_id": 36, "sent_start_pos": 6952, "sent_end_pos": 7564, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "By comparison, over 2000 different N-glycans have been described on mammalian proteins which arise from several 100 enzymes in the secretory pathway (Campbell and Yarema, 2005; Ohtsubo and Marth, 2006; Varki, 2006). Notwithstanding these differences, the Golgi of higher eukaryotes shares a remarkably high degree of homology, especially with respect to organization, proteome, and N-glycosylation capabilities. Plant proteins typically carry two major N-glycans, complex GnGnXF and paucimannosidic MMXF (Strasser et al., 2004a, 2007a; for glycan nomenclature see http://www.proglycan.com/upload/nomen_2007.pdf)."}
{"meta": {"doc_id": 2441, "sent_id": 37, "sent_start_pos": 7168, "sent_end_pos": 7664, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Notwithstanding these differences, the Golgi of higher eukaryotes shares a remarkably high degree of homology, especially with respect to organization, proteome, and N-glycosylation capabilities. Plant proteins typically carry two major N-glycans, complex GnGnXF and paucimannosidic MMXF (Strasser et al., 2004a, 2007a; for glycan nomenclature see http://www.proglycan.com/upload/nomen_2007.pdf). These two glycans contain core \u03b11,3-fucose and \u03b21,2-xylose which are plant-specific glyco-epitopes."}
{"meta": {"doc_id": 2441, "sent_id": 38, "sent_start_pos": 7364, "sent_end_pos": 7858, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant proteins typically carry two major N-glycans, complex GnGnXF and paucimannosidic MMXF (Strasser et al., 2004a, 2007a; for glycan nomenclature see http://www.proglycan.com/upload/nomen_2007.pdf). These two glycans contain core \u03b11,3-fucose and \u03b21,2-xylose which are plant-specific glyco-epitopes. They are not produced by mammalian cells and up to 50% of humans have been shown to carry substantial amounts of antibodies directed against these epitopes in their blood (Bardor et al., 2003)."}
{"meta": {"doc_id": 2441, "sent_id": 39, "sent_start_pos": 7565, "sent_end_pos": 8138, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "These two glycans contain core \u03b11,3-fucose and \u03b21,2-xylose which are plant-specific glyco-epitopes. They are not produced by mammalian cells and up to 50% of humans have been shown to carry substantial amounts of antibodies directed against these epitopes in their blood (Bardor et al., 2003). The abundantly present paucimannosidic structures (MMXF, truncated glycans lacking terminal GlcNAc residues; Dirnberger et al., 2001; Strasser et al., 2007a; Liebminger et al., 2011) are also a plant peculiarity, otherwise only found in insect cells (Altmann et al., 1999, 2001)."}
{"meta": {"doc_id": 2441, "sent_id": 40, "sent_start_pos": 7665, "sent_end_pos": 8320, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "They are not produced by mammalian cells and up to 50% of humans have been shown to carry substantial amounts of antibodies directed against these epitopes in their blood (Bardor et al., 2003). The abundantly present paucimannosidic structures (MMXF, truncated glycans lacking terminal GlcNAc residues; Dirnberger et al., 2001; Strasser et al., 2007a; Liebminger et al., 2011) are also a plant peculiarity, otherwise only found in insect cells (Altmann et al., 1999, 2001). In some cases plant proteins carry so-called Lewis A epitopes, terminally \u03b21,3-galactosylated and \u03b11,4-fucosylated structures (Fitchette-Laine et al., 1997; Strasser et al., 2007b)."}
{"meta": {"doc_id": 2441, "sent_id": 41, "sent_start_pos": 7859, "sent_end_pos": 8593, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The abundantly present paucimannosidic structures (MMXF, truncated glycans lacking terminal GlcNAc residues; Dirnberger et al., 2001; Strasser et al., 2007a; Liebminger et al., 2011) are also a plant peculiarity, otherwise only found in insect cells (Altmann et al., 1999, 2001). In some cases plant proteins carry so-called Lewis A epitopes, terminally \u03b21,3-galactosylated and \u03b11,4-fucosylated structures (Fitchette-Laine et al., 1997; Strasser et al., 2007b). The abundance of this epitope differs strongly between species (Fitchette et al., 1999; Wilson et al., 2001) and organs (Strasser et al., 2007b), but seems low in Arabidopsis and Nicotiana (Fitchette et al., 1999; Strasser et al., 2007b, 2008; Matsuo and Matsumura, 2011)."}
{"meta": {"doc_id": 2441, "sent_id": 42, "sent_start_pos": 8139, "sent_end_pos": 8748, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "In some cases plant proteins carry so-called Lewis A epitopes, terminally \u03b21,3-galactosylated and \u03b11,4-fucosylated structures (Fitchette-Laine et al., 1997; Strasser et al., 2007b). The abundance of this epitope differs strongly between species (Fitchette et al., 1999; Wilson et al., 2001) and organs (Strasser et al., 2007b), but seems low in Arabidopsis and Nicotiana (Fitchette et al., 1999; Strasser et al., 2007b, 2008; Matsuo and Matsumura, 2011). Noteworthy is also the absence of core \u03b11,6-fucosylation in plants, a glycan residue present on the vast majority of proteins produced in mammalian cells."}
{"meta": {"doc_id": 2441, "sent_id": 43, "sent_start_pos": 8321, "sent_end_pos": 9011, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The abundance of this epitope differs strongly between species (Fitchette et al., 1999; Wilson et al., 2001) and organs (Strasser et al., 2007b), but seems low in Arabidopsis and Nicotiana (Fitchette et al., 1999; Strasser et al., 2007b, 2008; Matsuo and Matsumura, 2011). Noteworthy is also the absence of core \u03b11,6-fucosylation in plants, a glycan residue present on the vast majority of proteins produced in mammalian cells. Removal of this residue from immunoglobulin G (IgG) glycans increases functional activities of antibodies due to a higher affinity to the antibody-dependent cell-mediated cytotoxicity (ADCC) inducing IgG receptor Fc\u03b3RIIIa (Shinkawa et al., 2003; Jefferis, 2009)."}
{"meta": {"doc_id": 2441, "sent_id": 44, "sent_start_pos": 8594, "sent_end_pos": 9158, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Noteworthy is also the absence of core \u03b11,6-fucosylation in plants, a glycan residue present on the vast majority of proteins produced in mammalian cells. Removal of this residue from immunoglobulin G (IgG) glycans increases functional activities of antibodies due to a higher affinity to the antibody-dependent cell-mediated cytotoxicity (ADCC) inducing IgG receptor Fc\u03b3RIIIa (Shinkawa et al., 2003; Jefferis, 2009). The limited glycosylation capacity of plants has turned out to be an advantage for the generation of proteins that need homogeneous glycosylation."}
{"meta": {"doc_id": 2441, "sent_id": 45, "sent_start_pos": 8749, "sent_end_pos": 9390, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Removal of this residue from immunoglobulin G (IgG) glycans increases functional activities of antibodies due to a higher affinity to the antibody-dependent cell-mediated cytotoxicity (ADCC) inducing IgG receptor Fc\u03b3RIIIa (Shinkawa et al., 2003; Jefferis, 2009). The limited glycosylation capacity of plants has turned out to be an advantage for the generation of proteins that need homogeneous glycosylation. For example, IgG antibodies produced in plants carry usually 1\u20132 different glycan structures (mainly GnGnXF) while the same antibodies produced in Chinese hamster ovary (CHO) cells bear 5\u20137 structures (Strasser et al., 2008, 2009)."}
{"meta": {"doc_id": 2441, "sent_id": 46, "sent_start_pos": 9012, "sent_end_pos": 9546, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The limited glycosylation capacity of plants has turned out to be an advantage for the generation of proteins that need homogeneous glycosylation. For example, IgG antibodies produced in plants carry usually 1\u20132 different glycan structures (mainly GnGnXF) while the same antibodies produced in Chinese hamster ovary (CHO) cells bear 5\u20137 structures (Strasser et al., 2008, 2009). For some applications, like testing of functional activities, and according to the demands from regulatory agencies, homogeneous glycosylation is required."}
{"meta": {"doc_id": 2441, "sent_id": 47, "sent_start_pos": 9159, "sent_end_pos": 9657, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "For example, IgG antibodies produced in plants carry usually 1\u20132 different glycan structures (mainly GnGnXF) while the same antibodies produced in Chinese hamster ovary (CHO) cells bear 5\u20137 structures (Strasser et al., 2008, 2009). For some applications, like testing of functional activities, and according to the demands from regulatory agencies, homogeneous glycosylation is required. Plants display a remarkable tolerance toward the manipulation of their intrinsic glycan biosynthetic pathways."}
{"meta": {"doc_id": 2441, "sent_id": 48, "sent_start_pos": 9391, "sent_end_pos": 9968, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "For some applications, like testing of functional activities, and according to the demands from regulatory agencies, homogeneous glycosylation is required. Plants display a remarkable tolerance toward the manipulation of their intrinsic glycan biosynthetic pathways. Elimination of complex glycans, knock-out of plant-specific xylosyl- and fucosyltransferases (XT and FT) or reduction/overproduction of the Lewis A epitope did not lead to any obvious phenotype in Arabidopsis thaliana under standard growth conditions (Von Schaewen et al., 1993; Strasser et al., 2004b, 2007b)."}
{"meta": {"doc_id": 2441, "sent_id": 49, "sent_start_pos": 9547, "sent_end_pos": 10224, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plants display a remarkable tolerance toward the manipulation of their intrinsic glycan biosynthetic pathways. Elimination of complex glycans, knock-out of plant-specific xylosyl- and fucosyltransferases (XT and FT) or reduction/overproduction of the Lewis A epitope did not lead to any obvious phenotype in Arabidopsis thaliana under standard growth conditions (Von Schaewen et al., 1993; Strasser et al., 2004b, 2007b). Also Lemna minor and N benthamiana, one of the major plant-based protein production platforms, tolerate a variety of glycoengineering steps without obvious phenotypes or impact on development (Cox et al., 2006; Strasser et al., 2008; Nagels et al., 2011)."}
{"meta": {"doc_id": 2441, "sent_id": 50, "sent_start_pos": 9658, "sent_end_pos": 10330, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Elimination of complex glycans, knock-out of plant-specific xylosyl- and fucosyltransferases (XT and FT) or reduction/overproduction of the Lewis A epitope did not lead to any obvious phenotype in Arabidopsis thaliana under standard growth conditions (Von Schaewen et al., 1993; Strasser et al., 2004b, 2007b). Also Lemna minor and N benthamiana, one of the major plant-based protein production platforms, tolerate a variety of glycoengineering steps without obvious phenotypes or impact on development (Cox et al., 2006; Strasser et al., 2008; Nagels et al., 2011). Only few cases of sensitive reactions to glycosylation changes have been described (Fanata et al., 2013)."}
{"meta": {"doc_id": 2441, "sent_id": 51, "sent_start_pos": 9969, "sent_end_pos": 10443, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Also Lemna minor and N benthamiana, one of the major plant-based protein production platforms, tolerate a variety of glycoengineering steps without obvious phenotypes or impact on development (Cox et al., 2006; Strasser et al., 2008; Nagels et al., 2011). Only few cases of sensitive reactions to glycosylation changes have been described (Fanata et al., 2013). This general tolerance for glycoengineering was a prerequisite for humanizing the plant N-glycosylation pathway."}
{"meta": {"doc_id": 2441, "sent_id": 52, "sent_start_pos": 10225, "sent_end_pos": 10666, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Only few cases of sensitive reactions to glycosylation changes have been described (Fanata et al., 2013). This general tolerance for glycoengineering was a prerequisite for humanizing the plant N-glycosylation pathway. A combination of knock-out/knock-down and knock-in approaches together with transient expression techniques has allowed the removal of potentially immunogenic residues, and the addition of new, human-type glyco-structures."}
{"meta": {"doc_id": 2441, "sent_id": 53, "sent_start_pos": 10331, "sent_end_pos": 10797, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "This general tolerance for glycoengineering was a prerequisite for humanizing the plant N-glycosylation pathway. A combination of knock-out/knock-down and knock-in approaches together with transient expression techniques has allowed the removal of potentially immunogenic residues, and the addition of new, human-type glyco-structures. Modular, semi-synthetic constructs assembled on multi-gene vectors enable the efficient manipulation of the glycosylation pathway."}
{"meta": {"doc_id": 2441, "sent_id": 54, "sent_start_pos": 10444, "sent_end_pos": 10852, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "A combination of knock-out/knock-down and knock-in approaches together with transient expression techniques has allowed the removal of potentially immunogenic residues, and the addition of new, human-type glyco-structures. Modular, semi-synthetic constructs assembled on multi-gene vectors enable the efficient manipulation of the glycosylation pathway. These glycoengineering strategies are addressed below."}
{"meta": {"doc_id": 2441, "sent_id": 55, "sent_start_pos": 10667, "sent_end_pos": 11103, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Modular, semi-synthetic constructs assembled on multi-gene vectors enable the efficient manipulation of the glycosylation pathway. These glycoengineering strategies are addressed below. Plant Glycoengineering\nEngineering of plant glycans toward human structures requires two main types of modification: (i) plant-specific reactions have to be eliminated and (ii) reactions taking place in humans but not in plants have to be introduced."}
{"meta": {"doc_id": 2441, "sent_id": 56, "sent_start_pos": 10798, "sent_end_pos": 11476, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "These glycoengineering strategies are addressed below. Plant Glycoengineering\nEngineering of plant glycans toward human structures requires two main types of modification: (i) plant-specific reactions have to be eliminated and (ii) reactions taking place in humans but not in plants have to be introduced. Reducing the unwanted plant-specific modifications, ie, \u03b21,2-xylosylation and core \u03b11,3-fucosylation, has initially been achieved by targeting the recombinant protein to the ER or co-overexpressing glycosylation enzymes competing for the same substrate (eg, Palacpac et al., 1999; Bakker et al., 2006; Frey et al., 2009; V\u00e9zina et al., 2009; Karg et al., 2010; see below)."}
{"meta": {"doc_id": 2441, "sent_id": 57, "sent_start_pos": 10853, "sent_end_pos": 11693, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Glycoengineering\nEngineering of plant glycans toward human structures requires two main types of modification: (i) plant-specific reactions have to be eliminated and (ii) reactions taking place in humans but not in plants have to be introduced. Reducing the unwanted plant-specific modifications, ie, \u03b21,2-xylosylation and core \u03b11,3-fucosylation, has initially been achieved by targeting the recombinant protein to the ER or co-overexpressing glycosylation enzymes competing for the same substrate (eg, Palacpac et al., 1999; Bakker et al., 2006; Frey et al., 2009; V\u00e9zina et al., 2009; Karg et al., 2010; see below). However, as these approaches interfere with the execution of endogenous glycosylation processes and cause the attachment of oligomannosidic or incompletely processed and aberrant glycans they are only of limited use."}
{"meta": {"doc_id": 2441, "sent_id": 58, "sent_start_pos": 11104, "sent_end_pos": 11982, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Reducing the unwanted plant-specific modifications, ie, \u03b21,2-xylosylation and core \u03b11,3-fucosylation, has initially been achieved by targeting the recombinant protein to the ER or co-overexpressing glycosylation enzymes competing for the same substrate (eg, Palacpac et al., 1999; Bakker et al., 2006; Frey et al., 2009; V\u00e9zina et al., 2009; Karg et al., 2010; see below). However, as these approaches interfere with the execution of endogenous glycosylation processes and cause the attachment of oligomannosidic or incompletely processed and aberrant glycans they are only of limited use. RNAi approaches targeting the transcript of the unwanted glycosyltransferases or complete knock-outs by T-DNA insertion have proven more successful (Koprivova et al., 2004; Strasser et al., 2004b, 2008; Cox et al., 2006; Sourrouille et al., 2008; Shin et al., 2011; Parsons et al., 2012)."}
{"meta": {"doc_id": 2441, "sent_id": 59, "sent_start_pos": 11477, "sent_end_pos": 12252, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "However, as these approaches interfere with the execution of endogenous glycosylation processes and cause the attachment of oligomannosidic or incompletely processed and aberrant glycans they are only of limited use. RNAi approaches targeting the transcript of the unwanted glycosyltransferases or complete knock-outs by T-DNA insertion have proven more successful (Koprivova et al., 2004; Strasser et al., 2004b, 2008; Cox et al., 2006; Sourrouille et al., 2008; Shin et al., 2011; Parsons et al., 2012). Importantly, such plants produce human-type GnGn glycans, which serve as an acceptor substrate for further mammalian modifications and were thus important milestones in the engineering of the plant N-glycosylation pathway toward the production of human-type structures."}
{"meta": {"doc_id": 2441, "sent_id": 60, "sent_start_pos": 11694, "sent_end_pos": 12522, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "RNAi approaches targeting the transcript of the unwanted glycosyltransferases or complete knock-outs by T-DNA insertion have proven more successful (Koprivova et al., 2004; Strasser et al., 2004b, 2008; Cox et al., 2006; Sourrouille et al., 2008; Shin et al., 2011; Parsons et al., 2012). Importantly, such plants produce human-type GnGn glycans, which serve as an acceptor substrate for further mammalian modifications and were thus important milestones in the engineering of the plant N-glycosylation pathway toward the production of human-type structures. Consequently, work over the past decade on the controlled expression of mammalian glycosyltransferases has established plant-based systems that synthesize a series of defined human-type glycan structures (Castilho et al., 2012; recently reviewed by Bosch et al., 2013)."}
{"meta": {"doc_id": 2441, "sent_id": 61, "sent_start_pos": 11983, "sent_end_pos": 12631, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Importantly, such plants produce human-type GnGn glycans, which serve as an acceptor substrate for further mammalian modifications and were thus important milestones in the engineering of the plant N-glycosylation pathway toward the production of human-type structures. Consequently, work over the past decade on the controlled expression of mammalian glycosyltransferases has established plant-based systems that synthesize a series of defined human-type glycan structures (Castilho et al., 2012; recently reviewed by Bosch et al., 2013). Recent studies demonstrate how even entire glycosylation-associated biosynthetic pathways can be introduced."}
{"meta": {"doc_id": 2441, "sent_id": 62, "sent_start_pos": 12253, "sent_end_pos": 12782, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Consequently, work over the past decade on the controlled expression of mammalian glycosyltransferases has established plant-based systems that synthesize a series of defined human-type glycan structures (Castilho et al., 2012; recently reviewed by Bosch et al., 2013). Recent studies demonstrate how even entire glycosylation-associated biosynthetic pathways can be introduced. Plants do not have the machinery to synthesize the sugar nucleotide precursor CMP-sialic acid (CMP-N-acetylneuraminic acid) necessary for sialylation."}
{"meta": {"doc_id": 2441, "sent_id": 63, "sent_start_pos": 12523, "sent_end_pos": 13119, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Recent studies demonstrate how even entire glycosylation-associated biosynthetic pathways can be introduced. Plants do not have the machinery to synthesize the sugar nucleotide precursor CMP-sialic acid (CMP-N-acetylneuraminic acid) necessary for sialylation. The simultaneous overexpression of six mammalian genes enabled the in planta generation of activated sialic acid, the transfer of the activated sugar nucleotide to the Golgi, the production of terminally galactosylated glycans and the transfer of sialic acid to these terminal galactoses (see Figures 1A\u2013D; Castilho et al., 2008, 2010)."}
{"meta": {"doc_id": 2441, "sent_id": 64, "sent_start_pos": 12632, "sent_end_pos": 13129, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plants do not have the machinery to synthesize the sugar nucleotide precursor CMP-sialic acid (CMP-N-acetylneuraminic acid) necessary for sialylation. The simultaneous overexpression of six mammalian genes enabled the in planta generation of activated sialic acid, the transfer of the activated sugar nucleotide to the Golgi, the production of terminally galactosylated glycans and the transfer of sialic acid to these terminal galactoses (see Figures 1A\u2013D; Castilho et al., 2008, 2010). FIGURE 1."}
{"meta": {"doc_id": 2441, "sent_id": 65, "sent_start_pos": 12783, "sent_end_pos": 13196, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The simultaneous overexpression of six mammalian genes enabled the in planta generation of activated sialic acid, the transfer of the activated sugar nucleotide to the Golgi, the production of terminally galactosylated glycans and the transfer of sialic acid to these terminal galactoses (see Figures 1A\u2013D; Castilho et al., 2008, 2010). FIGURE 1. N-glycoengineering in plants to produce tetra-sialylated proteins."}
{"meta": {"doc_id": 2441, "sent_id": 66, "sent_start_pos": 13120, "sent_end_pos": 13304, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "FIGURE 1. N-glycoengineering in plants to produce tetra-sialylated proteins. Schematic representation of an extensively glycoengineered plant-produced glycoprotein (erythropoietin; A)."}
{"meta": {"doc_id": 2441, "sent_id": 67, "sent_start_pos": 13130, "sent_end_pos": 13553, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "N-glycoengineering in plants to produce tetra-sialylated proteins. Schematic representation of an extensively glycoengineered plant-produced glycoprotein (erythropoietin; A). It represents the front of plant glycan engineering and illustrates, in short, the transformation of glycans present in Nicotiana benthamiana wild-type plants (GnGnXF) to finally obtain a glycosylation profile present on human serum EPO (NaNaNaNa)."}
{"meta": {"doc_id": 2441, "sent_id": 68, "sent_start_pos": 13197, "sent_end_pos": 13933, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Schematic representation of an extensively glycoengineered plant-produced glycoprotein (erythropoietin; A). It represents the front of plant glycan engineering and illustrates, in short, the transformation of glycans present in Nicotiana benthamiana wild-type plants (GnGnXF) to finally obtain a glycosylation profile present on human serum EPO (NaNaNaNa). For such intensive N-glycoengineering, a series of individual steps are necessary (B; 1): knock-out or knock-down of plant-specific \u03b21,2-XT and core \u03b11,3-FT, (2) introduction of GnTIV and GnTV responsible for branching, (3) introduction of \u03b21,4-GalT, (4) introduction of sialyltransferase in combination with the biosynthetic pathway to produce activated sialic acid (not shown)."}
{"meta": {"doc_id": 2441, "sent_id": 69, "sent_start_pos": 13305, "sent_end_pos": 14070, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "It represents the front of plant glycan engineering and illustrates, in short, the transformation of glycans present in Nicotiana benthamiana wild-type plants (GnGnXF) to finally obtain a glycosylation profile present on human serum EPO (NaNaNaNa). For such intensive N-glycoengineering, a series of individual steps are necessary (B; 1): knock-out or knock-down of plant-specific \u03b21,2-XT and core \u03b11,3-FT, (2) introduction of GnTIV and GnTV responsible for branching, (3) introduction of \u03b21,4-GalT, (4) introduction of sialyltransferase in combination with the biosynthetic pathway to produce activated sialic acid (not shown). Symbols for monosaccharides are given in (C), symbols depicting which monosaccharide atoms are involved in the linkage are given in (D)."}
{"meta": {"doc_id": 2441, "sent_id": 70, "sent_start_pos": 13554, "sent_end_pos": 14131, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "For such intensive N-glycoengineering, a series of individual steps are necessary (B; 1): knock-out or knock-down of plant-specific \u03b21,2-XT and core \u03b11,3-FT, (2) introduction of GnTIV and GnTV responsible for branching, (3) introduction of \u03b21,4-GalT, (4) introduction of sialyltransferase in combination with the biosynthetic pathway to produce activated sialic acid (not shown). Symbols for monosaccharides are given in (C), symbols depicting which monosaccharide atoms are involved in the linkage are given in (D). For detailed description see publications by Castilho et al."}
{"meta": {"doc_id": 2441, "sent_id": 71, "sent_start_pos": 13934, "sent_end_pos": 14157, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Symbols for monosaccharides are given in (C), symbols depicting which monosaccharide atoms are involved in the linkage are given in (D). For detailed description see publications by Castilho et al. (2010, 2011, 2012, 2013)."}
{"meta": {"doc_id": 2441, "sent_id": 72, "sent_start_pos": 14071, "sent_end_pos": 14568, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "For detailed description see publications by Castilho et al. (2010, 2011, 2012, 2013). A more detailed explanation of N-glycan nomenclature and graphical illustrations can be found at http://www.proglycan.com/upload/nomen_2007.pdf\nIn planta sialylation of glycans thereby highlights some of the reasons why simple overexpression of a mammalian glycosyltransferase in plants has not always proven successful in generating human-type glycans: acceptor as well as donor substrates need to be present."}
{"meta": {"doc_id": 2441, "sent_id": 73, "sent_start_pos": 14132, "sent_end_pos": 14597, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2010, 2011, 2012, 2013). A more detailed explanation of N-glycan nomenclature and graphical illustrations can be found at http://www.proglycan.com/upload/nomen_2007.pdf\nIn planta sialylation of glycans thereby highlights some of the reasons why simple overexpression of a mammalian glycosyltransferase in plants has not always proven successful in generating human-type glycans: acceptor as well as donor substrates need to be present. For example, when Wee et al."}
{"meta": {"doc_id": 2441, "sent_id": 74, "sent_start_pos": 14158, "sent_end_pos": 14782, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "A more detailed explanation of N-glycan nomenclature and graphical illustrations can be found at http://www.proglycan.com/upload/nomen_2007.pdf\nIn planta sialylation of glycans thereby highlights some of the reasons why simple overexpression of a mammalian glycosyltransferase in plants has not always proven successful in generating human-type glycans: acceptor as well as donor substrates need to be present. For example, when Wee et al. (1998) expressed the human \u03b12,6-sialyltransferase in Arabidopsis, activity of the enzyme could only be shown after applying donor and acceptor substrates in trans, as plants lack both."}
{"meta": {"doc_id": 2441, "sent_id": 75, "sent_start_pos": 14569, "sent_end_pos": 14818, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "For example, when Wee et al. (1998) expressed the human \u03b12,6-sialyltransferase in Arabidopsis, activity of the enzyme could only be shown after applying donor and acceptor substrates in trans, as plants lack both. The achievements by Palacpac et al."}
{"meta": {"doc_id": 2441, "sent_id": 76, "sent_start_pos": 14598, "sent_end_pos": 14840, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(1998) expressed the human \u03b12,6-sialyltransferase in Arabidopsis, activity of the enzyme could only be shown after applying donor and acceptor substrates in trans, as plants lack both. The achievements by Palacpac et al. (1999), Bakker et al."}
{"meta": {"doc_id": 2441, "sent_id": 77, "sent_start_pos": 14783, "sent_end_pos": 15092, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The achievements by Palacpac et al. (1999), Bakker et al. (2006) and others pointed out one more challenge, namely how delicate the glycosylation system is \u2013 coexpression of the human \u03b21,4-galactosyltransferase (\u03b21,4-GalT) had led to the production of galactosylated, but also of unusual, hybrid-type glycans."}
{"meta": {"doc_id": 2441, "sent_id": 78, "sent_start_pos": 14819, "sent_end_pos": 15293, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(1999), Bakker et al. (2006) and others pointed out one more challenge, namely how delicate the glycosylation system is \u2013 coexpression of the human \u03b21,4-galactosyltransferase (\u03b21,4-GalT) had led to the production of galactosylated, but also of unusual, hybrid-type glycans. The latter was due to activity of the galactosyltransferase at a suboptimal stage of the glycosylation pathway and interference with the endogenous glycosylation reactions (described in detail below)."}
{"meta": {"doc_id": 2441, "sent_id": 79, "sent_start_pos": 14841, "sent_end_pos": 15508, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2006) and others pointed out one more challenge, namely how delicate the glycosylation system is \u2013 coexpression of the human \u03b21,4-galactosyltransferase (\u03b21,4-GalT) had led to the production of galactosylated, but also of unusual, hybrid-type glycans. The latter was due to activity of the galactosyltransferase at a suboptimal stage of the glycosylation pathway and interference with the endogenous glycosylation reactions (described in detail below). Similar findings were reported upon overexpression of N-acetylglucosaminyltransferase (GnT) III (Rouwendal et al., 2007; Frey et al., 2009; Karg et al., 2010; Castilho et al., 2011; detailed description see below)."}
{"meta": {"doc_id": 2441, "sent_id": 80, "sent_start_pos": 15093, "sent_end_pos": 15862, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The latter was due to activity of the galactosyltransferase at a suboptimal stage of the glycosylation pathway and interference with the endogenous glycosylation reactions (described in detail below). Similar findings were reported upon overexpression of N-acetylglucosaminyltransferase (GnT) III (Rouwendal et al., 2007; Frey et al., 2009; Karg et al., 2010; Castilho et al., 2011; detailed description see below). These examples show that the final glycosylation profile of a co-expression approach depends on various factors, including the availability of (i) acceptor glycan and (ii) donor substrate as well as (iii) the correct subcellular targeting of the recombinant glycosyltransferase in order to avoid interference with the endogenous glycosylation machinery."}
{"meta": {"doc_id": 2441, "sent_id": 81, "sent_start_pos": 15294, "sent_end_pos": 16075, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Similar findings were reported upon overexpression of N-acetylglucosaminyltransferase (GnT) III (Rouwendal et al., 2007; Frey et al., 2009; Karg et al., 2010; Castilho et al., 2011; detailed description see below). These examples show that the final glycosylation profile of a co-expression approach depends on various factors, including the availability of (i) acceptor glycan and (ii) donor substrate as well as (iii) the correct subcellular targeting of the recombinant glycosyltransferase in order to avoid interference with the endogenous glycosylation machinery. Targeting Mechanism of Glycosyltransferases\nThe glycosylation reactions within the Golgi are carried out in a sequential, stepwise manner, and one reaction can be the prerequisite for another one \u2013 or inhibit it."}
{"meta": {"doc_id": 2441, "sent_id": 82, "sent_start_pos": 15509, "sent_end_pos": 16236, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "These examples show that the final glycosylation profile of a co-expression approach depends on various factors, including the availability of (i) acceptor glycan and (ii) donor substrate as well as (iii) the correct subcellular targeting of the recombinant glycosyltransferase in order to avoid interference with the endogenous glycosylation machinery. Targeting Mechanism of Glycosyltransferases\nThe glycosylation reactions within the Golgi are carried out in a sequential, stepwise manner, and one reaction can be the prerequisite for another one \u2013 or inhibit it. Therefore, the ordered sequential arrangement of enzymatic activities, ie, the correct subcellular localization of the involved enzymes is of utmost importance."}
{"meta": {"doc_id": 2441, "sent_id": 83, "sent_start_pos": 15863, "sent_end_pos": 16404, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Targeting Mechanism of Glycosyltransferases\nThe glycosylation reactions within the Golgi are carried out in a sequential, stepwise manner, and one reaction can be the prerequisite for another one \u2013 or inhibit it. Therefore, the ordered sequential arrangement of enzymatic activities, ie, the correct subcellular localization of the involved enzymes is of utmost importance. This tight regulation has consequences for the expression and targeting of heterologous glycosylation enzymes, as they need to fit precisely into the existing pathway."}
{"meta": {"doc_id": 2441, "sent_id": 84, "sent_start_pos": 16076, "sent_end_pos": 16559, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Therefore, the ordered sequential arrangement of enzymatic activities, ie, the correct subcellular localization of the involved enzymes is of utmost importance. This tight regulation has consequences for the expression and targeting of heterologous glycosylation enzymes, as they need to fit precisely into the existing pathway. Fine-tuning the subcellular localization of heterologously expressed glycosylation enzymes requires vast knowledge of the underlying targeting mechanisms."}
{"meta": {"doc_id": 2441, "sent_id": 85, "sent_start_pos": 16237, "sent_end_pos": 16691, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "This tight regulation has consequences for the expression and targeting of heterologous glycosylation enzymes, as they need to fit precisely into the existing pathway. Fine-tuning the subcellular localization of heterologously expressed glycosylation enzymes requires vast knowledge of the underlying targeting mechanisms. All known Golgi-resident N-glycosyltransferases are type II transmembrane proteins (reviewed by, eg, Schoberer and Strasser, 2011)."}
{"meta": {"doc_id": 2441, "sent_id": 86, "sent_start_pos": 16405, "sent_end_pos": 16822, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Fine-tuning the subcellular localization of heterologously expressed glycosylation enzymes requires vast knowledge of the underlying targeting mechanisms. All known Golgi-resident N-glycosyltransferases are type II transmembrane proteins (reviewed by, eg, Schoberer and Strasser, 2011). Their N-terminus is exposed to the cytoplasm, followed by a transmembrane domain, a stem, and the catalytic domain (see Figure 2)."}
{"meta": {"doc_id": 2441, "sent_id": 87, "sent_start_pos": 16560, "sent_end_pos": 17024, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "All known Golgi-resident N-glycosyltransferases are type II transmembrane proteins (reviewed by, eg, Schoberer and Strasser, 2011). Their N-terminus is exposed to the cytoplasm, followed by a transmembrane domain, a stem, and the catalytic domain (see Figure 2). The cytoplasmic part, transmembrane domain, and stem are referred to as CTS region and are responsible for targeting the enzyme to the correct compartment (Essl et al., 1999), and even sub-compartment."}
{"meta": {"doc_id": 2441, "sent_id": 88, "sent_start_pos": 16692, "sent_end_pos": 17196, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Their N-terminus is exposed to the cytoplasm, followed by a transmembrane domain, a stem, and the catalytic domain (see Figure 2). The cytoplasmic part, transmembrane domain, and stem are referred to as CTS region and are responsible for targeting the enzyme to the correct compartment (Essl et al., 1999), and even sub-compartment. This was shown by different Golgi-localized glycosyltransferases not present within the same sub-compartment (Saint-Jore-Dupas et al., 2006; Schoberer et al., 2009, 2010)."}
{"meta": {"doc_id": 2441, "sent_id": 89, "sent_start_pos": 16823, "sent_end_pos": 17206, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The cytoplasmic part, transmembrane domain, and stem are referred to as CTS region and are responsible for targeting the enzyme to the correct compartment (Essl et al., 1999), and even sub-compartment. This was shown by different Golgi-localized glycosyltransferases not present within the same sub-compartment (Saint-Jore-Dupas et al., 2006; Schoberer et al., 2009, 2010). FIGURE 2."}
{"meta": {"doc_id": 2441, "sent_id": 90, "sent_start_pos": 17025, "sent_end_pos": 17243, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "This was shown by different Golgi-localized glycosyltransferases not present within the same sub-compartment (Saint-Jore-Dupas et al., 2006; Schoberer et al., 2009, 2010). FIGURE 2. Structure of N-glycosyltransferases."}
{"meta": {"doc_id": 2441, "sent_id": 91, "sent_start_pos": 17197, "sent_end_pos": 17314, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "FIGURE 2. Structure of N-glycosyltransferases. Golgi-located glycosyltransferases are type II transmembrane proteins."}
{"meta": {"doc_id": 2441, "sent_id": 92, "sent_start_pos": 17207, "sent_end_pos": 17459, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Structure of N-glycosyltransferases. Golgi-located glycosyltransferases are type II transmembrane proteins. Their localization within the Golgi depends on the N-terminal CTS region, consisting of the cytosolic tail, the transmembrane domain and a stem."}
{"meta": {"doc_id": 2441, "sent_id": 93, "sent_start_pos": 17244, "sent_end_pos": 17523, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Golgi-located glycosyltransferases are type II transmembrane proteins. Their localization within the Golgi depends on the N-terminal CTS region, consisting of the cytosolic tail, the transmembrane domain and a stem. The C-terminal catalytic domain is directed to the Golgi lumen."}
{"meta": {"doc_id": 2441, "sent_id": 94, "sent_start_pos": 17315, "sent_end_pos": 17713, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Their localization within the Golgi depends on the N-terminal CTS region, consisting of the cytosolic tail, the transmembrane domain and a stem. The C-terminal catalytic domain is directed to the Golgi lumen. Research activities to elucidate the targeting mechanism(s) of type II transmembrane proteins revealed a basic conservation of processes between plants and mammals (Schoberer et al., 2010)."}
{"meta": {"doc_id": 2441, "sent_id": 95, "sent_start_pos": 17460, "sent_end_pos": 17855, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The C-terminal catalytic domain is directed to the Golgi lumen. Research activities to elucidate the targeting mechanism(s) of type II transmembrane proteins revealed a basic conservation of processes between plants and mammals (Schoberer et al., 2010). However, the question on how the fine-tuning of targeting works has not been answered definitively, but several factors have been identified."}
{"meta": {"doc_id": 2441, "sent_id": 96, "sent_start_pos": 17524, "sent_end_pos": 18025, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Research activities to elucidate the targeting mechanism(s) of type II transmembrane proteins revealed a basic conservation of processes between plants and mammals (Schoberer et al., 2010). However, the question on how the fine-tuning of targeting works has not been answered definitively, but several factors have been identified. For example, the cytoplasmic tail influences ER export of the enzyme (Schoberer et al., 2009) and can change the final destination of a protein (Jiang and Rogers, 1998)."}
{"meta": {"doc_id": 2441, "sent_id": 97, "sent_start_pos": 17714, "sent_end_pos": 18159, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "However, the question on how the fine-tuning of targeting works has not been answered definitively, but several factors have been identified. For example, the cytoplasmic tail influences ER export of the enzyme (Schoberer et al., 2009) and can change the final destination of a protein (Jiang and Rogers, 1998). In mammalian cells it has been shown to relocate the catalytic domain from one to another Golgi subcompartment (Uliana et al., 2006)."}
{"meta": {"doc_id": 2441, "sent_id": 98, "sent_start_pos": 17856, "sent_end_pos": 18291, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "For example, the cytoplasmic tail influences ER export of the enzyme (Schoberer et al., 2009) and can change the final destination of a protein (Jiang and Rogers, 1998). In mammalian cells it has been shown to relocate the catalytic domain from one to another Golgi subcompartment (Uliana et al., 2006). This might be due to formation of homo- or heterodimers of the enzymes or interaction with other proteins (Schoberer et al., 2013)."}
{"meta": {"doc_id": 2441, "sent_id": 99, "sent_start_pos": 18026, "sent_end_pos": 18449, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "In mammalian cells it has been shown to relocate the catalytic domain from one to another Golgi subcompartment (Uliana et al., 2006). This might be due to formation of homo- or heterodimers of the enzymes or interaction with other proteins (Schoberer et al., 2013). Also the length of the transmembrane domain might influence targeting (Pagny et al., 2003), as the membrane thickness of the Golgi changes from cis to trans."}
{"meta": {"doc_id": 2441, "sent_id": 100, "sent_start_pos": 18160, "sent_end_pos": 18593, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "This might be due to formation of homo- or heterodimers of the enzymes or interaction with other proteins (Schoberer et al., 2013). Also the length of the transmembrane domain might influence targeting (Pagny et al., 2003), as the membrane thickness of the Golgi changes from cis to trans. Finally, the composition of the lipid bilayer surrounding the enzyme might influence targeting, too (reviewed by Schoberer and Strasser, 2011)."}
{"meta": {"doc_id": 2441, "sent_id": 101, "sent_start_pos": 18292, "sent_end_pos": 18692, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Also the length of the transmembrane domain might influence targeting (Pagny et al., 2003), as the membrane thickness of the Golgi changes from cis to trans. Finally, the composition of the lipid bilayer surrounding the enzyme might influence targeting, too (reviewed by Schoberer and Strasser, 2011). This makes the CTS regions of glycosyltransferases key regulators for precise sub-Golgi targeting."}
{"meta": {"doc_id": 2441, "sent_id": 102, "sent_start_pos": 18450, "sent_end_pos": 18790, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Finally, the composition of the lipid bilayer surrounding the enzyme might influence targeting, too (reviewed by Schoberer and Strasser, 2011). This makes the CTS regions of glycosyltransferases key regulators for precise sub-Golgi targeting. Theoretically, CTS domains from any eukaryotic organism may serve as a suitable targeting domain."}
{"meta": {"doc_id": 2441, "sent_id": 103, "sent_start_pos": 18594, "sent_end_pos": 18957, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "This makes the CTS regions of glycosyltransferases key regulators for precise sub-Golgi targeting. Theoretically, CTS domains from any eukaryotic organism may serve as a suitable targeting domain. Recent genome sequencing projects provided an abundance of such sequences that may be used for targeted sub-Golgi localization (Ohtsubo and Marth, 2006; Varki, 2006)."}
{"meta": {"doc_id": 2441, "sent_id": 104, "sent_start_pos": 18693, "sent_end_pos": 19236, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Theoretically, CTS domains from any eukaryotic organism may serve as a suitable targeting domain. Recent genome sequencing projects provided an abundance of such sequences that may be used for targeted sub-Golgi localization (Ohtsubo and Marth, 2006; Varki, 2006). Nevertheless, as the molecular mechanisms that lie behind this fine-tuning of targeting are not fully understood, it is not entirely predictable how CTS sequences actually perform when fused to the catalytic domain of another glycosyltransferase and expressed in a foreign cell."}
{"meta": {"doc_id": 2441, "sent_id": 105, "sent_start_pos": 18791, "sent_end_pos": 19276, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Recent genome sequencing projects provided an abundance of such sequences that may be used for targeted sub-Golgi localization (Ohtsubo and Marth, 2006; Varki, 2006). Nevertheless, as the molecular mechanisms that lie behind this fine-tuning of targeting are not fully understood, it is not entirely predictable how CTS sequences actually perform when fused to the catalytic domain of another glycosyltransferase and expressed in a foreign cell. Thus, experimental testing is required."}
{"meta": {"doc_id": 2441, "sent_id": 106, "sent_start_pos": 18958, "sent_end_pos": 19571, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Nevertheless, as the molecular mechanisms that lie behind this fine-tuning of targeting are not fully understood, it is not entirely predictable how CTS sequences actually perform when fused to the catalytic domain of another glycosyltransferase and expressed in a foreign cell. Thus, experimental testing is required. Also the prediction of the exact size of the individual glycosyltransferase-domains (cytosolic tail, transmembrane domain, stem, catalytic domain) is difficult and even though bioinformatics prediction technology has improved in recent years, different algorithms can lead to different results."}
{"meta": {"doc_id": 2441, "sent_id": 107, "sent_start_pos": 19237, "sent_end_pos": 19676, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Thus, experimental testing is required. Also the prediction of the exact size of the individual glycosyltransferase-domains (cytosolic tail, transmembrane domain, stem, catalytic domain) is difficult and even though bioinformatics prediction technology has improved in recent years, different algorithms can lead to different results. Therefore, the reliability of the identification of the separate domains should be considered carefully."}
{"meta": {"doc_id": 2441, "sent_id": 108, "sent_start_pos": 19277, "sent_end_pos": 19851, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Also the prediction of the exact size of the individual glycosyltransferase-domains (cytosolic tail, transmembrane domain, stem, catalytic domain) is difficult and even though bioinformatics prediction technology has improved in recent years, different algorithms can lead to different results. Therefore, the reliability of the identification of the separate domains should be considered carefully. Chimeric Glycosyltransferases Used for in Planta Glycoengineering\nFirst steps to shift the plant N-glycosylation pattern from plant-specific N-glycans (ie, GnGnXF, MMXF, etc."}
{"meta": {"doc_id": 2441, "sent_id": 109, "sent_start_pos": 19572, "sent_end_pos": 19972, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Therefore, the reliability of the identification of the separate domains should be considered carefully. Chimeric Glycosyltransferases Used for in Planta Glycoengineering\nFirst steps to shift the plant N-glycosylation pattern from plant-specific N-glycans (ie, GnGnXF, MMXF, etc. ; see Figure 3A) toward the production of human-like structures were based on full-length mammalian glycosyltransferases."}
{"meta": {"doc_id": 2441, "sent_id": 110, "sent_start_pos": 19677, "sent_end_pos": 20186, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Chimeric Glycosyltransferases Used for in Planta Glycoengineering\nFirst steps to shift the plant N-glycosylation pattern from plant-specific N-glycans (ie, GnGnXF, MMXF, etc. ; see Figure 3A) toward the production of human-like structures were based on full-length mammalian glycosyltransferases. Expressing a human \u03b21,4-GalT in tobacco plants (Bakker et al., 2001) and tobacco BY2 cells (Palacpac et al., 1999) in fact resulted in galactosylated glycans, however, other oligosaccharides were produced as well."}
{"meta": {"doc_id": 2441, "sent_id": 111, "sent_start_pos": 19851, "sent_end_pos": 20526, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "; see Figure 3A) toward the production of human-like structures were based on full-length mammalian glycosyltransferases. Expressing a human \u03b21,4-GalT in tobacco plants (Bakker et al., 2001) and tobacco BY2 cells (Palacpac et al., 1999) in fact resulted in galactosylated glycans, however, other oligosaccharides were produced as well. In BY2 cells, unusual and incompletely processed glycans lacking xylose and fucose (eg, Man5A) were abundant (see Figure 3B), indicating interference of the heterologously expressed GalT with endogenous glycan processing enzymes like mannosidase II, GnTII and plant-specific \u03b21,2-xylosyltransferase and \u03b11,3-fucosyltransferase (XT and FT)."}
{"meta": {"doc_id": 2441, "sent_id": 112, "sent_start_pos": 19973, "sent_end_pos": 20720, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Expressing a human \u03b21,4-GalT in tobacco plants (Bakker et al., 2001) and tobacco BY2 cells (Palacpac et al., 1999) in fact resulted in galactosylated glycans, however, other oligosaccharides were produced as well. In BY2 cells, unusual and incompletely processed glycans lacking xylose and fucose (eg, Man5A) were abundant (see Figure 3B), indicating interference of the heterologously expressed GalT with endogenous glycan processing enzymes like mannosidase II, GnTII and plant-specific \u03b21,2-xylosyltransferase and \u03b11,3-fucosyltransferase (XT and FT). In tobacco plants, xylosylated, and fucosylated GnGnXF remained the main oligosaccharide (see Figure 3B) and only minor amounts of galactosylated oligosaccharides like AAXF or GnAXF were found."}
{"meta": {"doc_id": 2441, "sent_id": 113, "sent_start_pos": 20187, "sent_end_pos": 20852, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "In BY2 cells, unusual and incompletely processed glycans lacking xylose and fucose (eg, Man5A) were abundant (see Figure 3B), indicating interference of the heterologously expressed GalT with endogenous glycan processing enzymes like mannosidase II, GnTII and plant-specific \u03b21,2-xylosyltransferase and \u03b11,3-fucosyltransferase (XT and FT). In tobacco plants, xylosylated, and fucosylated GnGnXF remained the main oligosaccharide (see Figure 3B) and only minor amounts of galactosylated oligosaccharides like AAXF or GnAXF were found. This points to activity of the GalT at a later stage in tobacco plants, after completion of the endogenous glycosylation reactions."}
{"meta": {"doc_id": 2441, "sent_id": 114, "sent_start_pos": 20527, "sent_end_pos": 21099, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "In tobacco plants, xylosylated, and fucosylated GnGnXF remained the main oligosaccharide (see Figure 3B) and only minor amounts of galactosylated oligosaccharides like AAXF or GnAXF were found. This points to activity of the GalT at a later stage in tobacco plants, after completion of the endogenous glycosylation reactions. At this later stage, interference with the endogenous glycosylation reactions did not take place and therefore the amount of \u03b21,2-xylose and \u03b11,3-fucose \u2013 residues unwanted on proteins needed for human applications \u2013 remained basically unchanged."}
{"meta": {"doc_id": 2441, "sent_id": 115, "sent_start_pos": 20721, "sent_end_pos": 21426, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "This points to activity of the GalT at a later stage in tobacco plants, after completion of the endogenous glycosylation reactions. At this later stage, interference with the endogenous glycosylation reactions did not take place and therefore the amount of \u03b21,2-xylose and \u03b11,3-fucose \u2013 residues unwanted on proteins needed for human applications \u2013 remained basically unchanged. In order to transfer the down-regulation effect observed in BY2 cells to tobacco plants and reduce/eliminate the two plant-specific glycan residues (\u03b21,2-xylose and \u03b11,3-fucose), a chimeric version of the human GalT was constructed that contained the CTS region of the A thaliana \u03b21,2-xylosyltransferase (Bakker et al., 2006)."}
{"meta": {"doc_id": 2441, "sent_id": 116, "sent_start_pos": 20853, "sent_end_pos": 21627, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "At this later stage, interference with the endogenous glycosylation reactions did not take place and therefore the amount of \u03b21,2-xylose and \u03b11,3-fucose \u2013 residues unwanted on proteins needed for human applications \u2013 remained basically unchanged. In order to transfer the down-regulation effect observed in BY2 cells to tobacco plants and reduce/eliminate the two plant-specific glycan residues (\u03b21,2-xylose and \u03b11,3-fucose), a chimeric version of the human GalT was constructed that contained the CTS region of the A thaliana \u03b21,2-xylosyltransferase (Bakker et al., 2006). The intention was to generate a chimeric enzyme that acts in the medial Golgi, simultaneously or prior to the endogenously present \u03b21,2-xylosyltransferase and core \u03b11,3-fucosyltransferase (XT and FT)."}
{"meta": {"doc_id": 2441, "sent_id": 117, "sent_start_pos": 21100, "sent_end_pos": 21845, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "In order to transfer the down-regulation effect observed in BY2 cells to tobacco plants and reduce/eliminate the two plant-specific glycan residues (\u03b21,2-xylose and \u03b11,3-fucose), a chimeric version of the human GalT was constructed that contained the CTS region of the A thaliana \u03b21,2-xylosyltransferase (Bakker et al., 2006). The intention was to generate a chimeric enzyme that acts in the medial Golgi, simultaneously or prior to the endogenously present \u03b21,2-xylosyltransferase and core \u03b11,3-fucosyltransferase (XT and FT). As \u03b21,4-galactosylated proteins are no longer substrates for XT and FT (Staudacher et al., 1995; Kajiura et al., 2012), the expression in tobacco plants led to the intended, drastic decrease in plant-specific glycans."}
{"meta": {"doc_id": 2441, "sent_id": 118, "sent_start_pos": 21427, "sent_end_pos": 22099, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The intention was to generate a chimeric enzyme that acts in the medial Golgi, simultaneously or prior to the endogenously present \u03b21,2-xylosyltransferase and core \u03b11,3-fucosyltransferase (XT and FT). As \u03b21,4-galactosylated proteins are no longer substrates for XT and FT (Staudacher et al., 1995; Kajiura et al., 2012), the expression in tobacco plants led to the intended, drastic decrease in plant-specific glycans. However, the early activity of the \u03b21,4-GalT also led to the inhibition of other enzymes \u2013 like mannosidase II and GnTII \u2013 and thus to the generation of substantial amounts of unusual, incompletely processed glycans (oligomannosidic glycans, Man5A, etc."}
{"meta": {"doc_id": 2441, "sent_id": 119, "sent_start_pos": 21628, "sent_end_pos": 22116, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "As \u03b21,4-galactosylated proteins are no longer substrates for XT and FT (Staudacher et al., 1995; Kajiura et al., 2012), the expression in tobacco plants led to the intended, drastic decrease in plant-specific glycans. However, the early activity of the \u03b21,4-GalT also led to the inhibition of other enzymes \u2013 like mannosidase II and GnTII \u2013 and thus to the generation of substantial amounts of unusual, incompletely processed glycans (oligomannosidic glycans, Man5A, etc. ; see Figure 3C)."}
{"meta": {"doc_id": 2441, "sent_id": 120, "sent_start_pos": 21846, "sent_end_pos": 22255, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "However, the early activity of the \u03b21,4-GalT also led to the inhibition of other enzymes \u2013 like mannosidase II and GnTII \u2013 and thus to the generation of substantial amounts of unusual, incompletely processed glycans (oligomannosidic glycans, Man5A, etc. ; see Figure 3C). Altogether, the glycan profile was similar to the profile of BY2 cells expressing the full-length human \u03b21,4-GalT (Palacpac et al., 1999)."}
{"meta": {"doc_id": 2441, "sent_id": 121, "sent_start_pos": 22099, "sent_end_pos": 22427, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "; see Figure 3C). Altogether, the glycan profile was similar to the profile of BY2 cells expressing the full-length human \u03b21,4-GalT (Palacpac et al., 1999). This indicates that the chimeric construct in tobacco plants and the full-length, human GalT in BY2 cells show activity at a comparable stage of the glycosylation pathway."}
{"meta": {"doc_id": 2441, "sent_id": 122, "sent_start_pos": 22117, "sent_end_pos": 22437, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Altogether, the glycan profile was similar to the profile of BY2 cells expressing the full-length human \u03b21,4-GalT (Palacpac et al., 1999). This indicates that the chimeric construct in tobacco plants and the full-length, human GalT in BY2 cells show activity at a comparable stage of the glycosylation pathway. FIGURE 3."}
{"meta": {"doc_id": 2441, "sent_id": 123, "sent_start_pos": 22256, "sent_end_pos": 22502, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "This indicates that the chimeric construct in tobacco plants and the full-length, human GalT in BY2 cells show activity at a comparable stage of the glycosylation pathway. FIGURE 3. Expression of \u03b21,4-GalT and chimeric versions thereof in plants."}
{"meta": {"doc_id": 2441, "sent_id": 124, "sent_start_pos": 22428, "sent_end_pos": 22674, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "FIGURE 3. Expression of \u03b21,4-GalT and chimeric versions thereof in plants. Schematic presentation of various \u03b21,4-GalT constructs expressed in plants and the consequences on the glycosylation profile of total and recombinantly expressed proteins."}
{"meta": {"doc_id": 2441, "sent_id": 125, "sent_start_pos": 22438, "sent_end_pos": 22779, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Expression of \u03b21,4-GalT and chimeric versions thereof in plants. Schematic presentation of various \u03b21,4-GalT constructs expressed in plants and the consequences on the glycosylation profile of total and recombinantly expressed proteins. In the top panel \u03b21,4-GalT catalytic domain and various CTS regions are illustrated in different colors."}
{"meta": {"doc_id": 2441, "sent_id": 126, "sent_start_pos": 22503, "sent_end_pos": 22858, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Schematic presentation of various \u03b21,4-GalT constructs expressed in plants and the consequences on the glycosylation profile of total and recombinantly expressed proteins. In the top panel \u03b21,4-GalT catalytic domain and various CTS regions are illustrated in different colors. The color code is used to better visualize various chimeric fusion constructs."}
{"meta": {"doc_id": 2441, "sent_id": 127, "sent_start_pos": 22675, "sent_end_pos": 22964, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "In the top panel \u03b21,4-GalT catalytic domain and various CTS regions are illustrated in different colors. The color code is used to better visualize various chimeric fusion constructs. The bottom panel shows a Golgi stack and the hypothetical localization of different \u03b21,4-GalT constructs."}
{"meta": {"doc_id": 2441, "sent_id": 128, "sent_start_pos": 22780, "sent_end_pos": 23024, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The color code is used to better visualize various chimeric fusion constructs. The bottom panel shows a Golgi stack and the hypothetical localization of different \u03b21,4-GalT constructs. Green arrows indicate cargo flow from ER through the Golgi."}
{"meta": {"doc_id": 2441, "sent_id": 129, "sent_start_pos": 22859, "sent_end_pos": 23095, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The bottom panel shows a Golgi stack and the hypothetical localization of different \u03b21,4-GalT constructs. Green arrows indicate cargo flow from ER through the Golgi. Major glycan structures produced under the given conditions are shown."}
{"meta": {"doc_id": 2441, "sent_id": 130, "sent_start_pos": 22965, "sent_end_pos": 23256, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Green arrows indicate cargo flow from ER through the Golgi. Major glycan structures produced under the given conditions are shown. (A) Major glycoforms detected in wild-type plants (without the expression of \u03b21,4-GalT) are complex N-glycans carrying xylose and fucose (ie, GnGnXF, MMXF, etc."}
{"meta": {"doc_id": 2441, "sent_id": 131, "sent_start_pos": 23025, "sent_end_pos": 23283, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Major glycan structures produced under the given conditions are shown. (A) Major glycoforms detected in wild-type plants (without the expression of \u03b21,4-GalT) are complex N-glycans carrying xylose and fucose (ie, GnGnXF, MMXF, etc. ; eg, Bakker et al., 2001)."}
{"meta": {"doc_id": 2441, "sent_id": 132, "sent_start_pos": 23096, "sent_end_pos": 23441, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(A) Major glycoforms detected in wild-type plants (without the expression of \u03b21,4-GalT) are complex N-glycans carrying xylose and fucose (ie, GnGnXF, MMXF, etc. ; eg, Bakker et al., 2001). (B) Expression of full-length human \u03b21,4-GalT in BY2 tobacco cells (Palacpac et al., 1999) and tobacco plants (Bakker et al., 2001) led to different results."}
{"meta": {"doc_id": 2441, "sent_id": 133, "sent_start_pos": 23256, "sent_end_pos": 23582, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "; eg, Bakker et al., 2001). (B) Expression of full-length human \u03b21,4-GalT in BY2 tobacco cells (Palacpac et al., 1999) and tobacco plants (Bakker et al., 2001) led to different results. In BY2 cells, mainly galactosylated, hybrid-type glycans (like Man5A) as well as oligomannosidic glycans were found (Palacpac et al., 1999)."}
{"meta": {"doc_id": 2441, "sent_id": 134, "sent_start_pos": 23284, "sent_end_pos": 23719, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(B) Expression of full-length human \u03b21,4-GalT in BY2 tobacco cells (Palacpac et al., 1999) and tobacco plants (Bakker et al., 2001) led to different results. In BY2 cells, mainly galactosylated, hybrid-type glycans (like Man5A) as well as oligomannosidic glycans were found (Palacpac et al., 1999). In tobacco plants (Bakker et al., 2001) GnGnXF remained the major glycoform and only small amounts of galactosylated glycans were found."}
{"meta": {"doc_id": 2441, "sent_id": 135, "sent_start_pos": 23442, "sent_end_pos": 23942, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "In BY2 cells, mainly galactosylated, hybrid-type glycans (like Man5A) as well as oligomannosidic glycans were found (Palacpac et al., 1999). In tobacco plants (Bakker et al., 2001) GnGnXF remained the major glycoform and only small amounts of galactosylated glycans were found. These results indicate that \u03b21,4-GalT acted in BY2 cells at an earlier stage of the glycosylation pathway than in tobacco plants, leading to interference with endogenous glycosylation reactions in cells, but not in plants."}
{"meta": {"doc_id": 2441, "sent_id": 136, "sent_start_pos": 23583, "sent_end_pos": 24195, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "In tobacco plants (Bakker et al., 2001) GnGnXF remained the major glycoform and only small amounts of galactosylated glycans were found. These results indicate that \u03b21,4-GalT acted in BY2 cells at an earlier stage of the glycosylation pathway than in tobacco plants, leading to interference with endogenous glycosylation reactions in cells, but not in plants. (C) Major glycoforms detected upon expression of a chimeric GalT, that carries the CTS region of A thaliana \u03b21,2-xylosyltransferase (indicated in pale green) and targets the enzyme to a medial stage of the glycan processing pathway: Man5, ManGn, Man5A."}
{"meta": {"doc_id": 2441, "sent_id": 137, "sent_start_pos": 23720, "sent_end_pos": 24299, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "These results indicate that \u03b21,4-GalT acted in BY2 cells at an earlier stage of the glycosylation pathway than in tobacco plants, leading to interference with endogenous glycosylation reactions in cells, but not in plants. (C) Major glycoforms detected upon expression of a chimeric GalT, that carries the CTS region of A thaliana \u03b21,2-xylosyltransferase (indicated in pale green) and targets the enzyme to a medial stage of the glycan processing pathway: Man5, ManGn, Man5A. A drastically reduced amount of xylosylated and fucosylated glycans was detected (Bakker et al., 2006)."}
{"meta": {"doc_id": 2441, "sent_id": 138, "sent_start_pos": 23943, "sent_end_pos": 24403, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(C) Major glycoforms detected upon expression of a chimeric GalT, that carries the CTS region of A thaliana \u03b21,2-xylosyltransferase (indicated in pale green) and targets the enzyme to a medial stage of the glycan processing pathway: Man5, ManGn, Man5A. A drastically reduced amount of xylosylated and fucosylated glycans was detected (Bakker et al., 2006). The results point to an early activity of the chimeric \u03b21,4-GalT, most probably in medial Golgi stacks."}
{"meta": {"doc_id": 2441, "sent_id": 139, "sent_start_pos": 24196, "sent_end_pos": 24626, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "A drastically reduced amount of xylosylated and fucosylated glycans was detected (Bakker et al., 2006). The results point to an early activity of the chimeric \u03b21,4-GalT, most probably in medial Golgi stacks. (D) Targeting the GalT to an even earlier compartment by fusing it to the CTS of the cis-Golgi acting GnTI (indicated in yellow; V\u00e9zina et al., 2009) induced the production of nearly exclusively oligomannosidic structures."}
{"meta": {"doc_id": 2441, "sent_id": 140, "sent_start_pos": 24300, "sent_end_pos": 24692, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The results point to an early activity of the chimeric \u03b21,4-GalT, most probably in medial Golgi stacks. (D) Targeting the GalT to an even earlier compartment by fusing it to the CTS of the cis-Golgi acting GnTI (indicated in yellow; V\u00e9zina et al., 2009) induced the production of nearly exclusively oligomannosidic structures. Only minute amounts of galactosylated, hybrid Man5A were present."}
{"meta": {"doc_id": 2441, "sent_id": 141, "sent_start_pos": 24404, "sent_end_pos": 24941, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(D) Targeting the GalT to an even earlier compartment by fusing it to the CTS of the cis-Golgi acting GnTI (indicated in yellow; V\u00e9zina et al., 2009) induced the production of nearly exclusively oligomannosidic structures. Only minute amounts of galactosylated, hybrid Man5A were present. (E) Upon expression in a XT/FT knock-down plant line of a chimeric GalT carrying the late-Golgi CTS of rat \u03b12,6-sialyltransferase (indicated in orange) proteins carrying mainly galactosylated glycans (eg, AA) were generated (Strasser et al., 2009)."}
{"meta": {"doc_id": 2441, "sent_id": 142, "sent_start_pos": 24627, "sent_end_pos": 25073, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Only minute amounts of galactosylated, hybrid Man5A were present. (E) Upon expression in a XT/FT knock-down plant line of a chimeric GalT carrying the late-Golgi CTS of rat \u03b12,6-sialyltransferase (indicated in orange) proteins carrying mainly galactosylated glycans (eg, AA) were generated (Strasser et al., 2009). These results indicate that the ST-GalT fusion is indeed located in a late Golgi stack where final N-glycan processing takes place."}
{"meta": {"doc_id": 2441, "sent_id": 143, "sent_start_pos": 24693, "sent_end_pos": 25296, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(E) Upon expression in a XT/FT knock-down plant line of a chimeric GalT carrying the late-Golgi CTS of rat \u03b12,6-sialyltransferase (indicated in orange) proteins carrying mainly galactosylated glycans (eg, AA) were generated (Strasser et al., 2009). These results indicate that the ST-GalT fusion is indeed located in a late Golgi stack where final N-glycan processing takes place. Targeting the human \u03b21,4-GalT to an even earlier compartment (ER/cis-Golgi) by fusion with the CTS region of the A thaliana GnTI further increased the amount of oligomannosidic glycans (V\u00e9zina et al., 2009; see Figure 3D)."}
{"meta": {"doc_id": 2441, "sent_id": 144, "sent_start_pos": 24942, "sent_end_pos": 25441, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "These results indicate that the ST-GalT fusion is indeed located in a late Golgi stack where final N-glycan processing takes place. Targeting the human \u03b21,4-GalT to an even earlier compartment (ER/cis-Golgi) by fusion with the CTS region of the A thaliana GnTI further increased the amount of oligomannosidic glycans (V\u00e9zina et al., 2009; see Figure 3D). Galactosylated oligosaccharides were hardly found, indicating increased interference with the glycosylation machinery and the secretory pathway."}
{"meta": {"doc_id": 2441, "sent_id": 145, "sent_start_pos": 25074, "sent_end_pos": 25952, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Targeting the human \u03b21,4-GalT to an even earlier compartment (ER/cis-Golgi) by fusion with the CTS region of the A thaliana GnTI further increased the amount of oligomannosidic glycans (V\u00e9zina et al., 2009; see Figure 3D). Galactosylated oligosaccharides were hardly found, indicating increased interference with the glycosylation machinery and the secretory pathway. With the advent of XT/FT knock-down or knock-out lines (Koprivova et al., 2004; Cox et al., 2006; Sch\u00e4hs et al., 2007; Strasser et al., 2008; Shin et al., 2011) a more elegant way to prevent plant-specific glycosylation had been established and the aim of co-expressing human GalT in plants shifted from \u201cinterfering with endogenous reactions\u201d to \u201cgenerating homogeneously galactosylated, human-type glycans.\u201d This was achieved by a rationally designed construct targeting the GalT to a late Golgi compartment."}
{"meta": {"doc_id": 2441, "sent_id": 146, "sent_start_pos": 25297, "sent_end_pos": 26262, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Galactosylated oligosaccharides were hardly found, indicating increased interference with the glycosylation machinery and the secretory pathway. With the advent of XT/FT knock-down or knock-out lines (Koprivova et al., 2004; Cox et al., 2006; Sch\u00e4hs et al., 2007; Strasser et al., 2008; Shin et al., 2011) a more elegant way to prevent plant-specific glycosylation had been established and the aim of co-expressing human GalT in plants shifted from \u201cinterfering with endogenous reactions\u201d to \u201cgenerating homogeneously galactosylated, human-type glycans.\u201d This was achieved by a rationally designed construct targeting the GalT to a late Golgi compartment. Fusions of the catalytic GalT domain to the CTS region of \u03b12,6-sialyltransferase, an enzyme acting in the final steps of the mammalian glycosylation pathway, indeed resulted in the generation of human-type, mono- and di-galactosylated glycans in XT/FT knock-down plants (Strasser et al., 2009; see Figure 3E)."}
{"meta": {"doc_id": 2441, "sent_id": 147, "sent_start_pos": 25442, "sent_end_pos": 26360, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "With the advent of XT/FT knock-down or knock-out lines (Koprivova et al., 2004; Cox et al., 2006; Sch\u00e4hs et al., 2007; Strasser et al., 2008; Shin et al., 2011) a more elegant way to prevent plant-specific glycosylation had been established and the aim of co-expressing human GalT in plants shifted from \u201cinterfering with endogenous reactions\u201d to \u201cgenerating homogeneously galactosylated, human-type glycans.\u201d This was achieved by a rationally designed construct targeting the GalT to a late Golgi compartment. Fusions of the catalytic GalT domain to the CTS region of \u03b12,6-sialyltransferase, an enzyme acting in the final steps of the mammalian glycosylation pathway, indeed resulted in the generation of human-type, mono- and di-galactosylated glycans in XT/FT knock-down plants (Strasser et al., 2009; see Figure 3E). This was an important step for the in planta generation of proteins carrying fully human glycans."}
{"meta": {"doc_id": 2441, "sent_id": 148, "sent_start_pos": 25953, "sent_end_pos": 26507, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Fusions of the catalytic GalT domain to the CTS region of \u03b12,6-sialyltransferase, an enzyme acting in the final steps of the mammalian glycosylation pathway, indeed resulted in the generation of human-type, mono- and di-galactosylated glycans in XT/FT knock-down plants (Strasser et al., 2009; see Figure 3E). This was an important step for the in planta generation of proteins carrying fully human glycans. This semi-synthetic approach was applied to GnTs to further explore the consequences of generating hybrid constructs carrying foreign CTS regions."}
{"meta": {"doc_id": 2441, "sent_id": 149, "sent_start_pos": 26263, "sent_end_pos": 26782, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "This was an important step for the in planta generation of proteins carrying fully human glycans. This semi-synthetic approach was applied to GnTs to further explore the consequences of generating hybrid constructs carrying foreign CTS regions. One of the GnTs, \u03b21,4-mannosyl-\u03b21,4-N-acetylglucosaminyltransferase (GnTIII), catalyzes the formation of so-called bisected glycans (Carver et al., 1981; Narasimhan, 1982), a modification frequently found on human proteins but not present in plants (Rouwendal et al., 2007)."}
{"meta": {"doc_id": 2441, "sent_id": 150, "sent_start_pos": 26361, "sent_end_pos": 26963, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "This semi-synthetic approach was applied to GnTs to further explore the consequences of generating hybrid constructs carrying foreign CTS regions. One of the GnTs, \u03b21,4-mannosyl-\u03b21,4-N-acetylglucosaminyltransferase (GnTIII), catalyzes the formation of so-called bisected glycans (Carver et al., 1981; Narasimhan, 1982), a modification frequently found on human proteins but not present in plants (Rouwendal et al., 2007). Importantly, bisected \u2013 as well as the previously mentioned \u03b21,4-galactosylated glycans \u2013 cannot be modified with plant-specific xylose or fucose residues (Rouwendal et al., 2007)."}
{"meta": {"doc_id": 2441, "sent_id": 151, "sent_start_pos": 26508, "sent_end_pos": 27250, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "One of the GnTs, \u03b21,4-mannosyl-\u03b21,4-N-acetylglucosaminyltransferase (GnTIII), catalyzes the formation of so-called bisected glycans (Carver et al., 1981; Narasimhan, 1982), a modification frequently found on human proteins but not present in plants (Rouwendal et al., 2007). Importantly, bisected \u2013 as well as the previously mentioned \u03b21,4-galactosylated glycans \u2013 cannot be modified with plant-specific xylose or fucose residues (Rouwendal et al., 2007). In order to produce such bisected glycans and thus prevent the addition of plant-specific glyco-epitopes, fully human GnTIII and a hybrid construct (the catalytic domain was fused to the CTS region of A thaliana \u03b1-mannosidase II) were expressed in tobacco plants and BY-2 tobacco cells."}
{"meta": {"doc_id": 2441, "sent_id": 152, "sent_start_pos": 26783, "sent_end_pos": 27469, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Importantly, bisected \u2013 as well as the previously mentioned \u03b21,4-galactosylated glycans \u2013 cannot be modified with plant-specific xylose or fucose residues (Rouwendal et al., 2007). In order to produce such bisected glycans and thus prevent the addition of plant-specific glyco-epitopes, fully human GnTIII and a hybrid construct (the catalytic domain was fused to the CTS region of A thaliana \u03b1-mannosidase II) were expressed in tobacco plants and BY-2 tobacco cells. The chimeric constructs led to a stronger decrease in plant-specific glyco-epitopes most probably due to targeting to an early/medial Golgi subcompartment (Rouwendal et al., 2007; Frey et al., 2009; Karg et al., 2010)."}
{"meta": {"doc_id": 2441, "sent_id": 153, "sent_start_pos": 26964, "sent_end_pos": 27636, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "In order to produce such bisected glycans and thus prevent the addition of plant-specific glyco-epitopes, fully human GnTIII and a hybrid construct (the catalytic domain was fused to the CTS region of A thaliana \u03b1-mannosidase II) were expressed in tobacco plants and BY-2 tobacco cells. The chimeric constructs led to a stronger decrease in plant-specific glyco-epitopes most probably due to targeting to an early/medial Golgi subcompartment (Rouwendal et al., 2007; Frey et al., 2009; Karg et al., 2010). However, targeting of GnTIII to an early compartment not only inhibited unwanted reactions but also led to the generation of non-standard, mainly hybrid-type glycans."}
{"meta": {"doc_id": 2441, "sent_id": 154, "sent_start_pos": 27251, "sent_end_pos": 28045, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The chimeric constructs led to a stronger decrease in plant-specific glyco-epitopes most probably due to targeting to an early/medial Golgi subcompartment (Rouwendal et al., 2007; Frey et al., 2009; Karg et al., 2010). However, targeting of GnTIII to an early compartment not only inhibited unwanted reactions but also led to the generation of non-standard, mainly hybrid-type glycans. Transiently expressing a series of GnTIII-constructs containing different CTS regions (A thaliana Golgi mannosidase II, A thaliana core \u03b11,3-fucosyltransferase, A thaliana \u03b21,2-xyloslytransferase, and rat \u03b12,6-sialyltransferase) in XT/FT knock-down N benthamiana plants identified late targeting sequences as preferential for the production of naturally occurring, bisected N-glycans (Castilho et al., 2011)."}
{"meta": {"doc_id": 2441, "sent_id": 155, "sent_start_pos": 27470, "sent_end_pos": 28509, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "However, targeting of GnTIII to an early compartment not only inhibited unwanted reactions but also led to the generation of non-standard, mainly hybrid-type glycans. Transiently expressing a series of GnTIII-constructs containing different CTS regions (A thaliana Golgi mannosidase II, A thaliana core \u03b11,3-fucosyltransferase, A thaliana \u03b21,2-xyloslytransferase, and rat \u03b12,6-sialyltransferase) in XT/FT knock-down N benthamiana plants identified late targeting sequences as preferential for the production of naturally occurring, bisected N-glycans (Castilho et al., 2011). In a similar approach, enzymes responsible for branched glycans (ie, tri- and tetraantennary glycans; human \u03b11,3-mannosyl-\u03b21,4-N-acetylglucosaminyltransferase IVa (GnTIV) and human \u03b11,6-mannosyl-\u03b21,6-N-acetylglucosaminyltransferase V (GnTV)) were tested with different CTS regions (endogenous CTS region, rat \u03b12,6-sialyltransferase, A thaliana core \u03b11,3-fucosyltransferase, A thaliana \u03b21,2-xyloslytransferase; Castilho et al., 2011; Nagels et al., 2011, 2012a,b)."}
{"meta": {"doc_id": 2441, "sent_id": 156, "sent_start_pos": 27637, "sent_end_pos": 28805, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Transiently expressing a series of GnTIII-constructs containing different CTS regions (A thaliana Golgi mannosidase II, A thaliana core \u03b11,3-fucosyltransferase, A thaliana \u03b21,2-xyloslytransferase, and rat \u03b12,6-sialyltransferase) in XT/FT knock-down N benthamiana plants identified late targeting sequences as preferential for the production of naturally occurring, bisected N-glycans (Castilho et al., 2011). In a similar approach, enzymes responsible for branched glycans (ie, tri- and tetraantennary glycans; human \u03b11,3-mannosyl-\u03b21,4-N-acetylglucosaminyltransferase IVa (GnTIV) and human \u03b11,6-mannosyl-\u03b21,6-N-acetylglucosaminyltransferase V (GnTV)) were tested with different CTS regions (endogenous CTS region, rat \u03b12,6-sialyltransferase, A thaliana core \u03b11,3-fucosyltransferase, A thaliana \u03b21,2-xyloslytransferase; Castilho et al., 2011; Nagels et al., 2011, 2012a,b). The fusions with the medial Golgi-targeting CTS region of, eg, FT allowed the generation of a high degree of branched glycans on co-expressed reporter proteins, whereas the endogenous CTS and the late Golgi CTS from \u03b12,6-sialyltransferase did not lead to substantial amounts of branched glycans."}
{"meta": {"doc_id": 2441, "sent_id": 157, "sent_start_pos": 28046, "sent_end_pos": 28974, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "In a similar approach, enzymes responsible for branched glycans (ie, tri- and tetraantennary glycans; human \u03b11,3-mannosyl-\u03b21,4-N-acetylglucosaminyltransferase IVa (GnTIV) and human \u03b11,6-mannosyl-\u03b21,6-N-acetylglucosaminyltransferase V (GnTV)) were tested with different CTS regions (endogenous CTS region, rat \u03b12,6-sialyltransferase, A thaliana core \u03b11,3-fucosyltransferase, A thaliana \u03b21,2-xyloslytransferase; Castilho et al., 2011; Nagels et al., 2011, 2012a,b). The fusions with the medial Golgi-targeting CTS region of, eg, FT allowed the generation of a high degree of branched glycans on co-expressed reporter proteins, whereas the endogenous CTS and the late Golgi CTS from \u03b12,6-sialyltransferase did not lead to substantial amounts of branched glycans. Collectively these results demonstrate that it is not sufficient to \u201csimply\u201d introduce a foreign glycosylation enzyme into a plant to obtain a desired glycan structure."}
{"meta": {"doc_id": 2441, "sent_id": 158, "sent_start_pos": 28510, "sent_end_pos": 29227, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The fusions with the medial Golgi-targeting CTS region of, eg, FT allowed the generation of a high degree of branched glycans on co-expressed reporter proteins, whereas the endogenous CTS and the late Golgi CTS from \u03b12,6-sialyltransferase did not lead to substantial amounts of branched glycans. Collectively these results demonstrate that it is not sufficient to \u201csimply\u201d introduce a foreign glycosylation enzyme into a plant to obtain a desired glycan structure. Instead, the successful production of proteins with human-type N-glycosylation in plants harbors a large number of challenges and requires knowledge of glycosylation pathways, enzyme specificities and related topics, like subcellular protein transport."}
{"meta": {"doc_id": 2441, "sent_id": 159, "sent_start_pos": 28806, "sent_end_pos": 29305, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Collectively these results demonstrate that it is not sufficient to \u201csimply\u201d introduce a foreign glycosylation enzyme into a plant to obtain a desired glycan structure. Instead, the successful production of proteins with human-type N-glycosylation in plants harbors a large number of challenges and requires knowledge of glycosylation pathways, enzyme specificities and related topics, like subcellular protein transport. Semi-synthetic approaches serve as useful tools to approach these challenges."}
{"meta": {"doc_id": 2441, "sent_id": 160, "sent_start_pos": 28975, "sent_end_pos": 29584, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Instead, the successful production of proteins with human-type N-glycosylation in plants harbors a large number of challenges and requires knowledge of glycosylation pathways, enzyme specificities and related topics, like subcellular protein transport. Semi-synthetic approaches serve as useful tools to approach these challenges. Further Challenges\nIn recent years, a variety of expression hosts were glyco-engineered (recently reviewed by, eg, Jacobs and Callewaert, 2009; Loos and Steinkellner, 2012) and the first products with enhanced properties in animal studies have reached the clinic (Ratner, 2014)."}
{"meta": {"doc_id": 2441, "sent_id": 161, "sent_start_pos": 29228, "sent_end_pos": 29753, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Semi-synthetic approaches serve as useful tools to approach these challenges. Further Challenges\nIn recent years, a variety of expression hosts were glyco-engineered (recently reviewed by, eg, Jacobs and Callewaert, 2009; Loos and Steinkellner, 2012) and the first products with enhanced properties in animal studies have reached the clinic (Ratner, 2014). Plants, with their similar-to-human yet more simple N-glycosylation machinery and their amenability to glyco-engineering have been on the forefront of this development."}
{"meta": {"doc_id": 2441, "sent_id": 162, "sent_start_pos": 29306, "sent_end_pos": 29957, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Further Challenges\nIn recent years, a variety of expression hosts were glyco-engineered (recently reviewed by, eg, Jacobs and Callewaert, 2009; Loos and Steinkellner, 2012) and the first products with enhanced properties in animal studies have reached the clinic (Ratner, 2014). Plants, with their similar-to-human yet more simple N-glycosylation machinery and their amenability to glyco-engineering have been on the forefront of this development. Despite substantial achievements, the advantages of this system have been used only in a few in vivo studies (Bendandi et al., 2010; Forthal et al., 2010; Zeitlin et al., 2011, 2013; Hiatt et al., 2014)."}
{"meta": {"doc_id": 2441, "sent_id": 163, "sent_start_pos": 29585, "sent_end_pos": 30071, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plants, with their similar-to-human yet more simple N-glycosylation machinery and their amenability to glyco-engineering have been on the forefront of this development. Despite substantial achievements, the advantages of this system have been used only in a few in vivo studies (Bendandi et al., 2010; Forthal et al., 2010; Zeitlin et al., 2011, 2013; Hiatt et al., 2014). So far only one plant-produced product has reached the market, ie, glucocerebrosidase to treat Gaucher\u2019s disease."}
{"meta": {"doc_id": 2441, "sent_id": 164, "sent_start_pos": 29754, "sent_end_pos": 30199, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Despite substantial achievements, the advantages of this system have been used only in a few in vivo studies (Bendandi et al., 2010; Forthal et al., 2010; Zeitlin et al., 2011, 2013; Hiatt et al., 2014). So far only one plant-produced product has reached the market, ie, glucocerebrosidase to treat Gaucher\u2019s disease. This protein carries terminal mannose residues, a glycosylation form that confers enhanced efficacies (Grabowski et al., 2014)."}
{"meta": {"doc_id": 2441, "sent_id": 165, "sent_start_pos": 29958, "sent_end_pos": 30456, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "So far only one plant-produced product has reached the market, ie, glucocerebrosidase to treat Gaucher\u2019s disease. This protein carries terminal mannose residues, a glycosylation form that confers enhanced efficacies (Grabowski et al., 2014). Another plant-produced glyco-optimized protein drug has recently been used to treat patients: ZMapp, an experimental mAb cocktail against Ebola virus was given to several individuals during the ongoing Ebola epidemic (critically reviewed by Goodman, 2014)."}
{"meta": {"doc_id": 2441, "sent_id": 166, "sent_start_pos": 30072, "sent_end_pos": 30690, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "This protein carries terminal mannose residues, a glycosylation form that confers enhanced efficacies (Grabowski et al., 2014). Another plant-produced glyco-optimized protein drug has recently been used to treat patients: ZMapp, an experimental mAb cocktail against Ebola virus was given to several individuals during the ongoing Ebola epidemic (critically reviewed by Goodman, 2014). These antibodies had not yet gone through clinical studies but due to the dire predictions of Ebola virus infection and lack of other treatment options its application had been approved by regulatory authorities in several countries."}
{"meta": {"doc_id": 2441, "sent_id": 167, "sent_start_pos": 30200, "sent_end_pos": 30877, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Another plant-produced glyco-optimized protein drug has recently been used to treat patients: ZMapp, an experimental mAb cocktail against Ebola virus was given to several individuals during the ongoing Ebola epidemic (critically reviewed by Goodman, 2014). These antibodies had not yet gone through clinical studies but due to the dire predictions of Ebola virus infection and lack of other treatment options its application had been approved by regulatory authorities in several countries. With the appearance of efficient, transient expression methods, the rapid, scalable and cost-effective production of high-value recombinant proteins became possible (Gleba et al., 2014)."}
{"meta": {"doc_id": 2441, "sent_id": 168, "sent_start_pos": 30457, "sent_end_pos": 31050, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "These antibodies had not yet gone through clinical studies but due to the dire predictions of Ebola virus infection and lack of other treatment options its application had been approved by regulatory authorities in several countries. With the appearance of efficient, transient expression methods, the rapid, scalable and cost-effective production of high-value recombinant proteins became possible (Gleba et al., 2014). However, to realize the full potential of plant biotechnology, advanced, stably glyco-engineered plant strains in combination with semi-synthetic approaches will be needed."}
{"meta": {"doc_id": 2441, "sent_id": 169, "sent_start_pos": 30691, "sent_end_pos": 31265, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "With the appearance of efficient, transient expression methods, the rapid, scalable and cost-effective production of high-value recombinant proteins became possible (Gleba et al., 2014). However, to realize the full potential of plant biotechnology, advanced, stably glyco-engineered plant strains in combination with semi-synthetic approaches will be needed. Versatile, modular expression vectors like MoClo (Weber et al., 2011) and GoldenBraid (Sarrion-Perdigones et al., 2013) allow efficient shuffling of domains and will certainly speed up the generation of constructs."}
{"meta": {"doc_id": 2441, "sent_id": 170, "sent_start_pos": 30878, "sent_end_pos": 31410, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "However, to realize the full potential of plant biotechnology, advanced, stably glyco-engineered plant strains in combination with semi-synthetic approaches will be needed. Versatile, modular expression vectors like MoClo (Weber et al., 2011) and GoldenBraid (Sarrion-Perdigones et al., 2013) allow efficient shuffling of domains and will certainly speed up the generation of constructs. Quick assembly of multi-gene vectors also simplifies the remodeling of glycosylation pathways as recently demonstrated (Schneider et al., 2014)."}
{"meta": {"doc_id": 2441, "sent_id": 171, "sent_start_pos": 31051, "sent_end_pos": 31631, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Versatile, modular expression vectors like MoClo (Weber et al., 2011) and GoldenBraid (Sarrion-Perdigones et al., 2013) allow efficient shuffling of domains and will certainly speed up the generation of constructs. Quick assembly of multi-gene vectors also simplifies the remodeling of glycosylation pathways as recently demonstrated (Schneider et al., 2014). Moreover, new technologies for genome editing, like CRISPR and TALENs (Lozano-Juste and Cutler, 2014) allow efficient elimination of genes and facilitate metabolic engineering and reprogramming of biosynthetic processes."}
{"meta": {"doc_id": 2441, "sent_id": 172, "sent_start_pos": 31266, "sent_end_pos": 31835, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Quick assembly of multi-gene vectors also simplifies the remodeling of glycosylation pathways as recently demonstrated (Schneider et al., 2014). Moreover, new technologies for genome editing, like CRISPR and TALENs (Lozano-Juste and Cutler, 2014) allow efficient elimination of genes and facilitate metabolic engineering and reprogramming of biosynthetic processes. These developments in combination with computer modeling and simulation approaches that predict protein\u2013glycan interactions will accelerate the development of drugs with optimized and even new functions."}
{"meta": {"doc_id": 2441, "sent_id": 173, "sent_start_pos": 31411, "sent_end_pos": 32089, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Moreover, new technologies for genome editing, like CRISPR and TALENs (Lozano-Juste and Cutler, 2014) allow efficient elimination of genes and facilitate metabolic engineering and reprogramming of biosynthetic processes. These developments in combination with computer modeling and simulation approaches that predict protein\u2013glycan interactions will accelerate the development of drugs with optimized and even new functions. In sum, the currently available gene expression systems and the new tools offered by synthetic biology create an ideal environment for establishing a plant-based biomanufacturing platform that can compete with or even surpass current industry standards."}
{"meta": {"doc_id": 2441, "sent_id": 174, "sent_start_pos": 31632, "sent_end_pos": 32293, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "These developments in combination with computer modeling and simulation approaches that predict protein\u2013glycan interactions will accelerate the development of drugs with optimized and even new functions. In sum, the currently available gene expression systems and the new tools offered by synthetic biology create an ideal environment for establishing a plant-based biomanufacturing platform that can compete with or even surpass current industry standards. Conflict of Interest Statement\nThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}
{"meta": {"doc_id": 2441, "sent_id": 175, "sent_start_pos": 31836, "sent_end_pos": 32372, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "In sum, the currently available gene expression systems and the new tools offered by synthetic biology create an ideal environment for establishing a plant-based biomanufacturing platform that can compete with or even surpass current industry standards. Conflict of Interest Statement\nThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Acknowledgments\nWe thank J\u00fcrgen Retzer for assistance with figure preparation."}
{"meta": {"doc_id": 2441, "sent_id": 176, "sent_start_pos": 32090, "sent_end_pos": 32616, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Conflict of Interest Statement\nThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Acknowledgments\nWe thank J\u00fcrgen Retzer for assistance with figure preparation. This work was supported by grants from the Austrian Research Promotion Agency (FFG) Laura Bassi Centres of Expertise (Number 822757, to Herta Steinkellner) and from the Austrian Science Fund (FWF; Grant Number L575-B13, to Herta Steinkellner)."}
{"meta": {"doc_id": 2441, "sent_id": 177, "sent_start_pos": 32294, "sent_end_pos": 32643, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Acknowledgments\nWe thank J\u00fcrgen Retzer for assistance with figure preparation. This work was supported by grants from the Austrian Research Promotion Agency (FFG) Laura Bassi Centres of Expertise (Number 822757, to Herta Steinkellner) and from the Austrian Science Fund (FWF; Grant Number L575-B13, to Herta Steinkellner). References\nAebi, M (2013)."}
{"meta": {"doc_id": 2441, "sent_id": 178, "sent_start_pos": 32373, "sent_end_pos": 32685, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "This work was supported by grants from the Austrian Research Promotion Agency (FFG) Laura Bassi Centres of Expertise (Number 822757, to Herta Steinkellner) and from the Austrian Science Fund (FWF; Grant Number L575-B13, to Herta Steinkellner). References\nAebi, M (2013). N-linked protein glycosylation in the ER."}
{"meta": {"doc_id": 2441, "sent_id": 179, "sent_start_pos": 32617, "sent_end_pos": 32694, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "References\nAebi, M (2013). N-linked protein glycosylation in the ER. Biochim."}
{"meta": {"doc_id": 2441, "sent_id": 180, "sent_start_pos": 32644, "sent_end_pos": 32703, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "N-linked protein glycosylation in the ER. Biochim. Biophys."}
{"meta": {"doc_id": 2441, "sent_id": 181, "sent_start_pos": 32686, "sent_end_pos": 32725, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biochim. Biophys. Acta 1833, 2430\u20132437."}
{"meta": {"doc_id": 2441, "sent_id": 182, "sent_start_pos": 32695, "sent_end_pos": 32853, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biophys. Acta 1833, 2430\u20132437. doi: 10.1016/jbbamcr.2013.04.001\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nAggarwal, R S (2014)."}
{"meta": {"doc_id": 2441, "sent_id": 183, "sent_start_pos": 32704, "sent_end_pos": 32901, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Acta 1833, 2430\u20132437. doi: 10.1016/jbbamcr.2013.04.001\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nAggarwal, R S (2014). What\u2019s fueling the biotech engine-2012 to 2013."}
{"meta": {"doc_id": 2441, "sent_id": 184, "sent_start_pos": 32726, "sent_end_pos": 32906, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/jbbamcr.2013.04.001\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nAggarwal, R S (2014). What\u2019s fueling the biotech engine-2012 to 2013. Nat."}
{"meta": {"doc_id": 2441, "sent_id": 185, "sent_start_pos": 32854, "sent_end_pos": 32918, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "What\u2019s fueling the biotech engine-2012 to 2013. Nat. Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 186, "sent_start_pos": 32902, "sent_end_pos": 32929, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Nat. Biotechnol. 32, 32\u201339."}
{"meta": {"doc_id": 2441, "sent_id": 187, "sent_start_pos": 32907, "sent_end_pos": 33081, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biotechnol. 32, 32\u201339. doi: 10.1038/nbt.2794\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nAltmann, F, Fabini, G, Ahorn, H, and Wilson, I B (2001)."}
{"meta": {"doc_id": 2441, "sent_id": 188, "sent_start_pos": 32919, "sent_end_pos": 33132, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "32, 32\u201339. doi: 10.1038/nbt.2794\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nAltmann, F, Fabini, G, Ahorn, H, and Wilson, I B (2001). Genetic model organisms in the study of N-glycans."}
{"meta": {"doc_id": 2441, "sent_id": 189, "sent_start_pos": 32930, "sent_end_pos": 33155, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1038/nbt.2794\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nAltmann, F, Fabini, G, Ahorn, H, and Wilson, I B (2001). Genetic model organisms in the study of N-glycans. Biochimie 83, 703\u2013712."}
{"meta": {"doc_id": 2441, "sent_id": 190, "sent_start_pos": 33082, "sent_end_pos": 33323, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Genetic model organisms in the study of N-glycans. Biochimie 83, 703\u2013712. doi: 10.1016/S0300-9084(01)01297-4\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nAltmann, F, Staudacher, E, Wilson, I B, and Marz, L (1999)."}
{"meta": {"doc_id": 2441, "sent_id": 191, "sent_start_pos": 33133, "sent_end_pos": 33394, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biochimie 83, 703\u2013712. doi: 10.1016/S0300-9084(01)01297-4\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nAltmann, F, Staudacher, E, Wilson, I B, and Marz, L (1999). Insect cells as hosts for the expression of recombinant glycoproteins."}
{"meta": {"doc_id": 2441, "sent_id": 192, "sent_start_pos": 33156, "sent_end_pos": 33405, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/S0300-9084(01)01297-4\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nAltmann, F, Staudacher, E, Wilson, I B, and Marz, L (1999). Insect cells as hosts for the expression of recombinant glycoproteins. Glycoconj."}
{"meta": {"doc_id": 2441, "sent_id": 193, "sent_start_pos": 33324, "sent_end_pos": 33420, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Insect cells as hosts for the expression of recombinant glycoproteins. Glycoconj. J 16, 109\u2013123."}
{"meta": {"doc_id": 2441, "sent_id": 194, "sent_start_pos": 33395, "sent_end_pos": 33564, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Glycoconj. J 16, 109\u2013123. doi: 10.1023/A:1026488408951\nCrossRef Full Text | Google Scholar\nBakker, H, Bardor, M, Molthoff, J W, Gomord, V, Elbers, I, Stevens, L H,et al."}
{"meta": {"doc_id": 2441, "sent_id": 195, "sent_start_pos": 33406, "sent_end_pos": 33572, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J 16, 109\u2013123. doi: 10.1023/A:1026488408951\nCrossRef Full Text | Google Scholar\nBakker, H, Bardor, M, Molthoff, J W, Gomord, V, Elbers, I, Stevens, L H,et al. (2001)."}
{"meta": {"doc_id": 2441, "sent_id": 196, "sent_start_pos": 33421, "sent_end_pos": 33644, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1023/A:1026488408951\nCrossRef Full Text | Google Scholar\nBakker, H, Bardor, M, Molthoff, J W, Gomord, V, Elbers, I, Stevens, L H,et al. (2001). Galactose-extended glycans of antibodies produced by transgenic plants."}
{"meta": {"doc_id": 2441, "sent_id": 197, "sent_start_pos": 33565, "sent_end_pos": 33650, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2001). Galactose-extended glycans of antibodies produced by transgenic plants. Proc."}
{"meta": {"doc_id": 2441, "sent_id": 198, "sent_start_pos": 33573, "sent_end_pos": 33656, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Galactose-extended glycans of antibodies produced by transgenic plants. Proc. Natl."}
{"meta": {"doc_id": 2441, "sent_id": 199, "sent_start_pos": 33645, "sent_end_pos": 33662, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Proc. Natl. Acad."}
{"meta": {"doc_id": 2441, "sent_id": 200, "sent_start_pos": 33651, "sent_end_pos": 33667, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Natl. Acad. Sci."}
{"meta": {"doc_id": 2441, "sent_id": 201, "sent_start_pos": 33657, "sent_end_pos": 33686, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Acad. Sci. USA 98, 2899\u20132904."}
{"meta": {"doc_id": 2441, "sent_id": 202, "sent_start_pos": 33663, "sent_end_pos": 33876, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Sci. USA 98, 2899\u20132904. doi: 10.1073/pnas.031419998\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nBakker, H, Rouwendal, G J, Karnoup, A S, Florack, D E, Stoopen, G M, Helsper, J P,et al."}
{"meta": {"doc_id": 2441, "sent_id": 203, "sent_start_pos": 33668, "sent_end_pos": 33884, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "USA 98, 2899\u20132904. doi: 10.1073/pnas.031419998\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nBakker, H, Rouwendal, G J, Karnoup, A S, Florack, D E, Stoopen, G M, Helsper, J P,et al. (2006)."}
{"meta": {"doc_id": 2441, "sent_id": 204, "sent_start_pos": 33687, "sent_end_pos": 34021, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1073/pnas.031419998\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nBakker, H, Rouwendal, G J, Karnoup, A S, Florack, D E, Stoopen, G M, Helsper, J P,et al. (2006). An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes."}
{"meta": {"doc_id": 2441, "sent_id": 205, "sent_start_pos": 33877, "sent_end_pos": 34027, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2006). An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc."}
{"meta": {"doc_id": 2441, "sent_id": 206, "sent_start_pos": 33885, "sent_end_pos": 34033, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc. Natl."}
{"meta": {"doc_id": 2441, "sent_id": 207, "sent_start_pos": 34022, "sent_end_pos": 34039, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Proc. Natl. Acad."}
{"meta": {"doc_id": 2441, "sent_id": 208, "sent_start_pos": 34028, "sent_end_pos": 34044, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Natl. Acad. Sci."}
{"meta": {"doc_id": 2441, "sent_id": 209, "sent_start_pos": 34034, "sent_end_pos": 34064, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Acad. Sci. USA 103, 7577\u20137582."}
{"meta": {"doc_id": 2441, "sent_id": 210, "sent_start_pos": 34040, "sent_end_pos": 34246, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Sci. USA 103, 7577\u20137582. doi: 10.1073/pnas.0600879103\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nBardor, M, Faveeuw, C, Fitchette, A C, Gilbert, D, Galas, L, Trottein, F,et al."}
{"meta": {"doc_id": 2441, "sent_id": 211, "sent_start_pos": 34045, "sent_end_pos": 34254, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "USA 103, 7577\u20137582. doi: 10.1073/pnas.0600879103\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nBardor, M, Faveeuw, C, Fitchette, A C, Gilbert, D, Galas, L, Trottein, F,et al. (2003)."}
{"meta": {"doc_id": 2441, "sent_id": 212, "sent_start_pos": 34065, "sent_end_pos": 34359, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1073/pnas.0600879103\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nBardor, M, Faveeuw, C, Fitchette, A C, Gilbert, D, Galas, L, Trottein, F,et al. (2003). Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)-fucose and core xylose."}
{"meta": {"doc_id": 2441, "sent_id": 213, "sent_start_pos": 34247, "sent_end_pos": 34385, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2003). Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)-fucose and core xylose. Glycobiology 13, 427\u2013434."}
{"meta": {"doc_id": 2441, "sent_id": 214, "sent_start_pos": 34255, "sent_end_pos": 34566, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)-fucose and core xylose. Glycobiology 13, 427\u2013434. doi: 10.1093/glycob/cwg024\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nBendandi, M, Marillonnet, S, Kandzia, R, Thieme, F, Nickstadt, A, Herz, S,et al."}
{"meta": {"doc_id": 2441, "sent_id": 215, "sent_start_pos": 34360, "sent_end_pos": 34574, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Glycobiology 13, 427\u2013434. doi: 10.1093/glycob/cwg024\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nBendandi, M, Marillonnet, S, Kandzia, R, Thieme, F, Nickstadt, A, Herz, S,et al. (2010)."}
{"meta": {"doc_id": 2441, "sent_id": 216, "sent_start_pos": 34386, "sent_end_pos": 34677, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1093/glycob/cwg024\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nBendandi, M, Marillonnet, S, Kandzia, R, Thieme, F, Nickstadt, A, Herz, S,et al. (2010). Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin\u2019s lymphoma."}
{"meta": {"doc_id": 2441, "sent_id": 217, "sent_start_pos": 34567, "sent_end_pos": 34682, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2010). Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin\u2019s lymphoma. Ann."}
{"meta": {"doc_id": 2441, "sent_id": 218, "sent_start_pos": 34575, "sent_end_pos": 34689, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin\u2019s lymphoma. Ann. Oncol."}
{"meta": {"doc_id": 2441, "sent_id": 219, "sent_start_pos": 34678, "sent_end_pos": 34704, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Ann. Oncol. 21, 2420\u20132427."}
{"meta": {"doc_id": 2441, "sent_id": 220, "sent_start_pos": 34683, "sent_end_pos": 34826, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Oncol. 21, 2420\u20132427. doi: 10.1093/annonc/mdq256\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nBlizzard, R M (2012)."}
{"meta": {"doc_id": 2441, "sent_id": 221, "sent_start_pos": 34690, "sent_end_pos": 34861, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "21, 2420\u20132427. doi: 10.1093/annonc/mdq256\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nBlizzard, R M (2012). History of growth hormone therapy."}
{"meta": {"doc_id": 2441, "sent_id": 222, "sent_start_pos": 34705, "sent_end_pos": 34879, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1093/annonc/mdq256\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nBlizzard, R M (2012). History of growth hormone therapy. Indian J Pediatr."}
{"meta": {"doc_id": 2441, "sent_id": 223, "sent_start_pos": 34827, "sent_end_pos": 34890, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "History of growth hormone therapy. Indian J Pediatr. 79, 87\u201391."}
{"meta": {"doc_id": 2441, "sent_id": 224, "sent_start_pos": 34862, "sent_end_pos": 35014, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Indian J Pediatr. 79, 87\u201391. doi: 10.1007/s12098-011-0609-4\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nBlundell, J (1818)."}
{"meta": {"doc_id": 2441, "sent_id": 225, "sent_start_pos": 34880, "sent_end_pos": 35070, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "79, 87\u201391. doi: 10.1007/s12098-011-0609-4\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nBlundell, J (1818). Experiments on the transfusion of blood by the syringe."}
{"meta": {"doc_id": 2441, "sent_id": 226, "sent_start_pos": 34891, "sent_end_pos": 35075, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1007/s12098-011-0609-4\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nBlundell, J (1818). Experiments on the transfusion of blood by the syringe. Med."}
{"meta": {"doc_id": 2441, "sent_id": 227, "sent_start_pos": 35015, "sent_end_pos": 35081, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Experiments on the transfusion of blood by the syringe. Med. Chir."}
{"meta": {"doc_id": 2441, "sent_id": 228, "sent_start_pos": 35071, "sent_end_pos": 35088, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Med. Chir. Trans."}
{"meta": {"doc_id": 2441, "sent_id": 229, "sent_start_pos": 35076, "sent_end_pos": 35098, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Chir. Trans. 9, 56\u201392."}
{"meta": {"doc_id": 2441, "sent_id": 230, "sent_start_pos": 35082, "sent_end_pos": 35169, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Trans. 9, 56\u201392. Bosch, D, Castilho, A, Loos, A, Schots, A, and Steinkellner, H (2013)."}
{"meta": {"doc_id": 2441, "sent_id": 231, "sent_start_pos": 35089, "sent_end_pos": 35225, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "9, 56\u201392. Bosch, D, Castilho, A, Loos, A, Schots, A, and Steinkellner, H (2013). N-Glycosylation of plant-produced recombinant proteins."}
{"meta": {"doc_id": 2441, "sent_id": 232, "sent_start_pos": 35099, "sent_end_pos": 35231, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Bosch, D, Castilho, A, Loos, A, Schots, A, and Steinkellner, H (2013). N-Glycosylation of plant-produced recombinant proteins. Curr."}
{"meta": {"doc_id": 2441, "sent_id": 233, "sent_start_pos": 35170, "sent_end_pos": 35238, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "N-Glycosylation of plant-produced recombinant proteins. Curr. Pharm."}
{"meta": {"doc_id": 2441, "sent_id": 234, "sent_start_pos": 35226, "sent_end_pos": 35243, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Curr. Pharm. Des."}
{"meta": {"doc_id": 2441, "sent_id": 235, "sent_start_pos": 35232, "sent_end_pos": 35258, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Pharm. Des. 19, 5503\u20135512."}
{"meta": {"doc_id": 2441, "sent_id": 236, "sent_start_pos": 35239, "sent_end_pos": 35403, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Des. 19, 5503\u20135512. doi: 10.2174/1381612811319310006\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCampbell, C T, and Yarema, K J (2005)."}
{"meta": {"doc_id": 2441, "sent_id": 237, "sent_start_pos": 35244, "sent_end_pos": 35444, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "19, 5503\u20135512. doi: 10.2174/1381612811319310006\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCampbell, C T, and Yarema, K J (2005). Large-scale approaches for glycobiology."}
{"meta": {"doc_id": 2441, "sent_id": 238, "sent_start_pos": 35259, "sent_end_pos": 35457, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.2174/1381612811319310006\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCampbell, C T, and Yarema, K J (2005). Large-scale approaches for glycobiology. Genome Biol."}
{"meta": {"doc_id": 2441, "sent_id": 239, "sent_start_pos": 35404, "sent_end_pos": 35655, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Large-scale approaches for glycobiology. Genome Biol. 6:236. doi: 10.1186/gb-2005-6-11-236\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCarver, J P, Grey, A A, Winnik, F M, Hakimi, J, Ceccarini, C, and Atkinson, P H (1981)."}
{"meta": {"doc_id": 2441, "sent_id": 240, "sent_start_pos": 35445, "sent_end_pos": 35781, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Genome Biol. 6:236. doi: 10.1186/gb-2005-6-11-236\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCarver, J P, Grey, A A, Winnik, F M, Hakimi, J, Ceccarini, C, and Atkinson, P H (1981). Determination of the structure of four glycopeptides from hen ovalbumin using 360-MHz proton magnetic resonance spectroscopy."}
{"meta": {"doc_id": 2441, "sent_id": 241, "sent_start_pos": 35458, "sent_end_pos": 35809, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "6:236. doi: 10.1186/gb-2005-6-11-236\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCarver, J P, Grey, A A, Winnik, F M, Hakimi, J, Ceccarini, C, and Atkinson, P H (1981). Determination of the structure of four glycopeptides from hen ovalbumin using 360-MHz proton magnetic resonance spectroscopy. Biochemistry 20, 6600\u20136606."}
{"meta": {"doc_id": 2441, "sent_id": 242, "sent_start_pos": 35656, "sent_end_pos": 35980, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Determination of the structure of four glycopeptides from hen ovalbumin using 360-MHz proton magnetic resonance spectroscopy. Biochemistry 20, 6600\u20136606. doi: 10.1021/bi00526a013\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, Gattinger, P, Grass, J, Jez, J, Pabst, M, Altmann, F,et al."}
{"meta": {"doc_id": 2441, "sent_id": 243, "sent_start_pos": 35782, "sent_end_pos": 35988, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biochemistry 20, 6600\u20136606. doi: 10.1021/bi00526a013\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, Gattinger, P, Grass, J, Jez, J, Pabst, M, Altmann, F,et al. (2011)."}
{"meta": {"doc_id": 2441, "sent_id": 244, "sent_start_pos": 35810, "sent_end_pos": 36110, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1021/bi00526a013\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, Gattinger, P, Grass, J, Jez, J, Pabst, M, Altmann, F,et al. (2011). N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans."}
{"meta": {"doc_id": 2441, "sent_id": 245, "sent_start_pos": 35981, "sent_end_pos": 36136, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2011). N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Glycobiology 21, 813\u2013823."}
{"meta": {"doc_id": 2441, "sent_id": 246, "sent_start_pos": 35989, "sent_end_pos": 36322, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Glycobiology 21, 813\u2013823. doi: 10.1093/glycob/cwr009\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, Neumann, L, Daskalova, S, Mason, H S, Steinkellner, H, Altmann, F,et al."}
{"meta": {"doc_id": 2441, "sent_id": 247, "sent_start_pos": 36111, "sent_end_pos": 36330, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Glycobiology 21, 813\u2013823. doi: 10.1093/glycob/cwr009\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, Neumann, L, Daskalova, S, Mason, H S, Steinkellner, H, Altmann, F,et al. (2012)."}
{"meta": {"doc_id": 2441, "sent_id": 248, "sent_start_pos": 36137, "sent_end_pos": 36394, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1093/glycob/cwr009\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, Neumann, L, Daskalova, S, Mason, H S, Steinkellner, H, Altmann, F,et al. (2012). Engineering of sialylated mucin-type O-glycosylation in plants."}
{"meta": {"doc_id": 2441, "sent_id": 249, "sent_start_pos": 36323, "sent_end_pos": 36402, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2012). Engineering of sialylated mucin-type O-glycosylation in plants. J Biol."}
{"meta": {"doc_id": 2441, "sent_id": 250, "sent_start_pos": 36331, "sent_end_pos": 36408, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Engineering of sialylated mucin-type O-glycosylation in plants. J Biol. Chem."}
{"meta": {"doc_id": 2441, "sent_id": 251, "sent_start_pos": 36395, "sent_end_pos": 36426, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J Biol. Chem. 287, 36518\u201336526."}
{"meta": {"doc_id": 2441, "sent_id": 252, "sent_start_pos": 36403, "sent_end_pos": 36616, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Chem. 287, 36518\u201336526. doi: 10.1074/jbc.M112.402685\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, Neumann, L, Gattinger, P, Strasser, R, Vorauer-Uhl, K, Sterovsky, T,et al."}
{"meta": {"doc_id": 2441, "sent_id": 253, "sent_start_pos": 36409, "sent_end_pos": 36624, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "287, 36518\u201336526. doi: 10.1074/jbc.M112.402685\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, Neumann, L, Gattinger, P, Strasser, R, Vorauer-Uhl, K, Sterovsky, T,et al. (2013)."}
{"meta": {"doc_id": 2441, "sent_id": 254, "sent_start_pos": 36427, "sent_end_pos": 36710, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1074/jbc.M112.402685\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, Neumann, L, Gattinger, P, Strasser, R, Vorauer-Uhl, K, Sterovsky, T,et al. (2013). Generation of biologically active multi-sialylated recombinant human EPOFc in plants."}
{"meta": {"doc_id": 2441, "sent_id": 255, "sent_start_pos": 36617, "sent_end_pos": 36729, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2013). Generation of biologically active multi-sialylated recombinant human EPOFc in plants. PLoS ONE 8:e54836."}
{"meta": {"doc_id": 2441, "sent_id": 256, "sent_start_pos": 36625, "sent_end_pos": 36907, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Generation of biologically active multi-sialylated recombinant human EPOFc in plants. PLoS ONE 8:e54836. doi: 10.1371/journal.pone.0054836\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, Pabst, M, Leonard, R, Veit, C, Altmann, F, Mach, L,et al."}
{"meta": {"doc_id": 2441, "sent_id": 257, "sent_start_pos": 36711, "sent_end_pos": 36915, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "PLoS ONE 8:e54836. doi: 10.1371/journal.pone.0054836\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, Pabst, M, Leonard, R, Veit, C, Altmann, F, Mach, L,et al. (2008)."}
{"meta": {"doc_id": 2441, "sent_id": 258, "sent_start_pos": 36730, "sent_end_pos": 36997, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1371/journal.pone.0054836\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, Pabst, M, Leonard, R, Veit, C, Altmann, F, Mach, L,et al. (2008). Construction of a functional CMP-sialic acid biosynthesis pathway in Arabidopsis."}
{"meta": {"doc_id": 2441, "sent_id": 259, "sent_start_pos": 36908, "sent_end_pos": 37012, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2008). Construction of a functional CMP-sialic acid biosynthesis pathway in Arabidopsis. Plant Physiol."}
{"meta": {"doc_id": 2441, "sent_id": 260, "sent_start_pos": 36916, "sent_end_pos": 37026, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Construction of a functional CMP-sialic acid biosynthesis pathway in Arabidopsis. Plant Physiol. 147, 331\u2013339."}
{"meta": {"doc_id": 2441, "sent_id": 261, "sent_start_pos": 36998, "sent_end_pos": 37167, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Physiol. 147, 331\u2013339. doi: 10.1104/pp.108.117572\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, and Steinkellner, H (2012)."}
{"meta": {"doc_id": 2441, "sent_id": 262, "sent_start_pos": 37013, "sent_end_pos": 37238, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "147, 331\u2013339. doi: 10.1104/pp.108.117572\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, and Steinkellner, H (2012). Glyco-engineering in plants to produce human-like N-glycan structures."}
{"meta": {"doc_id": 2441, "sent_id": 263, "sent_start_pos": 37027, "sent_end_pos": 37250, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1104/pp.108.117572\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, and Steinkellner, H (2012). Glyco-engineering in plants to produce human-like N-glycan structures. Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 264, "sent_start_pos": 37168, "sent_end_pos": 37266, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Glyco-engineering in plants to produce human-like N-glycan structures. Biotechnol. J 7, 1088\u20131098."}
{"meta": {"doc_id": 2441, "sent_id": 265, "sent_start_pos": 37239, "sent_end_pos": 37445, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biotechnol. J 7, 1088\u20131098. doi: 10.1002/biot.201200032\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, Strasser, R, Stadlmann, J, Grass, J, Jez, J, Gattinger, P,et al."}
{"meta": {"doc_id": 2441, "sent_id": 266, "sent_start_pos": 37251, "sent_end_pos": 37453, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J 7, 1088\u20131098. doi: 10.1002/biot.201200032\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, Strasser, R, Stadlmann, J, Grass, J, Jez, J, Gattinger, P,et al. (2010)."}
{"meta": {"doc_id": 2441, "sent_id": 267, "sent_start_pos": 37267, "sent_end_pos": 37543, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1002/biot.201200032\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCastilho, A, Strasser, R, Stadlmann, J, Grass, J, Jez, J, Gattinger, P,et al. (2010). In planta protein sialylation through overexpression of the respective mammalian pathway."}
{"meta": {"doc_id": 2441, "sent_id": 268, "sent_start_pos": 37446, "sent_end_pos": 37551, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2010). In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol."}
{"meta": {"doc_id": 2441, "sent_id": 269, "sent_start_pos": 37454, "sent_end_pos": 37557, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol. Chem."}
{"meta": {"doc_id": 2441, "sent_id": 270, "sent_start_pos": 37544, "sent_end_pos": 37575, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J Biol. Chem. 285, 15923\u201315930."}
{"meta": {"doc_id": 2441, "sent_id": 271, "sent_start_pos": 37552, "sent_end_pos": 37760, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Chem. 285, 15923\u201315930. doi: 10.1074/jbc.M109.088401\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCox, K M, Sterling, J D, Regan, J T, Gasdaska, J R, Frantz, K K, Peele, C G,et al."}
{"meta": {"doc_id": 2441, "sent_id": 272, "sent_start_pos": 37558, "sent_end_pos": 37768, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "285, 15923\u201315930. doi: 10.1074/jbc.M109.088401\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCox, K M, Sterling, J D, Regan, J T, Gasdaska, J R, Frantz, K K, Peele, C G,et al. (2006)."}
{"meta": {"doc_id": 2441, "sent_id": 273, "sent_start_pos": 37576, "sent_end_pos": 37853, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1074/jbc.M109.088401\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nCox, K M, Sterling, J D, Regan, J T, Gasdaska, J R, Frantz, K K, Peele, C G,et al. (2006). Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor."}
{"meta": {"doc_id": 2441, "sent_id": 274, "sent_start_pos": 37761, "sent_end_pos": 37858, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2006). Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat."}
{"meta": {"doc_id": 2441, "sent_id": 275, "sent_start_pos": 37769, "sent_end_pos": 37870, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat. Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 276, "sent_start_pos": 37854, "sent_end_pos": 37885, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Nat. Biotechnol. 24, 1591\u20131597."}
{"meta": {"doc_id": 2441, "sent_id": 277, "sent_start_pos": 37859, "sent_end_pos": 38030, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biotechnol. 24, 1591\u20131597. doi: 10.1038/nbt1260\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nDefense Advanced Research Projects Agency [DARPA]."}
{"meta": {"doc_id": 2441, "sent_id": 278, "sent_start_pos": 37871, "sent_end_pos": 38038, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "24, 1591\u20131597. doi: 10.1038/nbt1260\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nDefense Advanced Research Projects Agency [DARPA]. (2012)."}
{"meta": {"doc_id": 2441, "sent_id": 279, "sent_start_pos": 37886, "sent_end_pos": 38115, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1038/nbt1260\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nDefense Advanced Research Projects Agency [DARPA]. (2012). DARPA Produces Over 10 Million Doses of H1N1 Vaccine Candidate in One Month."}
{"meta": {"doc_id": 2441, "sent_id": 280, "sent_start_pos": 38031, "sent_end_pos": 38211, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2012). DARPA Produces Over 10 Million Doses of H1N1 Vaccine Candidate in One Month. Available at: http://www.darpa.mil/NewsEvents/Releases/2012/07/25.aspx (accessed July 7, 2014)."}
{"meta": {"doc_id": 2441, "sent_id": 281, "sent_start_pos": 38039, "sent_end_pos": 38295, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "DARPA Produces Over 10 Million Doses of H1N1 Vaccine Candidate in One Month. Available at: http://www.darpa.mil/NewsEvents/Releases/2012/07/25.aspx (accessed July 7, 2014). Dirnberger, D, Steinkellner, H, Abdennebi, L, Remy, J J, and Van De Wiel, D (2001)."}
{"meta": {"doc_id": 2441, "sent_id": 282, "sent_start_pos": 38116, "sent_end_pos": 38389, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Available at: http://www.darpa.mil/NewsEvents/Releases/2012/07/25.aspx (accessed July 7, 2014). Dirnberger, D, Steinkellner, H, Abdennebi, L, Remy, J J, and Van De Wiel, D (2001). Secretion of biologically active glycoforms of bovine follicle stimulating hormone in plants."}
{"meta": {"doc_id": 2441, "sent_id": 283, "sent_start_pos": 38212, "sent_end_pos": 38394, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Dirnberger, D, Steinkellner, H, Abdennebi, L, Remy, J J, and Van De Wiel, D (2001). Secretion of biologically active glycoforms of bovine follicle stimulating hormone in plants. Eur."}
{"meta": {"doc_id": 2441, "sent_id": 284, "sent_start_pos": 38296, "sent_end_pos": 38405, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Secretion of biologically active glycoforms of bovine follicle stimulating hormone in plants. Eur. J Biochem."}
{"meta": {"doc_id": 2441, "sent_id": 285, "sent_start_pos": 38390, "sent_end_pos": 38421, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Eur. J Biochem. 268, 4570\u20134579."}
{"meta": {"doc_id": 2441, "sent_id": 286, "sent_start_pos": 38395, "sent_end_pos": 38549, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J Biochem. 268, 4570\u20134579. doi: 10.1046/j1432-1327.2001.02384.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nEibl, M M (2008)."}
{"meta": {"doc_id": 2441, "sent_id": 287, "sent_start_pos": 38406, "sent_end_pos": 38588, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "268, 4570\u20134579. doi: 10.1046/j1432-1327.2001.02384.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nEibl, M M (2008). History of immunoglobulin replacement."}
{"meta": {"doc_id": 2441, "sent_id": 288, "sent_start_pos": 38422, "sent_end_pos": 38597, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1046/j1432-1327.2001.02384.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nEibl, M M (2008). History of immunoglobulin replacement. Immunol."}
{"meta": {"doc_id": 2441, "sent_id": 289, "sent_start_pos": 38550, "sent_end_pos": 38611, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "History of immunoglobulin replacement. Immunol. Allergy Clin."}
{"meta": {"doc_id": 2441, "sent_id": 290, "sent_start_pos": 38589, "sent_end_pos": 38621, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Immunol. Allergy Clin. North Am."}
{"meta": {"doc_id": 2441, "sent_id": 291, "sent_start_pos": 38598, "sent_end_pos": 38634, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Allergy Clin. North Am. 28, 737\u2013764."}
{"meta": {"doc_id": 2441, "sent_id": 292, "sent_start_pos": 38612, "sent_end_pos": 38794, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "North Am. 28, 737\u2013764. doi: 10.1016/jiac.2008.06.004\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nElvin, J G, Couston, R G, and Van Der Walle, C F (2013)."}
{"meta": {"doc_id": 2441, "sent_id": 293, "sent_start_pos": 38622, "sent_end_pos": 38876, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "28, 737\u2013764. doi: 10.1016/jiac.2008.06.004\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nElvin, J G, Couston, R G, and Van Der Walle, C F (2013). Therapeutic antibodies: market considerations, disease targets and bioprocessing."}
{"meta": {"doc_id": 2441, "sent_id": 294, "sent_start_pos": 38635, "sent_end_pos": 38881, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/jiac.2008.06.004\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nElvin, J G, Couston, R G, and Van Der Walle, C F (2013). Therapeutic antibodies: market considerations, disease targets and bioprocessing. Int."}
{"meta": {"doc_id": 2441, "sent_id": 295, "sent_start_pos": 38795, "sent_end_pos": 38890, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Therapeutic antibodies: market considerations, disease targets and bioprocessing. Int. J Pharm."}
{"meta": {"doc_id": 2441, "sent_id": 296, "sent_start_pos": 38877, "sent_end_pos": 38902, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Int. J Pharm. 440, 83\u201398."}
{"meta": {"doc_id": 2441, "sent_id": 297, "sent_start_pos": 38882, "sent_end_pos": 39083, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J Pharm. 440, 83\u201398. doi: 10.1016/jijpharm.2011.12.039\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nEssl, D, Dirnberger, D, Gomord, V, Strasser, R, Faye, L, Glossl, J,et al."}
{"meta": {"doc_id": 2441, "sent_id": 298, "sent_start_pos": 38891, "sent_end_pos": 39091, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "440, 83\u201398. doi: 10.1016/jijpharm.2011.12.039\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nEssl, D, Dirnberger, D, Gomord, V, Strasser, R, Faye, L, Glossl, J,et al. (1999)."}
{"meta": {"doc_id": 2441, "sent_id": 299, "sent_start_pos": 38903, "sent_end_pos": 39267, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/jijpharm.2011.12.039\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nEssl, D, Dirnberger, D, Gomord, V, Strasser, R, Faye, L, Glossl, J,et al. (1999). The N-terminal 77 amino acids from tobacco N-acetylglucosaminyltransferase I are sufficient to retain a reporter protein in the Golgi apparatus of Nicotiana benthamiana cells."}
{"meta": {"doc_id": 2441, "sent_id": 300, "sent_start_pos": 39084, "sent_end_pos": 39278, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(1999). The N-terminal 77 amino acids from tobacco N-acetylglucosaminyltransferase I are sufficient to retain a reporter protein in the Golgi apparatus of Nicotiana benthamiana cells. FEBS Lett."}
{"meta": {"doc_id": 2441, "sent_id": 301, "sent_start_pos": 39092, "sent_end_pos": 39292, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The N-terminal 77 amino acids from tobacco N-acetylglucosaminyltransferase I are sufficient to retain a reporter protein in the Golgi apparatus of Nicotiana benthamiana cells. FEBS Lett. 453, 169\u2013173."}
{"meta": {"doc_id": 2441, "sent_id": 302, "sent_start_pos": 39268, "sent_end_pos": 39472, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "FEBS Lett. 453, 169\u2013173. doi: 10.1016/S0014-5793(99)00712-7\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nFanata, W I D, Lee, K H, Son, B H, Yoo, J Y, Harmoko, R, Ko, K S,et al."}
{"meta": {"doc_id": 2441, "sent_id": 303, "sent_start_pos": 39279, "sent_end_pos": 39480, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "453, 169\u2013173. doi: 10.1016/S0014-5793(99)00712-7\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nFanata, W I D, Lee, K H, Son, B H, Yoo, J Y, Harmoko, R, Ko, K S,et al. (2013)."}
{"meta": {"doc_id": 2441, "sent_id": 304, "sent_start_pos": 39293, "sent_end_pos": 39587, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/S0014-5793(99)00712-7\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nFanata, W I D, Lee, K H, Son, B H, Yoo, J Y, Harmoko, R, Ko, K S,et al. (2013). N-glycan maturation is crucial for cytokinin-mediated development and cellulose synthesis in Oryza sativa."}
{"meta": {"doc_id": 2441, "sent_id": 305, "sent_start_pos": 39473, "sent_end_pos": 39608, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2013). N-glycan maturation is crucial for cytokinin-mediated development and cellulose synthesis in Oryza sativa. Plant J 73, 966\u2013979."}
{"meta": {"doc_id": 2441, "sent_id": 306, "sent_start_pos": 39481, "sent_end_pos": 39723, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "N-glycan maturation is crucial for cytokinin-mediated development and cellulose synthesis in Oryza sativa. Plant J 73, 966\u2013979. doi: 10.1111/tpj.12087\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nFelts, J H (2000)."}
{"meta": {"doc_id": 2441, "sent_id": 307, "sent_start_pos": 39588, "sent_end_pos": 39766, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant J 73, 966\u2013979. doi: 10.1111/tpj.12087\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nFelts, J H (2000). Richard lower: anatomist and physiologist."}
{"meta": {"doc_id": 2441, "sent_id": 308, "sent_start_pos": 39609, "sent_end_pos": 39771, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1111/tpj.12087\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nFelts, J H (2000). Richard lower: anatomist and physiologist. Ann."}
{"meta": {"doc_id": 2441, "sent_id": 309, "sent_start_pos": 39724, "sent_end_pos": 39779, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Richard lower: anatomist and physiologist. Ann. Intern."}
{"meta": {"doc_id": 2441, "sent_id": 310, "sent_start_pos": 39767, "sent_end_pos": 39784, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Ann. Intern. Med."}
{"meta": {"doc_id": 2441, "sent_id": 311, "sent_start_pos": 39772, "sent_end_pos": 39798, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Intern. Med. 132, 420\u2013423."}
{"meta": {"doc_id": 2441, "sent_id": 312, "sent_start_pos": 39780, "sent_end_pos": 39979, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Med. 132, 420\u2013423. doi: 10.7326/0003-4819-132-5-200003070-00023\nCrossRef Full Text | Google Scholar\nFitchette, A C, Cabanes-Macheteau, M, Marvin, L, Martin, B, Satiat-Jeunemaitre, B, Gomord, V,et al."}
{"meta": {"doc_id": 2441, "sent_id": 313, "sent_start_pos": 39785, "sent_end_pos": 39987, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "132, 420\u2013423. doi: 10.7326/0003-4819-132-5-200003070-00023\nCrossRef Full Text | Google Scholar\nFitchette, A C, Cabanes-Macheteau, M, Marvin, L, Martin, B, Satiat-Jeunemaitre, B, Gomord, V,et al. (1999)."}
{"meta": {"doc_id": 2441, "sent_id": 314, "sent_start_pos": 39799, "sent_end_pos": 40074, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.7326/0003-4819-132-5-200003070-00023\nCrossRef Full Text | Google Scholar\nFitchette, A C, Cabanes-Macheteau, M, Marvin, L, Martin, B, Satiat-Jeunemaitre, B, Gomord, V,et al. (1999). Biosynthesis and immunolocalization of Lewis a-containing N-glycans in the plant cell."}
{"meta": {"doc_id": 2441, "sent_id": 315, "sent_start_pos": 39980, "sent_end_pos": 40089, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(1999). Biosynthesis and immunolocalization of Lewis a-containing N-glycans in the plant cell. Plant Physiol."}
{"meta": {"doc_id": 2441, "sent_id": 316, "sent_start_pos": 39988, "sent_end_pos": 40103, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biosynthesis and immunolocalization of Lewis a-containing N-glycans in the plant cell. Plant Physiol. 121, 333\u2013344."}
{"meta": {"doc_id": 2441, "sent_id": 317, "sent_start_pos": 40075, "sent_end_pos": 40298, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Physiol. 121, 333\u2013344. doi: 10.1104/pp.121.2.333\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nFitchette-Laine, A C, Gomord, V, Cabanes, M, Michalski, J C, Saint Macary, M, Foucher, B,et al."}
{"meta": {"doc_id": 2441, "sent_id": 318, "sent_start_pos": 40090, "sent_end_pos": 40306, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "121, 333\u2013344. doi: 10.1104/pp.121.2.333\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nFitchette-Laine, A C, Gomord, V, Cabanes, M, Michalski, J C, Saint Macary, M, Foucher, B,et al. (1997)."}
{"meta": {"doc_id": 2441, "sent_id": 319, "sent_start_pos": 40104, "sent_end_pos": 40391, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1104/pp.121.2.333\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nFitchette-Laine, A C, Gomord, V, Cabanes, M, Michalski, J C, Saint Macary, M, Foucher, B,et al. (1997). N-glycans harboring the Lewis a epitope are expressed at the surface of plant cells."}
{"meta": {"doc_id": 2441, "sent_id": 320, "sent_start_pos": 40299, "sent_end_pos": 40414, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(1997). N-glycans harboring the Lewis a epitope are expressed at the surface of plant cells. Plant J 12, 1411\u20131417."}
{"meta": {"doc_id": 2441, "sent_id": 321, "sent_start_pos": 40307, "sent_end_pos": 40603, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "N-glycans harboring the Lewis a epitope are expressed at the surface of plant cells. Plant J 12, 1411\u20131417. doi: 10.1046/j1365-313x.1997.12061411.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nForthal, D N, Gach, J S, Landucci, G, Jez, J, Strasser, R, Kunert, R,et al."}
{"meta": {"doc_id": 2441, "sent_id": 322, "sent_start_pos": 40392, "sent_end_pos": 40611, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant J 12, 1411\u20131417. doi: 10.1046/j1365-313x.1997.12061411.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nForthal, D N, Gach, J S, Landucci, G, Jez, J, Strasser, R, Kunert, R,et al. (2010)."}
{"meta": {"doc_id": 2441, "sent_id": 323, "sent_start_pos": 40415, "sent_end_pos": 40725, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1046/j1365-313x.1997.12061411.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nForthal, D N, Gach, J S, Landucci, G, Jez, J, Strasser, R, Kunert, R,et al. (2010). Fc-glycosylation influences Fc\u03b3 receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12."}
{"meta": {"doc_id": 2441, "sent_id": 324, "sent_start_pos": 40604, "sent_end_pos": 40736, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2010). Fc-glycosylation influences Fc\u03b3 receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12. J Immunol."}
{"meta": {"doc_id": 2441, "sent_id": 325, "sent_start_pos": 40612, "sent_end_pos": 40752, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Fc-glycosylation influences Fc\u03b3 receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12. J Immunol. 185, 6876\u20136882."}
{"meta": {"doc_id": 2441, "sent_id": 326, "sent_start_pos": 40726, "sent_end_pos": 40901, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J Immunol. 185, 6876\u20136882. doi: 10.4049/jimmunol.1002600\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nFrey, A D, Karg, S R, and Kallio, P T (2009)."}
{"meta": {"doc_id": 2441, "sent_id": 327, "sent_start_pos": 40737, "sent_end_pos": 41031, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "185, 6876\u20136882. doi: 10.4049/jimmunol.1002600\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nFrey, A D, Karg, S R, and Kallio, P T (2009). Expression of rat beta(1,4)-N-acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant-specific N-glycosylation."}
{"meta": {"doc_id": 2441, "sent_id": 328, "sent_start_pos": 40753, "sent_end_pos": 41049, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.4049/jimmunol.1002600\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nFrey, A D, Karg, S R, and Kallio, P T (2009). Expression of rat beta(1,4)-N-acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant-specific N-glycosylation. Plant Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 329, "sent_start_pos": 40902, "sent_end_pos": 41061, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Expression of rat beta(1,4)-N-acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant-specific N-glycosylation. Plant Biotechnol. J 7, 33\u201348."}
{"meta": {"doc_id": 2441, "sent_id": 330, "sent_start_pos": 41032, "sent_end_pos": 41215, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Biotechnol. J 7, 33\u201348. doi: 10.1111/j1467-7652.2008.00370.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nGleba, Y Y, Tuse, D, and Giritch, A (2014)."}
{"meta": {"doc_id": 2441, "sent_id": 331, "sent_start_pos": 41050, "sent_end_pos": 41266, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J 7, 33\u201348. doi: 10.1111/j1467-7652.2008.00370.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nGleba, Y Y, Tuse, D, and Giritch, A (2014). Plant viral vectors for delivery by Agrobacterium."}
{"meta": {"doc_id": 2441, "sent_id": 332, "sent_start_pos": 41062, "sent_end_pos": 41272, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1111/j1467-7652.2008.00370.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nGleba, Y Y, Tuse, D, and Giritch, A (2014). Plant viral vectors for delivery by Agrobacterium. Curr."}
{"meta": {"doc_id": 2441, "sent_id": 333, "sent_start_pos": 41216, "sent_end_pos": 41277, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant viral vectors for delivery by Agrobacterium. Curr. Top."}
{"meta": {"doc_id": 2441, "sent_id": 334, "sent_start_pos": 41267, "sent_end_pos": 41288, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Curr. Top. Microbiol."}
{"meta": {"doc_id": 2441, "sent_id": 335, "sent_start_pos": 41273, "sent_end_pos": 41297, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Top. Microbiol. Immunol."}
{"meta": {"doc_id": 2441, "sent_id": 336, "sent_start_pos": 41278, "sent_end_pos": 41311, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Microbiol. Immunol. 375, 155\u2013192."}
{"meta": {"doc_id": 2441, "sent_id": 337, "sent_start_pos": 41289, "sent_end_pos": 41430, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Immunol. 375, 155\u2013192. doi: 10.1007/82_2013_352\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nGoodman, J L (2014)."}
{"meta": {"doc_id": 2441, "sent_id": 338, "sent_start_pos": 41298, "sent_end_pos": 41498, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "375, 155\u2013192. doi: 10.1007/82_2013_352\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nGoodman, J L (2014). Studying \u201cSecret Serums\u201d \u2013 toward safe, effective ebola treatments."}
{"meta": {"doc_id": 2441, "sent_id": 339, "sent_start_pos": 41312, "sent_end_pos": 41506, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1007/82_2013_352\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nGoodman, J L (2014). Studying \u201cSecret Serums\u201d \u2013 toward safe, effective ebola treatments. N Engl."}
{"meta": {"doc_id": 2441, "sent_id": 340, "sent_start_pos": 41431, "sent_end_pos": 41513, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Studying \u201cSecret Serums\u201d \u2013 toward safe, effective ebola treatments. N Engl. J Med."}
{"meta": {"doc_id": 2441, "sent_id": 341, "sent_start_pos": 41499, "sent_end_pos": 41529, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "N Engl. J Med. 371, 1086\u20131089."}
{"meta": {"doc_id": 2441, "sent_id": 342, "sent_start_pos": 41507, "sent_end_pos": 41681, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J Med. 371, 1086\u20131089. doi: 10.1056/NEJMp1409817\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nGrabowski, G A, Golembo, M, and Shaaltiel, Y (2014)."}
{"meta": {"doc_id": 2441, "sent_id": 343, "sent_start_pos": 41514, "sent_end_pos": 41771, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "371, 1086\u20131089. doi: 10.1056/NEJMp1409817\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nGrabowski, G A, Golembo, M, and Shaaltiel, Y (2014). Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology."}
{"meta": {"doc_id": 2441, "sent_id": 344, "sent_start_pos": 41530, "sent_end_pos": 41776, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1056/NEJMp1409817\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nGrabowski, G A, Golembo, M, and Shaaltiel, Y (2014). Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology. Mol."}
{"meta": {"doc_id": 2441, "sent_id": 345, "sent_start_pos": 41682, "sent_end_pos": 41783, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology. Mol. Genet."}
{"meta": {"doc_id": 2441, "sent_id": 346, "sent_start_pos": 41772, "sent_end_pos": 41790, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Mol. Genet. Metab."}
{"meta": {"doc_id": 2441, "sent_id": 347, "sent_start_pos": 41777, "sent_end_pos": 41800, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Genet. Metab. 112, 1\u20138."}
{"meta": {"doc_id": 2441, "sent_id": 348, "sent_start_pos": 41784, "sent_end_pos": 41938, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Metab. 112, 1\u20138. doi: 10.1016/jymgme.2014.02.011\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nHelenius, A, and Aebi, M (2001)."}
{"meta": {"doc_id": 2441, "sent_id": 349, "sent_start_pos": 41791, "sent_end_pos": 41983, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "112, 1\u20138. doi: 10.1016/jymgme.2014.02.011\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nHelenius, A, and Aebi, M (2001). Intracellular functions of N-linked glycans."}
{"meta": {"doc_id": 2441, "sent_id": 350, "sent_start_pos": 41801, "sent_end_pos": 42007, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/jymgme.2014.02.011\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nHelenius, A, and Aebi, M (2001). Intracellular functions of N-linked glycans. Science 291, 2364\u20132369."}
{"meta": {"doc_id": 2441, "sent_id": 351, "sent_start_pos": 41939, "sent_end_pos": 42188, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Intracellular functions of N-linked glycans. Science 291, 2364\u20132369. doi: 10.1126/science.291.5512.2364\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nHiatt, A, Bohorova, N, Bohorov, O, Goodman, C, Kim, D, Pauly, M H,et al."}
{"meta": {"doc_id": 2441, "sent_id": 352, "sent_start_pos": 41984, "sent_end_pos": 42196, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Science 291, 2364\u20132369. doi: 10.1126/science.291.5512.2364\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nHiatt, A, Bohorova, N, Bohorov, O, Goodman, C, Kim, D, Pauly, M H,et al. (2014)."}
{"meta": {"doc_id": 2441, "sent_id": 353, "sent_start_pos": 42008, "sent_end_pos": 42308, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1126/science.291.5512.2364\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nHiatt, A, Bohorova, N, Bohorov, O, Goodman, C, Kim, D, Pauly, M H,et al. (2014). Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy."}
{"meta": {"doc_id": 2441, "sent_id": 354, "sent_start_pos": 42189, "sent_end_pos": 42314, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2014). Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy. Proc."}
{"meta": {"doc_id": 2441, "sent_id": 355, "sent_start_pos": 42197, "sent_end_pos": 42320, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy. Proc. Natl."}
{"meta": {"doc_id": 2441, "sent_id": 356, "sent_start_pos": 42309, "sent_end_pos": 42326, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Proc. Natl. Acad."}
{"meta": {"doc_id": 2441, "sent_id": 357, "sent_start_pos": 42315, "sent_end_pos": 42331, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Natl. Acad. Sci."}
{"meta": {"doc_id": 2441, "sent_id": 358, "sent_start_pos": 42321, "sent_end_pos": 42351, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Acad. Sci. USA 111, 5992\u20135997."}
{"meta": {"doc_id": 2441, "sent_id": 359, "sent_start_pos": 42327, "sent_end_pos": 42492, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Sci. USA 111, 5992\u20135997. doi: 10.1073/pnas.1402458111\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nJacobs, P P, and Callewaert, N (2009)."}
{"meta": {"doc_id": 2441, "sent_id": 360, "sent_start_pos": 42332, "sent_end_pos": 42561, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "USA 111, 5992\u20135997. doi: 10.1073/pnas.1402458111\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nJacobs, P P, and Callewaert, N (2009). N-glycosylation engineering of biopharmaceutical expression systems."}
{"meta": {"doc_id": 2441, "sent_id": 361, "sent_start_pos": 42352, "sent_end_pos": 42567, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1073/pnas.1402458111\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nJacobs, P P, and Callewaert, N (2009). N-glycosylation engineering of biopharmaceutical expression systems. Curr."}
{"meta": {"doc_id": 2441, "sent_id": 362, "sent_start_pos": 42493, "sent_end_pos": 42572, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "N-glycosylation engineering of biopharmaceutical expression systems. Curr. Mol."}
{"meta": {"doc_id": 2441, "sent_id": 363, "sent_start_pos": 42562, "sent_end_pos": 42577, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Curr. Mol. Med."}
{"meta": {"doc_id": 2441, "sent_id": 364, "sent_start_pos": 42568, "sent_end_pos": 42589, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Mol. Med. 9, 774\u2013800."}
{"meta": {"doc_id": 2441, "sent_id": 365, "sent_start_pos": 42573, "sent_end_pos": 42714, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Med. 9, 774\u2013800. doi: 10.2174/156652409789105552\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nJefferis, R (2009)."}
{"meta": {"doc_id": 2441, "sent_id": 366, "sent_start_pos": 42578, "sent_end_pos": 42782, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "9, 774\u2013800. doi: 10.2174/156652409789105552\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nJefferis, R (2009). Glycosylation as a strategy to improve antibody-based therapeutics."}
{"meta": {"doc_id": 2441, "sent_id": 367, "sent_start_pos": 42590, "sent_end_pos": 42787, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.2174/156652409789105552\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nJefferis, R (2009). Glycosylation as a strategy to improve antibody-based therapeutics. Nat."}
{"meta": {"doc_id": 2441, "sent_id": 368, "sent_start_pos": 42715, "sent_end_pos": 42792, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Glycosylation as a strategy to improve antibody-based therapeutics. Nat. Rev."}
{"meta": {"doc_id": 2441, "sent_id": 369, "sent_start_pos": 42783, "sent_end_pos": 42805, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Nat. Rev. Drug Discov."}
{"meta": {"doc_id": 2441, "sent_id": 370, "sent_start_pos": 42788, "sent_end_pos": 42817, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Rev. Drug Discov. 8, 226\u2013234."}
{"meta": {"doc_id": 2441, "sent_id": 371, "sent_start_pos": 42793, "sent_end_pos": 42947, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Drug Discov. 8, 226\u2013234. doi: 10.1038/nrd2804\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nJiang, L W, and Rogers, J C (1998)."}
{"meta": {"doc_id": 2441, "sent_id": 372, "sent_start_pos": 42806, "sent_end_pos": 43036, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "8, 226\u2013234. doi: 10.1038/nrd2804\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nJiang, L W, and Rogers, J C (1998). Integral membrane protein sorting to vacuoles in plant cells: evidence for two pathways."}
{"meta": {"doc_id": 2441, "sent_id": 373, "sent_start_pos": 42818, "sent_end_pos": 43049, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1038/nrd2804\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nJiang, L W, and Rogers, J C (1998). Integral membrane protein sorting to vacuoles in plant cells: evidence for two pathways. J Cell Biol."}
{"meta": {"doc_id": 2441, "sent_id": 374, "sent_start_pos": 42948, "sent_end_pos": 43065, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Integral membrane protein sorting to vacuoles in plant cells: evidence for two pathways. J Cell Biol. 143, 1183\u20131199."}
{"meta": {"doc_id": 2441, "sent_id": 375, "sent_start_pos": 43037, "sent_end_pos": 43238, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J Cell Biol. 143, 1183\u20131199. doi: 10.1083/jcb.143.5.1183\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nKajiura, H, Okamoto, T, Misaki, R, Matsuura, Y, and Fujiyama, K (2012)."}
{"meta": {"doc_id": 2441, "sent_id": 376, "sent_start_pos": 43050, "sent_end_pos": 43365, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "143, 1183\u20131199. doi: 10.1083/jcb.143.5.1183\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nKajiura, H, Okamoto, T, Misaki, R, Matsuura, Y, and Fujiyama, K (2012). Arabidopsis beta1,2-xylosyltransferase: substrate specificity and participation in the plant-specific N-glycosylation pathway."}
{"meta": {"doc_id": 2441, "sent_id": 377, "sent_start_pos": 43066, "sent_end_pos": 43375, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1083/jcb.143.5.1183\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nKajiura, H, Okamoto, T, Misaki, R, Matsuura, Y, and Fujiyama, K (2012). Arabidopsis beta1,2-xylosyltransferase: substrate specificity and participation in the plant-specific N-glycosylation pathway. J Biosci."}
{"meta": {"doc_id": 2441, "sent_id": 378, "sent_start_pos": 43239, "sent_end_pos": 43383, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Arabidopsis beta1,2-xylosyltransferase: substrate specificity and participation in the plant-specific N-glycosylation pathway. J Biosci. Bioeng."}
{"meta": {"doc_id": 2441, "sent_id": 379, "sent_start_pos": 43366, "sent_end_pos": 43395, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J Biosci. Bioeng. 113, 48\u201354."}
{"meta": {"doc_id": 2441, "sent_id": 380, "sent_start_pos": 43376, "sent_end_pos": 43547, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Bioeng. 113, 48\u201354. doi: 10.1016/jjbiosc.2011.09.011\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nKarg, S R, Frey, A D, and Kallio, P T (2010)."}
{"meta": {"doc_id": 2441, "sent_id": 381, "sent_start_pos": 43384, "sent_end_pos": 43760, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "113, 48\u201354. doi: 10.1016/jjbiosc.2011.09.011\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nKarg, S R, Frey, A D, and Kallio, P T (2010). Reduction of N-linked xylose and fucose by expression of rat beta1,4-N-acetylglucosaminyltransferase III in tobacco BY-2 cells depends on Golgi enzyme localization domain and genetic elements used for expression."}
{"meta": {"doc_id": 2441, "sent_id": 382, "sent_start_pos": 43396, "sent_end_pos": 43774, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/jjbiosc.2011.09.011\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nKarg, S R, Frey, A D, and Kallio, P T (2010). Reduction of N-linked xylose and fucose by expression of rat beta1,4-N-acetylglucosaminyltransferase III in tobacco BY-2 cells depends on Golgi enzyme localization domain and genetic elements used for expression. J Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 383, "sent_start_pos": 43548, "sent_end_pos": 43786, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Reduction of N-linked xylose and fucose by expression of rat beta1,4-N-acetylglucosaminyltransferase III in tobacco BY-2 cells depends on Golgi enzyme localization domain and genetic elements used for expression. J Biotechnol. 146, 54\u201365."}
{"meta": {"doc_id": 2441, "sent_id": 384, "sent_start_pos": 43761, "sent_end_pos": 43971, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J Biotechnol. 146, 54\u201365. doi: 10.1016/jjbiotec.2010.01.005\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nKoprivova, A, Stemmer, C, Altmann, F, Hoffmann, A, Kopriva, S, Gorr, G,et al."}
{"meta": {"doc_id": 2441, "sent_id": 385, "sent_start_pos": 43775, "sent_end_pos": 43979, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "146, 54\u201365. doi: 10.1016/jjbiotec.2010.01.005\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nKoprivova, A, Stemmer, C, Altmann, F, Hoffmann, A, Kopriva, S, Gorr, G,et al. (2004)."}
{"meta": {"doc_id": 2441, "sent_id": 386, "sent_start_pos": 43787, "sent_end_pos": 44062, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/jjbiotec.2010.01.005\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nKoprivova, A, Stemmer, C, Altmann, F, Hoffmann, A, Kopriva, S, Gorr, G,et al. (2004). Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans."}
{"meta": {"doc_id": 2441, "sent_id": 387, "sent_start_pos": 43972, "sent_end_pos": 44080, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2004). Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 388, "sent_start_pos": 43980, "sent_end_pos": 44094, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol. J 2, 517\u2013523."}
{"meta": {"doc_id": 2441, "sent_id": 389, "sent_start_pos": 44063, "sent_end_pos": 44276, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Biotechnol. J 2, 517\u2013523. doi: 10.1111/j1467-7652.2004.00100.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nLi, H, Sethuraman, N, Stadheim, T A, Zha, D, Prinz, B, Ballew, N,et al."}
{"meta": {"doc_id": 2441, "sent_id": 390, "sent_start_pos": 44081, "sent_end_pos": 44284, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J 2, 517\u2013523. doi: 10.1111/j1467-7652.2004.00100.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nLi, H, Sethuraman, N, Stadheim, T A, Zha, D, Prinz, B, Ballew, N,et al. (2006)."}
{"meta": {"doc_id": 2441, "sent_id": 391, "sent_start_pos": 44095, "sent_end_pos": 44351, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1111/j1467-7652.2004.00100.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nLi, H, Sethuraman, N, Stadheim, T A, Zha, D, Prinz, B, Ballew, N,et al. (2006). Optimization of humanized IgGs in glycoengineered Pichia pastoris."}
{"meta": {"doc_id": 2441, "sent_id": 392, "sent_start_pos": 44277, "sent_end_pos": 44356, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2006). Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat."}
{"meta": {"doc_id": 2441, "sent_id": 393, "sent_start_pos": 44285, "sent_end_pos": 44368, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat. Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 394, "sent_start_pos": 44352, "sent_end_pos": 44381, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Nat. Biotechnol. 24, 210\u2013215."}
{"meta": {"doc_id": 2441, "sent_id": 395, "sent_start_pos": 44357, "sent_end_pos": 44549, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biotechnol. 24, 210\u2013215. doi: 10.1038/nbt1178\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nLiebminger, E, Veit, C, Pabst, M, Batoux, M, Zipfel, C, Altmann, F,et al."}
{"meta": {"doc_id": 2441, "sent_id": 396, "sent_start_pos": 44369, "sent_end_pos": 44557, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "24, 210\u2013215. doi: 10.1038/nbt1178\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nLiebminger, E, Veit, C, Pabst, M, Batoux, M, Zipfel, C, Altmann, F,et al. (2011)."}
{"meta": {"doc_id": 2441, "sent_id": 397, "sent_start_pos": 44382, "sent_end_pos": 44690, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1038/nbt1178\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nLiebminger, E, Veit, C, Pabst, M, Batoux, M, Zipfel, C, Altmann, F,et al. (2011). Beta-N-acetylhexosaminidases HEXO1 and HEXO3 are responsible for the formation of paucimannosidic N-glycans in Arabidopsis thaliana."}
{"meta": {"doc_id": 2441, "sent_id": 398, "sent_start_pos": 44550, "sent_end_pos": 44698, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2011). Beta-N-acetylhexosaminidases HEXO1 and HEXO3 are responsible for the formation of paucimannosidic N-glycans in Arabidopsis thaliana. J Biol."}
{"meta": {"doc_id": 2441, "sent_id": 399, "sent_start_pos": 44558, "sent_end_pos": 44704, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Beta-N-acetylhexosaminidases HEXO1 and HEXO3 are responsible for the formation of paucimannosidic N-glycans in Arabidopsis thaliana. J Biol. Chem."}
{"meta": {"doc_id": 2441, "sent_id": 400, "sent_start_pos": 44691, "sent_end_pos": 44722, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J Biol. Chem. 286, 10793\u201310802."}
{"meta": {"doc_id": 2441, "sent_id": 401, "sent_start_pos": 44699, "sent_end_pos": 44861, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Chem. 286, 10793\u201310802. doi: 10.1074/jbc.M110.178020\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nLoos, A, and Steinkellner, H (2012)."}
{"meta": {"doc_id": 2441, "sent_id": 402, "sent_start_pos": 44705, "sent_end_pos": 44920, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "286, 10793\u201310802. doi: 10.1074/jbc.M110.178020\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nLoos, A, and Steinkellner, H (2012). IgG-Fc glycoengineering in non-mammalian expression hosts."}
{"meta": {"doc_id": 2441, "sent_id": 403, "sent_start_pos": 44723, "sent_end_pos": 44926, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1074/jbc.M110.178020\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nLoos, A, and Steinkellner, H (2012). IgG-Fc glycoengineering in non-mammalian expression hosts. Arch."}
{"meta": {"doc_id": 2441, "sent_id": 404, "sent_start_pos": 44862, "sent_end_pos": 44935, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "IgG-Fc glycoengineering in non-mammalian expression hosts. Arch. Biochem."}
{"meta": {"doc_id": 2441, "sent_id": 405, "sent_start_pos": 44921, "sent_end_pos": 44944, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Arch. Biochem. Biophys."}
{"meta": {"doc_id": 2441, "sent_id": 406, "sent_start_pos": 44927, "sent_end_pos": 44958, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biochem. Biophys. 526, 167\u2013173."}
{"meta": {"doc_id": 2441, "sent_id": 407, "sent_start_pos": 44936, "sent_end_pos": 45102, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biophys. 526, 167\u2013173. doi: 10.1016/jabb.2012.05.011\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nLozano-Juste, J, and Cutler, S R (2014)."}
{"meta": {"doc_id": 2441, "sent_id": 408, "sent_start_pos": 44945, "sent_end_pos": 45142, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "526, 167\u2013173. doi: 10.1016/jabb.2012.05.011\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nLozano-Juste, J, and Cutler, S R (2014). Plant genome engineering in full bloom."}
{"meta": {"doc_id": 2441, "sent_id": 409, "sent_start_pos": 44959, "sent_end_pos": 45160, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/jabb.2012.05.011\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nLozano-Juste, J, and Cutler, S R (2014). Plant genome engineering in full bloom. Trends Plant Sci."}
{"meta": {"doc_id": 2441, "sent_id": 410, "sent_start_pos": 45103, "sent_end_pos": 45173, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant genome engineering in full bloom. Trends Plant Sci. 19, 284\u2013287."}
{"meta": {"doc_id": 2441, "sent_id": 411, "sent_start_pos": 45143, "sent_end_pos": 45316, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Trends Plant Sci. 19, 284\u2013287. doi: 10.1016/jtplants.2014.02.014\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nMatsuo, K, and Matsumura, T (2011)."}
{"meta": {"doc_id": 2441, "sent_id": 412, "sent_start_pos": 45161, "sent_end_pos": 45474, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "19, 284\u2013287. doi: 10.1016/jtplants.2014.02.014\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nMatsuo, K, and Matsumura, T (2011). Deletion of fucose residues in plant N-glycans by repression of the GDP-mannose 4,6-dehydratase gene using virus-induced gene silencing and RNA interference."}
{"meta": {"doc_id": 2441, "sent_id": 413, "sent_start_pos": 45174, "sent_end_pos": 45492, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/jtplants.2014.02.014\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nMatsuo, K, and Matsumura, T (2011). Deletion of fucose residues in plant N-glycans by repression of the GDP-mannose 4,6-dehydratase gene using virus-induced gene silencing and RNA interference. Plant Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 414, "sent_start_pos": 45317, "sent_end_pos": 45506, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Deletion of fucose residues in plant N-glycans by repression of the GDP-mannose 4,6-dehydratase gene using virus-induced gene silencing and RNA interference. Plant Biotechnol. J 9, 264\u2013281."}
{"meta": {"doc_id": 2441, "sent_id": 415, "sent_start_pos": 45475, "sent_end_pos": 45693, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Biotechnol. J 9, 264\u2013281. doi: 10.1111/j1467-7652.2010.00553.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nMeuris, L, Santens, F, Elson, G, Festjens, N, Boone, M, Dos Santos, A,et al."}
{"meta": {"doc_id": 2441, "sent_id": 416, "sent_start_pos": 45493, "sent_end_pos": 45701, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J 9, 264\u2013281. doi: 10.1111/j1467-7652.2010.00553.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nMeuris, L, Santens, F, Elson, G, Festjens, N, Boone, M, Dos Santos, A,et al. (2014)."}
{"meta": {"doc_id": 2441, "sent_id": 417, "sent_start_pos": 45507, "sent_end_pos": 45796, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1111/j1467-7652.2010.00553.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nMeuris, L, Santens, F, Elson, G, Festjens, N, Boone, M, Dos Santos, A,et al. (2014). GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins."}
{"meta": {"doc_id": 2441, "sent_id": 418, "sent_start_pos": 45694, "sent_end_pos": 45801, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2014). GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins. Nat."}
{"meta": {"doc_id": 2441, "sent_id": 419, "sent_start_pos": 45702, "sent_end_pos": 45813, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins. Nat. Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 420, "sent_start_pos": 45797, "sent_end_pos": 45826, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Nat. Biotechnol. 32, 485\u2013489."}
{"meta": {"doc_id": 2441, "sent_id": 421, "sent_start_pos": 45802, "sent_end_pos": 45989, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biotechnol. 32, 485\u2013489. doi: 10.1038/nbt.2885\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nNagels, B, Van Damme, E J, Callewaert, N, and Weterings, K (2012a)."}
{"meta": {"doc_id": 2441, "sent_id": 422, "sent_start_pos": 45814, "sent_end_pos": 46061, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "32, 485\u2013489. doi: 10.1038/nbt.2885\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nNagels, B, Van Damme, E J, Callewaert, N, and Weterings, K (2012a). Introduction of tri-antennary N-glycans in Arabidopsis thaliana plants."}
{"meta": {"doc_id": 2441, "sent_id": 423, "sent_start_pos": 45827, "sent_end_pos": 46072, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1038/nbt.2885\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nNagels, B, Van Damme, E J, Callewaert, N, and Weterings, K (2012a). Introduction of tri-antennary N-glycans in Arabidopsis thaliana plants. Plant Sci."}
{"meta": {"doc_id": 2441, "sent_id": 424, "sent_start_pos": 45990, "sent_end_pos": 46090, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Introduction of tri-antennary N-glycans in Arabidopsis thaliana plants. Plant Sci. 185\u2013186, 161\u2013168."}
{"meta": {"doc_id": 2441, "sent_id": 425, "sent_start_pos": 46062, "sent_end_pos": 46286, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Sci. 185\u2013186, 161\u2013168. doi: 10.1016/jplantsci.2011.10.002\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nNagels, B, Van Damme, E J, Callewaert, N, Zabeau, L, Tavernier, J, Delanghe, J R,et al."}
{"meta": {"doc_id": 2441, "sent_id": 426, "sent_start_pos": 46073, "sent_end_pos": 46295, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "185\u2013186, 161\u2013168. doi: 10.1016/jplantsci.2011.10.002\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nNagels, B, Van Damme, E J, Callewaert, N, Zabeau, L, Tavernier, J, Delanghe, J R,et al. (2012b)."}
{"meta": {"doc_id": 2441, "sent_id": 427, "sent_start_pos": 46091, "sent_end_pos": 46446, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/jplantsci.2011.10.002\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nNagels, B, Van Damme, E J, Callewaert, N, Zabeau, L, Tavernier, J, Delanghe, J R,et al. (2012b). Biologically active, magnICON(\u00ae)-expressed EPO-Fc from stably transformed Nicotiana benthamiana plants presenting tetra-antennary N-glycan structures."}
{"meta": {"doc_id": 2441, "sent_id": 428, "sent_start_pos": 46287, "sent_end_pos": 46460, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2012b). Biologically active, magnICON(\u00ae)-expressed EPO-Fc from stably transformed Nicotiana benthamiana plants presenting tetra-antennary N-glycan structures. J Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 429, "sent_start_pos": 46296, "sent_end_pos": 46474, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biologically active, magnICON(\u00ae)-expressed EPO-Fc from stably transformed Nicotiana benthamiana plants presenting tetra-antennary N-glycan structures. J Biotechnol. 160, 242\u2013250."}
{"meta": {"doc_id": 2441, "sent_id": 430, "sent_start_pos": 46447, "sent_end_pos": 46658, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J Biotechnol. 160, 242\u2013250. doi: 10.1016/jjbiotec.2012.03.003\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nNagels, B, Van Damme, E J, Pabst, M, Callewaert, N, and Weterings, K (2011)."}
{"meta": {"doc_id": 2441, "sent_id": 431, "sent_start_pos": 46461, "sent_end_pos": 46738, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "160, 242\u2013250. doi: 10.1016/jjbiotec.2012.03.003\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nNagels, B, Van Damme, E J, Pabst, M, Callewaert, N, and Weterings, K (2011). Production of complex multiantennary N-glycans in Nicotiana benthamiana plants."}
{"meta": {"doc_id": 2441, "sent_id": 432, "sent_start_pos": 46475, "sent_end_pos": 46753, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/jjbiotec.2012.03.003\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nNagels, B, Van Damme, E J, Pabst, M, Callewaert, N, and Weterings, K (2011). Production of complex multiantennary N-glycans in Nicotiana benthamiana plants. Plant Physiol."}
{"meta": {"doc_id": 2441, "sent_id": 433, "sent_start_pos": 46659, "sent_end_pos": 46769, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Production of complex multiantennary N-glycans in Nicotiana benthamiana plants. Plant Physiol. 155, 1103\u20131112."}
{"meta": {"doc_id": 2441, "sent_id": 434, "sent_start_pos": 46739, "sent_end_pos": 46891, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Physiol. 155, 1103\u20131112. doi: 10.1104/pp.110.168773\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nNarasimhan, S (1982)."}
{"meta": {"doc_id": 2441, "sent_id": 435, "sent_start_pos": 46754, "sent_end_pos": 46926, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "155, 1103\u20131112. doi: 10.1104/pp.110.168773\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nNarasimhan, S (1982). Control of glycoprotein synthesis."}
{"meta": {"doc_id": 2441, "sent_id": 436, "sent_start_pos": 46770, "sent_end_pos": 47140, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1104/pp.110.168773\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nNarasimhan, S (1982). Control of glycoprotein synthesis. UDP-GlcNAc:glycopeptide beta 4-N-acetylglucosaminyltransferase III, an enzyme in hen oviduct which adds GlcNAc in beta 1-4 linkage to the beta-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides."}
{"meta": {"doc_id": 2441, "sent_id": 437, "sent_start_pos": 46892, "sent_end_pos": 47148, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Control of glycoprotein synthesis. UDP-GlcNAc:glycopeptide beta 4-N-acetylglucosaminyltransferase III, an enzyme in hen oviduct which adds GlcNAc in beta 1-4 linkage to the beta-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides. J Biol."}
{"meta": {"doc_id": 2441, "sent_id": 438, "sent_start_pos": 46927, "sent_end_pos": 47154, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "UDP-GlcNAc:glycopeptide beta 4-N-acetylglucosaminyltransferase III, an enzyme in hen oviduct which adds GlcNAc in beta 1-4 linkage to the beta-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides. J Biol. Chem."}
{"meta": {"doc_id": 2441, "sent_id": 439, "sent_start_pos": 47141, "sent_end_pos": 47172, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J Biol. Chem. 257, 10235\u201310242."}
{"meta": {"doc_id": 2441, "sent_id": 440, "sent_start_pos": 47149, "sent_end_pos": 47259, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Chem. 257, 10235\u201310242. Pubmed Abstract | Pubmed Full Text | Google Scholar\nOhtsubo, K, and Marth, J D (2006)."}
{"meta": {"doc_id": 2441, "sent_id": 441, "sent_start_pos": 47155, "sent_end_pos": 47319, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "257, 10235\u201310242. Pubmed Abstract | Pubmed Full Text | Google Scholar\nOhtsubo, K, and Marth, J D (2006). Glycosylation in cellular mechanisms of health and disease."}
{"meta": {"doc_id": 2441, "sent_id": 442, "sent_start_pos": 47173, "sent_end_pos": 47338, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Pubmed Abstract | Pubmed Full Text | Google Scholar\nOhtsubo, K, and Marth, J D (2006). Glycosylation in cellular mechanisms of health and disease. Cell 126, 855\u2013867."}
{"meta": {"doc_id": 2441, "sent_id": 443, "sent_start_pos": 47260, "sent_end_pos": 47503, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Glycosylation in cellular mechanisms of health and disease. Cell 126, 855\u2013867. doi: 10.1016/jcell.2006.08.019\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nOikawa, A, Lund, C H, Sakuragi, Y, and Scheller, H V (2013)."}
{"meta": {"doc_id": 2441, "sent_id": 444, "sent_start_pos": 47320, "sent_end_pos": 47570, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Cell 126, 855\u2013867. doi: 10.1016/jcell.2006.08.019\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nOikawa, A, Lund, C H, Sakuragi, Y, and Scheller, H V (2013). Golgi-localized enzyme complexes for plant cell wall biosynthesis."}
{"meta": {"doc_id": 2441, "sent_id": 445, "sent_start_pos": 47339, "sent_end_pos": 47588, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/jcell.2006.08.019\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nOikawa, A, Lund, C H, Sakuragi, Y, and Scheller, H V (2013). Golgi-localized enzyme complexes for plant cell wall biosynthesis. Trends Plant Sci."}
{"meta": {"doc_id": 2441, "sent_id": 446, "sent_start_pos": 47504, "sent_end_pos": 47599, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Golgi-localized enzyme complexes for plant cell wall biosynthesis. Trends Plant Sci. 18, 49\u201358."}
{"meta": {"doc_id": 2441, "sent_id": 447, "sent_start_pos": 47571, "sent_end_pos": 47795, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Trends Plant Sci. 18, 49\u201358. doi: 10.1016/jtplants.2012.07.002\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nPagny, S, Bouissonnie, F, Sarkar, M, Follet-Gueye, M L, Driouich, A, Schachter, H,et al."}
{"meta": {"doc_id": 2441, "sent_id": 448, "sent_start_pos": 47589, "sent_end_pos": 47803, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "18, 49\u201358. doi: 10.1016/jtplants.2012.07.002\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nPagny, S, Bouissonnie, F, Sarkar, M, Follet-Gueye, M L, Driouich, A, Schachter, H,et al. (2003)."}
{"meta": {"doc_id": 2441, "sent_id": 449, "sent_start_pos": 47600, "sent_end_pos": 47907, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/jtplants.2012.07.002\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nPagny, S, Bouissonnie, F, Sarkar, M, Follet-Gueye, M L, Driouich, A, Schachter, H,et al. (2003). Structural requirements for Arabidopsis beta1,2-xylosyltransferase activity and targeting to the Golgi."}
{"meta": {"doc_id": 2441, "sent_id": 450, "sent_start_pos": 47796, "sent_end_pos": 47928, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2003). Structural requirements for Arabidopsis beta1,2-xylosyltransferase activity and targeting to the Golgi. Plant J 33, 189\u2013203."}
{"meta": {"doc_id": 2441, "sent_id": 451, "sent_start_pos": 47804, "sent_end_pos": 48117, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Structural requirements for Arabidopsis beta1,2-xylosyltransferase activity and targeting to the Golgi. Plant J 33, 189\u2013203. doi: 10.1046/j0960-7412.2002.01604.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nPalacpac, N Q, Yoshida, S, Sakai, H, Kimura, Y, Fujiyama, K, Yoshida, T,et al."}
{"meta": {"doc_id": 2441, "sent_id": 452, "sent_start_pos": 47908, "sent_end_pos": 48125, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant J 33, 189\u2013203. doi: 10.1046/j0960-7412.2002.01604.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nPalacpac, N Q, Yoshida, S, Sakai, H, Kimura, Y, Fujiyama, K, Yoshida, T,et al. (1999)."}
{"meta": {"doc_id": 2441, "sent_id": 453, "sent_start_pos": 47929, "sent_end_pos": 48239, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1046/j0960-7412.2002.01604.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nPalacpac, N Q, Yoshida, S, Sakai, H, Kimura, Y, Fujiyama, K, Yoshida, T,et al. (1999). Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns."}
{"meta": {"doc_id": 2441, "sent_id": 454, "sent_start_pos": 48118, "sent_end_pos": 48245, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(1999). Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. Proc."}
{"meta": {"doc_id": 2441, "sent_id": 455, "sent_start_pos": 48126, "sent_end_pos": 48251, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. Proc. Natl."}
{"meta": {"doc_id": 2441, "sent_id": 456, "sent_start_pos": 48240, "sent_end_pos": 48257, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Proc. Natl. Acad."}
{"meta": {"doc_id": 2441, "sent_id": 457, "sent_start_pos": 48246, "sent_end_pos": 48262, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Natl. Acad. Sci."}
{"meta": {"doc_id": 2441, "sent_id": 458, "sent_start_pos": 48252, "sent_end_pos": 48281, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Acad. Sci. USA 96, 4692\u20134697."}
{"meta": {"doc_id": 2441, "sent_id": 459, "sent_start_pos": 48258, "sent_end_pos": 48418, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Sci. USA 96, 4692\u20134697. doi: 10.1073/pnas.96.8.4692\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nPandhal, J, and Wright, P C (2010)."}
{"meta": {"doc_id": 2441, "sent_id": 460, "sent_start_pos": 48263, "sent_end_pos": 48488, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "USA 96, 4692\u20134697. doi: 10.1073/pnas.96.8.4692\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nPandhal, J, and Wright, P C (2010). N-Linked glycoengineering for human therapeutic proteins in bacteria."}
{"meta": {"doc_id": 2441, "sent_id": 461, "sent_start_pos": 48282, "sent_end_pos": 48500, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1073/pnas.96.8.4692\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nPandhal, J, and Wright, P C (2010). N-Linked glycoengineering for human therapeutic proteins in bacteria. Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 462, "sent_start_pos": 48419, "sent_end_pos": 48506, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "N-Linked glycoengineering for human therapeutic proteins in bacteria. Biotechnol. Lett."}
{"meta": {"doc_id": 2441, "sent_id": 463, "sent_start_pos": 48489, "sent_end_pos": 48521, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biotechnol. Lett. 32, 1189\u20131198."}
{"meta": {"doc_id": 2441, "sent_id": 464, "sent_start_pos": 48501, "sent_end_pos": 48709, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Lett. 32, 1189\u20131198. doi: 10.1007/s10529-010-0289-6\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nParsons, J, Altmann, F, Arrenberg, C K, Koprivova, A, Beike, A K, Stemmer, C,et al."}
{"meta": {"doc_id": 2441, "sent_id": 465, "sent_start_pos": 48507, "sent_end_pos": 48717, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "32, 1189\u20131198. doi: 10.1007/s10529-010-0289-6\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nParsons, J, Altmann, F, Arrenberg, C K, Koprivova, A, Beike, A K, Stemmer, C,et al. (2012)."}
{"meta": {"doc_id": 2441, "sent_id": 466, "sent_start_pos": 48522, "sent_end_pos": 48833, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1007/s10529-010-0289-6\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nParsons, J, Altmann, F, Arrenberg, C K, Koprivova, A, Beike, A K, Stemmer, C,et al. (2012). Moss-based production of asialo-erythropoietin devoid of Lewis A and other plant-typical carbohydrate determinants."}
{"meta": {"doc_id": 2441, "sent_id": 467, "sent_start_pos": 48710, "sent_end_pos": 48851, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2012). Moss-based production of asialo-erythropoietin devoid of Lewis A and other plant-typical carbohydrate determinants. Plant Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 468, "sent_start_pos": 48718, "sent_end_pos": 48866, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Moss-based production of asialo-erythropoietin devoid of Lewis A and other plant-typical carbohydrate determinants. Plant Biotechnol. J 10, 851\u2013861."}
{"meta": {"doc_id": 2441, "sent_id": 469, "sent_start_pos": 48834, "sent_end_pos": 48994, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Biotechnol. J 10, 851\u2013861. doi: 10.1111/j1467-7652.2012.00704.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nRatner, M (2014)."}
{"meta": {"doc_id": 2441, "sent_id": 470, "sent_start_pos": 48852, "sent_end_pos": 49052, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J 10, 851\u2013861. doi: 10.1111/j1467-7652.2012.00704.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nRatner, M (2014). Genentech\u2019s glyco-engineered antibody to succeed Rituxan."}
{"meta": {"doc_id": 2441, "sent_id": 471, "sent_start_pos": 48867, "sent_end_pos": 49057, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1111/j1467-7652.2012.00704.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nRatner, M (2014). Genentech\u2019s glyco-engineered antibody to succeed Rituxan. Nat."}
{"meta": {"doc_id": 2441, "sent_id": 472, "sent_start_pos": 48995, "sent_end_pos": 49069, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Genentech\u2019s glyco-engineered antibody to succeed Rituxan. Nat. Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 473, "sent_start_pos": 49053, "sent_end_pos": 49078, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Nat. Biotechnol. 32, 6\u20137."}
{"meta": {"doc_id": 2441, "sent_id": 474, "sent_start_pos": 49058, "sent_end_pos": 49241, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biotechnol. 32, 6\u20137. doi: 10.1038/nbt0114-6b\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nRivera, A M, Strauss, K W, Van Zundert, A, and Mortier, E (2005)."}
{"meta": {"doc_id": 2441, "sent_id": 475, "sent_start_pos": 49070, "sent_end_pos": 49340, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "32, 6\u20137. doi: 10.1038/nbt0114-6b\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nRivera, A M, Strauss, K W, Van Zundert, A, and Mortier, E (2005). The history of peripheral intravenous catheters: how little plastic tubes revolutionized medicine."}
{"meta": {"doc_id": 2441, "sent_id": 476, "sent_start_pos": 49079, "sent_end_pos": 49359, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1038/nbt0114-6b\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nRivera, A M, Strauss, K W, Van Zundert, A, and Mortier, E (2005). The history of peripheral intravenous catheters: how little plastic tubes revolutionized medicine. Acta Anaesthesiol."}
{"meta": {"doc_id": 2441, "sent_id": 477, "sent_start_pos": 49242, "sent_end_pos": 49365, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The history of peripheral intravenous catheters: how little plastic tubes revolutionized medicine. Acta Anaesthesiol. Belg."}
{"meta": {"doc_id": 2441, "sent_id": 478, "sent_start_pos": 49341, "sent_end_pos": 49378, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Acta Anaesthesiol. Belg. 56, 271\u2013282."}
{"meta": {"doc_id": 2441, "sent_id": 479, "sent_start_pos": 49360, "sent_end_pos": 49494, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Belg. 56, 271\u2013282. Pubmed Abstract | Pubmed Full Text | Google Scholar\nRoth, J, Zuber, C, Park, S, Jang, I, Lee, Y, Kysela, K G,et al."}
{"meta": {"doc_id": 2441, "sent_id": 480, "sent_start_pos": 49366, "sent_end_pos": 49502, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "56, 271\u2013282. Pubmed Abstract | Pubmed Full Text | Google Scholar\nRoth, J, Zuber, C, Park, S, Jang, I, Lee, Y, Kysela, K G,et al. (2010)."}
{"meta": {"doc_id": 2441, "sent_id": 481, "sent_start_pos": 49379, "sent_end_pos": 49573, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Pubmed Abstract | Pubmed Full Text | Google Scholar\nRoth, J, Zuber, C, Park, S, Jang, I, Lee, Y, Kysela, K G,et al. (2010). Protein N-glycosylation, protein folding, and protein quality control."}
{"meta": {"doc_id": 2441, "sent_id": 482, "sent_start_pos": 49495, "sent_end_pos": 49578, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2010). Protein N-glycosylation, protein folding, and protein quality control. Mol."}
{"meta": {"doc_id": 2441, "sent_id": 483, "sent_start_pos": 49503, "sent_end_pos": 49597, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Protein N-glycosylation, protein folding, and protein quality control. Mol. Cells 30, 497\u2013506."}
{"meta": {"doc_id": 2441, "sent_id": 484, "sent_start_pos": 49574, "sent_end_pos": 49788, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Mol. Cells 30, 497\u2013506. doi: 10.1007/s10059-010-0159-z\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nRouwendal, G J, Wuhrer, M, Florack, D E, Koeleman, C A, Deelder, A M, Bakker, H,et al."}
{"meta": {"doc_id": 2441, "sent_id": 485, "sent_start_pos": 49579, "sent_end_pos": 49796, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Cells 30, 497\u2013506. doi: 10.1007/s10059-010-0159-z\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nRouwendal, G J, Wuhrer, M, Florack, D E, Koeleman, C A, Deelder, A M, Bakker, H,et al. (2007)."}
{"meta": {"doc_id": 2441, "sent_id": 486, "sent_start_pos": 49598, "sent_end_pos": 49948, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1007/s10059-010-0159-z\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nRouwendal, G J, Wuhrer, M, Florack, D E, Koeleman, C A, Deelder, A M, Bakker, H,et al. (2007). Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III."}
{"meta": {"doc_id": 2441, "sent_id": 487, "sent_start_pos": 49789, "sent_end_pos": 49974, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2007). Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III. Glycobiology 17, 334\u2013344."}
{"meta": {"doc_id": 2441, "sent_id": 488, "sent_start_pos": 49797, "sent_end_pos": 50171, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III. Glycobiology 17, 334\u2013344. doi: 10.1093/glycob/cwl078\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSaint-Jore-Dupas, C, Nebenfuhr, A, Boulaflous, A, Follet-Gueye, M L, Plasson, C, Hawes, C,et al."}
{"meta": {"doc_id": 2441, "sent_id": 489, "sent_start_pos": 49949, "sent_end_pos": 50179, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Glycobiology 17, 334\u2013344. doi: 10.1093/glycob/cwl078\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSaint-Jore-Dupas, C, Nebenfuhr, A, Boulaflous, A, Follet-Gueye, M L, Plasson, C, Hawes, C,et al. (2006)."}
{"meta": {"doc_id": 2441, "sent_id": 490, "sent_start_pos": 49975, "sent_end_pos": 50310, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1093/glycob/cwl078\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSaint-Jore-Dupas, C, Nebenfuhr, A, Boulaflous, A, Follet-Gueye, M L, Plasson, C, Hawes, C,et al. (2006). Plant N-glycan processing enzymes employ different targeting mechanisms for their spatial arrangement along the secretory pathway."}
{"meta": {"doc_id": 2441, "sent_id": 491, "sent_start_pos": 50172, "sent_end_pos": 50336, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2006). Plant N-glycan processing enzymes employ different targeting mechanisms for their spatial arrangement along the secretory pathway. Plant Cell 18, 3182\u20133200."}
{"meta": {"doc_id": 2441, "sent_id": 492, "sent_start_pos": 50180, "sent_end_pos": 50535, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant N-glycan processing enzymes employ different targeting mechanisms for their spatial arrangement along the secretory pathway. Plant Cell 18, 3182\u20133200. doi: 10.1105/tpc.105.036400\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSarrion-Perdigones, A, Vazquez-Vilar, M, Palaci, J, Castelijns, B, Forment, J, Ziarsolo, P,et al."}
{"meta": {"doc_id": 2441, "sent_id": 493, "sent_start_pos": 50311, "sent_end_pos": 50543, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Cell 18, 3182\u20133200. doi: 10.1105/tpc.105.036400\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSarrion-Perdigones, A, Vazquez-Vilar, M, Palaci, J, Castelijns, B, Forment, J, Ziarsolo, P,et al. (2013)."}
{"meta": {"doc_id": 2441, "sent_id": 494, "sent_start_pos": 50337, "sent_end_pos": 50628, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1105/tpc.105.036400\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSarrion-Perdigones, A, Vazquez-Vilar, M, Palaci, J, Castelijns, B, Forment, J, Ziarsolo, P,et al. (2013). GoldenBraid 2.0: a comprehensive DNA assembly framework for plant synthetic biology."}
{"meta": {"doc_id": 2441, "sent_id": 495, "sent_start_pos": 50536, "sent_end_pos": 50643, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2013). GoldenBraid 2.0: a comprehensive DNA assembly framework for plant synthetic biology. Plant Physiol."}
{"meta": {"doc_id": 2441, "sent_id": 496, "sent_start_pos": 50544, "sent_end_pos": 50659, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "GoldenBraid 2.0: a comprehensive DNA assembly framework for plant synthetic biology. Plant Physiol. 162, 1618\u20131631."}
{"meta": {"doc_id": 2441, "sent_id": 497, "sent_start_pos": 50629, "sent_end_pos": 50851, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Physiol. 162, 1618\u20131631. doi: 10.1104/pp.113.217661\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSch\u00e4hs, M, Strasser, R, Stadlmann, J, Kunert, R, Rademacher, T, and Steinkellner, H (2007)."}
{"meta": {"doc_id": 2441, "sent_id": 498, "sent_start_pos": 50644, "sent_end_pos": 50939, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "162, 1618\u20131631. doi: 10.1104/pp.113.217661\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSch\u00e4hs, M, Strasser, R, Stadlmann, J, Kunert, R, Rademacher, T, and Steinkellner, H (2007). Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern."}
{"meta": {"doc_id": 2441, "sent_id": 499, "sent_start_pos": 50660, "sent_end_pos": 50957, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1104/pp.113.217661\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSch\u00e4hs, M, Strasser, R, Stadlmann, J, Kunert, R, Rademacher, T, and Steinkellner, H (2007). Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 500, "sent_start_pos": 50852, "sent_end_pos": 50971, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol. J 5, 657\u2013663."}
{"meta": {"doc_id": 2441, "sent_id": 501, "sent_start_pos": 50940, "sent_end_pos": 51163, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Biotechnol. J 5, 657\u2013663. doi: 10.1111/j1467-7652.2007.00273.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchneider, J D, Marillonnet, S, Castilho, A, Gruber, C, Werner, S, Mach, L,et al."}
{"meta": {"doc_id": 2441, "sent_id": 502, "sent_start_pos": 50958, "sent_end_pos": 51171, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J 5, 657\u2013663. doi: 10.1111/j1467-7652.2007.00273.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchneider, J D, Marillonnet, S, Castilho, A, Gruber, C, Werner, S, Mach, L,et al. (2014)."}
{"meta": {"doc_id": 2441, "sent_id": 503, "sent_start_pos": 50972, "sent_end_pos": 51309, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1111/j1467-7652.2007.00273.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchneider, J D, Marillonnet, S, Castilho, A, Gruber, C, Werner, S, Mach, L,et al. (2014). Oligomerization status influences subcellular deposition and glycosylation of recombinant butyrylcholinesterase in Nicotiana benthamiana."}
{"meta": {"doc_id": 2441, "sent_id": 504, "sent_start_pos": 51164, "sent_end_pos": 51327, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2014). Oligomerization status influences subcellular deposition and glycosylation of recombinant butyrylcholinesterase in Nicotiana benthamiana. Plant Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 505, "sent_start_pos": 51172, "sent_end_pos": 51342, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Oligomerization status influences subcellular deposition and glycosylation of recombinant butyrylcholinesterase in Nicotiana benthamiana. Plant Biotechnol. J 12, 832\u2013839."}
{"meta": {"doc_id": 2441, "sent_id": 506, "sent_start_pos": 51310, "sent_end_pos": 51516, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Biotechnol. J 12, 832\u2013839. doi: 10.1111/pbi.12184\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchoberer, J, Liebminger, E, Botchway, S W, Strasser, R, and Hawes, C (2013)."}
{"meta": {"doc_id": 2441, "sent_id": 507, "sent_start_pos": 51328, "sent_end_pos": 51650, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J 12, 832\u2013839. doi: 10.1111/pbi.12184\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchoberer, J, Liebminger, E, Botchway, S W, Strasser, R, and Hawes, C (2013). Time-resolved fluorescence imaging reveals differential interactions of N-glycan processing enzymes across the Golgi stack in planta."}
{"meta": {"doc_id": 2441, "sent_id": 508, "sent_start_pos": 51343, "sent_end_pos": 51665, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1111/pbi.12184\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchoberer, J, Liebminger, E, Botchway, S W, Strasser, R, and Hawes, C (2013). Time-resolved fluorescence imaging reveals differential interactions of N-glycan processing enzymes across the Golgi stack in planta. Plant Physiol."}
{"meta": {"doc_id": 2441, "sent_id": 509, "sent_start_pos": 51517, "sent_end_pos": 51681, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Time-resolved fluorescence imaging reveals differential interactions of N-glycan processing enzymes across the Golgi stack in planta. Plant Physiol. 161, 1737\u20131754."}
{"meta": {"doc_id": 2441, "sent_id": 510, "sent_start_pos": 51651, "sent_end_pos": 51874, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Physiol. 161, 1737\u20131754. doi: 10.1104/pp.112.210757\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchoberer, J, Runions, J, Steinkellner, H, Strasser, R, Hawes, C, and Osterrieder, A (2010)."}
{"meta": {"doc_id": 2441, "sent_id": 511, "sent_start_pos": 51666, "sent_end_pos": 51971, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "161, 1737\u20131754. doi: 10.1104/pp.112.210757\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchoberer, J, Runions, J, Steinkellner, H, Strasser, R, Hawes, C, and Osterrieder, A (2010). Sequential depletion and acquisition of proteins during Golgi stack disassembly and reformation."}
{"meta": {"doc_id": 2441, "sent_id": 512, "sent_start_pos": 51682, "sent_end_pos": 51994, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1104/pp.112.210757\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchoberer, J, Runions, J, Steinkellner, H, Strasser, R, Hawes, C, and Osterrieder, A (2010). Sequential depletion and acquisition of proteins during Golgi stack disassembly and reformation. Traffic 11, 1429\u20131444."}
{"meta": {"doc_id": 2441, "sent_id": 513, "sent_start_pos": 51875, "sent_end_pos": 52142, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Sequential depletion and acquisition of proteins during Golgi stack disassembly and reformation. Traffic 11, 1429\u20131444. doi: 10.1111/j1600-0854.2010.01106.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchoberer, J, and Strasser, R (2011)."}
{"meta": {"doc_id": 2441, "sent_id": 514, "sent_start_pos": 51972, "sent_end_pos": 52230, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Traffic 11, 1429\u20131444. doi: 10.1111/j1600-0854.2010.01106.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchoberer, J, and Strasser, R (2011). Sub-compartmental organization of Golgi-resident N-glycan processing enzymes in plants."}
{"meta": {"doc_id": 2441, "sent_id": 515, "sent_start_pos": 51995, "sent_end_pos": 52235, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1111/j1600-0854.2010.01106.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchoberer, J, and Strasser, R (2011). Sub-compartmental organization of Golgi-resident N-glycan processing enzymes in plants. Mol."}
{"meta": {"doc_id": 2441, "sent_id": 516, "sent_start_pos": 52143, "sent_end_pos": 52253, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Sub-compartmental organization of Golgi-resident N-glycan processing enzymes in plants. Mol. Plant 4, 220\u2013228."}
{"meta": {"doc_id": 2441, "sent_id": 517, "sent_start_pos": 52231, "sent_end_pos": 52429, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Mol. Plant 4, 220\u2013228. doi: 10.1093/mp/ssq082\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchoberer, J, Vavra, U, Stadlmann, J, Hawes, C, Mach, L, Steinkellner, H,et al."}
{"meta": {"doc_id": 2441, "sent_id": 518, "sent_start_pos": 52236, "sent_end_pos": 52437, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant 4, 220\u2013228. doi: 10.1093/mp/ssq082\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchoberer, J, Vavra, U, Stadlmann, J, Hawes, C, Mach, L, Steinkellner, H,et al. (2009)."}
{"meta": {"doc_id": 2441, "sent_id": 519, "sent_start_pos": 52254, "sent_end_pos": 52536, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1093/mp/ssq082\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchoberer, J, Vavra, U, Stadlmann, J, Hawes, C, Mach, L, Steinkellner, H,et al. (2009). Arginine/lysine residues in the cytoplasmic tail promote ER export of plant glycosylation enzymes."}
{"meta": {"doc_id": 2441, "sent_id": 520, "sent_start_pos": 52430, "sent_end_pos": 52557, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2009). Arginine/lysine residues in the cytoplasmic tail promote ER export of plant glycosylation enzymes. Traffic 10, 101\u2013115."}
{"meta": {"doc_id": 2441, "sent_id": 521, "sent_start_pos": 52438, "sent_end_pos": 52746, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Arginine/lysine residues in the cytoplasmic tail promote ER export of plant glycosylation enzymes. Traffic 10, 101\u2013115. doi: 10.1111/j1600-0854.2008.00841.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchuster, M, Umana, P, Ferrara, C, Br\u00fcnker, P, Gerdes, C, Waxenecker, G,et al."}
{"meta": {"doc_id": 2441, "sent_id": 522, "sent_start_pos": 52537, "sent_end_pos": 52754, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Traffic 10, 101\u2013115. doi: 10.1111/j1600-0854.2008.00841.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchuster, M, Umana, P, Ferrara, C, Br\u00fcnker, P, Gerdes, C, Waxenecker, G,et al. (2005)."}
{"meta": {"doc_id": 2441, "sent_id": 523, "sent_start_pos": 52558, "sent_end_pos": 52862, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1111/j1600-0854.2008.00841.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSchuster, M, Umana, P, Ferrara, C, Br\u00fcnker, P, Gerdes, C, Waxenecker, G,et al. (2005). Improved effector functions of a therapeutic monoclonal lewis Y-specific antibody by glycoform engineering."}
{"meta": {"doc_id": 2441, "sent_id": 524, "sent_start_pos": 52747, "sent_end_pos": 52874, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2005). Improved effector functions of a therapeutic monoclonal lewis Y-specific antibody by glycoform engineering. Cancer Res."}
{"meta": {"doc_id": 2441, "sent_id": 525, "sent_start_pos": 52755, "sent_end_pos": 52889, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Improved effector functions of a therapeutic monoclonal lewis Y-specific antibody by glycoform engineering. Cancer Res. 65, 7934\u20137941."}
{"meta": {"doc_id": 2441, "sent_id": 526, "sent_start_pos": 52863, "sent_end_pos": 52997, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Cancer Res. 65, 7934\u20137941. Pubmed Abstract | Pubmed Full Text | Google Scholar\nShin, Y J, Chong, Y J, Yang, M S, and Kwon, T H (2011)."}
{"meta": {"doc_id": 2441, "sent_id": 527, "sent_start_pos": 52875, "sent_end_pos": 53148, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "65, 7934\u20137941. Pubmed Abstract | Pubmed Full Text | Google Scholar\nShin, Y J, Chong, Y J, Yang, M S, and Kwon, T H (2011). Production of recombinant human granulocyte macrophage-colony stimulating factor in rice cell suspension culture with a human-like N-glycan structure."}
{"meta": {"doc_id": 2441, "sent_id": 528, "sent_start_pos": 52890, "sent_end_pos": 53166, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Pubmed Abstract | Pubmed Full Text | Google Scholar\nShin, Y J, Chong, Y J, Yang, M S, and Kwon, T H (2011). Production of recombinant human granulocyte macrophage-colony stimulating factor in rice cell suspension culture with a human-like N-glycan structure. Plant Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 529, "sent_start_pos": 52998, "sent_end_pos": 53182, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Production of recombinant human granulocyte macrophage-colony stimulating factor in rice cell suspension culture with a human-like N-glycan structure. Plant Biotechnol. J 9, 1109\u20131119."}
{"meta": {"doc_id": 2441, "sent_id": 530, "sent_start_pos": 53149, "sent_end_pos": 53375, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Biotechnol. J 9, 1109\u20131119. doi: 10.1111/j1467-7652.2011.00636.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nShinkawa, T, Nakamura, K, Yamane, N, Shoji-Hosaka, E, Kanda, Y, Sakurada, M,et al."}
{"meta": {"doc_id": 2441, "sent_id": 531, "sent_start_pos": 53167, "sent_end_pos": 53383, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J 9, 1109\u20131119. doi: 10.1111/j1467-7652.2011.00636.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nShinkawa, T, Nakamura, K, Yamane, N, Shoji-Hosaka, E, Kanda, Y, Sakurada, M,et al. (2003)."}
{"meta": {"doc_id": 2441, "sent_id": 532, "sent_start_pos": 53183, "sent_end_pos": 53595, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1111/j1467-7652.2011.00636.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nShinkawa, T, Nakamura, K, Yamane, N, Shoji-Hosaka, E, Kanda, Y, Sakurada, M,et al. (2003). The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity."}
{"meta": {"doc_id": 2441, "sent_id": 533, "sent_start_pos": 53376, "sent_end_pos": 53603, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2003). The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol."}
{"meta": {"doc_id": 2441, "sent_id": 534, "sent_start_pos": 53384, "sent_end_pos": 53609, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol. Chem."}
{"meta": {"doc_id": 2441, "sent_id": 535, "sent_start_pos": 53596, "sent_end_pos": 53625, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J Biol. Chem. 278, 3466\u20133473."}
{"meta": {"doc_id": 2441, "sent_id": 536, "sent_start_pos": 53604, "sent_end_pos": 53762, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Chem. 278, 3466\u20133473. doi: 10.1074/jbc.M210665200\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSol\u00e1, R J, and Griebenow, K (2010)."}
{"meta": {"doc_id": 2441, "sent_id": 537, "sent_start_pos": 53610, "sent_end_pos": 53845, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "278, 3466\u20133473. doi: 10.1074/jbc.M210665200\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSol\u00e1, R J, and Griebenow, K (2010). Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy."}
{"meta": {"doc_id": 2441, "sent_id": 538, "sent_start_pos": 53626, "sent_end_pos": 53864, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1074/jbc.M210665200\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSol\u00e1, R J, and Griebenow, K (2010). Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. BioDrugs 24, 9\u201321."}
{"meta": {"doc_id": 2441, "sent_id": 539, "sent_start_pos": 53763, "sent_end_pos": 54081, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. BioDrugs 24, 9\u201321. doi: 10.2165/11530550-000000000-00000\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSourrouille, C, Marquet-Blouin, E, D\u2019Aoust, M A, Kiefer-Meyer, M C, Seveno, M, Pagny-Salehabadi, S,et al."}
{"meta": {"doc_id": 2441, "sent_id": 540, "sent_start_pos": 53846, "sent_end_pos": 54089, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "BioDrugs 24, 9\u201321. doi: 10.2165/11530550-000000000-00000\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSourrouille, C, Marquet-Blouin, E, D\u2019Aoust, M A, Kiefer-Meyer, M C, Seveno, M, Pagny-Salehabadi, S,et al. (2008)."}
{"meta": {"doc_id": 2441, "sent_id": 541, "sent_start_pos": 53865, "sent_end_pos": 54159, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.2165/11530550-000000000-00000\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nSourrouille, C, Marquet-Blouin, E, D\u2019Aoust, M A, Kiefer-Meyer, M C, Seveno, M, Pagny-Salehabadi, S,et al. (2008). Down-regulated expression of plant-specific glycoepitopes in alfalfa."}
{"meta": {"doc_id": 2441, "sent_id": 542, "sent_start_pos": 54082, "sent_end_pos": 54177, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2008). Down-regulated expression of plant-specific glycoepitopes in alfalfa. Plant Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 543, "sent_start_pos": 54090, "sent_end_pos": 54191, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Down-regulated expression of plant-specific glycoepitopes in alfalfa. Plant Biotechnol. J 6, 702\u2013721."}
{"meta": {"doc_id": 2441, "sent_id": 544, "sent_start_pos": 54160, "sent_end_pos": 54368, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Biotechnol. J 6, 702\u2013721. doi: 10.1111/j1467-7652.2008.00353.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStaudacher, E, Dalik, T, Wawra, P, Altmann, F, and Marz, L (1995)."}
{"meta": {"doc_id": 2441, "sent_id": 545, "sent_start_pos": 54178, "sent_end_pos": 54528, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J 6, 702\u2013721. doi: 10.1111/j1467-7652.2008.00353.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStaudacher, E, Dalik, T, Wawra, P, Altmann, F, and Marz, L (1995). Functional purification and characterization of a GDP-fucose: beta-N-acetylglucosamine (Fuc to Asn linked GlcNAc) alpha 1,3-fucosyltransferase from mung beans."}
{"meta": {"doc_id": 2441, "sent_id": 546, "sent_start_pos": 54192, "sent_end_pos": 54539, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1111/j1467-7652.2008.00353.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStaudacher, E, Dalik, T, Wawra, P, Altmann, F, and Marz, L (1995). Functional purification and characterization of a GDP-fucose: beta-N-acetylglucosamine (Fuc to Asn linked GlcNAc) alpha 1,3-fucosyltransferase from mung beans. Glycoconj."}
{"meta": {"doc_id": 2441, "sent_id": 547, "sent_start_pos": 54369, "sent_end_pos": 54554, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Functional purification and characterization of a GDP-fucose: beta-N-acetylglucosamine (Fuc to Asn linked GlcNAc) alpha 1,3-fucosyltransferase from mung beans. Glycoconj. J 12, 780\u2013786."}
{"meta": {"doc_id": 2441, "sent_id": 548, "sent_start_pos": 54529, "sent_end_pos": 54706, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Glycoconj. J 12, 780\u2013786. doi: 10.1007/BF00731239\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStoger, E, Fischer, R, Moloney, M, and Ma, J K (2014)."}
{"meta": {"doc_id": 2441, "sent_id": 549, "sent_start_pos": 54540, "sent_end_pos": 54785, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J 12, 780\u2013786. doi: 10.1007/BF00731239\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStoger, E, Fischer, R, Moloney, M, and Ma, J K (2014). Plant molecular pharming for the treatment of chronic and infectious diseases."}
{"meta": {"doc_id": 2441, "sent_id": 550, "sent_start_pos": 54555, "sent_end_pos": 54791, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1007/BF00731239\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStoger, E, Fischer, R, Moloney, M, and Ma, J K (2014). Plant molecular pharming for the treatment of chronic and infectious diseases. Annu."}
{"meta": {"doc_id": 2441, "sent_id": 551, "sent_start_pos": 54707, "sent_end_pos": 54796, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant molecular pharming for the treatment of chronic and infectious diseases. Annu. Rev."}
{"meta": {"doc_id": 2441, "sent_id": 552, "sent_start_pos": 54786, "sent_end_pos": 54808, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Annu. Rev. Plant Biol."}
{"meta": {"doc_id": 2441, "sent_id": 553, "sent_start_pos": 54792, "sent_end_pos": 54821, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Rev. Plant Biol. 65, 743\u2013768."}
{"meta": {"doc_id": 2441, "sent_id": 554, "sent_start_pos": 54797, "sent_end_pos": 55002, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Biol. 65, 743\u2013768. doi: 10.1146/annurev-arplant-050213-035850\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Altmann, F, Gl\u00f6ssl, J, and Steinkellner, H (2004a)."}
{"meta": {"doc_id": 2441, "sent_id": 555, "sent_start_pos": 54809, "sent_end_pos": 55145, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "65, 743\u2013768. doi: 10.1146/annurev-arplant-050213-035850\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Altmann, F, Gl\u00f6ssl, J, and Steinkellner, H (2004a). Unaltered complex N-glycan profiles in Nicotiana benthamiana despite drastic reduction of beta1,2- N-acetylglucosaminyltransferase I activity."}
{"meta": {"doc_id": 2441, "sent_id": 556, "sent_start_pos": 54822, "sent_end_pos": 55156, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1146/annurev-arplant-050213-035850\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Altmann, F, Gl\u00f6ssl, J, and Steinkellner, H (2004a). Unaltered complex N-glycan profiles in Nicotiana benthamiana despite drastic reduction of beta1,2- N-acetylglucosaminyltransferase I activity. Glycoconj."}
{"meta": {"doc_id": 2441, "sent_id": 557, "sent_start_pos": 55003, "sent_end_pos": 55171, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Unaltered complex N-glycan profiles in Nicotiana benthamiana despite drastic reduction of beta1,2- N-acetylglucosaminyltransferase I activity. Glycoconj. J 21, 275\u2013282."}
{"meta": {"doc_id": 2441, "sent_id": 558, "sent_start_pos": 55146, "sent_end_pos": 55358, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Glycoconj. J 21, 275\u2013282. doi: 10.1023/B:GLYC.0000045099.29038.04\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Altmann, F, Mach, L, Gl\u00f6ssl, J, and Steinkellner, H (2004b)."}
{"meta": {"doc_id": 2441, "sent_id": 559, "sent_start_pos": 55157, "sent_end_pos": 55486, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J 21, 275\u2013282. doi: 10.1023/B:GLYC.0000045099.29038.04\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Altmann, F, Mach, L, Gl\u00f6ssl, J, and Steinkellner, H (2004b). Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1,2-linked xylose and core alpha1,3-linked fucose."}
{"meta": {"doc_id": 2441, "sent_id": 560, "sent_start_pos": 55172, "sent_end_pos": 55497, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1023/B:GLYC.0000045099.29038.04\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Altmann, F, Mach, L, Gl\u00f6ssl, J, and Steinkellner, H (2004b). Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1,2-linked xylose and core alpha1,3-linked fucose. FEBS Lett."}
{"meta": {"doc_id": 2441, "sent_id": 561, "sent_start_pos": 55359, "sent_end_pos": 55511, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1,2-linked xylose and core alpha1,3-linked fucose. FEBS Lett. 561, 132\u2013136."}
{"meta": {"doc_id": 2441, "sent_id": 562, "sent_start_pos": 55487, "sent_end_pos": 55704, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "FEBS Lett. 561, 132\u2013136. doi: 10.1016/S0014-5793(04)00150-4\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Bondili, J S, Schoberer, J, Svoboda, B, Liebminger, E, Glossl, J,et al."}
{"meta": {"doc_id": 2441, "sent_id": 563, "sent_start_pos": 55498, "sent_end_pos": 55713, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "561, 132\u2013136. doi: 10.1016/S0014-5793(04)00150-4\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Bondili, J S, Schoberer, J, Svoboda, B, Liebminger, E, Glossl, J,et al. (2007a)."}
{"meta": {"doc_id": 2441, "sent_id": 564, "sent_start_pos": 55512, "sent_end_pos": 55808, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/S0014-5793(04)00150-4\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Bondili, J S, Schoberer, J, Svoboda, B, Liebminger, E, Glossl, J,et al. (2007a). Enzymatic properties and subcellular localization of Arabidopsis beta-N-acetylhexosaminidases."}
{"meta": {"doc_id": 2441, "sent_id": 565, "sent_start_pos": 55705, "sent_end_pos": 55823, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2007a). Enzymatic properties and subcellular localization of Arabidopsis beta-N-acetylhexosaminidases. Plant Physiol."}
{"meta": {"doc_id": 2441, "sent_id": 566, "sent_start_pos": 55714, "sent_end_pos": 55834, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Enzymatic properties and subcellular localization of Arabidopsis beta-N-acetylhexosaminidases. Plant Physiol. 145, 5\u201316."}
{"meta": {"doc_id": 2441, "sent_id": 567, "sent_start_pos": 55809, "sent_end_pos": 56014, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Physiol. 145, 5\u201316. doi: 10.1104/pp.107.101162\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Bondili, J S, Vavra, U, Schoberer, J, Svoboda, B, Glossl, J,et al."}
{"meta": {"doc_id": 2441, "sent_id": 568, "sent_start_pos": 55824, "sent_end_pos": 56023, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "145, 5\u201316. doi: 10.1104/pp.107.101162\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Bondili, J S, Vavra, U, Schoberer, J, Svoboda, B, Glossl, J,et al. (2007b)."}
{"meta": {"doc_id": 2441, "sent_id": 569, "sent_start_pos": 55835, "sent_end_pos": 56168, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1104/pp.107.101162\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Bondili, J S, Vavra, U, Schoberer, J, Svoboda, B, Glossl, J,et al. (2007b). A unique beta1,3-galactosyltransferase is indispensable for the biosynthesis of N-glycans containing Lewis a structures in Arabidopsis thaliana."}
{"meta": {"doc_id": 2441, "sent_id": 570, "sent_start_pos": 56015, "sent_end_pos": 56194, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2007b). A unique beta1,3-galactosyltransferase is indispensable for the biosynthesis of N-glycans containing Lewis a structures in Arabidopsis thaliana. Plant Cell 19, 2278\u20132292."}
{"meta": {"doc_id": 2441, "sent_id": 571, "sent_start_pos": 56024, "sent_end_pos": 56379, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "A unique beta1,3-galactosyltransferase is indispensable for the biosynthesis of N-glycans containing Lewis a structures in Arabidopsis thaliana. Plant Cell 19, 2278\u20132292. doi: 10.1105/tpc.107.052985\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Castilho, A, Stadlmann, J, Kunert, R, Quendler, H, Gattinger, P,et al."}
{"meta": {"doc_id": 2441, "sent_id": 572, "sent_start_pos": 56169, "sent_end_pos": 56387, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Cell 19, 2278\u20132292. doi: 10.1105/tpc.107.052985\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Castilho, A, Stadlmann, J, Kunert, R, Quendler, H, Gattinger, P,et al. (2009)."}
{"meta": {"doc_id": 2441, "sent_id": 573, "sent_start_pos": 56195, "sent_end_pos": 56515, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1105/tpc.107.052985\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Castilho, A, Stadlmann, J, Kunert, R, Quendler, H, Gattinger, P,et al. (2009). Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile."}
{"meta": {"doc_id": 2441, "sent_id": 574, "sent_start_pos": 56380, "sent_end_pos": 56523, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2009). Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile. J Biol."}
{"meta": {"doc_id": 2441, "sent_id": 575, "sent_start_pos": 56388, "sent_end_pos": 56529, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile. J Biol. Chem."}
{"meta": {"doc_id": 2441, "sent_id": 576, "sent_start_pos": 56516, "sent_end_pos": 56547, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J Biol. Chem. 284, 20479\u201320485."}
{"meta": {"doc_id": 2441, "sent_id": 577, "sent_start_pos": 56524, "sent_end_pos": 56728, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Chem. 284, 20479\u201320485. doi: 10.1074/jbc.M109.014126\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Stadlmann, J, Sch\u00e4hs, M, Stiegler, G, Quendler, H, Mach, L,et al."}
{"meta": {"doc_id": 2441, "sent_id": 578, "sent_start_pos": 56530, "sent_end_pos": 56736, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "284, 20479\u201320485. doi: 10.1074/jbc.M109.014126\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Stadlmann, J, Sch\u00e4hs, M, Stiegler, G, Quendler, H, Mach, L,et al. (2008)."}
{"meta": {"doc_id": 2441, "sent_id": 579, "sent_start_pos": 56548, "sent_end_pos": 56883, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1074/jbc.M109.014126\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nStrasser, R, Stadlmann, J, Sch\u00e4hs, M, Stiegler, G, Quendler, H, Mach, L,et al. (2008). Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure."}
{"meta": {"doc_id": 2441, "sent_id": 580, "sent_start_pos": 56729, "sent_end_pos": 56901, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2008). Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 581, "sent_start_pos": 56737, "sent_end_pos": 56915, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol. J 6, 392\u2013402."}
{"meta": {"doc_id": 2441, "sent_id": 582, "sent_start_pos": 56884, "sent_end_pos": 57078, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Biotechnol. J 6, 392\u2013402. doi: 10.1111/j1467-7652.2008.00330.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nUliana, A S, Giraudo, C G, and Maccioni, H J (2006)."}
{"meta": {"doc_id": 2441, "sent_id": 583, "sent_start_pos": 56902, "sent_end_pos": 57182, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J 6, 392\u2013402. doi: 10.1111/j1467-7652.2008.00330.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nUliana, A S, Giraudo, C G, and Maccioni, H J (2006). Cytoplasmic tails of SialT2 and GalNAcT impose their respective proximal and distal Golgi localization."}
{"meta": {"doc_id": 2441, "sent_id": 584, "sent_start_pos": 56916, "sent_end_pos": 57202, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1111/j1467-7652.2008.00330.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nUliana, A S, Giraudo, C G, and Maccioni, H J (2006). Cytoplasmic tails of SialT2 and GalNAcT impose their respective proximal and distal Golgi localization. Traffic 7, 604\u2013612."}
{"meta": {"doc_id": 2441, "sent_id": 585, "sent_start_pos": 57079, "sent_end_pos": 57385, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Cytoplasmic tails of SialT2 and GalNAcT impose their respective proximal and distal Golgi localization. Traffic 7, 604\u2013612. doi: 10.1111/j1600-0854.2006.00413.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nUmana, P, Jean-Mairet, J, Moudry, R, Amstutz, H, and Bailey, J E (1999)."}
{"meta": {"doc_id": 2441, "sent_id": 586, "sent_start_pos": 57183, "sent_end_pos": 57499, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Traffic 7, 604\u2013612. doi: 10.1111/j1600-0854.2006.00413.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nUmana, P, Jean-Mairet, J, Moudry, R, Amstutz, H, and Bailey, J E (1999). Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity."}
{"meta": {"doc_id": 2441, "sent_id": 587, "sent_start_pos": 57203, "sent_end_pos": 57504, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1111/j1600-0854.2006.00413.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nUmana, P, Jean-Mairet, J, Moudry, R, Amstutz, H, and Bailey, J E (1999). Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat."}
{"meta": {"doc_id": 2441, "sent_id": 588, "sent_start_pos": 57386, "sent_end_pos": 57516, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat. Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 589, "sent_start_pos": 57500, "sent_end_pos": 57529, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Nat. Biotechnol. 17, 176\u2013180."}
{"meta": {"doc_id": 2441, "sent_id": 590, "sent_start_pos": 57505, "sent_end_pos": 57703, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biotechnol. 17, 176\u2013180. doi: 10.1038/6179\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nvan Dussen, L, Zimran, A, Akkerman, E M, Aerts, J M, Petakov, M, Elstein, D,et al."}
{"meta": {"doc_id": 2441, "sent_id": 591, "sent_start_pos": 57517, "sent_end_pos": 57711, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "17, 176\u2013180. doi: 10.1038/6179\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nvan Dussen, L, Zimran, A, Akkerman, E M, Aerts, J M, Petakov, M, Elstein, D,et al. (2013)."}
{"meta": {"doc_id": 2441, "sent_id": 592, "sent_start_pos": 57530, "sent_end_pos": 57812, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1038/6179\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nvan Dussen, L, Zimran, A, Akkerman, E M, Aerts, J M, Petakov, M, Elstein, D,et al. (2013). Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease."}
{"meta": {"doc_id": 2441, "sent_id": 593, "sent_start_pos": 57704, "sent_end_pos": 57829, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2013). Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease. Blood Cells Mol."}
{"meta": {"doc_id": 2441, "sent_id": 594, "sent_start_pos": 57712, "sent_end_pos": 57834, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease. Blood Cells Mol. Dis."}
{"meta": {"doc_id": 2441, "sent_id": 595, "sent_start_pos": 57813, "sent_end_pos": 57847, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Blood Cells Mol. Dis. 50, 206\u2013211."}
{"meta": {"doc_id": 2441, "sent_id": 596, "sent_start_pos": 57830, "sent_end_pos": 57968, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Dis. 50, 206\u2013211. doi: 10.1016/jbcmd.2012.11.001\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nVarki, A (1993)."}
{"meta": {"doc_id": 2441, "sent_id": 597, "sent_start_pos": 57835, "sent_end_pos": 58039, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "50, 206\u2013211. doi: 10.1016/jbcmd.2012.11.001\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nVarki, A (1993). Biological roles of oligosaccharides: all of the theories are correct."}
{"meta": {"doc_id": 2441, "sent_id": 598, "sent_start_pos": 57848, "sent_end_pos": 58063, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/jbcmd.2012.11.001\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nVarki, A (1993). Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3, 97\u2013130."}
{"meta": {"doc_id": 2441, "sent_id": 599, "sent_start_pos": 57969, "sent_end_pos": 58143, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3, 97\u2013130. doi: 10.1093/glycob/3.2.97\nCrossRef Full Text | Google Scholar\nVarki, A (2006)."}
{"meta": {"doc_id": 2441, "sent_id": 600, "sent_start_pos": 58040, "sent_end_pos": 58214, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Glycobiology 3, 97\u2013130. doi: 10.1093/glycob/3.2.97\nCrossRef Full Text | Google Scholar\nVarki, A (2006). Nothing in glycobiology makes sense, except in the light of evolution."}
{"meta": {"doc_id": 2441, "sent_id": 601, "sent_start_pos": 58064, "sent_end_pos": 58233, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1093/glycob/3.2.97\nCrossRef Full Text | Google Scholar\nVarki, A (2006). Nothing in glycobiology makes sense, except in the light of evolution. Cell 126, 841\u2013845."}
{"meta": {"doc_id": 2441, "sent_id": 602, "sent_start_pos": 58144, "sent_end_pos": 58420, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Nothing in glycobiology makes sense, except in the light of evolution. Cell 126, 841\u2013845. doi: 10.1016/jcell.2006.08.022\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nV\u00e9zina, L P, Faye, L, Lerouge, P, D\u2019Aoust, M A, Marquet-Blouin, E, Burel, C,et al."}
{"meta": {"doc_id": 2441, "sent_id": 603, "sent_start_pos": 58215, "sent_end_pos": 58428, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Cell 126, 841\u2013845. doi: 10.1016/jcell.2006.08.022\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nV\u00e9zina, L P, Faye, L, Lerouge, P, D\u2019Aoust, M A, Marquet-Blouin, E, Burel, C,et al. (2009)."}
{"meta": {"doc_id": 2441, "sent_id": 604, "sent_start_pos": 58234, "sent_end_pos": 58538, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1016/jcell.2006.08.022\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nV\u00e9zina, L P, Faye, L, Lerouge, P, D\u2019Aoust, M A, Marquet-Blouin, E, Burel, C,et al. (2009). Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants."}
{"meta": {"doc_id": 2441, "sent_id": 605, "sent_start_pos": 58421, "sent_end_pos": 58556, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2009). Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 606, "sent_start_pos": 58429, "sent_end_pos": 58570, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol. J 7, 442\u2013455."}
{"meta": {"doc_id": 2441, "sent_id": 607, "sent_start_pos": 58539, "sent_end_pos": 58747, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Biotechnol. J 7, 442\u2013455. doi: 10.1111/j1467-7652.2009.00414.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nVon Schaewen, A, Sturm, A, O\u2019Neill, J, and Chrispeels, M J (1993)."}
{"meta": {"doc_id": 2441, "sent_id": 608, "sent_start_pos": 58557, "sent_end_pos": 58903, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "J 7, 442\u2013455. doi: 10.1111/j1467-7652.2009.00414.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nVon Schaewen, A, Sturm, A, O\u2019Neill, J, and Chrispeels, M J (1993). Isolation of a mutant Arabidopsis plant that lacks N-acetyl glucosaminyl transferase-I and is unable to synthesize golgi-modified complex N-linked glycans."}
{"meta": {"doc_id": 2441, "sent_id": 609, "sent_start_pos": 58571, "sent_end_pos": 58918, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1111/j1467-7652.2009.00414.x\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nVon Schaewen, A, Sturm, A, O\u2019Neill, J, and Chrispeels, M J (1993). Isolation of a mutant Arabidopsis plant that lacks N-acetyl glucosaminyl transferase-I and is unable to synthesize golgi-modified complex N-linked glycans. Plant Physiol."}
{"meta": {"doc_id": 2441, "sent_id": 610, "sent_start_pos": 58748, "sent_end_pos": 58934, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Isolation of a mutant Arabidopsis plant that lacks N-acetyl glucosaminyl transferase-I and is unable to synthesize golgi-modified complex N-linked glycans. Plant Physiol. 102, 1109\u20131118."}
{"meta": {"doc_id": 2441, "sent_id": 611, "sent_start_pos": 58904, "sent_end_pos": 59051, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Physiol. 102, 1109\u20131118. doi: 10.1104/pp.102.4.1109\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nWalsh, G (2010)."}
{"meta": {"doc_id": 2441, "sent_id": 612, "sent_start_pos": 58919, "sent_end_pos": 59086, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "102, 1109\u20131118. doi: 10.1104/pp.102.4.1109\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nWalsh, G (2010). Biopharmaceutical benchmarks 2010."}
{"meta": {"doc_id": 2441, "sent_id": 613, "sent_start_pos": 58935, "sent_end_pos": 59091, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1104/pp.102.4.1109\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nWalsh, G (2010). Biopharmaceutical benchmarks 2010. Nat."}
{"meta": {"doc_id": 2441, "sent_id": 614, "sent_start_pos": 59052, "sent_end_pos": 59103, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biopharmaceutical benchmarks 2010. Nat. Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 615, "sent_start_pos": 59087, "sent_end_pos": 59116, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Nat. Biotechnol. 28, 917\u2013924."}
{"meta": {"doc_id": 2441, "sent_id": 616, "sent_start_pos": 59092, "sent_end_pos": 59287, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biotechnol. 28, 917\u2013924. doi: 10.1038/nbt0910-917\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nWeber, E, Gruetzner, R, Werner, S, Engler, C, and Marillonnet, S (2011)."}
{"meta": {"doc_id": 2441, "sent_id": 617, "sent_start_pos": 59104, "sent_end_pos": 59346, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "28, 917\u2013924. doi: 10.1038/nbt0910-917\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nWeber, E, Gruetzner, R, Werner, S, Engler, C, and Marillonnet, S (2011). Assembly of designer TAL effectors by Golden Gate cloning."}
{"meta": {"doc_id": 2441, "sent_id": 618, "sent_start_pos": 59117, "sent_end_pos": 59365, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1038/nbt0910-917\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nWeber, E, Gruetzner, R, Werner, S, Engler, C, and Marillonnet, S (2011). Assembly of designer TAL effectors by Golden Gate cloning. PLoS ONE 6:e19722."}
{"meta": {"doc_id": 2441, "sent_id": 619, "sent_start_pos": 59288, "sent_end_pos": 59531, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Assembly of designer TAL effectors by Golden Gate cloning. PLoS ONE 6:e19722. doi: 10.1371/journal.pone.0019722\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nWee, E G, Sherrier, D J, Prime, T A, and Dupree, P (1998)."}
{"meta": {"doc_id": 2441, "sent_id": 620, "sent_start_pos": 59347, "sent_end_pos": 59599, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "PLoS ONE 6:e19722. doi: 10.1371/journal.pone.0019722\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nWee, E G, Sherrier, D J, Prime, T A, and Dupree, P (1998). Targeting of active sialyltransferase to the plant Golgi apparatus."}
{"meta": {"doc_id": 2441, "sent_id": 621, "sent_start_pos": 59366, "sent_end_pos": 59625, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1371/journal.pone.0019722\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nWee, E G, Sherrier, D J, Prime, T A, and Dupree, P (1998). Targeting of active sialyltransferase to the plant Golgi apparatus. Plant Cell 10, 1759\u20131768."}
{"meta": {"doc_id": 2441, "sent_id": 622, "sent_start_pos": 59532, "sent_end_pos": 59813, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Targeting of active sialyltransferase to the plant Golgi apparatus. Plant Cell 10, 1759\u20131768. doi: 10.1105/tpc.10.10.1759\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nWilson, I B, Zeleny, R, Kolarich, D, Staudacher, E, Stroop, C J, Kamerling, J P,et al."}
{"meta": {"doc_id": 2441, "sent_id": 623, "sent_start_pos": 59600, "sent_end_pos": 59821, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Cell 10, 1759\u20131768. doi: 10.1105/tpc.10.10.1759\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nWilson, I B, Zeleny, R, Kolarich, D, Staudacher, E, Stroop, C J, Kamerling, J P,et al. (2001)."}
{"meta": {"doc_id": 2441, "sent_id": 624, "sent_start_pos": 59626, "sent_end_pos": 59967, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1105/tpc.10.10.1759\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nWilson, I B, Zeleny, R, Kolarich, D, Staudacher, E, Stroop, C J, Kamerling, J P,et al. (2001). Analysis of Asn-linked glycans from vegetable foodstuffs: widespread occurrence of Lewis a, core alpha1,3-linked fucose and xylose substitutions."}
{"meta": {"doc_id": 2441, "sent_id": 625, "sent_start_pos": 59814, "sent_end_pos": 59993, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2001). Analysis of Asn-linked glycans from vegetable foodstuffs: widespread occurrence of Lewis a, core alpha1,3-linked fucose and xylose substitutions. Glycobiology 11, 261\u2013274."}
{"meta": {"doc_id": 2441, "sent_id": 626, "sent_start_pos": 59822, "sent_end_pos": 60118, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Analysis of Asn-linked glycans from vegetable foodstuffs: widespread occurrence of Lewis a, core alpha1,3-linked fucose and xylose substitutions. Glycobiology 11, 261\u2013274. doi: 10.1093/glycob/11.4.261\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nwww.federalgrants.com."}
{"meta": {"doc_id": 2441, "sent_id": 627, "sent_start_pos": 59968, "sent_end_pos": 60126, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Glycobiology 11, 261\u2013274. doi: 10.1093/glycob/11.4.261\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nwww.federalgrants.com. (2012)."}
{"meta": {"doc_id": 2441, "sent_id": 628, "sent_start_pos": 59994, "sent_end_pos": 60184, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1093/glycob/11.4.261\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nwww.federalgrants.com. (2012). Butyrylcholinesterase Expression in Plants Federal Grant."}
{"meta": {"doc_id": 2441, "sent_id": 629, "sent_start_pos": 60119, "sent_end_pos": 60306, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2012). Butyrylcholinesterase Expression in Plants Federal Grant. Available at: http://www.federalgrants.com/Butyrylcholinesterase-Expression-in-Plants-33798.html [accessed July 7, 2014]."}
{"meta": {"doc_id": 2441, "sent_id": 630, "sent_start_pos": 60127, "sent_end_pos": 60395, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Butyrylcholinesterase Expression in Plants Federal Grant. Available at: http://www.federalgrants.com/Butyrylcholinesterase-Expression-in-Plants-33798.html [accessed July 7, 2014]. Yamane-Ohnuki, N, Kinoshita, S, Inoue-Urakubo, M, Kusunoki, M, Iida, S, Nakano, R,et al."}
{"meta": {"doc_id": 2441, "sent_id": 631, "sent_start_pos": 60185, "sent_end_pos": 60403, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Available at: http://www.federalgrants.com/Butyrylcholinesterase-Expression-in-Plants-33798.html [accessed July 7, 2014]. Yamane-Ohnuki, N, Kinoshita, S, Inoue-Urakubo, M, Kusunoki, M, Iida, S, Nakano, R,et al. (2004)."}
{"meta": {"doc_id": 2441, "sent_id": 632, "sent_start_pos": 60307, "sent_end_pos": 60593, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Yamane-Ohnuki, N, Kinoshita, S, Inoue-Urakubo, M, Kusunoki, M, Iida, S, Nakano, R,et al. (2004). Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity."}
{"meta": {"doc_id": 2441, "sent_id": 633, "sent_start_pos": 60396, "sent_end_pos": 60605, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2004). Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity. Biotechnol."}
{"meta": {"doc_id": 2441, "sent_id": 634, "sent_start_pos": 60404, "sent_end_pos": 60613, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity. Biotechnol. Bioeng."}
{"meta": {"doc_id": 2441, "sent_id": 635, "sent_start_pos": 60594, "sent_end_pos": 60626, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Biotechnol. Bioeng. 87, 614\u2013622."}
{"meta": {"doc_id": 2441, "sent_id": 636, "sent_start_pos": 60606, "sent_end_pos": 60797, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Bioeng. 87, 614\u2013622. doi: 10.1002/bit.20151\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nZeitlin, L, Bohorov, O, Bohorova, N, Hiatt, A, Kim, D H, Pauly, M H,et al."}
{"meta": {"doc_id": 2441, "sent_id": 637, "sent_start_pos": 60614, "sent_end_pos": 60805, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "87, 614\u2013622. doi: 10.1002/bit.20151\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nZeitlin, L, Bohorov, O, Bohorova, N, Hiatt, A, Kim, D H, Pauly, M H,et al. (2013)."}
{"meta": {"doc_id": 2441, "sent_id": 638, "sent_start_pos": 60627, "sent_end_pos": 60933, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1002/bit.20151\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nZeitlin, L, Bohorov, O, Bohorova, N, Hiatt, A, Kim, D H, Pauly, M H,et al. (2013). Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model."}
{"meta": {"doc_id": 2441, "sent_id": 639, "sent_start_pos": 60798, "sent_end_pos": 60950, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2013). Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model. MAbs 5, 263\u2013269."}
{"meta": {"doc_id": 2441, "sent_id": 640, "sent_start_pos": 60806, "sent_end_pos": 61119, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model. MAbs 5, 263\u2013269. doi: 10.4161/mabs.23281\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nZeitlin, L, Pettitt, J, Scully, C, Bohorova, N, Kim, D, Pauly, M,et al."}
{"meta": {"doc_id": 2441, "sent_id": 641, "sent_start_pos": 60934, "sent_end_pos": 61127, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "MAbs 5, 263\u2013269. doi: 10.4161/mabs.23281\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nZeitlin, L, Pettitt, J, Scully, C, Bohorova, N, Kim, D, Pauly, M,et al. (2011)."}
{"meta": {"doc_id": 2441, "sent_id": 642, "sent_start_pos": 60951, "sent_end_pos": 61233, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.4161/mabs.23281\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nZeitlin, L, Pettitt, J, Scully, C, Bohorova, N, Kim, D, Pauly, M,et al. (2011). Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant."}
{"meta": {"doc_id": 2441, "sent_id": 643, "sent_start_pos": 61120, "sent_end_pos": 61239, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2011). Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proc."}
{"meta": {"doc_id": 2441, "sent_id": 644, "sent_start_pos": 61128, "sent_end_pos": 61245, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proc. Natl."}
{"meta": {"doc_id": 2441, "sent_id": 645, "sent_start_pos": 61234, "sent_end_pos": 61251, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Proc. Natl. Acad."}
{"meta": {"doc_id": 2441, "sent_id": 646, "sent_start_pos": 61240, "sent_end_pos": 61256, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Natl. Acad. Sci."}
{"meta": {"doc_id": 2441, "sent_id": 647, "sent_start_pos": 61246, "sent_end_pos": 61278, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Acad. Sci. USA 108, 20690\u201320694."}
{"meta": {"doc_id": 2441, "sent_id": 648, "sent_start_pos": 61252, "sent_end_pos": 61469, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Sci. USA 108, 20690\u201320694. doi: 10.1073/pnas.1108360108\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nZimran, A, Brill-Almon, E, Chertkoff, R, Petakov, M, Blanco-Favela, F, Munoz, E T,et al."}
{"meta": {"doc_id": 2441, "sent_id": 649, "sent_start_pos": 61257, "sent_end_pos": 61477, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "USA 108, 20690\u201320694. doi: 10.1073/pnas.1108360108\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nZimran, A, Brill-Almon, E, Chertkoff, R, Petakov, M, Blanco-Favela, F, Munoz, E T,et al. (2011)."}
{"meta": {"doc_id": 2441, "sent_id": 650, "sent_start_pos": 61279, "sent_end_pos": 61625, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1073/pnas.1108360108\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nZimran, A, Brill-Almon, E, Chertkoff, R, Petakov, M, Blanco-Favela, F, Munoz, E T,et al. (2011). Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease."}
{"meta": {"doc_id": 2441, "sent_id": 651, "sent_start_pos": 61470, "sent_end_pos": 61647, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "(2011). Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. Blood 118, 5767\u20135773."}
{"meta": {"doc_id": 2441, "sent_id": 652, "sent_start_pos": 61478, "sent_end_pos": 61937, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. Blood 118, 5767\u20135773. doi: 10.1182/blood-2011-07-366955\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nKeywords: glycoengineering, plant, glycosyltransferase, CTS, sub-Golgi targeting\nCitation: Loos A and Steinkellner H (2014) Plant glyco-biotechnology on the way to synthetic biology."}
{"meta": {"doc_id": 2441, "sent_id": 653, "sent_start_pos": 61626, "sent_end_pos": 61944, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Blood 118, 5767\u20135773. doi: 10.1182/blood-2011-07-366955\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nKeywords: glycoengineering, plant, glycosyltransferase, CTS, sub-Golgi targeting\nCitation: Loos A and Steinkellner H (2014) Plant glyco-biotechnology on the way to synthetic biology. Front."}
{"meta": {"doc_id": 2441, "sent_id": 654, "sent_start_pos": 61648, "sent_end_pos": 61955, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "doi: 10.1182/blood-2011-07-366955\nPubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar\nKeywords: glycoengineering, plant, glycosyltransferase, CTS, sub-Golgi targeting\nCitation: Loos A and Steinkellner H (2014) Plant glyco-biotechnology on the way to synthetic biology. Front. Plant Sci."}
{"meta": {"doc_id": 2441, "sent_id": 655, "sent_start_pos": 61938, "sent_end_pos": 62079, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Front. Plant Sci. 5:523. doi: 10.3389/fpls.2014.00523\nReceived: 10 July 2014; Accepted: 16 September 2014;\nPublished online: 08 October 2014."}
{"meta": {"doc_id": 2441, "sent_id": 656, "sent_start_pos": 61945, "sent_end_pos": 62351, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Plant Sci. 5:523. doi: 10.3389/fpls.2014.00523\nReceived: 10 July 2014; Accepted: 16 September 2014;\nPublished online: 08 October 2014. Edited by: Els J M Van Damme, Ghent University, Belgium\nReviewed by: Beronda L Montgomery, Michigan State University, USA\nBjoern Usadel, RWTH Aachen University, Germany\nThomas De Meyer, Vlaams Instituut voor Biotechnologie, Belgium\nCopyright \u00a9 2014 Loos and Steinkellner."}
{"meta": {"doc_id": 2441, "sent_id": 657, "sent_start_pos": 61956, "sent_end_pos": 62463, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "5:523. doi: 10.3389/fpls.2014.00523\nReceived: 10 July 2014; Accepted: 16 September 2014;\nPublished online: 08 October 2014. Edited by: Els J M Van Damme, Ghent University, Belgium\nReviewed by: Beronda L Montgomery, Michigan State University, USA\nBjoern Usadel, RWTH Aachen University, Germany\nThomas De Meyer, Vlaams Instituut voor Biotechnologie, Belgium\nCopyright \u00a9 2014 Loos and Steinkellner. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)."}
{"meta": {"doc_id": 2441, "sent_id": 658, "sent_start_pos": 62080, "sent_end_pos": 62695, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "Edited by: Els J M Van Damme, Ghent University, Belgium\nReviewed by: Beronda L Montgomery, Michigan State University, USA\nBjoern Usadel, RWTH Aachen University, Germany\nThomas De Meyer, Vlaams Instituut voor Biotechnologie, Belgium\nCopyright \u00a9 2014 Loos and Steinkellner. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice."}
{"meta": {"doc_id": 2441, "sent_id": 659, "sent_start_pos": 62352, "sent_end_pos": 62785, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms."}
{"meta": {"doc_id": 2441, "sent_id": 660, "sent_start_pos": 62464, "sent_end_pos": 62995, "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. *Correspondence: Herta Steinkellner, Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences, Muthgasse 18, 1190 Vienna, Austria e-mail: herta.steinkellner@boku.ac.at"}
{"meta": {"doc_id": 2441, "sent_id": 661, "sent_start_pos": 62696, "sent_end_pos": [], "title": "Plant glyco-biotechnology on the way to synthetic biology"}, "text": "No use, distribution or reproduction is permitted which does not comply with these terms. *Correspondence: Herta Steinkellner, Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences, Muthgasse 18, 1190 Vienna, Austria e-mail: herta.steinkellner@boku.ac.at "}
{"meta": {"doc_id": 2442, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 398, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": " Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs\nSioux Falls' entrepreneurship community welcomed in the Thanksgiving Day holiday by hosting a panel discussion with the founder of vegan food brand Tofurky. Tofurky founder and CEO, Seth Tibbott participated in a discussion hosted by Zeal, Startup Sioux Falls, and the South Dakota Biotech Association on Wednesday."}
{"meta": {"doc_id": 2442, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 635, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs\nSioux Falls' entrepreneurship community welcomed in the Thanksgiving Day holiday by hosting a panel discussion with the founder of vegan food brand Tofurky. Tofurky founder and CEO, Seth Tibbott participated in a discussion hosted by Zeal, Startup Sioux Falls, and the South Dakota Biotech Association on Wednesday. The event at Augustana University was titled \u201cRiding the Protein Highway: a Plant-Based Panel Discussion.\u201d\nEarlier in the day, Tibbott was also the featured speaker at Sioux Falls' 1 Million Cups event at the Museum of Visual Materials."}
{"meta": {"doc_id": 2442, "sent_id": 2, "sent_start_pos": 240, "sent_end_pos": 881, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "Tofurky founder and CEO, Seth Tibbott participated in a discussion hosted by Zeal, Startup Sioux Falls, and the South Dakota Biotech Association on Wednesday. The event at Augustana University was titled \u201cRiding the Protein Highway: a Plant-Based Panel Discussion.\u201d\nEarlier in the day, Tibbott was also the featured speaker at Sioux Falls' 1 Million Cups event at the Museum of Visual Materials. The discussion at Augustana was moderated by Kevin Kephart, Ph.D, a board member of South Dakota Biotech, and included Tibbott, Patrick Sayler of The Co-op Natural Foods, Kurt Loudenback of Grand Prairie Foods, and Phil Kerr of Prairie Aquatech."}
{"meta": {"doc_id": 2442, "sent_id": 3, "sent_start_pos": 399, "sent_end_pos": 1047, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "The event at Augustana University was titled \u201cRiding the Protein Highway: a Plant-Based Panel Discussion.\u201d\nEarlier in the day, Tibbott was also the featured speaker at Sioux Falls' 1 Million Cups event at the Museum of Visual Materials. The discussion at Augustana was moderated by Kevin Kephart, Ph.D, a board member of South Dakota Biotech, and included Tibbott, Patrick Sayler of The Co-op Natural Foods, Kurt Loudenback of Grand Prairie Foods, and Phil Kerr of Prairie Aquatech. Tibbott started his company in 1980 with little business background but a passion for tempeh\u2014a fermented soy product similar to tofu but with higher protein content."}
{"meta": {"doc_id": 2442, "sent_id": 4, "sent_start_pos": 636, "sent_end_pos": 1195, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "The discussion at Augustana was moderated by Kevin Kephart, Ph.D, a board member of South Dakota Biotech, and included Tibbott, Patrick Sayler of The Co-op Natural Foods, Kurt Loudenback of Grand Prairie Foods, and Phil Kerr of Prairie Aquatech. Tibbott started his company in 1980 with little business background but a passion for tempeh\u2014a fermented soy product similar to tofu but with higher protein content. Today, the company sells a variety of plant-based protein options, including the classic Tofurky holiday roast, burgers, sausages, and deli slices."}
{"meta": {"doc_id": 2442, "sent_id": 5, "sent_start_pos": 882, "sent_end_pos": 1362, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "Tibbott started his company in 1980 with little business background but a passion for tempeh\u2014a fermented soy product similar to tofu but with higher protein content. Today, the company sells a variety of plant-based protein options, including the classic Tofurky holiday roast, burgers, sausages, and deli slices. Sioux Falls\u2019 connection to Tofurky began recently when Kurt Loudenback, founder of Grand Prairie Foods, partnered with the company to produce its plant-based pockets."}
{"meta": {"doc_id": 2442, "sent_id": 6, "sent_start_pos": 1048, "sent_end_pos": 1547, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "Today, the company sells a variety of plant-based protein options, including the classic Tofurky holiday roast, burgers, sausages, and deli slices. Sioux Falls\u2019 connection to Tofurky began recently when Kurt Loudenback, founder of Grand Prairie Foods, partnered with the company to produce its plant-based pockets. The product is best described as a stuffed sandwich, and it\u2019s processed using Grand Prairie\u2019s signature co-extrusion technology which allows dough to be injected with various fillings."}
{"meta": {"doc_id": 2442, "sent_id": 7, "sent_start_pos": 1196, "sent_end_pos": 1654, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "Sioux Falls\u2019 connection to Tofurky began recently when Kurt Loudenback, founder of Grand Prairie Foods, partnered with the company to produce its plant-based pockets. The product is best described as a stuffed sandwich, and it\u2019s processed using Grand Prairie\u2019s signature co-extrusion technology which allows dough to be injected with various fillings. \u201cWe like dealing with new and innovative items that create a lot of buzz with consumers,\u201d Loudenback said."}
{"meta": {"doc_id": 2442, "sent_id": 8, "sent_start_pos": 1363, "sent_end_pos": 1742, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "The product is best described as a stuffed sandwich, and it\u2019s processed using Grand Prairie\u2019s signature co-extrusion technology which allows dough to be injected with various fillings. \u201cWe like dealing with new and innovative items that create a lot of buzz with consumers,\u201d Loudenback said. \u201cThe plant-based trend is growing at roughly five to six times the rate of food demand."}
{"meta": {"doc_id": 2442, "sent_id": 9, "sent_start_pos": 1548, "sent_end_pos": 1957, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "\u201cWe like dealing with new and innovative items that create a lot of buzz with consumers,\u201d Loudenback said. \u201cThe plant-based trend is growing at roughly five to six times the rate of food demand. We\u2019d been keeping our eye on this category and we saw it as a real growth opportunity for our business.\u201d\nPanelists spent a significant portion of the discussion covering the rapid growth of the plant-based protein."}
{"meta": {"doc_id": 2442, "sent_id": 10, "sent_start_pos": 1655, "sent_end_pos": 2035, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "\u201cThe plant-based trend is growing at roughly five to six times the rate of food demand. We\u2019d been keeping our eye on this category and we saw it as a real growth opportunity for our business.\u201d\nPanelists spent a significant portion of the discussion covering the rapid growth of the plant-based protein. Though it may seem like a trend, the conclusion was that it\u2019s not going away."}
{"meta": {"doc_id": 2442, "sent_id": 11, "sent_start_pos": 1743, "sent_end_pos": 2122, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "We\u2019d been keeping our eye on this category and we saw it as a real growth opportunity for our business.\u201d\nPanelists spent a significant portion of the discussion covering the rapid growth of the plant-based protein. Though it may seem like a trend, the conclusion was that it\u2019s not going away. \u201cThis is a real opportunity for the mainstreaming of plant-based foods,\u201d Tibbott said."}
{"meta": {"doc_id": 2442, "sent_id": 12, "sent_start_pos": 1958, "sent_end_pos": 2213, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "Though it may seem like a trend, the conclusion was that it\u2019s not going away. \u201cThis is a real opportunity for the mainstreaming of plant-based foods,\u201d Tibbott said. \u201cThe signs are everywhere with fast food places trying to get vegan and plant-based foods."}
{"meta": {"doc_id": 2442, "sent_id": 13, "sent_start_pos": 2036, "sent_end_pos": 2296, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "\u201cThis is a real opportunity for the mainstreaming of plant-based foods,\u201d Tibbott said. \u201cThe signs are everywhere with fast food places trying to get vegan and plant-based foods. The demand is here.\u201d\nTibbott also emphasized the opportunity in terms of business."}
{"meta": {"doc_id": 2442, "sent_id": 14, "sent_start_pos": 2123, "sent_end_pos": 2383, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "\u201cThe signs are everywhere with fast food places trying to get vegan and plant-based foods. The demand is here.\u201d\nTibbott also emphasized the opportunity in terms of business. \u201cPeople who jump on this now position themselves to be leaders in the field,\u201d he said."}
{"meta": {"doc_id": 2442, "sent_id": 15, "sent_start_pos": 2214, "sent_end_pos": 2614, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "The demand is here.\u201d\nTibbott also emphasized the opportunity in terms of business. \u201cPeople who jump on this now position themselves to be leaders in the field,\u201d he said. \u201cIt\u2019s a great time to be an entrepreneur.\u201d\nFor the business community in Sioux Falls, it\u2019s critical to pay attention to rapidly growing industries with the power to create a positive impact on health, economics or the environment."}
{"meta": {"doc_id": 2442, "sent_id": 16, "sent_start_pos": 2297, "sent_end_pos": 2867, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "\u201cPeople who jump on this now position themselves to be leaders in the field,\u201d he said. \u201cIt\u2019s a great time to be an entrepreneur.\u201d\nFor the business community in Sioux Falls, it\u2019s critical to pay attention to rapidly growing industries with the power to create a positive impact on health, economics or the environment. \u201cWe hope to host many more discussions surrounding growing industries that will spark the minds and hearts of entrepreneurs in our area as the innovations we implement today will affect generations ahead,\u201d said Brienne Maner, Zeal\u2019s executive director."}
{"meta": {"doc_id": 2442, "sent_id": 17, "sent_start_pos": 2384, "sent_end_pos": 3052, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "\u201cIt\u2019s a great time to be an entrepreneur.\u201d\nFor the business community in Sioux Falls, it\u2019s critical to pay attention to rapidly growing industries with the power to create a positive impact on health, economics or the environment. \u201cWe hope to host many more discussions surrounding growing industries that will spark the minds and hearts of entrepreneurs in our area as the innovations we implement today will affect generations ahead,\u201d said Brienne Maner, Zeal\u2019s executive director. \u201cWe appreciated the panelists driving diverse, impassioned and candid conversation surrounding the plant-based protein industry, as well as those in the community who engaged with us.\""}
{"meta": {"doc_id": 2442, "sent_id": 18, "sent_start_pos": 2615, "sent_end_pos": 3209, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "\u201cWe hope to host many more discussions surrounding growing industries that will spark the minds and hearts of entrepreneurs in our area as the innovations we implement today will affect generations ahead,\u201d said Brienne Maner, Zeal\u2019s executive director. \u201cWe appreciated the panelists driving diverse, impassioned and candid conversation surrounding the plant-based protein industry, as well as those in the community who engaged with us.\" Much of the discussion centered on the effects of plant-based diets on both the economy and the environment."}
{"meta": {"doc_id": 2442, "sent_id": 19, "sent_start_pos": 2868, "sent_end_pos": 3333, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "\u201cWe appreciated the panelists driving diverse, impassioned and candid conversation surrounding the plant-based protein industry, as well as those in the community who engaged with us.\" Much of the discussion centered on the effects of plant-based diets on both the economy and the environment. According to Kerr, there has never been a more critical time to understand the importance of protein in all of its sources."}
{"meta": {"doc_id": 2442, "sent_id": 20, "sent_start_pos": 3101, "sent_end_pos": 3461, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "Much of the discussion centered on the effects of plant-based diets on both the economy and the environment. According to Kerr, there has never been a more critical time to understand the importance of protein in all of its sources. As the globe\u2019s population continues to rise along with its standard of living, protein will be in more demand than ever before."}
{"meta": {"doc_id": 2442, "sent_id": 21, "sent_start_pos": 3210, "sent_end_pos": 3575, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "According to Kerr, there has never been a more critical time to understand the importance of protein in all of its sources. As the globe\u2019s population continues to rise along with its standard of living, protein will be in more demand than ever before. Beyond the economic demand, transitioning to plant-based protein would have a clear environmental effect as well."}
{"meta": {"doc_id": 2442, "sent_id": 22, "sent_start_pos": 3334, "sent_end_pos": 3660, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "As the globe\u2019s population continues to rise along with its standard of living, protein will be in more demand than ever before. Beyond the economic demand, transitioning to plant-based protein would have a clear environmental effect as well. According to Kephart, 83 percent of the globe\u2019s farmland supports animal industries."}
{"meta": {"doc_id": 2442, "sent_id": 23, "sent_start_pos": 3462, "sent_end_pos": 3828, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "Beyond the economic demand, transitioning to plant-based protein would have a clear environmental effect as well. According to Kephart, 83 percent of the globe\u2019s farmland supports animal industries. These industries produce 56 percent of the globe\u2019s agriculture-related greenhouse emissions but only 37 percent of its protein and 18 percent of its consumed calories."}
{"meta": {"doc_id": 2442, "sent_id": 24, "sent_start_pos": 3576, "sent_end_pos": 3936, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "According to Kephart, 83 percent of the globe\u2019s farmland supports animal industries. These industries produce 56 percent of the globe\u2019s agriculture-related greenhouse emissions but only 37 percent of its protein and 18 percent of its consumed calories. For such a high toll on the environment, animal-based proteins make up a small portion of what is consumed."}
{"meta": {"doc_id": 2442, "sent_id": 25, "sent_start_pos": 3661, "sent_end_pos": 4028, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "These industries produce 56 percent of the globe\u2019s agriculture-related greenhouse emissions but only 37 percent of its protein and 18 percent of its consumed calories. For such a high toll on the environment, animal-based proteins make up a small portion of what is consumed. Furthering the consumption of plant-based protein has the power to diminish these concerns."}
{"meta": {"doc_id": 2442, "sent_id": 26, "sent_start_pos": 3829, "sent_end_pos": 4209, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "For such a high toll on the environment, animal-based proteins make up a small portion of what is consumed. Furthering the consumption of plant-based protein has the power to diminish these concerns. Sayler, who is the general manager at The Co-op Natural Foods, says in the last four years since he\u2019s been working there the demand for plant-based protein has risen significantly."}
{"meta": {"doc_id": 2442, "sent_id": 27, "sent_start_pos": 3937, "sent_end_pos": 4359, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "Furthering the consumption of plant-based protein has the power to diminish these concerns. Sayler, who is the general manager at The Co-op Natural Foods, says in the last four years since he\u2019s been working there the demand for plant-based protein has risen significantly. When it comes to normalizing it as an alternative to animal-based protein, Sayler says he\u2019s noticed a shift, even in the simple act of merchandising."}
{"meta": {"doc_id": 2442, "sent_id": 28, "sent_start_pos": 4029, "sent_end_pos": 4482, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "Sayler, who is the general manager at The Co-op Natural Foods, says in the last four years since he\u2019s been working there the demand for plant-based protein has risen significantly. When it comes to normalizing it as an alternative to animal-based protein, Sayler says he\u2019s noticed a shift, even in the simple act of merchandising. \u201cStores are starting to stock those alternatives in the same section as the meat, which would have been unheard of before."}
{"meta": {"doc_id": 2442, "sent_id": 29, "sent_start_pos": 4210, "sent_end_pos": 4614, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "When it comes to normalizing it as an alternative to animal-based protein, Sayler says he\u2019s noticed a shift, even in the simple act of merchandising. \u201cStores are starting to stock those alternatives in the same section as the meat, which would have been unheard of before. Panelists agreed that we are still at the beginning of a long journey forward."}
{"meta": {"doc_id": 2442, "sent_id": 30, "sent_start_pos": 4360, "sent_end_pos": 4737, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "\u201cStores are starting to stock those alternatives in the same section as the meat, which would have been unheard of before. Panelists agreed that we are still at the beginning of a long journey forward. Tibbott noted that the industry is still quite young, with the vegan cheese market, for example, just around 25 years old."}
{"meta": {"doc_id": 2442, "sent_id": 31, "sent_start_pos": 4536, "sent_end_pos": 4823, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "Panelists agreed that we are still at the beginning of a long journey forward. Tibbott noted that the industry is still quite young, with the vegan cheese market, for example, just around 25 years old. As a young industry, it\u2019s important to remember there will be plenty of change ahead."}
{"meta": {"doc_id": 2442, "sent_id": 32, "sent_start_pos": 4615, "sent_end_pos": 4929, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "Tibbott noted that the industry is still quite young, with the vegan cheese market, for example, just around 25 years old. As a young industry, it\u2019s important to remember there will be plenty of change ahead. Elements like taste, texture, and an overall variety of products are only going to improve, says Tibbott."}
{"meta": {"doc_id": 2442, "sent_id": 33, "sent_start_pos": 4738, "sent_end_pos": 5041, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "As a young industry, it\u2019s important to remember there will be plenty of change ahead. Elements like taste, texture, and an overall variety of products are only going to improve, says Tibbott. \u201cThe most important thing for an entrepreneur is that they need to have a vision for the future,\u201d Tibbott said."}
{"meta": {"doc_id": 2442, "sent_id": 34, "sent_start_pos": 4824, "sent_end_pos": 5235, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "Elements like taste, texture, and an overall variety of products are only going to improve, says Tibbott. \u201cThe most important thing for an entrepreneur is that they need to have a vision for the future,\u201d Tibbott said. \u201cWe get the dream that we prepare for and this is a rewarding industry on so many levels, from creating a livelihood to doing something good for the planet, for animals and for people\u2019s health."}
{"meta": {"doc_id": 2442, "sent_id": 35, "sent_start_pos": 4930, "sent_end_pos": 5436, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "\u201cThe most important thing for an entrepreneur is that they need to have a vision for the future,\u201d Tibbott said. \u201cWe get the dream that we prepare for and this is a rewarding industry on so many levels, from creating a livelihood to doing something good for the planet, for animals and for people\u2019s health. If you look back when you get to my age, you\u2019re not going to be sad that you went into this field.\u201d\nThis article was produced by Startup Sioux Falls and syndicated by the Sioux Falls Business Journal."}
{"meta": {"doc_id": 2442, "sent_id": 36, "sent_start_pos": 5042, "sent_end_pos": 5582, "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "\u201cWe get the dream that we prepare for and this is a rewarding industry on so many levels, from creating a livelihood to doing something good for the planet, for animals and for people\u2019s health. If you look back when you get to my age, you\u2019re not going to be sad that you went into this field.\u201d\nThis article was produced by Startup Sioux Falls and syndicated by the Sioux Falls Business Journal. Startup Sioux Falls is a digital hub that aims to connect the communities, companies and non-profits that make up Sioux Falls' startup ecosystem."}
{"meta": {"doc_id": 2442, "sent_id": 37, "sent_start_pos": 5236, "sent_end_pos": [], "title": "Ahead of Thanksgiving, Tofurky founder gets welcome from Sioux Falls entrepreneurs"}, "text": "If you look back when you get to my age, you\u2019re not going to be sad that you went into this field.\u201d\nThis article was produced by Startup Sioux Falls and syndicated by the Sioux Falls Business Journal. Startup Sioux Falls is a digital hub that aims to connect the communities, companies and non-profits that make up Sioux Falls' startup ecosystem. "}
{"meta": {"doc_id": 2443, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 232, "title": "The food revolution"}, "text": " The food revolution\nTrends disrupting the food industry\nFood is no longer a private matter - whole economies and even national security depend on it. The choices we make about how and what to eat are shaping the world's food system."}
{"meta": {"doc_id": 2443, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 303, "title": "The food revolution"}, "text": "The food revolution\nTrends disrupting the food industry\nFood is no longer a private matter - whole economies and even national security depend on it. The choices we make about how and what to eat are shaping the world's food system. The influence of technology on the food industry is greater than ever."}
{"meta": {"doc_id": 2443, "sent_id": 2, "sent_start_pos": 150, "sent_end_pos": 480, "title": "The food revolution"}, "text": "The choices we make about how and what to eat are shaping the world's food system. The influence of technology on the food industry is greater than ever. Sweeping innovations, including trends in vertical farming, aquaculture, biotech, blockchain, and robotics, are transforming the way we produce food and will continue to do so."}
{"meta": {"doc_id": 2443, "sent_id": 3, "sent_start_pos": 233, "sent_end_pos": 650, "title": "The food revolution"}, "text": "The influence of technology on the food industry is greater than ever. Sweeping innovations, including trends in vertical farming, aquaculture, biotech, blockchain, and robotics, are transforming the way we produce food and will continue to do so. These are the main themes we explore in this report."}
{"meta": {"doc_id": 2443, "sent_id": 4, "sent_start_pos": 304, "sent_end_pos": 734, "title": "The food revolution"}, "text": "Sweeping innovations, including trends in vertical farming, aquaculture, biotech, blockchain, and robotics, are transforming the way we produce food and will continue to do so. These are the main themes we explore in this report. We know that the technology needed to revolutionize the food system already exists."}
{"meta": {"doc_id": 2443, "sent_id": 5, "sent_start_pos": 598, "sent_end_pos": 810, "title": "The food revolution"}, "text": "These are the main themes we explore in this report. We know that the technology needed to revolutionize the food system already exists. The trouble is that it\u2019s being developed in silos with limited integration."}
{"meta": {"doc_id": 2443, "sent_id": 6, "sent_start_pos": 651, "sent_end_pos": 877, "title": "The food revolution"}, "text": "We know that the technology needed to revolutionize the food system already exists. The trouble is that it\u2019s being developed in silos with limited integration. We invite you to explore how the food industry is about to change."}
{"meta": {"doc_id": 2443, "sent_id": 7, "sent_start_pos": 735, "sent_end_pos": 950, "title": "The food revolution"}, "text": "The trouble is that it\u2019s being developed in silos with limited integration. We invite you to explore how the food industry is about to change. Discover the drivers shaping the future of food and upcoming challenges."}
{"meta": {"doc_id": 2443, "sent_id": 8, "sent_start_pos": 811, "sent_end_pos": 1101, "title": "The food revolution"}, "text": "We invite you to explore how the food industry is about to change. Discover the drivers shaping the future of food and upcoming challenges. Population growth\nThe UN estimates farmers will need to produce at least 50% more food by 2050 because populations are growing and incomes are rising."}
{"meta": {"doc_id": 2443, "sent_id": 9, "sent_start_pos": 878, "sent_end_pos": 1189, "title": "The food revolution"}, "text": "Discover the drivers shaping the future of food and upcoming challenges. Population growth\nThe UN estimates farmers will need to produce at least 50% more food by 2050 because populations are growing and incomes are rising. Climate change\nChanging weather conditions will have a major impact on food production."}
{"meta": {"doc_id": 2443, "sent_id": 10, "sent_start_pos": 951, "sent_end_pos": 1363, "title": "The food revolution"}, "text": "Population growth\nThe UN estimates farmers will need to produce at least 50% more food by 2050 because populations are growing and incomes are rising. Climate change\nChanging weather conditions will have a major impact on food production. According to the UN, the most important agricultural regions worldwide may face substantial declines in agricultural output due to climate-related changes (eg extreme heat)."}
{"meta": {"doc_id": 2443, "sent_id": 11, "sent_start_pos": 1102, "sent_end_pos": 1444, "title": "The food revolution"}, "text": "Climate change\nChanging weather conditions will have a major impact on food production. According to the UN, the most important agricultural regions worldwide may face substantial declines in agricultural output due to climate-related changes (eg extreme heat). Water access\nWater use has tripled since the 1950s and demand continues to soar."}
{"meta": {"doc_id": 2443, "sent_id": 12, "sent_start_pos": 1190, "sent_end_pos": 1519, "title": "The food revolution"}, "text": "According to the UN, the most important agricultural regions worldwide may face substantial declines in agricultural output due to climate-related changes (eg extreme heat). Water access\nWater use has tripled since the 1950s and demand continues to soar. Under current trends, demand for water will exceed supply by 40 % in 2030."}
{"meta": {"doc_id": 2443, "sent_id": 13, "sent_start_pos": 1364, "sent_end_pos": 1658, "title": "The food revolution"}, "text": "Water access\nWater use has tripled since the 1950s and demand continues to soar. Under current trends, demand for water will exceed supply by 40 % in 2030. Food waste\nThe UN estimates 1.3 billion tons of food are lost or wasted annually, equating to roughly one-third of global food production."}
{"meta": {"doc_id": 2443, "sent_id": 14, "sent_start_pos": 1445, "sent_end_pos": 1807, "title": "The food revolution"}, "text": "Under current trends, demand for water will exceed supply by 40 % in 2030. Food waste\nThe UN estimates 1.3 billion tons of food are lost or wasted annually, equating to roughly one-third of global food production. Food is wasted in almost every category: 45% of fruit and vegetables, 30% of cereal products, 35% of fish and seafood, 20% of dairy and 20% of meat."}
{"meta": {"doc_id": 2443, "sent_id": 15, "sent_start_pos": 1520, "sent_end_pos": 1924, "title": "The food revolution"}, "text": "Food waste\nThe UN estimates 1.3 billion tons of food are lost or wasted annually, equating to roughly one-third of global food production. Food is wasted in almost every category: 45% of fruit and vegetables, 30% of cereal products, 35% of fish and seafood, 20% of dairy and 20% of meat. Major demographic shifts\nConsumer demands\nDemographic shifts are disrupting how food will be consumed in the future."}
{"meta": {"doc_id": 2443, "sent_id": 16, "sent_start_pos": 1659, "sent_end_pos": 2068, "title": "The food revolution"}, "text": "Food is wasted in almost every category: 45% of fruit and vegetables, 30% of cereal products, 35% of fish and seafood, 20% of dairy and 20% of meat. Major demographic shifts\nConsumer demands\nDemographic shifts are disrupting how food will be consumed in the future. Surging middle-class growth and increasing consumer demand for transparency and nutritious alternatives are forcing the food industry to adapt."}
{"meta": {"doc_id": 2443, "sent_id": 17, "sent_start_pos": 1808, "sent_end_pos": 2146, "title": "The food revolution"}, "text": "Major demographic shifts\nConsumer demands\nDemographic shifts are disrupting how food will be consumed in the future. Surging middle-class growth and increasing consumer demand for transparency and nutritious alternatives are forcing the food industry to adapt. According to Deloitte, by 2020 millennials will make up 40% of all consumers."}
{"meta": {"doc_id": 2443, "sent_id": 18, "sent_start_pos": 1925, "sent_end_pos": 2304, "title": "The food revolution"}, "text": "Surging middle-class growth and increasing consumer demand for transparency and nutritious alternatives are forcing the food industry to adapt. According to Deloitte, by 2020 millennials will make up 40% of all consumers. This group are adopting digital solutions that provide instant access to products and services they want without being confined to physically nearby choices."}
{"meta": {"doc_id": 2443, "sent_id": 19, "sent_start_pos": 2069, "sent_end_pos": 2558, "title": "The food revolution"}, "text": "According to Deloitte, by 2020 millennials will make up 40% of all consumers. This group are adopting digital solutions that provide instant access to products and services they want without being confined to physically nearby choices. Millennial consumers increasingly show a preference toward \u201cmindful eating\u201d \u2013 that is, choosing brands and foods that come from sustainable sources \u2013 and a conscious engagement with the food industry, and how food is produced and the way it is consumed."}
{"meta": {"doc_id": 2443, "sent_id": 20, "sent_start_pos": 2147, "sent_end_pos": 2645, "title": "The food revolution"}, "text": "This group are adopting digital solutions that provide instant access to products and services they want without being confined to physically nearby choices. Millennial consumers increasingly show a preference toward \u201cmindful eating\u201d \u2013 that is, choosing brands and foods that come from sustainable sources \u2013 and a conscious engagement with the food industry, and how food is produced and the way it is consumed. Digital living\nThe food and agriculture industry is on the cusp of digital revolution."}
{"meta": {"doc_id": 2443, "sent_id": 21, "sent_start_pos": 2305, "sent_end_pos": 2779, "title": "The food revolution"}, "text": "Millennial consumers increasingly show a preference toward \u201cmindful eating\u201d \u2013 that is, choosing brands and foods that come from sustainable sources \u2013 and a conscious engagement with the food industry, and how food is produced and the way it is consumed. Digital living\nThe food and agriculture industry is on the cusp of digital revolution. New technological advances and their proliferation across industries are gradually ushering in a new wave of food-related innovation."}
{"meta": {"doc_id": 2443, "sent_id": 22, "sent_start_pos": 2559, "sent_end_pos": 3004, "title": "The food revolution"}, "text": "Digital living\nThe food and agriculture industry is on the cusp of digital revolution. New technological advances and their proliferation across industries are gradually ushering in a new wave of food-related innovation. The speed of innovation led the WEF to declare 2016 the start of the Fourth Industrial Revolution, one based on the concept of merging of physical, digital, and biological technologies \u2013 or in food production, \"Farming 4.0.\""}
{"meta": {"doc_id": 2443, "sent_id": 23, "sent_start_pos": 2646, "sent_end_pos": 3277, "title": "The food revolution"}, "text": "New technological advances and their proliferation across industries are gradually ushering in a new wave of food-related innovation. The speed of innovation led the WEF to declare 2016 the start of the Fourth Industrial Revolution, one based on the concept of merging of physical, digital, and biological technologies \u2013 or in food production, \"Farming 4.0.\" The adoption of digital technologies (ie environment sensors, mobile computing, satellites and imaging, drones and the Internet of Things) in food production is drawing substantial interest from investors who see a clear and pressing need to bring farming into the future."}
{"meta": {"doc_id": 2443, "sent_id": 24, "sent_start_pos": 2780, "sent_end_pos": 3408, "title": "The food revolution"}, "text": "The speed of innovation led the WEF to declare 2016 the start of the Fourth Industrial Revolution, one based on the concept of merging of physical, digital, and biological technologies \u2013 or in food production, \"Farming 4.0.\" The adoption of digital technologies (ie environment sensors, mobile computing, satellites and imaging, drones and the Internet of Things) in food production is drawing substantial interest from investors who see a clear and pressing need to bring farming into the future. The impact of diffused innovation and the wide application of digital technologies are fundamental and transformational in nature."}
{"meta": {"doc_id": 2443, "sent_id": 25, "sent_start_pos": 3005, "sent_end_pos": 3561, "title": "The food revolution"}, "text": "The adoption of digital technologies (ie environment sensors, mobile computing, satellites and imaging, drones and the Internet of Things) in food production is drawing substantial interest from investors who see a clear and pressing need to bring farming into the future. The impact of diffused innovation and the wide application of digital technologies are fundamental and transformational in nature. Profit with impact\nGovernments all over the world are increasingly paying more attention to the United Nations\u2019 17 Sustainable Development Goals (SDGs)."}
{"meta": {"doc_id": 2443, "sent_id": 26, "sent_start_pos": 3278, "sent_end_pos": 3793, "title": "The food revolution"}, "text": "The impact of diffused innovation and the wide application of digital technologies are fundamental and transformational in nature. Profit with impact\nGovernments all over the world are increasingly paying more attention to the United Nations\u2019 17 Sustainable Development Goals (SDGs). Moreover, policymaker's decisions will be significantly influenced by climate-related changes, as people pressure city municipalities to clean the air, and food producers to reduce GHG emissions and waste, and rebuild biodiversity."}
{"meta": {"doc_id": 2443, "sent_id": 27, "sent_start_pos": 3409, "sent_end_pos": 4038, "title": "The food revolution"}, "text": "Profit with impact\nGovernments all over the world are increasingly paying more attention to the United Nations\u2019 17 Sustainable Development Goals (SDGs). Moreover, policymaker's decisions will be significantly influenced by climate-related changes, as people pressure city municipalities to clean the air, and food producers to reduce GHG emissions and waste, and rebuild biodiversity. Moreover, climate-related changes will significantly influence policymakers' decisions in the coming years, as people pressure city municipalities to clean the air, and food producers to reduce GHG emissions and waste, and rebuild biodiversity."}
{"meta": {"doc_id": 2443, "sent_id": 28, "sent_start_pos": 3562, "sent_end_pos": 4199, "title": "The food revolution"}, "text": "Moreover, policymaker's decisions will be significantly influenced by climate-related changes, as people pressure city municipalities to clean the air, and food producers to reduce GHG emissions and waste, and rebuild biodiversity. Moreover, climate-related changes will significantly influence policymakers' decisions in the coming years, as people pressure city municipalities to clean the air, and food producers to reduce GHG emissions and waste, and rebuild biodiversity. Many companies are plotting new technologies to improve the efficiency of food production, as sustainability becomes a key component of their business strategy."}
{"meta": {"doc_id": 2443, "sent_id": 29, "sent_start_pos": 3794, "sent_end_pos": 4269, "title": "The food revolution"}, "text": "Moreover, climate-related changes will significantly influence policymakers' decisions in the coming years, as people pressure city municipalities to clean the air, and food producers to reduce GHG emissions and waste, and rebuild biodiversity. Many companies are plotting new technologies to improve the efficiency of food production, as sustainability becomes a key component of their business strategy. Impact rather than profit will become a core value of food companies."}
{"meta": {"doc_id": 2443, "sent_id": 30, "sent_start_pos": 4039, "sent_end_pos": 4502, "title": "The food revolution"}, "text": "Many companies are plotting new technologies to improve the efficiency of food production, as sustainability becomes a key component of their business strategy. Impact rather than profit will become a core value of food companies. Order food delivery demand driven by young consumers\nordering frequency per week\nFood innovation\nGene-editing, plant-based protein, 3D food printing, and personalized nutrition can make food much healthier and much more sustainable."}
{"meta": {"doc_id": 2443, "sent_id": 31, "sent_start_pos": 4200, "sent_end_pos": 4714, "title": "The food revolution"}, "text": "Impact rather than profit will become a core value of food companies. Order food delivery demand driven by young consumers\nordering frequency per week\nFood innovation\nGene-editing, plant-based protein, 3D food printing, and personalized nutrition can make food much healthier and much more sustainable. Smart farming\nVertical farming, lab-grown food, and algae aquaculture, and the components of the Fourth Industrial Revolution (big data and AI) can reduce resource use, boost yields, and improve crop resilience."}
{"meta": {"doc_id": 2443, "sent_id": 32, "sent_start_pos": 4270, "sent_end_pos": 4895, "title": "The food revolution"}, "text": "Order food delivery demand driven by young consumers\nordering frequency per week\nFood innovation\nGene-editing, plant-based protein, 3D food printing, and personalized nutrition can make food much healthier and much more sustainable. Smart farming\nVertical farming, lab-grown food, and algae aquaculture, and the components of the Fourth Industrial Revolution (big data and AI) can reduce resource use, boost yields, and improve crop resilience. Supply chain innovation\nBlockchain, food delivery apps, Internet of Things, and bioplastics can reduce food waste, improve provenance, limit fraud risks, and increase traceability."}
{"meta": {"doc_id": 2443, "sent_id": 33, "sent_start_pos": 4503, "sent_end_pos": 5110, "title": "The food revolution"}, "text": "Smart farming\nVertical farming, lab-grown food, and algae aquaculture, and the components of the Fourth Industrial Revolution (big data and AI) can reduce resource use, boost yields, and improve crop resilience. Supply chain innovation\nBlockchain, food delivery apps, Internet of Things, and bioplastics can reduce food waste, improve provenance, limit fraud risks, and increase traceability. Barcoding technologies\nOffers opportunity to consumers, brands and food producers\nOverall market: USD 700bn market by 2030\nOverall, we estimate the food innovation opportunity represents a USD 700bn market by 2030."}
{"meta": {"doc_id": 2443, "sent_id": 34, "sent_start_pos": 4715, "sent_end_pos": 5190, "title": "The food revolution"}, "text": "Supply chain innovation\nBlockchain, food delivery apps, Internet of Things, and bioplastics can reduce food waste, improve provenance, limit fraud risks, and increase traceability. Barcoding technologies\nOffers opportunity to consumers, brands and food producers\nOverall market: USD 700bn market by 2030\nOverall, we estimate the food innovation opportunity represents a USD 700bn market by 2030. We expect it to grow more than fivefold, at a 15% CAGR, from USD 135bn in 2018."}
{"meta": {"doc_id": 2443, "sent_id": 35, "sent_start_pos": 4896, "sent_end_pos": 5398, "title": "The food revolution"}, "text": "Barcoding technologies\nOffers opportunity to consumers, brands and food producers\nOverall market: USD 700bn market by 2030\nOverall, we estimate the food innovation opportunity represents a USD 700bn market by 2030. We expect it to grow more than fivefold, at a 15% CAGR, from USD 135bn in 2018. Online food delivery: USD 365bn market by 2030\nOnline food delivery is set to be the largest segment, expanding from a market worth USD 60bn in 2018 to USD 365bn, a mid-teen CAGR, according to our forecasts."}
{"meta": {"doc_id": 2443, "sent_id": 36, "sent_start_pos": 5111, "sent_end_pos": 5530, "title": "The food revolution"}, "text": "We expect it to grow more than fivefold, at a 15% CAGR, from USD 135bn in 2018. Online food delivery: USD 365bn market by 2030\nOnline food delivery is set to be the largest segment, expanding from a market worth USD 60bn in 2018 to USD 365bn, a mid-teen CAGR, according to our forecasts. Emerging markets, improving logistics, and a structural shift from offline to online food delivery are likely to drive this growth."}
{"meta": {"doc_id": 2443, "sent_id": 37, "sent_start_pos": 5191, "sent_end_pos": 5631, "title": "The food revolution"}, "text": "Online food delivery: USD 365bn market by 2030\nOnline food delivery is set to be the largest segment, expanding from a market worth USD 60bn in 2018 to USD 365bn, a mid-teen CAGR, according to our forecasts. Emerging markets, improving logistics, and a structural shift from offline to online food delivery are likely to drive this growth. Farming 4.0: USD 90bn market by 2030\nFarming 4.0 is another promising segment within that timeframe."}
{"meta": {"doc_id": 2443, "sent_id": 38, "sent_start_pos": 5399, "sent_end_pos": 5702, "title": "The food revolution"}, "text": "Emerging markets, improving logistics, and a structural shift from offline to online food delivery are likely to drive this growth. Farming 4.0: USD 90bn market by 2030\nFarming 4.0 is another promising segment within that timeframe. We anticipate it expanding from a USD 15bn market in 2018 to USD 90bn."}
{"meta": {"doc_id": 2443, "sent_id": 39, "sent_start_pos": 5531, "sent_end_pos": 5861, "title": "The food revolution"}, "text": "Farming 4.0: USD 90bn market by 2030\nFarming 4.0 is another promising segment within that timeframe. We anticipate it expanding from a USD 15bn market in 2018 to USD 90bn. Plant-based protein: USD 85bn market by 2030\nWe expect the plant-based meat market to expand from USD 4.6bn in 2018 to USD 85bn at the end of the next decade."}
{"meta": {"doc_id": 2443, "sent_id": 40, "sent_start_pos": 5632, "sent_end_pos": [], "title": "The food revolution"}, "text": "We anticipate it expanding from a USD 15bn market in 2018 to USD 90bn. Plant-based protein: USD 85bn market by 2030\nWe expect the plant-based meat market to expand from USD 4.6bn in 2018 to USD 85bn at the end of the next decade. "}
{"meta": {"doc_id": 2444, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 369, "title": "Fonterra dips hoof in alternative animal products"}, "text": " Business\nFonterra dips hoof in alternative animal products\nFonterra has bought a stake in a Boston biotech start-up that wants to develop cow-free protein for use in products like cheese and drinks. But while the co-op says there\u2019s room in its future for both dairy and \"dairy-like\" products, it insists cow-free protein isn't necessarily more environmentally-friendly."}
{"meta": {"doc_id": 2444, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 510, "title": "Fonterra dips hoof in alternative animal products"}, "text": "Business\nFonterra dips hoof in alternative animal products\nFonterra has bought a stake in a Boston biotech start-up that wants to develop cow-free protein for use in products like cheese and drinks. But while the co-op says there\u2019s room in its future for both dairy and \"dairy-like\" products, it insists cow-free protein isn't necessarily more environmentally-friendly. Fonterra is dipping a hoof in the lab-grown food market by investing in a Boston biotechnology start-up backed by Bill Gates and Jeff Bezos."}
{"meta": {"doc_id": 2444, "sent_id": 2, "sent_start_pos": 199, "sent_end_pos": 679, "title": "Fonterra dips hoof in alternative animal products"}, "text": "But while the co-op says there\u2019s room in its future for both dairy and \"dairy-like\" products, it insists cow-free protein isn't necessarily more environmentally-friendly. Fonterra is dipping a hoof in the lab-grown food market by investing in a Boston biotechnology start-up backed by Bill Gates and Jeff Bezos. Motif Ingredients -- whose homepage features a block of (presumably animal-free) cheese -- plans to create lab-grown alternatives to milk protein, egg and meat protein."}
{"meta": {"doc_id": 2444, "sent_id": 3, "sent_start_pos": 370, "sent_end_pos": 960, "title": "Fonterra dips hoof in alternative animal products"}, "text": "Fonterra is dipping a hoof in the lab-grown food market by investing in a Boston biotechnology start-up backed by Bill Gates and Jeff Bezos. Motif Ingredients -- whose homepage features a block of (presumably animal-free) cheese -- plans to create lab-grown alternatives to milk protein, egg and meat protein. The goal is making cheaper food ingredients without cows, sheep or chickens by using genetically modified microbes (yeast, fungi and other tiny organisms) to ferment foods like sugar, ultimately brewing proteins that its founders hope will taste and function like animal proteins."}
{"meta": {"doc_id": 2444, "sent_id": 4, "sent_start_pos": 511, "sent_end_pos": 1272, "title": "Fonterra dips hoof in alternative animal products"}, "text": "Motif Ingredients -- whose homepage features a block of (presumably animal-free) cheese -- plans to create lab-grown alternatives to milk protein, egg and meat protein. The goal is making cheaper food ingredients without cows, sheep or chickens by using genetically modified microbes (yeast, fungi and other tiny organisms) to ferment foods like sugar, ultimately brewing proteins that its founders hope will taste and function like animal proteins. The start-up, Motif Ingredients, was launched today with a USD $90m initial investment from Fonterra, Gingko Bioworks, Louis Dreyfus Companies, Viking Global Investors and Breakthrough Energy Ventures -- an R&D fund started by Bill Gates and backed by billionaires Gates, Jeff Bezos, Richard Branson and others."}
{"meta": {"doc_id": 2444, "sent_id": 5, "sent_start_pos": 680, "sent_end_pos": 1472, "title": "Fonterra dips hoof in alternative animal products"}, "text": "The goal is making cheaper food ingredients without cows, sheep or chickens by using genetically modified microbes (yeast, fungi and other tiny organisms) to ferment foods like sugar, ultimately brewing proteins that its founders hope will taste and function like animal proteins. The start-up, Motif Ingredients, was launched today with a USD $90m initial investment from Fonterra, Gingko Bioworks, Louis Dreyfus Companies, Viking Global Investors and Breakthrough Energy Ventures -- an R&D fund started by Bill Gates and backed by billionaires Gates, Jeff Bezos, Richard Branson and others. New Zealand's dairy co-op is walking a careful line -- assuring farmers that cows' milk remains the priority and insisting it is not clear that cow-free protein will be more environmentally friendly."}
{"meta": {"doc_id": 2444, "sent_id": 6, "sent_start_pos": 961, "sent_end_pos": 1627, "title": "Fonterra dips hoof in alternative animal products"}, "text": "The start-up, Motif Ingredients, was launched today with a USD $90m initial investment from Fonterra, Gingko Bioworks, Louis Dreyfus Companies, Viking Global Investors and Breakthrough Energy Ventures -- an R&D fund started by Bill Gates and backed by billionaires Gates, Jeff Bezos, Richard Branson and others. New Zealand's dairy co-op is walking a careful line -- assuring farmers that cows' milk remains the priority and insisting it is not clear that cow-free protein will be more environmentally friendly. With an extra two billion mouths to feed in coming decades, Fonterra says there won't be enough cows or land to supply enough protein the traditional way."}
{"meta": {"doc_id": 2444, "sent_id": 7, "sent_start_pos": 1273, "sent_end_pos": 1716, "title": "Fonterra dips hoof in alternative animal products"}, "text": "New Zealand's dairy co-op is walking a careful line -- assuring farmers that cows' milk remains the priority and insisting it is not clear that cow-free protein will be more environmentally friendly. With an extra two billion mouths to feed in coming decades, Fonterra says there won't be enough cows or land to supply enough protein the traditional way. With that in mind, it wants to be part of the move to make animal-free protein, it says."}
{"meta": {"doc_id": 2444, "sent_id": 8, "sent_start_pos": 1473, "sent_end_pos": 1792, "title": "Fonterra dips hoof in alternative animal products"}, "text": "With an extra two billion mouths to feed in coming decades, Fonterra says there won't be enough cows or land to supply enough protein the traditional way. With that in mind, it wants to be part of the move to make animal-free protein, it says. It may, one day, become a customer of Motif's for its ingredients business."}
{"meta": {"doc_id": 2444, "sent_id": 9, "sent_start_pos": 1628, "sent_end_pos": 1988, "title": "Fonterra dips hoof in alternative animal products"}, "text": "With that in mind, it wants to be part of the move to make animal-free protein, it says. It may, one day, become a customer of Motif's for its ingredients business. Fonterra's Judith Swales, head of the co-op's Global Consumer and Foodservice business, says Fonterra was in talks with Gingko and other investors for about 12 months before today's announcement."}
{"meta": {"doc_id": 2444, "sent_id": 10, "sent_start_pos": 1717, "sent_end_pos": 2165, "title": "Fonterra dips hoof in alternative animal products"}, "text": "It may, one day, become a customer of Motif's for its ingredients business. Fonterra's Judith Swales, head of the co-op's Global Consumer and Foodservice business, says Fonterra was in talks with Gingko and other investors for about 12 months before today's announcement. While she wouldn't disclose how much of the Motif's $90m start-up money was from Fonterra , she said the co-op was a minority shareholder and wouldn't have a seat on the board."}
{"meta": {"doc_id": 2444, "sent_id": 11, "sent_start_pos": 1793, "sent_end_pos": 2364, "title": "Fonterra dips hoof in alternative animal products"}, "text": "Fonterra's Judith Swales, head of the co-op's Global Consumer and Foodservice business, says Fonterra was in talks with Gingko and other investors for about 12 months before today's announcement. While she wouldn't disclose how much of the Motif's $90m start-up money was from Fonterra , she said the co-op was a minority shareholder and wouldn't have a seat on the board. Fonterra doesn't expect a profitable commercial product to emerge for somewhere between 3-7 years, but if and when it does it may supply ingredients for foods like cheese, drinks and infant formula."}
{"meta": {"doc_id": 2444, "sent_id": 12, "sent_start_pos": 1989, "sent_end_pos": 2498, "title": "Fonterra dips hoof in alternative animal products"}, "text": "While she wouldn't disclose how much of the Motif's $90m start-up money was from Fonterra , she said the co-op was a minority shareholder and wouldn't have a seat on the board. Fonterra doesn't expect a profitable commercial product to emerge for somewhere between 3-7 years, but if and when it does it may supply ingredients for foods like cheese, drinks and infant formula. A major driver for a growing wave of investment in alternative proteins is making food without animal farming's environmental impact."}
{"meta": {"doc_id": 2444, "sent_id": 13, "sent_start_pos": 2166, "sent_end_pos": 2747, "title": "Fonterra dips hoof in alternative animal products"}, "text": "Fonterra doesn't expect a profitable commercial product to emerge for somewhere between 3-7 years, but if and when it does it may supply ingredients for foods like cheese, drinks and infant formula. A major driver for a growing wave of investment in alternative proteins is making food without animal farming's environmental impact. A rival to Motif, Silicone Valley's Perfect Day (\"All the dairy you love, with none of the dairy cows\"), claims preliminary university research shows its overall environmental impact is substantially lower than that of conventionally produced milk."}
{"meta": {"doc_id": 2444, "sent_id": 14, "sent_start_pos": 2365, "sent_end_pos": 2848, "title": "Fonterra dips hoof in alternative animal products"}, "text": "A major driver for a growing wave of investment in alternative proteins is making food without animal farming's environmental impact. A rival to Motif, Silicone Valley's Perfect Day (\"All the dairy you love, with none of the dairy cows\"), claims preliminary university research shows its overall environmental impact is substantially lower than that of conventionally produced milk. But Swales insists it is not clear that cow-free alternatives will be more environmentally friendly."}
{"meta": {"doc_id": 2444, "sent_id": 15, "sent_start_pos": 2499, "sent_end_pos": 3022, "title": "Fonterra dips hoof in alternative animal products"}, "text": "A rival to Motif, Silicone Valley's Perfect Day (\"All the dairy you love, with none of the dairy cows\"), claims preliminary university research shows its overall environmental impact is substantially lower than that of conventionally produced milk. But Swales insists it is not clear that cow-free alternatives will be more environmentally friendly. She says the genetically engineered microbes like yeast that are used during the fermentation process still need a food source, such as sugar, which must be grown somewhere."}
{"meta": {"doc_id": 2444, "sent_id": 16, "sent_start_pos": 2748, "sent_end_pos": 3099, "title": "Fonterra dips hoof in alternative animal products"}, "text": "But Swales insists it is not clear that cow-free alternatives will be more environmentally friendly. She says the genetically engineered microbes like yeast that are used during the fermentation process still need a food source, such as sugar, which must be grown somewhere. \"It needs land to produce it and there's waste to be disposed of at the end."}
{"meta": {"doc_id": 2444, "sent_id": 17, "sent_start_pos": 2849, "sent_end_pos": 3164, "title": "Fonterra dips hoof in alternative animal products"}, "text": "She says the genetically engineered microbes like yeast that are used during the fermentation process still need a food source, such as sugar, which must be grown somewhere. \"It needs land to produce it and there's waste to be disposed of at the end. It's not clear it\u2019s going to be any better for the environment.\""}
{"meta": {"doc_id": 2444, "sent_id": 18, "sent_start_pos": 3023, "sent_end_pos": 3362, "title": "Fonterra dips hoof in alternative animal products"}, "text": "\"It needs land to produce it and there's waste to be disposed of at the end. It's not clear it\u2019s going to be any better for the environment.\" The co-op has made clear it will still be promoting cow's milk as being more valuable and nutritionally better than proteins created by new methods, while seeking a stake in the newer alternatives."}
{"meta": {"doc_id": 2444, "sent_id": 19, "sent_start_pos": 3100, "sent_end_pos": 3417, "title": "Fonterra dips hoof in alternative animal products"}, "text": "It's not clear it\u2019s going to be any better for the environment.\" The co-op has made clear it will still be promoting cow's milk as being more valuable and nutritionally better than proteins created by new methods, while seeking a stake in the newer alternatives. \"It\u2019s not a case of either/or, but both,\u201d said Swales."}
{"meta": {"doc_id": 2444, "sent_id": 20, "sent_start_pos": 3165, "sent_end_pos": 3552, "title": "Fonterra dips hoof in alternative animal products"}, "text": "The co-op has made clear it will still be promoting cow's milk as being more valuable and nutritionally better than proteins created by new methods, while seeking a stake in the newer alternatives. \"It\u2019s not a case of either/or, but both,\u201d said Swales. \"This is a long-term strategic play but consumers are changing and we can see that."}
{"meta": {"doc_id": 2444, "sent_id": 21, "sent_start_pos": 3363, "sent_end_pos": 3617, "title": "Fonterra dips hoof in alternative animal products"}, "text": "\"It\u2019s not a case of either/or, but both,\u201d said Swales. \"This is a long-term strategic play but consumers are changing and we can see that. We believe necessity will become mother of invention,\" she says."}
{"meta": {"doc_id": 2444, "sent_id": 22, "sent_start_pos": 3469, "sent_end_pos": 3722, "title": "Fonterra dips hoof in alternative animal products"}, "text": "\"This is a long-term strategic play but consumers are changing and we can see that. We believe necessity will become mother of invention,\" she says. One risk is that Fonterra's farmer-shareholders may see this as their company investing in a competitor."}
{"meta": {"doc_id": 2444, "sent_id": 23, "sent_start_pos": 3553, "sent_end_pos": 3841, "title": "Fonterra dips hoof in alternative animal products"}, "text": "We believe necessity will become mother of invention,\" she says. One risk is that Fonterra's farmer-shareholders may see this as their company investing in a competitor. While Motif will not make liquid milk alternatives, it plans to create ingredients that would normally come from milk."}
{"meta": {"doc_id": 2444, "sent_id": 24, "sent_start_pos": 3618, "sent_end_pos": 3931, "title": "Fonterra dips hoof in alternative animal products"}, "text": "One risk is that Fonterra's farmer-shareholders may see this as their company investing in a competitor. While Motif will not make liquid milk alternatives, it plans to create ingredients that would normally come from milk. That may create a perception that the co-op risks under-cutting its ingredients business."}
{"meta": {"doc_id": 2444, "sent_id": 25, "sent_start_pos": 3723, "sent_end_pos": 4095, "title": "Fonterra dips hoof in alternative animal products"}, "text": "While Motif will not make liquid milk alternatives, it plans to create ingredients that would normally come from milk. That may create a perception that the co-op risks under-cutting its ingredients business. Because at the end of the day the market's going to grow by two billion extra people and not everyone can afford the highest quality ingredients."}
{"meta": {"doc_id": 2444, "sent_id": 26, "sent_start_pos": 3842, "sent_end_pos": 4178, "title": "Fonterra dips hoof in alternative animal products"}, "text": "That may create a perception that the co-op risks under-cutting its ingredients business. Because at the end of the day the market's going to grow by two billion extra people and not everyone can afford the highest quality ingredients. As consumers change, this is a way too meet growth, not eat into our core markets."}
{"meta": {"doc_id": 2444, "sent_id": 27, "sent_start_pos": 3950, "sent_end_pos": 4389, "title": "Fonterra dips hoof in alternative animal products"}, "text": "Because at the end of the day the market's going to grow by two billion extra people and not everyone can afford the highest quality ingredients. As consumers change, this is a way too meet growth, not eat into our core markets. We want to be able to explain to customers the difference between the two and why New Zealand's [grass-fed dairy] with its nutritional profile is best you can get\u2026and not be defensive about this new nutrition.\""}
{"meta": {"doc_id": 2444, "sent_id": 28, "sent_start_pos": 4096, "sent_end_pos": 4513, "title": "Fonterra dips hoof in alternative animal products"}, "text": "As consumers change, this is a way too meet growth, not eat into our core markets. We want to be able to explain to customers the difference between the two and why New Zealand's [grass-fed dairy] with its nutritional profile is best you can get\u2026and not be defensive about this new nutrition.\" Motif is a spin-off bio-engineering business founded by a fast-growing Boston-based biotech company called Ginkgo Bioworks."}
{"meta": {"doc_id": 2444, "sent_id": 29, "sent_start_pos": 4179, "sent_end_pos": 4805, "title": "Fonterra dips hoof in alternative animal products"}, "text": "We want to be able to explain to customers the difference between the two and why New Zealand's [grass-fed dairy] with its nutritional profile is best you can get\u2026and not be defensive about this new nutrition.\" Motif is a spin-off bio-engineering business founded by a fast-growing Boston-based biotech company called Ginkgo Bioworks. Gingko\u2019s other projects include creating genetically-engineered mammal cells for pharmaceutical research, growing cannabis extracts in the lab from genetically-modified yeast, and using microbes to cultivate sugars found in human breast milk for adding to infant formula, among other things."}
{"meta": {"doc_id": 2444, "sent_id": 30, "sent_start_pos": 4390, "sent_end_pos": 4919, "title": "Fonterra dips hoof in alternative animal products"}, "text": "Motif is a spin-off bio-engineering business founded by a fast-growing Boston-based biotech company called Ginkgo Bioworks. Gingko\u2019s other projects include creating genetically-engineered mammal cells for pharmaceutical research, growing cannabis extracts in the lab from genetically-modified yeast, and using microbes to cultivate sugars found in human breast milk for adding to infant formula, among other things. Fonterra had previously been accused of underestimating the threat from alternative proteins' growing popularity."}
{"meta": {"doc_id": 2444, "sent_id": 31, "sent_start_pos": 4514, "sent_end_pos": 5189, "title": "Fonterra dips hoof in alternative animal products"}, "text": "Gingko\u2019s other projects include creating genetically-engineered mammal cells for pharmaceutical research, growing cannabis extracts in the lab from genetically-modified yeast, and using microbes to cultivate sugars found in human breast milk for adding to infant formula, among other things. Fonterra had previously been accused of underestimating the threat from alternative proteins' growing popularity. When the former PM\u2019s chief science adviser Sir Peter Gluckman stressed the growing threat to New Zealand\u2019s exports from new food technologies, Fonterra responded with a statement stressing that cow milk's nutritional profile would be \u201calmost impossible\u201d to manufacture."}
{"meta": {"doc_id": 2444, "sent_id": 32, "sent_start_pos": 4806, "sent_end_pos": 5264, "title": "Fonterra dips hoof in alternative animal products"}, "text": "Fonterra had previously been accused of underestimating the threat from alternative proteins' growing popularity. When the former PM\u2019s chief science adviser Sir Peter Gluckman stressed the growing threat to New Zealand\u2019s exports from new food technologies, Fonterra responded with a statement stressing that cow milk's nutritional profile would be \u201calmost impossible\u201d to manufacture. The statement added that Fonterra was \u201ckeeping tabs\u201d on alternative foods."}
{"meta": {"doc_id": 2444, "sent_id": 33, "sent_start_pos": 4920, "sent_end_pos": 5403, "title": "Fonterra dips hoof in alternative animal products"}, "text": "When the former PM\u2019s chief science adviser Sir Peter Gluckman stressed the growing threat to New Zealand\u2019s exports from new food technologies, Fonterra responded with a statement stressing that cow milk's nutritional profile would be \u201calmost impossible\u201d to manufacture. The statement added that Fonterra was \u201ckeeping tabs\u201d on alternative foods. Swales said today that the company never had its \"head in the sand\", it was just waiting for the right opportunity."}
{"meta": {"doc_id": 2444, "sent_id": 34, "sent_start_pos": 5190, "sent_end_pos": 5466, "title": "Fonterra dips hoof in alternative animal products"}, "text": "The statement added that Fonterra was \u201ckeeping tabs\u201d on alternative foods. Swales said today that the company never had its \"head in the sand\", it was just waiting for the right opportunity. \"A few years ago this probably sounded like sci-fi,\" she said."}
{"meta": {"doc_id": 2444, "sent_id": 35, "sent_start_pos": 5288, "sent_end_pos": 5627, "title": "Fonterra dips hoof in alternative animal products"}, "text": "Swales said today that the company never had its \"head in the sand\", it was just waiting for the right opportunity. \"A few years ago this probably sounded like sci-fi,\" she said. New Zealand\u2019s beef and lamb sector has publicly grappled with the risk from animal-alternatives, producing a detailed report last year on the future of protein."}
{"meta": {"doc_id": 2444, "sent_id": 36, "sent_start_pos": 5404, "sent_end_pos": 5856, "title": "Fonterra dips hoof in alternative animal products"}, "text": "\"A few years ago this probably sounded like sci-fi,\" she said. New Zealand\u2019s beef and lamb sector has publicly grappled with the risk from animal-alternatives, producing a detailed report last year on the future of protein. In another report on alternative proteins last year, MPI stressed the risk to New Zealand from relying too heavily on just a few products, at a time when climate and other impacts of farming are increasingly under the spotlight."}
{"meta": {"doc_id": 2444, "sent_id": 37, "sent_start_pos": 5467, "sent_end_pos": 6207, "title": "Fonterra dips hoof in alternative animal products"}, "text": "New Zealand\u2019s beef and lamb sector has publicly grappled with the risk from animal-alternatives, producing a detailed report last year on the future of protein. In another report on alternative proteins last year, MPI stressed the risk to New Zealand from relying too heavily on just a few products, at a time when climate and other impacts of farming are increasingly under the spotlight. \u201cNew Zealand's animal-based protein export revenue alone accounts for 60 percent of New Zealand's total primary exports....Dependency on a few markets and products creates risks and therefore innovation and assessment of consumer and market trends are critical to ensure the long-term success of primary industries in New Zealand,\u201d said the Ministry."}
{"meta": {"doc_id": 2444, "sent_id": 38, "sent_start_pos": 5628, "sent_end_pos": 6310, "title": "Fonterra dips hoof in alternative animal products"}, "text": "In another report on alternative proteins last year, MPI stressed the risk to New Zealand from relying too heavily on just a few products, at a time when climate and other impacts of farming are increasingly under the spotlight. \u201cNew Zealand's animal-based protein export revenue alone accounts for 60 percent of New Zealand's total primary exports....Dependency on a few markets and products creates risks and therefore innovation and assessment of consumer and market trends are critical to ensure the long-term success of primary industries in New Zealand,\u201d said the Ministry. Business journalist and Newsroom columnist Rod Oram said Fonterra should be investing in new proteins."}
{"meta": {"doc_id": 2444, "sent_id": 39, "sent_start_pos": 5857, "sent_end_pos": 6440, "title": "Fonterra dips hoof in alternative animal products"}, "text": "\u201cNew Zealand's animal-based protein export revenue alone accounts for 60 percent of New Zealand's total primary exports....Dependency on a few markets and products creates risks and therefore innovation and assessment of consumer and market trends are critical to ensure the long-term success of primary industries in New Zealand,\u201d said the Ministry. Business journalist and Newsroom columnist Rod Oram said Fonterra should be investing in new proteins. However he believes it will be a big challenge convincing farmers the venture is complementary to cows milk and not a competitor."}
{"meta": {"doc_id": 2444, "sent_id": 40, "sent_start_pos": 6208, "sent_end_pos": 6594, "title": "Fonterra dips hoof in alternative animal products"}, "text": "Business journalist and Newsroom columnist Rod Oram said Fonterra should be investing in new proteins. However he believes it will be a big challenge convincing farmers the venture is complementary to cows milk and not a competitor. While Oram says the two can work side-by-side, there was a risk alternative foods would take over if the environmental gap between the two was too large."}
{"meta": {"doc_id": 2444, "sent_id": 41, "sent_start_pos": 6311, "sent_end_pos": 6886, "title": "Fonterra dips hoof in alternative animal products"}, "text": "However he believes it will be a big challenge convincing farmers the venture is complementary to cows milk and not a competitor. While Oram says the two can work side-by-side, there was a risk alternative foods would take over if the environmental gap between the two was too large. While the new technologies may come with an \"ick\" factor for some shoppers, some market-watchers believe consumers will embrace GMO and lab-grown alternatives as ingredients in other products, such as chocolate or biscuits, before they come around to the idea of synthetic \"milk\" and \"meat\"."}
{"meta": {"doc_id": 2444, "sent_id": 42, "sent_start_pos": 6441, "sent_end_pos": 7191, "title": "Fonterra dips hoof in alternative animal products"}, "text": "While Oram says the two can work side-by-side, there was a risk alternative foods would take over if the environmental gap between the two was too large. While the new technologies may come with an \"ick\" factor for some shoppers, some market-watchers believe consumers will embrace GMO and lab-grown alternatives as ingredients in other products, such as chocolate or biscuits, before they come around to the idea of synthetic \"milk\" and \"meat\". Fearing losing sales, United States farmers seek a crack-down on companies using the word milk to label anything that is not from the udders of a lactating mammal, meaning almond, oat, rice, soy and other plant-based products might have to be sold as \u201cmylk\u201d or other alternative names like \u201cplant-juice\u201d."}
{"meta": {"doc_id": 2444, "sent_id": 43, "sent_start_pos": 6595, "sent_end_pos": 7296, "title": "Fonterra dips hoof in alternative animal products"}, "text": "While the new technologies may come with an \"ick\" factor for some shoppers, some market-watchers believe consumers will embrace GMO and lab-grown alternatives as ingredients in other products, such as chocolate or biscuits, before they come around to the idea of synthetic \"milk\" and \"meat\". Fearing losing sales, United States farmers seek a crack-down on companies using the word milk to label anything that is not from the udders of a lactating mammal, meaning almond, oat, rice, soy and other plant-based products might have to be sold as \u201cmylk\u201d or other alternative names like \u201cplant-juice\u201d. The plant-based protein industry argues that consumers know perfectly well what they\u2019re getting already."}
{"meta": {"doc_id": 2444, "sent_id": 44, "sent_start_pos": 6887, "sent_end_pos": 7599, "title": "Fonterra dips hoof in alternative animal products"}, "text": "Fearing losing sales, United States farmers seek a crack-down on companies using the word milk to label anything that is not from the udders of a lactating mammal, meaning almond, oat, rice, soy and other plant-based products might have to be sold as \u201cmylk\u201d or other alternative names like \u201cplant-juice\u201d. The plant-based protein industry argues that consumers know perfectly well what they\u2019re getting already. The possibility of a New Zealand Inc. marketing strategy that straddles both animal and non-animal products did not sit well with some New Zealand First and National MPs when Air New Zealand decided to offer a plant-based burger alongside the meat options on one of its business class routes last year."}
{"meta": {"doc_id": 2444, "sent_id": 45, "sent_start_pos": 7192, "sent_end_pos": 7778, "title": "Fonterra dips hoof in alternative animal products"}, "text": "The plant-based protein industry argues that consumers know perfectly well what they\u2019re getting already. The possibility of a New Zealand Inc. marketing strategy that straddles both animal and non-animal products did not sit well with some New Zealand First and National MPs when Air New Zealand decided to offer a plant-based burger alongside the meat options on one of its business class routes last year. Among the critics was Mark Patterson, the primary industries spokesperson for New Zealand First, who called the burger a \u201cslap in the face\u201d for this country\u2019s red meat producers."}
{"meta": {"doc_id": 2444, "sent_id": 46, "sent_start_pos": 7297, "sent_end_pos": 7968, "title": "Fonterra dips hoof in alternative animal products"}, "text": "The possibility of a New Zealand Inc. marketing strategy that straddles both animal and non-animal products did not sit well with some New Zealand First and National MPs when Air New Zealand decided to offer a plant-based burger alongside the meat options on one of its business class routes last year. Among the critics was Mark Patterson, the primary industries spokesperson for New Zealand First, who called the burger a \u201cslap in the face\u201d for this country\u2019s red meat producers. Help us create a sustainable future for independent local journalism\nAs New Zealand moves from crisis to recovery mode the need to support local industry has been brought into sharp relief."}
{"meta": {"doc_id": 2444, "sent_id": 47, "sent_start_pos": 7600, "sent_end_pos": 8084, "title": "Fonterra dips hoof in alternative animal products"}, "text": "Among the critics was Mark Patterson, the primary industries spokesperson for New Zealand First, who called the burger a \u201cslap in the face\u201d for this country\u2019s red meat producers. Help us create a sustainable future for independent local journalism\nAs New Zealand moves from crisis to recovery mode the need to support local industry has been brought into sharp relief. As our journalists work to ask the hard questions about our recovery, we also look to you, our readers for support."}
{"meta": {"doc_id": 2444, "sent_id": 48, "sent_start_pos": 7779, "sent_end_pos": 8256, "title": "Fonterra dips hoof in alternative animal products"}, "text": "Help us create a sustainable future for independent local journalism\nAs New Zealand moves from crisis to recovery mode the need to support local industry has been brought into sharp relief. As our journalists work to ask the hard questions about our recovery, we also look to you, our readers for support. If you can help us, please click the button to ensure we can continue to provide quality independent journalism you can trust."}
{"meta": {"doc_id": 2444, "sent_id": 49, "sent_start_pos": 7969, "sent_end_pos": [], "title": "Fonterra dips hoof in alternative animal products"}, "text": "As our journalists work to ask the hard questions about our recovery, we also look to you, our readers for support. If you can help us, please click the button to ensure we can continue to provide quality independent journalism you can trust. "}
{"meta": {"doc_id": 2448, "sent_id": 0, "sent_start_pos": [], "sent_end_pos": 397, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": " As the population sets to explode to about 10 billion people on the planet by 2050, many are concerned we're moving into a situation where we cannot produce enough of the essential nutrients to feed our populous using traditional agriculture. Some claim we've already exceeded the carrying capacity of the earth\u2014or the maximum population size of a species the environment can sustain indefinitely."}
{"meta": {"doc_id": 2448, "sent_id": 1, "sent_start_pos": 0, "sent_end_pos": 586, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "As the population sets to explode to about 10 billion people on the planet by 2050, many are concerned we're moving into a situation where we cannot produce enough of the essential nutrients to feed our populous using traditional agriculture. Some claim we've already exceeded the carrying capacity of the earth\u2014or the maximum population size of a species the environment can sustain indefinitely. And core to human and animal nutrition has been protein, the polymer chains of amino acids that are the building blocks of body tissue and provide necessary fuel to get us through our day."}
{"meta": {"doc_id": 2448, "sent_id": 2, "sent_start_pos": 243, "sent_end_pos": 784, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "Some claim we've already exceeded the carrying capacity of the earth\u2014or the maximum population size of a species the environment can sustain indefinitely. And core to human and animal nutrition has been protein, the polymer chains of amino acids that are the building blocks of body tissue and provide necessary fuel to get us through our day. Protein is consumed in many forms, from the meat of land animals and sea creatures, to plants like soy and yellow pea that now underpin a huge market shift in protein sources for human consumption."}
{"meta": {"doc_id": 2448, "sent_id": 3, "sent_start_pos": 398, "sent_end_pos": 948, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "And core to human and animal nutrition has been protein, the polymer chains of amino acids that are the building blocks of body tissue and provide necessary fuel to get us through our day. Protein is consumed in many forms, from the meat of land animals and sea creatures, to plants like soy and yellow pea that now underpin a huge market shift in protein sources for human consumption. Traditional protein production, mainly from animals, consumes a large quantity of natural resources and puts our environment at risk as the world population grows."}
{"meta": {"doc_id": 2448, "sent_id": 4, "sent_start_pos": 587, "sent_end_pos": 1217, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "Protein is consumed in many forms, from the meat of land animals and sea creatures, to plants like soy and yellow pea that now underpin a huge market shift in protein sources for human consumption. Traditional protein production, mainly from animals, consumes a large quantity of natural resources and puts our environment at risk as the world population grows. Plant-based protein has been considered a more efficient way to take the energy of the sun and nutrients in the soil and convert them into something people and animals want to eat."}
{"meta": {"doc_id": 2448, "sent_id": 5, "sent_start_pos": 785, "sent_end_pos": 1471, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "Traditional protein production, mainly from animals, consumes a large quantity of natural resources and puts our environment at risk as the world population grows. Plant-based protein has been considered a more efficient way to take the energy of the sun and nutrients in the soil and convert them into something people and animals want to eat. Recently, however, scientists have been developing microbial \"factories,\" and even taking ingredients out of the air, to produce new forms of protein."}
{"meta": {"doc_id": 2448, "sent_id": 6, "sent_start_pos": 1037, "sent_end_pos": 1759, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "Plant-based protein has been considered a more efficient way to take the energy of the sun and nutrients in the soil and convert them into something people and animals want to eat. Recently, however, scientists have been developing microbial \"factories,\" and even taking ingredients out of the air, to produce new forms of protein. This past month, Finnish startup Solar Foods came out of stealth to promote its new innovation, a protein derived through gas-based fermentation\u2014or using enzymatic reactions to convert carbon dioxide, with a minimal amount of water, nutrients and electricity, into human-edible proteins."}
{"meta": {"doc_id": 2448, "sent_id": 7, "sent_start_pos": 1321, "sent_end_pos": 1883, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "Recently, however, scientists have been developing microbial \"factories,\" and even taking ingredients out of the air, to produce new forms of protein. This past month, Finnish startup Solar Foods came out of stealth to promote its new innovation, a protein derived through gas-based fermentation\u2014or using enzymatic reactions to convert carbon dioxide, with a minimal amount of water, nutrients and electricity, into human-edible proteins. The new form of protein, dubbed Solein, will be produced in a powdered form to be used similar to flour in food production."}
{"meta": {"doc_id": 2448, "sent_id": 8, "sent_start_pos": 1472, "sent_end_pos": 2054, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "This past month, Finnish startup Solar Foods came out of stealth to promote its new innovation, a protein derived through gas-based fermentation\u2014or using enzymatic reactions to convert carbon dioxide, with a minimal amount of water, nutrients and electricity, into human-edible proteins. The new form of protein, dubbed Solein, will be produced in a powdered form to be used similar to flour in food production. \"Disconnecting from agriculture and fossil resources in food production is our key value and differentiator to all other [proteins],\" says CEO and founder, Pasi Vainikka."}
{"meta": {"doc_id": 2448, "sent_id": 9, "sent_start_pos": 1760, "sent_end_pos": 2221, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "The new form of protein, dubbed Solein, will be produced in a powdered form to be used similar to flour in food production. \"Disconnecting from agriculture and fossil resources in food production is our key value and differentiator to all other [proteins],\" says CEO and founder, Pasi Vainikka. While he says algae comes close, Pasi continues, \"the [production of Solein] is the most environmentally friendly\" of all protein development methods out there today."}
{"meta": {"doc_id": 2448, "sent_id": 10, "sent_start_pos": 1884, "sent_end_pos": 2343, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "\"Disconnecting from agriculture and fossil resources in food production is our key value and differentiator to all other [proteins],\" says CEO and founder, Pasi Vainikka. While he says algae comes close, Pasi continues, \"the [production of Solein] is the most environmentally friendly\" of all protein development methods out there today. And Solar Foods is not the only company using fermentation to develop proteins that can be consumed by humans or animals."}
{"meta": {"doc_id": 2448, "sent_id": 11, "sent_start_pos": 2055, "sent_end_pos": 2534, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "While he says algae comes close, Pasi continues, \"the [production of Solein] is the most environmentally friendly\" of all protein development methods out there today. And Solar Foods is not the only company using fermentation to develop proteins that can be consumed by humans or animals. Recently, NovoNutrients also highlighted the use of gas-based fermentation to produce nutrients for fish feed, a commodity product that's a huge cost for scaling farm-raised fish production."}
{"meta": {"doc_id": 2448, "sent_id": 12, "sent_start_pos": 2222, "sent_end_pos": 2769, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "And Solar Foods is not the only company using fermentation to develop proteins that can be consumed by humans or animals. Recently, NovoNutrients also highlighted the use of gas-based fermentation to produce nutrients for fish feed, a commodity product that's a huge cost for scaling farm-raised fish production. With fermentation-derived proteins, NovoNutrients hopes to cut the cost and provide a better product to an aquaculture sector that needs to scale with the worldwide demand for more protein (and other essential nutrients) from the sea."}
{"meta": {"doc_id": 2448, "sent_id": 13, "sent_start_pos": 2344, "sent_end_pos": 3026, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "Recently, NovoNutrients also highlighted the use of gas-based fermentation to produce nutrients for fish feed, a commodity product that's a huge cost for scaling farm-raised fish production. With fermentation-derived proteins, NovoNutrients hopes to cut the cost and provide a better product to an aquaculture sector that needs to scale with the worldwide demand for more protein (and other essential nutrients) from the sea. And at many other startups, entrepreneurs are working on fermentation-based protein development that looks more akin to our long history of brewing, bread-making and wine-making, the natural process of using organisms to convert one substance into another."}
{"meta": {"doc_id": 2448, "sent_id": 14, "sent_start_pos": 2535, "sent_end_pos": 3127, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "With fermentation-derived proteins, NovoNutrients hopes to cut the cost and provide a better product to an aquaculture sector that needs to scale with the worldwide demand for more protein (and other essential nutrients) from the sea. And at many other startups, entrepreneurs are working on fermentation-based protein development that looks more akin to our long history of brewing, bread-making and wine-making, the natural process of using organisms to convert one substance into another. In the case of wine, yeasts break down sugars into alcohol, giving us the magical elixir we so love."}
{"meta": {"doc_id": 2448, "sent_id": 15, "sent_start_pos": 2770, "sent_end_pos": 3250, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "And at many other startups, entrepreneurs are working on fermentation-based protein development that looks more akin to our long history of brewing, bread-making and wine-making, the natural process of using organisms to convert one substance into another. In the case of wine, yeasts break down sugars into alcohol, giving us the magical elixir we so love. Leveraging this ancient science, startups like Geltor and Perfect Day have grown collagen and dairy proteins respectively."}
{"meta": {"doc_id": 2448, "sent_id": 16, "sent_start_pos": 3027, "sent_end_pos": 3526, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "In the case of wine, yeasts break down sugars into alcohol, giving us the magical elixir we so love. Leveraging this ancient science, startups like Geltor and Perfect Day have grown collagen and dairy proteins respectively. And Motif Ingredients, a well-funded spin off from Ginko Bioworks, has also announced they'll be using fermentation to \"brew vital proteins and nutrients that power your body and please your palate.\""}
{"meta": {"doc_id": 2448, "sent_id": 17, "sent_start_pos": 3128, "sent_end_pos": 3764, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "Leveraging this ancient science, startups like Geltor and Perfect Day have grown collagen and dairy proteins respectively. And Motif Ingredients, a well-funded spin off from Ginko Bioworks, has also announced they'll be using fermentation to \"brew vital proteins and nutrients that power your body and please your palate.\" These biotech startups have raised tens of millions of dollars to scale the production of their products in the last several years, and products from Geltor and Perfect Day, using their novel proteins, are just hitting markets this year."}
{"meta": {"doc_id": 2448, "sent_id": 18, "sent_start_pos": 3327, "sent_end_pos": 3984, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "And Motif Ingredients, a well-funded spin off from Ginko Bioworks, has also announced they'll be using fermentation to \"brew vital proteins and nutrients that power your body and please your palate.\" These biotech startups have raised tens of millions of dollars to scale the production of their products in the last several years, and products from Geltor and Perfect Day, using their novel proteins, are just hitting markets this year. Rob Rhinehart, the founder of Soylent and now an early-stage biotech investor through Mars Bio VC, highlights why investors are so interested in this space: \"We need to develop safer and more efficient forms of protein."}
{"meta": {"doc_id": 2448, "sent_id": 19, "sent_start_pos": 3527, "sent_end_pos": 4192, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "These biotech startups have raised tens of millions of dollars to scale the production of their products in the last several years, and products from Geltor and Perfect Day, using their novel proteins, are just hitting markets this year. Rob Rhinehart, the founder of Soylent and now an early-stage biotech investor through Mars Bio VC, highlights why investors are so interested in this space: \"We need to develop safer and more efficient forms of protein. The best way to do this is to use biological tools such as single-celled organisms that can be engineered much more quickly and precisely than a whole plant or animal and produce the same product or better.\""}
{"meta": {"doc_id": 2448, "sent_id": 20, "sent_start_pos": 3765, "sent_end_pos": 4334, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "Rob Rhinehart, the founder of Soylent and now an early-stage biotech investor through Mars Bio VC, highlights why investors are so interested in this space: \"We need to develop safer and more efficient forms of protein. The best way to do this is to use biological tools such as single-celled organisms that can be engineered much more quickly and precisely than a whole plant or animal and produce the same product or better.\" Solar Foods is still early in their production and are working with food companies to make use of their protein \"flour\" in new food products."}
{"meta": {"doc_id": 2448, "sent_id": 21, "sent_start_pos": 3985, "sent_end_pos": 4451, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "The best way to do this is to use biological tools such as single-celled organisms that can be engineered much more quickly and precisely than a whole plant or animal and produce the same product or better.\" Solar Foods is still early in their production and are working with food companies to make use of their protein \"flour\" in new food products. They will be raising more funding through 2019 to scale up production and bring first generation products to market."}
{"meta": {"doc_id": 2448, "sent_id": 22, "sent_start_pos": 4193, "sent_end_pos": 4669, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "Solar Foods is still early in their production and are working with food companies to make use of their protein \"flour\" in new food products. They will be raising more funding through 2019 to scale up production and bring first generation products to market. Gas-based fermentation holds a lot of promise, given it is a method that consumes industrial waste, like carbon dioxide, which helps remove this pollutant from the atmosphere as a side-benefit of using this technique."}
{"meta": {"doc_id": 2448, "sent_id": 23, "sent_start_pos": 4335, "sent_end_pos": 4923, "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "They will be raising more funding through 2019 to scale up production and bring first generation products to market. Gas-based fermentation holds a lot of promise, given it is a method that consumes industrial waste, like carbon dioxide, which helps remove this pollutant from the atmosphere as a side-benefit of using this technique. And as entrepreneurs, investors and food manufacturers get excited by fermentation (in general) as a method to create proteins, the world will gain more of this essential nutrient leveraging methods that will use less of our precious, natural resources."}
{"meta": {"doc_id": 2448, "sent_id": 24, "sent_start_pos": 4452, "sent_end_pos": [], "title": "Making Protein From Thin Air? Yes, Startups Are Doing It."}, "text": "Gas-based fermentation holds a lot of promise, given it is a method that consumes industrial waste, like carbon dioxide, which helps remove this pollutant from the atmosphere as a side-benefit of using this technique. And as entrepreneurs, investors and food manufacturers get excited by fermentation (in general) as a method to create proteins, the world will gain more of this essential nutrient leveraging methods that will use less of our precious, natural resources. "}
